Citrus Sinensis ID: 015816
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 399 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.832 | 0.728 | 0.702 | 1e-139 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.967 | 0.912 | 0.577 | 1e-136 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.754 | 0.727 | 0.681 | 1e-124 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.781 | 0.732 | 0.513 | 5e-90 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.729 | 0.683 | 0.537 | 1e-87 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.719 | 0.582 | 0.541 | 2e-87 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.711 | 0.692 | 0.556 | 7e-86 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.766 | 0.786 | 0.490 | 1e-84 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.729 | 0.593 | 0.528 | 3e-84 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.819 | 0.801 | 0.482 | 7e-84 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 496 bits (1276), Expect = e-139, Method: Compositional matrix adjust.
Identities = 236/336 (70%), Positives = 271/336 (80%), Gaps = 4/336 (1%)
Query: 56 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
QI A T FRELAAAT NF ++ LGEGGFGRVYKG L+S Q VA+KQLDRNG+QGNRE
Sbjct: 68 QIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNRE 127
Query: 116 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 175
FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+MPLGS+EDHLHDL P K+ LDWN R
Sbjct: 128 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMR 187
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
MKIAAGAA+GLE+LHDKA PPVIYRD K SNILLD G+HPKLSDFGLAKLGP GD +HVS
Sbjct: 188 MKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVS 247
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 295
TRVMGTYGYCAPEYA TGQLT+KSDVYSFGVV LE+++GRKA+D+ EQ+LVAWARP
Sbjct: 248 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARP 307
Query: 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355
LF DR + +ADP L+G++P R YQALAVA+MC+ EQ RP+IADVVTAL+YLA+Q
Sbjct: 308 LFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQA 367
Query: 356 YESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSE 391
Y+ + + + G T+ D GG GS+
Sbjct: 368 YDPSKDDSRRNRDERGARLITRNDD----GGGSGSK 399
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1250), Expect = e-136, Method: Compositional matrix adjust.
Identities = 247/428 (57%), Positives = 294/428 (68%), Gaps = 42/428 (9%)
Query: 1 MGWFPCSGDSFRKAKNKKKMKMQQKTLDRINSI-------------PDKLKMNSSLRVKE 47
MG F CS S ++++ K + +K + S+ D K++ V
Sbjct: 1 MGCFGCSKKSSKRSETNKDTVINRKIVGGTTSVAKSDKRDDQTQPSSDSTKVSPYRDVNN 60
Query: 48 ASEDGASDQIT----------------AQTLTFRELAAATKNFRSESLLGEGGFGRVYKG 91
G DQ++ AQT TF+ELA AT NFRS+ LGEGGFG+V+KG
Sbjct: 61 EGGVGKEDQLSLDVKGLNLNDQVTGKKAQTFTFQELAEATGNFRSDCFLGEGGFGKVFKG 120
Query: 92 YLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151
+E ++Q VAIKQLDRNGVQG REF+VEVL LSL HPNLV LIG+CA+GDQRLLVYEYM
Sbjct: 121 TIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYM 180
Query: 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 211
P GS+EDHLH L GKKPLDWNTRMKIAAGAARGLEYLHD+ PPVIYRDLKCSNILL
Sbjct: 181 PQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGE 240
Query: 212 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 271
Y PKLSDFGLAK+GP GD THVSTRVMGTYGYCAP+YA TGQLT KSD+YSFGVVLLE+
Sbjct: 241 DYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 300
Query: 272 LSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 331
++GRKA+D +K +Q+LV WARPLF+DR + DP LQGQYP RG YQALA++AMCV
Sbjct: 301 ITGRKAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMCV 360
Query: 332 HEQPDMRPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSE 391
EQP MRPV++DVV AL +LAS KY DP +P+ + G K + R E
Sbjct: 361 QEQPTMRPVVSDVVLALNFLASSKY------------DPNSPSSSSG-KNPSFHRDRDDE 407
Query: 392 RERTRKLK 399
+R +K
Sbjct: 408 EKRPHLVK 415
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 445 bits (1144), Expect = e-124, Method: Compositional matrix adjust.
Identities = 205/301 (68%), Positives = 251/301 (83%)
Query: 53 ASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG 112
++ I AQT +FRELA ATKNFR E L+GEGGFGRVYKG LE VA+KQLDRNG+QG
Sbjct: 58 VTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQG 117
Query: 113 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 172
N+EF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYEYM GS+EDHL DL+P + PLDW
Sbjct: 118 NKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDW 177
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
+TR++IA GAA GLEYLHDKA PPVIYRDLK +NILLD ++ KLSDFGLAKLGPVGD
Sbjct: 178 DTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQ 237
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292
HVS+RVMGTYGYCAPEY +TGQLT KSDVYSFGVVLLE+++GR+ +DT++ EQ+LV W
Sbjct: 238 HVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTW 297
Query: 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352
A+P+F++ +R +ADP L+G +P + QA+AVAAMC+ E+ +RP+++DVVTAL +L
Sbjct: 298 AQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLG 357
Query: 353 S 353
+
Sbjct: 358 T 358
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (849), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 175/341 (51%), Positives = 223/341 (65%), Gaps = 29/341 (8%)
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD---------VAIKQLDRNGV 110
+ TF EL AT+NFR +SLLGEGGFG V+KG+++ VA+K+L G
Sbjct: 69 KAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGY 128
Query: 111 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
QG++E+L EV L L HPNLV L+GYC +G+ RLLVYE+MP GS+E+HL G +PL
Sbjct: 129 QGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHL--FRRGAQPL 186
Query: 171 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230
W RMK+A GAA+GL +LHD AK VIYRD K +NILLD ++ KLSDFGLAK GP GD
Sbjct: 187 TWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGD 245
Query: 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290
THVST+VMGT+GY APEY TG+LT KSDVYSFGVVLLE+LSGR+AVD SK EQSLV
Sbjct: 246 KTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLV 305
Query: 291 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350
WA P D+ + I D L GQYP +G Y A ++A C++ +RP +++V+ L
Sbjct: 306 DWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQ 365
Query: 351 LASQKYESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSE 391
L S K PGT G+++ +++ RGS
Sbjct: 366 LESTK--------------PGTGV---GNRQAQIDSPRGSN 389
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (828), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 163/303 (53%), Positives = 210/303 (69%), Gaps = 12/303 (3%)
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD---------VAIKQLDRNGV 110
+ TF EL ATKNFR ++LLGEGGFG V+KG+++ + VA+KQL G
Sbjct: 72 KAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGF 131
Query: 111 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
QG++E+L EV L L HPNLV L+GYCA+G+ RLLVYE+MP GS+E+HL G +PL
Sbjct: 132 QGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHL--FRRGAQPL 189
Query: 171 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230
W RMK+A GAA+GL +LH+ AK VIYRD K +NILLD ++ KLSDFGLAK GP GD
Sbjct: 190 TWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGD 248
Query: 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290
NTHVST+V+GT+GY APEY TG+LT KSDVYSFGVVLLE++SGR+A+D S E SLV
Sbjct: 249 NTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLV 308
Query: 291 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350
WA P D+ + I D +L GQYP +G + A +A C++ +RP +++V+ L
Sbjct: 309 DWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQ 368
Query: 351 LAS 353
L S
Sbjct: 369 LES 371
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (828), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 162/299 (54%), Positives = 206/299 (68%), Gaps = 12/299 (4%)
Query: 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLES---------INQDVAIKQLDRNGVQG 112
TF +L +T+NFR ESLLGEGGFG V+KG++E VA+K L+ +G+QG
Sbjct: 130 FTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQG 189
Query: 113 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 172
++E+L E+ L L HPNLV L+GYC + DQRLLVYE+MP GS+E+HL S PL W
Sbjct: 190 HKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPW 246
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
+ RMKIA GAA+GL +LH++A PVIYRD K SNILLD Y+ KLSDFGLAK P T
Sbjct: 247 SIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKT 306
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292
HVSTRVMGTYGY APEY TG LT KSDVYSFGVVLLE+L+GR+++D ++ E +LV W
Sbjct: 307 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 366
Query: 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351
ARP D+ R + DP L+G + +G + +AA C+ P +RP ++DVV AL L
Sbjct: 367 ARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 7e-86, Method: Compositional matrix adjust.
Identities = 163/293 (55%), Positives = 203/293 (69%), Gaps = 9/293 (3%)
Query: 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLES------INQDVAIKQLDRNGVQGNRE 115
T EL TK+FR + +LGEGGFG VYKGY++ + VA+K L++ G+QG+RE
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 116 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 175
+L EV L L HPNLV LIGYC + D RLLVYE+M GS+E+HL PL W+ R
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHL--FRKTTAPLSWSRR 174
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
M IA GAA+GL +LH+ A+ PVIYRD K SNILLD Y KLSDFGLAK GP GD THVS
Sbjct: 175 MMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 295
TRVMGTYGY APEY TG LT +SDVYSFGVVLLE+L+GRK+VD ++ + EQ+LV WARP
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293
Query: 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
D+ + I DP L+ QY R +A ++A C+ + P RP+++DVV L
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 346
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 314 bits (804), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 158/322 (49%), Positives = 216/322 (67%), Gaps = 16/322 (4%)
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD---------VAIKQLDRNGV 110
+ + EL +AT+NFR +S++GEGGFG V+KG+++ + +A+K+L++ G
Sbjct: 54 KNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGF 113
Query: 111 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
QG+RE+L E+ L L HPNLV LIGYC + + RLLVYE+M GS+E+HL +PL
Sbjct: 114 QGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPL 173
Query: 171 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230
WNTR+++A GAARGL +LH+ A+P VIYRD K SNILLD Y+ KLSDFGLA+ GP+GD
Sbjct: 174 SWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGD 232
Query: 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290
N+HVSTRVMGT GY APEY TG L++KSDVYSFGVVLLE+LSGR+A+D ++ E +LV
Sbjct: 233 NSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLV 292
Query: 291 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM---CVHEQPDMRPVIADVVTA 347
WARP ++ R + DP LQGQY +AL +A + C+ RP + ++V
Sbjct: 293 DWARPYLTNKRRLLRVMDPRLQGQY---SLTRALKIAVLALDCISIDAKSRPTMNEIVKT 349
Query: 348 LAYLASQKYESDAEKVQSPCLD 369
+ L QK S ++ +D
Sbjct: 350 MEELHIQKEASKEQQNPQISID 371
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 160/303 (52%), Positives = 205/303 (67%), Gaps = 12/303 (3%)
Query: 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLES---------INQDVAIKQLDRNGVQG 112
+F +L AT+NFR ESLLGEGGFG V+KG++E VA+K L+ +G+QG
Sbjct: 124 FSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQG 183
Query: 113 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 172
++E+L E+ L L HPNLV L+GYC + DQRLLVYE+MP GS+E+HL S PL W
Sbjct: 184 HKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPW 240
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
+ RMKIA GAA+GL +LH++A PVIYRD K SNILLD Y+ KLSDFGLAK P T
Sbjct: 241 SIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKT 300
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292
HVSTRVMGTYGY APEY TG LT KSDVYSFGVVLLE+L+GR+++D ++ E +LV W
Sbjct: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
Query: 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352
ARP D+ R + DP L+G + +G + +AA C+ +RP +++VV L L
Sbjct: 361 ARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLP 420
Query: 353 SQK 355
K
Sbjct: 421 HLK 423
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (796), Expect = 7e-84, Method: Compositional matrix adjust.
Identities = 167/346 (48%), Positives = 223/346 (64%), Gaps = 19/346 (5%)
Query: 22 MQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLG 81
++ K + + +P K LR D A++ + A T+ EL T NFR + +LG
Sbjct: 31 VEDKHIKEVQKLPSNPKEVEDLR-----RDSAANPLIA--FTYEELKNITSNFRQDRVLG 83
Query: 82 EGGFGRVYKGYLESINQD--------VAIKQLD-RNGVQGNREFLVEVLMLSLLHHPNLV 132
GGFG VYKG+++ D VA+K D N QG+RE+L EV+ L L HPNLV
Sbjct: 84 GGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHPNLV 143
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
LIGYC + + R+L+YEYM GSVE++L S PL W RMKIA GAA+GL +LH+
Sbjct: 144 KLIGYCCEDNHRVLIYEYMARGSVENNL--FSRVLLPLSWAIRMKIAFGAAKGLAFLHE- 200
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
AK PVIYRD K SNILLD Y+ KLSDFGLAK GPVGD +HVSTR+MGTYGY APEY T
Sbjct: 201 AKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMT 260
Query: 253 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 312
G LT SDVYSFGVVLLE+L+GRK++D S+ EQ+L+ WA PL +++ + I DP++
Sbjct: 261 GHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMN 320
Query: 313 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYES 358
+YP + +A +A C++ P RP++ D+V +L L + + E+
Sbjct: 321 CEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQATEEEA 366
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 399 | ||||||
| 225439781 | 396 | PREDICTED: serine/threonine-protein kina | 0.989 | 0.997 | 0.743 | 1e-172 | |
| 351721314 | 383 | protein kinase-like protein [Glycine max | 0.944 | 0.984 | 0.771 | 1e-171 | |
| 356548196 | 383 | PREDICTED: serine/threonine-protein kina | 0.944 | 0.984 | 0.768 | 1e-170 | |
| 357510543 | 377 | Serine/threonine protein kinase PBS1 [Me | 0.937 | 0.992 | 0.774 | 1e-170 | |
| 356505176 | 379 | PREDICTED: serine/threonine-protein kina | 0.939 | 0.989 | 0.767 | 1e-170 | |
| 255568454 | 389 | receptor serine-threonine protein kinase | 0.954 | 0.979 | 0.750 | 1e-169 | |
| 356572387 | 380 | PREDICTED: serine/threonine-protein kina | 0.939 | 0.986 | 0.759 | 1e-168 | |
| 224069304 | 393 | predicted protein [Populus trichocarpa] | 0.934 | 0.949 | 0.771 | 1e-167 | |
| 449440049 | 395 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.992 | 0.738 | 1e-166 | |
| 255568155 | 375 | receptor serine-threonine protein kinase | 0.932 | 0.992 | 0.763 | 1e-165 |
| >gi|225439781|ref|XP_002276042.1| PREDICTED: serine/threonine-protein kinase PBS1 [Vitis vinifera] gi|297741502|emb|CBI32634.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1575), Expect = e-172, Method: Compositional matrix adjust.
Identities = 296/398 (74%), Positives = 331/398 (83%), Gaps = 3/398 (0%)
Query: 1 MGWFPCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQ 60
MGWF CSG S + K K+K + Q ++ + +KLK N S VKEAS++G D I AQ
Sbjct: 1 MGWFLCSGKSNQATKKKRKKPVDQI---QVQTTSEKLKANPSFNVKEASKNGGPDHIAAQ 57
Query: 61 TLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV 120
T TFRELAAATKNFR E LLGEGGFGRVYKG + + NQ VAIKQLDRNG+QGNREFLVEV
Sbjct: 58 TFTFRELAAATKNFRGECLLGEGGFGRVYKGRIANTNQAVAIKQLDRNGLQGNREFLVEV 117
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLHD+S GKK LDWNTRMKIAA
Sbjct: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDVSLGKKRLDWNTRMKIAA 177
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
GAA+GLEYLHDKA PPVIYRDLKCSNILL +HPKLSDFGLAKLGPVGDNTHVSTRVMG
Sbjct: 178 GAAKGLEYLHDKASPPVIYRDLKCSNILLGEDFHPKLSDFGLAKLGPVGDNTHVSTRVMG 237
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300
TYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SKAA E +LVAWARPLF+DR
Sbjct: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEHNLVAWARPLFKDR 297
Query: 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDA 360
+ +ADP LQGQYP RG YQALAVAAMCV EQP++RP+I DVVTAL YLA+Q Y+ D
Sbjct: 298 RKFLHMADPMLQGQYPLRGLYQALAVAAMCVQEQPNLRPLIVDVVTALTYLAAQTYDPDT 357
Query: 361 EKVQSPCLDPGTPTRTKGDKERKLNGGRGSERERTRKL 398
+ VQS + P TP R K D +RKL GS+++RTR+L
Sbjct: 358 QPVQSSRVAPSTPPRAKKDGDRKLPSSAGSQKDRTRRL 395
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721314|ref|NP_001237717.1| protein kinase-like protein [Glycine max] gi|223452496|gb|ACM89575.1| protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1562), Expect = e-171, Method: Compositional matrix adjust.
Identities = 293/380 (77%), Positives = 326/380 (85%), Gaps = 3/380 (0%)
Query: 1 MGWFPCSGDS---FRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQI 57
MGW PCSG S + K +KM+ Q +D I + P KLK NSS+ KE+S++G + I
Sbjct: 1 MGWIPCSGSSNSKKKLKKKLEKMEAQNSLVDPIKATPGKLKRNSSMNSKESSKNGNPEHI 60
Query: 58 TAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL 117
AQT +FRELA AT+NF++E LLGEGGFGRVYKG LE+INQ VAIKQLDRNG+QGNREFL
Sbjct: 61 AAQTFSFRELATATRNFKAECLLGEGGFGRVYKGRLENINQIVAIKQLDRNGLQGNREFL 120
Query: 118 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 177
VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+M LGS+EDHLHD+SPGKK LDWNTRMK
Sbjct: 121 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSLGSLEDHLHDISPGKKELDWNTRMK 180
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237
IAAGAARGLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVG+NTHVSTR
Sbjct: 181 IAAGAARGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTR 240
Query: 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 297
VMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SKAA EQ+LVAWARPLF
Sbjct: 241 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEQNLVAWARPLF 300
Query: 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 357
+DR + S +ADP LQGQYP RG YQALAVAAMCV EQ +MRPVIADVVTAL+YLA QKY+
Sbjct: 301 KDRRKFSQMADPMLQGQYPSRGLYQALAVAAMCVQEQANMRPVIADVVTALSYLALQKYD 360
Query: 358 SDAEKVQSPCLDPGTPTRTK 377
+ + VQS L PGTP R+K
Sbjct: 361 PNTQTVQSSRLAPGTPPRSK 380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356548196|ref|XP_003542489.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1559), Expect = e-170, Method: Compositional matrix adjust.
Identities = 292/380 (76%), Positives = 326/380 (85%), Gaps = 3/380 (0%)
Query: 1 MGWFPCSGDS---FRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQI 57
MGW PCSG S + K +KM+ Q +D I + P KLK N S+ K +S++G + I
Sbjct: 1 MGWIPCSGSSNTKKKLKKKLEKMEGQSSLVDPIKATPGKLKRNPSMNSKNSSKNGNPEHI 60
Query: 58 TAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL 117
AQT +FRELA AT+NFR+E LLGEGGFGRVYKG LE+INQ VAIKQLDRNG+QGNREFL
Sbjct: 61 AAQTFSFRELATATRNFRAECLLGEGGFGRVYKGRLENINQIVAIKQLDRNGLQGNREFL 120
Query: 118 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 177
VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+M LGS+EDHLHD+SPGKK LDWNTRMK
Sbjct: 121 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSLGSLEDHLHDISPGKKRLDWNTRMK 180
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237
IAAGAARGLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVG+NTHVSTR
Sbjct: 181 IAAGAARGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTR 240
Query: 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 297
VMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SKAA EQ+LVAWARPLF
Sbjct: 241 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEQNLVAWARPLF 300
Query: 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 357
+DR + S +ADP LQGQYPPRG +QALAVAAMCV EQ +MRPVIADVVTAL+YLASQKY+
Sbjct: 301 KDRRKFSQMADPMLQGQYPPRGLFQALAVAAMCVQEQANMRPVIADVVTALSYLASQKYD 360
Query: 358 SDAEKVQSPCLDPGTPTRTK 377
+ + +QS L PGTP R+K
Sbjct: 361 PNTQTLQSSRLAPGTPPRSK 380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510543|ref|XP_003625560.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] gi|355500575|gb|AES81778.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1559), Expect = e-170, Method: Compositional matrix adjust.
Identities = 292/377 (77%), Positives = 325/377 (86%), Gaps = 3/377 (0%)
Query: 1 MGWFPCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQ 60
MGW PCSG+S K K KM++Q +I + P KLK NSS K+ S++G+++ I AQ
Sbjct: 1 MGWIPCSGNSGTK-KKIVKMEVQDSVAPQIKATPGKLKRNSSTNSKDTSKNGSTEHIAAQ 59
Query: 61 TLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV 120
T +FRELA AT+NFR+E LLGEGGFGRVYKG+LESINQ VAIKQLDRNG+QGNREFLVEV
Sbjct: 60 TFSFRELATATRNFRAECLLGEGGFGRVYKGHLESINQVVAIKQLDRNGLQGNREFLVEV 119
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG +EDHLHD+SP KK LDWNTRMKIAA
Sbjct: 120 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDHLHDISPAKKRLDWNTRMKIAA 179
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
GAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVG+NTHVSTRVMG
Sbjct: 180 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTRVMG 239
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300
TYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SK+AAEQ+LVAWARPLF+DR
Sbjct: 240 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDYSKSAAEQNLVAWARPLFKDR 299
Query: 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDA 360
+ S +ADP LQGQYP RG YQALAVAAMCV EQ +MRPVIADVVTAL+YLA QK+ D
Sbjct: 300 RKFSQMADPMLQGQYPSRGLYQALAVAAMCVQEQANMRPVIADVVTALSYLALQKH--DP 357
Query: 361 EKVQSPCLDPGTPTRTK 377
VQ+ L P TPTRT+
Sbjct: 358 NTVQNSRLAPSTPTRTR 374
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505176|ref|XP_003521368.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 602 bits (1553), Expect = e-170, Method: Compositional matrix adjust.
Identities = 290/378 (76%), Positives = 323/378 (85%), Gaps = 3/378 (0%)
Query: 1 MGWFPCSGDSFRKAKNK-KKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITA 59
MGW PCSG + KNK +KM++Q + +I + P KLK NSS + K+ S++G D I A
Sbjct: 1 MGWIPCSG--YSGTKNKVEKMEVQDSLVGQIKATPGKLKRNSSTKSKDTSKNGNPDHIAA 58
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVE 119
QT FRELA AT+NFR++ LLGEGGFGRVYKG LESINQ VAIKQLDRNG+QGNREFLVE
Sbjct: 59 QTFAFRELATATRNFRNDCLLGEGGFGRVYKGRLESINQVVAIKQLDRNGLQGNREFLVE 118
Query: 120 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG +EDHLHD+ PGKK LDWNTRMKIA
Sbjct: 119 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDHLHDIPPGKKRLDWNTRMKIA 178
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
AGAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVG+NTHVSTRVM
Sbjct: 179 AGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTRVM 238
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299
GTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SK+A EQ+LVAWARPLF+D
Sbjct: 239 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKSAGEQNLVAWARPLFKD 298
Query: 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESD 359
R + S +ADP L GQYPPRG YQALAVAAMCV EQ ++RPVIADVVTAL+YLASQKY+ +
Sbjct: 299 RRKFSQMADPTLHGQYPPRGLYQALAVAAMCVQEQANLRPVIADVVTALSYLASQKYDPN 358
Query: 360 AEKVQSPCLDPGTPTRTK 377
VQS P TP RT+
Sbjct: 359 THTVQSSRHAPSTPPRTR 376
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568454|ref|XP_002525201.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223535498|gb|EEF37167.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 602 bits (1551), Expect = e-169, Method: Compositional matrix adjust.
Identities = 289/385 (75%), Positives = 325/385 (84%), Gaps = 4/385 (1%)
Query: 1 MGWFPCSGDSFRKA--KNKKK-MKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQI 57
MGW PCSG S + KNKKK + + ++D+ +KL+ +S VK A + G SD I
Sbjct: 1 MGWIPCSGISRANSTTKNKKKVIIINHNSVDQTKPTSEKLRSHSRTSVKAAPKHGGSDNI 60
Query: 58 TAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL 117
TAQT TF EL A KNFR+E LGEGGFGRVYKGYLES NQ VAIKQL+RNG+QGNREFL
Sbjct: 61 TAQTFTFSELVTAAKNFRAECFLGEGGFGRVYKGYLESTNQVVAIKQLNRNGLQGNREFL 120
Query: 118 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 177
VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHL+++SPG K LDWNTRMK
Sbjct: 121 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLYEISPGVKTLDWNTRMK 180
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237
IAAGAA+GLEYLHDKA PPVIYRDLKCSNILL +GYHPKLSDFGLAKLGPVGDNTHVSTR
Sbjct: 181 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGQGYHPKLSDFGLAKLGPVGDNTHVSTR 240
Query: 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 297
VMGTYGYCAPEYA TGQLTLKSDVYS GVVLLEI++GR+A+D SKA EQ+LVAWARPLF
Sbjct: 241 VMGTYGYCAPEYAMTGQLTLKSDVYSLGVVLLEIITGRRAIDNSKATGEQNLVAWARPLF 300
Query: 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 357
+DR + L+ADP LQGQYPPRG YQALA+AAMCV EQP++RPVIADVVTAL+YLASQKY+
Sbjct: 301 KDRKKFKLMADPMLQGQYPPRGLYQALAIAAMCVQEQPNLRPVIADVVTALSYLASQKYD 360
Query: 358 SDAEKVQSPCLDPGTPTRTKGDKER 382
+ + QSP PGTP RTK + +R
Sbjct: 361 PEVQTAQSPRWTPGTP-RTKREAKR 384
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356572387|ref|XP_003554350.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 597 bits (1538), Expect = e-168, Method: Compositional matrix adjust.
Identities = 288/379 (75%), Positives = 322/379 (84%), Gaps = 4/379 (1%)
Query: 1 MGWFPCSGDSFRKAKNK-KKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITA 59
MGW PCSG + KNK +KM+ Q + +I + KLK NSS + K+ S++G D I A
Sbjct: 1 MGWIPCSG--YSGTKNKVEKMEAQDSLVGQIKATTGKLKRNSSTKSKDTSKNGNPDHIAA 58
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVE 119
QT +FRELA AT+NFR+E LLGEGGFGRVYKG LESINQ VAIKQLDRNG+QGNREFLVE
Sbjct: 59 QTFSFRELATATRNFRAECLLGEGGFGRVYKGRLESINQVVAIKQLDRNGLQGNREFLVE 118
Query: 120 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG +EDHLHD+ PGKK LDWNTRMKIA
Sbjct: 119 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDHLHDIPPGKKQLDWNTRMKIA 178
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
AGAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVG+NTHVSTRVM
Sbjct: 179 AGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTRVM 238
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299
GTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SK+A EQ+LVAWARPLF+D
Sbjct: 239 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKSAGEQNLVAWARPLFKD 298
Query: 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESD 359
R + S +ADP LQGQYPPRG YQ +AVAAMCV EQ +MRPVIADVVTAL+YLASQ+Y+ +
Sbjct: 299 RRKFSQMADPTLQGQYPPRGLYQVIAVAAMCVQEQANMRPVIADVVTALSYLASQRYDPN 358
Query: 360 AEKV-QSPCLDPGTPTRTK 377
+ QS PGTP R +
Sbjct: 359 TQHTGQSSRHAPGTPPRNR 377
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224069304|ref|XP_002326325.1| predicted protein [Populus trichocarpa] gi|222833518|gb|EEE71995.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1535), Expect = e-167, Method: Compositional matrix adjust.
Identities = 294/381 (77%), Positives = 322/381 (84%), Gaps = 8/381 (2%)
Query: 1 MGWFPCSGDSFRKAKNKK--------KMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDG 52
M W PCSG S R KNKK ++ + QK LD+ + P++L+ + LRVK S++G
Sbjct: 1 MEWIPCSGISKRATKNKKNNDNNNKNRVIVNQKPLDQTKTSPERLRNDYPLRVKGESKNG 60
Query: 53 ASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG 112
SD TAQT TFRELA ATKNFR+E LLGEGGFGRVYKGYLES NQ VAIKQL+RNG+QG
Sbjct: 61 GSDSTTAQTFTFRELAFATKNFRAECLLGEGGFGRVYKGYLESTNQVVAIKQLNRNGLQG 120
Query: 113 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 172
NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLH++ PGK LDW
Sbjct: 121 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHEVPPGKNWLDW 180
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
NTRMKIAAGAA+GLE+LHDKA PPVIYRDLKCSNILLD YHPKLSDFGLAKLGPVGDNT
Sbjct: 181 NTRMKIAAGAAKGLEHLHDKASPPVIYRDLKCSNILLDESYHPKLSDFGLAKLGPVGDNT 240
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292
HVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SKA EQ+LVAW
Sbjct: 241 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKATGEQNLVAW 300
Query: 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352
ARPLF+DR + S IADP LQGQYPPRG YQALAVAAMCV EQP+MRPVIADVVTAL YLA
Sbjct: 301 ARPLFKDRKKFSDIADPMLQGQYPPRGLYQALAVAAMCVQEQPNMRPVIADVVTALTYLA 360
Query: 353 SQKYESDAEKVQSPCLDPGTP 373
SQKY+ DAE Q P +P
Sbjct: 361 SQKYDPDAETGQRSRYPPASP 381
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440049|ref|XP_004137797.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] gi|449519164|ref|XP_004166605.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1519), Expect = e-166, Method: Compositional matrix adjust.
Identities = 296/401 (73%), Positives = 336/401 (83%), Gaps = 9/401 (2%)
Query: 1 MGWFPCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQ 60
M W PCSG+S RK K+KK K++ + R++ I KLK SS E S+ G S+ I AQ
Sbjct: 1 MIWIPCSGNSNRKLKSKKLNKLESQN-TRVDLINGKLKTISSF--SETSKGGGSEPIKAQ 57
Query: 61 TLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV 120
+FRELAAAT+NFR++ LLGEGGFGRVYKG LESINQ VAIKQLDRNG+QGNREFLVEV
Sbjct: 58 IFSFRELAAATRNFRADCLLGEGGFGRVYKGKLESINQVVAIKQLDRNGLQGNREFLVEV 117
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
LMLSLLHHPNLVNLIGYCADGDQRLL+YEYMPLGS++DHLHD+SPG K +DWNTRM+IAA
Sbjct: 118 LMLSLLHHPNLVNLIGYCADGDQRLLIYEYMPLGSLDDHLHDISPGTKFIDWNTRMRIAA 177
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
GAARGLEYLHDKA PPVIYRDLK SNILLD+GYHPKLSDFGLAKLGPVGDNTHVSTRVMG
Sbjct: 178 GAARGLEYLHDKASPPVIYRDLKSSNILLDKGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 237
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300
TYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SKAA EQ+LV+WARPLF+DR
Sbjct: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDDSKAAGEQNLVSWARPLFKDR 297
Query: 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDA 360
R + +ADP L+GQYP RG YQALA+AAMCV EQP+MRPVIADVVTAL+YLASQ+Y+
Sbjct: 298 LRFAQMADPMLRGQYPSRGLYQALAIAAMCVQEQPNMRPVIADVVTALSYLASQRYD--- 354
Query: 361 EKVQSPCLDPG---TPTRTKGDKERKLNGGRGSERERTRKL 398
+ P PG TP R D +RKLNGGR +R T++L
Sbjct: 355 PGIILPNDSPGSAYTPPRANRDSDRKLNGGRRYDRNPTKRL 395
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568155|ref|XP_002525053.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223535634|gb|EEF37300.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1516), Expect = e-165, Method: Compositional matrix adjust.
Identities = 288/377 (76%), Positives = 319/377 (84%), Gaps = 5/377 (1%)
Query: 1 MGWFPCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQ 60
MGWFPC+G K+ N K K++++ D+I S DK K + +L VKE S+DG SD I A
Sbjct: 1 MGWFPCAG----KSSNDAKKKLKKRPDDQIPSSSDKTKPSLALDVKETSKDGGSDHIAAH 56
Query: 61 TLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV 120
T TFRELAAATKNFR++ LLGEGGFGRVYKG LES +Q VAIKQLDRNG+QGNREFLVEV
Sbjct: 57 TFTFRELAAATKNFRADCLLGEGGFGRVYKGRLESTSQVVAIKQLDRNGLQGNREFLVEV 116
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLHDL P KK LDWNTRMKIAA
Sbjct: 117 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWNTRMKIAA 176
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
GAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVGD THVSTRVMG
Sbjct: 177 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG 236
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300
TYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D S+AA E +LVAWARPLF+DR
Sbjct: 237 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSRAAGEHNLVAWARPLFKDR 296
Query: 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDA 360
+ +ADP LQGQYP RG YQALAVAAMCV EQP+MRP+IADVVTAL YLASQKY+ +
Sbjct: 297 RKFPQMADPLLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLASQKYDPET 356
Query: 361 EKVQSPCLDPGTPTRTK 377
+ +Q TP RT+
Sbjct: 357 QPIQGSRTGISTP-RTR 372
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 399 | ||||||
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.937 | 0.989 | 0.730 | 2.5e-145 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.964 | 0.750 | 0.673 | 4e-136 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.899 | 0.787 | 0.664 | 1.3e-125 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.832 | 0.783 | 0.674 | 3.2e-120 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.814 | 0.895 | 0.680 | 4.2e-118 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.817 | 0.844 | 0.673 | 2.7e-116 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.771 | 0.743 | 0.673 | 9.7e-112 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.791 | 0.829 | 0.654 | 8.7e-111 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.804 | 0.825 | 0.617 | 6.3e-108 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.771 | 0.791 | 0.623 | 1.4e-103 |
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1420 (504.9 bits), Expect = 2.5e-145, P = 2.5e-145
Identities = 277/379 (73%), Positives = 308/379 (81%)
Query: 1 MGWFPCSGDSF--RXXXXXXXXXXXXXTLDRINSIPDKLKMNSSLRVKEASEDGASDQIT 58
MGW PCSG S + D S +K + SSL E+ G SD I
Sbjct: 1 MGWIPCSGKSSGRNKTRRNGDHKLDRKSSDCSVSTSEKSRAKSSL--SESKSKG-SDHIV 57
Query: 59 AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV 118
AQT TF ELA AT+NFR E L+GEGGFGRVYKGYL S +Q AIKQLD NG+QGNREFLV
Sbjct: 58 AQTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFLV 117
Query: 119 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLHD+SPGK+PLDWNTRMKI
Sbjct: 118 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMKI 177
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
AAGAA+GLEYLHDK PPVIYRDLKCSNILLD Y PKLSDFGLAKLGPVGD +HVSTRV
Sbjct: 178 AAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRV 237
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 298
MGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D+S++ EQ+LVAWARPLF+
Sbjct: 238 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPLFK 297
Query: 299 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYES 358
DR + S +ADP LQGQYPPRG YQALAVAAMCV EQP++RP+IADVVTAL+YLASQK++
Sbjct: 298 DRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALSYLASQKFDP 357
Query: 359 DAEKVQSPCLDPGTPTRTK 377
A+ VQ PGTP R+K
Sbjct: 358 LAQPVQGSLFAPGTPPRSK 376
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1315 (468.0 bits), Expect = 4.0e-136, Sum P(2) = 4.0e-136
Identities = 266/395 (67%), Positives = 299/395 (75%)
Query: 2 GWFPCSGDSFRXXXXXXXXXXXXXTLD----RINSIP-DKLKMNSSLRVKE---ASEDGA 53
G PC G S + D + + I DK K K+ A ++G
Sbjct: 3 GCLPCFGSSAKDAASKDSVKKELSAKDGSVTQSHHISLDKSKSRRGPEQKKELTAPKEGP 62
Query: 54 SDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN 113
+ I AQT TFRELAAATKNFR E LLGEGGFGRVYKG LE+ Q VA+KQLDRNG+QGN
Sbjct: 63 TAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDRNGLQGN 122
Query: 114 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 173
REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLHDL P K+PLDW+
Sbjct: 123 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLDWS 182
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
TRM IAAGAA+GLEYLHDKA PPVIYRDLK SNILL GYHPKLSDFGLAKLGPVGD TH
Sbjct: 183 TRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDKTH 242
Query: 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 293
VSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVV LE+++GRKA+D ++A E +LVAWA
Sbjct: 243 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVAWA 302
Query: 294 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353
RPLF+DR + +ADP LQG+YP RG YQALAVAAMC+ EQ RP+I DVVTAL YLAS
Sbjct: 303 RPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 362
Query: 354 QKYESDAEKVQSPCLDPGTP-TRTKGDKERKLNGG 387
Q ++ +A Q+ G P RT+ D+ R L G
Sbjct: 363 QTFDPNAPSGQNSRSGSGPPFIRTRDDR-RSLGDG 396
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1234 (439.4 bits), Expect = 1.3e-125, P = 1.3e-125
Identities = 246/370 (66%), Positives = 285/370 (77%)
Query: 28 DRINSIP---DKL--KMNS-SLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLG 81
+ I+ +P +KL K N S R DG QI A T FRELAAAT NF ++ LG
Sbjct: 35 NNISGLPSGGEKLSSKTNGGSKRELLLPRDGLG-QIAAHTFAFRELAAATMNFHPDTFLG 93
Query: 82 EGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141
EGGFGRVYKG L+S Q VA+KQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADG
Sbjct: 94 EGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG 153
Query: 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 201
DQRLLVYE+MPLGS+EDHLHDL P K+ LDWN RMKIAAGAA+GLE+LHDKA PPVIYRD
Sbjct: 154 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRD 213
Query: 202 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 261
K SNILLD G+HPKLSDFGLAKLGP GD +HVSTRVMGTYGYCAPEYA TGQLT+KSDV
Sbjct: 214 FKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDV 273
Query: 262 YSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 321
YSFGVV LE+++GRKA+D+ EQ+LVAWARPLF DR + +ADP L+G++P R Y
Sbjct: 274 YSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALY 333
Query: 322 QALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKE 381
QALAVA+MC+ EQ RP+IADVVTAL+YLA+Q Y+ + + + G T+ D
Sbjct: 334 QALAVASMCIQEQAATRPLIADVVTALSYLANQAYDPSKDDSRRNRDERGARLITRNDD- 392
Query: 382 RKLNGGRGSE 391
GG GS+
Sbjct: 393 ---GGGSGSK 399
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1183 (421.5 bits), Expect = 3.2e-120, P = 3.2e-120
Identities = 230/341 (67%), Positives = 264/341 (77%)
Query: 47 EASEDGASDQIT---AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIK 103
+A + D++ AQT TF EL+ +T NF+S+ LGEGGFG+VYKG++E INQ VAIK
Sbjct: 68 DAKDTNVEDEVIVKKAQTFTFEELSVSTGNFKSDCFLGEGGFGKVYKGFIEKINQVVAIK 127
Query: 104 QLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL 163
QLDRNG QG REF+VEVL LSL HPNLV LIG+CA+G QRLLVYEYMPLGS+++HLHDL
Sbjct: 128 QLDRNGAQGIREFVVEVLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLGSLDNHLHDL 187
Query: 164 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223
GK PL WNTRMKIAAGAARGLEYLHD KPPVIYRDLKCSNIL+D GYH KLSDFGLA
Sbjct: 188 PSGKNPLAWNTRMKIAAGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYHAKLSDFGLA 247
Query: 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283
K+GP G THVSTRVMGTYGYCAP+YA TGQLT KSDVYSFGVVLLE+++GRKA D ++
Sbjct: 248 KVGPRGSETHVSTRVMGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITGRKAYDNTRT 307
Query: 284 AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 343
QSLV WA PLF+DR + DP L+G YP RG YQALA+AAMCV EQP MRPVIAD
Sbjct: 308 RNHQSLVEWANPLFKDRKNFKKMVDPLLEGDYPVRGLYQALAIAAMCVQEQPSMRPVIAD 367
Query: 344 VVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKERKL 384
VV AL +LAS KY+ + Q T TK D+E+ L
Sbjct: 368 VVMALDHLASSKYDRSHRQKQD------NVTETKVDEEKTL 402
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1163 (414.5 bits), Expect = 4.2e-118, P = 4.2e-118
Identities = 222/326 (68%), Positives = 266/326 (81%)
Query: 34 PDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYL 93
P+ K + V + +G S+ + A+ TFRELA ATKNFR E L+GEGGFGRVYKG L
Sbjct: 8 PNSPKRTTG-EVVAKNANGPSNNMGARIFTFRELATATKNFRQECLIGEGGFGRVYKGKL 66
Query: 94 ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153
E+ Q VA+KQLDRNG+QG REFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEYMPL
Sbjct: 67 ENPAQVVAVKQLDRNGLQGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPL 126
Query: 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213
GS+EDHL DL PG+KPLDWNTR+KIA GAA+G+EYLHD+A PPVIYRDLK SNILLD Y
Sbjct: 127 GSLEDHLLDLEPGQKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEY 186
Query: 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
KLSDFGLAKLGPVGD HVS+RVMGTYGYCAPEY +TG LT KSDVYSFGVVLLE++S
Sbjct: 187 VAKLSDFGLAKLGPVGDTLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELIS 246
Query: 274 GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 333
GR+ +DT + + EQ+LV WA P+F+D TR+ +ADP L+G YP + QA+AVAAMC+HE
Sbjct: 247 GRRVIDTMRPSHEQNLVTWALPIFRDPTRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHE 306
Query: 334 QPDMRPVIADVVTALAYLASQKYESD 359
+P +RP+++DV+TAL++L + S+
Sbjct: 307 EPTVRPLMSDVITALSFLGASSNSSN 332
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1146 (408.5 bits), Expect = 2.7e-116, P = 2.7e-116
Identities = 223/331 (67%), Positives = 266/331 (80%)
Query: 38 KMNSSLRVKEASEDGAS---DQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLE 94
K +SS R + SE+ A I+A TFREL ATKNF ++ LGEGGFGRVYKG +E
Sbjct: 44 KTDSSRR-RYISEEIAKLGKGNISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIE 102
Query: 95 SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154
+ Q VA+KQLDRNG QGNREFLVEV+MLSLLHH NLVNL+GYCADGDQR+LVYEYM G
Sbjct: 103 TPEQVVAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNG 162
Query: 155 SVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213
S+EDHL +L+ KK PLDW+TRMK+AAGAARGLEYLH+ A PPVIYRD K SNILLD +
Sbjct: 163 SLEDHLLELARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEF 222
Query: 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+PKLSDFGLAK+GP G THVSTRVMGTYGYCAPEYA TGQLT+KSDVYSFGVV LE+++
Sbjct: 223 NPKLSDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMIT 282
Query: 274 GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 333
GR+ +DT+K EQ+LV WA PLF+DR + +L+ADP L+G+YP +G YQALAVAAMC+ E
Sbjct: 283 GRRVIDTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQE 342
Query: 334 QPDMRPVIADVVTALAYLASQKYESDAEKVQ 364
+ RP+++DVVTAL YLA K E D + V+
Sbjct: 343 EAATRPMMSDVVTALEYLAVTKTEEDGQTVE 373
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1103 (393.3 bits), Expect = 9.7e-112, P = 9.7e-112
Identities = 208/309 (67%), Positives = 254/309 (82%)
Query: 46 KEASEDG-ASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQ 104
K ED ++ I AQT +FRELA ATKNFR E L+GEGGFGRVYKG LE VA+KQ
Sbjct: 50 KNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQ 109
Query: 105 LDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 164
LDRNG+QGN+EF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYEYM GS+EDHL DL+
Sbjct: 110 LDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLT 169
Query: 165 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224
P + PLDW+TR++IA GAA GLEYLHDKA PPVIYRDLK +NILLD ++ KLSDFGLAK
Sbjct: 170 PDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAK 229
Query: 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284
LGPVGD HVS+RVMGTYGYCAPEY +TGQLT KSDVYSFGVVLLE+++GR+ +DT++
Sbjct: 230 LGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPK 289
Query: 285 AEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
EQ+LV WA+P+F++ +R +ADP L+G +P + QA+AVAAMC+ E+ +RP+++DV
Sbjct: 290 DEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDV 349
Query: 345 VTALAYLAS 353
VTAL +L +
Sbjct: 350 VTALGFLGT 358
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1094 (390.2 bits), Expect = 8.7e-111, P = 8.7e-111
Identities = 208/318 (65%), Positives = 252/318 (79%)
Query: 59 AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV 118
A++ TF+ELAAAT+NFR +LLGEGGFGRVYKG L+S Q VAIKQL+ +G+QGNREF+V
Sbjct: 63 ARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDS-GQVVAIKQLNPDGLQGNREFIV 121
Query: 119 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
EVLMLSLLHHPNLV LIGYC GDQRLLVYEYMP+GS+EDHL DL ++PL WNTRMKI
Sbjct: 122 EVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKI 181
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
A GAARG+EYLH A PPVIYRDLK +NILLD+ + PKLSDFGLAKLGPVGD THVSTRV
Sbjct: 182 AVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRV 241
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 298
MGTYGYCAPEYA +G+LT+KSD+Y FGVVLLE+++GRKA+D + EQ+LV W+RP +
Sbjct: 242 MGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLK 301
Query: 299 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYES 358
D+ + + DP L+G+YP R A+A+ AMC++E+ RP I D+V AL YLA+Q
Sbjct: 302 DQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSH 361
Query: 359 DAEKVQSPCLDPG-TPTR 375
+A V SP + TP R
Sbjct: 362 EARNVSSPSPEISRTPRR 379
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1067 (380.7 bits), Expect = 6.3e-108, P = 6.3e-108
Identities = 200/324 (61%), Positives = 260/324 (80%)
Query: 57 ITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF 116
I A++ FRELA AT +FR E L+GEGGFGRVYKG +E Q VA+KQLDRNG+QGNREF
Sbjct: 54 IKAKSFKFRELATATNSFRQEFLIGEGGFGRVYKGKMEKTGQVVAVKQLDRNGLQGNREF 113
Query: 117 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 176
LVE+ LSLLHHPNL NLIGYC DGDQRLLV+E+MPLGS+EDHL D+ G++PLDWN+R+
Sbjct: 114 LVEIFRLSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLEDHLLDVVVGQQPLDWNSRI 173
Query: 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
+IA GAA+GLEYLH+KA PPVIYRD K SNILL+ + KLSDFGLAKLG VGD +VS+
Sbjct: 174 RIALGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGDTQNVSS 233
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296
RV+GTYGYCAPEY KTGQLT+KSDVYSFGVVLLE+++G++ +DT++ EQ+LV WA+P+
Sbjct: 234 RVVGTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRVIDTTRPCHEQNLVTWAQPI 293
Query: 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 356
F++ R +ADP LQG++P + QA+A+AAMC+ E+P +RP+I+DVVTAL++++++
Sbjct: 294 FREPNRFPELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIVRPLISDVVTALSFMSTET- 352
Query: 357 ESDAEKVQSPCLDPGTPTRTKGDK 380
+ L+P +P +T D+
Sbjct: 353 -GSPSGLTGTALNPLSP-KTVEDQ 374
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1026 (366.2 bits), Expect = 1.4e-103, P = 1.4e-103
Identities = 195/313 (62%), Positives = 237/313 (75%)
Query: 64 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLML 123
F+EL AAT NF + ++GEGGFGRVYKG+L S+NQ VA+K+LDRNG+QG REF EV++L
Sbjct: 75 FKELIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQVVAVKRLDRNGLQGTREFFAEVMVL 134
Query: 124 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
SL HPNLVNLIGYC + +QR+LVYE+MP GS+EDHL DL G LDW TRM+I GAA
Sbjct: 135 SLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGSLEDHLFDLPEGSPSLDWFTRMRIVHGAA 194
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
+GLEYLHD A PPVIYRD K SNILL ++ KLSDFGLA+LGP HVSTRVMGTYG
Sbjct: 195 KGLEYLHDYADPPVIYRDFKASNILLQSDFNSKLSDFGLARLGPTEGKDHVSTRVMGTYG 254
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303
YCAPEYA TGQLT KSDVYSFGVVLLEI+SGR+A+D + EQ+L++WA PL +DR
Sbjct: 255 YCAPEYAMTGQLTAKSDVYSFGVVLLEIISGRRAIDGDRPTEEQNLISWAEPLLKDRRMF 314
Query: 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKV 363
+ I DP L G YP +G +QALA+AAMC+ E+ + RP++ DVVTAL +LA E V
Sbjct: 315 AQIVDPNLDGNYPVKGLHQALAIAAMCLQEEAETRPLMGDVVTALEFLAKP-----IEVV 369
Query: 364 QSPCLDPGTPTRT 376
+ P +PT+T
Sbjct: 370 DNTNTTPASPTQT 382
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00280110 | hypothetical protein (393 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 399 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-58 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-55 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-55 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-29 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-27 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-26 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-21 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-20 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-16 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 4e-58
Identities = 74/195 (37%), Positives = 104/195 (53%), Gaps = 11/195 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYC 138
LGEGGFG VY + + VAIK + + E L E+ +L L+HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
D + LV EY GS++D L + + L + ++I GLEYLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 199 YRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLT 256
+RDLK NILLD KL+DFGL+KL + + + ++GT Y APE G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 257 LKSDVYSFGVVLLEI 271
KSD++S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 2e-55
Identities = 78/202 (38%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 77 ESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNL 131
LGEG FG VYKG L+ +VA+K L + Q EFL E ++ L HPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L+G C + + ++V EYMP G + D+L P K L + + A ARG+EYL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES 121
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K I+RDL N L+ K+SDFGL++ D V + APE K
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLK 177
Query: 252 TGQLTLKSDVYSFGVVLLEILS 273
G+ T KSDV+SFGV+L EI +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 2e-55
Identities = 75/200 (37%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 80 LGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNL 134
LGEG FG VYKG L E VA+K L + R EFL E ++ L HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+G C G+ +V EYMP G + D L + L +++A A+G+EYL K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
++RDL N L+ K+SDFGL++ D + APE K G+
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 255 LTLKSDVYSFGVVLLEILSG 274
T KSDV+SFGV+L EI +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 5e-55
Identities = 72/202 (35%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 77 ESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNL 131
LGEG FG VYKG L+ +VA+K L + + EFL E ++ L HPN+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L+G C + + +V EYM G + +L + L + + A ARG+EYL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLES 120
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K I+RDL N L+ K+SDFGL++ D + APE K
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLK 176
Query: 252 TGQLTLKSDVYSFGVVLLEILS 273
G+ T KSDV+SFGV+L EI +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 5e-53
Identities = 78/205 (38%), Positives = 103/205 (50%), Gaps = 12/205 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNL 131
+ LG G FG VYK + + VA+K L + ++ E+ +L L HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V LI D D LV EY G L D PL + KIA RGLEYLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGD----LFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
+I+RDLK NILLD K++DFGLAK + ++ ++T V GT Y APE
Sbjct: 117 NG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLL 171
Query: 252 TGQL-TLKSDVYSFGVVLLEILSGR 275
G K DV+S GV+L E+L+G+
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-52
Identities = 89/286 (31%), Positives = 127/286 (44%), Gaps = 42/286 (14%)
Query: 80 LGEGGFGRVYKGYLESIN---QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLI 135
LGEG FG VYKG L+ + +VA+K L + + R +FL E ++ L HPN+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHL-----HDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
G C + + LV EYM G + D+L SP K L + A A+G+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
K ++RDL N L+ K+SDFGL++ D T + APE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 251 KTGQLTLKSDVYSFGVVLLEILS-------GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303
K G T KSDV+SFGV+L EI + G + + + R
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY-------------LRKGYR- 225
Query: 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349
+ PE Y P Y+ + C P+ RP +++V L
Sbjct: 226 --LPKPE----YCPDELYE---LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-52
Identities = 78/277 (28%), Positives = 118/277 (42%), Gaps = 35/277 (12%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLV 132
+ LGEG FG+VY + + VAIK + + ++ +RE L E+ +L L HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
L D D+ LV EY G + D L + L + LEYLH K
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLHSK 116
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
+++RDLK NILLD H KL+DFGLA+ + ++T V GT Y APE
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLG 170
Query: 253 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 312
D++S GV+L E+L+G +P F + + +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTG-------------------KPPFPGDDQLLELFKKIGK 211
Query: 313 GQYPPRGFYQALAVAAM-----CVHEQPDMRPVIADV 344
+ P ++ A + + P+ R +
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 5e-37
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVL-----MLSLLHHPNLVN 133
LLG G FG VY + + +A+K ++ + G+ E +E L +LS L HPN+V
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 134 LIGYC--ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-----TRMKIAAGAARGL 186
G + + + EY+ GS+ L L TR + GL
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQIL-----EGL 114
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
YLH +++RD+K +NIL+D KL+DFG AK + + V GT + A
Sbjct: 115 AYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE + + +D++S G ++E+ +G+
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 9/202 (4%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 133
F +G+GGFG VYK + ++VAIK + + + + E+ +L HPN+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
G D+ +V E+ GS++D L + L + + +GLEYLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+I+RD+K +NILL KL DFGL+ +T ++GT + APE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 254 QLTLKSDVYSFGVVLLEILSGR 275
K+D++S G+ +E+ G+
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 69/227 (30%), Positives = 114/227 (50%), Gaps = 21/227 (9%)
Query: 74 FRSESLLGEGGFGRVYKGY----LESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHH 128
+LG G FG VYKG E + VAIK L + + N+E L E +++ + H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAAR 184
P++V L+G C Q L+ + MPLG + D++ + + + L+W ++ A+
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGS-QYLLNWCVQI------AK 120
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
G+ YL +K +++RDL N+L+ H K++DFGLAKL V + + + +
Sbjct: 121 GMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290
A E T KSDV+S+GV + E+++ G K + A L+
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 94/297 (31%), Positives = 134/297 (45%), Gaps = 57/297 (19%)
Query: 80 LGEGGFGRVYKGYLESIN-----QDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVN 133
LGEG FG+VYKG L N VAIK L N + +EF E ++S L HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAG 181
L+G C +++EY+ G + + L SP K LD + + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
A G+EYL + ++RDL N L+ G K+SDFGL++ D V ++ +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF--- 297
+ PE G+ T +SD++SFGVVL EI S G +P +
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYG------------------LQPYYGFS 231
Query: 298 -QD-----RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
Q+ R+R L+ PE P R + A+ C +E P RP D+ T L
Sbjct: 232 NQEVIEMIRSRQ-LLPCPE---DCPARVY----ALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVN 133
LGEG FG+V + D VA+K L+ +G Q +F E+ +L L H N+V
Sbjct: 12 LGEGHFGKVELCRYD-PLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 134 LIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
G C R L+ EY+P GS+ D+L ++ + ++ +G++YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGS 127
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST--RVMGTYGYCAPEY 249
+ I+RDL NIL++ K+SDFGLAK+ P + + + Y APE
Sbjct: 128 QR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 250 AKTGQLTLKSDVYSFGVVLLEILS 273
+T + + SDV+SFGV L E+ +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 70/199 (35%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY 137
+ +G+G FG V G Q VA+K L + + FL E +++ L HPNLV L+G
Sbjct: 12 ATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
G+ +V EYM GS+ D+L S G+ + ++ A G+EYL +K
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEKN---F 123
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 257
++RDL N+L+ K+SDFGLAK G S ++ + APE + + +
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---QDSGKL--PVKWTAPEALREKKFST 178
Query: 258 KSDVYSFGVVLLEILS-GR 275
KSDV+SFG++L EI S GR
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-32
Identities = 82/215 (38%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLML-SLLHH 128
++R LGEG FG VY + VA+K L + ++E FL E+ +L SL H
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
PN+V L + D LV EY+ GS+ED L K PL + + I A LEY
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQILSALEY 116
Query: 189 LHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKL----GPVGDNTHVSTRVMGTYG 243
LH K +I+RD+K NILLDR G KL DFGLAKL G + + +GT G
Sbjct: 117 LHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 244 YCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + SD++S G+ L E+L+G
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 8/202 (3%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+ F E LG G FG V++G L VAIK L + + ++F EV L L H +L
Sbjct: 6 EEFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
++L C+ G+ ++ E M GS+ L SP + L + + +A A G+ YL +
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLR--SPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
+ I+RDL NIL+ K++DFGLA+L + ++ ++S+ Y + APE A
Sbjct: 123 QN---SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 252 TGQLTLKSDVYSFGVVLLEILS 273
G + KSDV+SFG++L E+ +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 71/200 (35%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ G VA+K L + G FL E ++ L H LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNG-TTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ + +V EYM GS+ D L K L + +AA A G+ YL + I+
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIH 126
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL NIL+ K++DFGLA+L + D+ + + G + APE A G+ T
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARL--IEDDEYTAR--EGAKFPIKWTAPEAANYGRFT 182
Query: 257 LKSDVYSFGVVLLEILS-GR 275
+KSDV+SFG++L EI++ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVN 133
LGEG FG+V+ G + + VA+K L R+ F E +L+ H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----------GKKPLDWNTRMKIAAGAA 183
G C +GD ++V+EYM G + L P L + ++IA A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
G+ YL A ++RDL N L+ K+ DFG+++ D V M
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ PE + T +SDV+SFGVVL EI +
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 5e-29
Identities = 71/201 (35%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIG 136
LG+G FG+V + + A+K L + + +E L E +LS ++HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 137 YCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+ A + LV EY P G + HL G+ + R AA LEYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEER-ARF-YAAEIVLALEYLHSLG- 113
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+IYRDLK NILLD H KL+DFGLAK + + +T GT Y APE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLGKG 169
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
D +S GV+L E+L+G+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-29
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 79 LLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNL 134
LG+G FG V +G + VA+K L + + +FL E ++ L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD--WNTRMKIAAGAARGLEYLHDK 192
G ++V E PLGS+ D L + G + + ++IA G + YL K
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG----MRYLESK 116
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST---RVMGTYGYCAPEY 249
I+RDL NILL K+ DFGL + P ++ +V +V + +CAPE
Sbjct: 117 R---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171
Query: 250 AKTGQLTLKSDVYSFGVVLLEILS 273
+T + SDV+ FGV L E+ +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-28
Identities = 64/253 (25%), Positives = 106/253 (41%), Gaps = 39/253 (15%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPN 130
+ +G+G FG+VY +S + +K++D N + RE + EV +L L+HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
++ + + +V EY G + + KP + L+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-- 248
+ +++RD+K NI L KL DFG++K+ + ++ V+GT Y +PE
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC 175
Query: 249 ----YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304
Y KSD++S G VL E+ + + F+
Sbjct: 176 QNKPYNY------KSDIWSLGCVLYELCTLKHP-------------------FEGENLLE 210
Query: 305 LIADPELQGQYPP 317
L L+GQYPP
Sbjct: 211 LA-LKILKGQYPP 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-28
Identities = 66/197 (33%), Positives = 95/197 (48%), Gaps = 8/197 (4%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGY 137
+G+G FG VYKG L+ N +VA+K + FL E +L HPN+V LIG
Sbjct: 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
C +V E +P GS+ L K L ++++ AA G+EYL K
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 257
I+RDL N L+ K+SDFG+++ G T + APE G+ T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 258 KSDVYSFGVVLLEILSG 274
+SDV+S+G++L E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIG 136
L+G G FG VYKG VAIKQ+ ++ + + E+ +L L HPN+V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
D ++ EY GS+ + P + L ++ +GL YLH++
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLHEQG--- 119
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
VI+RD+K +NIL + KL+DFG+A + D + V+GT + APE + +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 257 LKSDVYSFGVVLLEILSGR 275
SD++S G ++E+L+G
Sbjct: 178 TASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 83/288 (28%), Positives = 138/288 (47%), Gaps = 41/288 (14%)
Query: 79 LLGEGGFGRVYKGYL---ESINQDVAIKQLDR-NGVQGNREFLVEVLMLSLLHHPNLVNL 134
++G+G FG VY G L + A+K L+R ++ +FL E +++ HPN+++L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 135 IGYCADGD-QRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHD 191
+G C + L+V YM G + + + + P K L + A+G+EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL-- 114
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK------LGPVGDNTHVSTRVMGTYGYC 245
A ++RDL N +LD + K++DFGLA+ V ++T V +
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WM 169
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305
A E +T + T KSDV+SFGV+L E++ T A + ++ D T + L
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELM-------TRGAPPYPDVDSF------DITVYLL 216
Query: 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353
LQ +Y P Y+ V C H +P+MRP +++V+ + + S
Sbjct: 217 QGRRLLQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 33/228 (14%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-----FLVEVLMLSLL 126
+F+ ++GEG F V + N++ AIK LD+ Q +E +E +L+ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDK--RQLIKEKKVKYVKIEKEVLTRL 58
Query: 127 -HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
HP ++ L D + V EY P G + ++ LD AA
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLA 114
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVM----- 239
LEYLH K +I+RDLK NILLD+ H K++DFG AK L P
Sbjct: 115 LEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 240 ------------GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
GT Y +PE SD+++ G ++ ++L+G+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 34/212 (16%)
Query: 79 LLGEGGFGRVYKGYLESINQD----VAIKQ--LDRNGVQGN---REFLVEVLMLSLLHHP 129
LLG G FG VY+G +N D A+K+ L +G G ++ E+ +LS L HP
Sbjct: 7 LLGSGSFGSVYEG----LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V +G + D + E +P GS+ L +P+ +I G LEYL
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYL 118
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-----GTYGY 244
HD+ ++RD+K +NIL+D KL+DFG+AK V G+ +
Sbjct: 119 HDRN---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYW 167
Query: 245 CAPEY-AKTGQLTLKSDVYSFGVVLLEILSGR 275
APE A+ G L +D++S G +LE+ +G+
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHP 129
+ +++ +GEG G VYK + ++VAIK++ + N+E ++ E+L++ HP
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHP 75
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-TRMK---IAAGAA-- 183
N+V+ GD+ +V EYM GS L D+ + N RM IA
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGS----LTDI------ITQNFVRMNEPQIAYVCREV 125
Query: 184 -RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR--VMG 240
+GLEYLH + VI+RD+K NILL + KL+DFG A S R V+G
Sbjct: 126 LQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL----TKEKSKRNSVVG 178
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
T + APE K K D++S G++ +E+ G
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 82/266 (30%), Positives = 122/266 (45%), Gaps = 37/266 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ GY + VAIK L + G FL E ++ L HP LV L
Sbjct: 14 LGAGQFGEVWMGYYNG-HTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ ++ EYM GS+ D L +P L N + +AA A G+ ++ K I+
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIH 125
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLK 258
RDL+ +NIL+ K++DFGLA+L + DN + + + APE G T+K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 259 SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP-- 316
SDV+SFG++L EI V + R + T +I + E + P
Sbjct: 184 SDVWSFGILLTEI------------------VTYGRIPYPGMTNPEVIQNLERGYRMPRP 225
Query: 317 ---PRGFYQALAVAAMCVHEQPDMRP 339
P Y+ + +C E+P+ RP
Sbjct: 226 DNCPEELYE---LMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 92/301 (30%), Positives = 135/301 (44%), Gaps = 39/301 (12%)
Query: 66 ELAAATKNFRSESLLGEGGFGRVYKG--YLESIN--QDVAIKQL-DRNGVQGNREFLVEV 120
EL + F E LGE FG++YKG YL ++ Q VAIK L D N Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG-------------K 167
+++ LHHPN+V L+G +++EY+ G + + L SP K
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 168 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227
LD + IA A G+EYL + +++DL NIL+ H K+SD GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
D V + + + PE G+ + SD++SFGVVL EI S + + Q
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS--FGLQPYYGFSNQ 233
Query: 288 SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347
++ R + L+ E PPR + ++ C E P RP D+ T
Sbjct: 234 EVIEMVR-------KRQLLPCSE---DCPPRMY----SLMTECWQEGPSRRPRFKDIHTR 279
Query: 348 L 348
L
Sbjct: 280 L 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 82/283 (28%), Positives = 129/283 (45%), Gaps = 36/283 (12%)
Query: 75 RSESLLGEGGFGRVYKGYLESINQDV--AIKQL-DRNGVQGNREFLVEVLMLSLLHHPNL 131
+ E+++ G G YKG +SI + +K++ D N + + E+ + L HPN+
Sbjct: 693 KEENVISRGKKGASYKG--KSIKNGMQFVVKEINDVNSIPSS-----EIADMGKLQHPNI 745
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V LIG C L++EY+ ++ + L +LS W R KIA G A+ L +LH
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS-------WERRRKIAIGIAKALRFLHC 798
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG----DNTHVSTRVMGTYGYCAP 247
+ P V+ +L I++D P L +L G D + Y AP
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-----AYVAP 847
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307
E +T +T KSD+Y FG++L+E+L+G+ D S+V WAR + D I
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWI- 905
Query: 308 DPELQGQYP--PRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
DP ++G + + +A C P RP DV+ L
Sbjct: 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LG+G FG VY+G + + + VAIK ++ N R EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLH------DLSPGKKPLDWNTRMKIAAGAARGLE 187
L+G + G L+V E M G ++ +L + +PG P +++AA A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YL K ++RDL N ++ K+ DFG+ + D + + + AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E K G T KSDV+SFGVVL E+ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-25
Identities = 70/202 (34%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD----VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNL 134
LGEG FG+V + N VA+K L R Q N + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 135 IGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
G C++ + L+ EY+PLGS+ D+L K L+ + A G+ YLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAK 251
I+RDL N+LLD K+ DFGLAK P G + V + A E K
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 252 TGQLTLKSDVYSFGVVLLEILS 273
+ + SDV+SFGV L E+L+
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V++G L + VA+K L + G ++FL E ++ L HP L+ L C
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ +V E M GS+ ++L + L + +AA A G+ YL + I+
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N+L+ K++DFGLA++ + ++ + + G + APE A + +
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARV--IKEDIYEARE--GAKFPIKWTAPEAALYNRFS 182
Query: 257 LKSDVYSFGVVLLEILS-GR 275
+KSDV+SFG++L EI++ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 67/203 (33%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+G G VY N+ VAIK++D Q + + L EV +S +HPN+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAARGLEYLHDKAKP 195
GD+ LV Y+ GS L D+ P IA +GLEYLH +
Sbjct: 69 VVGDELWLVMPYLSGGS----LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTH-VSTRVMGTYGYCAPEYAKTG 253
I+RD+K NILL K++DFG+ A L GD T V +GT + APE +
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 254 Q-LTLKSDVYSFGVVLLEILSGR 275
K+D++SFG+ +E+ +G
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 32/272 (11%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPN 130
+F + +G+G FG V+K ++ + A+KQ+D + + E + E +L+ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
++ D + +V EY G + L +PL + + GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
K +++RD+K N+ LD + K+ D G+AKL + DNT+ + ++GT Y +PE
Sbjct: 119 SKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELC 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310
+ KSDV++ GVVL E +G+ D + A +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDA------NNQGALILKI-------------- 213
Query: 311 LQGQYPP--RGFYQALA-VAAMCVHEQPDMRP 339
++G +PP + + Q LA + C+ + RP
Sbjct: 214 IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 80 LGEGGFGRVYKGYLESINQ---DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLI 135
LG G FG V KG + +VA+K L + G +EFL E +++ L HP +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
G C G+ +LV E PLG + +L P + ++ A G+ YL K
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESKH 115
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYA 250
++RDL N+LL + K+SDFG+++ LG + + G + + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRWPLKWYAPECI 170
Query: 251 KTGQLTLKSDVYSFGVVLLEILS 273
G+ + KSDV+S+GV L E S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 78 SLLGEGGFGRV----YKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 133
LG+G FG V Y ++ + VA+K+L + + R+F E+ +L L H N+V
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 134 LIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
G C +R LV EY+P GS+ D+L ++ LD + A+ +G+EYL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG---TYGYCAPE 248
K ++RDL NIL++ K+ DFGL K+ P D + R G + Y APE
Sbjct: 127 KR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APE 181
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILS 273
+ ++ SDV+SFGVVL E+ +
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 60/192 (31%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G +G VY+G + + VA+K L + ++ EFL E ++ + HPNLV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
++ E+M G++ D+L + ++ ++ + +A + +EYL K I+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS 259
RDL N L+ + K++DFGL++L GD + APE + ++KS
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 260 DVYSFGVVLLEI 271
DV++FGV+L EI
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNL 131
+ +LG+G G VYK + + A+K++ +G + R+ L+ E+ L P +
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV 61
Query: 132 VNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGAARGLEY 188
V G + +G+ + V EYM GS+ D L KK + IA +GL+Y
Sbjct: 62 VKCYGAFYKEGEISI-VLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDY 114
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAP 247
LH K +I+RD+K SN+L++ K++DFG++K L D + T V GT Y +P
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSP 169
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGR 275
E + + +D++S G+ LLE G+
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 5e-24
Identities = 78/277 (28%), Positives = 128/277 (46%), Gaps = 32/277 (11%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPN 130
+F+ LG+G +G VYK S NQ A+K++D + Q RE V E+ +L+ ++HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+++ DG++ +V EY P G + + +K + +I RGL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
++ +++RDLK +NILL K+ D G++K V T +GT Y APE
Sbjct: 121 EQK---ILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKT-QIGTPHYMAPEVW 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310
K + KSD++S G +L E+ + P F+ R+ L
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATF-------------------APPFEARSMQDL-RYKV 213
Query: 311 LQGQYP--PRGFYQALAVAAM-CVHEQPDMRPVIADV 344
+G+YP P + Q L + +P +RP +
Sbjct: 214 QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 70/212 (33%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHH 128
+F LG G FGRV + + A+K L + + ++ L E +L + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P LVNL G D LV EY+P G + HL G+ P R AA LEY
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPV-ARF-YAAQVVLALEY 116
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH ++YRDLK N+LLD + K++DFG AK V T+ + GT Y APE
Sbjct: 117 LHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGTPEYLAPE 168
Query: 249 ------YAKTGQLTLKSDVYSFGVVLLEILSG 274
Y K D ++ G+++ E+L+G
Sbjct: 169 IILSKGYGKA------VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 133
F LGEG +G VYK + Q VAIK + +E + E+ +L P +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAARGLEYLH 190
G +V EY GSV D + + K L T +IAA +GLEYLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITN---KTL---TEEEIAAILYQTLKGLEYLH 116
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
K I+RD+K NILL+ KL+DFG++ G + D V+GT + APE
Sbjct: 117 SNKK---IHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ K+D++S G+ +E+ G+
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 45/217 (20%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHPNLVNLI 135
+GEG +G+VYK + + VA+K++ F + E+ +L L HPN+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 136 GYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------G 185
+ +V+EYM HDL+ G L + +K + G
Sbjct: 65 EIVTSKGKGSIYMVFEYMD--------HDLT-G---LLDSPEVKFTESQIKCYMKQLLEG 112
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
L+YLH +++RD+K SNIL++ KL+DFGLA+ N+ T + T Y
Sbjct: 113 LQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYR 168
Query: 246 APE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE Y + D++S G +L E+ G+
Sbjct: 169 PPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 5e-23
Identities = 69/212 (32%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSL 125
R LLG G FG V+KG +SI VAIK + DR+G Q +E +L +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH----DLSPGKKPLDWNTRMKIAAG 181
L H +V L+G C G LV + PLGS+ DH+ L P ++ L+W ++
Sbjct: 66 LDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDP-QRLLNWCVQI----- 118
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
A+G+ YL + +++R+L NILL +++DFG+A L D + +
Sbjct: 119 -AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ A E G+ T +SDV+S+GV + E++S
Sbjct: 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 5e-23
Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 83 GGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCA 139
G +GRV+ +S AIK + + + + L E +LS P +V L Y
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 140 DGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
G + L LV EY+P G + L ++ LD + A LEYLH +I
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLH---SNGII 115
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS------TRVMGTYGYCAPEYAKT 252
+RDLK NIL+D H KL+DFGL+K+G V +++ R++GT Y APE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 253 GQLTLKSDVYSFGVVLLEILSG 274
+ D +S G +L E L G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 5e-23
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
LG G G V K + +A+K + ++ L E+ +L + P +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+ + EYM GS++ L + + KIA +GL YLH+K K +I
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM--------GTYGYCAPEYA 250
+RD+K SNIL++ KL DFG VS +++ GT Y APE
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSYMAPERI 171
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ ++KSD++S G+ L+E+ +GR
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 69/200 (34%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ G DVAIK + R G +F+ E ++ L HPNLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRG-KIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+V EYM G + ++L + GK +W M + +EYL I+
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDM--CSDVCEAMEYLESNG---FIH 123
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N L+ K+SDFGLA+ V D+ + S+ GT + PE + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRFS 179
Query: 257 LKSDVYSFGVVLLEILSGRK 276
KSDV+SFGV++ E+ S K
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 77 ESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNL 131
E ++G G FG V +G L+ + DVAIK L + G +FL E ++ HPN+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
+ L G +++ EYM GS++ L +D GK + + G A G++YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLREND---GK--FTVGQLVGMLRGIASGMKYL 122
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----Y 244
+ ++RDL NIL++ K+SDFG L +++ + G G +
Sbjct: 123 SEMN---YVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYTTKG--GKIPIRW 174
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
APE + T SDV+SFG+V+ E++S
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLV 132
F +G+G FG VYK + NQ VAIK +D + E + E+ LS P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
G G + ++ EY GS L L PG LD I GLEYLH++
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC---LDLLKPG--KLDETYIAFILREVLLGLEYLHEE 117
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
K I+RD+K +NILL KL+DFG++ G + +GT + APE K
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 253 GQLTLKSDVYSFGVVLLEILSG 274
K+D++S G+ +E+ G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 68/203 (33%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIG 136
LG GGFGRV ++S N+ A+K + + + + E +L +HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 137 YCADGDQRLLVY---EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
Y D++ +Y EY G + L D G ++ R A EYLH++
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILRDR--GLFD-EYTARF-YIACVVLAFEYLHNRG 113
Query: 194 KPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
+IYRDLK N+LLD GY KL DFG AK G T GT Y APE
Sbjct: 114 ---IIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILN 166
Query: 253 GQLTLKSDVYSFGVVLLEILSGR 275
D +S G++L E+L+GR
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 40/283 (14%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGY 137
+GEG +G VYK + + VAIK++ + L E+ +L L+HPN++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
LV+E+M D + ++ L + +GL + H +
Sbjct: 67 FRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAKT-G 253
++RDLK N+L++ KL+DFGLA+ PV TH V TR Y APE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDK 174
Query: 254 QLTLKSDVYSFGVVLLEILSGR-------------KAVDTSKAAAEQSLVAWARPLFQDR 300
+ D++S G + E+LS R K T + P F
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW-----PKFTSL 229
Query: 301 TRHSLIADPELQGQYPPRGF----YQALAVAAMCVHEQPDMRP 339
R+ + P+ G P+ F QAL + + +H P R
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG+V+ ++ + VA+K L ++F E +L++L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK-----------PLDWNTRMKIAAGAA 183
G C +G L+V+EYM G + L P K L + IA+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
G+ YL A ++RDL N L+ +G K+ DFG+++ D V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ PE + T +SD++SFGVVL EI +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 3e-22
Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 18/198 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+GEG FG V +G E Q VA+K + + + FL E +++ LHH NLV L+G
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ +V E M G++ + L + G+ + ++ + A G+EYL K +++
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVG-DNTHVSTRVMGTYGYCAPEYAKTGQLTLK 258
RDL NIL+ K+SDFGLA++G +G DN+ + + + APE K + + K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSK 177
Query: 259 SDVYSFGVVLLEILS-GR 275
SDV+S+GV+L E+ S GR
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 4e-22
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQ--LDRNGVQG---NREFLV----EVLMLSLLHH 128
+L+G G FG VY G S + +A+KQ L R L E+ +L L H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
N+V +G D D + EY+P GSV L++ ++ L N +I +GL Y
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNY 121
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-----LGPVGDNTHVSTRVMGTYG 243
LH++ +I+RD+K +NIL+D K+SDFG++K N + + G+
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVF 177
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ APE K T K+D++S G +++E+L+G+
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 6e-22
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 44/221 (19%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHP 129
+ LGEG +G VYK + + VA+K++ + G+ L E+ +L L HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHP 58
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA------ 183
N+V L+ + LV+EY DL KK LD ++
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCD--------MDL---KKYLD-KRPGPLSPNLIKSIMYQ 106
Query: 184 --RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
RGL Y H +++RDLK NIL++R KL+DFGLA+ + T+ + V+ T
Sbjct: 107 LLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-T 161
Query: 242 YGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 275
Y APE + L S D++S G + E+++G+
Sbjct: 162 LWYRAPE------ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-22
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+G G FG V+ GY + VAIK + R G +F+ E ++ L HP LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLE-KRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ LV+E+M G + D+L + T + + G+ YL VI+
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N L+ K+SDFG+ + V D+ + S+ GT + +PE + +
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSST--GTKFPVKWSSPEVFSFSKYS 179
Query: 257 LKSDVYSFGVVLLEILS 273
KSDV+SFGV++ E+ S
Sbjct: 180 SKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 6e-22
Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 79 LLGEGGFGRVYKGYLESINQD------VAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNL 131
LG G FG VY+G I VA+K L + Q +EFL E ++S +HPN+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP---LDWNTRMKIAAGAARGLEY 188
V L+G C + + ++ E M G + +L D + L + I A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 189 LHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
L I+RDL N L+ D K+ DFGLA+ D +
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE G+ T +SDV+SFGV++ EIL+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 6e-22
Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 39/231 (16%)
Query: 73 NFRSESLLGEGGFGRVYK----GYLESINQD-VAIKQL-DRNGVQGNREFLVEVLMLSLL 126
N +G+G FGRV++ G L VA+K L + +F E +++
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------------GKK 168
HPN+V L+G CA G L++EYM G + + L SP
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 169 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228
PL ++ IA A G+ YL ++ ++RDL N L+ K++DFGL++
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 229 GD------NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
D N + R M PE + T +SDV+++GVVL EI S
Sbjct: 183 ADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 7e-22
Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 80 LGEGGFGRVY------------KGYLESINQD----VAIKQLDRNGVQGNR-EFLVEVLM 122
LGEG FG V+ K + E+ N D VA+K L + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 123 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-------DLSPGKKPLDWNTR 175
LS L PN+ L+G C ++ EYM G + L L+ K L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
+ +A A G+ YL ++RDL N L+ + Y K++DFG+++ D V
Sbjct: 133 LYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
R + A E G+ T KSDV++FGV L EIL+
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 7e-22
Identities = 65/208 (31%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQ-LDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
S LGEG G V K L++ A+K ++ L E+ + P +V G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 137 YCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRM------KIAAGAARGLEY 188
D + EY GS++ S KK R+ KIA +GL Y
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLD------SIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAP 247
LH + +I+RD+K SNILL R KL DFG++ +L T GT Y AP
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAP 172
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGR 275
E + ++ SDV+S G+ LLE+ R
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 8e-22
Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 19/220 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPN 130
+ ++G G FG V+ ++ + V IKQ+ + + E +L LL HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAARGL 186
++ + ++V EY P G++ +++ L L + ++ +A L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------L 114
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
++H K +++RDLK NILLD+ K+ DFG++K+ + + T V+GT Y
Sbjct: 115 HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYI 168
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285
+PE + KSD+++ G VL E+ S ++A + + A
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 9e-22
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLL-HHPNLVNL 134
+LG+G FG+V L+ + A+K L ++ V + + +VE +L+L +P L +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+ V E++ G + H+ D K D AA GL++LH K
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+IYRDLK N++LDR H K++DFG+ K GDN ++ GT Y APE + +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLK 172
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
T D +SFGV+L E+L G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSL-LHHPNLVNL 134
+LG+G FG+V L+ N+ AIK L ++ V + + +VE +L+L HP L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 135 IGYCA--DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
+C + V EY+ G + H+ D AA GL++LH K
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK 115
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
+IYRDLK N+LLD+ H K++DFG+ K G+ ++ GT Y APE K
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170
Query: 253 GQLTLKSDVYSFGVVLLEILSGR 275
+ D +SFGV+L E+L G+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 71/213 (33%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM--------LSL 125
FR ++LG G FG+V + + AIK L + + E VE LM +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANS 58
Query: 126 LHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAA 183
HP LVNL C + + V EY G + H+H + R AA
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVV 111
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGT 241
GL+YLH+ ++YRDLK N+LLD K++DFGL K +G GD T ST GT
Sbjct: 112 LGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT--ST-FCGT 164
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
+ APE T D + GV++ E+L G
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIG 136
LG+GGFG V +++ + A K+LD+ + +G + L E +L + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
D LV M G ++ H++++ G+ + AA GLE+LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR--- 115
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
++YRDLK N+LLD + ++SD GLA G GT GY APE +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYD 172
Query: 257 LKSDVYSFGVVLLEILSGR 275
D ++ G L E+++GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-21
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLL-H 127
++ + E ++GEG FG+V + + + + + AIK L + + R+F E+ +L L H
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-----DLSPG-------KKPLDWNTR 175
HPN++NL+G C + + EY P G++ D L + P L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
++ A+ A G++YL +K I+RDL N+L+ K++DFGL++ G+ +V
Sbjct: 122 LQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK 174
Query: 236 TRVMGTYG--YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ MG + A E T KSDV+SFGV+L EI+S
Sbjct: 175 -KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 5e-21
Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNRE---FLVEVLMLSLLH 127
N+R LLG+G FGRVY Y +++A+KQ+ D + + +E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 128 HPNLVNLIGYCADGDQRLLVY-EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
H +V G C D+ L ++ EYMP GSV+D L L K G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGV 117
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 245
EYLH +++RD+K +NIL D + KL DFG +K L + + V GT +
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
+PE K+DV+S G ++E+L+
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 9e-21
Identities = 69/201 (34%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLL-HHPNLVNL 134
+LG+G FG+V+ L+ NQ AIK L ++ V + + +VE +LSL HP L +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+ V EY+ G + H+ D AA GL++LH K
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSKG- 116
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
++YRDLK NILLD H K++DFG+ K +GD + GT Y APE +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQK 172
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
D +SFGV+L E+L G+
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 45/303 (14%)
Query: 80 LGEGGFGRVYKGYLESINQD-----------------VAIKQLDRNGVQGNR-EFLVEVL 121
LGEG FG V+ + + QD VA+K L + + R +FL EV
Sbjct: 13 LGEGQFGEVHLCEVVN-PQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 122 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL--HDLSPGKKP---------- 169
+LS L PN++ L+G C D D ++ EYM G + L H L ++
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 170 ---LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226
+ +++ + +A A G++YL + ++RDL N L+ K++DFG+++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286
GD + R + + A E G+ T SDV++FGV L EIL K + E
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248
Query: 287 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346
Q ++ A F+D+ R + P P+G Y+ + C RP +D+
Sbjct: 249 Q-VIENAGEFFRDQGRQVYLFRPPP----CPQGLYELM---LQCWSRDCRERPSFSDIHA 300
Query: 347 ALA 349
L
Sbjct: 301 FLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 71/213 (33%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 79 LLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPNLVNL 134
++GEG FG+V K + + + D AIK++ + + R+F E+ +L L HHPN++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLH-----DLSPG-------KKPLDWNTRMKIAAGA 182
+G C L EY P G++ D L + P L + AA
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
ARG++YL K I+RDL NIL+ Y K++DFGL++ G +V + MG
Sbjct: 122 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 173
Query: 243 G--YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ A E T SDV+S+GV+L EI+S
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 80 LGEGGFGRVY--KGYLESINQD---VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG+V+ + Y S +D VA+K L + ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGA 182
G C DGD ++V+EYM G + L P K L + + IA+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
A G+ YL A ++RDL N L+ K+ DFG+++ D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ PE + T +SDV+SFGV+L EI +
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVN 133
LG G FG VY+G + D VA+K L + Q +FL+E L++S +H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK---PLDWNTRMKIAAGAARGLEYLH 190
LIG + R ++ E M G ++ L + P + L + A A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 191 DKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+ I+RD+ N LL G K++DFG+A+ R M + P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E G T K+DV+SFGV+L EI S
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQ--LDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY 137
+G G FG+VY + +A+K+ + N + +E E+ +L LL HPNLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
++ + EY G++E+ L + LD + GL YLH +
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSHG---I 120
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM----GTYGYCAPEYAKTG 253
++RD+K +NI LD KL DFG A + +NT + GT Y APE G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 254 QLTLK---SDVYSFGVVLLEILSGRK 276
+ +D++S G V+LE+ +G++
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 77/204 (37%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIG 136
+G G FG VY N+ VAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
LV EY LGS D L KKPL I GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHER-- 136
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKL-GPVGDNTHVSTRVMGTYGYCAPEY---AKT 252
I+RD+K NILL KL+DFG A L P N+ V GT + APE
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFV-----GTPYWMAPEVILAMDE 188
Query: 253 GQLTLKSDVYSFGVVLLEILSGRK 276
GQ K DV+S G+ +E L+ RK
Sbjct: 189 GQYDGKVDVWSLGITCIE-LAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-20
Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 37/275 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V G DVAIK + + G EF+ E ++ L H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+V EYM G + ++L + +P +++ G+ YL K I+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESKQ---FIH 123
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N L+D K+SDFGL++ V D+ + S+ +G+ + PE + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFS 179
Query: 257 LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ-- 314
KSDV++FGV++ E+ S K + +R +S + QG
Sbjct: 180 SKSDVWAFGVLMWEVYSLGK-------------------MPYERFNNSETVEKVSQGLRL 220
Query: 315 YPPRGFYQAL-AVAAMCVHEQPDMRPVIADVVTAL 348
Y P + + A+ C HE+ + RP +++++
Sbjct: 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPNLV 132
LG G FG+V + +++ VA+K L RE L+ E+ ++S L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
NL+G C G L++ EY G + + L + L + + A+G+ +L K
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAFLASK 160
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEY 249
I+RDL N+LL G K+ DFGLA+ + D+ +V + R+ + APE
Sbjct: 161 N---CIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARL--PVKWMAPES 214
Query: 250 AKTGQLTLKSDVYSFGVVLLEILS 273
T +SDV+S+G++L EI S
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 27/255 (10%)
Query: 80 LGEGGFGRVY----KGYLESINQD----------VAIKQLDRNGVQGNR-EFLVEVLMLS 124
LGEG FG V+ +G E + + VA+K L + + R +FL E+ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 125 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD--------LSPGKKPLDWNTRM 176
L +PN++ L+G C D ++ EYM G + L + + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
+A A G++YL A ++RDL N L+ Y K++DFG+++ GD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296
R + + A E G+ T SDV++FGV L E+ + K S + EQ ++
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-VIENTGEF 248
Query: 297 FQDRTRHSLIADPEL 311
F+++ R ++ L
Sbjct: 249 FRNQGRQIYLSQTPL 263
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLI-GYC 138
LG+G FG+VYK + A K + + +F+VE+ +LS HPN+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+ +L+ E+ G+++ + +L ++ L + L +LH VI
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VI 125
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-----KTG 253
+RDLK NILL KL+DFG++ + +GT + APE K
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDN 183
Query: 254 QLTLKSDVYSFGVVLLEILSGR 275
K+D++S G+ L+E+
Sbjct: 184 PYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 78/269 (28%), Positives = 120/269 (44%), Gaps = 32/269 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+G+G FG VYKG + VAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
G + ++ EY+ GS D L PG PL+ I +GL+YLH + K I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---KPG--PLEETYIATILREILKGLDYLHSERK---I 123
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 258
+RD+K +N+LL KL+DFG+A G + D +GT + APE K K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 259 SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY--P 316
+D++S G+ +E+ G L+ P P L+GQY P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQYSKP 228
Query: 317 PRGFYQALAVAAMCVHEQPDMRPVIADVV 345
+ F +A C+++ P RP +++
Sbjct: 229 FKEFVEA------CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQL-DRNGVQGNREFLVE 119
E+ +T F E LGE FG+VYKG+L Q VAIK L D+ EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 120 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------------K 167
+M S L HPN+V L+G +++ Y + + L SP K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 168 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227
L+ + I A G+E+L + V+++DL N+L+ + K+SD GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
D + + + +PE G+ ++ SD++S+GVVL E+ S
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 4e-20
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 29/227 (12%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGVQGN-REFLVEVLMLSLL 126
N LGEG FG+V K + VA+K L N R+ L E +L +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL--------------------HDLSPG 166
+HP+++ L G C+ LL+ EY GS+ L + +P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 167 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226
++ L + A +RG++YL A+ +++RDL N+L+ G K+SDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
D+ ++ + A E T +SDV+SFGV+L EI++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 71/198 (35%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ G N VA+K L + G FL E ++ L H LV L +
Sbjct: 14 LGNGQFGEVWMGTWNG-NTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ + +V EYM GS+ D L D G+ L + +AA A G+ Y+ + I+
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKD-GEGRA-LKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLK 258
RDL+ +NIL+ G K++DFGLA+L + DN + + + + APE A G+ T+K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 259 SDVYSFGVVLLEILS-GR 275
SDV+SFG++L E+++ GR
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-20
Identities = 68/196 (34%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGY 137
LLG+G FG V+KG L+ VA+K + Q + +FL E +L HPN+V LIG
Sbjct: 2 LLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
C QR +Y M L D L L K L +K A AA G+ YL K
Sbjct: 61 CT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 257
I+RDL N L+ K+SDFG+++ G + + + + APE G+ +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSS 173
Query: 258 KSDVYSFGVVLLEILS 273
+SDV+S+G++L E S
Sbjct: 174 ESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ GY + + VA+K L + G + FL E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMGYYNN-STKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ ++ EYM GS+ D L GK L + +A A G+ Y+ K I+
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIH 126
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLK 258
RDL+ +N+L+ K++DFGLA++ + DN + + + APE G T+K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 259 SDVYSFGVVLLEILS 273
SDV+SFG++L EI++
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 5e-20
Identities = 68/210 (32%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 79 LLGEGGFGRVYKGYL----ESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVN 133
+LG G FG VYKG E++ VAIK L+ G + N EF+ E L+++ + HP+LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLH---DLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
L+G C + LV + MP G + D++H D + L+W ++ A+G+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
++ +++RDL N+L+ H K++DFGLA+L + + + + A E
Sbjct: 127 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 251 KTGQLTLKSDVYSFGVVLLEILS-GRKAVD 279
+ T +SDV+S+GV + E+++ G K D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 7e-20
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LSLL-HHPNLV 132
+LG+G FG+V L+ ++ A+K L ++ + + + VE M L+L HP L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLT 59
Query: 133 NLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLH 190
L C RL V EY+ G + H+ +P R + AA GL++LH
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLH 113
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
++ +IYRDLK N+LLD H K++DFG+ K G +G T ++ GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEIL 168
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
D ++ GV+L E+L+G+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 71/219 (32%), Positives = 109/219 (49%), Gaps = 26/219 (11%)
Query: 73 NFRSESLLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLL-HH 128
+ + + ++GEG FG+V K + + + D AIK++ + + R+F E+ +L L HH
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-----DLSPG-------KKPLDWNTRM 176
PN++NL+G C L EY P G++ D L + P L +
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
AA ARG++YL K I+RDL NIL+ Y K++DFGL++ G +V
Sbjct: 128 HFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179
Query: 237 RVMGTYG--YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ MG + A E T SDV+S+GV+L EI+S
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 32/214 (14%)
Query: 79 LLGEGGFGRVYKGYLESINQDV------AIKQLD--RNGVQGNREFLVEVL-----MLSL 125
LG G F Y+ +DV A+KQ+ RN +E +VE L +++
Sbjct: 7 QLGTGAFSSCYQA------RDVKTGTLMAVKQVTYVRNT-SSEQEEVVEALRKEIRLMAR 59
Query: 126 LHHPNLVNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 184
L+HP+++ ++G C D L V E+M GSV L K+ + N ++ R
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----R 114
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLA-KLGPVGDNT-HVSTRVMGT 241
GL YLH+ +I+RD+K +N+L+D G +++DFG A +L G +++GT
Sbjct: 115 GLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ APE + Q DV+S G V++E+ + +
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 66/197 (33%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
+G G FG V+ G L + N VA+K + +FL E +L HPN+V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
Q+ +Y M L D L L L +++ AA G+EYL K I
Sbjct: 63 T---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT--YGYCAPEYAKTGQLT 256
+RDL N L+ K+SDFG+++ D + ST M + APE G+ +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 257 LKSDVYSFGVVLLEILS 273
+SDV+SFG++L E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 74/270 (27%), Positives = 121/270 (44%), Gaps = 27/270 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ G + + VAIK + G +F+ E ++ L HP LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-VAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+V E+M G + L+ L + L + + + G+EYL + I+
Sbjct: 70 QQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIH 123
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLK 258
RDL N L+ K+SDFG+ + V D+ + S+ + PE + + K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 259 SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 318
SDV+SFGV++ E+ + K K+ E + + +R + P+L
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYE---------VVEMISRGFRLYRPKLASMT--- 229
Query: 319 GFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
Y+ V C HE+P+ RP A+++ A+
Sbjct: 230 -VYE---VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHP 129
+F ++G+G FG+V + A+K +++ R L E +L L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEY 188
LVNL D + LV + + G + HL + ++K LEY
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----EQVKFWICEIVLALEY 115
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH K +I+RD+K NILLD H ++DF +A T T GT GY APE
Sbjct: 116 LHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPE 169
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRK 276
++ D +S GV E L G++
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 4e-19
Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 80 LGEGGFGRVY----KGYLESINQD------------VAIKQLDRNGVQGNR-EFLVEVLM 122
LGEG FG V+ +G + +++D VA+K L + + R +FL E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 123 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD-------WNTR 175
+S L PN++ L+ C D ++ EYM G + L P + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
+ +A A G++YL + ++RDL N L+ + Y K++DFG+++ GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 295
R + + + E G+ T SDV++FGV L EIL+ K S+ + EQ ++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTGE 248
Query: 296 LFQDRTRHSLIADPEL 311
F+D+ R + P L
Sbjct: 249 FFRDQGRQVYLPKPAL 264
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 4e-19
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPNLVNLIGY 137
+G+G FG V K +S + + K++D N + ++ LV EV +L L HPN+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 138 CADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--DKA 193
D + L V EY G + + +K ++ +I L H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
V++RDLK +NI LD + KL DFGLAK+ +G ++ + +GT Y +PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTPYYMSPEQLNHM 185
Query: 254 QLTLKSDVYSFGVVLLEILSGR 275
KSD++S G ++ E+ +
Sbjct: 186 SYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 5e-19
Identities = 69/228 (30%), Positives = 111/228 (48%), Gaps = 26/228 (11%)
Query: 55 DQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR 114
++I + T + K + +G+G G VY + Q+VAIKQ++ Q +
Sbjct: 2 EEILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKK 60
Query: 115 EFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 173
E ++ E+L++ HPN+VN + GD+ +V EY+ GS+ D + +
Sbjct: 61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------- 109
Query: 174 TRMKIAAGAA------RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLG 226
T M AA + LE+LH VI+RD+K NILL KL+DFG A++
Sbjct: 110 TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
P + + ST V GT + APE K D++S G++ +E++ G
Sbjct: 167 P--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 5e-19
Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 32/269 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+G+G FG V+KG + VAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+ ++ EY+ GS D L PG PLD I +GL+YLH + K I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLE---PG--PLDETQIATILREILKGLDYLHSEKK---I 123
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 258
+RD+K +N+LL KL+DFG+A G + D +GT + APE K K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 259 SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY--P 316
+D++S G+ +E+ G L+ P P L+G Y P
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNYSKP 228
Query: 317 PRGFYQALAVAAMCVHEQPDMRPVIADVV 345
+ F +A C++++P RP +++
Sbjct: 229 LKEFVEA------CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 7e-19
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 79 LLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPNL 131
LGEG FG+V K ++ VA+K L + + + + + E+ M+ ++ H N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----GKKPLDWNTRMKI--------A 179
+NL+G C +V EY G++ D L P + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
ARG+E+L K I+RDL N+L+ + K++DFGLA+ + +
Sbjct: 139 YQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTN 193
Query: 240 G--TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
G + APE T +SDV+SFGV+L EI +
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-19
Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
++ R E LG+G FG V+ G + VAIK L + G FL E ++ L H L
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 63
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L ++ + +V EYM GS+ D L K L + +AA A G+ Y+
Sbjct: 64 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVE- 119
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYA 250
+ ++RDL+ +NIL+ K++DFGLA+L + DN + + + + APE A
Sbjct: 120 --RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 251 KTGQLTLKSDVYSFGVVLLEI 271
G+ T+KSDV+SFG++L E+
Sbjct: 176 LYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 72/203 (35%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIG 136
+G G FG VY N+ VA+K++ +G Q N ++ + EV L L HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
LV EY LGS D L KKPL I GA +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHNM-- 142
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---AKTG 253
I+RD+K NILL KL+DFG A ++ +GT + APE G
Sbjct: 143 -IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEG 195
Query: 254 QLTLKSDVYSFGVVLLEILSGRK 276
Q K DV+S G+ +E L+ RK
Sbjct: 196 QYDGKVDVWSLGITCIE-LAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 8e-19
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 80 LGEGGFGRVY--KGYLESINQD---VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG+V+ + Y QD VA+K L ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------GKKP--LDWNTRMKIAAGAARG 185
G C +GD ++V+EYM G + L P G +P L + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
+ YL A ++RDL N L+ K+ DFG+++ D V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
PE + T +SDV+S GVVL EI +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 9e-19
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LG+G FG VY+G + + +D VAIK ++ R EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDL------SPGKKPLDWNTRMKIAAGAARGLE 187
L+G + G L++ E M G ++ +L L +P + P +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YL+ ++RDL N ++ + K+ DFG+ + D + + + +P
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEI 271
E K G T SDV+SFGVVL EI
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 9e-19
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 79 LLGEGGFGRVYKGYL---ESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVN 133
+LGEG FG V +G L + VA+K + + + EFL E + HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 134 LIGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGAARG 185
LIG C + +++ +M G + L G P + K A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD---NTHVSTRVMGTY 242
+EYL ++ I+RDL N +L ++DFGL+K GD ++ +
Sbjct: 126 MEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ A E T KSDV++FGV + EI +
Sbjct: 181 -WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 74 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHH 128
F+ +LG G FG VYKG E + VAIK+L + + N+E L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH---DLSPGKKPLDWNTRMKIAAGAARG 185
P++ L+G C +L + + MP G + D++ D + L+W ++ A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
+ YL ++ +++RDL N+L+ H K++DFGLAKL + + + +
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVD 279
A E T +SDV+S+GV + E+++ G K D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 70/217 (32%), Positives = 98/217 (45%), Gaps = 36/217 (16%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLML-SLLHHPNLVNLIG- 136
++GEG +G+VYK + Q VAIK +D + E E +L +HPN+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 137 -----YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IAAGAARG 185
+ DQ LV E GSV D + K R+K I RG
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRG 125
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTY 242
L YLH+ VI+RD+K NILL + KL DFG+ A+L D+T + R +GT
Sbjct: 126 LAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DST-LGRRNTFIGTP 177
Query: 243 GYCAPE-----YAKTGQLTLKSDVYSFGVVLLEILSG 274
+ APE +SDV+S G+ +E+ G
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH 127
A K + +G+G FG V G + VA+K + + + FL E +++ L
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLR 57
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
H NLV L+G + L +V EYM GS+ D+L S G+ L + +K + +
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAM 115
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 245
EYL ++RDL N+L+ K+SDFGL K D + + +
Sbjct: 116 EYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WT 166
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS-GR 275
APE + + + KSDV+SFG++L EI S GR
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 39/217 (17%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQL-------DRNGVQGNREFLVEVLMLSLLHHP 129
LGEG + VYK + + VAIK++ ++G+ N L E+ +L L HP
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQELKHP 62
Query: 130 NLVNLIG-YCADGDQRL-LVYEYMPLGSVEDHLHD----LSPG-KKPLDWNTRMKIAAGA 182
N++ L+ + + LV+E+M +E + D L+P K T
Sbjct: 63 NIIGLLDVFGH--KSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT-------- 111
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD-NTHVSTRVMGT 241
RGLEYLH +++RDLK +N+L+ KL+DFGLA+ G N ++ +V+ T
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNRKMTHQVV-T 165
Query: 242 YGYCAPEY---AKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE A+ + D++S G + E+L
Sbjct: 166 RWYRAPELLFGAR--HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-18
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQ--LDRNGVQGN----REFLVEVLMLSLLHHPNLV 132
+LG+G +G VY G L + Q +A+KQ LD + V + EV +L L H N+V
Sbjct: 7 VLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
+G C D + + E++P GS+ L+ P +P+ +I G A YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNN 121
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK----LGPVGDNTHVSTRVMGTYGYCAPE 248
V++RD+K +N++L KL DFG A+ +G G ++++ + GT + APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
KSD++S G + E+ +G+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE----------FLVEVLMLSLLHH 128
L+G+G +GRVY + + +A+KQ++ R E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
N+V +G+ + + EY+P GS+ L ++ L ++ GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAY 123
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM---GTYGYC 245
LH K +++RDLK N+L+D K+SDFG++K D+ + + + M G+ +
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYDNDQNMSMQGSVFWM 177
Query: 246 APEYAKTGQ--LTLKSDVYSFGVVLLEILSGRK 276
APE + + K D++S G V+LE+ +GR+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 70/282 (24%), Positives = 124/282 (43%), Gaps = 32/282 (11%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLH 127
NF+ E +G+G F VYK + VA+K++ + + ++ L E+ +L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
HPN++ + + ++ +V E G + + K+ + T K LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
++H K +++RD+K +N+ + KL D GL + T + ++GT Y +P
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 175
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR-HSLI 306
E KSD++S G +L E+ AA QS P + D+ +SL
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM------------AALQS------PFYGDKMNLYSLC 217
Query: 307 ADPELQGQYPP---RGFYQAL-AVAAMCVHEQPDMRPVIADV 344
E + YPP + + L + + C++ P+ RP I+ V
Sbjct: 218 KKIE-KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 36/288 (12%)
Query: 74 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHH 128
+ +LG G FG VYKG E++ VAIK L N + N+E L E +++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH---DLSPGKKPLDWNTRMKIAAGAARG 185
P + L+G C +L V + MP G + D++ D + L+W ++ A+G
Sbjct: 69 PYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKG 121
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
+ YL + +++RDL N+L+ H K++DFGLA+L + + + + +
Sbjct: 122 MSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304
A E + T +SDV+S+GV + E+++ G K D R
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG----------------IPAREIPD 222
Query: 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352
L+ E Q PP + C + RP ++V + +A
Sbjct: 223 LLEKGERLPQ-PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-18
Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 11/203 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
++ R + LG+G FG V+ G + VAIK L + G FL E ++ L H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L ++ + +V E+M GS+ D L + K L + +AA A G+ Y+
Sbjct: 64 VPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIE- 119
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYA 250
+ I+RDL+ +NIL+ K++DFGLA+L + DN + + + + APE A
Sbjct: 120 --RMNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 251 KTGQLTLKSDVYSFGVVLLEILS 273
G+ T+KSDV+SFG++L E+++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 5e-18
Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 35/206 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL------DRNGVQGNREFLVEVLMLSLLHHPNLVN 133
+G G +G VYK + + VAIK + D +Q E+ ML HPN+V
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ------EISMLKECRHPNIVA 64
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA---AGAARGLEYLH 190
G D+ +V EY GS++D + PL + ++IA +GL YLH
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVT---RGPL---SELQIAYVCRETLKGLAYLH 118
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAP 247
+ K I+RD+K +NILL KL+DFG+ A+L T ++ R +GT + AP
Sbjct: 119 ETGK---IHRDIKGANILLTEDGDVKLADFGVSAQL----TAT-IAKRKSFIGTPYWMAP 170
Query: 248 EYA---KTGQLTLKSDVYSFGVVLLE 270
E A + G K D+++ G+ +E
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 66/201 (32%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLH-HPNLVNL 134
+LG+G FG+V L+ + A+K L ++ + + + + E +LSL HP L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 135 IGYCADGDQRLL-VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
C RL V E++ G + H+ + D AA L +LHDK
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG 116
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+IYRDLK N+LLD H KL+DFG+ K G + + ST GT Y APE +
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG-IFNGKTTST-FCGTPDYIAPEILQEM 171
Query: 254 QLTLKSDVYSFGVVLLEILSG 274
D ++ GV+L E+L G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 8e-18
Identities = 60/198 (30%), Positives = 84/198 (42%), Gaps = 21/198 (10%)
Query: 83 GGFGRVYKGYLESINQDVAIKQLDR------NGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
G FG VY S AIK L + N V + +M+ P + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK--AERAIMMIQGESPYVAKLYY 64
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
D LV EY+ G + L G P DW + A G+E LH +
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAK--QYIAEVVLGVEDLHQRG--- 117
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
+I+RD+K N+L+D+ H KL+DFGL++ G + + +GT Y APE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDD 171
Query: 257 LKSDVYSFGVVLLEILSG 274
SD +S G V+ E L G
Sbjct: 172 KMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 8e-18
Identities = 57/209 (27%), Positives = 88/209 (42%), Gaps = 27/209 (12%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVN 133
++GEG +G V K ++ + VAIK+ D V+ + L EV +L L H N+VN
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK--KTALREVKVLRQLRHENIVN 64
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
L + LV+EY+ L L L + + + Y H
Sbjct: 65 LKEAFRRKGRLYLVFEYVE----RTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+I+RD+K NIL+ KL DFG A+ + ++ V T Y APE
Sbjct: 121 ---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE----- 171
Query: 254 QLTLKS-------DVYSFGVVLLEILSGR 275
L + DV++ G ++ E+L G
Sbjct: 172 -LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-18
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 15/212 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
+F +LG+G FG+V + ++ AIK L ++ + + + +VE +L+L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 130 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
+ + C RL V EY+ G + H+ + K+P + AA A GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEIAIGLFF 116
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 247
LH K +IYRDLK N++LD H K++DFG+ K G T TR GT Y AP
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAP 170
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
E D ++FGV+L E+L+G+ D
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 69/207 (33%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
L+GEG +G V K + Q VAIK+ D V + + E+ ML L H NLVNL
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV--KKIAMREIRMLKQLRHENLVNL 65
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDH--LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
I + LV+E++ DH L DL LD + K RG+E+ H
Sbjct: 66 IEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEY-- 249
+I+RD+K NIL+ + KL DFG A+ L G+ V T + T Y APE
Sbjct: 120 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLV 173
Query: 250 --AKTGQLTLKSDVYSFGVVLLEILSG 274
K G+ D+++ G ++ E+L+G
Sbjct: 174 GDTKYGRAV---DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 9e-18
Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 14/222 (6%)
Query: 55 DQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR 114
++I + T + K + +G+G G V+ + Q+VAIKQ++ Q +
Sbjct: 2 EEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKK 60
Query: 115 EFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 173
E ++ E+L++ L +PN+VN + GD+ +V EY+ GS+ D + + +D
Sbjct: 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-----MDEA 115
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNT 232
+ + LE+LH VI+RD+K N+LL KL+DFG A++ P + +
Sbjct: 116 QIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQS 170
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
ST V GT + APE K D++S G++ +E++ G
Sbjct: 171 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 15/206 (7%)
Query: 79 LLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLV 132
LG G FG V+ E V +K L + + EF E+ M L H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHL-----HDLSPGKKPLDWNTRMKIAAGAARGLE 187
L+G C + + ++ EY LG ++ L D PL ++ + A G++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+L + ++RDL N L+ K+S L+K + + + AP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLRWLAP 187
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E + + KSDV+SFGV++ E+ +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 68/208 (32%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV------EVLMLSLLHHPNLVN 133
+GEG +G V+K Q VAIK+ V+ + ++ E+ ML L HPNLVN
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDH--LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
LI + LV+EY DH L++L + + + KI + + + H
Sbjct: 65 LIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH- 117
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNT-HVSTRVMGTYGYCAPE 248
K I+RD+K NIL+ + KL DFG A++ GP D T +V+TR Y APE
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE 170
Query: 249 YAKTGQLTLKS--DVYSFGVVLLEILSG 274
G DV++ G V E+L+G
Sbjct: 171 LL-VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 15/212 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
+F +LG+G FG+V + ++ AIK L ++ V + + +VE +L+L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 130 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
+ + C RL V EY+ G + H+ + K+P + AA + GL +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFF 116
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 247
LH + +IYRDLK N++LD H K++DFG+ K V V+TR GT Y AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIAP 170
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
E D +++GV+L E+L+G+ D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIG 136
LG G FGRV + + AIK L + + ++ E +L L HP +VN++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKP 195
D ++ + E++ G + HL G+ P N K A EYLH K
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR--KAGRFP---NDVAKFYHAELVLAFEYLHSKD-- 138
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
+IYRDLK N+LLD H K++DFG AK V D T + GT Y APE ++
Sbjct: 139 -IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---LCGTPEYLAPEVIQSKGH 192
Query: 256 TLKSDVYSFGVVLLEILSG 274
D ++ GV+L E ++G
Sbjct: 193 GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPN 130
FR +LG+GGFG V + + + A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+VNL D LV M G ++ H++++ G + + AA GLE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLH 119
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ +YRDLK NILLD H ++SD GLA P G++ + RV GT GY APE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ TL D + G ++ E++ G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNL 134
+GEG FG VY+G S + VA+K RE FL E ++ HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
IG + + +V E PLG + +L K LD + + + + L YL K
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR- 127
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAKTG 253
++RD+ N+L+ KL DFGL++ + D ++ +++ + APE
Sbjct: 128 --FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFR 183
Query: 254 QLTLKSDVYSFGVVLLEILS 273
+ T SDV+ FGV + EIL
Sbjct: 184 RFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 77 ESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLV 132
+ ++G G FG V++G L+ + VAIK L + R +FL E ++ H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
L G +++ EYM G+++ +L D ++ G A G++YL D
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDM 126
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAK 251
++RDL NIL++ K+SDFGL++ L + T+ ++ + APE
Sbjct: 127 N---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 252 TGQLTLKSDVYSFGVVLLEILS 273
+ T SDV+SFG+V+ E++S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 77 ESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNL 131
E ++G G FG V +G L+ + VAIK L ++G + R+FL E ++ HPN+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
++L G +++ E+M G+++ L + G+ + M G A G++YL +
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGM--LRGIAAGMKYLSE 124
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCA 246
++RDL NIL++ K+SDFGL++ + D+T T G + A
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRF--LEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILS 273
PE + T SDV+S+G+V+ E++S
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPN 130
FR +LG+GGFG V + + + A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V+L D LV M G ++ H++++ D + AA GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLH 119
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ ++YRDLK NILLD H ++SD GLA P G+ + RV GT GY APE
Sbjct: 120 RER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVV 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
K + T D + G ++ E++ G+
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 2e-17
Identities = 72/203 (35%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIG 136
+G G FG VY N+ VAIK++ +G Q N ++ + EV L + HPN + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
LV EY LGS D L KKPL I GA +GL YLH
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 145
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---AKTG 253
+I+RD+K NILL KL+DFG A + ++ +GT + APE G
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEG 199
Query: 254 QLTLKSDVYSFGVVLLEILSGRK 276
Q K DV+S G+ +E L+ RK
Sbjct: 200 QYDGKVDVWSLGITCIE-LAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 80 LGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LG+G FG VY+G I VA+K ++ + R EFL E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDL------SPGKKPLDWNTRMKIAAGAARGLE 187
L+G + G L+V E M G ++ +L L +PG+ P +++AA A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YL+ K ++RDL N ++ + K+ DFG+ + D + + + AP
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E K G T SD++SFGVVL EI S
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 80 LGEGGFGRVYKGY--LESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIG 136
LG G FG V KG + DVAIK L + R E + E ++ L +P +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLEYLHDKAKP 195
C + + +LV E G L+ GKK + + +++ + G++YL K
Sbjct: 63 VC-EAEALMLVMEMASGGP----LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN-- 115
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYAKT 252
++RDL N+LL ++ K+SDFGL+K LG D+++ R G + + APE
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINF 172
Query: 253 GQLTLKSDVYSFGVVLLEILS 273
+ + +SDV+S+G+ + E S
Sbjct: 173 RKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 137
+GEG G V+K + VA+K++ ++G + L E+ L HP +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
G +LV EYMP + + L D +PL +G+ Y+H +
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---I 120
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--YAKTGQL 255
++RDLK +N+L+ K++DFGLA+L + S +V T Y APE Y +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGAR-KY 178
Query: 256 TLKSDVYSFGVVLLEILSGR 275
D+++ G + E+L+G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 74 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLH 127
LL EG FGR++ G L ++V +K + + +Q L E +L L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGLS 66
Query: 128 HPNLVNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHD--LSPGKKPLDWNTR--MKIAAGA 182
H N++ ++ C DG+ ++Y YM G+++ L L P +T+ + +A
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGP-----VGDNTHVST 236
A G+ YLH + VI++D+ N ++D K++D L++ L P +GDN +
Sbjct: 127 ACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M A E + + SDV+SFGV+L E+++
Sbjct: 184 KWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-17
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNRE---FLVEVLMLSLLH 127
N+R LLG+G FGRVY Y +++A+KQ+ D + ++E E+ +L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 128 HPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
H +V G D +R L E+MP GS++D L L N K G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEG 118
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 244
+ YLH +++RD+K +NIL D + KL DFG +K L + + V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+PE K+D++S G ++E+L+ +
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHHPNLVNLIGY 137
LG+G FG + V K+++ R + R+ L E+++LSLL HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
D + L+ EY G++ D + + + + + + Y+H K +
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 257
++RD+K NI L + KL DFG++K+ +G ++ V+GT Y +PE + +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 258 KSDVYSFGVVLLEILSGRKAVDTS 281
KSD+++ G VL E+L+ ++ D +
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
++ + E LG G FG V+ + VA+K + + G FL E ++ L H L
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKL 63
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L + ++ E+M GS+ D L K+PL + +A A G+ ++
Sbjct: 64 VKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ 120
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYA 250
+ I+RDL+ +NIL+ K++DFGLA++ + DN + + + APE
Sbjct: 121 RN---YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAI 175
Query: 251 KTGQLTLKSDVYSFGVVLLEILS-GR 275
G T+KSDV+SFG++L+EI++ GR
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 19/193 (9%)
Query: 98 QDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-VYEYMPL 153
+VAIK L + + + F E + + L+HPN+V L+ L V+EY+P
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---D 210
++ + L L ++ L H++ +++RDLK NI++
Sbjct: 64 RTLREVLA----ADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 211 RGYHPKLSDFGLAKLGP-VGDNTHV----STRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 265
H K+ DFG+ L P V D +T V+GT YCAPE + +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 266 VVLLEILSGRKAV 278
++ LE L+G++ V
Sbjct: 177 LIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 68/198 (34%), Positives = 91/198 (45%), Gaps = 19/198 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIG 136
+G G FG VY ++ VAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
LV EY LGS D L KKPL + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---AKTG 253
+I+RD+K NILL KL DFG A + + +GT + APE G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVILAMDEG 189
Query: 254 QLTLKSDVYSFGVVLLEI 271
Q K DV+S G+ +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV--EVLMLSLLHHP 129
+ +G G FGRV+ A+K + ++ +E V E +L + HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 130 NLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
++ L + + DQR L + EY+P G + +L + G+ +T + A+ LE
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR--NSGR--FSNSTGLFYASEIVCALE 115
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YLH K ++YRDLK NILLD+ H KL+DFG AK + D T + GT Y AP
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LCGTPEYLAP 167
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
E ++ D ++ G+++ E+L G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-17
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIG 136
LG+GGFG V +++ + A K+LD+ ++ G + L+E +L ++ P +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 137 YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
Y + L LV M G ++ H++++ G++ L+ + +A G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
++YRD+K N+LLD + +LSD GLA G T+ GT GY APE K
Sbjct: 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPY 171
Query: 256 TLKSDVYSFGVVLLEILSGR 275
+ D ++ G + E+++GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPN 130
FR +LG+GGFG V + + + A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V+L D LV M G ++ H++ + G+ + + AA GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ ++YRDLK NILLD H ++SD GLA P G + RV GT GY APE
Sbjct: 120 ---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVV 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282
K + T D ++ G +L E+++G+ K
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNRE---FLVEVLMLSLLH 127
N+R LLG+G FGRVY Y +++A KQ+ D + ++E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 128 HPNLVNLIGYCADGDQRLLV--YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
H +V G D ++ L EYMP GSV+D L L + K G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEG 118
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 244
+ YLH +++RD+K +NIL D + KL DFG +K L + + V GT +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+PE K+DV+S G ++E+L+ +
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 67/279 (24%), Positives = 121/279 (43%), Gaps = 30/279 (10%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHP 129
NF+ E +G G F VY+ + VA+K++ + + ++ + E+ +L L+HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N++ + + ++ +V E G + + K+ + T K +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H + V++RD+K +N+ + KL D GL + T + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309
KSD++S G +L E+ AA QS P + D+ +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM------------AALQS------PFYGDKMNLFSLCQK 219
Query: 310 ELQGQYPP---RGFYQAL-AVAAMCVHEQPDMRPVIADV 344
Q YPP + + L + +MC++ PD RP I V
Sbjct: 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 1e-16
Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 50/218 (22%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF--------LVEVLML-SLLHHPN 130
LG+G FG VY + + VAIK++ ++F L EV L L HPN
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGAARGLEY 188
+V L + D+ V+EYM E +L+ L KP + I +GL +
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN----THVSTRVMGTYGY 244
+H K +RDLK N+L+ K++DFGLA+ + +VSTR Y
Sbjct: 115 IH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WY 164
Query: 245 CAPEYAKTGQLTLKSDVYS-------FGVVLLEILSGR 275
APE + L+S YS G ++ E+ + R
Sbjct: 165 RAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 2e-16
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+G+G FG V+KG Q VAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
G + ++ EY+ GS D L P D + +GL+YLH + K I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSEKK---I 123
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 258
+RD+K +N+LL KL+DFG+A G + D +GT + APE + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 259 SDVYSFGVVLLEILSG 274
+D++S G+ +E+ G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 38/278 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-LSLLHH---PNLVNLI 135
LG G G V K +A K + + ++L L ++H P +V+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH---IGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 136 G-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
G + + + + E+M GS++ P + KIA GL YL++ +
Sbjct: 70 GAFLNENNI-CMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAPEYAKT 252
+++RD+K SNIL++ KL DFG++ G+ N+ T V GT Y +PE +
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFV-GTSTYMSPERIQG 176
Query: 253 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 312
G+ T+KSDV+S G+ ++E+ G+ A + P+ ++ +P +
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPF----AFSNIDDDGQDDPMGILDLLQQIVQEPPPR 232
Query: 313 ---GQYPP--RGFYQALAVAAMCVHEQPDMRPVIADVV 345
+P R F A C+ + P RP +
Sbjct: 233 LPSSDFPEDLRDFVDA------CLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHHPN 130
+ +GEG FG++Y +S ++ IK++D + V+ EV++L+ + HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAARGL 186
+V + + +V EY G + ++ L + L W ++ + GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GL 114
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
+++HD+ +++RD+K NI L + G KL DFG+A+ + D+ ++ +GT Y
Sbjct: 115 KHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYL 169
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEI 271
+PE + K+D++S G VL E+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLD-----RNGVQGNREFLVEVLMLSLLHHP 129
LGEG FG V +G L NQD VA+K + R+ ++ +FL E + + HP
Sbjct: 7 LGEGEFGSVMEGQL---NQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHP 60
Query: 130 NLVNLIGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAG 181
N++ LIG C + +++ +M G + L G P T+M K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
A G+EYL K+ I+RDL N +L+ + ++DFGL+K GD
Sbjct: 121 IASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 271
+ A E T KSDV+SFGV + EI
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPN 130
FR +LG+GGFG V + + + A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V+L D LV M G ++ H++++ G D + AA GLE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ ++YRDLK NILLD H ++SD GLA P G+ V RV GT GY APE
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVI 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ T D + G ++ E++ G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSL-LHHPNLVNL 134
+LG+G FG+V L+ ++ AIK L ++ + + + + E +L+L HP L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
D+ V EY+ G D + + +K D AA L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
VIYRDLK NILLD H KL+DFG+ K G + T +T GT Y APE + +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELE 172
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
D ++ GV++ E+++G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-16
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNR-EFLVEVLMLSLLHH 128
+ E ++G G FG V G L+ + VAIK L + R +FL E ++ H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGL 186
PN+++L G ++V EYM GS++ L HD L + + G A G+
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGM 119
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG---TYG 243
+YL D ++RDL NIL++ K+SDFGL+++ + D+ + G
Sbjct: 120 KYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIR 174
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE + T SDV+S+G+V+ E++S
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 24/202 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+GEG G V +S + VA+K++D Q RE L EV+++ HPN+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM---KIAA---GAARGLEYLHDK 192
GD+ +V E++ G++ D + +TRM +IA + L +LH +
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVT-----------HTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
VI+RD+K +ILL KLSDFG V ++GT + APE
Sbjct: 135 G---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 253 GQLTLKSDVYSFGVVLLEILSG 274
+ D++S G++++E++ G
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNRE---FLVEVLMLSLLH 127
N+R LLG G FG VY Y +++A+KQ+ D + + ++E E+ +L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 128 HPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
H +V G D +++ L EYMP GS++D L L N + +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA----LTENVTRRYTRQILQG 118
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 244
+ YLH +++RD+K +NIL D + KL DFG +K + + + V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+PE K+DV+S ++E+L+
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLH 127
F + +GEG +G VY+ + + VA+K++ +R+G+ + L E+ +L L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLR 64
Query: 128 HPNLVNLIGYCADGDQR---LLVYEY--MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 182
HPN+V L G LV EY L S+ D++ P + +
Sbjct: 65 HPNIVELKEVVV-GKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQL 117
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
RGL+YLH+ +I+RDLK SN+LL K++DFGLA+ G T + T
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTL 172
Query: 243 GYCAPE--YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE T T D+++ G +L E+L+ +
Sbjct: 173 WYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 7e-16
Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+G+G G VY + Q+VAI+Q++ Q +E ++ E+L++ +PN+VN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
GD+ +V EY+ GS+ D + + +D + + LE+LH VI
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQ---VI 138
Query: 199 YRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 257
+RD+K NILL KL+DFG A++ P + ++GT + APE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 258 KSDVYSFGVVLLEILSG 274
K D++S G++ +E++ G
Sbjct: 196 KVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 7e-16
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 80 LGEGGFGRVYKGYLE--SINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
LG G FG V KG + + VA+K L D N E L E ++ L +P +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
G C + + +LV E LG L+ K + ++ + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY--GYCAPEYAKTG 253
++RDL N+LL ++ K+SDFGL+K D + + G + + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 254 QLTLKSDVYSFGVVLLEILS 273
+ + KSDV+SFGV++ E S
Sbjct: 174 KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 7e-16
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 14/197 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+G+G G VY + Q+VAIKQ++ Q +E ++ E+L++ +PN+VN +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
GD+ +V EY+ GS+ D + + +D + + L++LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALDFLHSNQ---VI 137
Query: 199 YRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 257
+RD+K NILL KL+DFG A++ P + + ST V GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 258 KSDVYSFGVVLLEILSG 274
K D++S G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-16
Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 33/227 (14%)
Query: 80 LGEGGFGRVYKGYLESINQD----------VAIKQLDRNGVQGNREFLVEVLMLSLLHHP 129
LG+G F +YKG L + V +K L + + F ++S L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHK 61
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
+LV L G C D+ ++V EY+ G ++ LH L W ++ +A A L YL
Sbjct: 62 HLVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYL 117
Query: 190 HDKAKPPVIYRDLKCSNILLDR-----GYHP--KLSDFGLAKLGPVGDNTHVSTRVMGTY 242
DK +++ ++ NIL+ R GY P KLSD G+ V R+
Sbjct: 118 EDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI---- 168
Query: 243 GYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
+ APE + GQ LT+ +D +SFG LLEI S + ++ +++E+
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPN 130
LGEG FG+V I++D VA+K L + + + LV E+ M+ ++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKI 178
++NL+G C ++ EY G++ ++L P + + + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
ARG+EYL A I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE T +SDV+SFGV++ EI +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 45/223 (20%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLV----EVLMLSLLHHPNLV 132
+GEG +G+VYK + + VA+K++ + +E F + E+ +L L+H N+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 133 NLIGYCADGDQRL----------LVYEYMP---LGSVEDHL------HDLSPGKKPLDWN 173
NL D L LV+EYM +G +E L H S K+ L+
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE-- 127
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
GL Y H K ++RD+KCSNILL+ KL+DFGLA+L ++
Sbjct: 128 -----------GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 234 VSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGR 275
+ +V+ T Y PE + + DV+S G +L E+ + +
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 70/282 (24%), Positives = 109/282 (38%), Gaps = 26/282 (9%)
Query: 80 LGEGGFGRVYKGYLESINQD--VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+G G FG+V G V +K+L FL EV L+HPN++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL-DWNTRMKIAAGAARGLEYLHDKAKP 195
C + LLV E+ PLG ++++L + + ++A A GL +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----- 250
I+ DL N L K+ D+GLA D + APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 251 --KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308
T KS+++S GV + E L + EQ L R + +
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWE-LFTAADQPYPDLSDEQVLKQVV------REQDIKLPK 232
Query: 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350
P+L +Y R +Y+ + + P+ RP +V L Y
Sbjct: 233 PQLDLKYSDR-WYEVMQFCWL----DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 80 LGEGGFGRV----YKGYLESINQDVAIKQLD-RNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG+V Y ++ + VA+K L +G + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 135 IGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
G C + L+ E++P GS++++L K ++ ++K A +G++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST----RVMGTYGYCAPE 248
++RDL N+L++ + K+ DFGL K + + T + Y APE
Sbjct: 129 Q---YVHRDLAARNVLVESEHQVKIGDFGLTK--AIETDKEYYTVKDDLDSPVFWY-APE 182
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILS 273
+ + SDV+SFGV L E+L+
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 45/217 (20%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQ----LDRNGVQGN--REFLVEVL-MLSLLHHPN 130
+ +GEG +G VYK + + VA+K+ L G+ + RE + +L L HPN
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE--IALLKQLESFEHPN 62
Query: 131 LVNLIGYCA--DGDQRL---LVYEYMPLGSVEDHLHDL-----SPGKKPLDWNTRMKIAA 180
+V L+ C D+ L LV+E+ V+ L PG L T +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPG---LPPETIKDLMR 114
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
RG+++LH +++RDLK NIL+ K++DFGLA+ + T V+
Sbjct: 115 QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVV 168
Query: 241 TYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEI 271
T Y APE YA D++S G + E+
Sbjct: 169 TLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM---LSLLHH 128
+ + +G G G+VYK + +A+KQ+ R G N+E +LM + L H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSH 71
Query: 129 --PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
P +V GY + E M + D L L + P+ + K+ + L
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELM--STCLDKL--LKRIQGPIPEDILGKMTVAIVKAL 127
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
YL K K VI+RD+K SNILLD + KL DFG++ G + D + TR G Y A
Sbjct: 128 HYL--KEKHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCAAYMA 182
Query: 247 PEY----AKTGQLTLKSDVYSFGVVLLEILSGR 275
PE + +++DV+S G+ L+E+ +G+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 32/280 (11%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHP 129
NFR E +G G F VY+ VA+K++ D + + + E+ +L L+HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N++ + ++ +V E G + + K+ + T K LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H + V++RD+K +N+ + KL D GL + T + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR-HSLIAD 308
KSD++S G +L E+ AA QS P + D+ +SL
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM------------AALQS------PFYGDKMNLYSLCKK 219
Query: 309 PELQGQYPP---RGFYQAL-AVAAMCVHEQPDMRPVIADV 344
E Q YPP + + L + MC++ P+ RP I V
Sbjct: 220 IE-QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPN 130
LGEG FG+V + I++ VA+K L N + L+ E+ ++ L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-------DLSPG-----KKPLDWNTRMKI 178
++NL+G C ++ EY G++ + L D + ++ L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
A ARG+EYL + I+RDL N+L+ K++DFGLA+ D ++
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE T +SDV+SFG+++ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 15/212 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
+F +LG+G FG+V + ++ AIK L ++ V + + +VE +L+L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 130 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
+ + C RL V EY+ G + + + K+P + AA A GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFF 116
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 247
LH K +IYRDLK N++LD H K++DFG+ K + D V+T+ GT Y AP
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-MWDG--VTTKTFCGTPDYIAP 170
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
E D ++FGV+L E+L+G+ +
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 6e-15
Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 41/275 (14%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-----EVLMLSLLHH 128
++ L+G G +G VY+G + VA+K ++ + + V EV +LS L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQ 58
Query: 129 ---PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
PN+ G G + ++ EY GSV + +K + R + A
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA----- 113
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
L+Y+H K VI+RD+K +NIL+ + KL DFG+A L + N+ + +GT +
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWM 168
Query: 246 APEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304
APE G+ K+D++S G+ + E+ +G A L+ ++P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--------- 219
Query: 305 LIADPELQGQYPPRGFYQALA-VAAMCVHEQPDMR 338
P L+ G+ + L A C+ E+P R
Sbjct: 220 ----PRLED----NGYSKLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 51/155 (32%), Positives = 74/155 (47%), Gaps = 20/155 (12%)
Query: 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
KIA + LEYLH K VI+RD+K SN+L++R KL DFG++ G + D+ T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKT 161
Query: 237 RVMGTYGYCAPEY----AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--SLV 290
G Y APE +KSDV+S G+ ++E+ +GR D+ K +Q +V
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221
Query: 291 AWARPL---------FQDRTRHSLIADPELQGQYP 316
P FQD L + + + YP
Sbjct: 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP 256
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPN 130
LGEG FG+V I++D VA+K L + + LV E+ M+ ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKI 178
++NL+G C ++ EY G++ ++L P ++ L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
A ARG+EYL A I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE T +SDV+SFGV+L EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN----REFLVEVLMLSLLHHPNLVNL 134
L+G+GG G VY Y ++ VA+K++ R + N + FL E + + L HP +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 135 IGYCADGDQRLLVYEYMP------LGSVEDHLHDLSPGKKPLDWNTRMK----IAAGAAR 184
C+DGD VY MP L S+ + K L T + I
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL----------------GPV 228
+EY+H K V++RDLK NILL + D+G A
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ + +++GT Y APE + +D+Y+ GV+L ++L+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-15
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG+G FG+VYK + A K +D + +++VE+ +L+ HPN+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ ++ E+ G+V+ + +L ++PL + L YLH+ +I+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIH 126
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEY-----AK 251
RDLK NIL KL+DFG++ NT R +GT + APE +K
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 252 TGQLTLKSDVYSFGVVLLEI 271
K+DV+S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 69/208 (33%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHH---PNLV 132
++G GGFG VY + A+K LD+ + QG L E +MLSL+ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHD 191
+ D+ + + M G + HL + + M+ AA GLE++H+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA----KLGPVGDNTHVSTRVMGTYGYCAP 247
+ V+YRDLK +NILLD H ++SD GLA K P H S +GT+GY AP
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VGTHGYMAP 164
Query: 248 EYAKTGQLTLKS-DVYSFGVVLLEILSG 274
E + G S D +S G +L ++L G
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNL 131
NF+ LGEG + VYKG + + VA+K++ + +G + E+ ++ L H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L ++ +LV+EYM ++ ++ D + LD NT +G+ + H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
V++RDLK N+L+++ KL+DFGLA+ + NT + V T Y AP+
Sbjct: 119 NR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPD-VL 172
Query: 252 TGQLTLKS--DVYSFGVVLLEILSGR 275
G T + D++S G ++ E+++GR
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 30/209 (14%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHH---PNLV 132
++G GGFG VY + A+K LD+ + QG L E +MLSL+ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+ D+ + + M G + HL H + K+ + T + + GLE++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMH 114
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA----KLGPVGDNTHVSTRVMGTYGYCA 246
++ V+YRDLK +NILLD H ++SD GLA K P H S +GT+GY A
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VGTHGYMA 163
Query: 247 PEYAKTGQLTLKS-DVYSFGVVLLEILSG 274
PE + G S D +S G +L ++L G
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
+LG+G +G VY S +AIK++ + + E+ + S L H N+V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGK-KPLDWNTRMKIAAGAA--RGLEYLHDKAKP 195
++ + E +P GS L L K PL N + I GL+YLHD
Sbjct: 75 SENGFFKIFMEQVPGGS----LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ-- 128
Query: 196 PVIYRDLKCSNILLDRGYHP--KLSDFG----LAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
+++RD+K N+L++ Y K+SDFG LA + P + GT Y APE
Sbjct: 129 -IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPCTET------FTGTLQYMAPEV 180
Query: 250 AKTGQ--LTLKSDVYSFGVVLLEILSGR 275
G +D++S G ++E+ +G+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPN 130
LGEG FG+V ++++ VA+K L + + + + + E+ M+ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHL---------HDLSPGKKP---LDWNTRMKI 178
++NL+G C ++ EY G++ ++L + +P + P L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
A ARG+EYL K I+RDL N+L+ K++DFGLA+ D H+
Sbjct: 146 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197
Query: 239 MGTYG-----YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
T G + APE T +SDV+SFGV+L EI +
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 77/283 (27%), Positives = 115/283 (40%), Gaps = 32/283 (11%)
Query: 79 LLGEGGFGRVYKGYLESIN---QDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVN 133
+LG+G FG V + L+S + Q VA+K L D EFL E + HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 134 LIGYC--ADGDQRL----LVYEYMPLGSVEDHLHDLSPGKKP--LDWNTRMKIAAGAARG 185
LIG + RL ++ +M G + L G++P L T ++ A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
+EYL K I+RDL N +L+ ++DFGL+K GD +
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305
A E T SDV++FGV + EI++ + T A E S + + L
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQ---TPYAGVENSEI-----------YNYL 228
Query: 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
I L + PP + C +P RP + L
Sbjct: 229 IKGNRL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLD------RNGVQGNREFLVEVLMLSLLHHPNLVN 133
LG+GGFG V + + + A K+L+ R G +G +VE +L+ +H +V+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGA---MVEKRILAKVHSRFIVS 57
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
L LV M G + H++++ A GLE+LH +
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+IYRDLK N+LLD + ++SD GLA + D + GT G+ APE +
Sbjct: 118 ---IIYRDLKPENVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 254 QLTLKSDVYSFGVVLLEILSGR 275
+ D ++ GV L E+++ R
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 44/212 (20%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVN- 133
++GEG FGR + +Q A+K++ + V+ +R+ E ++L+ + HPN+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 134 ------------LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
++ YC GD + ++ L P L W +M +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDL---------MQKIKLQRGKLFPEDTILQWFVQMCL--- 111
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVM 239
G++++H+K V++RD+K NI L + KL DFG A+L P + T V
Sbjct: 112 ---GVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV- 161
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 271
GT Y PE + KSD++S G +L E+
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 42/213 (19%)
Query: 82 EGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREF----LVEVLMLSLLHHPNLVNL- 134
EG +G VY+ + + VA+K+L ++ +G F L E+ +L L HPN+V +
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEK-EG---FPITSLREINILLKLQHPNIVTVK 70
Query: 135 -IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA---------- 183
+ ++ D+ +V EY+ HDL K ++ MK +
Sbjct: 71 EVVVGSNLDKIYMVMEYVE--------HDL---KSLME---TMKQPFLQSEVKCLMLQLL 116
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
G+ +LHD +++RDLK SN+LL+ K+ DFGLA+ G T+++ T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLW 171
Query: 244 YCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + + D++S G + E+L+ +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG-YC 138
LG+G FG+VYK + A K ++ + +++VE+ +L+ +HP +V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
DG +++ E+ P G+V+ + +L G I L+YLH +I
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLHSMK---II 132
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYA----- 250
+RDLK N+LL KL+DFG++ N R +GT + APE
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 251 KTGQLTLKSDVYSFGVVLLEI 271
K K+D++S G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 34/270 (12%)
Query: 80 LGEGGFGRVYKG-------YLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
LG+G F +++KG Y E +V +K LD++ + F M+S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
G C GD+ ++V EY+ GS++ +L + + W ++++A A L +L DK
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT--YGYCAPEYA 250
+ + ++ N+LL R K + KL G + V + + + PE
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 251 KTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309
+ Q L+L +D +SFG L EI SG D +A + + L RH
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG---GDKPLSALDS-----QKKLQFYEDRH------ 222
Query: 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRP 339
Q P + + + C+ +PD RP
Sbjct: 223 ----QLPAPKWTELANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 73/230 (31%), Positives = 105/230 (45%), Gaps = 68/230 (29%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL-D--RNGVQGNREFLVEVLMLS-LLHHPNLVNLI 135
LG+G +G V+K + VA+K++ D RN R F E++ L L HPN+V L+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73
Query: 136 G-YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA----------- 182
A+ D+ + LV+EYM E LH + I A
Sbjct: 74 NVIKAENDKDIYLVFEYM-----ETDLHAV--------------IRANILEDVHKRYIMY 114
Query: 183 --ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNT------- 232
+ L+Y+H VI+RDLK SNILL+ KL+DFGLA+ L + +N
Sbjct: 115 QLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 275
+V+TR Y APE + L S Y+ GV +L E+L G+
Sbjct: 172 YVATR-----WYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
+G G +G V + + VAIK++ + + R L E+ +L L H N++ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-ILREIKLLRHLRHENIIGL 64
Query: 135 IGYCADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGAARGLEY 188
+ +V E M E LH + +PL + ++ RGL+Y
Sbjct: 65 LDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDHIQYFLYQILRGLKY 118
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY----GY 244
LH A VI+RDLK SNIL++ K+ DFGLA+ D + Y Y
Sbjct: 119 LH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDEKGFLTEYVVTRWY 172
Query: 245 CAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE Y T D++S G + E+L+ +
Sbjct: 173 RAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL---VEVLMLSLLHHPNLVN 133
+G G FG V K + +A+K++ + ++ L ++V+M S P +V
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYIVK 67
Query: 134 LIGYC-ADGDQRLLVYEYMPLGSVED-----HLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
G +GD + E M + S++ + K + KIA + L
Sbjct: 68 FYGALFREGDC-WICMELMDI-SLDKFYKYVYEV----LKSVIPEEILGKIAVATVKALN 121
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCA 246
YL ++ K +I+RD+K SNILLDR + KL DFG++ +L ++ TR G Y A
Sbjct: 122 YLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMA 175
Query: 247 PEYAKTGQLT---LKSDVYSFGVVLLEILSGR 275
PE ++SDV+S G+ L E+ +G+
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 79 LLGEGGFGRVY---KGYLESINQDVAIKQL--------DRNGVQGNREFLVEVLMLSLLH 127
+LG+G FG+V+ K Q A+K L DR + R+ L EV +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------N 56
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 185
HP +V L Y + +L L+ +++ G + L K+ + +K A A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALA 110
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
L++LH +IYRDLK NILLD H KL+DFGL+K + S GT Y
Sbjct: 111 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSG 274
APE T +D +SFGV++ E+L+G
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G VYKG + Q VA+K++ + GV + E+ +L L HPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA--IREISLLKELQHPNIVCLQ 65
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
+ L++E++ + ++ +L D P + +D +G+ + H +
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
V++RDLK N+L+D KL+DFGLA+ G V T + T Y APE
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 256 -TLKSDVYSFGVVLLEILSGR 275
+ D++S G + E+ + +
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 72/238 (30%), Positives = 94/238 (39%), Gaps = 43/238 (18%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVL----MLSLLH 127
K+F+ LLG+G GRV+ L+ + A+K LD+ + R + VL +L+ L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLD 59
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL---SPGKKPLDWNTRMKIAAGAAR 184
HP L L LV +Y P G L L PGK + R AA
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGE----LFRLLQRQPGKCLSEEVARF-YAAEVLL 114
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---------- 234
LEYLH ++YRDLK NILL H LSDF L+K V
Sbjct: 115 ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 235 --------------STRVM---GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
S R GT Y APE D ++ G++L E+L G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
HP LV L C + RL V E++ G + H+ +K + + R +A + L
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQR---QRKLPEEHARF-YSAEISLAL 109
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGY 244
+LH++ +IYRDLK N+LLD H KL+D+G+ K + P GD T + GT Y
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT---STFCGTPNY 162
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
APE + D ++ GV++ E+++GR D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 64/200 (32%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVE-VLMLSLLHHPNLVNLI 135
+G+G FG+V ++ + A+K L + + +E + E ++L + HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAK 194
D+ V +Y+ G + HL +P R + AA A L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSLN- 116
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+IYRDLK NILLD H L+DFGL K G T ++ GT Y APE +
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQP 172
Query: 255 LTLKSDVYSFGVVLLEILSG 274
D + G VL E+L G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 37/217 (17%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVA-------IKQLDRNGVQGNREFLVEVLMLSL 125
+F LG G G V K +A IK RN Q RE L +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN--QIIRE-------LKV 52
Query: 126 LHHPNLVNLIGY----CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
LH N ++G+ +DG+ + + E+M GS++ L G+ P + ++ IA
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLK--KAGRIPENILGKISIAV- 108
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD---NTHVSTRV 238
RGL YL +K K +++RD+K SNIL++ KL DFG++ G + D N+ V TR
Sbjct: 109 -LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFVGTR- 162
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y +PE + T++SD++S G+ L+E+ GR
Sbjct: 163 ----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 66/237 (27%), Positives = 102/237 (43%), Gaps = 49/237 (20%)
Query: 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREF----LVEVL 121
+++ LGEG FG VYK + VA+K++ +++G F L E+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG------FPITALREIK 59
Query: 122 MLSLLHHPNLVNLIGYCAD-----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 176
+L L HPN+V LI + +R VY P HDLS L N +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-----HDLSG----LLENPSV 110
Query: 177 KIAAGAAR--------GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--- 225
K+ + G+ YLH+ +++RD+K +NIL+D K++DFGLA+
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 226 ------GPVGDNTHVSTRVMGTYGYCAPEY-AKTGQLTLKSDVYSFGVVLLEILSGR 275
G G T T ++ T Y PE + T D++ G V E+ + R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+GEG G V + + VA+K++D Q EV+++ HH N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IAAGAARGLEYLHDKA 193
GD+ +V E++ G++ D + +TRM + R L YLH++
Sbjct: 90 VGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIATVCLSVLRALSYLHNQG 138
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
VI+RD+K +ILL KLSDFG V ++GT + APE
Sbjct: 139 ---VIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRL 193
Query: 254 QLTLKSDVYSFGVVLLEILSG 274
+ D++S G++++E++ G
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 54/155 (34%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
+P LV L C RL LV EY+ G + H+ ++ L AA L
Sbjct: 55 NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIAL 109
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGY 244
+LH++ +IYRDLK N+LLD H KL+D+G+ K LGP GD T + GT Y
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNY 162
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
APE + + D ++ GV++ E+++GR D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLI 135
LLG+G FG+V ++ + A+K L + + E + E +L HP L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAK 194
D+ V EY G + HL ++ + R + A LEYLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD- 115
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
V+YRD+K N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
D + GVV+ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 64/200 (32%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLI 135
LLG+G FG+V ++ + A+K L + + E L E +L HP L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
D+ V EY+ G + HL S + + TR A L+YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRF-YGAEIVSALDYLHSGK-- 115
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
++YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 116 -IVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 256 TLKSDVYSFGVVLLEILSGR 275
D + GVV+ E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLI 135
LLG+G FG+V ++ + A+K L + + E L E +L HP L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAK 194
D+ V EY G + HL ++ + R + A L+YLH ++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLH--SE 114
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
D + GVV+ E++ GR
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 52/155 (33%), Positives = 77/155 (49%), Gaps = 13/155 (8%)
Query: 127 HHPNLVNLIGYCADGDQRLL-VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
+HP LV L C + RL V EY+ G + H+ ++ L +A +
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLA 108
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG-PVGDNTHVSTRVMGTYGY 244
L YLH++ +IYRDLK N+LLD H KL+D+G+ K G GD T + GT Y
Sbjct: 109 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNY 162
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
APE + D ++ GV++ E+++GR D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPN 130
+++ S +G G +G+V + + VAIK+L R + + R + E+ +L + H N
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHEN 75
Query: 131 LVNLIG-YCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
++ L+ + VY L + L+++ +K D + + + RGL+
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGAD--LNNIVKCQKLSDDHIQF-LVYQILRGLK 132
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
Y+H +I+RDLK SNI ++ K+ DFGLA+ +V+TR Y AP
Sbjct: 133 YIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 184
Query: 248 E-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
E Y +T D++S G ++ E+L+G+
Sbjct: 185 EIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 36/287 (12%)
Query: 80 LGEGGFGRVYKGYLES--INQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+G G FG+V G + S V +K+L + VQ +FL E L H NL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLH------DLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
C + LLV E+ PLG ++ +L ++P D T ++A A GL +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-----DPTTLQRMACEIALGLLHLH 117
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
K I+ DL N LL K+ D+GL+ D ++ + APE
Sbjct: 118 ---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 251 KT--GQL-----TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303
G L T +S+V+S GV + E+ + +++ ++ + R +
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELF--ELGSQPYRHLSDEQVLT-----YTVREQQ 227
Query: 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350
+ P L+ R +Y+ + + QP+ RP +V L+Y
Sbjct: 228 LKLPKPRLKLPLSDR-WYEVMQFCWL----QPEQRPSAEEVHLLLSY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHPNLVNLIG 136
+G G +G VYK + + AIK + ++ +F V E++M+ H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
D+ + E+ GS++D H P L + ++ +GL YLH K K
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA---KTG 253
++RD+K +NILL H KL+DFG++ + +GT + APE A + G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 254 QLTLKSDVYSFGVVLLEI 271
D+++ G+ +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 137
+GEG FG+ + + IK+++ + + E EV +LS + HPN+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
+ +V +Y G + ++ L P + LDW ++ +A L+++HD+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK 121
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+++RD+K NI L + KL DFG+A++ + ++ +GT Y +PE +
Sbjct: 122 ---ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICENR 176
Query: 254 QLTLKSDVYSFGVVLLEILSGRKA 277
KSD+++ G VL E+ + + A
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 64/213 (30%), Positives = 90/213 (42%), Gaps = 20/213 (9%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLV 132
F L+G G +G+VYKG Q AIK +D G + E E+ ML HH N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 133 NLIGYCAD------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
G DQ LV E+ GSV D + + +W I RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
+LH VI+RD+K N+LL KL DFG++ + +GT + A
Sbjct: 125 SHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMA 179
Query: 247 PEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 274
PE + KSD++S G+ +E+ G
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEV-LMLSLLHHPNLVNL 134
++G+G FG+V +S A+K L + + +E + E ++L L HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKA 193
++ V +Y+ G + HL +P R + AA A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSLN 116
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+IYRDLK NILLD H L+DFGL K G + T ++ GT Y APE +
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 254 QLTLKSDVYSFGVVLLEILSG 274
D + G VL E+L G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+G G FG V + Q+VAIK++ + V R + E+ +L L H N+++L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76
Query: 137 -YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
+ + + V E + LH L + PL+ RGL+Y+H
Sbjct: 77 IFISPLEDIYFVTELL-----GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG-- 128
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ- 254
V++RDLK SNIL++ K+ DFGLA++ +VSTR Y APE T Q
Sbjct: 129 -VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQK 182
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
++ D++S G + E+L G+
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-----EVLMLSLLH---HPNL 131
+G G +G VYK VA+K + VQ N + L EV +L L HPN+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 132 VNLIGYCADG--DQRL---LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
V L+ CA D+ LV+E++ + +L + P P + T + RGL
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAE--TIKDLMRQFLRGL 121
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYC 245
++LH +++RDLK NIL+ G KL+DFGLA++ + ++ T V+ T Y
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYR 174
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
APE D++S G + E+ RK + + A+Q
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 79 LLGEGGFGRVYKGYLESINQD-VAIKQLD-RNGVQGN---------REFLVEVLML-SLL 126
LG G FG VYK ++ Q+ +A+K+++ N G + + EV ++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD----WNTRMKIAAGA 182
HPN+V + D+ +V + + + +H + L K+ WN +++
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
L YLH + + +++RDL +NI+L ++DFGLAK + + T V+GT
Sbjct: 126 ---LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL-TSVVGTI 177
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEI 271
Y PE K K+DV++FG +L ++
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD---------RNGVQGNREFLVEVLM 122
+++ S +GEG +G V + VAIK++ R L E+ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT--------LREIKI 56
Query: 123 LSLLHHPNLVNL------IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 176
L H N++ + + + D +V E M E L+ L + + + +
Sbjct: 57 LRRFKHENIIGILDIIRPPSFESFNDV-YIVQELM-----ETDLYKLIKTQHLSNDHIQY 110
Query: 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG-PVGDNTHVS 235
+ RGL+Y+H V++RDLK SN+LL+ K+ DFGLA++ P D+T
Sbjct: 111 FLYQ-ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGR 275
T + T Y APE + K+ D++S G +L E+LS R
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 45/229 (19%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD------RNGVQGNREFLVEVLMLSLL 126
+F + L+ G +G VY + Q A+K+++ RN +Q + VE +L+
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQ---QVFVERDILTFA 58
Query: 127 HHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 184
+P +V++ +C+ +R L V EY+ G L ++ P+D RM A
Sbjct: 59 ENPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDM-ARMYFAE-TVL 112
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-------STR 237
LEYLH+ +++RDLK N+L+ H KL+DFGL+K+G + T++ TR
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 238 ------VMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSG 274
V GT Y APE Y K D ++ G++L E L G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEV-LMLSLLHHPNLVNL 134
++G+G FG+V + + A+K L + V +E + E ++L + HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKA 193
++ V +++ G + HL +P R + AA A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSIN 116
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
++YRDLK NILLD H L+DFGL K G +T +T GT Y APE +
Sbjct: 117 ---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQ 171
Query: 254 QLTLKSDVYSFGVVLLEILSG 274
D + G VL E+L G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 63/200 (31%), Positives = 88/200 (44%), Gaps = 12/200 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLI 135
LLG+G FG+V ++ + A+K L + + E L E +L HP L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
D+ V EY G + HL + R A L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARF-YGAEIVSALGYLHSCD-- 115
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 256 TLKSDVYSFGVVLLEILSGR 275
D + GVV+ E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 59/235 (25%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLD----RNGVQGNREF----------LVEVLMLSL 125
LGEG +G+V K Y + VAIK++ N V +R+ L E+ +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IA 179
+ H N++ L+ +GD LV + M DL KK +D R+ I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA--------SDL---KKVVDRKIRLTESQVKCIL 125
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-------LGPVGDNT 232
GL LH K ++RDL +NI ++ K++DFGLA+ + +
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 233 HVSTRVMGTYG-----YCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 275
+ R T Y APE L + + D++S G + E+L+G+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPE------LLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 46/204 (22%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNL- 134
+GEG +G VYK + + VA+K++ + GV + E+ +L L+HPN+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IREISLLKELNHPNIVRLL 64
Query: 135 -IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKK-----PLDWNTRMKIAA---GAAR 184
+ + + +L LV+E++ L DL KK PL I + +
Sbjct: 65 DVVHS---ENKLYLVFEFLDL--------DL---KKYMDSSPLTGLDPPLIKSYLYQLLQ 110
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LG-PVGDNTHVSTRVMGTY 242
G+ Y H V++RDLK N+L+DR KL+DFGLA+ G PV TH V+ T
Sbjct: 111 GIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TL 163
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGV 266
Y APE + L S YS V
Sbjct: 164 WYRAPE------ILLGSRQYSTPV 181
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQ----LDRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
LG+G +G VYK +A+K+ LD + + ++E+ +L P +V+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF---NQIIMELDILHKAVSPYIVDFY 65
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
G + EYM GS+ D L+ + + + +I +GL++L ++
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAKTG 253
+I+RD+K +N+L++ KL DFG V N ++ +G Y APE K+G
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFG------VSGNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 254 QL------TLKSDVYSFGVVLLEILSGR 275
T++SDV+S G+ +LE+ GR
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 68/236 (28%), Positives = 94/236 (39%), Gaps = 43/236 (18%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE----FLVEVLMLSLLH 127
+F ++G G FG V+ + Q A+K L R R E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADAD 59
Query: 128 HPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
P +V L Y + D+ L V EYMP G + + L P + R IA
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEET-ARFYIAELVL-A 113
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK----------------LGPVG 229
L+ +H I+RD+K NIL+D H KL+DFGL K
Sbjct: 114 LDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 230 DNTHVSTR-----------VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
DN V R +GT Y APE + L+ D +S GV+L E+L G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+GEG G V ++S + VA+K++D Q EV+++ H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IAAGAARGLEYLHDKA 193
GD+ +V E++ G++ D + +TRM + + L LH +
Sbjct: 88 VGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIAAVCLAVLKALSVLHAQG 136
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
VI+RD+K +ILL KLSDFG V ++GT + APE
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRL 191
Query: 254 QLTLKSDVYSFGVVLLEILSG 274
+ D++S G++++E++ G
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-12
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGN--REFLVEVLMLSLL 126
K+ + E +LG G FG + +G L+ ++ VAI L R G R FL E L L
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQF 63
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVED----HLHDLSPGKKPLDWNTRMKIAAGA 182
H N+V L G G+ ++V EYM G+++ H L G+ M + G
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQ-------LMGMLPGL 116
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
A G++YL + +++ L +L++ K+S F + + T + G
Sbjct: 117 ASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKS 170
Query: 243 G--YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE + + SDV+SFG+V+ E++S
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 36/108 (33%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
L++LH + +IYRD+K NILLD H L+DFGL+K + + + GT Y
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYM 173
Query: 246 APEYAKTGQLTLKS--DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 291
APE + G D +S GV+ E+L+G QS ++
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHH 128
NF+ +GEG +G VYK + + VA+K++ + GV + E+ +L L+H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNH 58
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR---- 184
PN+V L+ ++ LV+E++ DL KK +D + I +
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLH--------QDL---KKFMDASPLSGIPLPLIKSYLF 107
Query: 185 ----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LG-PVGDNTHVSTRV 238
GL + H V++RDLK N+L++ KL+DFGLA+ G PV TH V
Sbjct: 108 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EV 161
Query: 239 MGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGRKAV 278
+ T Y APE + D++S G + E+++ R+A+
Sbjct: 162 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 64/205 (31%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---------GNREFLVEVLMLSLLHHPN 130
+G+G FG+VY+ + + A+K L + + G R LV L+ P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE---SPF 57
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V L LV +YM G + HL G+ D + IA LE+LH
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ--KEGRFSED-RAKFYIAE-LVLALEHLH 113
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-Y 249
K ++YRDLK NILLD H L DFGL+K + T + GT Y APE
Sbjct: 114 ---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVL 168
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSG 274
T D +S GV++ E+ G
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 74/236 (31%), Positives = 106/236 (44%), Gaps = 29/236 (12%)
Query: 56 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
+ L L T + +G+G +G+VYK + A+K LD + E
Sbjct: 6 PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEE 64
Query: 116 FLVEVLML-SLLHHPNLVNLIG--YCAD---GDQRLLVYEYMPLGSVEDHLHDLSPGKKP 169
E +L SL +HPN+V G Y AD G Q LV E GSV + + L +
Sbjct: 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 170 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPV 228
LD I GA GL++LH+ +I+RD+K +NILL KL DFG+ A+L
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQL--- 178
Query: 229 GDNTHVSTRV-----MGTYGYCAPEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 274
STR+ +GT + APE Q + DV+S G+ +E+ G
Sbjct: 179 -----TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNLVN---- 133
+G G +G V + VAIK++ + + L E+ +L H N++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
L AD +V + M E LH + +PL RGL+Y+H
Sbjct: 73 LRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN 127
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYA 250
VI+RDLK SN+L++ ++ DFG+A+ P ++ + T + T Y APE
Sbjct: 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-EHKYFMTEYVATRWYRAPELL 183
Query: 251 KT-GQLTLKSDVYSFGVVLLEILSGRKAV 278
+ + T D++S G + E+L GR+ +
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 68/216 (31%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLV 132
F ++G G +G+VYKG Q AIK +D + E +E+ ML HH N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 133 NLIGY------CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
G DQ LV E+ GSV D + + DW I RGL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYG 243
+LH VI+RD+K N+LL KL DFG+ A+L D T V R +GT
Sbjct: 135 AHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPY 186
Query: 244 YCAPEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 274
+ APE + +SD++S G+ +E+ G
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 34/208 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEV-LMLSLLHHPNLVNLI 135
+GEG F V K + AIK + ++ Q N L E+ + L HPN++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 136 GYCADGDQ-RL-LVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLEYLHDK 192
D RL LV+E M + +L++L G+K PL + L+++H
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH------VSTRVMGTYGYCA 246
+ +RD+K NIL+ KL+DFG + G + +STR Y A
Sbjct: 120 G---IFHRDIKPENILIK-DDILKLADFGSCR----GIYSKPPYTEYISTR-----WYRA 166
Query: 247 PEYAKT-GQLTLKSDVYSFGVVLLEILS 273
PE T G K D+++ G V EILS
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 75/260 (28%), Positives = 112/260 (43%), Gaps = 28/260 (10%)
Query: 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVL 121
+L ++F ++G G FG V +S Q A+K L + + + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 122 MLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
+++ + +V L + A D + L V EYMP G D ++ +S P W R A
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGG---DLVNLMSNYDIPEKW-ARFYTA 149
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRV 238
L+ +H I+RD+K N+LLD+ H KL+DFG K+ G T V
Sbjct: 150 E-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV 204
Query: 239 MGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 294
GT Y +PE K+ G + D +S GV L E+L G DT A SLV
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DTPFYA--DSLVGTYS 257
Query: 295 PLFQDRTRHSLIADPELQGQ 314
+ + + D E+ Q
Sbjct: 258 KIMDHKNSLTFPDDIEISKQ 277
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 34/211 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNL- 134
+GEG +G VYK N+ +A+K++ + GV + E+ +L + H N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIVRLQ 67
Query: 135 -IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG----AARGLEY 188
+ + ++RL LV+EY+ L ++ H+ D SP D+ ++ RG+ Y
Sbjct: 68 DVVHS---EKRLYLVFEYLDL-DLKKHM-DSSP-----DFAKNPRLIKTYLYQILRGIAY 117
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAK-LG-PVGDNTHVSTRVMGTYGYC 245
H V++RDLK N+L+DR + KL+DFGLA+ G PV TH T Y
Sbjct: 118 CHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYR 170
Query: 246 APE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE + + D++S G + E+++ +
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDV-AIKQLDRNGVQGNRE---FLVEVLMLSLLH 127
K+F +SL+G G FG V + E D+ A+K + ++ + F E +LS+ +
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
P + L D D LV EY P G D L L+ + D + A +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGG---DLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYCA 246
+H ++RD+K N+L+DR H KL+DFG A+L + S +GT Y A
Sbjct: 117 SVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPDYIA 171
Query: 247 PEYAKT------GQLTLKSDVYSFGVVLLEILSGR 275
PE T G ++ D +S GV+ E++ GR
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEV-LMLSLLHHPNLVNL 134
++G+G FG+V ++ + A+K L + + +E + E ++L + HP LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKA 193
D+ V +Y+ G + HL +P R + AA A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSLN 116
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
++YRDLK NILLD H L+DFGL K + N ST GT Y APE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNGTTST-FCGTPEYLAPEVLHKQ 171
Query: 254 QLTLKSDVYSFGVVLLEILSG 274
D + G VL E+L G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 78 SLLGEGGFGRVY---KGYLESINQDVAIKQLDRNGVQGNRE----FLVEVLMLSLLHHPN 130
+LG+GG+G+V+ K + A+K L + + N++ E +L + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V+LI G + L+ EY+ G + HL + +T + + LE+LH
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLH 117
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEY 249
+ +IYRDLK NILLD H KL+DFGL K TH GT Y APE
Sbjct: 118 QQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEI 171
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSG 274
D +S G ++ ++L+G
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFL-VEVLMLSLLHHPNLVN---- 133
+G+G +G V + + IK+L+ RN + R+ E +LS L HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 134 ----------LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
++G+C GD +Y +++ L P + ++W ++ +A
Sbjct: 68 WEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA---- 114
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
L+YLH+K +++RDLK N+ L R K+ D G+A++ + + +++ ++GT
Sbjct: 115 --LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 277
Y +PE KSDV++ G + E+ + + A
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIK--QLDRNGVQGNREFLVEVLMLSLLHHP 129
++ + + +LG G G VYK Y + +A+K LD V+ ++ + E+ +L P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSP 59
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
++ G ++ + E+M GS++ + K P R IA +GL YL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGR--IAVAVVKGLTYL 111
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
+++RD+K SN+L++ KL DFG++ ++ +GT Y APE
Sbjct: 112 WSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPER 164
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGR 275
Q + SDV+S G+ +E+ GR
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 80 LGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQGNREFL-------VEVL-MLSLLHHPN 130
+GEG +G+V+K L++ + VA+K R VQ E + V VL L HPN
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 131 LVNLIGYCA----DGDQRL-LVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
+V L C D + +L LV+E++ L + D + + PG T +
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPT---ETIKDMMFQLL 120
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
RGL++LH V++RDLK NIL+ KL+DFGLA++ T V+ T
Sbjct: 121 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLW 174
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE D++S G + E+ +
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 80 LGEGGFGRVY--------KGYLESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPN 130
LG+G FG VY + +++ + +L+ N VQ N E +LS L HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHPA 63
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V + D ++ EY ++ L +L K L N + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ +++RDLK NI L + K+ DFG+++L + + ++T GT Y +PE
Sbjct: 124 QRR---ILHRDLKAKNIFL-KNNLLKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177
Query: 251 KTGQLTLKSDVYSFGVVLLEI 271
K KSD++S G +L E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 61/193 (31%), Positives = 88/193 (45%), Gaps = 43/193 (22%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQ-LDRNGVQGNREF----LVEVLMLSLLHHPNLVNL 134
+G+G FG V+K + Q VA+K+ L N +G F L E+ +L LL H N+VNL
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNL 76
Query: 135 IGYC---ADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR-- 184
I C A R LV+E+ HDL+ L N +K +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCE--------HDLAG----LLSNKNVKFTLSEIKKV 124
Query: 185 ------GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK---LGPVGDNTHVS 235
GL Y+H +++RD+K +NIL+ + KL+DFGLA+ L +
Sbjct: 125 MKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 236 TRVMGTYGYCAPE 248
RV+ T Y PE
Sbjct: 182 NRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 64/237 (27%)
Query: 74 FRSESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGN-------REFLVEVLMLS 124
+ E +G G +GRVYK + ++ AIK+ + Q RE + +L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLR 57
Query: 125 LLHHPNLVNLIGYC-ADGDQRL-LVYEYMPLGSVEDHLHDL--------SPGKKPLDWNT 174
L H N+V+L+ D+ + L+++Y HDL + + +
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAE--------HDLWQIIKFHRQAKRVSIPPSM 109
Query: 175 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAKL---- 225
+ G+ YLH V++RDLK +NIL+ +RG K+ D GLA+L
Sbjct: 110 VKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG-VVKIGDLGLARLFNAP 165
Query: 226 --GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILS 273
+ V+ T Y APE L L + D+++ G + E+L+
Sbjct: 166 LKPLADLD-----PVVVTIWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 68/224 (30%), Positives = 99/224 (44%), Gaps = 39/224 (17%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-----REFLVEVLMLSLLHHPNLVNL 134
LGEG + VYKG + Q VA+K++ +G RE +L L H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDLKHANIVTL 68
Query: 135 IGYCADGDQRLLVYEYM--PLGS-VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
LV+EY+ L ++D LS N R+ + RGL Y H
Sbjct: 69 HDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH------NVRLFLFQ-LLRGLAYCHQ 121
Query: 192 KAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP--- 247
+ V++RDLK N+L+ +RG KL+DFGLA+ V T+ + V T Y P
Sbjct: 122 RR---VLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVL 175
Query: 248 ----EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
EY + L D++ G + E+ +GR S +Q
Sbjct: 176 LGSTEY--STSL----DMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 65/250 (26%), Positives = 114/250 (45%), Gaps = 35/250 (14%)
Query: 48 ASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR 107
A ED +++ + + K+++ +++G G FG VY+ ++ VAIK++ +
Sbjct: 46 AGEDEDEEKMIDNDIN----RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ 101
Query: 108 NGVQGNREFLVEVLMLSLLHHPNLVNLIGY----CADGDQRLL----VYEYMPLGSVEDH 159
+ NRE L+ + L+H N++ L Y C +++ + V E++P +V +
Sbjct: 102 DPQYKNRELLI----MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKY 156
Query: 160 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLS 218
+ + L + R L Y+H K + +RDLK N+L+D H KL
Sbjct: 157 MKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC 213
Query: 219 DFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLE----- 270
DFG AK L +++ +R Y APE T D++S G ++ E
Sbjct: 214 DFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268
Query: 271 -ILSGRKAVD 279
I SG+ +VD
Sbjct: 269 PIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHH 128
K+F+ + +G+GG+G+V+ + + VA+K++ ++ + R L E +L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN------TRMKIAAGA 182
LV L+ D + L EY+P G L++L L + M A A
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV----LSEDHARFYMAEMFEAVDA 116
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
L Y+H RDLK N L+D H KL+DFGL+K N+ V+G+
Sbjct: 117 LHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSP 162
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
Y APE + D +S G +L E L G
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 54/198 (27%), Positives = 104/198 (52%), Gaps = 19/198 (9%)
Query: 123 LSLLHHPNLVNLIGYC----ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
L +LH N ++G+ +DG+ + + E+M GS++ L + K + K+
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKE----AKRIPEEILGKV 108
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
+ RGL YL +K + +++RD+K SNIL++ KL DFG++ G + D+ ++
Sbjct: 109 SIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF- 297
+GT Y +PE + +++SD++S G+ L+E+ GR + A +++ + RP+
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI--FGRPVVD 220
Query: 298 -QDRTRHSLIADPELQGQ 314
++ HS+ P G+
Sbjct: 221 GEEGEPHSISPRPRPPGR 238
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGVQGNREF---LVEV 120
R+ ++F LG G FGRV ++ + VAIK+ +++ + ++ E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
+L+ ++HP VNL G D LV E++ G L K + AA
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAA 138
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR--- 237
EYL ++YRDLK N+LLD+ K++DFG AK+ V TR
Sbjct: 139 QIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYT 187
Query: 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
+ GT Y APE +D ++ G+ + EIL G
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 87/343 (25%), Positives = 142/343 (41%), Gaps = 68/343 (19%)
Query: 73 NFRSESLLGEGGFGRVY-----------KGYLESINQDVAIKQLDRNGVQGNREFLVEVL 121
NF +LG G +G+V+ K Y + Q A+ Q + E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTE------ 54
Query: 122 MLSLLHH----PNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 176
++L H P LV L Y + +L L+ +Y+ G + HL+ + +
Sbjct: 55 -RNVLEHVRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEV 107
Query: 177 KIAAGAA-RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTH 233
+ +G LE+LH K ++YRD+K NILLD H L+DFGL+K L + T+
Sbjct: 108 RFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164
Query: 234 VSTRVMGTYGYCAPEY--AKTGQLTLKSDVYSFGVVLLEILSG------------RKAVD 279
GT Y APE K G D +S G+++ E+L+G + V
Sbjct: 165 ---SFCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
Query: 280 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRG--------FYQALAVAAMCV 331
+ ++ P QD L DP+ + P+G F++ L A+ +
Sbjct: 221 RRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALAL 280
Query: 332 HE-QPDMRPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTP 373
+ P RP I + + + ++++ ++ E V SP GTP
Sbjct: 281 RKVNPPFRPSIRNELDVGNF--AEEF-TNLEPVYSP---AGTP 317
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 18/196 (9%)
Query: 87 RVYKGYLESINQDVAIKQL--DRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143
+YKG N++V I+ G + E+ L + N++ + G+ D
Sbjct: 35 SIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 144 RL----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
L L+ EY G + + L +K L + T++ +A +GL L+ P Y
Sbjct: 93 DLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--Y 146
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS 259
++L + L+ Y K+ GL K+ +V+ V +Y +++ T+K
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSE---YTIKD 203
Query: 260 DVYSFGVVLLEILSGR 275
D+YS GVVL EI +G+
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 19/219 (8%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYC 138
LGEG + VYKG Q VA+K + +G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 139 ADGDQRLLVYEYMPLGSVE---DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
+ V+EYM + H L P +N R+ + RGL Y+H +
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHP------YNVRLFMFQ-LLRGLAYIHGQH-- 123
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
+++RDLK N+L+ KL+DFGLA+ + T+ S V T Y P+ G
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGAT 179
Query: 256 TLKS--DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292
S D++ G + +E+L G+ A EQ W
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 66/235 (28%), Positives = 101/235 (42%), Gaps = 29/235 (12%)
Query: 57 ITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR-NGVQGNRE 115
++ +T+ F + + +G+G +G+V+K + A+K LD + + E
Sbjct: 3 LSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE 62
Query: 116 FLVEVLMLSLLHHPNLVNLIG--YCAD---GDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
+L +L HPN+V G Y D GDQ LV E GSV D + K L
Sbjct: 63 AEYNILK-ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV------KGFL 115
Query: 171 DWNTRMK------IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224
RM+ I A GL++LH I+RD+K +NILL KL DFG++
Sbjct: 116 KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS- 171
Query: 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 274
+ +GT + APE Q + DV+S G+ +E+ G
Sbjct: 172 -AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+GEG G V + + VA+K +D Q RE L EV+++ H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
G++ ++ E++ G++ D + L+ + + L YLH + VI
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 258
+RD+K +ILL KLSDFG + + ++GT + APE +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 259 SDVYSFGVVLLEILSG 274
D++S G++++E++ G
Sbjct: 198 VDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIG 136
+G+G FG+V + + A+K + + + E L E +L+ ++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKP 195
++ LV ++ G + HL G+ L +R + A LE LH K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ--REGRFDL---SRARFYTAELLCALENLH---KF 112
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
VIYRDLK NILLD H L DFGL KL D+ + GT Y APE
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGY 170
Query: 256 TLKSDVYSFGVVLLEILSG 274
T D ++ GV+L E+L+G
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 49/157 (31%), Positives = 88/157 (56%), Gaps = 15/157 (9%)
Query: 123 LSLLHHPNLVNLIGYC----ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
L +LH N ++G+ +DG+ + + E+M GS++ L G+ P ++ I
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLK--KAGRIPEQILGKVSI 110
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
A +GL YL +K K +++RD+K SNIL++ KL DFG++ G + D+ ++
Sbjct: 111 AV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+GT Y +PE + +++SD++S G+ L+E+ GR
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 11/213 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 138
LGEG + V+KG + VA+K++ +G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
LV+EY+ ++ ++ D G N ++ + RGL Y H + V+
Sbjct: 74 HTDKSLTLVFEYLD-KDLKQYMDDC--GNIMSMHNVKIFLYQ-ILRGLAYCH---RRKVL 126
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTL 257
+RDLK N+L++ KL+DFGLA+ V T+ + V T Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184
Query: 258 KSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290
+ D++ G + E+ SGR S E L+
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVL 121
R+L +++ ++G G FG V +S + A+K L + + + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 122 MLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
+++ + P +V L +CA D + L V EYMP G D ++ +S P W
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGG---DLVNLMSNYDVPEKWAKFY--T 148
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRV 238
A L+ +H +I+RD+K N+LLD+ H KL+DFG K+ G T V
Sbjct: 149 AEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAV 204
Query: 239 MGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSG 274
GT Y +PE K+ G + D +S GV L E+L G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNL 131
++ + ++G+G +G V + VAIK+++ V L E+ +L LL HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 132 VNLIGYCADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
V + +R +V+E M E LH + L R L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYC 245
+Y+H V +RDLK NIL + K+ DFGLA++ T + T + T Y
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 246 APEYAKT--GQLTLKSDVYSFGVVLLEILSGR 275
APE + + T D++S G + E+L+G+
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 19/181 (10%)
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGL 186
PN+V L Y D LV ++ G + H+ P + W M +A L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------L 98
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYC 245
+ LH + ++ RDL +NILLD H +L+ F +++ D V YC
Sbjct: 99 DALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305
APE + T D +S G +L E+L+G K + + + P + SL
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSEEARSL 208
Query: 306 I 306
+
Sbjct: 209 L 209
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 47/157 (29%), Positives = 72/157 (45%), Gaps = 29/157 (18%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G V+K ++ VA+K++ D GV + L E+ +L L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLE 187
+ LV+EY DL KK D + I +GL
Sbjct: 66 DVLHSDKKLTLVFEYCD--------QDL---KKYFD-SCNGDIDPEIVKSFMFQLLKGLA 113
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224
+ H V++RDLK N+L+++ KL+DFGLA+
Sbjct: 114 FCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVL 121
R+L +++ ++G G FG V +S + A+K L + + + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 122 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS-PGKKPLDWNTRMKIAA 180
+++ + P +V L D +V EYMP G + + + + P K + + +A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG----LAKLGPVGDNTHVST 236
A + ++H RD+K N+LLD+ H KL+DFG + K G V +T V
Sbjct: 156 DAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-- 204
Query: 237 RVMGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSG 274
GT Y +PE K+ G + D +S GV L E+L G
Sbjct: 205 ---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGY 137
+G G +G VYK + A+K + G+ L+ E+ M+ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA---AGAARGLEYLHDKAK 194
++ + EY GS++D H P + ++IA +GL YLH K K
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGP-------LSELQIAYVCRETLQGLAYLHSKGK 127
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA---K 251
++RD+K +NILL KL+DFG+A + +GT + APE A K
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 252 TGQLTLKSDVYSFGVVLLEI 271
G D+++ G+ +E+
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 68/265 (25%), Positives = 102/265 (38%), Gaps = 70/265 (26%)
Query: 75 RSESLLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGN--REFLVEV-LMLSLL 126
+ LG G FG+V + I + VA+K L + G + + + E+ +++ +
Sbjct: 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTELKILIHIG 68
Query: 127 HHPNLVNLIGYCADGDQRLLV-YEYMPLGSVEDHL----HDLSPGKKPLDWNTRMKIAAG 181
HH N+VNL+G C L+V EY G++ ++L SP + MK G
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEG 128
Query: 182 AARGL--------------------------EYLHDKAKPPV------------------ 197
+ L E + K P+
Sbjct: 129 KKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEF 188
Query: 198 ------IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPE 248
I+RDL NILL K+ DFGLA+ D +V R+ + APE
Sbjct: 189 LASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPE 245
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILS 273
T +SDV+SFGV+L EI S
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 39/256 (15%)
Query: 32 SIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKG 91
++P L SS +S + +A + EL + +G G G VYK
Sbjct: 42 AVPLPLPPPSSSSSSSSSSSASGSAPSAA-KSLSELERVNR-------IGSGAGGTVYKV 93
Query: 92 YLESINQDVAIKQLDRNGVQGNREFLV------EVLMLSLLHHPNLVNLIGYCADGDQRL 145
+ A+K + GN E V E+ +L ++HPN+V +
Sbjct: 94 IHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148
Query: 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 205
++ E+M GS+E G D +A G+ YLH + +++RD+K S
Sbjct: 149 VLLEFMDGGSLE--------GTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPS 197
Query: 206 NILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAKT----GQLT-LKS 259
N+L++ + K++DFG+++ L D + S +GT Y +PE T G
Sbjct: 198 NLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDGYAG 254
Query: 260 DVYSFGVVLLEILSGR 275
D++S GV +LE GR
Sbjct: 255 DIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 73/287 (25%), Positives = 114/287 (39%), Gaps = 48/287 (16%)
Query: 73 NFRSESLLGEGGFGRVY-----------KGYLESINQDVAIKQLDRNGVQGNREFLVEVL 121
NF +LG G +G+V+ K Y + + I Q + E V
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV--- 57
Query: 122 MLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
+ + P LV L Y D +L L+ +Y+ G + HL K+ ++I +
Sbjct: 58 LEHIRQSPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKE-----QEVQIYS 111
Query: 181 GA-ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
G LE+LH K +IYRD+K NILLD H L+DFGL+K D +
Sbjct: 112 GEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFC 167
Query: 240 GTYGYCAPEYAKTGQLTLKS--DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW----- 292
GT Y AP+ + G D +S GV++ E+L+G Q+ ++
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 227
Query: 293 -------ARPLFQDRTRHSLIADPELQGQYPPRG--------FYQAL 324
L +D + L+ DP+ + P F+Q +
Sbjct: 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH 127
A+ + L G GRV+ V +K G +G L+E ++L ++
Sbjct: 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI----GQKGTT--LIEAMLLQNVN 115
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
HP+++ + G +V + D L+ +PL + + I GL
Sbjct: 116 HPSVIRMKDTLVSGAITCMVLPHYS----SDLYTYLTKRSRPLPIDQALIIEKQILEGLR 171
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YLH + +I+RD+K NI ++ + D G A+ PV + + GT AP
Sbjct: 172 YLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVETNAP 225
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E + K+D++S G+VL E+L+
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 138
LGEG + VYKG + + VA+K++ +G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
LV+EY+ ++ +L D G N ++ + RGL Y H + V+
Sbjct: 74 HTEKSLTLVFEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQ-LLRGLNYCHRRK---VL 126
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTL 257
+RDLK N+L++ KL+DFGLA+ + T+ + V T Y P+ + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 258 KSDVYSFGVVLLEILSGR 275
+ D++ G + E+ +GR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 16/149 (10%)
Query: 83 GGFGRVYKGYLESINQDVAIK------QLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
G FG+VY G ++ ++ A+K +++N V + E L+L P +V+L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVH---QVQAERDALALSKSPFIVHLYY 71
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
+ LV EY+ G V+ LH D +K + A L+YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRHG--- 124
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKL 225
+I+RDLK N+L+ H KL+DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 138
LGEG + V+KG + VA+K++ +G + EV +L L H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 139 ADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
LV+EY+ L D+ +L + + RGL Y H +
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNL------MSMHNVKIFMFQLLRGLSYCHKRK--- 123
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQL 255
+++RDLK N+L++ KL+DFGLA+ V T+ + V T Y P+ + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEY 181
Query: 256 TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290
+ D++ G +L E+ +GR S E L+
Sbjct: 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 11/210 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 138
LGEG + VYKG + + VA+K + +G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+ LV+EY+ + D PG + N ++ + RGL Y+H + ++
Sbjct: 73 HTKETLTLVFEYVHTDLCQ--YMDKHPGGLHPE-NVKLFLFQ-LLRGLSYIHQRY---IL 125
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTL 257
+RDLK N+L+ KL+DFGLA+ V +T+ + V T Y P+ + + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTEYST 183
Query: 258 KSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
D++ G + +E++ G A K +Q
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 41/127 (32%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 207
Y+ V++ L D G + L + ARG+E+L K ++RDL N+
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268
Query: 208 LLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAKTGQLTLKSDVYSFGV 266
LL +G K+ DFGLA+ + D+ +VS + APE T SDV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 267 VLLEILS 273
+L EI S
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 14/206 (6%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLLHHP 129
F ++GEG +G V K + + VAIK+ + + N E L E+ ML L
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQE 60
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V L + LV+EY+ +E L + P P + K+ + + ++ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-----KVRSYIYQLIKAI 113
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H K +++RD+K N+L+ KL DFG A+ G N + T + T Y +PE
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPEL 172
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGR 275
D++S G +L E+ G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+G G +G V N+ VAIK++ N + R L E+ +L L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIKD 71
Query: 137 YCADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
+ +VYE M + LH + + L + RGL+Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
V++RDLK SN+LL+ K+ DFGLA+ + T + T Y APE
Sbjct: 127 AN---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPE--- 178
Query: 252 TGQLTLKS-------DVYSFGVVLLEILSGRK 276
L L DV+S G + E+L GRK
Sbjct: 179 ---LLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 13/203 (6%)
Query: 80 LGEGGFGRVYKG--YLESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+G G FG+V Y ++ V +K+L N + EFL + +L HPN++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
C + LLV+EY LG ++ +L ++ ++A A G+ ++H K
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK----- 251
++ DL N L K+ D+G+ D + APE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 252 --TGQLTLKSDVYSFGVVLLEIL 272
T + T S+V++ GV L E+
Sbjct: 180 LITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNLVNLIGY 137
+G G +G V Y + Q VA+K+L R + R E+ +L + H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 138 ---CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+ VY L + L+++ +K D + + I RGL+Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGAD--LNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIHSAG- 138
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------ 248
+I+RDLK SN+ ++ ++ DFGLA+ +V+TR Y APE
Sbjct: 139 --IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWM 191
Query: 249 -YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y +T D++S G ++ E+L G+
Sbjct: 192 HYNQT------VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
RGL+YLH +++RD+K N+L++ K+ DFGLA++ ++ H++ V+ Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 244 YCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGR 275
Y APE G T D++S G + E+L R
Sbjct: 170 YRAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 61/250 (24%), Positives = 93/250 (37%), Gaps = 32/250 (12%)
Query: 35 DKLKMNSSLRVKEASEDGASDQITAQT----LTFRELAAATKNFRSE--SLLGEGGFGRV 88
D + + +A E+ S Q T A+ + S L G G V
Sbjct: 52 DDVTHATD---YDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEV 108
Query: 89 Y--KGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146
+ + + + V +K V G + E+ +L + H ++NLI +
Sbjct: 109 FVCTKHGDEQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163
Query: 147 VYEYMPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 203
V MP + DL PL + I L YLH + +I+RD+K
Sbjct: 164 V---MP-----KYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVK 212
Query: 204 CSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVY 262
NI LD + L DFG A KL +T GT +PE K+D++
Sbjct: 213 TENIFLDEPENAVLGDFGAACKLD-AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIW 271
Query: 263 SFGVVLLEIL 272
S G+VL E+
Sbjct: 272 SAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 68/270 (25%), Positives = 103/270 (38%), Gaps = 61/270 (22%)
Query: 41 SSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVY----KGYLE-- 94
S L EA D A AQ + FR L G FG+++ + E
Sbjct: 118 SHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAH-FRVIDDLPAGAFGKIFICALRASTEEA 176
Query: 95 -------SINQDVA-----IKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 142
S NQ I + + G + + E+L L L+H N++ +
Sbjct: 177 EARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI-------- 228
Query: 143 QRLLVYE---YMPLGSVEDHLH------DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
+ +L E YM + L+ +PL TR I +EY+HDK
Sbjct: 229 EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDKK 287
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLA----------KLGPVGDNTHVSTRVMGTYG 243
+I+RD+K NI L+ L DFG A G VG S ++ G
Sbjct: 288 ---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG 344
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
YC ++T D++S G++LL++LS
Sbjct: 345 YC--------EIT---DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 128
K +++ +G G G V Y Q+VAIK+L R N R + VLM L++H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLM-KLVNH 74
Query: 129 PNLVNLIGYCADGDQRLL-----VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
N++ L+ Q+ L VY M L ++ +L + + LD +
Sbjct: 75 KNIIGLLN--VFTPQKSLEEFQDVYLVMEL--MDANLCQVI--QMDLDHERMSYLLYQML 128
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
G+++LH +I+RDLK SNI++ K+ DFGLA+ G + ++ V+ Y
Sbjct: 129 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY- 182
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE D++S G ++ E++ G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 80 LGEGGFGRVYKG-YLESINQD-VAIKQLDR--NGVQGNREFLVEV-LMLSLLHHPNLVNL 134
LG+G +G V E+ ++ VAIK++ + + L E+ L+ H N+ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 135 IGY-CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
+Y Y L +E LH + +PL GL+Y+H
Sbjct: 68 YDMDIVFPGNFNELYLYEEL--MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN 125
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK---LGPVGDNTHVSTRVMGTYGYCAPEYA 250
V++RDLK N+L++ K+ DFGLA+ P G+N T + T Y APE
Sbjct: 126 ---VLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVATRWYRAPEIM 181
Query: 251 KTGQLTLKS-DVYSFGVVLLEILSGRKAV 278
+ Q K+ DV+S G +L E+L GRK V
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 69/262 (26%), Positives = 101/262 (38%), Gaps = 71/262 (27%)
Query: 79 LLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLH---HPN 130
+LG G FG+V + I++ VA+K L + L+ L + L+H H N
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKI-LIHIGNHLN 72
Query: 131 LVNLIGYCADGDQRLLV-YEYMPLGSVEDHLH----------DLSPGKKPLDWNT----- 174
+VNL+G C + L+V E+ G++ + L + SP ++
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 175 -RMKIAAGAARGLEYLHDKAK-----PP-------------------------------- 196
+I AG A L + PP
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 197 --VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYAK 251
I+RDL NILL K+ DFGLA+ D +V S R+ + APE
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIF 249
Query: 252 TGQLTLKSDVYSFGVVLLEILS 273
T +SDV+SFGV+L EI S
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
A+G+ +L K I+RDL NILL G K+ DFGLA+ N V
Sbjct: 224 AKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE T +SDV+S+G++L EI S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 37/113 (32%), Positives = 61/113 (53%), Gaps = 11/113 (9%)
Query: 165 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224
PLD + ++ ++ A+G+++L K I+RD+ N+LL G K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 225 LGPVGDNTHVSTRVMGT----YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ D+ +V V G + APE T++SDV+S+G++L EI S
Sbjct: 261 -DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 37/154 (24%), Positives = 55/154 (35%), Gaps = 17/154 (11%)
Query: 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLV-N 133
S LL G RVY L + ++D +K +RE EV +L LL V
Sbjct: 2 SIKLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADRER--EVAILQLLARKGLPVPK 57
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
++ L+ E++ G D + + A L LH
Sbjct: 58 VLASGESDGWSYLLMEWIE-GETLDEVSEEEKEDIAEQ----------LAELLAKLHQLP 106
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227
+ + DL NIL+D G + D+ A GP
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIK----QLDRNGVQGNREFLVEV-LMLSLLHHPNLVNL 134
+GEG +G+VYK ++ + VA+K ++D G+ L E+ L+ L +V L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIVRL 66
Query: 135 IGY----CADGDQRL-LVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
+ +G L LV+EY+ L D + PG +PL T +G+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMD-SNGRGPG-RPLPAKTIKSFMYQLLKGVA 124
Query: 188 YLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLG--PVGDNTHVSTRVMGTYGY 244
+ H K V++RDLK N+L+D+ K++D GL + PV TH + T Y
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWY 177
Query: 245 CAPEYAKTG-QLTLKSDVYSFGVVLLEILSG 274
APE + D++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 30/83 (36%), Positives = 47/83 (56%)
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
+I+RD+K +NILL KL DFG +K+ + V GT Y APE + +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 257 LKSDVYSFGVVLLEILSGRKAVD 279
K+D++S GV+L E+L+ ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---------NGVQGNREFLV--EV 120
++F ++G G FG V L++ ++ A+K L++ + R+ LV +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 121 LMLSLLHHP-----NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 175
++ LH+ NL ++ Y GD L+ ++ ED L P +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAE 110
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
M IA + L Y+H RD+K NIL+D H +L+DFG + L + D T S
Sbjct: 111 MVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQS 160
Query: 236 TRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSG 274
+ +GT Y +PE + G+ + D +S GV + E+L G
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 45/221 (20%)
Query: 80 LGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG- 136
+G G +G VYK + ++D A+KQ++ G+ + E+ +L L HPN+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 66
Query: 137 YCADGDQRL-LVYEYMPLGSVEDHLHDL----------SPGKKPLDWNTRM--KIAAGAA 183
+ + D+++ L+++Y HDL KKP+ M +
Sbjct: 67 FLSHADRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAK-----LGPVGDNTH 233
G+ YLH V++RDLK +NIL+ +RG K++D G A+ L P+ D
Sbjct: 119 DGIHYLHANW---VLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLAD--- 171
Query: 234 VSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILS 273
V+ T+ Y APE + K+ D+++ G + E+L+
Sbjct: 172 -LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 40/221 (18%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 128
+ + S +G G +G V + + VAIK+L R + + R + E+ +L + H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQH 73
Query: 129 PNLVNLI-----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGK-KPLDWNTRMKIAAG 181
N++ L+ D Q LV YM + H LS K + L +
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM------- 126
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
GL+Y+H +I+RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 127 -LCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR---- 178
Query: 242 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y +T D++S G ++ E+L+G+
Sbjct: 179 -WYRAPEVILNWMHYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPN 130
+++ S +G G +G V + VA+K+L R + + R + E+ +L + H N
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 77
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVED-------------HLHDLSPGKKPLDWNTRMK 177
++ L+ + P S+E+ L+++ +K D + +
Sbjct: 78 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237
I RGL+Y+H +I+RDLK SN+ ++ K+ DFGLA+ +V+TR
Sbjct: 126 IYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181
Query: 238 VMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 275
Y APE D++S G ++ E+L+GR
Sbjct: 182 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 27/230 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 128
K +++ +G G G V Y ++++VAIK+L R N R + E++++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 129 PNLVNLIGYCADGDQRLL-----VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
N+++L+ Q+ L VY M L ++ +L + + LD +
Sbjct: 76 KNIISLLNVFTP--QKSLEEFQDVYLVMEL--MDANLCQVI--QMELDHERMSYLLYQML 129
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
G+++LH +I+RDLK SNI++ K+ DFGLA+ G + ++ V+ Y
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY- 183
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS------GRKAVDTSKAAAEQ 287
Y APE D++S G ++ E++ GR +D EQ
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 64/252 (25%), Positives = 96/252 (38%), Gaps = 66/252 (26%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---------VQGNREFLVEVLM 122
+F S ++G G FG V + A+K+L ++ V+ R+ L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-- 58
Query: 123 LSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-TRMKIA 179
+P +V L Y + D + L+ EY+P G + L K TR IA
Sbjct: 59 ----DNPWVVKL--YYSFQDENYLYLIMEYLPGGD----MMTLLMKKDTFTEEETRFYIA 108
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--------------- 224
++ +H K I+RD+K N+LLD H KLSDFGL
Sbjct: 109 E-TILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 225 --LGPVGDNTHVSTR-------------------VMGTYGYCAPE-YAKTGQLTLKSDVY 262
L + +GT Y APE + +TG + D +
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWW 223
Query: 263 SFGVVLLEILSG 274
S GV++ E+L G
Sbjct: 224 SLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 59/190 (31%), Positives = 82/190 (43%), Gaps = 28/190 (14%)
Query: 167 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226
KK L + + A+G+E+L A I+RDL NILL K+ DFGLA+
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-D 228
Query: 227 PVGDNTHV---STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSK 282
D +V R+ + APE T++SDV+SFGV+L EI S G K
Sbjct: 229 IYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286
Query: 283 AAAEQSLVAWARPLFQ-DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 341
E + R L + R R PE+ YQ + C H +P RP
Sbjct: 287 IDEE-----FCRRLKEGTRMRAPDYTTPEM---------YQTM---LDCWHGEPSQRPTF 329
Query: 342 ADVVTALAYL 351
+++V L L
Sbjct: 330 SELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 35/219 (15%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 128
K +++ +G G G V Y + ++VAIK+L R N R + E++++ ++H
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-----------TRMK 177
N++ L+ + P S+E+ D+ + +D N RM
Sbjct: 83 KNIIGLLNV------------FTPQKSLEE-FQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 178 -IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
+ G+++LH +I+RDLK SNI++ K+ DFGLA+ G + ++
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 184
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
V+ Y Y APE D++S G ++ E++ G
Sbjct: 185 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 45/221 (20%)
Query: 80 LGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG- 136
+G G +G VYK + ++ A+KQ++ G+ + E+ +L L HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKV 66
Query: 137 YCADGDQRL-LVYEYMPLGSVEDHLHDL----------SPGKKPLDWNTRM--KIAAGAA 183
+ + D+++ L+++Y HDL KKP+ M +
Sbjct: 67 FLSHSDRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAK-----LGPVGDNTH 233
G+ YLH V++RDLK +NIL+ +RG K++D G A+ L P+ D
Sbjct: 119 DGIHYLHANW---VLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLAD--- 171
Query: 234 VSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILS 273
V+ T+ Y APE + K+ D+++ G + E+L+
Sbjct: 172 -LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 15/106 (14%)
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
M +A + L Y+H RD+K N+LLD+ H +L+DFG + L + D T
Sbjct: 109 AEMVLAIDSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTV 158
Query: 234 VSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSG 274
S +GT Y +PE + G+ + D +S GV + E+L G
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 28/77 (36%), Positives = 45/77 (58%)
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
+++RDLK +NI L KL DFG +K + V++ GT Y APE + + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 257 LKSDVYSFGVVLLEILS 273
K+D++S GV+L E+L+
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 122 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
++S + H +L + G C G + ++V E++ G ++ L G+ P+ W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAW--KITVAQQ 125
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHP--KLSDFGLAKLGPVGDNTHV 234
A L YL DK +++ ++ NILL R G P KLSD G++ + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 235 STRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEI 271
R+ + APE G L+ +D +SFG LLEI
Sbjct: 182 E-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 47/184 (25%), Positives = 76/184 (41%), Gaps = 21/184 (11%)
Query: 98 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 157
+ V IK R G E +L ++HP+++ L G L+ L +
Sbjct: 118 EHVVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFTCLI-----LPRYK 166
Query: 158 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK- 216
L+ K+ + + I R ++YLH+ +I+RD+K NI ++ HP
Sbjct: 167 TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFIN---HPGD 220
Query: 217 --LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
L DFG A PV N + GT APE D++S G+VL E+ +
Sbjct: 221 VCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
Query: 275 RKAV 278
++
Sbjct: 280 HDSL 283
|
Length = 391 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 49/217 (22%), Positives = 85/217 (39%), Gaps = 30/217 (13%)
Query: 76 SESLLGEGGFGR--VYKGYLESINQDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHPN 130
+L+G+ V+ + N VA+K+++ + + + E++ L HPN
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLD-SCSKEDLKLLQQEIITSRQLQHPN 60
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA---AGAARGLE 187
++ + + +V M GS ED L P P + IA L+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALD 115
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA--------KLGPVGDNTHVSTRVM 239
Y+H K I+R +K S+ILL LS + + V D S + +
Sbjct: 116 YIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 240 GTYGYCAPEYAKTGQL--TLKSDVYSFGVVLLEILSG 274
+ +PE + KSD+YS G+ E+ +G
Sbjct: 173 P---WLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 128
K ++ +G G G V + + +VA+K+L R N R + E+++L ++H
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNH 79
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-----------TRMK 177
N+++L+ + P S+E+ D+ + +D N RM
Sbjct: 80 KNIISLLNV------------FTPQKSLEE-FQDVYLVMELMDANLCQVIHMELDHERMS 126
Query: 178 -IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
+ G+++LH +I+RDLK SNI++ K+ DFGLA+ N ++
Sbjct: 127 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFMMTP 181
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
V+ Y Y APE D++S G ++ E++ G
Sbjct: 182 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGT 241
A G+E+L K ++RDL N+L+ G K+ DFGLA+ + D+ ++S
Sbjct: 249 ANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYISKGSTFLP 304
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE T SDV+SFG++L EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 6/82 (7%)
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT----- 252
++RD+K N+LLD H +L+DFG + L D T S+ +GT Y +PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 253 GQLTLKSDVYSFGVVLLEILSG 274
G+ + D +S GV + E+L G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 72/275 (26%), Positives = 102/275 (37%), Gaps = 66/275 (24%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLD------RNG---VQGNREFLVEVLMLS 124
F +G G FG V N A+K L RN V+ R+ L E
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA---- 58
Query: 125 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 184
+ +V L D D V +Y+P G + L L ++ L R IA
Sbjct: 59 --DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTC 112
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL---------------------- 222
+E +H K I+RD+K NIL+DR H KL+DFGL
Sbjct: 113 AIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 223 -------------AKLGPVGD-NTHVSTRVM-----GTYGYCAPE-YAKTGQLTLKSDVY 262
+L P+ R + GT Y APE +TG L D +
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWW 228
Query: 263 SFGVVLLEILSGRKA-VDTSKAAAEQSLVAWARPL 296
S GV+L E+L G+ + + A + ++ W L
Sbjct: 229 SVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G G V+ ++ VA+K++ Q + L E+ ++ L H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 140 DGDQRL--------------LVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
L +V EYM L +V + PL
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--------GPLSEEHARLFMYQLL 124
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGT 241
RGL+Y+H V++RDLK +N+ ++ K+ DFGLA+ + P + + + T
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 242 YGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILSGR 275
Y +P T D+++ G + E+L+G+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 7/82 (8%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPNLV 132
LG G FG+V + + ++ VA+K L + RE L+ E+ +LS L H N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 133 NLIGYCADGDQRLLVYEYMPLG 154
NL+G C G L++ EY G
Sbjct: 106 NLLGACTHGGPVLVITEYCCYG 127
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 34/166 (20%)
Query: 73 NFRSESLLGEGGFGRVY--------KGY-LESINQDVAIKQLDRNGVQGNREFLVEVLML 123
+F + ++G+G FG V K Y ++++ + K+ V+ R+ L E
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES--- 58
Query: 124 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN------TRMK 177
P +V+L D L+ E++P G + L + ++ TR
Sbjct: 59 ---DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML---------IKYDTFSEDVTRFY 106
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223
+A +E +H K I+RD+K NIL+DRG H KLSDFGL+
Sbjct: 107 MAE-CVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 56/244 (22%), Positives = 99/244 (40%), Gaps = 48/244 (19%)
Query: 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL 125
++ +T+ F+ SLLGEG FG+V + + + A+K + RN + R+ +E+ +
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVK-IVRNVPKYTRDAKIEIQFMEK 181
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS-------PGKKP--LDW---- 172
+ AD R PL ++ + + + P P LDW
Sbjct: 182 VRQ----------ADPADRF------PLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH 225
Query: 173 ---NTR--MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-----------RGYHPK 216
+ R +I L+Y H + +++ DLK NIL++ R P
Sbjct: 226 GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPD 283
Query: 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
+ LG D H T ++ T Y +PE +D++S G ++ E+ +G+
Sbjct: 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343
Query: 277 AVDT 280
DT
Sbjct: 344 LYDT 347
|
Length = 467 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 29/89 (32%), Positives = 42/89 (47%), Gaps = 7/89 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVL--MLSLLHHPNLV 132
LG G FGRV + ++ VA+K L ++ L+ L M L H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLH 161
NL+G C G ++ EY G + D+LH
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPN 130
+R +G G +G V VAIK+L R + + R + E+ +L + H N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHEN 75
Query: 131 LVNLIG-YCADG--DQRLLVYEYMP-----LGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 182
++ L+ + D D+ Y MP LG + H + L + +
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLSEDRIQFLVYQM 127
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
+GL+Y+H +I+RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 128 LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR----- 179
Query: 243 GYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 275
Y APE T D++S G ++ E+L+G+
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 18/167 (10%)
Query: 119 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
EV++ HPN++ G ++ +M GS L P + + I
Sbjct: 49 EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP--EGMSEALIGNI 106
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD----FGLAKLGP----VGD 230
GA RGL YLH I+R++K S+IL+ LS + L + G V D
Sbjct: 107 LFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163
Query: 231 NTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGR 275
ST V+ + +PE + +KSD+YS G+ E+ +GR
Sbjct: 164 FPQFSTSVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 47/164 (28%), Positives = 67/164 (40%), Gaps = 23/164 (14%)
Query: 115 EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 174
E +V LM +PN + L +L+ +Y+ G L DL + L
Sbjct: 58 EPMVHQLMK---DNPNFIKLYYSVTTLKGHVLIMDYIKDGD----LFDLLKKEGKLSEAE 110
Query: 175 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTH 233
KI L LH K +I+ D+K N+L DR L D+GL K
Sbjct: 111 VKKIIRQLVEALNDLH-KHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCK--------I 159
Query: 234 VSTRVM--GTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSG 274
+ T GT Y +PE K G S D ++ GV+ E+L+G
Sbjct: 160 IGTPSCYDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 72 KNFRSESLLGEGGFGRV-----YKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSL 125
LG G FG+V Y + VA+K L + RE L+ E+ +LS
Sbjct: 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94
Query: 126 L-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL 160
L +H N+VNL+G C G L++ EY G + + L
Sbjct: 95 LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR--EFLVEVLMLSLLHHPNLVNLIG- 136
+G G FG V+ + + K + G++ + ++EV ++ L H N+V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 137 YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
+ +Q+L ++ E+ G + ++ ++ + + I L Y H+
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 196 P----VIYRDLKCSNILLDRGYH-----------------PKLSDFGLAKLGPVGDNTHV 234
P V++RDLK NI L G K+ DFGL+K + H
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH- 199
Query: 235 STRVMGTYGYCAPEYA--KTGQLTLKSDVYSFGVVLLEILSGR 275
+GT Y +PE +T KSD+++ G ++ E+ SG+
Sbjct: 200 --SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVL--MLSLLHHPNL 131
+LG G FG+V +G +++ VA+K L ++ L+ L M L H N+
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLH 161
VNL+G C ++ EY G + ++LH
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 67/272 (24%), Positives = 98/272 (36%), Gaps = 68/272 (25%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---------QGNREFLVEVLMLSLLHHPN 130
LG G FG V A+K L + V + R+ L E +
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA------DNEW 62
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V L D D V +Y+P G + L + G P D R IA +E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLL--IRMGIFPEDL-ARFYIAELTC-AVESVH 118
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL---------AKLGPVGDNTH-------- 233
K I+RD+K NIL+DR H KL+DFGL +K GD+
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 234 ----------------------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 265
++ ++GT Y APE T D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 266 VVLLEILSGRKA-VDTSKAAAEQSLVAWARPL 296
V+L E+L G+ + + + ++ W L
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 399 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.63 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.62 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.46 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.44 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.37 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.34 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.32 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.31 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.97 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.92 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.83 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.78 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.75 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.74 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.68 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.59 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.56 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.52 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.46 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.41 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.36 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.32 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.31 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.3 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.26 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.22 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.15 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.15 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.14 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.07 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.02 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.88 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.84 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.7 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.69 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.6 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.53 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.49 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.43 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.39 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.38 | |
| PLN02236 | 344 | choline kinase | 97.38 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.19 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.06 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.03 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.99 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.96 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.93 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.83 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.5 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.47 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.41 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.21 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.17 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.16 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.04 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.99 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=411.64 Aligned_cols=291 Identities=57% Similarity=0.965 Sum_probs=251.1
Q ss_pred cccccCHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEE
Q 015816 58 TAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY 137 (399)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 137 (399)
....+++.++..+|++|...+.||+|+||.||+|...+ +..||||++........++|..|+.++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56779999999999999999999999999999999987 58999998876543314569999999999999999999999
Q ss_pred EecCC-eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceE
Q 015816 138 CADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (399)
Q Consensus 138 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 216 (399)
|.+.+ +.+||+||+++|+|.++|+..... +++|..+++|+.++|+||+|||....++||||||||+|||||+++.+|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99998 599999999999999999974321 899999999999999999999999888999999999999999999999
Q ss_pred EecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh
Q 015816 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
|+|||+|+..+.. .....+...||.+|+|||++..+..+.++|||||||+|.||+||+.+.+.........+..|..+.
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999764431 111111117999999999999999999999999999999999999999876645555578888776
Q ss_pred hccccccccccCcccc-CCCCh-HhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 297 FQDRTRHSLIADPELQ-GQYPP-RGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
..+. ....+.|+.+. ..+++ .....+..+...|++.+|..||+|.+|++.|..+..
T Consensus 297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 6665 67778898887 56665 678889999999999999999999999999965544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-55 Score=395.10 Aligned_cols=276 Identities=26% Similarity=0.342 Sum_probs=230.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++++.||+|+||+||.++.+++++.||+|++++..... .+....|..||..++||+||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999999999999999998764433 45678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
+||+.||.|..+|++ .+.+++..+.-++.+|+.||.|||++| ||||||||+|||||.+|+++|+|||+|+...
T Consensus 104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999997 788999999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
. ....+.+++||+.|||||++.+..|+.++|+||||+++|||++|.+||...+.....+.+....
T Consensus 177 ~--~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------------- 241 (357)
T KOG0598|consen 177 K--DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------------- 241 (357)
T ss_pred c--CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-------------
Confidence 2 2233445899999999999999999999999999999999999999998876654433332111
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCC---CHHHHHHHHHHHHhccCCCcccccCCCCCCCCC
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRP---VIADVVTALAYLASQKYESDAEKVQSPCLDPGT 372 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~eil~~L~~l~~~~~~~~~~~~~~~~~~~~~ 372 (399)
....+.-...+..+++.++|..||++|. .-.+-++....+....|+........|++.|..
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~ 305 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNV 305 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCC
Confidence 0011111334788999999999999995 333335666677777777777776666555543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=411.67 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=217.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.+|...+.||+|||+.||.+++..+|+.||+|++.+... ...+.+.+||+|.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 569999999999999999999999999999999986433 34567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|+|..++|..+++. ..++++.+++.+++||+.||.|||+++ |+|||||..|+||+++.+|||+|||+|.....
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999986 688999999999999999999999999 99999999999999999999999999987432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
......+.+|||.|+|||++.....+..+||||+||+||.||.|++||+.....+....+.....
T Consensus 171 --~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y------------- 235 (592)
T KOG0575|consen 171 --DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY------------- 235 (592)
T ss_pred --cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-------------
Confidence 33445678999999999999999999999999999999999999999998755443333221111
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..|.....+..+||.++|+.||.+|||+.+|+..
T Consensus 236 -----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 -----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1223344488899999999999999999999964
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-54 Score=386.18 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=209.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecCC-eeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~ 150 (399)
+.+..+.||+|..|+||+|+|+.+++.+|+|++..+. ....+++.+|+++++.++||+||.+|+.|.... .++|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4556788999999999999999999999999996443 334578999999999999999999999999988 59999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|++|+|.+.+.. .+.+++...-.|+.+|++||.|||+ ++ ||||||||+||||+..|.|||||||.+......
T Consensus 160 MDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999987 5789999999999999999999996 77 999999999999999999999999999853222
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchH--HHHHHHHHhhhhhhcccccccccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA--AAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||..... .....+..+. ....
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v~~p------- 298 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---VDEP------- 298 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---hcCC-------
Confidence 45668899999999999999999999999999999999999999977511 1111222111 1100
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
-|.+... ....++..++..||++||.+|||+.++++.
T Consensus 299 pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1112121 133488999999999999999999999964
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-54 Score=390.47 Aligned_cols=207 Identities=30% Similarity=0.450 Sum_probs=187.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
..+|.+.+.||.|+||+||+|+++.++..||||.+.+.. ....+.+..|+++|+.++|||||.+++++.+++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457889999999999999999999999999999998764 334466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC------CceEEecccC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG------YHPKLSDFGL 222 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~------~~~kl~Dfg~ 222 (399)
|||.||+|.+|++. .+.+++..+..++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999998 668999999999999999999999999 9999999999999864 4689999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHH
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 287 (399)
|+... ......+.+|++.|||||++....|+.|+|+||+|+++|++++|+.||+.....+..
T Consensus 162 AR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~ 223 (429)
T KOG0595|consen 162 ARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL 223 (429)
T ss_pred hhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 99644 344456689999999999999999999999999999999999999999976655443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=392.86 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=211.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc-------hHHHHHHHHHHhhcCCCCccceEEEEecCC
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-------NREFLVEVLMLSLLHHPNLVNLIGYCADGD 142 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 142 (399)
..+.|.+.+.||+|+||.|-+|..+.+|+.||||++++..... ...+.+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4456889999999999999999999999999999997543222 233579999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC---CceEEec
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSD 219 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~D 219 (399)
..|+||||+.||+|.+.+.. ++.+.+.....+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999987 778899999999999999999999999 9999999999999765 7899999
Q ss_pred ccCCccCCCCCCcceeeeeccCccccCccccccCCC---CcccceeehhHHHHHHHhCCCCcccchHHH-HHHHHHhhhh
Q 015816 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL---TLKSDVYSFGVVLLEILSGRKAVDTSKAAA-EQSLVAWARP 295 (399)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~ 295 (399)
||+|+... ......+.|||+.|.|||++.+..+ ..++|+||+||+||-+|+|.+||....... ..+.+.....
T Consensus 323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY 399 (475)
T ss_pred cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence 99999643 4445667899999999999976543 347899999999999999999998654432 1111111110
Q ss_pred hhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. +......+..++..+||.+||..||++|||+.|+|+.
T Consensus 400 ~--------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 400 A--------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred c--------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 0 1112234566789999999999999999999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-55 Score=377.97 Aligned_cols=259 Identities=23% Similarity=0.340 Sum_probs=214.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEE-EEecCCe-eEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQ-RLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~-~~~~~~~-~~lv 147 (399)
.+|++++.||.|+||.||++.+..+|..+|.|.+.-.. ....+....|+.+|++|+|||||++++ .+.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 35788899999999999999999999999999987332 233466889999999999999999998 4444444 8999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||.+|+|...++...+.++.+++..+|+++.|++.||..+|++- ...|+||||||.||+|+.+|.|||+|||+++..
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999988888899999999999999999999999931 123999999999999999999999999999873
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
..........+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+.+-......+...
T Consensus 179 --~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg------------- 243 (375)
T KOG0591|consen 179 --SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG------------- 243 (375)
T ss_pred --cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-------------
Confidence 33344456689999999999999999999999999999999999999999887433322222111
Q ss_pred cCccccCCCC-hHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 307 ADPELQGQYP-PRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 307 ~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
++ ..+| ...+..+.+||..|+..||+.||+...+++.+.
T Consensus 244 ---d~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 ---DY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ---CC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 01 1123 345678999999999999999999666665544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=386.83 Aligned_cols=256 Identities=36% Similarity=0.556 Sum_probs=210.3
Q ss_pred CCCCeeeecCceEEEEEEECCCCeE-EEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCccceEEEEecCC-eeEEEEEe
Q 015816 75 RSESLLGEGGFGRVYKGYLESINQD-VAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYEY 150 (399)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~ 150 (399)
.+.+.||.|+||+||+|.+++ +. ||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. .+++||||
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344569999999999999984 55 9999997654332 458999999999999999999999999987 79999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-ceEEecccCCccCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVG 229 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 229 (399)
+++|+|.++++.. ....+++..++.++.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999874 25789999999999999999999999875 89999999999999998 9999999999853221
Q ss_pred CCcceeeeeccCccccCccccc--cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAK--TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
. ...+...||+.|||||++. ...|+.++||||||++||||+||+.||............ + ... .
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v--~----~~~-~----- 263 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV--V----VGG-L----- 263 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--H----hcC-C-----
Confidence 1 2233367999999999999 569999999999999999999999999887652221111 0 000 0
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
-+.+... .+..+..|+..||+.||..||++.+++..|+.+...
T Consensus 264 Rp~~p~~----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 264 RPPIPKE----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CCCCCcc----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 1111122 333888999999999999999999999999988754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=385.50 Aligned_cols=265 Identities=26% Similarity=0.365 Sum_probs=220.8
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhc-CCCCccceEEEEecCCe
Q 015816 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 143 (399)
.....+|.+++.||.|+|++|++|+.+.+++.||||++.+..... .+.+..|-.+|.+| .||.|++|+..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445678999999999999999999999999999999997654432 23467788999999 79999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
+|+|+||+++|+|.++|.. .+.|++..++.++.||+.||+|||++| ||||||||+|||||.+++++|+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999998 688999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc---------ce--eeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHh
Q 015816 224 KLGPVGDNT---------HV--STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292 (399)
Q Consensus 224 ~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 292 (399)
+.+...... .. ...++||..|.+||++.+...+..+|||+||||||+|+.|.+||...+..-.-..+..
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~ 301 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA 301 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence 875432211 11 1458999999999999999999999999999999999999999987665322111110
Q ss_pred hhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccCCC
Q 015816 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYES 358 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~ 358 (399)
+.-.+++..+..+.+|+.++|..||.+|+++.+|- +..++..-.|+.
T Consensus 302 ------------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk-~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 302 ------------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIK-AHPFFEGVDWEN 348 (604)
T ss_pred ------------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHh-hCcccccCChhh
Confidence 11233334445889999999999999999997765 444555555555
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=361.01 Aligned_cols=265 Identities=25% Similarity=0.298 Sum_probs=213.9
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.|+.+..+|+|+||.||+|++++||+.||||++..... ...+-.++|+.+|++|+|||+|.++++|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 57788899999999999999999999999999865432 2234578999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
|+. ++.+-|... ...++...+..+++|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+....
T Consensus 83 ~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 83 CDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred cch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 985 444445442 567899999999999999999999999 99999999999999999999999999987432
Q ss_pred CcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh--------hhhhcccc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA--------RPLFQDRT 301 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~ 301 (399)
.....+..+.|.+|+|||.+-+ ..|+..+||||+||++.||++|.+.|.+.+..+..-.+... ...|....
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 3444566789999999998866 78999999999999999999999999887766554333221 12222222
Q ss_pred ccccccCcc-----ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 302 RHSLIADPE-----LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 302 ~~~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
....+..|+ ....-.+.....+.+++..||+.||++|++-++++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 222222222 222233445668899999999999999999999984
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-50 Score=376.40 Aligned_cols=256 Identities=31% Similarity=0.455 Sum_probs=216.3
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+++.+.||+|.||.||.|.++. ...||+|.+... ....+.|.+|+.+|++|+|+|||+++++|..++.+|||||||+.
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 4567889999999999999986 458999999754 33457788999999999999999999999998899999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|+|.+||+.. .+..+...+.+.++.|||+|++||++++ +|||||...||||+++..+||+|||+|+.. ..+...
T Consensus 286 GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~ 359 (468)
T KOG0197|consen 286 GSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYT 359 (468)
T ss_pred CcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc-CCCcee
Confidence 9999999972 3677899999999999999999999999 999999999999999999999999999942 222232
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcccc
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 312 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
......-...|.|||++..+.++.+||||||||+||||+| |+.|+......+....+... .+
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-----------------yR 422 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-----------------YR 422 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-----------------Cc
Confidence 3333344678999999999999999999999999999999 99999887665554443221 12
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 313 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 313 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
-..|+.++..+.+|+..||+.+|++|||++.+...|+.+...
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 234445556999999999999999999999999999877653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=379.08 Aligned_cols=271 Identities=23% Similarity=0.278 Sum_probs=217.7
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
....++|++++.||+|+||.||+|+.+.||..||+|++.+..... ...+..|-.+|....+|+||++|..|++.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345678999999999999999999999999999999998765443 35577899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
||||||++||++..+|.. ...|++..+..++.+++.||+.||..| +|||||||+|+|||..|++||+|||+|.
T Consensus 217 YLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999987 789999999999999999999999999 9999999999999999999999999985
Q ss_pred cCCC----------------------CCCc----c-------------------eeeeeccCccccCccccccCCCCccc
Q 015816 225 LGPV----------------------GDNT----H-------------------VSTRVMGTYGYCAPEYAKTGQLTLKS 259 (399)
Q Consensus 225 ~~~~----------------------~~~~----~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 259 (399)
-... .+.. . .....+|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3110 0000 0 01125799999999999999999999
Q ss_pred ceeehhHHHHHHHhCCCCcccchHHH-HHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCC
Q 015816 260 DVYSFGVVLLEILSGRKAVDTSKAAA-EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR 338 (399)
Q Consensus 260 DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 338 (399)
|+||||||+||||.|.+||......+ -..+..|........ .. ....+..+||.+||. ||++|
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~--------------~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EV--------------DLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cC--------------cccHHHHHHHHHHhc-CHHHh
Confidence 99999999999999999998766543 344444443221111 00 111478899999999 99999
Q ss_pred CC---HHHHHHHHHHHHhccCCCcccc
Q 015816 339 PV---IADVVTALAYLASQKYESDAEK 362 (399)
Q Consensus 339 Ps---~~eil~~L~~l~~~~~~~~~~~ 362 (399)
.- ++||- ....+..-.|+...+.
T Consensus 434 LG~~G~~EIK-~HPfF~~v~W~~l~~~ 459 (550)
T KOG0605|consen 434 LGSKGAEEIK-KHPFFKGVDWDHLREM 459 (550)
T ss_pred cCcccHHHHh-cCCccccCCcchhhcC
Confidence 75 44443 3344555555544433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=374.71 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=214.5
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccC----CC-cchHHHHHHHHHHhhcC-CCCccceEEEEecCC
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN----GV-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 142 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 142 (399)
.....|.+.+.||+|+||+|+.|.+..++..||+|++... .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999999999999999987664 11 22345678999999999 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC-CceEEeccc
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFG 221 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg 221 (399)
.+|+||||+.||+|.+++.. .+++.+.++..+++||+.|++|||++| |+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999997 688999999999999999999999999 9999999999999999 999999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCC-CC-cccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ-LT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..........+ ...
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki------~~~ 238 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI------RKG 238 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH------hcC
Confidence 998753 2233345678999999999999877 86 7899999999999999999999984432221111 000
Q ss_pred ccccccccCccccCCCChHh-HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 300 RTRHSLIADPELQGQYPPRG-FYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.. .+|... ..++..|+.+||..||..|+|+.+|+ ....+..
T Consensus 239 -----~~-------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 239 -----EF-------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred -----Cc-------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 01 111111 44888999999999999999999999 5555554
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=386.05 Aligned_cols=279 Identities=27% Similarity=0.407 Sum_probs=235.6
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcC-CCCccceEEEEecCCe
Q 015816 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 143 (399)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 143 (399)
....++|.++++||+|+||+|++|..+.+++.||||++++..... .+..+.|..|+...+ ||+++.++..|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999999999999999998775543 356788888888775 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
+|+||||+.||++..+.+ ...|++..+..++..|+.||+|||++| |||||||.+|||||.+|.+||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 999999999999666555 477999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
+.... ....+.+++||+.|||||++.+..|+.++|+|||||+|||||.|..||.+.+..+.-+-+..-
T Consensus 516 Ke~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d---------- 583 (694)
T KOG0694|consen 516 KEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND---------- 583 (694)
T ss_pred cccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Confidence 86332 233567799999999999999999999999999999999999999999987665443222111
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCH----HHHHHHHHHHHhccCCCcccccCCCCCCCCCCc
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI----ADVVTALAYLASQKYESDAEKVQSPCLDPGTPT 374 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~~L~~l~~~~~~~~~~~~~~~~~~~~~p~ 374 (399)
+ -.+|...+.+...|+.++|..+|++|.-+ ++.+..-..+....|+....+...|++.|...+
T Consensus 584 ----~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~ 650 (694)
T KOG0694|consen 584 ----E----VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKG 650 (694)
T ss_pred ----C----CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCC
Confidence 1 12333445588899999999999999977 778888888888888888888777777765443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=347.33 Aligned_cols=237 Identities=28% Similarity=0.362 Sum_probs=205.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|+..+.||.|+||.|.+++.+.+|..||+|++++..... .+...+|..+|+.+.||+++++++.+.+.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888999999999999999999999999999998664433 355788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||++||.|..+++. .+++++..++.++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS- 195 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence 99999999999997 788999999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
..+.+.||||.|+|||++....|+.++|+|||||++|||+.|.+||........-+.+ ....
T Consensus 196 ----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI------~~~~-------- 257 (355)
T KOG0616|consen 196 ----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI------LEGK-------- 257 (355)
T ss_pred ----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH------HhCc--------
Confidence 1255689999999999999999999999999999999999999999877663322211 1110
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCC
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMR 338 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 338 (399)
-.+|+.-...+.+|+.++|+.|-..|
T Consensus 258 ----v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 ----VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 12333334488999999999999999
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=361.72 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=206.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCC--eeEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVY 148 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~ 148 (399)
..+|...+.||+|+||.||++.+..+|..+|||.+........+.+.+|+.+|++++|||||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345777889999999999999999999999999987664333667899999999999999999999754444 689999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-CCceEEecccCCccCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGP 227 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~ 227 (399)
||+++|+|.+++.... ..|++..+..+++||++||+|||++| ||||||||+|||++. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999732 27999999999999999999999999 999999999999999 7999999999987643
Q ss_pred C-CCCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccc-hHHHHHHHHHhhhhhhccccccc
Q 015816 228 V-GDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTS-KAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 228 ~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
. ...........||+.|||||++.++ ....++|||||||++.||+||+.||... ..... +.... .. .
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~--~~~ig----~~---~- 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA--LLLIG----RE---D- 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH--HHHHh----cc---C-
Confidence 2 1122223457799999999999863 3345999999999999999999999863 11111 11000 00 0
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
..| .+|...+..+.+++.+|+..||+.||||.++|+..-
T Consensus 240 --~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 --SLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred --CCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111 334445558899999999999999999999997544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-50 Score=369.64 Aligned_cols=268 Identities=24% Similarity=0.298 Sum_probs=218.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHH--HHHHHHHHhhcC-CCCccceEEEEecCC-eeE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE--FLVEVLMLSLLH-HPNLVNLIGYCADGD-QRL 145 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-hpniv~~~~~~~~~~-~~~ 145 (399)
.-++|.+.+.||.|.||.||+|+.+.+|..||||.+...... .++ -.+|+..|++|+ |||||++.+++.+.+ .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 446899999999999999999999999999999999765333 332 368999999999 999999999999888 999
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+|||||+ .+|+++++++ ...|++..+..|+.||++||+|+|.+| +.||||||+|||+.....|||+|||+|+.
T Consensus 87 fVfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 9999998 8999999975 678999999999999999999999999 99999999999999999999999999995
Q ss_pred CCCCCCcceeeeeccCccccCcccc-ccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc-
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH- 303 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 303 (399)
. ......+..+.|.+|+|||++ +.+.|+.+.||||+|||++|+.+-++.|.+.+..+..-.+..+..........
T Consensus 160 v---~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 V---RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred c---ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 3 334445677899999999976 56889999999999999999999999999887766654444332211111110
Q ss_pred -------ccccCcccc----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 304 -------SLIADPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 304 -------~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
-.+.-|.+. ....+....++.+||..||++||.+||||.+.++.-
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 111111111 112233567899999999999999999999999753
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=375.00 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=214.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC-Cc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.-|++++-||.|+-|.|.+|++..||+.+|||++.+.. .. ....+.+||-||+.+.||||+++|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34888999999999999999999999999999997652 22 2345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||++||.|.+++.. +++|++.++..++.||+.|+.|+|..+ |+||||||+|+|||..++|||+|||+|..
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsL--- 161 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASL--- 161 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeec---
Confidence 99999999999997 899999999999999999999999999 99999999999999999999999999984
Q ss_pred CCCcceeeeeccCccccCccccccCCCC-cccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
........+.||++.|.|||++.+.+|+ .++||||+|||||.||||+.||+..+.......+... .|
T Consensus 162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G--~f---------- 229 (786)
T KOG0588|consen 162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG--VF---------- 229 (786)
T ss_pred ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC--cc----------
Confidence 3334445667899999999999999986 7899999999999999999999966544333222111 11
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
+.|...+.++.+|+.+||.+||..|.|++||++.-.
T Consensus 230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 122333448889999999999999999999997543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=357.16 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=217.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcch-HHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
..+.|++...||.|.-++||+|+...+++.||||+++....... +.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 45689999999999999999999999999999999986655444 78899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
.||.+|++.+.+.... ...+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.+.....
T Consensus 104 pfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999866 345999999999999999999999999 99999999999999999999999998765333
Q ss_pred CC-Cccee-eeeccCccccCccccc--cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 229 GD-NTHVS-TRVMGTYGYCAPEYAK--TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 229 ~~-~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
.. ..... ..++||++|||||++. ...|+.|+||||||++..||.+|..||.........-+.....+.....
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t---- 254 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT---- 254 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc----
Confidence 22 22222 5578999999999964 3689999999999999999999999999887765544443332221110
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+.+-.. .....+.+++..||+.||.+|||++++++
T Consensus 255 ~~~~~d~~k----~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDK----KFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhh----hhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 011111111 12237889999999999999999999996
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=333.12 Aligned_cols=269 Identities=25% Similarity=0.311 Sum_probs=216.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.+|...+.||+|.||.||+|++..+|+.||||++...... ......+||..|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678889999999999999999999999999999765333 23567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|++ .+|...+++ ....|+..++..++.++++||+|||++. |+||||||.|+||+.+|.+||+|||+++.+...
T Consensus 82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 998 899999987 3568999999999999999999999999 999999999999999999999999999975544
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh--hhhccccccccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR--PLFQDRTRHSLI 306 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 306 (399)
... .+..+-|.+|.|||.+.+ ..|+..+||||.|||+.||+.|.+-|.+.+..+....+-... |...........
T Consensus 155 ~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Ccc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 333 333478999999997754 689999999999999999999998888776665554432221 211121122222
Q ss_pred cCccccC--------CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 307 ADPELQG--------QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 307 ~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
.|-.... ..-+.....+.+|+.++|..||.+|+|+.|.++.-.
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 1111111 122334557799999999999999999999996543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=369.18 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=214.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
..|.....||+|+-|.||.|....+++.||||.+........+-+++|+.+|+.++|+|||.+++.|...+.+++||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 35888899999999999999999999999999998877777777899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
+||+|.+.+.. ..+++.++..|+++++.||+|||.++ |+|||||.+|||++.+|.+||+|||+|......
T Consensus 353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~-- 422 (550)
T KOG0578|consen 353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE-- 422 (550)
T ss_pred CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccc--
Confidence 99999999985 45999999999999999999999999 999999999999999999999999999764332
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHh-hhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-ARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 310 (399)
.......+||+.|||||+.....|++++||||||++++||+-|++||-.........++.. ..+.
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~-------------- 488 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPK-------------- 488 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCC--------------
Confidence 2245668899999999999999999999999999999999999999976444322222211 1111
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+......+.+++.+||+.||.+|+++.|+|+
T Consensus 489 --lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 489 --LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred --cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1223334458899999999999999999999996
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=360.97 Aligned_cols=266 Identities=23% Similarity=0.283 Sum_probs=210.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecC--CeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv 147 (399)
+.|+..+.||+|.||.||+|++..+|+.||+|++..... ....-..+||.||++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 458888999999999999999999999999999975542 2234467899999999999999999998776 689999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
+|||+ -+|.-++.. ..-.|++.++..++.||+.||+|||++| |+|||||.+|||||.+|.+||+|||+|++..
T Consensus 197 FeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 99998 578877764 2457999999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
..... ..+..+-|.+|.|||++.+ ..|+.++|+||+||||.||++|++.|.+....+....+-..-......... ..
T Consensus 270 ~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~ 347 (560)
T KOG0600|consen 270 PSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VS 347 (560)
T ss_pred CCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cc
Confidence 44332 2455678999999998865 689999999999999999999999999887776665542221111111111 11
Q ss_pred cCcc--cc---CCCCh-------HhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 307 ADPE--LQ---GQYPP-------RGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 307 ~~~~--~~---~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..|. .. ..+.. .......+|+..+|..||.+|.||.++|+
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1110 00 01111 12346788999999999999999999884
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=364.04 Aligned_cols=247 Identities=30% Similarity=0.416 Sum_probs=214.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.... +.+.+.+|++|++.++|||||.++++|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4688889999999999999999999999999999876443 34668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+.| +|..+|.+ .+.++++.+..|+.|++.||.|||+.+ |+|||+||.|||++.+|.+|+||||+|+.+.
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~-- 151 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS-- 151 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc--
Confidence 9985 99999998 888999999999999999999999999 9999999999999999999999999999743
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
......+...|||.|||||+..+..|+..+|+|||||++||+++|++||.......... .+..+..
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~------~I~~d~v-------- 217 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVK------SILKDPV-------- 217 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHH------HHhcCCC--------
Confidence 34556677889999999999999999999999999999999999999997654432222 1122111
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+|+.....+..++..+|.+||.+|.+-.+++.
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 122344457888999999999999999999885
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=360.78 Aligned_cols=264 Identities=28% Similarity=0.414 Sum_probs=206.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-----CCCeEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecC-C
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG-D 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~ 142 (399)
.++|++.+.||+|+||.||+|.+. .++..||||++..... .....+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467999999999999999999752 3456899999875432 2345688999999999 899999999988764 4
Q ss_pred eeEEEEEecCCCCHHHHhhccCC---------------------------------------------------------
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSP--------------------------------------------------------- 165 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 165 (399)
.+++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 58899999999999999975321
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccc
Q 015816 166 -GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244 (399)
Q Consensus 166 -~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 244 (399)
...++++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0235888999999999999999999999 999999999999999999999999999754322222222233467889
Q ss_pred cCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHH
Q 015816 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 323 (399)
Q Consensus 245 ~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 323 (399)
+|||++.+..++.++|||||||++|||++ |..||........ ... ....... . ..+...+..+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~----~~~~~~~------~----~~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQ----RLKDGTR------M----RAPENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHH----HHhcCCC------C----CCCCCCCHHH
Confidence 99999999999999999999999999997 9999976432211 000 0111000 0 1112233478
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 324 LAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 324 ~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=356.45 Aligned_cols=249 Identities=29% Similarity=0.428 Sum_probs=211.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
..|+....||+|+||.||+|.+..+++.||+|++...... ..+.+..|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3466778999999999999999999999999999866544 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
|.||++.+.+.. ...+.+..+..++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||++-.....
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~- 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT- 164 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech-
Confidence 999999999986 556689999999999999999999999 999999999999999999999999998753322
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.....+++||+.|||||++....|+.++||||||++.+||++|.+|+.........-+ ...-.-|.
T Consensus 165 -~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------Ipk~~PP~ 230 (467)
T KOG0201|consen 165 -VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------IPKSAPPR 230 (467)
T ss_pred -hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------ccCCCCCc
Confidence 2233668999999999999999999999999999999999999999987544211111 11111233
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+.+.+.+ .+.+++..||..||+.||+|.++++
T Consensus 231 L~~~~S~----~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 231 LDGDFSP----PFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccccCH----HHHHHHHHHhhcCcccCcCHHHHhh
Confidence 4444444 7899999999999999999999985
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=357.48 Aligned_cols=242 Identities=27% Similarity=0.356 Sum_probs=200.9
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 154 (399)
+.||+|+||.||+|.++.+|+.||||++..... .....+..|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999875422 22345778999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcce
Q 015816 155 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 234 (399)
Q Consensus 155 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 234 (399)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence 99999976 567999999999999999999999999 999999999999999999999999998742211 122
Q ss_pred eeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCC
Q 015816 235 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ 314 (399)
Q Consensus 235 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
....+||+.|+|||++.+..++.++|||||||++|||++|..||............. .. .. .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~------~~--------~~----~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------ME--------EI----R 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH------cC--------CC----C
Confidence 234579999999999999999999999999999999999999997654332211110 00 01 1
Q ss_pred CChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 315 YPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 315 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
++......+.+|+.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1222344788999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=349.55 Aligned_cols=275 Identities=27% Similarity=0.388 Sum_probs=212.0
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999999999999999998754322 22457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999998886432 346899999999999999999999999 999999999999999999999999998753222
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
. ......||..|+|||++.+..++.++|||||||++|+|++|+.||............. ......
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~~--------- 220 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVKED--------- 220 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhhcc---------
Confidence 1 1233568999999999999999999999999999999999999998654321111110 000000
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHHHHhccCCCcccccCCCCCCC
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVTALAYLASQKYESDAEKVQSPCLDP 370 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~~l~~~~~~~~~~~~~~~~~~~ 370 (399)
...++......+.+|+.+||+.||.+||+ ++++++. ..+....+.........|+..|
T Consensus 221 --~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h-~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05631 221 --QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH-PIFKNINFKRLEANMLEPPFCP 283 (285)
T ss_pred --cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC-HhhcCCCHHHHHhCcCCcCCCC
Confidence 01122223347889999999999999997 7888752 2233333333333333444433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=326.35 Aligned_cols=268 Identities=25% Similarity=0.316 Sum_probs=220.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCC-----ee
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QR 144 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~ 144 (399)
..++|++.+.||.|||+-||++....++..||+|++.-....+.+..++|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4578999999999999999999999999999999998776677788999999999999999999998765443 48
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
||+++|+..|+|.+.+......+..+++.+++.|+.+|++||++||+.. +|..||||||+|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999988777778999999999999999999999986 579999999999999999999999999998
Q ss_pred cCCCCCCcc-------eeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh
Q 015816 225 LGPVGDNTH-------VSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 225 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 294 (399)
..+...... .......|..|.|||.+. +...++++|||||||+||+|+.|..||+.... ...
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~Gg------- 249 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGG------- 249 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCC-------
Confidence 644332221 112245789999999884 56788999999999999999999999975432 111
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
.....+.++.+...-..+.++.+.+++..||+.||.+||++.+++..++.+.
T Consensus 250 ------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 ------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111122222222222336679999999999999999999999999988653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=332.99 Aligned_cols=294 Identities=22% Similarity=0.279 Sum_probs=225.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCccceEEEEec--CCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 147 (399)
++|+.++.|++|+||.||+|+++.+++.||+|+++...... ----++||.+|.+++|||||.+-.+..- -+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45888899999999999999999999999999997543111 1235789999999999999999887754 4679999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
||||+ -+|..++... .++|...++.-++.|+++|++|||.+. |+||||||+|+|++..|.+||+|||+|+...
T Consensus 156 Me~~E-hDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHH-hhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 99998 6899999874 478999999999999999999999998 9999999999999999999999999999643
Q ss_pred CCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
......+..+-|.+|.|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+....+..+.+-...............
T Consensus 229 --sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 --SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred --CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 33344566788999999998865 679999999999999999999999999887766555442222111111111111
Q ss_pred cCc-------------cccCCCChH-hHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccCCCcccccCCCCCCCCC
Q 015816 307 ADP-------------ELQGQYPPR-GFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQSPCLDPGT 372 (399)
Q Consensus 307 ~~~-------------~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~~~~~~~ 372 (399)
.-+ .+...+... ..+.-++|+..+|..||.+|.|+.+.|+ ..|.........|..-|+.
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~-------h~~F~e~P~p~~P~~~Pt~ 379 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK-------HEYFRETPLPIDPSMFPTW 379 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc-------ccccccCCCCCChhhcCCC
Confidence 011 111122222 2357788999999999999999999884 3444444444556666777
Q ss_pred CccccCccc
Q 015816 373 PTRTKGDKE 381 (399)
Q Consensus 373 p~~~~~~~~ 381 (399)
|.+..+...
T Consensus 380 P~k~~~~~~ 388 (419)
T KOG0663|consen 380 PAKSEQQRV 388 (419)
T ss_pred ccccccccC
Confidence 776655554
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=346.39 Aligned_cols=249 Identities=23% Similarity=0.408 Sum_probs=212.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchH---HHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
..+|++.+.||+|.||.|-+|.....|+.||||.|.+....+.. .+.+||+||+.|+||||+.+|++|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999999889999999999887665554 467899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||..+|.|++|+.+ .+.|++.++..+++||..|+.|+|.++ ++|||||.+|||+|.++++||+|||++....
T Consensus 132 MEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999998 788999999999999999999999999 9999999999999999999999999997533
Q ss_pred CCCCcceeeeeccCccccCccccccCCCC-cccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
. .....++||++-|.+||++++.+|. +.+|-|||||+||.|+.|..||++.........+. ...+.
T Consensus 205 ~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs--~GaYr-------- 271 (668)
T KOG0611|consen 205 D---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS--RGAYR-------- 271 (668)
T ss_pred c---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh--ccccc--------
Confidence 2 2334668999999999999999885 78999999999999999999999876543221110 00010
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
.| ..+....-||++||..||++|-|+.+|....
T Consensus 272 -EP--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 -EP--------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -CC--------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11 1112556699999999999999999998754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=349.28 Aligned_cols=257 Identities=28% Similarity=0.354 Sum_probs=204.0
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--------------chHHHHHHHHHHhhcCCCCccce
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------------GNREFLVEVLMLSLLHHPNLVNL 134 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~hpniv~~ 134 (399)
...++|++.+.||+|.||.|-+|++..+++.||||++.+.... ..+.+.+||.||++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999999999999999999753221 22578899999999999999999
Q ss_pred EEEEecC--CeeEEEEEecCCCCHHHHhhccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC
Q 015816 135 IGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKP-LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 211 (399)
Q Consensus 135 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~ 211 (399)
+++..+. +.+|||+|||..|.+..--. ..+ +++.+++.|+++++.||+|||.+| ||||||||+|+||++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 9998764 67999999999887543322 344 999999999999999999999999 999999999999999
Q ss_pred CCceEEecccCCccCCCCCC---cceeeeeccCccccCccccccCC----CCcccceeehhHHHHHHHhCCCCcccchHH
Q 015816 212 GYHPKLSDFGLAKLGPVGDN---THVSTRVMGTYGYCAPEYAKTGQ----LTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (399)
Q Consensus 212 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~g~~pf~~~~~~ 284 (399)
+|+|||+|||.+.....+.. .......+|||.|+|||...++. .+.+.||||+||+||-|+.|+.||-.....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 99999999999976433211 11122367999999999886632 357889999999999999999999776543
Q ss_pred HHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 285 AEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
..-+.+ ... .+.-...++..+.+.+||.++|.+||+.|.+..+|.....
T Consensus 326 ~l~~KI------vn~----------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 326 ELFDKI------VND----------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHHH------hcC----------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 322111 111 1111112244568999999999999999999999886554
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=324.55 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=213.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++++.||+|-||.||+|+.+.++-.||+|++.+.... ...++.+|++|-+.|+||||+++|++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35799999999999999999999999999999999765432 346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
+||.+.|+|...|.... ...+++..+..++.|+|.||.|+|.++ |+||||||+|+|++..+.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999998533 567899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.......+||..|.|||+..+..++..+|+|++|++.||++.|.+||......+--..+..+
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-------------- 237 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-------------- 237 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--------------
Confidence 33456689999999999999999999999999999999999999999865532211111111
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...+|+.....+.++|.+|+..+|.+|.+..|+++.
T Consensus 238 ----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 ----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 012233444588999999999999999999999864
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=343.24 Aligned_cols=265 Identities=27% Similarity=0.343 Sum_probs=215.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchH---HHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.+.|++++.||.|.-|+||+|..++++..+|+|++++......+ +...|-+||+.++||.++.||+.|+.+...|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 35688889999999999999999999999999999877655443 456799999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
||||+||+|..+++... ...|++..++.++.+|+.||+|||..| ||+|||||+||||.++|+|.|+||.++....
T Consensus 156 meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999998754 678999999999999999999999999 9999999999999999999999999875321
Q ss_pred CC--------------------------------CCc----------------------ceeeeeccCccccCccccccC
Q 015816 228 VG--------------------------------DNT----------------------HVSTRVMGTYGYCAPEYAKTG 253 (399)
Q Consensus 228 ~~--------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~ 253 (399)
.. ... .....++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 10 000 011236899999999999999
Q ss_pred CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 015816 254 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 333 (399)
Q Consensus 254 ~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 333 (399)
..+.++|+|+|||++||||.|..||.+....+-...+ + ... +.+ .-.+.....+.+||+++|.+
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI--v----~~~--------l~F--p~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI--V----GQP--------LKF--PEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH--h----cCC--------CcC--CCCCcchhHHHHHHHHHhcc
Confidence 9999999999999999999999999876554322111 1 110 001 11113455889999999999
Q ss_pred CCCCCCC----HHHHHHHHHHHHhccCC
Q 015816 334 QPDMRPV----IADVVTALAYLASQKYE 357 (399)
Q Consensus 334 dP~~RPs----~~eil~~L~~l~~~~~~ 357 (399)
||.+|.- +.||- ...++..-.|.
T Consensus 375 dP~kRlg~~rGA~eIK-~HpFF~gVnWa 401 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIK-RHPFFEGVNWA 401 (459)
T ss_pred ChhhhhccccchHHhh-cCccccCCChh
Confidence 9999987 66654 45555565665
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=354.77 Aligned_cols=254 Identities=25% Similarity=0.333 Sum_probs=208.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.+..+++.||||++..... .....+..|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368999999999999999999999999999999875422 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999976 567899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
......||+.|+|||++.+..++.++|||||||++|||++|..||..................+.. ....+
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~ 224 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR----PVYDD 224 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC----CCCCc
Confidence 223456999999999999999999999999999999999999999876543322211111100000 00000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
+. ......+.+++.+||..+|.+||++.++++.
T Consensus 225 ~~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PR------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cc------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 1223478899999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=354.80 Aligned_cols=245 Identities=27% Similarity=0.357 Sum_probs=204.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.+|++.+.||+|+||.||+|.++.+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 568899999999999999999999999999999865322 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999986 567899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||............ ....
T Consensus 171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i------~~~~-------- 231 (329)
T PTZ00263 171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI------LAGR-------- 231 (329)
T ss_pred C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH------hcCC--------
Confidence 1 12356999999999999999999999999999999999999999765432211111 0000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 346 (399)
. .++......+.+|+.+||+.||.+||+ +.+++.
T Consensus 232 ~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 232 L----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred c----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 111112336889999999999999997 577664
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=350.88 Aligned_cols=246 Identities=25% Similarity=0.296 Sum_probs=205.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.++.+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 368899999999999999999999999999999864322 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999986 567999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............. .. .
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~------~~--------~ 214 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL------AG--------K 214 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC--------C
Confidence 1 223569999999999999999999999999999999999999997654432211111 00 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVTA 347 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 347 (399)
. .++......+.+|+.+||+.||.+||+ +.++++.
T Consensus 215 ~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 L----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred c----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0 111222347889999999999999995 7777743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=345.96 Aligned_cols=267 Identities=21% Similarity=0.230 Sum_probs=205.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||.||+|+++.+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 368999999999999999999999999999999875432 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|++++.+..+... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998766655433 456899999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhh--------cccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF--------QDRT 301 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~ 301 (399)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||................... ....
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 21 11233568999999999998899999999999999999999999998654433221111110000 0000
Q ss_pred ccccccCcccc------CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 302 RHSLIADPELQ------GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 302 ~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.......+... ..+.......+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000001000 0111123457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=338.85 Aligned_cols=270 Identities=23% Similarity=0.300 Sum_probs=212.9
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEecc--CCCcchHHHHHHHHHHhhcCCCCccceEEEEec-----C
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-----G 141 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~ 141 (399)
.....|...+.||.|+||.|..|.++.+|+.||||++.. ......+...+|+.+|+.++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344567777899999999999999999999999999973 334456778899999999999999999998865 3
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
..+|+|+|+|+ .+|...++. +..|+...+..+++||++||.|+|+.+ |+||||||.|+|++.+..+||+|||
T Consensus 99 ~DvYiV~elMe-tDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 57899999995 889999986 566999999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCcccc-ccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
+|+...........+..+-|.+|.|||++ ....|+.+.||||+|||+.||++|++.|.+........++....+.....
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99975433233344667889999999976 45789999999999999999999999998877655544433222111100
Q ss_pred ccccccc----------Ccccc----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 301 TRHSLIA----------DPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 301 ~~~~~~~----------~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. ...+. .|... ...-+.......+|+.+||..||.+|+|++|.|+.
T Consensus 251 ~-l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 D-LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred H-HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 00000 00000 01112334578999999999999999999999963
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=352.13 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=216.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCe-eEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ-RLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~ 148 (399)
++|..++.+|+|+||.+++++++.++..|++|.+...... ..+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788999999999999999999999999999999765443 34567889999999999999999999998888 99999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
+||+||+|.+.+.... +..+++..+..|+.|++.|+.|||++. |+|||||+.|||++.++.|+|+|||+|+....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998754 567999999999999999999999998 99999999999999999999999999997443
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.. ....+.+||+.||.||++.+.+|+.++|||||||++|||++-+++|...+.......+ ..
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki------~~---------- 220 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI------NR---------- 220 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH------hh----------
Confidence 32 3455678999999999999999999999999999999999999999876543322111 00
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
......+.....++..|+..||+.+|..||++.++|..
T Consensus 221 -~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 -GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 01123344455589999999999999999999999986
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=351.84 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=200.8
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 154 (399)
+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 23356788999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcce
Q 015816 155 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 234 (399)
Q Consensus 155 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 234 (399)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence 99999876 567999999999999999999999999 999999999999999999999999998742211 112
Q ss_pred eeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCC
Q 015816 235 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ 314 (399)
Q Consensus 235 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||............. . ... .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~------~--------~~~----~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------M--------EDI----K 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc------c--------CCc----c
Confidence 234579999999999999999999999999999999999999997654332211110 0 011 1
Q ss_pred CChHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 015816 315 YPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 347 (399)
Q Consensus 315 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 347 (399)
++......+.+++.+||+.||.+|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1222334788999999999999997 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=345.11 Aligned_cols=266 Identities=22% Similarity=0.298 Sum_probs=204.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.+|++.+.||.|+||.||+|.++.++..||+|++...... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5699999999999999999999999999999998754322 335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 98 5899988652 345789999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccc--------
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT-------- 301 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 301 (399)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.......................
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 11233468999999998865 5689999999999999999999999977654433322211110000000
Q ss_pred ccccccCccccC----CCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 302 RHSLIADPELQG----QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 302 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.......+.... ...+....++.+|+.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000010000 001122347889999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=359.40 Aligned_cols=264 Identities=27% Similarity=0.428 Sum_probs=210.3
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 67 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.......+.+...||+|.||+||+|.+.+ .||||++....... .+.|.+|+.++++-+|.||+-+.|+|..+..
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 33344556778999999999999999975 59999998665543 4679999999999999999999999998877
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
.||+.+|+|-+|+.+|+.. ...|.....+.|++||++|+.|||.++ |||||||..|||+.++++|||+|||++.
T Consensus 463 AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999999864 356889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 301 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (399)
.-.............|...|||||+++ ..+|++.+|||||||++|||++|..||........ +....+.
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--ifmVGrG------ 608 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--IFMVGRG------ 608 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--EEEeccc------
Confidence 533332223333455888999999985 35799999999999999999999999984332211 1100000
Q ss_pred ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 302 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
....|... .....+.++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 609 --~l~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 --YLMPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred --ccCccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 01111111 111234489999999999999999999999998887765
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=349.51 Aligned_cols=266 Identities=23% Similarity=0.296 Sum_probs=209.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4679999999999999999999999999999999875432 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999976 56789999999999999999999985 5 99999999999999999999999999875322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc--cc-
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH--SL- 305 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~- 305 (399)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||............. .+........ ..
T Consensus 157 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 230 (331)
T cd06649 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHSIS 230 (331)
T ss_pred c----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccccC
Confidence 1 1233568999999999999999999999999999999999999997654432221110 0000000000 00
Q ss_pred -----------------------------ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 306 -----------------------------IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 306 -----------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
+...............++.+|+.+||+.||++|||+.++++...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 00000000001123457899999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=348.64 Aligned_cols=240 Identities=26% Similarity=0.318 Sum_probs=197.3
Q ss_pred eeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986532 22335678899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceee
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (399)
.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccc
Confidence 999976 567999999999999999999999999 999999999999999999999999998752221 12233
Q ss_pred eeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCC
Q 015816 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 316 (399)
Q Consensus 237 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
...||+.|+|||++.+..++.++|||||||++|+|++|..||........... ..... . .++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~------~~~~~--------~----~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK------ILQEP--------L----RFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH------HHcCC--------C----CCC
Confidence 45799999999999999999999999999999999999999976543322111 11100 0 112
Q ss_pred hHhHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 015816 317 PRGFYQALAVAAMCVHEQPDMRPV---IADVVT 346 (399)
Q Consensus 317 ~~~~~~l~~li~~cl~~dP~~RPs---~~eil~ 346 (399)
......+.+++.+||+.||.+||+ +.+++.
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 223347889999999999999985 555553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=370.19 Aligned_cols=262 Identities=31% Similarity=0.466 Sum_probs=222.1
Q ss_pred CCCCCCeeeecCceEEEEEEECC-----CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
+.+..+.||+|+||+||+|+.-+ ....||||.++..... ...+|.+|++++..|+|||||+|+|+|.+++.+|+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 44566789999999999998643 3567999999876555 56789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceE
Q 015816 147 VYEYMPLGSVEDHLHDLSPG----------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 216 (399)
|+|||..|||.++|...... ..+|+..+.+.|+.|||.|++||-++. +|||||...|+||+++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 99999999999999854321 234889999999999999999999999 99999999999999999999
Q ss_pred EecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhh
Q 015816 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARP 295 (399)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~ 295 (399)
|+|||+++.....+.........-..+|||||.|..++||.+||||||||+|||+++ |..|+......+....+...
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g-- 721 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG-- 721 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC--
Confidence 999999997655555554444455789999999999999999999999999999999 99999877665554443211
Q ss_pred hhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.+ ..+|...+.++.+|+..||+.+|++||++.||-.+|..+...
T Consensus 722 --------------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 722 --------------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred --------------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 11 244555566999999999999999999999999999987653
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=348.45 Aligned_cols=242 Identities=30% Similarity=0.437 Sum_probs=195.2
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhh-cCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.+..+++.||||++..... ...+.+..|..++.. .+||||+++++++......|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999875321 223445667777765 4899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999999976 567999999999999999999999999 9999999999999999999999999987532221 2
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|..||............. .. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~--------~~---- 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL------ND--------RP---- 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------cC--------CC----
Confidence 2334579999999999999999999999999999999999999998654432211110 00 01
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.++......+.+++.+||+.||.+||++.+.+.
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111222347788999999999999998764443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=352.30 Aligned_cols=242 Identities=28% Similarity=0.449 Sum_probs=203.6
Q ss_pred CCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCC
Q 015816 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 155 (399)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 155 (399)
.++.||.|+-|.||+|+.+ ++.||||++... -..+|+-|++|+||||+.|.|+|.....+|||||||..|-
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3578999999999999998 689999997532 1247899999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCccee
Q 015816 156 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235 (399)
Q Consensus 156 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 235 (399)
|...|+. ..+++......|..+||.|+.|||.+. |||||||.-||||..+..|||+|||.++... .....
T Consensus 199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~---~~STk 268 (904)
T KOG4721|consen 199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELS---DKSTK 268 (904)
T ss_pred HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhh---hhhhh
Confidence 9999997 788999999999999999999999999 9999999999999999999999999998522 22334
Q ss_pred eeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCC
Q 015816 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY 315 (399)
Q Consensus 236 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
..++||..|||||++.+.+.++|+|||||||+|||||||..||........ .| . +..-.+....
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----Iw-----G-------VGsNsL~Lpv 332 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IW-----G-------VGSNSLHLPV 332 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EE-----e-------ccCCcccccC
Confidence 558899999999999999999999999999999999999999975433211 00 0 0111122233
Q ss_pred ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 316 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 316 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
|...+..+.-|+.+||+--|.+||++.+|+..|+-+.
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 4445558888999999999999999999999886443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=339.65 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=200.7
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEec----CCeeEEEEEe
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEY 150 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~ 150 (399)
..||+|++|.||+|.+. |+.||||.+....... .+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 67999999999999984 8999999997653333 3567899999999999999999999876 3578999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
+++|+|.+++.. ...+++...+.++.|++.||.|||+. + ++||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999986 56789999999999999999999984 7 889999999999999999999999998753221
Q ss_pred CCcceeeeeccCccccCcccccc--CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||............ .....
T Consensus 177 -----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i------~~~~~------ 239 (283)
T PHA02988 177 -----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNN------ 239 (283)
T ss_pred -----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcCC------
Confidence 123458899999999976 68999999999999999999999999866433221111 00000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.+ ..+...+..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 240 ~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 SL----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CC----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 00 1111233478999999999999999999999999987753
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=366.08 Aligned_cols=254 Identities=21% Similarity=0.243 Sum_probs=209.0
Q ss_pred CCCCCCeeeecCceEEEEEEECCC-CeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESI-NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.|.+.+.||+|+||.||+|....+ ++.||+|.+..........+..|+.+++.++|||||++++++...+..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 489999999999999999998877 7889999876554444456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++|+|.+++........++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988754444567999999999999999999999999 99999999999999999999999999986433322
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||............. ... . .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~------~~~--~----~--- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL------YGK--Y----D--- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCC--C----C---
Confidence 223345679999999999999999999999999999999999999997654432211110 000 0 0
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+......+.+++.+||+.||+.||++.+++.
T Consensus 290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011122347889999999999999999999975
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=331.64 Aligned_cols=269 Identities=22% Similarity=0.309 Sum_probs=211.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCC-ccceEEEEecCC------e
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPN-LVNLIGYCADGD------Q 143 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~------~ 143 (399)
.|...+.||+|+||+||+|+.+.+|+.||+|++...... .-....+|+.+|+.++|+| ||.+++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 466667799999999999999999999999999765332 2244678999999999999 999999998877 7
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
+++|+||++ -+|..++.........++...+..+++||+.||+|||+++ |+||||||+||||+..|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 899999997 7999999886543356788899999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
+..... ....+..++|..|.|||++.+. .|+...||||+|||++||+++++.|......+....+-...........
T Consensus 168 ra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 853322 2234556789999999998775 8999999999999999999999999887775444333222221111111
Q ss_pred cccccCccccCCCC------------hHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 303 HSLIADPELQGQYP------------PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 303 ~~~~~~~~~~~~~~------------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
......+.....++ +.......+++.+||+.+|.+|.|+..+++.
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 22221222111111 1111477889999999999999999999965
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=348.03 Aligned_cols=242 Identities=27% Similarity=0.361 Sum_probs=199.4
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 154 (399)
+.||+|+||.||+|.+..+|..||+|++..... .....+..|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999999999999999875422 22345678999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcce
Q 015816 155 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 234 (399)
Q Consensus 155 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 234 (399)
+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCc
Confidence 99998876 567999999999999999999999999 999999999999999999999999998742211 111
Q ss_pred eeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCC
Q 015816 235 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ 314 (399)
Q Consensus 235 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||............. .. .. .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~------~~--------~~----~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------ME--------EI----R 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh------cC--------CC----C
Confidence 233569999999999999999999999999999999999999997654332211110 00 00 1
Q ss_pred CChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 315 YPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 315 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
++......+.+++.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1222334788999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=342.79 Aligned_cols=265 Identities=27% Similarity=0.387 Sum_probs=204.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECC----------------CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccce
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES----------------INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNL 134 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~ 134 (399)
.+|++.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999998643 3457999998754332 23568899999999999999999
Q ss_pred EEEEecCCeeEEEEEecCCCCHHHHhhccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 015816 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199 (399)
Q Consensus 135 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH 199 (399)
++++.+.+..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999999865311 1135788899999999999999999999 999
Q ss_pred cCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh--CCCC
Q 015816 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKA 277 (399)
Q Consensus 200 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~p 277 (399)
|||||+|||++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999975433322222233456789999999988899999999999999999987 5677
Q ss_pred cccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 278 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 278 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
|.......... .....+....... ....++..+..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus 242 ~~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQVIE---NAGEFFRDQGRQV-------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHHHH---HHHHHhhhccccc-------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76543322211 1111111110000 01112223448899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=365.59 Aligned_cols=262 Identities=25% Similarity=0.306 Sum_probs=215.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEE-Eec------C
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGY-CAD------G 141 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~-~~~------~ 141 (399)
...++++.+.|.+|||+.||+|.+...|..||+|++-..+....+.+.+||.+|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4467889999999999999999999977999999987666666678899999999997 9999999993 221 1
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
-+++|+||||.||.|-+++..+. ...|++.++++|+.|+++|+++||.. ++||||||||-+||||+.+|..||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 36789999999999999998765 34499999999999999999999998 4779999999999999999999999999
Q ss_pred CCccCCCCCCcce-------eeeeccCccccCcccc---ccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHH
Q 015816 222 LAKLGPVGDNTHV-------STRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 291 (399)
Q Consensus 222 ~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~ 291 (399)
.+........... ......|+.|+|||++ .+..+++|+|||||||+||-|+....||+.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 9864222211110 0113468999999987 6789999999999999999999999999875321
Q ss_pred hhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 292 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.|.+..+.-.-.+.....+.+||..||+.||.+||++-+++..+..+...
T Consensus 265 -------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 -------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 12222332223356777999999999999999999999999999888754
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=335.36 Aligned_cols=271 Identities=24% Similarity=0.328 Sum_probs=209.7
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCC-----eeEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRLLV 147 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~lv 147 (399)
.|+..+++|.|+||.||+|....+++.||||++-.+. +--.+|+.+|+.+.|||||++..+|.... +..||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4677899999999999999999999999999975432 22235999999999999999998875432 34689
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC-CceEEecccCCccC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLG 226 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~ 226 (399)
|||++ .+|..+++.+...+..++.-.+.-+.+||++||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99998 7999999976666788999999999999999999999999 9999999999999976 89999999999975
Q ss_pred CCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc-----
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR----- 300 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 300 (399)
..+.. ......|..|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.+.+..+....+..+.......
T Consensus 177 ~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 44433 244567899999998765 689999999999999999999999999877665544432222111100
Q ss_pred -cccccccCccccCC-----CChHhHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHHHhc
Q 015816 301 -TRHSLIADPELQGQ-----YPPRGFYQALAVAAMCVHEQPDMRPVIADVVT--ALAYLASQ 354 (399)
Q Consensus 301 -~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~l~~~ 354 (399)
........|.+... +......++.+|+.++|..+|.+|.++.+++. ..+.+...
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 00011112222211 22334458999999999999999999999995 34444443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=346.97 Aligned_cols=241 Identities=29% Similarity=0.440 Sum_probs=195.7
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhh-cCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.++.+|+.||+|++..... .....+..|..++.. ++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999975421 233456678878765 4899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DN 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CC
Confidence 999999976 567899999999999999999999999 999999999999999999999999998642211 12
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|..||............... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--------------~~~--- 214 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--------------TPH--- 214 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------CCC---
Confidence 234467999999999999999999999999999999999999999765443221111000 011
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 345 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 345 (399)
.+......+.+++.+||+.||.+||++.+.+
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 215 -YPRWITKESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 1112234788899999999999999985433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=353.20 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=203.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 478999999999999999999999999999999975322 22345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999986 567999999999999999999999999 99999999999999999999999999864321
Q ss_pred CCCcc------------------------------------eeeeeccCccccCccccccCCCCcccceeehhHHHHHHH
Q 015816 229 GDNTH------------------------------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 272 (399)
Q Consensus 229 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 272 (399)
..... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11000 011246999999999999999999999999999999999
Q ss_pred hCCCCcccchHHHHHHHH-HhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 015816 273 SGRKAVDTSKAAAEQSLV-AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV---IADVVT 346 (399)
Q Consensus 273 ~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~ 346 (399)
+|..||............ .+.. ....+. .......+.+||.+|+. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~----------~~~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKE----------TLQFPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCC----------ccCCCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999865543221111 1000 000000 00123377889999996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=352.43 Aligned_cols=253 Identities=25% Similarity=0.278 Sum_probs=201.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.|++.+.||+|+||+||+|.+..+++.||||++...... ....+..|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999999999999999999754322 23467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999986 567899999999999999999999999 999999999999999999999999997532100
Q ss_pred CC---------------------------------------------cceeeeeccCccccCccccccCCCCcccceeeh
Q 015816 230 DN---------------------------------------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSF 264 (399)
Q Consensus 230 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 264 (399)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123579999999999998899999999999
Q ss_pred hHHHHHHHhCCCCcccchHHHHHHH-HHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHH--ccccCCCCCCCH
Q 015816 265 GVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM--CVHEQPDMRPVI 341 (399)
Q Consensus 265 G~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~ 341 (399)
||++|||++|..||........... ..+... ...+ .......++.+|+.+ |+..+|..||++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----------~~~~-----~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENT----------LHIP-----PQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccccc----------cCCC-----CCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999976544322211 110000 0000 001122377888888 455666679999
Q ss_pred HHHHHH
Q 015816 342 ADVVTA 347 (399)
Q Consensus 342 ~eil~~ 347 (399)
.+++..
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999963
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=349.34 Aligned_cols=246 Identities=25% Similarity=0.315 Sum_probs=203.0
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCC-eEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
++|++.+.||+|+||.||+|.++.++ ..||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46889999999999999999876654 689999986432 22345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999986 567999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||............ ....
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i------~~~~------- 244 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI------LEGI------- 244 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH------hcCC-------
Confidence 11 23457999999999999989999999999999999999999999865433221111 0000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 347 (399)
. .++......+.+++.+||+.||.+|+ ++.++++.
T Consensus 245 -~----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 -I----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -C----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 11222234678899999999999995 78887753
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=345.00 Aligned_cols=241 Identities=31% Similarity=0.448 Sum_probs=195.6
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhh-cCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.+..+++.||||++..... .....+..|..++.. ++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999875421 223456677888875 5899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999999976 467899999999999999999999999 9999999999999999999999999987422211 1
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
......||..|+|||++.+..++.++|||||||++|+|++|..||............... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--------------~~~--- 214 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--------------NPC--- 214 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------CCC---
Confidence 223457999999999999999999999999999999999999999765443222111100 011
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 345 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 345 (399)
++......+.+++.+||+.||.+||++.+-+
T Consensus 215 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 215 -YPRWLTREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred -CCccCCHHHHHHHHHHhccCHhhcCCChHHH
Confidence 1112234788899999999999999997433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=347.48 Aligned_cols=243 Identities=27% Similarity=0.357 Sum_probs=199.5
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 154 (399)
+.||+|+||.||+|.+..++..||+|++..... .....+..|+.++..++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 22345678999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 155 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 155 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GA 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cc
Confidence 99998876 5679999999999999999999997 78 999999999999999999999999998642211 11
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|..||............... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--------------~~---- 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------------EI---- 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--------------CC----
Confidence 223356999999999999999999999999999999999999999765443222211100 00
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 347 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 347 (399)
.++......+.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11122234788999999999999996 89998853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=354.99 Aligned_cols=261 Identities=27% Similarity=0.406 Sum_probs=205.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-----CCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecCCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 143 (399)
.++|++.+.||+|+||.||+|.+ ..++..||||++..... ...+.+.+|+.++..+ +||||+++++++.+...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35789999999999999999974 34577899999865432 2345688999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCC----------------------------------------------------------
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSP---------------------------------------------------------- 165 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 165 (399)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999965221
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCc
Q 015816 166 -------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (399)
Q Consensus 166 -------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 232 (399)
....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1135788999999999999999999999 999999999999999999999999999754332222
Q ss_pred ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......++..|+|||++.+..++.++|||||||++|||++ |..||........ ...... .....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~~~----~~~~~-------- 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKMIK----EGYRM-------- 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHHHH----hCccC--------
Confidence 22222345678999999999999999999999999999998 8899875432211 111111 00000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
..+...+.++.+|+.+||+.||++|||+.++++.|+.
T Consensus 337 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 --LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0111123478899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=346.31 Aligned_cols=242 Identities=28% Similarity=0.384 Sum_probs=198.7
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCC-CccceEEEEecCCeeEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHP-NLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lv~ 148 (399)
+|++.+.||+|+||.||+|.++.+++.||||++.... ....+.+..|+.++..++|+ +|+.+++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999999999999999987542 12345677899999999765 5888999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999976 567899999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||............. .. .
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~------~~--------~ 217 (324)
T cd05587 154 G--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM------EH--------N 217 (324)
T ss_pred C--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------cC--------C
Confidence 1 122334579999999999999999999999999999999999999998654432211110 00 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 341 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 341 (399)
..++......+.+++.+||+.||.+|++.
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ----VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01122233478899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=323.08 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=213.3
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc----ch----HHHHHHHHHHhhc-CCCCccceEEEEe
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----GN----REFLVEVLMLSLL-HHPNLVNLIGYCA 139 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~----~~~~~E~~~l~~l-~hpniv~~~~~~~ 139 (399)
.+-..|.-.+.||.|..++|.++.++.+|..+|+|++...... .. +.-..|+.||+++ .||+|+.+.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3445677888999999999999999999999999998643211 11 3456799999987 5999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEec
Q 015816 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219 (399)
Q Consensus 140 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 219 (399)
.+...++|+|.|+.|.|.++|.+ .-.+++.....|++|+++|++|||..+ ||||||||+|||++++.+++|+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 99999999999999999999997 778999999999999999999999999 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeeeccCccccCcccccc------CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh
Q 015816 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 293 (399)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 293 (399)
||++.....+. .....+|||+|+|||.+.. ..|+..+|+||+|||||.|+.|.+||-.....-...++...
T Consensus 167 FGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG 243 (411)
T KOG0599|consen 167 FGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG 243 (411)
T ss_pred cceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence 99998654443 3456789999999998843 56889999999999999999999999877665554444333
Q ss_pred hhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 294 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...|... -..+......+||.+||+.||.+|.|+.|.|..
T Consensus 244 kyqF~sp--------------eWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 244 KYQFRSP--------------EWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ccccCCc--------------chhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 3222221 122344578899999999999999999999963
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=354.84 Aligned_cols=263 Identities=27% Similarity=0.419 Sum_probs=206.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCC-----CeEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCccceEEEEecCCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 143 (399)
.++|++.+.||+|+||.||+|++..+ +..||||++...... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 35799999999999999999986443 357999999754322 335688999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCC----------------------------------------------------------
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSP---------------------------------------------------------- 165 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 165 (399)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceeee
Q 015816 166 --------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237 (399)
Q Consensus 166 --------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 237 (399)
...++++..++.|+.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1235788999999999999999999999 99999999999999999999999999875432222212222
Q ss_pred eccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCC
Q 015816 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 316 (399)
Q Consensus 238 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
..++..|+|||++.+..++.++|||||||++|+|++ |+.||........ ...... ... . ...+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~~----~~~------~----~~~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMVK----RGY------Q----MSRP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHHH----ccc------C----ccCC
Confidence 335678999999988999999999999999999997 9999976433211 110000 000 0 0011
Q ss_pred hHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 317 PRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 317 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 112347889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=337.79 Aligned_cols=259 Identities=34% Similarity=0.503 Sum_probs=209.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCC-----eEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+...... ....+.+|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 46888999999999999999987655 68999998654332 2356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC
Q 015816 146 LVYEYMPLGSVEDHLHDLSPG------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~ 213 (399)
++|||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 999999999999999753211 156889999999999999999999999 99999999999999999
Q ss_pred ceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHh
Q 015816 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAW 292 (399)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~ 292 (399)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i-- 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI-- 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999875433322222334457889999999988899999999999999999998 99999765443222111
Q ss_pred hhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
. ... . ...+...+..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus 240 -~----~~~------~----~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 -R----SRQ------L----LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -H----cCC------c----CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 0 000 0 01122233489999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=352.44 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=201.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.++.+++.||||++..... .....+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 368899999999999999999999999999999864322 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999976 567899999999999999999999999 99999999999999999999999999863211
Q ss_pred CCCc---------------------------------------------ceeeeeccCccccCccccccCCCCcccceee
Q 015816 229 GDNT---------------------------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 263 (399)
Q Consensus 229 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 263 (399)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCcccchHHHHHH-HHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCC---C
Q 015816 264 FGVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR---P 339 (399)
Q Consensus 264 lG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---P 339 (399)
|||++|||++|..||.......... +..+.. .+..+. .......+.+|+.+||. +|.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------~~~~p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRE----------TLYFPD-----DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccCC----------ccCCCC-----CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 9999999999999997654432211 111100 000000 00123478889999997 67765 5
Q ss_pred CHHHHHHH
Q 015816 340 VIADVVTA 347 (399)
Q Consensus 340 s~~eil~~ 347 (399)
++.++++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 99998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=345.64 Aligned_cols=238 Identities=29% Similarity=0.415 Sum_probs=195.4
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.++.+++.||||++.... ......+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999987532 12335567788888776 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence 999999976 567999999999999999999999999 999999999999999999999999998742211 12
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~~~--------~---- 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LNDE--------V---- 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------hcCC--------C----
Confidence 233457999999999999999999999999999999999999999865543221111 1100 0
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIA 342 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 342 (399)
..+......+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 11122334788999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=350.16 Aligned_cols=254 Identities=25% Similarity=0.300 Sum_probs=207.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.+..+++.||||++..... .....+..|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 368999999999999999999999999999999875422 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999986 467999999999999999999999999 99999999999999999999999999875432
Q ss_pred CC---------------------------CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccc
Q 015816 229 GD---------------------------NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (399)
Q Consensus 229 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 281 (399)
.. .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001123356999999999999999999999999999999999999999876
Q ss_pred hHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 015816 282 KAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-IADVVTA 347 (399)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~ 347 (399)
............. . ....+.. .. ....+.+||.+||. ||.+||+ +.++++.
T Consensus 234 ~~~~~~~~i~~~~----~-----~~~~p~~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWK----E-----SLRFPPD-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccC----C-----cccCCCC-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 5432211111000 0 0000000 01 23478899999997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=345.09 Aligned_cols=243 Identities=28% Similarity=0.397 Sum_probs=198.3
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.+..+++.||||++..... .....+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999999999999999999875422 2234567788888865 799999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GV 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Cc
Confidence 999999976 567999999999999999999999999 999999999999999999999999998742221 12
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i------~~~~--------~---- 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI------LHDD--------V---- 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH------HcCC--------C----
Confidence 223456999999999999999999999999999999999999999876543322111 1100 0
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRP-------VIADVVTA 347 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~eil~~ 347 (399)
..+......+.+++.+||+.||++|| ++.++++.
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01112234788999999999999999 77777743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=344.73 Aligned_cols=245 Identities=28% Similarity=0.410 Sum_probs=198.2
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHH---hhcCCCCccceEEEEecCCeeEEE
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLML---SLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+..|+.++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999999999999999997542 12234566666555 566899999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988863 56999999999999999999999999 9999999999999999999999999986422
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. ........|++.|+|||++.+..++.++|||||||++|+|++|+.||............. ..
T Consensus 153 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~------~~-------- 216 (324)
T cd05589 153 GF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV------ND-------- 216 (324)
T ss_pred CC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC--------
Confidence 11 122234679999999999999999999999999999999999999998654432221111 00
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
.+ .++......+.+++.+||+.||.+|| ++.++++
T Consensus 217 ~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 EV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00 11122234788999999999999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=346.14 Aligned_cols=266 Identities=22% Similarity=0.320 Sum_probs=200.8
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecC-----CeeE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRL 145 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~ 145 (399)
+|++.+.||+|+||.||+|.+..++..||||++.... ......+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999999999999999986432 22345688999999999999999999987543 2479
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 789998875 567999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCC-cceeeeeccCccccCcccccc--CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh------
Q 015816 226 GPVGDN-THVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL------ 296 (399)
Q Consensus 226 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------ 296 (399)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||..................
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 322211 112234569999999999865 67899999999999999999999999765433221111000000
Q ss_pred --hccccc------cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 297 --FQDRTR------HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 297 --~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...... ........+.. ..+.....+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQ-KFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHH-hcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 00000000000 001123467899999999999999999999963
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=349.27 Aligned_cols=255 Identities=23% Similarity=0.248 Sum_probs=200.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||+||+|.++.+++.||||++..... .....+..|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 368999999999999999999999999999999975322 22345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||++||+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999986 567999999999999999999999999 99999999999999999999999999874321
Q ss_pred CCCc---------------------------------ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCC
Q 015816 229 GDNT---------------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275 (399)
Q Consensus 229 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~ 275 (399)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0012357999999999999999999999999999999999999
Q ss_pred CCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 015816 276 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH--EQPDMRPVIADVVTA 347 (399)
Q Consensus 276 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~eil~~ 347 (399)
.||...........+.... .....+. . ......+.+++.+++. .++..||++.+|++.
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~---------~~~~~p~---~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQETYKKVMNWK---------ETLIFPP---E--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHHHHHHHcCc---------CcccCCC---c--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9997654432221111000 0000000 0 0122366777777554 234456899999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=340.41 Aligned_cols=260 Identities=27% Similarity=0.461 Sum_probs=207.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeE----EEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.+|++.+.||+|+||.||+|.+..++.. ||+|++..... ...+.+..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 4689999999999999999998665554 89999865432 3346788999999999999999999999765 5789
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999862 346889999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.............++..|+|||++.+..++.++|||||||++|||++ |..||............. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~--- 229 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGER--- 229 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-------CCCC---
Confidence 43322222222334678999999999999999999999999999998 999997654333221111 0000
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
. ..++.....+.+++.+||..+|.+||++.+++..|..+....
T Consensus 230 ~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 230 L-------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred C-------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0 011122347888999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=344.90 Aligned_cols=242 Identities=28% Similarity=0.365 Sum_probs=198.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 148 (399)
+|++.+.||+|+||.||+|.+..+++.||||++...... ....+..|..++..+ +|++|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 578899999999999999999999999999998754221 223466788888776 5899999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999976 567999999999999999999999999 99999999999999999999999999874221
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||............. ...
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~------~~~-------- 217 (323)
T cd05616 154 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHN-------- 217 (323)
T ss_pred C--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH------hCC--------
Confidence 1 112234579999999999999999999999999999999999999998765432221111 000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 341 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 341 (399)
..++......+.+++.+||+.||.+|++.
T Consensus 218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01122234478899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=351.60 Aligned_cols=251 Identities=25% Similarity=0.271 Sum_probs=199.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
+|++.+.||+|+||.||+|++..+++.||+|++..... .....+..|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58889999999999999999999999999999875422 223467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999976 457899999999999999999999999 999999999999999999999999997532100
Q ss_pred C---------------------------------------------CcceeeeeccCccccCccccccCCCCcccceeeh
Q 015816 230 D---------------------------------------------NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSF 264 (399)
Q Consensus 230 ~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 264 (399)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000123469999999999999999999999999
Q ss_pred hHHHHHHHhCCCCcccchHHHHHHHH-HhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC---
Q 015816 265 GVVLLEILSGRKAVDTSKAAAEQSLV-AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV--- 340 (399)
Q Consensus 265 G~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs--- 340 (399)
||++|||++|+.||............ .+... ...+ ........+.+++.+|+ .+|.+|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------~~~p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTS----------LHIP-----PQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC----------cCCC-----CcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 99999999999999865443222111 10000 0000 00112336777888876 59999987
Q ss_pred HHHHHH
Q 015816 341 IADVVT 346 (399)
Q Consensus 341 ~~eil~ 346 (399)
+.++++
T Consensus 299 ~~ei~~ 304 (382)
T cd05625 299 ADEIKA 304 (382)
T ss_pred HHHHhc
Confidence 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=343.99 Aligned_cols=252 Identities=27% Similarity=0.298 Sum_probs=216.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcC-CCCccceEEEEecCCeeE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 145 (399)
....|++.+.||.|.||.||+|+.+.+|+.+|+|++.+..... ...+.+|+.+|+++. |||||.++++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4467999999999999999999999999999999998765543 357899999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC----CCceEEeccc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR----GYHPKLSDFG 221 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Dfg 221 (399)
+|||+|.||.|.+.+... .+++..+..++.||+.|+.|||+.| |+||||||+|+|+.. ++.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999874 3999999999999999999999999 999999999999964 3579999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 301 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (399)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+...
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~-------- 253 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG-------- 253 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--------
Confidence 9986443 34456688999999999999999999999999999999999999999876644332211111
Q ss_pred ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 302 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+..+.....+.....+.+++..|+..||..|+|+.++|+
T Consensus 254 ------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 254 ------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 113333444455668999999999999999999999997
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=324.79 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=210.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
++++|++-+.||+|.|+.||++.+..+|+.+|+|+++.+. ....+++.+|+.|.+.|+|||||++++.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567888889999999999999999999999999987543 33557889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---CCceEEecccCCc
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAK 224 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~~ 224 (399)
+|++.|++|..-|.. ..-+++..+-.+++||++||.|+|.++ |||||+||+|+|+-. .--+||+|||++.
T Consensus 89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999999877765 355789999999999999999999999 999999999999954 3468999999998
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
... ........+|||.|||||++...+|+..+|||+.||+||-||.|.+||........-+.+...
T Consensus 162 ~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g----------- 227 (355)
T KOG0033|consen 162 EVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG----------- 227 (355)
T ss_pred EeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc-----------
Confidence 644 334445578999999999999999999999999999999999999999874433221111100
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+-.+.....+...++..+|+++||..||.+|.|+.|.|.
T Consensus 228 ---~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 228 ---AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111222334445568999999999999999999998874
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=337.08 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=199.0
Q ss_pred eeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
||+|+||+||+|.++.+++.||+|.+...... ..+.+..|+.+++.++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998654322 224567899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceee
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (399)
..++.........+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9888654444567999999999999999999999999 99999999999999999999999999875332221 123
Q ss_pred eeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHH-HHHHHhhhhhhccccccccccCccccCCC
Q 015816 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQY 315 (399)
Q Consensus 237 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..... ..... . ..+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~~--------~----~~~ 220 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RILND--------S----VTY 220 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH---hhccc--------C----CCC
Confidence 35689999999999999999999999999999999999999975432111 11110 00000 0 012
Q ss_pred ChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 316 PPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 316 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
+...+..+.+++.+||+.||++|| +++++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 223344788999999999999999 6677774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=352.51 Aligned_cols=253 Identities=25% Similarity=0.237 Sum_probs=201.8
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
+|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68999999999999999999999999999999864322 223557889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999976 567899999999999999999999999 999999999999999999999999997522100
Q ss_pred CC-----------------------------------------cceeeeeccCccccCccccccCCCCcccceeehhHHH
Q 015816 230 DN-----------------------------------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 268 (399)
Q Consensus 230 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 268 (399)
.. .......+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 0001234799999999999999999999999999999
Q ss_pred HHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCC---CHHHHH
Q 015816 269 LEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP---VIADVV 345 (399)
Q Consensus 269 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~eil 345 (399)
|||++|+.||................. ....+ ........+.+++.+|+ .+|.+|+ ++.+++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~---------~~~~~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWET---------TLHIP-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCc---------cccCC-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999999987654332211110000 00000 01112336777888876 5999999 889988
Q ss_pred HH
Q 015816 346 TA 347 (399)
Q Consensus 346 ~~ 347 (399)
+.
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=332.49 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=205.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC---CCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.+|++.+.||+|+||.||+|.++ ..+..||+|.+...... ....+.+|+.++.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46889999999999999999875 34678999998765332 235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.++++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999752 347899999999999999999999999 9999999999999999999999999876422
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
... ........++..|+|||.+.+..++.++|||||||++||+++ |..||............ .....
T Consensus 159 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-------~~~~~---- 226 (266)
T cd05064 159 SEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-------EDGFR---- 226 (266)
T ss_pred ccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------HCCCC----
Confidence 111 111112335678999999999999999999999999999875 99999765443221111 00000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
. ..+...+..+.+++..||+.+|.+||++.+|++.|..+
T Consensus 227 --~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 --L----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --C----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 11222334788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=361.46 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=209.2
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCC-----
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 142 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 142 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 346899999999999999999999999999999998755332 2345788999999999999999988765432
Q ss_pred ---eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEec
Q 015816 143 ---QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219 (399)
Q Consensus 143 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 219 (399)
.+++||||+++|+|.+++.........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 368999999999999999865544567999999999999999999999999 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||............ ...
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~------~~~ 260 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT------LAG 260 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------hcC
Confidence 99987643322222234467999999999999999999999999999999999999999765433221111 000
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. . ...++.....+.+++.+||+.||.+||++.++++.
T Consensus 261 ~-------~----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 R-------Y----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C-------C----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 0 01122233478899999999999999999999863
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=338.63 Aligned_cols=267 Identities=22% Similarity=0.269 Sum_probs=201.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.++|++.+.||.|+||.||+|.++.+++.||||++...... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46799999999999999999999999999999998754322 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 6888887642 456899999999999999999999999 999999999999999999999999998642221
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHH-HHHHhhhhhhcc--cccccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQD--RTRHSL 305 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~--~~~~~~ 305 (399)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ............ ......
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 1 11233568999999998865 46889999999999999999999999764332111 111100000000 000000
Q ss_pred --ccCccccCC-CCh---------HhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 --IADPELQGQ-YPP---------RGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 --~~~~~~~~~-~~~---------~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+..... .+. .....+.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000 000 01246788999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=334.87 Aligned_cols=262 Identities=27% Similarity=0.392 Sum_probs=210.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-----CCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.+|.+.+.||.|+||.||++... .++..+|+|.+..........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56889999999999999999863 3456799999876544445678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEE
Q 015816 147 VYEYMPLGSVEDHLHDLS---------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 217 (399)
||||+++++|.+++.... .....+++..++.++.||+.||+|||+++ ++||||||+|||++.++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999997532 11235899999999999999999999999 999999999999999999999
Q ss_pred ecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhh
Q 015816 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||............. .
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~--~-- 237 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT--Q-- 237 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--c--
Confidence 99999875432222222223345778999999998999999999999999999998 999997654432211110 0
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.. ....... .+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 238 --~~-------~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 238 --GR-------VLQRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred --CC-------cCCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 00 0001111 22378999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=340.91 Aligned_cols=242 Identities=27% Similarity=0.383 Sum_probs=197.6
Q ss_pred CeeeecCceEEEEEEEC---CCCeEEEEEEeccCCC----cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 78 SLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+.||+|+||.||+|.+. .+++.||||++..... .....+..|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999874 4688999999865321 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 153 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE- 153 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-
Confidence 999999999976 567899999999999999999999999 999999999999999999999999998642211
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........||+.|+|||++.+..++.++|||||||++|||++|+.||............ ....
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~------~~~~---------- 216 (323)
T cd05584 154 -GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI------LKGK---------- 216 (323)
T ss_pred -CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH------HcCC----------
Confidence 11223356999999999999889999999999999999999999999865443221111 1000
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
...++.....+.+++.+||+.||++|| ++.++++
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 011222334788999999999999999 7888776
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=334.41 Aligned_cols=258 Identities=28% Similarity=0.416 Sum_probs=207.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECC-----CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
.+|.+.+.||+|+||.||+|.+.. ++..||||.+...... ....+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999998753 3678999998755433 3467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCce
Q 015816 146 LVYEYMPLGSVEDHLHDLS----------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 215 (399)
+||||+++++|.+++.... .....+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999997532 12345889999999999999999999999 9999999999999999999
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhh
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~ 294 (399)
+|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.............
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~--- 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT--- 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---
Confidence 9999999875322222122223346788999999999999999999999999999998 999997655433222211
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
.. .. ...+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 239 ----~~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ----QG-RL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----cC-Cc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00 00 0011122347899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=336.05 Aligned_cols=253 Identities=28% Similarity=0.416 Sum_probs=204.1
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
+|++.+.||+|+||.||++.+..+++.||+|++...... ....+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999999989999999998654322 22456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886532 356999999999999999999999999 999999999999999999999999998753322
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||............. .. ....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~--~~-~~~~--------- 220 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--RR-VKED--------- 220 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH--HH-hhhc---------
Confidence 1 1123468999999999998899999999999999999999999998654322111110 00 0000
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 347 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 347 (399)
...++......+.+|+.+||+.||++|| ++.++++.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 --QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111222344788999999999999999 78888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=342.54 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=197.1
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.++.+++.||||++..... ...+.+..|..++..+ +||||+++++++.+...+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999999999999999975422 2234577899999888 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence 999998875 567999999999999999999999999 999999999999999999999999998642111 11
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHH--HHHHHHhhhhhhccccccccccCccc
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA--EQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||+...... ......+........ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------~--- 221 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-------Q--- 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-------C---
Confidence 2234579999999999999999999999999999999999999996422111 000000110000000 0
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPV------IADVVT 346 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~ 346 (399)
...+......+.+++.+||+.||.+||+ +.++++
T Consensus 222 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 222 -IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 0112223347889999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=346.60 Aligned_cols=262 Identities=31% Similarity=0.459 Sum_probs=213.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCe---E-EEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQ---D-VAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.+-.+.+.||+|+||.||+|..+..+. . ||||...... .....+|++|+.+|++++|||||++||++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 455666899999999999999875322 3 8999987532 23446799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++|||+|+||+|.++|+.. ...++..+.+.++.+.|.||+|||+++ +|||||...|+|++.++.+||+|||+++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999973 236999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcceee-eeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 225 LGPVGDNTHVST-RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 225 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
... ...... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||...........+. .+
T Consensus 311 ~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~------~~--- 378 (474)
T KOG0194|consen 311 AGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV------KN--- 378 (474)
T ss_pred CCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH------hc---
Confidence 532 111111 1235678999999999999999999999999999999 889998876653322210 11
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccCCC
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYES 358 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~ 358 (399)
......+...+..+..++.+||..+|++||+|.++.+.|+.+.......
T Consensus 379 -------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 379 -------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred -------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 1112223344558888999999999999999999999999998765543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=343.47 Aligned_cols=266 Identities=22% Similarity=0.287 Sum_probs=206.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.++|++.+.||.|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4689999999999999999999999999999999875432 233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|+++++|.+++.. ...+++..+..++.||+.||.|||+. + |+|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999976 56689999999999999999999974 6 99999999999999999999999999864321
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh-hhccc---cccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-LFQDR---TRHS 304 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~---~~~~ 304 (399)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||................. ..... ....
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 1 12234689999999999988999999999999999999999999976543322211100000 00000 0000
Q ss_pred cc------cCcc--------------cc---CCCC-hHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 305 LI------ADPE--------------LQ---GQYP-PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 305 ~~------~~~~--------------~~---~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.. ..+. .. ...+ .....++.+|+.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00 0000 00 0000 0123468899999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=334.88 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=198.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECC-CCeEEEEEEeccCCCc--chHHHHHHHHHHhhc---CCCCccceEEEEe-----c
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCA-----D 140 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpniv~~~~~~~-----~ 140 (399)
++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368999999999999999999854 4788999998654322 234566777777665 6999999999885 2
Q ss_pred CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 141 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
...+++||||++ ++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999997 69999987532 345899999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHH-HHHHhhhhhhcc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQD 299 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~ 299 (399)
|++...... .......||+.|+|||++.+..++.++|||||||++|||++|.+||......... .+..........
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 998753322 2223456899999999998889999999999999999999999999865543322 111111000000
Q ss_pred cc-ccccccCccc-------cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 300 RT-RHSLIADPEL-------QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 300 ~~-~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.. .........+ .....+.....+.+|+.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 0000000000 00111223457789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=344.48 Aligned_cols=253 Identities=25% Similarity=0.304 Sum_probs=204.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+..|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 468899999999999999999999999999999975422 23355788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999862 357999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcceeeeeccCccccCccccc------cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAK------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
... .......||+.|+|||++. ...++.++|||||||++|+|++|..||............ ... ..
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~~-~~ 226 (330)
T cd05601 155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI------MNF-QR 226 (330)
T ss_pred CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH------HcC-CC
Confidence 221 1223356999999999986 467889999999999999999999999765443221111 000 00
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
....+ ..+.....+.+|+..||+ +|.+||++.+++.
T Consensus 227 --~~~~~-----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 --FLKFP-----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --ccCCC-----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00000 011233478889999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=330.04 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=211.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.+|++.+.||.|+||.||+|++..+++.||||.+..... .....+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 578999999999999999999999999999998864322 22346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.........+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999998765444566899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.. .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ....... .. ..
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~~~~~----~~------~~ 225 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLCQKIE----QC------DY 225 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHHHHHh----cC------CC
Confidence 21 112234688999999999888899999999999999999999999865432111 1111110 00 00
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
+.. ........+.+++.+||+.+|++||++.++++.|+++.
T Consensus 226 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000 11123347889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.82 Aligned_cols=266 Identities=23% Similarity=0.308 Sum_probs=200.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecC--------C
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--------D 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------~ 142 (399)
..+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999999999999999885432 2345699999999999999999876432 2
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-ceEEeccc
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFG 221 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg 221 (399)
.+++||||++ ++|.+++.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4679999998 5788877654444678999999999999999999999999 99999999999999664 79999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh--hhhc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR--PLFQ 298 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~ 298 (399)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||................ +...
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 997543222 1233568999999998865 469999999999999999999999997654432221111100 0000
Q ss_pred c---------ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 299 D---------RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 299 ~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. ...........+...++...+.++.+|+.+||+.||.+|||+.++++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 000000001111112233344588999999999999999999999954
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=338.09 Aligned_cols=242 Identities=28% Similarity=0.431 Sum_probs=198.3
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.++.+++.||||++.... ......+..|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997542 22335567888888877 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 999999876 567999999999999999999999999 9999999999999999999999999986422111 1
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ... ..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i------~~~--------~~---- 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI------LED--------EV---- 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH------HcC--------CC----
Confidence 223356999999999999999999999999999999999999999765433221111 000 00
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVI-----ADVVT 346 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~ 346 (399)
..+......+.+|+.+||+.||.+||++ .++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1112233478899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=345.73 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=195.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.+|+..+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++|+||+++++++.+...+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4567788999999999999999999999999998654322 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.... ..++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999886432 3567788899999999999999999 9999999999999999999999999987532211
Q ss_pred CcceeeeeccCccccCcccccc-----CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||................ ...
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~~------ 292 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MSQ------ 292 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--ccC------
Confidence 11233569999999998743 234568999999999999999999997433221111111000 000
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.+ ..+......+.+||.+||+.||++|||+.|+++.
T Consensus 293 --~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 --PP----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1112233478999999999999999999999974
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=341.47 Aligned_cols=238 Identities=27% Similarity=0.354 Sum_probs=192.9
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHH-HHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.++.+|+.||||++..... .....+..|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999865322 12234555554 56789999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence 999999976 567999999999999999999999999 999999999999999999999999998742211 12
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|..||............ .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~--------~---- 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI------LNKP--------L---- 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH------HcCC--------C----
Confidence 233456999999999999999999999999999999999999999765433221111 1100 0
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIA 342 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 342 (399)
..++.....+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11122234788999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=345.27 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=201.5
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
..++|++.+.||+|+||.||+|.++.+++.||+|++.+... .....+..|+.+++.++||||+++++++.++..+|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 45689999999999999999999999999999999864321 223457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 121 VMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999974 45899999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccC----CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTG----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
.... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+ ......
T Consensus 193 ~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i------~~~~~~ 265 (370)
T cd05621 193 DETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI------MDHKNS 265 (370)
T ss_pred ccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCcc
Confidence 2211 1112345799999999998654 3789999999999999999999999765432221111 100000
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTA 347 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 347 (399)
...+. .......+.+++..||..++.. |+++.++++.
T Consensus 266 ---~~~p~-----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 ---LNFPE-----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---cCCCC-----cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00000 0112346788999999855543 8899999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=326.15 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=199.6
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 369999999999999998899999998764432 2345688999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceee
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (399)
.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999742 346899999999999999999999999 9999999999999999999999999987532211111111
Q ss_pred eeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCC
Q 015816 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY 315 (399)
Q Consensus 237 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||............. ... ....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-------~~~----------~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-------QGV----------RLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-------cCC----------CCCC
Confidence 1123457999999998899999999999999999998 889987544332211111 000 0011
Q ss_pred ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 316 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 316 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2223347889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=347.00 Aligned_cols=255 Identities=23% Similarity=0.272 Sum_probs=203.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
..++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+..|+.+++.++||||+++++++.+....|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 34679999999999999999999999999999999864321 223457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999874 45889999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeeeeccCccccCccccccC----CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTG----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
.... ........||+.|+|||++.+. .++.++|||||||++|||++|..||...........+ .....
T Consensus 193 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~~~- 264 (370)
T cd05596 193 DANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------MDHKN- 264 (370)
T ss_pred cCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH------HcCCC-
Confidence 2211 1112345699999999998653 4889999999999999999999999865432211111 00000
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTA 347 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 347 (399)
....+. ....+..+.+|+.+||+.+|.+ |+++.++++.
T Consensus 265 --~~~~~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 --SLTFPD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --cCCCCC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000000 1123348889999999999987 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=338.89 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=193.4
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.++.+++.||+|++..... .....+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975422 2334577888888776 799999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|+|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CC
Confidence 999998876 567999999999999999999999999 999999999999999999999999998742211 11
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHH--HHHHHHhhhhhhccccccccccCccc
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA--EQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......+........ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------~--- 221 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------Q--- 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-------C---
Confidence 2234579999999999999999999999999999999999999996321110 000000010000000 0
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVI 341 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 341 (399)
...+......+.+++.+||+.||++||++
T Consensus 222 -~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 -IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11222334478899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=333.05 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=211.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-----CCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+........+.+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999864 3456799999876555555678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc
Q 015816 147 VYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 214 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 214 (399)
||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975321 1245899999999999999999999999 999999999999999999
Q ss_pred eEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhh
Q 015816 215 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWA 293 (399)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~ 293 (399)
++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~--- 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI--- 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence 99999999875333222222233456788999999999999999999999999999999 99998765443322111
Q ss_pred hhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 294 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
. ..... ..+...+..+.+++.+||+.+|++||++.++++.|..+..
T Consensus 239 ~----~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 239 T----QGRVL----------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred h----CCCCC----------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 0 00000 0011123478899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=338.64 Aligned_cols=239 Identities=26% Similarity=0.332 Sum_probs=195.4
Q ss_pred CeeeecCceEEEEEEE---CCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecC
Q 015816 78 SLLGEGGFGRVYKGYL---ESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 152 (399)
+.||+|+||.||++.+ ..+|+.||+|++..... .....+..|+.++++++||||+++++++.+...+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999886 35789999999975432 223456789999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCc
Q 015816 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (399)
Q Consensus 153 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 232 (399)
+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... .
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~ 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--E 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--C
Confidence 9999999975 567999999999999999999999999 999999999999999999999999998753222 1
Q ss_pred ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcccc
Q 015816 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 312 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ....
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i------~~~~------------ 214 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI------LKAK------------ 214 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH------HcCC------------
Confidence 2233457999999999999889999999999999999999999999765433221111 0000
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHH
Q 015816 313 GQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 343 (399)
Q Consensus 313 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 343 (399)
...+......+.+|+.+||+.||.+||++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0111222347889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=329.56 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=211.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
..+|++.+.||.|+||.||+|.+.. +..+|+|++..........+..|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3568889999999999999999988 899999999876665667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999998632 456899999999999999999999999 9999999999999999999999999987542221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||............ ....
T Consensus 159 --~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~---~~~~------------ 221 (261)
T cd05148 159 --YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI---TAGY------------ 221 (261)
T ss_pred --ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH---HhCC------------
Confidence 11223346778999999988899999999999999999998 89999765432221111 1100
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 --RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0011222334788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=324.28 Aligned_cols=274 Identities=26% Similarity=0.353 Sum_probs=224.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHH---HHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|..+++||+|.||+|.+++-+.+++.||||++++.-....++ -..|-.+|+..+||++..+...|+..+++|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 57889999999999999999999999999999998775554443 456889999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+.||.|.-+|.. ...+++..+..+...|+.||.|||+++ ||.||||.+|+|+|.+|+|||+|||+++..
T Consensus 248 eyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~-- 318 (516)
T KOG0690|consen 248 EYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE-- 318 (516)
T ss_pred EEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--
Confidence 99999999988876 677999999999999999999999999 999999999999999999999999999852
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.........++|||.|+|||++....|+.++|+|.+||++|||++|+.||........-.++..- +
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--------------d 384 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--------------D 384 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--------------h
Confidence 22334456789999999999999999999999999999999999999999765543322222100 1
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHHHHhccCCCcccccCCCCCCCCCC
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTALAYLASQKYESDAEKVQSPCLDPGTP 373 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~~l~~~~~~~~~~~~~~~~~~~~~p 373 (399)
..+|.....+...|+..+|..||.+|. .+.||. +...+..-.|.....+...|++.|..-
T Consensus 385 ----~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~-~h~FF~~v~W~~~~~Kki~PPfKPqVt 449 (516)
T KOG0690|consen 385 ----LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIM-RHRFFASVDWEATYRKKIEPPFKPQVT 449 (516)
T ss_pred ----ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHH-hhhhhccCCHHHHHHhccCCCCCCCcc
Confidence 123333344788899999999999994 334443 445666667766666666666655443
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=331.27 Aligned_cols=260 Identities=26% Similarity=0.434 Sum_probs=205.5
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECC-----CCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCe
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 143 (399)
..++|++.+.||+|+||.||+|.++. ++..||||++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35679999999999999999998753 356799999864322 234568899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEE
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPG------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 217 (399)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999999753211 234678899999999999999999999 999999999999999999999
Q ss_pred ecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhh
Q 015816 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.............
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~----- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM----- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 99999875332222211222345788999999998899999999999999999999 788987654432222110
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
... . +. .+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 236 -~~~--~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 -EGG--L-----LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -cCC--c-----CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 000 0 00 11122347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=326.91 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=208.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.+|++.+.||.|+||.||+|.++.++..||+|.+... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3577889999999999999999999999999998754 233567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999997532 356899999999999999999999999 99999999999999999999999999875332211
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||............ . ... .+
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---~----~~~------~~- 224 (263)
T cd05052 160 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---E----KGY------RM- 224 (263)
T ss_pred -eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H----CCC------CC-
Confidence 11111234568999999998999999999999999999998 99999765433221111 0 000 01
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
..+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 225 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11222334889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=340.13 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=199.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC---CCCeEEEEEEeccCCC----cchHHHHHHHHHHhhc-CCCCccceEEEEecCCee
Q 015816 73 NFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 144 (399)
+|++.+.||+|+||.||+|++. .++..||+|++..... ...+.+..|+.+++.+ +||||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999999874 4689999999864321 2234577899999999 489999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999976 567999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||............ ......
T Consensus 154 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~----- 225 (332)
T cd05614 154 EFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILK----- 225 (332)
T ss_pred cccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhc-----
Confidence 5322221 122345799999999998765 4789999999999999999999999643221111100 000000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
.++.+ +......+.+++.+||+.||++|| +++++++
T Consensus 226 ---~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ---CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 01111 222334788999999999999999 6777775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=341.73 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=194.0
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.+..+++.||+|++..... ...+.+..|+.++.++ +||||+.+++++.+...+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975432 2234577899998888 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GD 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CC
Confidence 999998875 567999999999999999999999999 999999999999999999999999998742111 12
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...................... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~ 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-----------PI 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-----------CC
Confidence 2334679999999999999999999999999999999999999996432111100000000000000 00
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVI 341 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 341 (399)
..+......+.+++.+||+.||.+|+++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1122233477889999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=348.31 Aligned_cols=260 Identities=18% Similarity=0.198 Sum_probs=199.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.+|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 57999999999999999999999999999999753 234678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 166 ~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 166 K-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred C-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 6 789888876 567899999999999999999999999 9999999999999999999999999986422111
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchH-------HH-HHHHHHhhhhh---hccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA-------AA-EQSLVAWARPL---FQDR 300 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~-~~~~~~~~~~~---~~~~ 300 (399)
........||+.|+|||++.+..++.++|||||||++|||++|..||..... .. ...+....... +...
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1122345799999999999999999999999999999999999988643211 00 00000000000 0000
Q ss_pred -----------cccccccCccccCCC--ChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 -----------TRHSLIADPELQGQY--PPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 -----------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
........+...... ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000000 0123457889999999999999999999995
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=325.61 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=207.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCC---CeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
++|++.+.||+|+||.||+|.++.+ ...||||.+...... ....+..|+.+++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5689999999999999999998654 457999998654332 235688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999752 347899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
............++..|+|||.+.+..++.++||||||+++|+|++ |..||............ .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~---~~----~~~~--- 227 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV---ED----GYRL--- 227 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH---Hc----CCCC---
Confidence 2222222222345678999999998899999999999999999998 99999654433221111 00 0000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 228 -------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112234788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=331.95 Aligned_cols=263 Identities=29% Similarity=0.417 Sum_probs=209.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCC-----CeEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecCC
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 142 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 142 (399)
...+|++.+.||+|+||.||+|.+... ...+|+|.+..... .....+.+|+.+++.+ +||||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 345688999999999999999998643 37899999875422 2335688899999999 7999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLS------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~ 210 (399)
..+++|||+++|+|..++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 9999999999999999997532 22457899999999999999999999999 99999999999999
Q ss_pred CCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHH
Q 015816 211 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (399)
Q Consensus 211 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~ 289 (399)
.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999975433222222222335678999999988999999999999999999997 9999976544332211
Q ss_pred HHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 290 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
.. .... ...+......+.+|+.+||..||++|||+.++++.|+.+.
T Consensus 247 ~~-------~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 LK-------EGYR----------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH-------cCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 10 0000 0111223347889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=331.46 Aligned_cols=251 Identities=35% Similarity=0.542 Sum_probs=196.7
Q ss_pred CCCeeeecCceEEEEEEEC----CCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 76 SESLLGEGGFGRVYKGYLE----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+.+.||.|+||.||+|.+. ..+..|+||.+...... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999998 45678999999654332 357899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++|+|.+++.... ...+++..++.|+.||+.||.|||+++ ++|+||+++|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999741 367999999999999999999999999 9999999999999999999999999997642222
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
.........+...|+|||.+.+..++.++||||||+++|||++ |+.||................ .
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-------~------- 223 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-------R------- 223 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-------E-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------c-------
Confidence 2222333457789999999998889999999999999999999 789987664433221111000 0
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
...+...+..+.+++..||+.||++|||+.++++.|
T Consensus 224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011112233788999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=338.96 Aligned_cols=241 Identities=27% Similarity=0.338 Sum_probs=193.8
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHH-HHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.++.+++.||+|++..... .....+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999999999999999999865321 1223344444 456788999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
++|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc--CCC
Confidence 999999976 567889999999999999999999999 99999999999999999999999999874221 112
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|..||............ .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i------~~~~------------~ 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI------LNKP------------L 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH------HhCC------------c
Confidence 233457999999999999999999999999999999999999999765443221111 0000 0
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 345 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 345 (399)
..++.....+.+++.+||+.||.+||++.+.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 11122334788999999999999999887543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=327.90 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=204.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCe----EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.+|++.+.||+|+||.||+|.+..+++ .+++|.+..... ....++..|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 468888999999999999999977666 477777753322 223567778889999999999999998764 56789
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
++||+++|+|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999752 356899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.............++..|+|||.+.+..++.++|||||||++|||++ |..||.........+... ... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~---~ 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGE---R 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCC---c
Confidence 33322222233457788999999988899999999999999999998 999997654433222211 000 0
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
...+ ..+ ...+.+++.+||..||.+|||+.++++.|..+...
T Consensus 230 ~~~~---~~~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 230 LAQP---QIC----TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCCC---CCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0011 111 23678899999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=365.71 Aligned_cols=264 Identities=32% Similarity=0.462 Sum_probs=216.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCe-----EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQ-----DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
.+.++.+.||+|.||.||.|....... .||||.+..... ....+|.+|..+|+.++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345677899999999999999865433 499999976543 34567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 146 LVYEYMPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
|++|||.||+|..||++... ....|+..+.+.++.|||+|+.||++++ +|||||...|+||++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999997422 1456899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccc
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRT 301 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (399)
|+.....+.........-...|||||.+..+.++.++|||||||+|||++| |..||......+..... . ...
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~--~-----~gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV--L-----EGG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH--H-----hCC
Confidence 995433333332222234578999999999999999999999999999999 99999876655433211 1 111
Q ss_pred ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 302 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
+.+.|+.++..+.+|+..||+.+|++||++..|++++..+....
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 12334455558889999999999999999999999998876543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=345.61 Aligned_cols=265 Identities=25% Similarity=0.376 Sum_probs=208.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCC-----CeEEEEEEeccCCCc-chHHHHHHHHHHhhcC-CCCccceEEEEecCC
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 142 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 142 (399)
..++|++.+.||+|+||.||+|.+... +..||||++...... ..+.+.+|+.+++.+. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 356799999999999999999987432 347999999754332 3456889999999996 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCC---------------------------------------------------------
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSP--------------------------------------------------------- 165 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 165 (399)
..|||||||++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999864210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec
Q 015816 166 -----------------------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (399)
Q Consensus 166 -----------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~ 210 (399)
....+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0135788899999999999999999999 99999999999999
Q ss_pred CCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHH
Q 015816 211 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (399)
Q Consensus 211 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~ 289 (399)
.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--
Confidence 999999999999875432222222223456788999999998899999999999999999997 99998754322111
Q ss_pred HHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 290 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.... .... .+ ..+...+..+.+++.+||+.||++||++.+|.+.|+.+..
T Consensus 350 ~~~~----~~~~------~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 YNKI----KSGY------RM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHH----hcCC------CC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0000 0000 00 1112233478999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=335.74 Aligned_cols=238 Identities=27% Similarity=0.344 Sum_probs=192.5
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHH-HHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999865322 12234555554 67889999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CC
Confidence 999998875 567899999999999999999999999 999999999999999999999999998742111 11
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
......||+.|+|||++.+..++.++|||||||++|||++|..||............ .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i------~~~~------------~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI------LHKP------------L 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH------hcCC------------C
Confidence 223457999999999999999999999999999999999999999765432211111 1000 1
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIA 342 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 342 (399)
..++.....+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12223344788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=329.40 Aligned_cols=246 Identities=26% Similarity=0.393 Sum_probs=195.7
Q ss_pred eeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
||+|+||.||++..+.+|+.||+|.+...... ....+..|+++++.++||||+++++++.+....++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998653322 233456799999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceee
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (399)
.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~ 152 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTIT 152 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceee
Confidence 98886532 345899999999999999999999999 999999999999999999999999998753322 1223
Q ss_pred eeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHH-HHHHHhhhhhhccccccccccCccccCCC
Q 015816 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQY 315 (399)
Q Consensus 237 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
...|+..|+|||++.+..++.++|||||||++|+|++|..||........ .... ....... .....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~--------~~~~~-- 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK---RRTLEDE--------VKFEH-- 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH---HHhhccc--------ccccc--
Confidence 35689999999999988899999999999999999999999975432111 1111 1111000 00000
Q ss_pred ChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 316 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 316 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
......+.+|+.+||+.||++||++.|+++.
T Consensus 220 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 220 -QNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred -ccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 1123378899999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=344.23 Aligned_cols=253 Identities=23% Similarity=0.254 Sum_probs=200.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.++.+++.||||++.... ......+..|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999999999999999986432 223356778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||++||+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999976 567999999999999999999999999 99999999999999999999999999864321
Q ss_pred CCCc---------------------------------ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCC
Q 015816 229 GDNT---------------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275 (399)
Q Consensus 229 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~ 275 (399)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0012346999999999999999999999999999999999999
Q ss_pred CCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 015816 276 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV---IADVVT 346 (399)
Q Consensus 276 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~ 346 (399)
.||...........+.... ..+..+. . ......+.+|+.+++ .||.+|++ +.++++
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~---------~~~~~p~---~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQETYRKVMNWK---------ETLVFPP---E--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHHHHHHHHHcCC---------CceecCC---C--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 9997655433221111000 0000000 0 012337788888876 49999985 555553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=338.72 Aligned_cols=242 Identities=27% Similarity=0.380 Sum_probs=197.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 148 (399)
+|++.+.||+|+||.||+|.++.+|+.||+|++..... ...+.+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47788999999999999999999999999999875321 22345778888888876 577888999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++|+|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999976 567999999999999999999999999 99999999999999999999999999874221
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||............ ....
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~~~~-------- 217 (323)
T cd05615 154 D--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI------MEHN-------- 217 (323)
T ss_pred C--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC--------
Confidence 1 11223456999999999999999999999999999999999999999875443221111 0000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 341 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 341 (399)
..++......+.+++.+||+.+|.+|++.
T Consensus 218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01122223478889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.08 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=204.2
Q ss_pred HHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecC
Q 015816 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (399)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 141 (399)
.++....++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+..|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 3344455789999999999999999999999999999999864321 2234577899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
..+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999999874 45899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccC----CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhh
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 297 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 297 (399)
++....... ........||+.|+|||++.+. .++.++|||||||++|||++|..||...........+ .
T Consensus 188 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~ 260 (371)
T cd05622 188 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------M 260 (371)
T ss_pred ceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH------H
Confidence 987543221 1112345799999999998653 3889999999999999999999999865443221111 1
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 015816 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTAL 348 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L 348 (399)
... ....+ .........+.+++..||..++.+ |+++.++++..
T Consensus 261 ~~~-~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHK-NSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCC-CcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 000 00000 001123347888999999844433 77999988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=339.81 Aligned_cols=241 Identities=27% Similarity=0.352 Sum_probs=194.1
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHH-HHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.+..+|+.||+|++..... .....+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999865321 22334555554 56779999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|+|..++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 999998875 567999999999999999999999999 999999999999999999999999998742211 12
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|..||............ ... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~------~~~----~~-------- 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI------LHK----PL-------- 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH------HcC----Cc--------
Confidence 233457999999999999999999999999999999999999999765433221111 110 00
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 345 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 345 (399)
..++.....+.+++.+||+.+|.+||++.+.+
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 11122334778899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=328.44 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=204.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999999999999999998755444456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.. ..++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999875 567899999999999999999999999 9999999999999999999999999987542211
Q ss_pred CcceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.......|+..|+|||.+. ...++.++|||||||++|+|++|+.||............ . .....
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~---------~~~~~ 227 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--S---------KSNFQ 227 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--e---------cCCCC
Confidence 1122346889999999874 455788999999999999999999998644321110000 0 00000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.+... ........+.+++.+||+.+|++|||++++++.
T Consensus 228 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 228 PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 01110 011223478899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=326.42 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=211.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.+|++.+.||.|+||.||+|.+..++..||||.+...... ....+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999999988999999988653322 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.........+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998754444567899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|..||........ ....... . ...
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----~------~~~ 225 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKIE----Q------CDY 225 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHhhhhh----c------CCC
Confidence 22 112234688999999999888999999999999999999999999965432111 1110000 0 000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
+.. .+......+.+++.+||+.||.+|||+.+|++.++.+.
T Consensus 226 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 111 01123347889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=323.68 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=212.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 579999999999999999999998899999998864322 23457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|..++.........+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999999765544567899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.. .......++..|+|||.+.+..++.++|||||||++|+|++|..||........ ...... .... .
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~------~ 225 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKI----EKCD------Y 225 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-HHHhhh----hcCC------C
Confidence 21 112334688999999999888999999999999999999999999865432110 011000 0000 0
Q ss_pred ccccCCCCh-HhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 309 PELQGQYPP-RGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 309 ~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
...+. .....+.+++.+||..+|++|||+.+|++.|+.+.
T Consensus 226 ----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 ----PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01111 23347889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=322.97 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=202.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||+|..+. +..+|+|.+.... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 458888999999999999998875 5689999886443 33467888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++|+|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999998752 246899999999999999999999999 99999999999999999999999999875322111
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.||.............. .. ....+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-------~~---~~~~~- 223 (256)
T cd05114 156 -TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-------GF---RLYRP- 223 (256)
T ss_pred -eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------CC---CCCCC-
Confidence 11122235668999999988899999999999999999999 8999976544322221110 00 00011
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
......+.+++.+||+.+|++||++.++++.|
T Consensus 224 ------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 ------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11223788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=328.89 Aligned_cols=259 Identities=31% Similarity=0.431 Sum_probs=205.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC----CCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLE----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.+|++.+.||+|+||.||+|.+. .++..||+|.+...... ....+.+|+.+++.++||||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46788899999999999999853 34678999998743322 23568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC
Q 015816 147 VYEYMPLGSVEDHLHDLSP-------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~ 213 (399)
||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999863211 1235889999999999999999999999 99999999999999999
Q ss_pred ceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHh
Q 015816 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAW 292 (399)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~ 292 (399)
.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||..............
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999975433322222333446778999999988899999999999999999998 9999976443222111110
Q ss_pred hhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
... ......+ +..+.+++.+||+.||.+||++.+|++.|..
T Consensus 242 -------~~~------~~~~~~~----~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 -------RQL------LPCSEDC----PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -------CCc------CCCCCCC----CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 000 0011122 3378889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=324.41 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=203.6
Q ss_pred CCCCCeeeecCceEEEEEEECCC---CeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCe-----
Q 015816 74 FRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ----- 143 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----- 143 (399)
|++.+.||+|+||.||+|.+..+ +..||||.+...... ....+..|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999997653 478999998754322 23578899999999999999999998866554
Q ss_pred -eEEEEEecCCCCHHHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 144 -RLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 144 -~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
.++||||+++++|..++.... .....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999986432 12346899999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........... .. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~---~~----~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY---LR----H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HH----c
Confidence 99876433322222222335678999999988899999999999999999999 8899876543221111 11 0
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
.. .+ ..+......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 231 ~~------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN------RL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC------CC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00 11222334889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=324.13 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=206.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+......++||||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 3578899999999999999999765 67799998865432 356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999997532 456888999999999999999999999 9999999999999999999999999997643221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
. .......++..|+|||++.+..++.++|||||||++|+|++ |..||............ .... . .
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~~~~----~------~ 223 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL---QRGY----R------M 223 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH---HcCC----C------C
Confidence 1 11122345678999999988899999999999999999998 99999765433221111 1000 0 0
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
. .....+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 P----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 0112234788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=330.03 Aligned_cols=258 Identities=28% Similarity=0.391 Sum_probs=204.8
Q ss_pred CCCCCCeeeecCceEEEEEEECCC-----CeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
+|++.+.||.|+||.||+|.+..+ +..||||++...... ..+.+..|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 467788999999999999987543 578999998754332 23568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc
Q 015816 147 VYEYMPLGSVEDHLHDLS------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 214 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 214 (399)
++||+++++|.+++.... .....+++..++.++.|++.||.|||+++ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 11245888999999999999999999999 999999999999999999
Q ss_pred eEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhh
Q 015816 215 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWA 293 (399)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~ 293 (399)
+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.............
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~-- 240 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR-- 240 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH--
Confidence 99999999875433322222233446789999999988899999999999999999998 888887654432221111
Q ss_pred hhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 294 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
... .. .++...+..+.+|+..||+.+|.+||++.+|++.|..
T Consensus 241 -----~~~------~~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 -----NRQ------VL----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----cCC------cC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 000 00 1122233478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=328.60 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=202.6
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.|+..+.||+|+||.||+|.+..+++.||+|.+....... ...+..|+.+++.++|+||+.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999999999999999987543322 2456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999986532 346899999999999999999999999 999999999999999999999999998753322
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|..||............... .... .
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~---~~~~-------~- 221 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VKEV-------Q- 221 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh---hhhh-------h-
Confidence 11 12346899999999999999999999999999999999999999754321111111000 0000 0
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVTA 347 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 347 (399)
...+......+.+|+.+||+.||.+||| +.++++.
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 ---EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ---hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0011122337889999999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=336.90 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=205.0
Q ss_pred cCCCCCCeeeecCceEEEEEEECC-----CCeEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecC-Ce
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG-DQ 143 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~ 143 (399)
++|++.+.||.|+||.||+|.+.. +++.||+|++..... ...+.+..|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 479999999999999999997543 457899999875432 2235678899999999 899999999988654 56
Q ss_pred eEEEEEecCCCCHHHHhhccCCC---------------------------------------------------------
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPG--------------------------------------------------------- 166 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------- 166 (399)
++++|||+++++|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999998642210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccC
Q 015816 167 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246 (399)
Q Consensus 167 ~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 246 (399)
..++++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++................++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 136899999999999999999999999 99999999999999999999999999976433222222223456778999
Q ss_pred ccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHH
Q 015816 247 PEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 325 (399)
Q Consensus 247 PE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 325 (399)
||++.+..++.++|||||||++|||++ |..||........ ... .+...... ..+......+.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~~~~~~----------~~~~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLKEGTRM----------RAPEYATPEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHhccCCC----------CCCccCCHHHHH
Confidence 999999999999999999999999998 9999975332111 110 01110000 011122347899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 326 VAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 326 li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
++.+||+.+|++||++.++++.|+.+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=327.66 Aligned_cols=265 Identities=24% Similarity=0.307 Sum_probs=198.7
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhc---CCCCccceEEEEec-----CC
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCAD-----GD 142 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpniv~~~~~~~~-----~~ 142 (399)
+|++.+.||+|+||.||+|.++.+++.||+|.+...... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488899999999999999999999999999998753222 223456677777665 79999999998864 34
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5799999998 58988887532 345899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH-HHhhhhhhccc-
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQDR- 300 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~- 300 (399)
+....... ......||..|+|||++.+..++.++|||||||++|+|++|.+||........... ...........
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 87532211 12334689999999999988999999999999999999999999976544332211 11110000000
Q ss_pred ccccccc-------CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIA-------DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
....... .+.....+.+.....+.+++.+||+.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 000001112233457889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=322.75 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=206.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 3568899999999999999999765 5789999987543 3356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999997632 346899999999999999999999999 9999999999999999999999999987643211
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||............ .... .
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~~~----~------- 222 (261)
T cd05068 158 -YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV---DQGY----R------- 222 (261)
T ss_pred -ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---HcCC----C-------
Confidence 111111223457999999998899999999999999999999 99999765433221111 0000 0
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
...+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 011122334789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=324.99 Aligned_cols=252 Identities=31% Similarity=0.489 Sum_probs=206.2
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchH--HHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR--EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
|++.+.||+|+||+||+|.+..+++.||+|++......... ...+|+.+++.++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67789999999999999999999999999999876543332 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.. ...+++..++.++.||++||.+||+.+ |+|+||||+||+++.++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred ccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 99999999984 577899999999999999999999999 999999999999999999999999998743 122
Q ss_pred cceeeeeccCccccCccccc-cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh-hhccccccccccCc
Q 015816 232 THVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-LFQDRTRHSLIADP 309 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 309 (399)
........++..|+|||++. +..++.++||||||+++|+|++|..||................. ......
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-------- 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT--------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc--------
Confidence 23334466899999999998 88999999999999999999999999987633322222211111 110000
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.........+.+++.+||+.||++|||+.++++
T Consensus 224 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 ----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ----cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011258999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=327.67 Aligned_cols=261 Identities=28% Similarity=0.415 Sum_probs=207.1
Q ss_pred CCCCCCeeeecCceEEEEEEECC-----CCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999998753 235689998865432 234568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 015816 147 VYEYMPLGSVEDHLHDLSP--------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 206 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~N 206 (399)
||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999864321 1245889999999999999999999999 9999999999
Q ss_pred eeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHH
Q 015816 207 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (399)
Q Consensus 207 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~ 285 (399)
||+++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999875332222111223346778999999988899999999999999999998 999997654332
Q ss_pred HHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 286 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
..... .... ....+......+.+++..||+.+|++||++.++++.|+.+..
T Consensus 238 ~~~~~---~~~~--------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNLL---KTGY--------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHH---hCCC--------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 22111 1000 001112223478899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=321.78 Aligned_cols=253 Identities=28% Similarity=0.378 Sum_probs=205.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-----chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
++|++.+.||.|++|.||.|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4789999999999999999999999999999998644221 22467889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999986 567899999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcc-eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 227 PVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 227 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||............ . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~----~~~----- 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI--A----TQP----- 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH--h----ccC-----
Confidence 2211111 112345788999999999988999999999999999999999999754332111000 0 000
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.. ...+......+.+++.+||..+|.+|||+.++++.
T Consensus 224 -~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -TN----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CC----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00 11222333478899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=321.96 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=205.9
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
+|++.+.||.|+||.||++.+..+++.||+|.+.... ....+.+..|+.+++.++||||+++++.+.+...+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999999999999999986432 234466788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.... ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 9999999886532 456899999999999999999999999 999999999999999999999999998753221
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||............. .. ..
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~------~~--~~-------- 217 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC------QG--SY-------- 217 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh------cC--CC--------
Confidence 122234568999999999998899999999999999999999999998654322211110 00 00
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...+......+.+++.+||+.||++||++.+++..
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 -KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01112223468889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=326.99 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=207.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCC-----CeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|++.+.||+|+||.||+|.++.. +..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 35788999999999999999998643 37899999865432 2335688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEe
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPG------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 218 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 218 (399)
++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999754321 234788999999999999999999999 9999999999999999999999
Q ss_pred cccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhh
Q 015816 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF 297 (399)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~ 297 (399)
|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.............
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~------ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI------ 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh------
Confidence 9999875433322222233456789999999988899999999999999999998 999997654433222111
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
... .+.. +...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 -~~~------~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGG------HLDL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCC------CCCC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 0011 1122347889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=333.45 Aligned_cols=266 Identities=22% Similarity=0.309 Sum_probs=203.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.+|++.+.||+|+||.||+|.++.++..||+|.+...... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5689999999999999999999999999999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 98 5888888652 345899999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh--------hcccc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL--------FQDRT 301 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~ 301 (399)
.......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......+........... +....
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 11223457899999998864 56899999999999999999999999876554332222111000 00000
Q ss_pred ccccccCcccc----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 302 RHSLIADPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 302 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.......+... ....+.....+.+|+.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 0011123447889999999999999999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=320.73 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=206.8
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|++.+.||+|+||.||+|.+..+++.|++|.+.... ......+..|+.+++.++||||+++++++.+....++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999999999999999986542 23446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998632 457899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||............ .... .+
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~~-------~~- 219 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI------IRGV-------FP- 219 (256)
T ss_pred --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HcCC-------CC-
Confidence 1223346889999999999999999999999999999999999999766532211110 0000 00
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 ---PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111223478999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=327.22 Aligned_cols=259 Identities=28% Similarity=0.418 Sum_probs=205.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC-----CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4578899999999999999999987 7789999988654332 235688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC---ceEEe
Q 015816 145 LLVYEYMPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLS 218 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~ 218 (399)
++||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ ++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999976421 1235899999999999999999999999 99999999999998654 59999
Q ss_pred cccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhh
Q 015816 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF 297 (399)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~ 297 (399)
|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~------ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT------ 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------
Confidence 9999975422111111112234568999999998899999999999999999997 999998654433222111
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
.. .. ...+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 236 ~~-~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GG-GR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cC-Cc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 00 0112223347889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=329.00 Aligned_cols=266 Identities=28% Similarity=0.410 Sum_probs=208.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCC----------------eEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccc
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESIN----------------QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVN 133 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~ 133 (399)
..+|++.+.||+|+||.||+|.+...+ ..||+|.+...... ....+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357899999999999999999876543 56899998755332 3457889999999999999999
Q ss_pred eEEEEecCCeeEEEEEecCCCCHHHHhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 015816 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 206 (399)
Q Consensus 134 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~N 206 (399)
+++++......++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999976331 1236899999999999999999999999 9999999999
Q ss_pred eeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh--CCCCcccchHH
Q 015816 207 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAA 284 (399)
Q Consensus 207 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~~~ 284 (399)
|+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875433322222334456788999999988899999999999999999998 67788654332
Q ss_pred HHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 285 AEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
.. .......+....... ....++..+.++.+++.+||+.||.+|||+.+|++.|+
T Consensus 241 ~~---~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QV---IENAGHFFRDDGRQI-------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH---HHHHHhccccccccc-------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 21 111111111110000 01112223358999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=323.63 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=201.0
Q ss_pred CCCCCeeeecCceEEEEEEECCCCe--EEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecC------Ce
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQ--DVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQ 143 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~ 143 (399)
|.+.+.||+|+||.||+|.+..++. .||+|.+.... ....+.+..|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999999887665 69999886542 22345688899999999999999999987432 24
Q ss_pred eEEEEEecCCCCHHHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 144 RLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
.+++|||+++|+|.+++.... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999875321 12345899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
++................+++.|+|||.+.+..++.++|||||||++|||++ |..||............ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-------~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL-------RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HcC
Confidence 9986433222111222346778999999999999999999999999999999 88999764433221111 110
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
.. . ..++.....+.+++.+||+.||++|||+.++++.|+.+
T Consensus 231 ~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NR------L----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0 01112234788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=329.56 Aligned_cols=260 Identities=30% Similarity=0.445 Sum_probs=204.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeE--EEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQD--VAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 147 (399)
++|++.+.||+|+||.||+|.++.++.. +|+|.+..... .....+.+|+.++.++ +||||+++++++.+.+.+++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5788899999999999999998877754 57777654322 2335688899999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCce
Q 015816 148 YEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 215 (399)
|||+++++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999975321 1236899999999999999999999999 9999999999999999999
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhh
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~ 294 (399)
+|+|||++..... ........++..|+|||++.+..++.++|||||||++|+|+| |..||............
T Consensus 164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---- 236 (303)
T cd05088 164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 236 (303)
T ss_pred EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH----
Confidence 9999999863211 111111234667999999988889999999999999999998 99999755433221111
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.... ... .+...+..+.+|+.+||+.+|++||++.++++.|..+...
T Consensus 237 ---~~~~------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 237 ---PQGY------RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred ---hcCC------cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 000 1111233788999999999999999999999999877544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=325.31 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=205.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCe----EEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
..+|++.+.||.|+||.||+|.+..++. .||+|++...... ....+.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 3568889999999999999999876666 4899998654332 345688899999999999999999998764 578
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999999752 346899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
..............++..|+|||.+.+..++.++|||||||++|||++ |..||............. . ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~----~~~-- 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE---K----GER-- 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---C----CCc--
Confidence 433222211122235678999999988899999999999999999998 999997654332221111 0 000
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
+ ..++.....+.+++.+||+.||++||++.++++.|..+...
T Consensus 230 ----~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 ----L----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----C----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0 00112233788999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=328.75 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=207.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.+|++.+.||.|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++.+..+...|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57999999999999999999999999999999998766556677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 99999999864 45899999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......... .... ... ...
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~----~~~--~~~------ 235 (296)
T cd06654 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIA----TNG--TPE------ 235 (296)
T ss_pred -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHh----cCC--CCC------
Confidence 1122346889999999998888999999999999999999999999765432211 1000 000 000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+......+.+++.+||..+|++||++.++++
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0112223347888999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=330.59 Aligned_cols=265 Identities=25% Similarity=0.377 Sum_probs=204.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCC--------------CeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESI--------------NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIG 136 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~ 136 (399)
++|++.+.||+|+||.||+|.+..+ ...||+|.+...... ....+.+|+.++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999987543 235999998754322 2356889999999999999999999
Q ss_pred EEecCCeeEEEEEecCCCCHHHHhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcee
Q 015816 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSP--------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (399)
Q Consensus 137 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nil 208 (399)
++......++||||+++++|.+++..... ....+++..++.++.||+.||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999865321 1124788999999999999999999999 999999999999
Q ss_pred ecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh--CCCCcccchHHHH
Q 015816 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAAAE 286 (399)
Q Consensus 209 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~~~~~ 286 (399)
++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999875433222222223345778999999988899999999999999999998 6678876443322
Q ss_pred HHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 287 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
.... ...+........ ...++..+..+.+|+.+||+.||++|||+.+|++.|.
T Consensus 242 ~~~~---~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENT---GEFFRNQGRQIY-------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHH---HHhhhhcccccc-------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111 111111000000 0111122348999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=326.40 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=206.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-----CCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
++|.+.+.||+|+||.||+|... .++..+|+|.+..........+.+|+.+++.++||||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46788899999999999999743 3567899999876555555678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCce
Q 015816 147 VYEYMPLGSVEDHLHDLSP-----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 215 (399)
||||+++++|.+++..... ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999975321 1135889999999999999999999999 9999999999999999999
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhh
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~ 294 (399)
+|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||................
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 9999999875332221111222345678999999999999999999999999999998 999996654433221111000
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
.......+ +..+.+|+.+||+.||.+||++.++++.|+
T Consensus 242 -------------~~~~~~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 -------------ELERPRTC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -------------cCCCCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00011122 237889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=340.51 Aligned_cols=266 Identities=21% Similarity=0.300 Sum_probs=202.9
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCC-----eeE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 145 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~ 145 (399)
+|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999899999999986432 223456889999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 688888865 567999999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh--hhc----
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP--LFQ---- 298 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~---- 298 (399)
..... ........++..|+|||++.+. .++.++|||||||++|||++|+.||...........+..... ...
T Consensus 153 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 33221 1122234578999999998764 589999999999999999999999976654332222111000 000
Q ss_pred ------cccccccccCccc--cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 299 ------DRTRHSLIADPEL--QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 299 ------~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..........+.. ...........+.+|+.+||+.||++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000 001112234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=328.17 Aligned_cols=260 Identities=28% Similarity=0.431 Sum_probs=204.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCe--EEEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQ--DVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 147 (399)
++|++.+.||+|+||.||+|.++.++. .+++|.+.... ....+.+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999999887665 46888876422 22345688999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCce
Q 015816 148 YEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 215 (399)
|||+++++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999975321 1235889999999999999999999999 9999999999999999999
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhh
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~ 294 (399)
||+|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||............
T Consensus 159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~---- 231 (297)
T cd05089 159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL---- 231 (297)
T ss_pred EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 9999999863211 111111223557999999988899999999999999999997 99999765443221110
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.... .+ ..+...+..+.+|+.+||+.+|.+||+++++++.|..+...
T Consensus 232 ---~~~~------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 232 ---PQGY------RM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred ---hcCC------CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 00 11112234788999999999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=324.98 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=203.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46888899999999999999999999999999987654444566788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.. ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 99999999876 567999999999999999999999999 999999999999999999999999998653221
Q ss_pred cceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 232 THVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
........|+..|+|||++. ...++.++|||||||++|+|++|..||............ ....+. .
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~~~~~~---------~ 228 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TKSNFQ---------P 228 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--hccCCC---------C
Confidence 11223456899999999874 456889999999999999999999998654322211110 000000 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+.... .......+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000 0112236888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=328.47 Aligned_cols=265 Identities=26% Similarity=0.387 Sum_probs=210.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-------CCCeEEEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCccceEEEEecC
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLE-------SINQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 141 (399)
..+|++.+.||+|+||.||+|++. ..+..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457889999999999999999753 234579999986442 23346788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill 209 (399)
...++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999976321 1235788899999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHH
Q 015816 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~ 288 (399)
+.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999999976433222222223346678999999988899999999999999999998 788887654332221
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 289 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
.. ..... ...+...+..+.+|+.+||+.+|.+|||+.++++.|..+....
T Consensus 251 ~~-------~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 251 LL-------KEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HH-------HcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11 00000 0111223347889999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=337.24 Aligned_cols=265 Identities=22% Similarity=0.292 Sum_probs=200.1
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCC-----
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 142 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 142 (399)
..++|++.+.||+|+||.||+|.+..+|..||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999999999999999986432 223456788999999999999999999986543
Q ss_pred -eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 143 -QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 143 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
..|+||||++ ++|...+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 4799999997 56766664 24888999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHH-HHH---------
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVA--------- 291 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~--------- 291 (399)
++..... ........||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ...
T Consensus 169 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred Ccccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 9874321 112233568999999999999999999999999999999999999997654322110 000
Q ss_pred ------hhhhhhcccccccccc------Ccccc--CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 292 ------WARPLFQDRTRHSLIA------DPELQ--GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 292 ------~~~~~~~~~~~~~~~~------~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
................ +.... ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000000000 00000 00011123467899999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=361.95 Aligned_cols=258 Identities=20% Similarity=0.309 Sum_probs=202.7
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEec--CCee
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 144 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 144 (399)
....+|++.+.||.|+||.||+|.+..++..||+|++...... ....+..|+.+++.++|||||+++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3456899999999999999999999999999999998754332 34568899999999999999999998854 4568
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeecCCCCCceeecC---------
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK----PPVIYRDLKCSNILLDR--------- 211 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~----~~ivH~Dlkp~Nill~~--------- 211 (399)
||||||+++++|.++|.........+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999998654445679999999999999999999998431 23999999999999964
Q ss_pred --------CCceEEecccCCccCCCCCCcceeeeeccCccccCcccccc--CCCCcccceeehhHHHHHHHhCCCCcccc
Q 015816 212 --------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (399)
Q Consensus 212 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~ 281 (399)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++||||||||||+|++|..||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 235899999999753222 12234569999999999854 45899999999999999999999999754
Q ss_pred hHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 282 KAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..... +.... ... +.+.. ......+.+||..||+.+|.+||++.+++.
T Consensus 247 ~~~~q--li~~l----k~~--------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFSQ--LISEL----KRG--------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHHH--HHHHH----hcC--------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 32211 11100 000 00000 112247889999999999999999999995
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=319.61 Aligned_cols=248 Identities=29% Similarity=0.415 Sum_probs=198.2
Q ss_pred eeeecCceEEEEEEE--CCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCC
Q 015816 79 LLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 154 (399)
.||+|+||.||+|.+ ..++..+|+|++..... ...+.+..|+.+++.++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999965 45678999999864432 234578899999999999999999998864 5678999999999
Q ss_pred CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc-
Q 015816 155 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH- 233 (399)
Q Consensus 155 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 233 (399)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999975 457899999999999999999999999 9999999999999999999999999987543322211
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcccc
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 312 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
......++..|+|||.+....++.++|||||||++|||++ |..||............. ... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-------~~~------~---- 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-------SGE------R---- 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCC------C----
Confidence 1122234578999999988889999999999999999998 999997654432222111 100 0
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 313 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 313 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
...+...+..+.++|.+||+.||++||++.+|.+.|+.+
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 011222334788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=329.73 Aligned_cols=263 Identities=27% Similarity=0.393 Sum_probs=207.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECC-------CCeEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecCC
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 142 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 142 (399)
++|.+.+.||+|+||.||+|.+.. +...+|+|.+..... .....+..|+.+++.+ +||||+++++++....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 569999999999999999998643 235699999875422 2345688899999999 7999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~ 210 (399)
..++||||+++++|.+++..... ....+++.+++.++.||+.||+|||+.+ ++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999976421 1235899999999999999999999999 99999999999999
Q ss_pred CCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHH
Q 015816 211 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (399)
Q Consensus 211 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~ 289 (399)
.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999875432221111222234578999999988899999999999999999998 8899876543322211
Q ss_pred HHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 290 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.. ... ....+......+.+|+.+||+.+|++|||+.++++.|..+...
T Consensus 255 ~~-------~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 255 LK-------EGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HH-------cCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11 000 0011222334888999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=338.72 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=207.4
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-C-----CCccceEEEEecCCeeEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-H-----PNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~~~~~~~~~~~~~l 146 (399)
+|++.+.||+|+||.|.+|.+..|++.||||+++.. ....++-..|+.+|..|+ | -|||+++++|...+++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 689999999999999999999999999999999654 444566678999999997 4 389999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC--CceEEecccCCc
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG--YHPKLSDFGLAK 224 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfg~~~ 224 (399)
|+|.+. .+|.++++... ..+|+...++.++.||+.||.+||..+ |||+||||+||||.+. ..|||+|||+|.
T Consensus 266 VfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999996 89999999855 456999999999999999999999999 9999999999999764 479999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh---------
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP--------- 295 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------- 295 (399)
...... .....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..+....+.-+..
T Consensus 340 ~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 340 FESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 532221 245678899999999999999999999999999999999999988776554433221111
Q ss_pred ------hhcc-cc-----cccc--------------------ccCc----cccCCCChHhHHHHHHHHHHccccCCCCCC
Q 015816 296 ------LFQD-RT-----RHSL--------------------IADP----ELQGQYPPRGFYQALAVAAMCVHEQPDMRP 339 (399)
Q Consensus 296 ------~~~~-~~-----~~~~--------------------~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 339 (399)
.+.. .. .... ...| .+...........+.+++.+||..||..|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0111 00 0000 0000 000011113346778999999999999999
Q ss_pred CHHHHHH
Q 015816 340 VIADVVT 346 (399)
Q Consensus 340 s~~eil~ 346 (399)
|+.+.++
T Consensus 495 tp~qal~ 501 (586)
T KOG0667|consen 495 TPAQALN 501 (586)
T ss_pred CHHHHhc
Confidence 9999996
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=337.06 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=201.4
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecC------
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 141 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 141 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999999999999999999875422 2335678899999999999999999988643
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
...|+||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 35799999997 56777764 24888999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHH-HHHh--------
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAW-------- 292 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~-------- 292 (399)
++..... ........||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ....
T Consensus 165 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9975322 112233568999999999999999999999999999999999999997654322211 0000
Q ss_pred -------hhhhhccccccccccCccc--------cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 293 -------ARPLFQDRTRHSLIADPEL--------QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 293 -------~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
................+.. ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000000000000 001111223577899999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=331.00 Aligned_cols=256 Identities=21% Similarity=0.230 Sum_probs=199.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ......+..|+.++..++|+||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46899999999999999999999999999999986432 122345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999752 356899999999999999999999999 99999999999999999999999999865322
Q ss_pred CCCcceeeeeccCccccCcccccc-----CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
... .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||............ .....
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i------~~~~~-- 225 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHKE-- 225 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH------HcCCC--
Confidence 211 11223469999999999863 46788999999999999999999999765432221111 00000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPD--MRPVIADVVTA 347 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~eil~~ 347 (399)
....+.. .+..+..+.+++.+||..+++ .||++.++++.
T Consensus 226 -~~~~~~~----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 226 -HFQFPPD----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -cccCCCc----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000110 111334778899988765433 37899988865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=327.42 Aligned_cols=267 Identities=23% Similarity=0.291 Sum_probs=206.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688999999999999999999999999999998754322 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
+++++|.+++.. ...+++..+..++.||+.||.|||+ .+ ++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999986 4678999999999999999999997 57 999999999999999999999999998643211
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc-----c
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH-----S 304 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 304 (399)
......|+..|+|||++.+..++.++|||||||++|+|++|..||......................... .
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 1233568999999999988889999999999999999999999997544322211111000000000000 0
Q ss_pred cccCc--------------cccCCCC-hHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 305 LIADP--------------ELQGQYP-PRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 305 ~~~~~--------------~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
....+ ......+ ......+.+++.+||..||++||++.++++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000 0000000 012346889999999999999999999997644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=330.40 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=212.5
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
=|.+++.||+|.|+.|-+|++.-+|+.||||++++..... ...++.|+..|+.++|||||++|++...+..+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3778889999999999999999999999999998765543 35688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec-CCCceEEecccCCccCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 229 (399)
-++|+|++||-.. ...+.+..+.+++.||+.|+.|+|... +|||||||+||.+- .-|-|||+|||++..+..+
T Consensus 99 GD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999864 467999999999999999999999999 99999999998764 5689999999999765443
Q ss_pred CCcceeeeeccCccccCccccccCCCC-cccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. ..+..+|+..|.|||++.+..|+ +++||||||||||.|++|++||...+..+-..++ +|
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI----------------mD 233 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI----------------MD 233 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh----------------hc
Confidence 3 34567899999999999999887 6799999999999999999999876543322221 12
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..-..|.....+..+||..||..||++|-+.++|+.
T Consensus 234 --CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 --CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 223456677789999999999999999999988874
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=327.19 Aligned_cols=265 Identities=26% Similarity=0.409 Sum_probs=204.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECC----------------CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccce
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES----------------INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNL 134 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~ 134 (399)
++|++.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 469999999999999999986542 3457999998754322 34578899999999999999999
Q ss_pred EEEEecCCeeEEEEEecCCCCHHHHhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCce
Q 015816 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG-------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 207 (399)
Q Consensus 135 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Ni 207 (399)
++++...+..++||||+++++|.+++...... ...+++..++.++.||+.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99999999999999999999999999763211 234788899999999999999999999 99999999999
Q ss_pred eecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh--CCCCcccchHHH
Q 015816 208 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAAA 285 (399)
Q Consensus 208 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~~~~ 285 (399)
|++.++.++|+|||++................++..|+|||...++.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999875432222122222345678999999888899999999999999999998 778886543322
Q ss_pred HHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 286 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
... .....+......... ..+...+..+.+|+.+||+.||.+||++.+|++.|.
T Consensus 242 ~~~---~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIE---NTGEFFRDQGRQVYL-------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHH---HHHHHHhhccccccC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 211 111111111000000 011122347889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.29 Aligned_cols=254 Identities=24% Similarity=0.336 Sum_probs=208.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||.|+||.||+|.+..+++.+++|++........+.+.+|+.+++.++||||+++++++.+...+|++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999999889999999997665555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-- 154 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-- 154 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh--
Confidence 999999998762 257999999999999999999999999 999999999999999999999999998753221
Q ss_pred cceeeeeccCccccCccccccC---CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 232 THVSTRVMGTYGYCAPEYAKTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
........++..|+|||.+.+. .++.++|||||||++|+|++|..||............. ...+. .
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~~~~~---------~ 223 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--KSNFP---------P 223 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCC---------C
Confidence 1112334688899999998776 88999999999999999999999997654332211110 00000 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+. ..........+.+++.+||..+|.+|||+.+++.
T Consensus 224 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 1112334557899999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.92 Aligned_cols=252 Identities=33% Similarity=0.487 Sum_probs=206.6
Q ss_pred CeeeecCceEEEEEEECCC---CeEEEEEEeccCCCcc-hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.+... +..|++|.+....... .+.+..|+.++..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999866 8899999997654433 56788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 154 GSVEDHLHDLSPG-----KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 154 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
++|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999874221 367999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
...........++..|+|||.+....++.++|||||||++|+|++ |..||............ . ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~----~~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL---R----KGY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---H----cCC------
Confidence 332222334557889999999988899999999999999999999 69999876433221111 1 000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
....+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112222448899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=326.32 Aligned_cols=259 Identities=27% Similarity=0.394 Sum_probs=206.0
Q ss_pred cCCCCCCeeeecCceEEEEEEE-----CCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecCCee
Q 015816 72 KNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 144 (399)
++|.+.+.||+|+||.||+|.+ ..++..||+|.+..... ...+.+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5699999999999999999975 33456899999875432 2335688999999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+++++|.+++.... ...+++.++..++.||+.||+|||+++ |+|+||||+|||++.++.++|+|||++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999997522 234899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......... ..... ....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~~~----~~~~- 262 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKLIK----EGYR- 262 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHHHH----cCCc-
Confidence 5433222222222346788999999999899999999999999999998 99998765432211 00000 0000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
...+......+.+++.+||..+|++|||+.++++.|..+
T Consensus 263 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 ---------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001112234788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=323.23 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=209.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC----CCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEec-CCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLES----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 144 (399)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678899999999999999999876 358899998864422 234568889999999999999999998766 5678
Q ss_pred EEEEEecCCCCHHHHhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPG----KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
++++||+++++|.+++...... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999764321 156899999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
|+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||......... .+.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~~~-- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA---AYLKDGY-- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH---HHHHcCC--
Confidence 99975433222222222346778999999988899999999999999999999 99999765443221 1111100
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.. .. +...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus 237 -----~~---~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 -----RL---AQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -----CC---CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 00 00 111233788999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=324.96 Aligned_cols=270 Identities=27% Similarity=0.412 Sum_probs=203.9
Q ss_pred CC-CCCCeeeecCceEEEEEEE----CCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecC--Cee
Q 015816 73 NF-RSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 144 (399)
Q Consensus 73 ~~-~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 144 (399)
+| ++.+.||+|+||.||++.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 8889999999999988653 45678999999875432 2346688999999999999999999988653 468
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+++++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 999999999999999974 45999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcc-eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 225 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 225 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ............. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~-~~ 233 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVV-RL 233 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchh-hh
Confidence 643322111 11223456779999999888999999999999999999999999865432111 0000000000000 00
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
....+.......+...+..+.+++..||+.+|++|||+.++++.|+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000001111122333458999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=335.13 Aligned_cols=241 Identities=24% Similarity=0.302 Sum_probs=190.4
Q ss_pred eeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhc---CCCCccceEEEEecCCeeEEEEEecCC
Q 015816 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL---HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
||+|+||.||+|+++.+++.||||++...... ....+..|..++..+ +||||+.+++++.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999998653222 223345566776655 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999999876 567999999999999999999999999 9999999999999999999999999987422211 1
Q ss_pred eeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcccc
Q 015816 234 VSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 312 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
......||..|+|||++.+. .++.++|||||||++|+|++|..||............... . ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~------~--------~~~~ 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG------K--------VRFP 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC------C--------CCCC
Confidence 22345699999999998654 5899999999999999999999999765433221111100 0 0000
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 015816 313 GQYPPRGFYQALAVAAMCVHEQPDMRP----VIADVVT 346 (399)
Q Consensus 313 ~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~eil~ 346 (399)
.. .....+.+++.+||+.||.+|| ++.++++
T Consensus 218 ~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred Cc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00 1223778899999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.87 Aligned_cols=252 Identities=28% Similarity=0.404 Sum_probs=202.1
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.|+..+.||.|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||+.+++.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367778999999999999999999999999998754322 22446789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999998886532 346999999999999999999999999 999999999999999999999999998653221
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||............... .... ..
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~---~~~~-------~~ 222 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR---VLET-------EE 222 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---hhcc-------cc
Confidence 1 122346899999999999889999999999999999999999999765432221111100 0000 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 346 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 346 (399)
.++......+.+|+..||+.||++||+ +.+++.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111222337788999999999999999 566664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=323.89 Aligned_cols=263 Identities=27% Similarity=0.426 Sum_probs=206.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECC-----CCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCe
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 143 (399)
..++|++.+.||+|+||.||+|..+. .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45689999999999999999997652 355899998864432 223457889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEE
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSP------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 217 (399)
.++||||+++|+|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 1234577888999999999999999999 999999999999999999999
Q ss_pred ecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhh
Q 015816 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||............
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~------ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------ 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------
Confidence 99999875333222222222345778999999998899999999999999999998 78898765443222111
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
.. .. .+.. +...+..+.+++.+||+.||++|||+.++++.|....
T Consensus 235 ~~-~~------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MD-GG------YLDQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred Hc-CC------CCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00 00 0001 1112347899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=319.11 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=201.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.+|++.+.||+|+||.||+|.++. +..+|+|++..... ....+..|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 357888999999999999998874 67899999864432 3456888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~- 154 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ- 154 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc-
Confidence 999999999752 346899999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||............ ...+ .
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~~~----------~-- 219 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV---SAGY----------R-- 219 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH---HcCC----------c--
Confidence 111111223457999999998899999999999999999999 89999765433221111 0000 0
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
...+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 220 --~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 --LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011112334789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=319.49 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=202.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||.|.+.. +..||+|.+.... .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 468888999999999999998765 4569999987543 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
.+++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~- 154 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE- 154 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc-
Confidence 999999999752 236899999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||............... ...
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-------~~~------- 220 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-------LRL------- 220 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-------CCC-------
Confidence 111112335678999999988889999999999999999998 99999765443221111100 000
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
..+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112347899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=318.49 Aligned_cols=254 Identities=30% Similarity=0.421 Sum_probs=203.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.+|++.+.||+|+||.||+|.+..+ ..||+|++..... ....+.+|+.+++.++||||+++++++.+ ...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 4699999999999999999998765 4699999875432 34578899999999999999999998754 5689999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999997532 346899999999999999999999999 99999999999999999999999999875432221
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
. ......++..|+|||+..+..++.++|||||||++|+|++ |..||............. ... .
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-------~~~------~-- 221 (262)
T cd05071 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGY------R-- 221 (262)
T ss_pred c-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-------cCC------C--
Confidence 1 1122346678999999988899999999999999999999 888987654322211110 000 0
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
...+...+..+.+|+.+||+.||++||++.++++.|+..
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011122344788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=320.37 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=204.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCe---EEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.+|++.+.||+|+||.||+|.++.++. .||||.+.... ......+..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357889999999999999999886654 69999986542 22345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998752 356899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCCcceeee-ec--cCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 228 VGDNTHVSTR-VM--GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 228 ~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
.......... .. .+..|+|||.+.+..++.++|||||||++|||++ |..||............ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i---~~~~~----- 229 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI---EQDYR----- 229 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH---HcCCc-----
Confidence 2221111111 11 2457999999999999999999999999999886 99999765443221111 11000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
...+...+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ---------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 001112234788899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=326.37 Aligned_cols=266 Identities=22% Similarity=0.301 Sum_probs=203.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 578999999999999999999999999999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
++ ++|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 6898888752 356899999999999999999999999 9999999999999999999999999987532211
Q ss_pred CcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc-------
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR------- 302 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------- 302 (399)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|++||........................
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 11223457889999998865 45788999999999999999999999866543222111111000000000
Q ss_pred -cccccCccccCC----CChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 303 -HSLIADPELQGQ----YPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 303 -~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
......+..... ..+.....+.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000111111 11122347889999999999999999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=326.64 Aligned_cols=263 Identities=27% Similarity=0.409 Sum_probs=207.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECC-------CCeEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecCC
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 142 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 142 (399)
.+|.+.+.||+|+||.||+|.+.. ....||+|.+..... .....+..|+.+++.+ +||||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 578899999999999999998632 345799999875432 2345688899999999 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~ 210 (399)
..++||||+++|+|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 99999999999999999976321 1245899999999999999999999999 99999999999999
Q ss_pred CCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHH
Q 015816 211 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (399)
Q Consensus 211 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~ 289 (399)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999975432222111222234567999999998899999999999999999999 8899976543322221
Q ss_pred HHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 290 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.. .... . ..+...+..+.+++.+||+.+|++|||+.++++.|..+...
T Consensus 249 ~~-------~~~~------~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 249 LR-------EGHR------M----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HH-------cCCC------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11 0000 0 11222334788999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=323.01 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=203.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
+.|++.+.||.|+||.||+|.+..++..|++|.+........+.+..|+.+++.++||||+++++.+..+..+++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999999999999999997665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|..++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 999998887642 356899999999999999999999999 999999999999999999999999988642211
Q ss_pred cceeeeeccCccccCccccc-----cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 232 THVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
........++..|+|||++. ...++.++|||||||++|+|++|..||......... ..... . . .
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~~~~----~-~-~--- 232 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKIAK----S-E-P--- 232 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH--HHHhc----C-C-C---
Confidence 11123356889999999884 345788999999999999999999999764432111 11000 0 0 0
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+. ...+......+.+++.+||..||++||++.++++
T Consensus 233 --~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 --PT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --cc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 0111222347888999999999999999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=318.20 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=203.5
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---------hHHHHHHHHHHhhcCCCCccceEEEEecCCe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 143 (399)
+|.+...||.|+||.||+|.+..+++.||+|.+....... .+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999999889999999886543221 1457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999976 467899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCC----cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 224 KLGPVGDN----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 224 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
........ ........|+..|+|||.+.+..++.++|||||||++|+|++|+.||............ . .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~-----~ 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI--G-----E 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH--h-----c
Confidence 76432111 11112345889999999999889999999999999999999999999765332211000 0 0
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+. .+......+.+++.+||+.||.+||++.++++
T Consensus 227 ------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ------NASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------cCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00111 12223347889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=325.20 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=207.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999999999999999997665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|..++.. ..+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999864 46899999999999999999999999 99999999999999999999999999875322211
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||............ .. .. ....
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~--~~----~~--~~~~----- 235 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--AT----NG--TPEL----- 235 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh----cC--Cccc-----
Confidence 122346889999999999888999999999999999999999999776543222111 00 00 0000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+......+.+++.+||..||.+||++.+++.
T Consensus 236 --~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 --QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011122337888999999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=322.45 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=199.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 367888999999999999999999999999999865422 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999986542 3688899999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH-HHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 309 (399)
......||..|+|||++.+..++.++|||||||++|+|++|..||........... ...... ..... .+
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~------~~ 218 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDED------PP 218 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-HhccC------CC
Confidence 12335689999999999998999999999999999999999999965332111100 000000 00000 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.+. .......+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000 11123378899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=337.43 Aligned_cols=263 Identities=26% Similarity=0.379 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-----CCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcC-CCCccceEEEEecCCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 143 (399)
.++|.+.+.||+|+||.||+|++. .++..||||++...... ..+.+..|+.+|..+. ||||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346788899999999999999964 34568999999754322 2346889999999997 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCC----------------------------------------------------------
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSP---------------------------------------------------------- 165 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 165 (399)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 015816 166 ------------------------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 166 ------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill 209 (399)
....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1134678889999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHH
Q 015816 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~ 288 (399)
+.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999999975322221111223457788999999998899999999999999999998 889987543222110
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 289 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
.... ... ....+......+.+|+.+||+.+|..||++.+|++.|+.+.
T Consensus 353 --~~~~----~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 --NAIK----RGY----------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HHHH----cCC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0000 000 00112223348899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=321.45 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=202.6
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
|++.+.||.|+||.||+|.+..++..+++|.+..........+.+|+.+++.++||||+++++++..+...++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 67788999999999999999999999999998765544556788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
++|..++... ..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~ 158 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ 158 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--cc
Confidence 9999887642 457999999999999999999999999 999999999999999999999999998653221 11
Q ss_pred eeeeeccCccccCccccc-----cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 234 VSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
......|+..|+|||++. +..++.++|||||||++|+|++|.+||............ .. .. ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~----~~--~~~~-- 228 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI--AK----SE--PPTL-- 228 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH--hh----cC--CCCC--
Confidence 123346899999999883 456788999999999999999999999765432211111 00 00 0000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..+......+.+++.+||+.||.+||++.++++.
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 -----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223478999999999999999999998853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.39 Aligned_cols=193 Identities=24% Similarity=0.371 Sum_probs=167.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
...+|++.+.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 446799999999999999999999999999999985432 23468999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
++. ++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 138 ~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 996 6888888652 467999999999999999999999999 999999999999999999999999998742211
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 278 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf 278 (399)
.......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223356999999999999999999999999999999999865443
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.38 Aligned_cols=253 Identities=29% Similarity=0.430 Sum_probs=202.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.++++++||||+++++++. ....++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 468899999999999999998775 67799999875433 3467889999999999999999999885 45689999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999997532 346899999999999999999999999 99999999999999999999999999975332211
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||............ . ... .
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~---~----~~~------~-- 221 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV---E----RGY------R-- 221 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---H----cCC------C--
Confidence 11112235678999999988899999999999999999999 89999765433221111 0 000 0
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
...+...+..+.+|+.+||..+|.+|||+.++++.|+.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 --MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01122233478999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=323.88 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=205.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC-----CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|++.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+|+.+++.++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4578999999999999999998753 5789999998754332 235688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSP------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 206 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~N 206 (399)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999975321 1235788999999999999999999999 9999999999
Q ss_pred eeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHH
Q 015816 207 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (399)
Q Consensus 207 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~ 285 (399)
||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875322221111222335677999999988899999999999999999998 888886544332
Q ss_pred HHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 286 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
..... .... . ...+...+..+.+|+.+||+.+|.+|||+.|+++.|+
T Consensus 241 ~~~~~-------~~~~-~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 VIYYV-------RDGN-V---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHH-------hcCC-C---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11111 0000 0 0111122347899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.01 Aligned_cols=265 Identities=21% Similarity=0.273 Sum_probs=201.1
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecC------
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 141 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 141 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999999999999999987532 22345678899999999999999999987543
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
...|+||||++ ++|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999997 577777742 4788999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH-Hhhh------
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWAR------ 294 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~------ 294 (399)
++..... ........||..|+|||++.+..++.++|||||||++|+|++|+.||............ ....
T Consensus 172 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9975322 11223356899999999999999999999999999999999999999765443221111 0000
Q ss_pred ---------hhhcccccccccc----Cccc----cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 295 ---------PLFQDRTRHSLIA----DPEL----QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 295 ---------~~~~~~~~~~~~~----~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
............. .+.. ...........+.+|+.+||+.||.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000000 0000 000111123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=355.50 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=207.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.+|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4799999999999999999999999999999999754222 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 149 EYMPLGSVEDHLHDLSP-------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
||++|++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999874311 1234667788999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCC----------------cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHH
Q 015816 222 LAKLGPVGDN----------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (399)
Q Consensus 222 ~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 285 (399)
++........ .......+||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9975411110 001123469999999999999999999999999999999999999997643221
Q ss_pred HHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHh
Q 015816 286 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-VIADVVTALAYLAS 353 (399)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~~ 353 (399)
..... .. ..+.... .....+..+.+++.+||+.||++|| +++++++.|+.+..
T Consensus 239 i~~~~-----~i---------~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYRD-----VI---------LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhh-----hc---------cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11000 00 0000000 0012233788899999999999996 66777788877654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=347.41 Aligned_cols=264 Identities=20% Similarity=0.256 Sum_probs=196.7
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC------CCccceEEEEecC-
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH------PNLVNLIGYCADG- 141 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~~~~- 141 (399)
....+|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+..|+.+++.++| ++++.+++++...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 34578999999999999999999999999999999986432 223445667777777654 4588898988764
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCC-------
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGY------- 213 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~------- 213 (399)
..+|+|||++ +++|.+++.. ...+++..+..|+.||+.||.|||+ .+ ||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 5789999988 6889998876 5679999999999999999999998 58 99999999999998765
Q ss_pred ---------ceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHH
Q 015816 214 ---------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (399)
Q Consensus 214 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 284 (399)
.+||+|||.+... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||+.....
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 4999999987532 11233467999999999999999999999999999999999999999876543
Q ss_pred HHHHHHHhhhhhhc-----------------cccccccccCccc----cCCCC---hHhHHHHHHHHHHccccCCCCCCC
Q 015816 285 AEQSLVAWARPLFQ-----------------DRTRHSLIADPEL----QGQYP---PRGFYQALAVAAMCVHEQPDMRPV 340 (399)
Q Consensus 285 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~----~~~~~---~~~~~~l~~li~~cl~~dP~~RPs 340 (399)
............+. .........++.. ..... ......+.+||.+||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 33222211110000 0000000000000 00000 001235779999999999999999
Q ss_pred HHHHHH
Q 015816 341 IADVVT 346 (399)
Q Consensus 341 ~~eil~ 346 (399)
+.|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999996
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=324.09 Aligned_cols=265 Identities=24% Similarity=0.324 Sum_probs=207.9
Q ss_pred cCHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEe-
Q 015816 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCA- 139 (399)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~- 139 (399)
+.++.+....++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445566667889999999999999999999999999999999876432 2235678899999999 6999999999874
Q ss_pred ----cCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCce
Q 015816 140 ----DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (399)
Q Consensus 140 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 215 (399)
.+...++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345789999999999999988754333567899999999999999999999999 9999999999999999999
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCcccccc-----CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~ 290 (399)
+|+|||++....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||......... .
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F 239 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h
Confidence 999999987543221 11223468999999998753 45789999999999999999999999765332111 0
Q ss_pred HhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 291 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.. .. .......+ +......+.+|+.+||+.||++|||+.++++.
T Consensus 240 ~~-----~~-~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 KI-----PR-NPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hc-----cc-cCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00 00 00000001 11122368889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.66 Aligned_cols=256 Identities=20% Similarity=0.220 Sum_probs=199.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478999999999999999999999999999999864321 12344778899999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||++||+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999752 356899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCcceeeeeccCccccCcccccc-----CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ .....
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i------~~~~~-- 225 (331)
T cd05624 155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHEE-- 225 (331)
T ss_pred CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH------HcCCC--
Confidence 211 11223569999999999865 56889999999999999999999999765432221111 00000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTA 347 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 347 (399)
...-+... ...+..+.+++.+||..++++ |+++.++++.
T Consensus 226 -~~~~p~~~----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 -RFQFPSHI----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -cccCCCcc----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00001111 122347888999999866544 4678887753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=316.34 Aligned_cols=249 Identities=31% Similarity=0.487 Sum_probs=199.6
Q ss_pred CeeeecCceEEEEEEECCCC---eEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESIN---QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.+...+ ..||+|.+...... ..+.+..|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999876554 78999998765442 3457889999999999999999999876 4568999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999986 457899999999999999999999999 9999999999999999999999999987543322211
Q ss_pred e-eeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 234 V-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 234 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||............... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-------~~--------- 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-------ER--------- 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-------Cc---------
Confidence 1 111224568999999998999999999999999999998 99999765443222111100 00
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
...+...+..+.+++.+||..+|.+||++.++++.|+.+
T Consensus 217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 011122234788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=318.48 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=204.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCe---EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.+|+..+.||+|+||.||+|.+..++. .+|+|.+..... ...+.+..|+.+++.++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467888999999999999999876554 799999865432 2345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999752 356899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCccee-eeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 228 VGDNTHVS-TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 228 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
........ .....+..|+|||++.+..++.++|||||||++|||++ |..||............ . ....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i---~----~~~~--- 228 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---N----DGFR--- 228 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---h----cCCC---
Confidence 22211111 11223457999999988899999999999999999997 99999754432211111 1 0000
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
. ..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 229 --~-----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 --L-----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --C-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00111234788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=320.59 Aligned_cols=253 Identities=28% Similarity=0.381 Sum_probs=201.5
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEecC------C
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG------D 142 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~------~ 142 (399)
....|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.++..+ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888999999999999999999999999999986543 3445688899999998 699999999998753 4
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
.+|+||||+++++|.+++.... ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 6899999999999999998632 356899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccc-----cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhh
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 297 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 297 (399)
+...... ........|+..|+|||++. +..++.++|||||||++|+|++|..||............
T Consensus 158 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~------- 228 (272)
T cd06637 158 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------- 228 (272)
T ss_pred ceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-------
Confidence 8753221 11223456899999999885 346888999999999999999999999754332211111
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... . .... ........+.+|+.+||..+|.+|||+.++++
T Consensus 229 ~~~-~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRN-P-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcC-C-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 0 0000 01112337889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=315.74 Aligned_cols=250 Identities=31% Similarity=0.479 Sum_probs=206.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 357889999999999999999876 78999999976543 456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999997632 236899999999999999999999999 9999999999999999999999999997542111
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
....++..|+|||.+....++.++||||||+++|+|++ |..||............ .. ... .
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~----~~~------~ 218 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV---EK----GYR------M 218 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---hc----CCC------C
Confidence 12335678999999988899999999999999999997 99999765443221111 10 000 0
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
..+...+..+.+++.+||..+|++|||+.++++.|+.
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 ----EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ----CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1111223478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=326.41 Aligned_cols=256 Identities=21% Similarity=0.234 Sum_probs=199.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||++.++.+++.||+|++.+... .....+..|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368899999999999999999999999999999864321 12344778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999752 356899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcceeeeeccCccccCccccc-----cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
.. ........||+.|+|||++. ...++.++|||||||++|||++|+.||............ .....
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i------~~~~~-- 225 (332)
T cd05623 155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHKE-- 225 (332)
T ss_pred CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH------hCCCc--
Confidence 11 11223356999999999985 356889999999999999999999999765433221111 00000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTA 347 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 347 (399)
....+.. .......+.+|+.+|+..+++. |+++.++++.
T Consensus 226 -~~~~p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 -RFQFPAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -cccCCCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000111 1122347888999988665444 6899998865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=315.37 Aligned_cols=249 Identities=27% Similarity=0.384 Sum_probs=197.3
Q ss_pred eeeecCceEEEEEEEC--CCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCC
Q 015816 79 LLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 155 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 155 (399)
.||+|+||.||+|.+. ..+..||+|++...... ..+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999775 44567999998655332 23568899999999999999999998864 57899999999999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcce-
Q 015816 156 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV- 234 (399)
Q Consensus 156 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~- 234 (399)
|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998742 457899999999999999999999999 99999999999999999999999999875332222111
Q ss_pred eeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 235 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 235 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||............... . ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------~----------~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-------K----------RL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-------C----------CC
Confidence 111223578999999988889999999999999999996 99999765443322211100 0 01
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
.+++..+.++.+++.+||..+|++||++.+|++.|..+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12223345888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=331.00 Aligned_cols=264 Identities=20% Similarity=0.295 Sum_probs=199.5
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecC-----
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 141 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 141 (399)
...++|++.+.||.|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 345789999999999999999999999999999999865422 2335677899999999999999999987543
Q ss_pred -CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 142 -DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 142 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
...|++++++ +++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 3568999988 689988876 356999999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH-Hhhhh---
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARP--- 295 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~--- 295 (399)
|++...... .....||..|+|||++.+ ..++.++|||||||++|+|++|..||............ .....
T Consensus 163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999753221 233468999999999876 57899999999999999999999999765432221111 00000
Q ss_pred hhccccc----------cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 296 LFQDRTR----------HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 296 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
....... ........+. .........+.+|+.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000000000 0000112357889999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=316.46 Aligned_cols=254 Identities=30% Similarity=0.459 Sum_probs=204.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|..+. ++.||+|.+..... ....+.+|+.+++.++||||+++++++. .+..++||||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4578899999999999999998765 78899999875433 3567889999999999999999999874 4578999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999986532 456899999999999999999999999 9999999999999999999999999987533211
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........++..|+|||++....++.++||||||+++|+|++ |+.||............ . .... .
T Consensus 157 -~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~----~~~~------~ 222 (260)
T cd05067 157 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL---E----RGYR------M 222 (260)
T ss_pred -cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---H----cCCC------C
Confidence 111122345678999999998899999999999999999999 99999765433222111 0 0000 0
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
..+...+..+.+++.+||+.+|++||++++++..|+.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1111223478999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=321.98 Aligned_cols=266 Identities=22% Similarity=0.269 Sum_probs=201.6
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|++.+.||.|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 47888999999999999999999999999999864422 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
++ ++|.+++..... ...+++..++.++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP- 154 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence 98 689888875432 357899999999999999999999999 999999999999999999999999998753222
Q ss_pred CcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH-Hhhhhhhccc-------c
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPLFQDR-------T 301 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~~~-------~ 301 (399)
........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||............ .......... .
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 111223457889999998865 45789999999999999999999999765433221110 0000000000 0
Q ss_pred ----ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 302 ----RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 302 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.......... .........++.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0011123347789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=318.60 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=207.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCe----EEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.+|++.+.||+|+||.||+|.++.+|. .||+|.+...... ....+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568889999999999999999876654 5899988655432 34568899999999999999999999987 78999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.++|+|||++...
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999752 345899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.............++..|+|||.+....++.++|||||||++||+++ |..||............. ... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~---~ 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-------KGE---R 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------CCC---C
Confidence 43222211122224568999999988899999999999999999998 999998765433221111 000 0
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
. ..+......+.+++.+||..||..||++.++++.|..+..
T Consensus 230 ~-------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 L-------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred C-------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 1111122368889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.59 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=207.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
..+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36799999999999999999999988999999999766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999864 46899999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......+++.|+|||.+.+..++.++|||||||++|+|++|..||........... .... . .+.
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-------~~~~-~-----~~~ 234 (297)
T cd06656 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATN-G-----TPE 234 (297)
T ss_pred --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------eccC-C-----CCC
Confidence 112234688999999999988999999999999999999999999965432111000 0000 0 000
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122233467889999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.46 Aligned_cols=263 Identities=21% Similarity=0.228 Sum_probs=200.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC--CCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
..+|++.+.||.|+||.||+|... .++..||+|.+... ..+.+|+.+++.++||||+++++++......|+||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999864 34678999987543 23567999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|++. ++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 166 e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9996 788888854 567999999999999999999999999 99999999999999999999999999875443
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHH-HHHHHhhhhhhcccc-ccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRT-RHSLI 306 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~ 306 (399)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+..... .+.... .....
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~ 316 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQN 316 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCc
Confidence 3333333346799999999999999999999999999999999999999965432111 11111000 000000 00000
Q ss_pred -----------cCccccCCCC-------hHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 307 -----------ADPELQGQYP-------PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 307 -----------~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
........+. ......+.++|.+||..||++|||+.+++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 0113467889999999999999999999965
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.90 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=205.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||.|+||.||+|.+..++..||+|.+........+.+..|+.+++.++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56889999999999999999999889999999987655455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 999999998752 356999999999999999999999999 999999999999999999999999988653221
Q ss_pred cceeeeeccCccccCccccc-----cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 232 THVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
........|+..|+|||++. ...++.++|||||||++|+|++|+.||............ . .. .....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~--~----~~--~~~~~ 228 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI--L----KS--EPPTL 228 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH--h----cC--CCCCc
Confidence 11223456899999999874 345788999999999999999999999765433221111 0 00 00000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..+......+.+++..||+.+|.+||++.++++.
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 -------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1111223478899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=317.38 Aligned_cols=252 Identities=31% Similarity=0.460 Sum_probs=197.6
Q ss_pred CeeeecCceEEEEEEECCCCe--EEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQ--DVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.+..++. .+++|.+..... .....+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999987775 468888764322 2345688899999999 799999999999999999999999999
Q ss_pred CCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 154 GSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 154 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999975321 1235889999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||............ ...
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-------~~~ 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------PQG 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-------hCC
Confidence 9853111 111111234567999999988899999999999999999997 99999754432211111 000
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
.. . ..+......+.+|+.+||+.||.+|||+.+++..|..+.
T Consensus 228 ~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YR------L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC------C----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 0 011112337889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=322.91 Aligned_cols=272 Identities=26% Similarity=0.390 Sum_probs=203.3
Q ss_pred cCCCCCCeeeecCceEEEEEEE----CCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEec--CCeeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 145 (399)
.+|++.+.||+|+||.||+|.. ..++..||+|.+........+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788999999999999999974 45688999999876655555678899999999999999999998754 34689
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999752 346899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcce-eeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh-hhhcccccc
Q 015816 226 GPVGDNTHV-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PLFQDRTRH 303 (399)
Q Consensus 226 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~ 303 (399)
......... .....++..|+|||++.+..++.++|||||||++|||++|..++................ ...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 235 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH--L 235 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH--H
Confidence 433222111 111223456999999998899999999999999999999887764332211100000000 000000 0
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
............+...+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000000011122344789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=317.11 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=204.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCC---eEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESIN---QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.+|++.+.||+|+||.||+|.++.++ ..+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999986443 4799999865432 2345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++... ...+++.+++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999752 346899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCccee-eeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 228 VGDNTHVS-TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 228 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
........ ....++..|+|||.+.+..++.++|||||||++|++++ |..||............ .... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~---~~~~----~--- 227 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI---EEGY----R--- 227 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH---hCCC----c---
Confidence 32211111 11223568999999998899999999999999999886 99999765433221111 1000 0
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
. ..+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 228 ---~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ---L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00111234788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=326.98 Aligned_cols=263 Identities=27% Similarity=0.403 Sum_probs=207.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCC-------CeEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecCC
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESI-------NQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 142 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 142 (399)
.+|++.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.+++++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 4689999999999999999986432 24689998864322 2346788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~ 210 (399)
..+++|||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 99999999999999999975321 1235888999999999999999999999 99999999999999
Q ss_pred CCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHH
Q 015816 211 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (399)
Q Consensus 211 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~ 289 (399)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999875432222212222334567999999999999999999999999999998 8899876544332221
Q ss_pred HHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 290 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.. .... ...+......+.+++.+||+.+|.+|||+.++++.|..+...
T Consensus 249 ~~-------~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 249 LK-------EGHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HH-------cCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 11 0000 011122234788999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=329.29 Aligned_cols=263 Identities=28% Similarity=0.421 Sum_probs=202.6
Q ss_pred cCCCCCCeeeecCceEEEEEEE-----CCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCccceEEEEecC-Ce
Q 015816 72 KNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG-DQ 143 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~ 143 (399)
++|++.+.||+|+||.||+|.+ ..+++.||||++...... ....+.+|+.++..+ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5799999999999999999985 345789999999754322 335688899999999 689999999988654 46
Q ss_pred eEEEEEecCCCCHHHHhhccCC----------------------------------------------------------
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSP---------------------------------------------------------- 165 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 165 (399)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999864210
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeecc
Q 015816 166 -----GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240 (399)
Q Consensus 166 -----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 240 (399)
....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 0124788889999999999999999999 99999999999999999999999999875322221111222345
Q ss_pred CccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHh
Q 015816 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRG 319 (399)
Q Consensus 241 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (399)
+..|+|||++.+..++.++|||||||++|+|++ |..||........ .... ....... .. +...
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~----~~~~~~~---~~-------~~~~ 307 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRR----LKEGTRM---RA-------PDYT 307 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHH----HhccCCC---CC-------CCCC
Confidence 678999999988899999999999999999997 9999875432211 1100 0000000 00 1111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 320 FYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 320 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
...+.+++..||+.||++|||+.++++.|+.+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2368889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=341.31 Aligned_cols=263 Identities=20% Similarity=0.216 Sum_probs=198.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
..|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|++++|||||++++++......++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 46999999999999999999999999999999642 234568999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
. ++|..++... ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.++|+|||++........
T Consensus 243 ~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 R-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred C-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 6 7888888652 346999999999999999999999999 99999999999999999999999999975432222
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchH--------HHHHHHHHhhhhhhcccccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA--------AAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~~ 303 (399)
........||..|+|||++.+..++.++|||||||+||||++|..|+..... .....++.............
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 2223345699999999999999999999999999999999998765432111 11111111111000000000
Q ss_pred -------------ccccCccccCCCCh---HhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 304 -------------SLIADPELQGQYPP---RGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 304 -------------~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.....+........ .....+.+||.+||+.||.+|||+.|+|+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000000000 112367889999999999999999999963
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=340.96 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=212.2
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecC
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 152 (399)
.|.+...||.|+||.||+|..+.++...|.|+|........+.++-||+||..+.||+||++++.|...+.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 35667789999999999999999999999999987766677889999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCc
Q 015816 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (399)
Q Consensus 153 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 232 (399)
||-+...+.+. ...|++.++..+++|++.||.|||+++ |||||||..|||++-+|.|+|+|||++.. .....
T Consensus 113 GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK--n~~t~ 184 (1187)
T KOG0579|consen 113 GGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK--NKSTR 184 (1187)
T ss_pred CchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc--chhHH
Confidence 99998888764 678999999999999999999999999 99999999999999999999999999864 22222
Q ss_pred ceeeeeccCccccCcccc-----ccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 233 HVSTRVMGTYGYCAPEYA-----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.....+.|||+|||||+. ...+|+.++||||||++|.||..+.+|....+.....-.+....|
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP------------ 252 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP------------ 252 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC------------
Confidence 334567899999999976 457899999999999999999999999887665443322211111
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
|. .-.|......+.+++.+||..||..||+++++++
T Consensus 253 -PT--LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 253 -PT--LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -Cc--ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 01 1224455668899999999999999999999985
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=314.86 Aligned_cols=248 Identities=28% Similarity=0.405 Sum_probs=200.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEe-cCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~ 150 (399)
++|++.+.||+|+||.||+|... +..||+|.+.... ..+.+.+|+.+++.++|+|++++++++. .....++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46889999999999999999876 6789999986432 3457889999999999999999999764 55678999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999997632 345899999999999999999999999 9999999999999999999999999987432211
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||............ .... .+
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-------~~~~------~~ 218 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGY------KM 218 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcCC------CC
Confidence 22335678999999998899999999999999999998 99998754332211111 0000 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
..++..+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 ----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1112233478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=314.51 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=203.2
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEec-CCeeEEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYE 149 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e 149 (399)
+|++.+.||.|++|.||++.++.+++.||+|.+..... ...+.+..|+.+++.++|||++++++.+.. ...+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48899999999999999999999899999999865432 234568889999999999999999998764 446799999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++++|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997632 456899999999999999999999999 999999999999999999999999998754222
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
. .......|++.|+|||++.+..++.++|||||||++|+|++|+.||............ .... .+
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~------~~~~-------~~ 220 (257)
T cd08223 156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI------IEGK-------LP 220 (257)
T ss_pred C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------HhcC-------CC
Confidence 1 1223456889999999999999999999999999999999999999765432211110 0000 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+......+.+++.+||+.||++||++.++++
T Consensus 221 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 ----PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ----CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 112223347889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=315.93 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=194.8
Q ss_pred CeeeecCceEEEEEEEC--CCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCC
Q 015816 78 SLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 154 (399)
+.||+|+||.||+|... .++..+|+|.+...... ....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35999999999999865 34567999998755432 3356888999999999999999999999999999999999999
Q ss_pred CHHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 155 SVEDHLHDLSP-GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 155 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
+|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975332 1235677788899999999999999999 9999999999999999999999999987532222111
Q ss_pred eeeeeccCccccCccccccC-------CCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 234 VSTRVMGTYGYCAPEYAKTG-------QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
......++..|+|||++.+. .++.++|||||||++|||++ |..||............ .. .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~--~~------~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT--VR------EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH--hh------cccCC
Confidence 12234578889999988542 35789999999999999996 99999765443321111 00 00011
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
...+.+.... ...+.+++..|| .+|++|||+.+|++.|+
T Consensus 230 ~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1122222122 236778999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=319.18 Aligned_cols=266 Identities=26% Similarity=0.313 Sum_probs=204.0
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||.||+|.++.+++.||+|++..... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 368899999999999999999999999999999864432 223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++++|..++.. ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9998888877654 456999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh-hhhhc-------cc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLFQ-------DR 300 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~-------~~ 300 (399)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+........ ..... ..
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 1223457889999999865 56889999999999999999999999765543322111110 00000 00
Q ss_pred cccccccCccccCC-----CChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADPELQGQ-----YPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
........+..... ..+.....+.+|+.+||+.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000110000 01122457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=318.10 Aligned_cols=250 Identities=28% Similarity=0.393 Sum_probs=205.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999999999999999987543 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.. .++++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999975 37899999999999999999999999 9999999999999999999999999987643221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......|+..|+|||.+.+..++.++|||||||++|+|++|..||............ . .. . .+.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~----~~-~-----~~~ 217 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI---P----KN-N-----PPS 217 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh---h----hc-C-----CCC
Confidence 1223356888999999999888999999999999999999999999765432211111 0 00 0 001
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
+... .....+.+++.+||..+|++|||++++++.
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 023378889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=317.68 Aligned_cols=252 Identities=30% Similarity=0.441 Sum_probs=200.3
Q ss_pred CeeeecCceEEEEEEECCCC------eEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 78 SLLGEGGFGRVYKGYLESIN------QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+.||+|+||.||+|.++... +.+|||.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36999999999999986544 7899998865432 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-----ceEEecccC
Q 015816 151 MPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-----HPKLSDFGL 222 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~Dfg~ 222 (399)
+++++|.+++..... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975321 1245789999999999999999999999 99999999999999877 899999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccc
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRT 301 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (399)
+................++..|+|||++.+..++.++|||||||++|+|++ |..||............ . ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~---~----~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV---T----AGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH---h----cCC
Confidence 875432222222223345788999999999999999999999999999998 99999765433221111 0 000
Q ss_pred ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 302 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
....+...+..+.+++.+||..+|.+||++.++++.|.
T Consensus 231 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00112223457889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=312.22 Aligned_cols=248 Identities=30% Similarity=0.444 Sum_probs=200.6
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
+.||.|+||.||+|.+.. ++.||+|.+...... ....+..|+.++++++||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 369999999999999988 999999998765443 446788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceee
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (399)
.+++... ...+++..++.++.|++.||.|||+++ ++||||+|+|||++.++.++|+|||++.............
T Consensus 80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9999752 346889999999999999999999999 9999999999999999999999999987532211111111
Q ss_pred eeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCC
Q 015816 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY 315 (399)
Q Consensus 237 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||............... . . ...
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~---~-------~-------~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG---Y-------R-------MPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC---C-------C-------CCC
Confidence 2234567999999988899999999999999999999 88898765443222211100 0 0 011
Q ss_pred ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 316 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 316 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
+...+..+.+++.+||..+|.+|||+.++++.|.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1222347899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=314.20 Aligned_cols=250 Identities=27% Similarity=0.372 Sum_probs=206.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||.|+||.||+|.+..++..|++|.+..... ...+.+|+.+++.++||||+++++++.+....|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999998899999999865432 567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 81 GAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 999999998652 457899999999999999999999999 9999999999999999999999999987543221
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||............ ... ...
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------~~~--------~~~ 217 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------PNK--------PPP 217 (256)
T ss_pred -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------ccC--------CCC
Confidence 1223345889999999999889999999999999999999999999765432211110 000 000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
....+......+.+++.+||+.||++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01112223347899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=314.29 Aligned_cols=255 Identities=30% Similarity=0.457 Sum_probs=206.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||.|+||.||+|.++. +..||||.+..... ....+..|+.+++.++||||+++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4679999999999999999999875 57899999875433 456788999999999999999999999998999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.... ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999997632 356899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........++..|+|||.+.+..++.++|||||||++|+|++ |+.||............ ...+.
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~---~~~~~----------- 222 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV---ERGYR----------- 222 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCCC-----------
Confidence 111122235678999999998899999999999999999998 99999765432221111 10000
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
...+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 ---MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00111123478899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=336.38 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=208.0
Q ss_pred eeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCHHH
Q 015816 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 158 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~ 158 (399)
+||+|.||+||-|++..+...+|||-+........+-+..||.+-+.|+|.|||+++|.+.+++.+-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999999999999999987777777778899999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-CCceEEecccCCccCCCCCCccee
Q 015816 159 HLHDLSPGKKPL--DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVS 235 (399)
Q Consensus 159 ~l~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 235 (399)
+|... =+++ .+...-.+..||++||.|||.+. |||||||-+||||+. .|.+||+|||.++.. ..-...+
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRL--AginP~T 733 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRL--AGINPCT 733 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhh--ccCCccc
Confidence 99862 3566 78888899999999999999999 999999999999985 689999999999863 3334455
Q ss_pred eeeccCccccCccccccC--CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 236 TRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 236 ~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.++.||..|||||++..+ .|+.++|||||||++.||.||++||.......- ..|.-.. -....
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGm-------yKvHP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGM-------YKVHP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcc-------eecCC
Confidence 667899999999999654 689999999999999999999999976543211 1111110 01123
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+|.....+...+|.+|+..||..||++.++|+
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 456677788999999999999999999999996
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=320.82 Aligned_cols=263 Identities=24% Similarity=0.396 Sum_probs=203.0
Q ss_pred cCCCCCCeeeecCceEEEEEEE----CCCCeEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecC--Cee
Q 015816 72 KNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 144 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 144 (399)
+.|++.+.||+|+||.||+|.. ..++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999984 4568899999986543 22345788999999999999999999998775 568
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||++|++|.+++... ...+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999999652 346899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCc-ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHH---------HHHHhhh
Q 015816 225 LGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ---------SLVAWAR 294 (399)
Q Consensus 225 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---------~~~~~~~ 294 (399)
........ .......++..|+|||++.+..++.++|||||||++|+|++++.|+......... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV- 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-
Confidence 54322211 1122345677899999998889999999999999999999987765322111000 000000
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
....... ....+...+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 237 ~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000 0011122344899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=313.43 Aligned_cols=250 Identities=28% Similarity=0.420 Sum_probs=201.4
Q ss_pred CeeeecCceEEEEEEECC-CC--eEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLES-IN--QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|++|.||+|.+.. .+ ..||||.+..... ...+.+..|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999865 23 3699999987655 455678999999999999999999999988 889999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCc-
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT- 232 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 232 (399)
++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999986321 56899999999999999999999999 999999999999999999999999999764332211
Q ss_pred ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||.............. .. ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------~~---~~~----- 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK------EG---ERL----- 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh------cC---CcC-----
Confidence 11123457789999999998899999999999999999998 9999975544332211110 00 000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011122347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=313.04 Aligned_cols=253 Identities=29% Similarity=0.409 Sum_probs=201.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.+|++...||.|+||.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++.++||||+++++++. ....++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 4588899999999999999998764 469999876543 23467889999999999999999999875 45689999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999997532 345899999999999999999999999 99999999999999999999999999975432211
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||........... ......
T Consensus 158 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~~~~~------------ 221 (260)
T cd05069 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ---VERGYR------------ 221 (260)
T ss_pred -cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCCC------------
Confidence 11122346678999999988899999999999999999999 8999976543322111 110000
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
...+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112233478999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=325.44 Aligned_cols=265 Identities=17% Similarity=0.193 Sum_probs=197.0
Q ss_pred CCCeeeec--CceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 76 SESLLGEG--GFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 76 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
+.++||+| +|++||++.++.+|+.||||.+...... ..+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999999999999999998754322 2345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999996532 345899999999999999999999999 99999999999999999999999986543211100
Q ss_pred -c----ceeeeeccCccccCcccccc--CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc--
Q 015816 232 -T----HVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR-- 302 (399)
Q Consensus 232 -~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 302 (399)
. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||............ ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH--hcCCcccccccc
Confidence 0 01112346778999999875 46899999999999999999999999754332211000 0000000000
Q ss_pred -----------cccccCcc-----------------ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 303 -----------HSLIADPE-----------------LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 303 -----------~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.....+.. ............+.+|+.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000000 0000111223478899999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=316.90 Aligned_cols=248 Identities=26% Similarity=0.370 Sum_probs=209.8
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
|.++..||+|+||.||+|.++.+|+.+|||.+.-. .+.+++..|+.||.++..|++|++||.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 66778899999999999999999999999998643 3567899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|++.+.+..+ ..+|++.++..+++..+.||+|||... -+|||||..|||++.+|..||+|||++-.. .+...
T Consensus 113 GSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQL--TDTMA 184 (502)
T KOG0574|consen 113 GSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQL--TDTMA 184 (502)
T ss_pred CcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchh--hhhHH
Confidence 9999999863 678999999999999999999999998 899999999999999999999999998642 22223
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
....+.||+.|||||++..-.|+.++||||||++..||.-|++||....... ..|-.. ..|...-
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------AIFMIP------T~PPPTF 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------AIFMIP------TKPPPTF 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------eeEecc------CCCCCCC
Confidence 3445789999999999999999999999999999999999999997643321 111111 1111112
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..|.....++.+++++||-..|++|-|+.++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 334455668899999999999999999998876
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=315.21 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=202.2
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc----------chHHHHHHHHHHhhcCCCCccceEEEEecCC
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----------GNREFLVEVLMLSLLHHPNLVNLIGYCADGD 142 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 142 (399)
+|.+.+.||.|+||.||+|....+++.||+|.+...... ..+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999999988999999987532111 1235778999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999986 467899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccccCC--CCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
+................|+..|+|||.+.... ++.++|+||||+++|+|++|..||......... ... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~----~~~~ 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM--FKL----GNKR 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH--HHh----hccc
Confidence 87543222222223356889999999987654 889999999999999999999999654332111 000 0000
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. .+.+........+..+.+++.+||+.+|+.|||+.++++
T Consensus 229 --~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 --S----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred --c----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0 001111111223458899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=315.40 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=202.6
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34555666678999999999999999989999999987665556677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-CCceEEecccCCcc
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPL--DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKL 225 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~ 225 (399)
||+++++|.+++... ...+ ++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++..
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999752 2345 78889999999999999999999 999999999999986 67999999999875
Q ss_pred CCCCCCcceeeeeccCccccCccccccC--CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
..... .......|+..|+|||++.+. .++.++||||||+++|+|++|..||.......... +......
T Consensus 159 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~~----- 228 (268)
T cd06624 159 LAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMFK----- 228 (268)
T ss_pred cccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhhc-----
Confidence 32211 112234588999999998654 37899999999999999999999996543211110 0000000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+ ..+......+.+++.+||+.+|.+|||+.+++.
T Consensus 229 ---~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ---IHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---cCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011 122233347889999999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=312.15 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=206.9
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|++.+.||.|+||.||.+....+++.+++|.+.... ......+.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999999999999999986543 23346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997632 356899999999999999999999999 9999999999999999999999999987543222
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||............ ... ...
T Consensus 156 --~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~------~~~--~~~------ 219 (256)
T cd08221 156 --SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI------VQG--NYT------ 219 (256)
T ss_pred --ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HcC--CCC------
Confidence 1223456899999999998888999999999999999999999999765432221111 000 000
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..+......+.+++.+||+.+|.+||++.++++.
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 ---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0012223478889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=316.07 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=205.2
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.|+..+.||.|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 47778899999999999999998899999999875432 33456888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.. .++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 99999999863 46899999999999999999999999 9999999999999999999999999987533222
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......++..|+|||++.+..++.++|+|||||++|||++|..||............ .. ..
T Consensus 156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~----------~~ 217 (277)
T cd06640 156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PK----------NN 217 (277)
T ss_pred -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------hc----------CC
Confidence 1122345788999999998888999999999999999999999999765432211110 00 00
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
........+..+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 012223345578899999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.24 Aligned_cols=240 Identities=28% Similarity=0.477 Sum_probs=192.3
Q ss_pred CeeeecCceEEEEEEECCCCe-------EEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 78 SLLGEGGFGRVYKGYLESINQ-------DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+.||.|+||.||+|.++..+. .||+|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999999866544 3888887655444456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc--------eEEecccC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--------PKLSDFGL 222 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~kl~Dfg~ 222 (399)
+++|+|..++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999752 346899999999999999999999999 999999999999987765 69999998
Q ss_pred CccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCC-CCcccchHHHHHHHHHhhhhhhccc
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
+..... .....++..|+|||++.+ ..++.++|||||||++|+|++|. .||............ ...
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-------~~~ 221 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-------EDR 221 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------Hcc
Confidence 864221 223457889999999976 45899999999999999999985 666543332211111 000
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
...+......+.+|+.+||+.||++|||+.++++.|
T Consensus 222 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 ------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112222334788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=319.47 Aligned_cols=267 Identities=24% Similarity=0.308 Sum_probs=205.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368899999999999999999999999999999865422 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|++++.+..+... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998766665544 456899999999999999999999999 999999999999999999999999998764333
Q ss_pred CCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc--------c
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD--------R 300 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~ 300 (399)
.. .......++..|+|||++.+. .++.++||||||+++|+|++|.+||..................+.. .
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 22 122335678999999999887 8899999999999999999999999765443222111110000000 0
Q ss_pred ccccc-----ccCcc-ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSL-----IADPE-LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~-----~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..... ...+. ....++...+..+.+++.+||..+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 00000 001122223568899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=333.11 Aligned_cols=244 Identities=32% Similarity=0.426 Sum_probs=205.7
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
|.-++.||.|+||.||.|++..+.+.||||++.-..... ...++.|+..|.+++|||+|.+.|+|..+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 556678999999999999999999999999998665543 35689999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
|- |+-.|.+.-. ..++-+.++..|+.+.+.||+|||+.+ .||||||..|||+++.|.|||+|||.+....
T Consensus 108 Cl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 108 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA--- 177 (948)
T ss_pred Hh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC---
Confidence 96 7888888653 578999999999999999999999999 9999999999999999999999999987532
Q ss_pred CcceeeeeccCccccCcccc---ccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 231 NTHVSTRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
....++|||.|||||++ ..+.|+-++||||||++..||.-.++|+...+...-.-.+....
T Consensus 178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe------------- 241 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------- 241 (948)
T ss_pred ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-------------
Confidence 23457899999999988 45899999999999999999999999987765543322221111
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.|.+. .++....+..++..||++-|.+|||.++++.
T Consensus 242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11111 2345567888999999999999999998875
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=321.16 Aligned_cols=259 Identities=29% Similarity=0.468 Sum_probs=204.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCe----EEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.+|+..+.||+|+||.||+|.+..++. .||+|.+...... ....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 567888999999999999999877676 4788887654322 234678899999999999999999998764 5679
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
++||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998752 346899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.............++..|+|||++.+..++.++|||||||++|||++ |..||............. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~--- 229 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-------KGER--- 229 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCC---
Confidence 32222111222345778999999998999999999999999999997 999997654332222211 0000
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
. ..++.....+.+++..||..+|++||++.++++.|..+...
T Consensus 230 ~-------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 L-------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 00111234788899999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=319.11 Aligned_cols=263 Identities=25% Similarity=0.319 Sum_probs=206.0
Q ss_pred CHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEecC
Q 015816 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (399)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 141 (399)
.+.++....++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.++..+ +||||+++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 33444556788999999999999999999999999999999986532 2245677899999988 799999999998754
Q ss_pred -----CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceE
Q 015816 142 -----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (399)
Q Consensus 142 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 216 (399)
...++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3589999999999999998754434567899999999999999999999999 99999999999999999999
Q ss_pred EecccCCccCCCCCCcceeeeeccCccccCccccccC-----CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHH
Q 015816 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 291 (399)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~ 291 (399)
|+|||++........ ......|+..|+|||++... .++.++|||||||++|+|++|+.||......... ..
T Consensus 169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~--~~ 244 (291)
T cd06639 169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL--FK 244 (291)
T ss_pred Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--HH
Confidence 999999875332211 12234588999999987543 3689999999999999999999999765432211 11
Q ss_pred hhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 292 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... .. ..... .+......+.+++.+||+.+|++||++.++++
T Consensus 245 ~~~----~~--~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 IPR----NP--PPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred Hhc----CC--CCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 100 00 00000 11122347889999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=328.47 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=219.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcch-HHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
....+.+.||+|-||.|.+|.... +..||||.++....... .+|..|+++|.+|+|||||.++++|..++.+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 356788999999999999999876 79999999987765544 7899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++|+|.+++..... ..+.......|+.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||+++-...++
T Consensus 617 mEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999987432 22455667889999999999999999 9999999999999999999999999999766677
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh--CCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
........+-..+|||||.+..++++.++|||+||+++||+++ ...||.....+...+.. ...+.....
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~---~~~~~~~~~------ 762 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA---GEFFRDQGR------ 762 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh---hhhcCCCCc------
Confidence 6766667778899999999999999999999999999999876 67888766554433222 222222221
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
......|+-.+..+.+++..||..+-.+||+++++...|+..
T Consensus 763 -~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 -QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122233444556889999999999999999999999887753
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=312.61 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=205.8
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEec--CCeeEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVY 148 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~ 148 (399)
+|++.+.||.|+||.||+|.+..++..||+|.+...... ..+.+..|+.+++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999999999999999998754332 33568889999999999999999998754 45679999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-----DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
||+++++|.+++........++++..++.++.||+.||.||| +.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999875444578999999999999999999999 777 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
....... .......|+..|+|||++.+..++.++||||||+++|+|++|..||........... .. ...
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~----~~~-- 226 (265)
T cd08217 158 KILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK---IK----EGK-- 226 (265)
T ss_pred ccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH---Hh----cCC--
Confidence 8643322 112334689999999999988899999999999999999999999986543221111 10 000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. ...+......+.+++.+||+.+|++||++.+|++
T Consensus 227 ----~----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 ----F----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----C----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 1122233458899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=322.06 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=202.5
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
|.....||.|+||.||++.+..++..||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 44456799999999999999989999999998765544556788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++....... .
T Consensus 104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~ 173 (292)
T cd06658 104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P 173 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence 999998863 46899999999999999999999999 9999999999999999999999999986532221 1
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
......|+..|+|||.+.+..++.++||||||+++|||++|..||............ ...+. +.+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~~----------~~~~~ 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RDNLP----------PRVKD 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCC----------Ccccc
Confidence 223356899999999998889999999999999999999999999765432221111 00000 00000
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.......+.+++.+||..||.+|||+.++++.
T Consensus 241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01123367889999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.66 Aligned_cols=247 Identities=31% Similarity=0.444 Sum_probs=197.7
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
+.||+|+||.||+|... ++..||+|.+...... ....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36999999999999876 4889999998754332 234688899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceee
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (399)
.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~ 152 (250)
T cd05085 80 LSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSG 152 (250)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCC
Confidence 9998752 346899999999999999999999999 99999999999999999999999999864322111 1111
Q ss_pred eeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCC
Q 015816 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY 315 (399)
Q Consensus 237 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
...++..|+|||++.+..++.++||||||+++|+|++ |..||............ .... ....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~---~~~~--------------~~~~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV---EKGY--------------RMSC 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---HcCC--------------CCCC
Confidence 2234677999999998899999999999999999998 99999765433221111 0000 0011
Q ss_pred ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 316 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 316 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2223348899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=317.82 Aligned_cols=260 Identities=26% Similarity=0.361 Sum_probs=204.2
Q ss_pred CHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEec-
Q 015816 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD- 140 (399)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~- 140 (399)
+..++......|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34445556678999999999999999999999999999999986542 2345678899999988 69999999999853
Q ss_pred -----CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCce
Q 015816 141 -----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (399)
Q Consensus 141 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 215 (399)
...+|++|||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 467899999999999999997633 356889999999999999999999999 9999999999999999999
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCccccc-----cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~ 290 (399)
+|+|||++....... .......|+..|+|||.+. +..++.++|||||||++|+|++|..||............
T Consensus 161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 999999987432111 1123356899999999875 356888999999999999999999999654322211110
Q ss_pred HhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 291 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.... .+... ....+..+.+++.+||+.||.+||++.++++
T Consensus 239 -------~~~~------~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 -------PRNP------PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------hhCC------CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 00000 1112347899999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.88 Aligned_cols=256 Identities=24% Similarity=0.317 Sum_probs=203.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||++.+..+++.||+|.+..... .....+..|+.+++.++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368899999999999999999999999999999875532 22346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999976 467899999999999999999999999 99999999999999999999999999864211
Q ss_pred CCC-------------cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh
Q 015816 229 GDN-------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 295 (399)
Q Consensus 229 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 295 (399)
... ........|+..|+|||.+.+..++.++|||||||++|+|++|..||............ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~--~~- 230 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--IS- 230 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh-
Confidence 100 00111245788999999998889999999999999999999999999754332211111 00
Q ss_pred hhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
. ....+.... ..+..+.+++.+||+.||++||++.++.+.|+
T Consensus 231 ---~-----~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 231 ---D-----DIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ---c-----ccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 0 000111111 12337889999999999999999766665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=318.17 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=208.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.....+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 568888999999999999999999999999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
+++++|.+++.. .+.+++..+..++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999876 5679999999999999999999997 57 999999999999999999999999998642111
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHH-----HHHHHhhhhhhccccccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-----QSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 304 (399)
......|+..|+|||++.+..++.++|||||||++|+|++|..||........ ..............
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 12235689999999999888999999999999999999999999986543211 11111111111100
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
.+.+.. ...+..+.+|+.+||+.||++|||+.|+++....+.
T Consensus 230 ---~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 ---PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ---CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 000000 112347889999999999999999999998765444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=318.59 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=202.5
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.|+..+.||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 35667789999999999999998899999999875432 23456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999998863 56899999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......|+..|+|||++.+..++.++|||||||++|||++|..||.......... . .... ..+.+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~----~~~~------~~~~~ 221 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---L----IPKN------SPPTL 221 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---h----hhcC------CCCCC
Confidence 11223458889999999999899999999999999999999999987543221110 0 0000 01111
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12233478899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=318.06 Aligned_cols=245 Identities=27% Similarity=0.353 Sum_probs=204.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 368899999999999999999999999999999865432 23456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999986 567999999999999999999999999 99999999999999999999999999876432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|..||............ ... .
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~--------~ 214 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI------LEG--------K 214 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------hcC--------C
Confidence 2 23346899999999998888999999999999999999999999765532211111 000 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
. ..+......+.+++.+||..||.+|+ ++.++++
T Consensus 215 ~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 V----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred c----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0 11112234788999999999999998 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=315.15 Aligned_cols=256 Identities=28% Similarity=0.362 Sum_probs=203.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEecCC------
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD------ 142 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~------ 142 (399)
.+++|++.+.||.|+||.||+|.++.+++.|++|++..... ..+.+..|+.+++.+ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45789999999999999999999998899999999875433 346788999999998 6999999999997644
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
.+++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998764433567999999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCcccccc-----CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhh
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 297 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 297 (399)
+...... ........|+..|+|||++.. ..++.++|||||||++|+|++|..||............ .
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~ 231 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI------P 231 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh------h
Confidence 8653221 122233568899999998753 35788999999999999999999999754322111100 0
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... .+. ...+......+.+|+.+||..||++|||+.++++
T Consensus 232 ~~~-------~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNP-------PPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccC-------CCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 000 0111223447889999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=310.34 Aligned_cols=252 Identities=33% Similarity=0.497 Sum_probs=203.4
Q ss_pred CCCCCeeeecCceEEEEEEECCCC----eEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 74 FRSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
+++.+.||.|+||.||+|.+...+ ..||+|.+...... ....+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456788999999999999998766 89999999765443 4567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.... ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999997622 112899999999999999999999999 99999999999999999999999999976433
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
...... ....++..|+|||.+.+..++.++||||||+++|+|++ |.+||............. ....
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~----- 222 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-------KGYR----- 222 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------cCCC-----
Confidence 321111 12337789999999988899999999999999999998 888887643322211110 0000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
. ..+...+..+.+++.+||..||++|||+.++++.|
T Consensus 223 -~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -L----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -C----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 01111334788999999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=320.36 Aligned_cols=266 Identities=26% Similarity=0.335 Sum_probs=203.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||.||+|.++.+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 3688899999999999999999988999999998654322 24567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++++|..+... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999888887764 456899999999999999999999999 999999999999999999999999998753222
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc--------
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR-------- 300 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 300 (399)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||..................+...
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 12233457899999998865 457889999999999999999999997554322211111100000000
Q ss_pred cccccccCcccc-----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADPELQ-----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
........+... ....+.....+.+|+.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000000 0111233457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=328.02 Aligned_cols=252 Identities=21% Similarity=0.279 Sum_probs=201.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccC--CCcchHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 147 (399)
...|++++.||+||-+.||++...+ .+.||+|++... +......|.+|+..|.+|+ |.+||++++|-..++.+|+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3569999999999999999998765 567888776533 2234467999999999995 89999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||-+ .+|..+|.... ..++...+..++.|++.|+.++|.+| |||.||||.|+|+-. |.+||+|||+|....
T Consensus 439 mE~Gd-~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eeccc-ccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99865 79999998732 23343488899999999999999999 999999999999975 689999999999877
Q ss_pred CCCCcceeeeeccCccccCccccccC-----------CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTG-----------QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
.....-.....+||+.||+||.+... +.+.++||||||||||+|+.|++||.......
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~----------- 579 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI----------- 579 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-----------
Confidence 66666667778999999999988542 25688999999999999999999997643210
Q ss_pred hccccccccccCccccCCCChHhH-HHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGF-YQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.....+.+|.....++.... .++.+++..||+.||++||++.++|+
T Consensus 580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11223334433333332221 23999999999999999999999995
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=312.45 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=201.7
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
+|++.+.||.|+||.||+|... +++.+|+|.+...... ....+.+|+.+++.++|+||+++++++.+....++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4788999999999999999874 5889999998643221 12457889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++++|.+++.. ..++++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999976 457899999999999999999999999 999999999999999999999999998753
Q ss_pred CCC----CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 227 PVG----DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 227 ~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
... ..........|+..|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 224 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR-------- 224 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc--------
Confidence 211 11111223468999999999998899999999999999999999999997644322111110000
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+.+ +......+.+++.+||+.+|.+||++.++++
T Consensus 225 ---~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 ---GLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001111 2223347889999999999999999999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=318.89 Aligned_cols=264 Identities=28% Similarity=0.468 Sum_probs=205.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECC----CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEec--CCee
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 144 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 144 (399)
++|++.+.||+|+||.||+|.... ++..||||++...... ....+..|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 467788999999999999998653 4789999999765443 35678999999999999999999999887 5678
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999752 235999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcc-eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHH--------HHHHhhhh
Q 015816 225 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--------SLVAWARP 295 (399)
Q Consensus 225 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--------~~~~~~~~ 295 (399)
......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 644222111 111223556799999998889999999999999999999999998654322110 00000000
Q ss_pred hhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
...... ....+...+..+.+|+.+||+.+|.+|||+.+++++|+.+
T Consensus 238 ~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000000 0011112234788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=313.95 Aligned_cols=251 Identities=28% Similarity=0.391 Sum_probs=198.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-----cchHHHHHHHHHHhhcCCCCccceEEEEec--CCee
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 144 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 144 (399)
.+|+..+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468899999999999999999999999999999864321 123457889999999999999999998875 3578
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++++||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999976 456899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCC-CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 225 LGPVGD-NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 225 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
...... .........++..|+|||.+.+..++.++|||||||++|+|++|+.||............ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~------~~~---- 224 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI------ATQ---- 224 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH------hcC----
Confidence 532211 111112345889999999999888999999999999999999999999754322111100 000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+ ..+......+.+++ .||..+|++||++.++++
T Consensus 225 --~~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 --PTNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0011 11222333566677 688899999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=320.66 Aligned_cols=254 Identities=30% Similarity=0.370 Sum_probs=204.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+..|+.+++.++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688899999999999999999999999999999765433 3356888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+.+++|.+++.... ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987532 357899999999999999999999999 99999999999999999999999999865322
Q ss_pred CCCc---------------------------ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccc
Q 015816 229 GDNT---------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (399)
Q Consensus 229 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 281 (399)
.... .......||..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0111246889999999999889999999999999999999999999765
Q ss_pred hHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 015816 282 KAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV----IADVVT 346 (399)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~ 346 (399)
......... ..... .... .......+.+++.+||+.||++||+ +.+++.
T Consensus 236 ~~~~~~~~~------~~~~~--------~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDETFSNI------LKKEV--------TFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHHHHHH------hcCCc--------cCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 443221110 00000 0000 0113448899999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=313.08 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=204.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCC---CeEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.+|.+.+.||+|+||.||+|.+... ...||||...... ....+.+.+|+.+++.++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4688889999999999999987643 3469999886544 2344678899999999999999999999876 467899
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999752 345899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
... ........++..|+|||.+....++.++|||||||++|+|++ |..||............. ...
T Consensus 159 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-------~~~----- 225 (270)
T cd05056 159 DES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-------NGE----- 225 (270)
T ss_pred ccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------cCC-----
Confidence 221 111122234568999999988889999999999999999996 999997665432221110 000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
... .++..+..+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus 226 -~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 -RLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000 112223478899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=316.89 Aligned_cols=239 Identities=24% Similarity=0.383 Sum_probs=189.0
Q ss_pred eeeecCceEEEEEEECC------------------------CCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccce
Q 015816 79 LLGEGGFGRVYKGYLES------------------------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 134 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 134 (399)
.||+|+||.||+|.... ....||+|++..........+..|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998532 124589999876544445678889999999999999999
Q ss_pred EEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-
Q 015816 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY- 213 (399)
Q Consensus 135 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~- 213 (399)
++++.+....++||||+++|+|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 99999999999999999999999988642 456899999999999999999999999 99999999999997643
Q ss_pred ------ceEEecccCCccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHH-hCCCCcccchHHH
Q 015816 214 ------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEIL-SGRKAVDTSKAAA 285 (399)
Q Consensus 214 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~ 285 (399)
.++++|||++..... .....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 489999998753211 112347888999998865 56899999999999999995 6999997654332
Q ss_pred HHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 286 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
...... ... ..+......+.+++.+||+.+|++|||+.++++.|
T Consensus 230 ~~~~~~-------~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFYE-------KKH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHH-------hcc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 211110 000 00111123688899999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.38 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=204.0
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
+|+..+.||+|+||.||+|.+..+++.||+|++...... ..+.+..|+.+++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999999999999999998643311 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-ceEEecccCCcc
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKL 225 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~ 225 (399)
||||+++++|.+++.. ..++++..++.++.||+.||.|||+++ ++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999976 567899999999999999999999999 99999999999998776 599999999875
Q ss_pred CCCCCC--cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 226 GPVGDN--THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 226 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
...... ........|+..|+|||.+.+..++.++||||||+++|+|++|..||................ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~---- 226 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA---SA---- 226 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---cc----
Confidence 432211 111223468899999999988899999999999999999999999996543211111110000 00
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. .....+......+.+++.+||..+|.+||++.+++.
T Consensus 227 --~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 --T----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --C----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0 011222334457889999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=310.35 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=203.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++++.+ ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 3578899999999999999998764 5679999886432 234678899999999999999999999887 778999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999997532 456788999999999999999999999 9999999999999999999999999987543221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
. .......++..|+|||++....++.++|+|||||++|++++ |..||............ . ....
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~----~~~~------- 221 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---E----RGYR------- 221 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---h----CCCC-------
Confidence 1 11122345678999999998899999999999999999999 99999765433221111 0 0000
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
...+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 222 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112233478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=310.54 Aligned_cols=250 Identities=21% Similarity=0.331 Sum_probs=204.9
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|++.+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 58889999999999999999999999999999864322 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~- 154 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST- 154 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc-
Confidence 99999999987522 346899999999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........|+..|+|||++.+..++.++|+|||||++|+|++|..||............ .... .+
T Consensus 155 -~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--~~~~-----------~~- 219 (256)
T cd08218 155 -VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI--IRGS-----------YP- 219 (256)
T ss_pred -hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH--hcCC-----------CC-
Confidence 11122345888999999999889999999999999999999999999765433221111 0000 00
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+......+.+++.+||+.+|.+||++.++++
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 ---PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ---CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111223347899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=316.36 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=202.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++++++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999999899999999886542 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
+++++|..++.... ....+++..+..++.||+.||.|||+ .+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999887521 13478999999999999999999997 47 999999999999999999999999998643211
Q ss_pred CCcceeeeeccCccccCccccccC------CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
......++..|+|||.+.+. .++.++|||||||++|+|++|..||............. ......
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~--- 226 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---AIVDGD--- 226 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH---HHhhcC---
Confidence 12234588899999988543 35889999999999999999999996543222111110 000000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
....++.....+.+++.+||+.+|++||++.++++.
T Consensus 227 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 --------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 011222344578899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=311.02 Aligned_cols=251 Identities=26% Similarity=0.344 Sum_probs=200.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-----cchHHHHHHHHHHhhcCCCCccceEEEEecC--Cee
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 144 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 144 (399)
.+|++.+.||+|+||.||+|.+..++..||||.+..... ...+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478899999999999999999999999999998853221 1234678899999999999999999988764 467
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999976 456899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCC-cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 225 LGPVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 225 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||............ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~------~~~~--- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI------ATQP--- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH------hcCC---
Confidence 5322111 11122345889999999998888999999999999999999999999754322211100 0000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.....++.....+.+++.+||. +|++||+++++++
T Consensus 226 -------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0112233444577889999995 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=311.99 Aligned_cols=240 Identities=24% Similarity=0.379 Sum_probs=189.8
Q ss_pred CeeeecCceEEEEEEECCC------------CeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 78 SLLGEGGFGRVYKGYLESI------------NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
+.||+|+||.||+|..... ...|++|++..........+..|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986422 3358999886654444456888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc-------eEEe
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-------PKLS 218 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------~kl~ 218 (399)
+||||+++++|..++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999888642 356899999999999999999999999 999999999999987654 8999
Q ss_pred cccCCccCCCCCCcceeeeeccCccccCccccc-cCCCCcccceeehhHHHHHHH-hCCCCcccchHHHHHHHHHhhhhh
Q 015816 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEIL-SGRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
|||++..... .....++..|+|||.+. +..++.++|||||||++|+|+ +|..||............ .
T Consensus 155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~-- 223 (262)
T cd05077 155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---E-- 223 (262)
T ss_pred CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---h--
Confidence 9999864321 12245788999999886 567899999999999999998 588888654322211110 0
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
.. . .........+.+|+.+||+.||.+||++.+|++.|
T Consensus 224 --~~---~---------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 --GQ---C---------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --cC---c---------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 0 00111234788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=320.86 Aligned_cols=199 Identities=25% Similarity=0.341 Sum_probs=162.5
Q ss_pred CCeeeecCceEEEEEEEC--CCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEec--CCeeEEEEEecC
Q 015816 77 ESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMP 152 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~ 152 (399)
.+.||+|+||.||+|.++ .+++.||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999976 367899999986543 23457789999999999999999998854 456899999986
Q ss_pred CCCHHHHhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee----cCCCceEEecccCC
Q 015816 153 LGSVEDHLHDLS-----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLA 223 (399)
Q Consensus 153 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~~ 223 (399)
++|.+++.... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 68888875321 11236899999999999999999999999 9999999999999 45678999999999
Q ss_pred ccCCCCCC-cceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccc
Q 015816 224 KLGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (399)
Q Consensus 224 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~ 281 (399)
........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 75432211 111234568999999999876 46899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=311.72 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=190.8
Q ss_pred eeeecCceEEEEEEECC--CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCC
Q 015816 79 LLGEGGFGRVYKGYLES--INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 155 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 155 (399)
.||+|+||.||+|.... ....+|+|.+...... ....+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999997543 3457888887644322 23567889999999999999999999999999999999999999
Q ss_pred HHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcce
Q 015816 156 VEDHLHDLSPG-KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 234 (399)
Q Consensus 156 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 234 (399)
|.+++...... ....++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764321 233567888999999999999999999 99999999999999999999999999864322221111
Q ss_pred eeeeccCccccCccccc-------cCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 235 STRVMGTYGYCAPEYAK-------TGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 235 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.....++..|+|||++. ...++.++|||||||++|||++ |..||............ ... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~~~------~~~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV--VRE------QDIKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH--hhc------cCccC
Confidence 22334677899999874 3457889999999999999999 78888765432211110 000 00011
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
..+.+.. .....+.+++..|| .||++|||+.+|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1122222 22336677888898 59999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=309.22 Aligned_cols=248 Identities=28% Similarity=0.420 Sum_probs=203.1
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-----cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
+|+..+.||+|+||.||+|....++..|++|.+..... ...+.+.+|+.+++.++||||+++++++.+...+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999998899999999865331 2335688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999976 456899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceeeeeccCccccCccccccCC-CCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
... ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||............ .. .. .
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~--~~---~---- 219 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI--GR--SK---E---- 219 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH--Hh--cc---c----
Confidence 222 223456889999999987766 899999999999999999999999765422111110 00 00 0
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+ ..++.....+.+++.+||+.+|.+||++.+++.
T Consensus 220 -~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 -LP----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -CC----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00 112223347888999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=319.40 Aligned_cols=249 Identities=20% Similarity=0.289 Sum_probs=202.7
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
|+....||.|+||.||+|.+..+++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33445799999999999999988999999998765545556788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
++|..++.. ..+++..++.++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~ 172 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 172 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence 999988753 56899999999999999999999999 9999999999999999999999999986432221 1
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
......|+..|+|||++.+..++.++|||||||++|||++|+.||............ ... . .. . .
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~----~-~~---~----~ 237 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL---RDS----P-PP---K----L 237 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hcc----C-CC---C----c
Confidence 223356899999999999889999999999999999999999999755432221111 000 0 00 0 0
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0011223368889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=315.45 Aligned_cols=261 Identities=26% Similarity=0.314 Sum_probs=205.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecC--CeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~ 148 (399)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... .....+.+|+++++.++||||+++++++.+. ..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 367888999999999999999999999999999875433 2346688999999999999999999988653 4689999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.........+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988754444567899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchH--HHHHHHHHhhhhhhccccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA--AAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ....+...+..... .....
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 229 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP----NPELK 229 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC----chhhc
Confidence 11 1234578899999999999999999999999999999999999976532 11112222211100 00000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..+... ......+.+++.+||..+|.+|||+.|+++.
T Consensus 230 ~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DEPGNG----IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cCCCCC----CchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000000 1123478899999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=309.96 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=191.3
Q ss_pred eeeecCceEEEEEEECCC--CeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCC
Q 015816 79 LLGEGGFGRVYKGYLESI--NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 155 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 155 (399)
.||+|+||.||+|..... ...+++|.+..... ...+.+.+|+.+++.++||||+++++.+.+....|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999976432 23566777664432 234678999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCccee
Q 015816 156 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235 (399)
Q Consensus 156 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 235 (399)
|.+++.........+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999864333445777888999999999999999999 999999999999999999999999997642221111222
Q ss_pred eeeccCccccCcccccc-------CCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 236 TRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 236 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
....++..|+|||++.. ..++.++|||||||++|||++ |..||............ .. . ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~~----~--~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV--IK----D--QQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--Hh----h--cccccC
Confidence 34568899999998743 245789999999999999997 56788654432211111 00 0 001111
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
++.+... ....+.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222222 2236788999999 67999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=313.00 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=203.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECC-----CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
++|++...||.|+||.||+|+.+. +.+.|++|.+...... ....+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 568889999999999999999754 3467999988654333 3467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPG-----KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
+||||+++++|.+++...... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999763311 126899999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
|++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||........... ... .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~---~~~---~ 234 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR---LQA---G 234 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH---HHc---C
Confidence 9986432111 111223346778999999988889999999999999999999 8889865433221111 100 0
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
... ...+...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 235 ~~~----------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLE----------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcC----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 0011122348899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=314.54 Aligned_cols=267 Identities=24% Similarity=0.327 Sum_probs=204.6
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|++.+.||.|+||.||+|.+..+|..||+|++..... .....+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58889999999999999999998899999999876542 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+ +++|.+++... ..++++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998753 356999999999999999999999999 9999999999999999999999999987643322
Q ss_pred CcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH-Hhhh-------hhhcccc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWAR-------PLFQDRT 301 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~-------~~~~~~~ 301 (399)
. .......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||............ .... +.+....
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 1 11233468999999998865 45689999999999999999998888655432221111 0000 0000000
Q ss_pred ccccccCccc----cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 302 RHSLIADPEL----QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 302 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
....+..+.. .....+.....+.+++.+||+.+|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 001112234688999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=308.51 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=203.4
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|++.+.||+|+||.||+|.+..+++.+|||.+..... .....+..|+.+++.++||||+++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 58888999999999999999999999999999875432 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC-CceEEecccCCccCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 229 (399)
+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997632 345899999999999999999999999 9999999999999865 46899999998754322
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|..||............ .. .. .
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~--~~----~~-------~- 218 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI--MS----GT-------F- 218 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH--Hh----cC-------C-
Confidence 1 122346889999999999888999999999999999999999999765432211111 00 00 0
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+......+.+++.+||+.+|.+|||+.++++
T Consensus 219 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 ---APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0111123347889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=315.33 Aligned_cols=265 Identities=23% Similarity=0.322 Sum_probs=199.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||.|+||.||+|.++.+++.||||.+...... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5789999999999999999999988999999998654322 234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 85 ~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 98 5999988753 346899999999999999999999999 9999999999999999999999999986432211
Q ss_pred CcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHH-HHHHHhh-hhhhccc----cc-
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWA-RPLFQDR----TR- 302 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~-~~~~~~~----~~- 302 (399)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ....... ....... ..
T Consensus 158 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11122346889999998865 5688999999999999999999999975542111 1111000 0000000 00
Q ss_pred --c-----ccccCccccCCCChHh--HHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 303 --H-----SLIADPELQGQYPPRG--FYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 303 --~-----~~~~~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. .......+.... +.. ...+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000000000000 011 157788999999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=310.79 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=207.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||.|+||.||+|....++..+|+|++..... .....+.+|+.+++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 478999999999999999999988899999999875432 2456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++..... ...+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976321 246899999999999999999999999 9999999999999999999999999987644332
Q ss_pred Cc--ceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 231 NT--HVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 231 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. .......|+..|+|||++... .++.++|+|||||++|+|++|+.||......... ...... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~~~~~---~-------- 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLTLQN---D-------- 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HHHhcC---C--------
Confidence 22 122345689999999998776 7899999999999999999999999765432211 111110 0
Q ss_pred CccccCCC-ChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 308 DPELQGQY-PPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 308 ~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+.+.... ....+..+.+++.+||+.||++||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00010000 1123347889999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=317.01 Aligned_cols=265 Identities=25% Similarity=0.287 Sum_probs=201.9
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-----chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
+|++.+.||.|+||.||+|.+..+++.||||.+...... ....+..|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999999988999999999755432 234567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+ +++|.+++... ...+++..++.++.||++||.|||+++ |+|+||+|+|||++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999999752 137999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH-Hhhh-hhhccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWAR-PLFQDRTRHS 304 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~-~~~~~~~~~~ 304 (399)
... .......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||............ .... +.........
T Consensus 154 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 221 11222346788999998854 56789999999999999999998888754433221111 0000 0000000000
Q ss_pred cccCc---cc-----cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 305 LIADP---EL-----QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 305 ~~~~~---~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+. .. ...........+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000 00 00111233467889999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=315.66 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=198.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHH-HhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||.||+|.++.+|+.||+|.+..... .....+..|+.+ ++.++||||+++++++......|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 468899999999999999999999999999999875432 223455566665 566789999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|++ ++|.+++.........+++..++.++.||+.||+|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 788888876444456799999999999999999999997 8 99999999999999999999999999875322
Q ss_pred CCCcceeeeeccCccccCcccccc----CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
. .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........ .+..... .
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~----~----- 223 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLKQVVE----E----- 223 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHHHHHh----c-----
Confidence 1 11223458889999998864 4578899999999999999999999964322110 1110000 0
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..+.+.. ...+..+.+++.+||..+|++||++.++++.
T Consensus 224 --~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 --PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred --CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 1123478899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=308.96 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=208.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||.|++|.||+|.+..+++.|++|++..... .....+.+|+.++..++||||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999999999999999999876544 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
+++++|.+++.. ...+++..++.++.||+.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999986 4679999999999999999999999 99 999999999999999999999999998754322
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|..||................ .. ..+
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~-------~~~ 221 (264)
T cd06623 154 LD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DG-------PPP 221 (264)
T ss_pred CC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cC-------CCC
Confidence 21 1223468899999999999899999999999999999999999997664211111111111 00 001
Q ss_pred cccCCCChH-hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 310 ELQGQYPPR-GFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 310 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.. +.. .+..+.+++.+||..+|++||++.++++.
T Consensus 222 ~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SL----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CC----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 111 33488999999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=317.47 Aligned_cols=263 Identities=19% Similarity=0.246 Sum_probs=198.7
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|++.+.||.|+||.||+|.+..+|+.||+|.+...... ....+.+|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999999999999999998653221 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
++ ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 5888887642 456999999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchH-HHHHHHHHh-hh-------hhhccc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKA-AAEQSLVAW-AR-------PLFQDR 300 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~~~~-~~-------~~~~~~ 300 (399)
.......++..|+|||++.+. .++.++|||||||++|+|++|..||..... ......... .. +.....
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 112234578899999988664 478999999999999999999988643322 111111100 00 000000
Q ss_pred cccccccCcccc-----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADPELQ-----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..... .+... ....+.....+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKP--YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccc--cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 00000 0111233457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=310.45 Aligned_cols=238 Identities=29% Similarity=0.459 Sum_probs=192.1
Q ss_pred CeeeecCceEEEEEEECCCC----------eEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 78 SLLGEGGFGRVYKGYLESIN----------QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
+.||+|+||.||+|.+..++ ..|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999998766 45888887654332 5778899999999999999999999988 778999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-------ceEEecc
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-------HPKLSDF 220 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~~kl~Df 220 (399)
|||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999862 227899999999999999999999999 99999999999999887 7999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccC--CCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhh
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF 297 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~ 297 (399)
|++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.............
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~------ 220 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ------ 220 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh------
Confidence 99875322 2234467889999999776 78999999999999999999 577776553221111110
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
.. .. .+......+.+++.+||..+|.+|||+.++++.|
T Consensus 221 -~~---~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 -DQ---HR---------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -cC---CC---------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 00 0011114788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=350.57 Aligned_cols=292 Identities=22% Similarity=0.263 Sum_probs=223.9
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEec
Q 015816 64 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCAD 140 (399)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 140 (399)
..++.....+|++.++||+|+||.|.+++++.+++.||+|++++... ....-|..|-.+|..-+.+-|++++.+|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 44555566789999999999999999999999999999999986432 233457888999998899999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 141 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
..++|+|||||+||+|..++.. ..++++..++.++..|+.||.-||+.| +|||||||+|||||..|+|||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999987 347999999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccc----c-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK----T-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 295 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 295 (399)
|.|..+... ........+|||.|++||++. + +.|+..+|+||+||++|||+.|..||.......- ...
T Consensus 220 GsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT------Y~K 292 (1317)
T KOG0612|consen 220 GSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET------YGK 292 (1317)
T ss_pred hhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH------HHH
Confidence 998765432 233345578999999999984 3 6799999999999999999999999976543221 111
Q ss_pred hhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC---HHHHHHHHHHHHhccCCCcccccCCCCCCCCC
Q 015816 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV---IADVVTALAYLASQKYESDAEKVQSPCLDPGT 372 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~L~~l~~~~~~~~~~~~~~~~~~~~~ 372 (399)
++.- ...+..|.. ...+....+||.+.+. +|+.|.. ++++- ...++....|...-+..++=.+..+.
T Consensus 293 Im~h---k~~l~FP~~-----~~VSeeakdLI~~ll~-~~e~RLgrngiedik-~HpFF~g~~W~~iR~~~pP~vPevss 362 (1317)
T KOG0612|consen 293 IMNH---KESLSFPDE-----TDVSEEAKDLIEALLC-DREVRLGRNGIEDIK-NHPFFEGIDWDNIRESVPPVVPEVSS 362 (1317)
T ss_pred Hhch---hhhcCCCcc-----cccCHHHHHHHHHHhc-ChhhhcccccHHHHH-hCccccCCChhhhhhcCCCCCCcCCC
Confidence 1110 011111100 1245588889988775 5888887 77764 44566677774433333222333344
Q ss_pred CccccCc
Q 015816 373 PTRTKGD 379 (399)
Q Consensus 373 p~~~~~~ 379 (399)
|+-++++
T Consensus 363 d~DTsnF 369 (1317)
T KOG0612|consen 363 DDDTSNF 369 (1317)
T ss_pred CCccccc
Confidence 4445544
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=309.02 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=202.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.+|++.+.||.|+||.||+|.+.. +..+|+|.+.... .....+..|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 467888999999999999998865 6789999886443 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999998752 346899999999999999999999999 99999999999999999999999999875322111
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||............ ... .....
T Consensus 156 -~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~---~~~~~-- 222 (256)
T cd05112 156 -TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-------NAG---FRLYK-- 222 (256)
T ss_pred -cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-------hCC---CCCCC--
Confidence 11112235678999999988899999999999999999998 99999765433221111 000 00000
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
+...+..+.+|+.+||+.+|++|||+.++++.|+
T Consensus 223 -----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 -----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112347889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=308.90 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=193.7
Q ss_pred CeeeecCceEEEEEEECC---CCeEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEe-cCCeeEEEEEecC
Q 015816 78 SLLGEGGFGRVYKGYLES---INQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMP 152 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~~ 152 (399)
+.||+|+||.||+|.+.. .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998653 34679999885432 233467888999999999999999999875 4556899999999
Q ss_pred CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCc
Q 015816 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (399)
Q Consensus 153 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 232 (399)
+++|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999752 334678888999999999999999999 999999999999999999999999998753221111
Q ss_pred --ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhC-CCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 233 --HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 233 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
.......++..|+|||.+.+..++.++|||||||++|||++| .+||............ . .. . .+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~---~---~~----~---~~ 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL---L---QG----R---RL 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---h---cC----C---CC
Confidence 111123467789999999888999999999999999999995 5667654332211111 0 00 0 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
.....+ +..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 222 ~~~~~~----~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYC----PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001112 237889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=311.09 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=204.4
Q ss_pred CCCCCCeeeecCceEEEEEEECC-CCeEEEEEEeccCCC----------cchHHHHHHHHHHhh-cCCCCccceEEEEec
Q 015816 73 NFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNGV----------QGNREFLVEVLMLSL-LHHPNLVNLIGYCAD 140 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~ 140 (399)
+|++.+.||+|+||.||+|.++. +++.+|+|.+..... .....+..|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 688999998853221 122446778887764 799999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCCceEEec
Q 015816 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSD 219 (399)
Q Consensus 141 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~D 219 (399)
.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999987654445679999999999999999999996 67 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||............. ....
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~--~~~~-- 230 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV--EAVY-- 230 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh--hccC--
Confidence 99997533222 2334568999999999998889999999999999999999999997654332211110 0000
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
.+..... ....+.+++.+||+.||++||++.|+..++.
T Consensus 231 --------~~~~~~~----~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 --------EPLPEGM----YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --------CcCCccc----CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000111 2237889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=311.65 Aligned_cols=248 Identities=27% Similarity=0.349 Sum_probs=204.9
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
+|++.+.||.|+||.||+|.+..++..||+|++..... ...+.+..|+.++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58889999999999999999998999999999975432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+.+++|.+++.. ..++++..+..++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999976 457999999999999999999999999 999999999999999999999999998754322
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|..||............... ..
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~---------- 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ----ET---------- 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh----cc----------
Confidence 1 223355889999999998888999999999999999999999999866532111111110 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCH--HHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI--ADVV 345 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~eil 345 (399)
.....++..+..+.+++.+||+.||.+||++ .|++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0011222233588899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=320.37 Aligned_cols=280 Identities=27% Similarity=0.374 Sum_probs=223.0
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
+.|+.-++||+||||.||-++.+.||+.||.|.+.+..... ..-.++|-.||++++.++||.+-.+|+..+.+|||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45888899999999999999999999999999987654432 234678999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
..|.||+|.-+|.+.. ...+++..++.++.+|+.||++||+.+ ||.|||||+|||+|+.|+|.|+|+|+|..+..
T Consensus 265 tlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999998754 467999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
+.. ....+||.+|||||++.++.|+...|+|||||+||||+.|+.||..........-+.. ... .+
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr--r~~---------~~ 405 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR--RTL---------ED 405 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH--HHh---------cc
Confidence 332 3334899999999999999999999999999999999999999976544322211100 000 01
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHH----HHHHHHHHHHhccCCCcccccCCCCCCCCCC
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIA----DVVTALAYLASQKYESDAEKVQSPCLDPGTP 373 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~----eil~~L~~l~~~~~~~~~~~~~~~~~~~~~p 373 (399)
+ ..++..-++++.+|.+.+|+.||.+|.-.. +=+++...+....|.........|++-|.+-
T Consensus 406 ~---~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~ 471 (591)
T KOG0986|consen 406 P---EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPG 471 (591)
T ss_pred h---hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcc
Confidence 1 123334445888999999999999996443 2233444555566666666666666666443
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=309.93 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=200.9
Q ss_pred CCCCCeeeecCceEEEEEEEC---CCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCC------
Q 015816 74 FRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 142 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 142 (399)
|++.+.||+|+||.||+|.+. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667889999999999999864 3578999999865432 23456889999999999999999999886542
Q ss_pred eeEEEEEecCCCCHHHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
..++++||+.+|+|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875321 11235789999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
|++................+++.|++||.+.+..++.++|||||||++|+|++ |.+||............ . .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~---~----~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL---I----K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH---H----c
Confidence 99875433222212223345678999999998899999999999999999999 88998765433221111 0 0
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
.. .. ..++..+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 231 ~~------~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GN------RL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC------cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00 01112334889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=306.74 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=204.0
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|.+.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+..|+.+++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588889999999999999999988999999998765443 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999986 456899999999999999999999999 9999999999999999999999999987643322
Q ss_pred Ccce--eeeeccCccccCccccccCC---CCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 231 NTHV--STRVMGTYGYCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 231 ~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||............ ... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~--~------- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGA--G------- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--Hhc--C-------
Confidence 2111 11245788999999998766 889999999999999999999999754321111100 000 0
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+.+... ......+.+++.+||+.+|.+||++.+++.
T Consensus 223 -~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -HKPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001000 011347788999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=314.31 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=200.5
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|+..+.||.|+||.||+|.++.+++.||||.+...... ....+.+|+.++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488899999999999999999999999999998644322 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+. ++|..++.... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 68988886532 456899999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeeeeccCccccCccccccCC-CCcccceeehhHHHHHHHhCCCCcccchHHHHHHH-HHhhhhhh-------ccc-
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLF-------QDR- 300 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~-------~~~- 300 (399)
.......++..|+|||++.+.. ++.++|||||||++|+|+||+.||........... ........ ...
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1122335788999999886644 68899999999999999999999976543221111 11000000 000
Q ss_pred ---cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 ---TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..........+ ....+.....+.++|.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 0011122346788999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=307.66 Aligned_cols=246 Identities=29% Similarity=0.463 Sum_probs=198.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||++.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4688999999999999999864 47889999986432 346788999999999999999999998764 579999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 9999999997632 346899999999999999999999999 999999999999999999999999998753221
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
......+..|+|||.+.+..++.++|||||||++|+|++ |..||............. ....
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~-------- 215 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------KGYR-------- 215 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------CCCC--------
Confidence 112234568999999988899999999999999999998 999997654432221111 0000
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
...+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 216 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 216 --MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 0011122347889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=314.55 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=205.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.+|++.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++.+...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57899999999999999999998889999999987555455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~- 169 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc-
Confidence 99999999974 45889999999999999999999999 9999999999999999999999999886432221
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||............ .... .+.
T Consensus 170 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~-------~~~- 234 (293)
T cd06647 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG-------TPE- 234 (293)
T ss_pred -cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCC-------CCC-
Confidence 1122346889999999998888999999999999999999999999764332111000 0000 000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...+......+.+++.+||+.+|.+||++.+++..
T Consensus 235 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 -LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112233478899999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=309.38 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=203.2
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
-|++.+.||.|+||.||+|.+..++..||||.+..... .....+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 37788899999999999999998899999999864432 23356888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 99999999863 46899999999999999999999999 9999999999999999999999999986532221
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||............. ... .+.+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~------~~~~ 221 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-------KNN------PPTL 221 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-------cCC------CCCC
Confidence 11223458889999999988889999999999999999999999997544322111110 000 0111
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
+......+.+++.+||+.+|.+||++.++++.
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223478899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=311.00 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=202.9
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecC
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 152 (399)
.|...+.||.|++|.||+|.+..+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 34556789999999999999998899999999875544455678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCc
Q 015816 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (399)
Q Consensus 153 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 232 (399)
+++|.+++.. .++++..+..++.||+.||+|||+++ |+||||+|+||+++.++.++|+|||.+...... .
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~ 169 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--V 169 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccC--C
Confidence 9999999875 46899999999999999999999999 999999999999999999999999987643222 1
Q ss_pred ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcccc
Q 015816 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 312 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.......|+..|+|||.+.+..++.++|||||||++|+|++|..||............ ... .. +...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~---~~~-----~~-----~~~~ 236 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI---RDN-----LP-----PKLK 236 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH---Hhc-----CC-----CCCc
Confidence 1223346899999999998888999999999999999999999999764432221111 000 00 0000
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 313 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 313 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+......+.+++.+||+.+|++||++.++++
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01112347899999999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=311.14 Aligned_cols=267 Identities=23% Similarity=0.277 Sum_probs=199.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc-hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
+++|++.+.||+|+||.||+|.+..++..||+|.+....... ...+.+|+.+++.++|+||+++++++......|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 468999999999999999999999999999999986543322 2457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 7777776542 345788899999999999999999999 999999999999999999999999998753221
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh-hh-----------
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PL----------- 296 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~----------- 296 (399)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.............+.. ..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 1 11223457899999999865 457889999999999999999999997654322111111100 00
Q ss_pred hccccccccccC-ccccCCCC--hHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 297 FQDRTRHSLIAD-PELQGQYP--PRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 297 ~~~~~~~~~~~~-~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
............ +....... -.....+.+++.+|+..||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 00000000 011347788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=317.61 Aligned_cols=199 Identities=24% Similarity=0.337 Sum_probs=162.0
Q ss_pred CCeeeecCceEEEEEEECC--CCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEec--CCeeEEEEEecC
Q 015816 77 ESLLGEGGFGRVYKGYLES--INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMP 152 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~ 152 (399)
...||+|+||.||+|.++. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999764 56789999986543 23457789999999999999999998853 567899999987
Q ss_pred CCCHHHHhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee----cCCCceEEecccCC
Q 015816 153 LGSVEDHLHDLS-----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLA 223 (399)
Q Consensus 153 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~~ 223 (399)
++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57888775321 12345899999999999999999999999 9999999999999 56679999999999
Q ss_pred ccCCCCCCc-ceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccc
Q 015816 224 KLGPVGDNT-HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (399)
Q Consensus 224 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~ 281 (399)
......... .......||+.|+|||++.+ ..++.++|||||||++|||+||.+||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 754322111 11233568999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=314.60 Aligned_cols=277 Identities=26% Similarity=0.376 Sum_probs=229.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHH---HHHHHHHHhhc-CCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 147 (399)
.+|.++.+||+|+||.|.+|..+++.+.||||++.+.-....+. -+.|-.+|... +-|.+++++..|+.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999999999999999998765443332 35566777665 467999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+.||+|--.+++ -+.+.+..+..++.+|+-||-|||++| ||.||||.+|||+|.+|+|||+|||+++...
T Consensus 429 MEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999998 567888899999999999999999999 9999999999999999999999999998633
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. ...+.+++||+.|+|||++...+|+.++|+||+||+||||+.|++||++....+.-..+ ..
T Consensus 502 ~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI------~e--------- 564 (683)
T KOG0696|consen 502 FD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI------ME--------- 564 (683)
T ss_pred cC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------HH---------
Confidence 22 33356689999999999999999999999999999999999999999987665432111 00
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCC----CCHHHHHHHHHHHHhccCCCcccccCCCCCCCCCCcc
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMR----PVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTR 375 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R----Ps~~eil~~L~~l~~~~~~~~~~~~~~~~~~~~~p~~ 375 (399)
-.-.+|...+.+...++...|..+|.+| |..++-++....+....|+........|+..|....+
T Consensus 565 ---hnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~ 633 (683)
T KOG0696|consen 565 ---HNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCG 633 (683)
T ss_pred ---ccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccC
Confidence 0123444555688899999999999999 5667777777788888888888777777777765433
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=309.24 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=204.0
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
+|++.+.||.|+||.||+|.++.+++.||+|.+..... .....+.+|+.+++.++||||+++++++......++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 57788899999999999999999999999999876533 33456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
++++|.+++... ...+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999999863 2678999999999999999999999 88 9999999999999999999999999986432111
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ............. .+.
T Consensus 156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~-------~~~ 223 (265)
T cd06605 156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNEP-------PPR 223 (265)
T ss_pred ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcCC-------CCC
Confidence 1115688999999999999999999999999999999999999965421100 0011111111000 001
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
+... .....+.++|.+||..||++|||+.+++..
T Consensus 224 ~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1000 133478899999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=325.00 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=209.9
Q ss_pred CCCCCeeeecCceEEEEEEECC----CCeEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 74 FRSESLLGEGGFGRVYKGYLES----INQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.+..+.||.|.||.||.|.... ..-.||||.-+.+. ....+.|+.|..+|++++|||||+++|+|.+. ..+|||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 4455789999999999998743 34569999887643 34567899999999999999999999999874 789999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|.++.|.|..||+.. +..|+......++.||+.||+|||+.. +|||||...|||+.....|||+|||+++....
T Consensus 470 EL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 470 ELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999973 567899999999999999999999999 99999999999999999999999999997655
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
....... ...-..-|||||.++-..++.++|||-|||.+||++. |..||......+..- .+.+
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEn-------- 607 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIEN-------- 607 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecC--------
Confidence 5443332 3445678999999999999999999999999999988 999998643322100 0000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.-+..+|+.++..|..|+.+||+.+|.+||.+.++...|..+..
T Consensus 608 --GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 608 --GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11124455556689999999999999999999999998877764
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=309.58 Aligned_cols=267 Identities=22% Similarity=0.328 Sum_probs=202.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
+|++.+.||.|++|.||+|.+..+|..||||++...... ....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588899999999999999999999999999998755332 3456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
+ ++|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 D-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred C-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 8 589888875332 356899999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH-HHhhhhhhccc----ccccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQDR----TRHSL 305 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~----~~~~~ 305 (399)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||........... ........... .....
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 11223457889999998865 4578999999999999999999999976543322111 11100000000 00000
Q ss_pred c--cCc----cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 I--ADP----ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 ~--~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. ..+ .......+.....+.+++.+||+.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 000 0001111223457889999999999999999999984
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=309.01 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=201.8
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcC---CCCccceEEEEecCCeeEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~ 148 (399)
.|++.+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 47788899999999999999999999999999875432 33456888999999987 999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999864 47899999999999999999999999 99999999999999999999999999876433
Q ss_pred CCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||............ ... .
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~------~ 218 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------PKS------K 218 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------ccC------C
Confidence 22 22233468999999998865 45789999999999999999999999765432211100 000 0
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.+.+... .....+.+++.+||+.||++||++.+++..
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111111 123478899999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=305.79 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=203.6
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|++.+.||.|+||.||+|.++.+|..||+|.+..... ...+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 57888999999999999999999999999999865422 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-ceEEecccCCccCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVG 229 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 229 (399)
+++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999997532 345899999999999999999999999 99999999999999886 4699999998754322
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||.......... .......
T Consensus 156 --~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~-------- 219 (257)
T cd08225 156 --MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL------KICQGYF-------- 219 (257)
T ss_pred --cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH------HHhcccC--------
Confidence 112223458899999999988889999999999999999999999997543322111 0011000
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
....+.....+.+++.+||..+|++|||+.++++.
T Consensus 220 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 ---APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01112233478999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=310.40 Aligned_cols=264 Identities=23% Similarity=0.269 Sum_probs=200.7
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
|++.+.||.|++|.||+|.++.+|..||+|++...... ....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67788999999999999999999999999998754322 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
+ ++|.+++.... ...+++..++.++.||+.||+|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 6 68999987632 246899999999999999999999999 99999999999999999999999999875322211
Q ss_pred cceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH-HHhhhhhhc----------c
Q 015816 232 THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQ----------D 299 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~----------~ 299 (399)
......++..|+|||++.+. .++.++||||||+++|+|++|..||........... ......... .
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 11223568899999987654 578999999999999999999999976544222111 110000000 0
Q ss_pred cc-ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 300 RT-RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 300 ~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.. ...... ........+.....+.+++.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhccccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 000000 00001112233457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=311.00 Aligned_cols=266 Identities=22% Similarity=0.289 Sum_probs=202.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecC--CeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv 147 (399)
++|++.+.||.|+||.||+|.+..+++.+|+|.+...... ....+.+|+.+++.++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4688899999999999999999999999999998754322 223567899999999999999999998877 889999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||++ ++|.+++... ...+++..++.++.||+.||+|||+++ ++|+||||+|||++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99998 5999888752 236899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH-Hhhhh-------hh-
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARP-------LF- 297 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~-------~~- 297 (399)
... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||............ ..... .+
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 321 112234578899999988654 4689999999999999999999999765443222111 00000 00
Q ss_pred --ccc--cccccccCccccCCCChH-hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 298 --QDR--TRHSLIADPELQGQYPPR-GFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 298 --~~~--~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... ..........+...++.. ....+.+++.+||+.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 000000011111122222 3457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=323.89 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=211.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
....|.+.+.||+|.|+.|.+|++..++..||||.+++.... ....+.+|+++|+.++|||||+++.+...+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345799999999999999999999999999999999876443 335688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+.+|.+.+|+.. .+...+..+..++.|+.+|++|||+++ |||||||++||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 999999999999997 677888999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCCcceeeeeccCccccCccccccCCCC-cccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
........+|++.|.|||++.+..|+ +.+|+||+|++||.|+.|..||++....... .+......
T Consensus 207 ---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~rvl~gk~ 272 (596)
T KOG0586|consen 207 ---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------PRVLRGKY 272 (596)
T ss_pred ---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------chheeeee
Confidence 33445668899999999999987774 7899999999999999999999864322111 11000000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.++--...+..+||+++|-.+|.+|+++.++.+.
T Consensus 273 -------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 -------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -------cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1122223467779999999999999999999864
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=326.92 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=198.0
Q ss_pred CCCCeeeecCceEEEEEEECCCCeEEEEEEeccC----CCcchHHHHHHHHHHhhcCCCCccceEEEEecCCe--eEEEE
Q 015816 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN----GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--RLLVY 148 (399)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~lv~ 148 (399)
+...+||+|+|-+||+|.+..+|..||--.++.. .....+.|..|+.+|+.|+|||||++|+++.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4556799999999999999999999986544321 22234679999999999999999999999987655 78999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-CCceEEecccCCccCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGP 227 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~ 227 (399)
|.+..|+|..|+.. .+.++...+..|++||++||.|||++ .|||||||||-+||||+. -|.|||+|+|+|....
T Consensus 123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999998 67789999999999999999999998 478999999999999986 4899999999998632
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHH--HHHHHhhhhhhcccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE--QSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 305 (399)
. .....+.|||.|||||+.. ..|+..+||||||++|.||+|+..||........ ...+....| .....
T Consensus 198 ~----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP-----~sl~k 267 (632)
T KOG0584|consen 198 K----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP-----AALSK 267 (632)
T ss_pred c----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH-----HHhhc
Confidence 2 2233478999999999986 7999999999999999999999999976554322 111111111 01111
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+.| .++.++|.+||.. ...|||+.|+|.
T Consensus 268 V~d------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 VKD------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred cCC------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 112 2678899999999 999999999995
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=300.68 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=207.0
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecC
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 152 (399)
+|++.+.||+|++|.||+|.+..++..+++|++..........+.+|+.+++.++||||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47788999999999999999998899999999976655456778999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCc
Q 015816 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (399)
Q Consensus 153 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 232 (399)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998762 257999999999999999999999999 99999999999999999999999999876433221
Q ss_pred ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcccc
Q 015816 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 312 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||.............. ........
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~---- 219 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--------NGPPGLRN---- 219 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--------cCCCCcCc----
Confidence 2345688999999999888899999999999999999999999976533222111100 00000000
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 313 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 313 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.......+.+++.+||+.||++|||+.++++
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 ---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111347899999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=310.23 Aligned_cols=269 Identities=21% Similarity=0.253 Sum_probs=199.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcC-CCCccceEEEEecCCe-----
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ----- 143 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~----- 143 (399)
++|++.+.||+|+||.||+|.+..+++.||||.+...... ....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688999999999999999999999999999998654322 2356788999999995 6999999999887665
Q ss_pred eEEEEEecCCCCHHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-CCceEEeccc
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPG-KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFG 221 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg 221 (399)
.|+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+++ |+||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 898888754322 356899999999999999999999999 999999999999998 8999999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHH-HHHhhh-hhhc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWAR-PLFQ 298 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~-~~~~ 298 (399)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......... ...... +...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9875322111 1122346888999998754 567999999999999999999999997654332211 111000 0000
Q ss_pred ccccccccc----Cc----cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 299 DRTRHSLIA----DP----ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 299 ~~~~~~~~~----~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
......... .+ .......+.....+.++|.+||..||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000 00 0000111223457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=315.02 Aligned_cols=268 Identities=25% Similarity=0.319 Sum_probs=202.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhc-CCCCccceEEEEecC--Cee
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG--DQR 144 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~ 144 (399)
..++|++.+.||+|+||.||+|.+..++..+|+|++.... ......+..|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567899999999999999999999889999999885432 22335577899999999 999999999988653 468
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||++ ++|..++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 699998875 37889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCc---ceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh----
Q 015816 225 LGPVGDNT---HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL---- 296 (399)
Q Consensus 225 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---- 296 (399)
........ .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 64333221 12234568999999998754 56889999999999999999999999765433221111000000
Q ss_pred --------hccccc--cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 297 --------FQDRTR--HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 297 --------~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...... ......... ....+.....+.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPL-DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccch-hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000 000000000 01111234588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=308.33 Aligned_cols=245 Identities=27% Similarity=0.371 Sum_probs=195.3
Q ss_pred eeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
||+|+||+||+|.+..+|+.||+|.+..... .....+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999999999999999865432 2234567899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceee
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (399)
.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccc
Confidence 99997632 246899999999999999999999999 99999999999999999999999999875322 11122
Q ss_pred eeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCC
Q 015816 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 316 (399)
Q Consensus 237 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
...++..|+|||++.+..++.++|||||||++|+|++|+.||............. ..... .. ...+
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~--------~~----~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLE--------MA----VEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hcccc--------cc----ccCC
Confidence 3457889999999988889999999999999999999999997654311111110 00000 00 1112
Q ss_pred hHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 317 PRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 317 ~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
......+.+++.+||+.||.+|| ++.+++.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 22234788999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=308.11 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=207.7
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
..+.|++.+.||.|+||.||+|.+..++..|++|++..... ....+..|+.+++.++|+||+++++.+......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 34568888999999999999999998899999999976544 45678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998721 37999999999999999999999999 999999999999999999999999987643221
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
. .......++..|+|||.+.+..++.++|||||||++|+|++|..||............ ... . ..
T Consensus 170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--~~~----~--~~----- 234 (286)
T cd06614 170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--TTK----G--IP----- 234 (286)
T ss_pred h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hhc----C--CC-----
Confidence 1 1122345788999999998888999999999999999999999999765443221111 000 0 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
.. ..+......+.+++.+||+.+|..||++.++++..
T Consensus 235 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 235 PL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred CC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 00 00111234788999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=301.79 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=208.9
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|++.+.||.|+||.||+|.+..++..||+|++..... .....+..|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 57888999999999999999998899999999976543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999875433477999999999999999999999999 9999999999999999999999999987533222
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......|++.|+|||.+.+..++.++||||||+++|+|++|..||............ .... .+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~-------~~- 221 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI------LKGQ-------YP- 221 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH------hcCC-------CC-
Confidence 2233356889999999998888999999999999999999999999765432221111 0000 00
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+......+.+++.+||..+|++|||+.++++
T Consensus 222 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 ---PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111123347889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=311.06 Aligned_cols=268 Identities=24% Similarity=0.318 Sum_probs=201.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCccceEEEEecC--CeeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 146 (399)
.++|++.+.||.|+||.||+|.+..+|+.||+|.+....... ...+.+|+.++++++|+||+++++++... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457999999999999999999999999999999986443221 23466799999999999999999998765 56899
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+. ++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999997 5888888753 356899999999999999999999999 999999999999999999999999998764
Q ss_pred CCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc-----
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR----- 300 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 300 (399)
.... .......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||......................
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 3221 11122345788999998865 568999999999999999999999998655443322221110000000
Q ss_pred ---cccccccCc--ccc--CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 301 ---TRHSLIADP--ELQ--GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 301 ---~~~~~~~~~--~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
........+ ... ..........+.++|.+||+.||++|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 000 00001124467889999999999999999999953
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=318.61 Aligned_cols=265 Identities=23% Similarity=0.293 Sum_probs=201.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecC------
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 141 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 141 (399)
..++|++.+.||+|+||.||+|.+..+++.||||.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999999999999999986432 22345677899999999999999999988643
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
...|+||||+. ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999997 688888763 2889999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHH-HHHhh-------
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWA------- 293 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~------- 293 (399)
++....... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... +....
T Consensus 164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 997532211 1223457899999999999999999999999999999999999997654322111 00000
Q ss_pred --------hhhhccccccc-----cc----cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 294 --------RPLFQDRTRHS-----LI----ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 294 --------~~~~~~~~~~~-----~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
........... .. ..+......+......+.+++.+||+.||++|||+.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000 00 00000001112234578899999999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=314.93 Aligned_cols=269 Identities=20% Similarity=0.252 Sum_probs=200.1
Q ss_pred CCCCCCeeeecCceEEEEEEECC--CCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecC--CeeE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLES--INQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRL 145 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 145 (399)
+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999988 89999999997632 23345678899999999999999999999988 8899
Q ss_pred EEEEecCCCCHHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC----CCceEEecc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPG-KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR----GYHPKLSDF 220 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Df 220 (399)
+||||++ ++|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999997 5777777643322 247899999999999999999999999 999999999999999 899999999
Q ss_pred cCCccCCCCCC-cceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHH-------HHHHHH
Q 015816 221 GLAKLGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA-------EQSLVA 291 (399)
Q Consensus 221 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~~~ 291 (399)
|++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|++||....... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99876433222 111223467889999998765 468899999999999999999999997543321 000000
Q ss_pred hhhhhhc-----------cc---------cccccccCccccCCCCh--HhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 292 WARPLFQ-----------DR---------TRHSLIADPELQGQYPP--RGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 292 ~~~~~~~-----------~~---------~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... .+. .. ..........+...... .....+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 000 00 00000000000000000 22346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=300.34 Aligned_cols=254 Identities=23% Similarity=0.272 Sum_probs=201.1
Q ss_pred HhcCCCCC-CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEec----CCe
Q 015816 70 ATKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD----GDQ 143 (399)
Q Consensus 70 ~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~~~ 143 (399)
.+++|.+. .+||-|-.|.|..+.++.|++.+|+|++.. .....+|+++--.. .|||||.+++++++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667665 679999999999999999999999999753 34456688776655 59999999998865 356
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---CCceEEecc
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDF 220 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Df 220 (399)
+.+|||.|+||.|...+++.. ...+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|... +-.+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 789999999999999999854 567999999999999999999999999 999999999999964 457999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
|+|+... ......+.+-|+.|.|||++...+|+..+|+||+||++|-||+|.+||........ .+.+...
T Consensus 209 GFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-------spgMk~r 278 (400)
T KOG0604|consen 209 GFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------SPGMKRR 278 (400)
T ss_pred ccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-------ChhHHhH
Confidence 9998522 12334456789999999999999999999999999999999999999965433211 0111111
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..... -.+...-....++...++|+.+|..+|.+|.|+.++++
T Consensus 279 I~~gq---y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 279 IRTGQ---YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hhccC---ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11100 01111112345678889999999999999999999985
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.36 Aligned_cols=261 Identities=24% Similarity=0.272 Sum_probs=196.7
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcC-CCCccceEEEEecC--CeeEEEEE
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLLVYE 149 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~e 149 (399)
|++.+.||+|+||.||+|.+..++..||+|++...... .......|+.++.++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67788999999999999999999999999998754222 2234457888888885 99999999999987 88999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|++ ++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++. +.++|+|||++......
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5888887652 356899999999999999999999999 999999999999999 99999999999754222
Q ss_pred CCcceeeeeccCccccCccccc-cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh--------hhccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP--------LFQDR 300 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~ 300 (399)
.. .....++..|+|||++. +..++.++|||||||++|||++|..||......+.......... .+...
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 11 12345789999999764 45678999999999999999999999976544322111100000 00000
Q ss_pred cccccccCcccc----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. ......+... ....+..+..+.+++.+||+.+|++||++.++++
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 R-HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred c-cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0 0000000000 0011233568999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=308.77 Aligned_cols=243 Identities=26% Similarity=0.327 Sum_probs=189.7
Q ss_pred eeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHh---hcCCCCccceEEEEecCCeeEEEEEecC
Q 015816 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLS---LLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~---~l~hpniv~~~~~~~~~~~~~lv~e~~~ 152 (399)
.||+|+||.||+|.+..+++.||+|.+....... ...+..|..+++ ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999986543221 122344444333 3479999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCc
Q 015816 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (399)
Q Consensus 153 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 232 (399)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--- 150 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence 9999999876 567999999999999999999999999 999999999999999999999999998643221
Q ss_pred ceeeeeccCccccCccccc-cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 233 HVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
......|+..|+|||.+. +..++.++|||||||++|+|++|..||............... . ....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~--------~~~~-- 216 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L--------TVNV-- 216 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---h--------cCCc--
Confidence 112346899999999886 456899999999999999999999999754322111111000 0 0011
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 347 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 347 (399)
..++.....+.+++.+||+.||.+|| ++.++++.
T Consensus 217 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 --ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12222344888999999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=300.81 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=207.1
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecC--CeeEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVY 148 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~ 148 (399)
+|+..+.||+|++|.||+|.+..++..|++|++..... ...+.+.+|+.++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47788999999999999999998899999999876543 3456788999999999999999999999988 8999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999986 348999999999999999999999999 99999999999999999999999999876443
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
...........++..|+|||.+.+..++.++||||||+++|+|++|..||........ ... ... .
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~~----------~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-ALY----KIG----------S 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHH----hcc----------c
Confidence 3221112345688999999999888899999999999999999999999977651111 000 000 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.......+......+.+++.+||+.||++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 00011122223458899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.21 Aligned_cols=269 Identities=21% Similarity=0.281 Sum_probs=203.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEec----CCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 144 (399)
..+|++.+.||.|+||.||+|.++.++..||+|++..... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3689999999999999999999999999999999875422 234567789999999999999999988753 3568
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 689888875 566999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCc--ceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc--
Q 015816 225 LGPVGDNT--HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD-- 299 (399)
Q Consensus 225 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 299 (399)
........ .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 53222111 11223468899999998865 56899999999999999999999999765443322211110000000
Q ss_pred ------c-----cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 300 ------R-----TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 300 ------~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. ........+.......+.....+.+++.+||+.+|.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 00000000000001112234588999999999999999999998864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.09 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=207.6
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|++.+.||.|+||.||++.++.+++.+|+|.+..... .....+..|+.+++.++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47888999999999999999999999999999875432 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999999764444567899999999999999999999999 999999999999999999999999998764332
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||............. .. .
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~~------~-------- 217 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ--RG------K-------- 217 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cC------C--------
Confidence 1223458899999999999999999999999999999999999997665432211110 00 0
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
....+......+.+++.+||+.+|++||++.++++
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 -YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01112233457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=331.02 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=217.6
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCe---EEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
...++++||.|.||.|++|+.+..|+ .||||.++..... ....|+.|+.||-++.||||++|.|+........||+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 45688999999999999999987664 6999999865543 4467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|||++|+|..+|... .+.|++.+...+++.|+.|+.||-+.+ .|||||...|||++.+..+|++|||+++....
T Consensus 710 EyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999874 466999999999999999999999999 99999999999999999999999999997544
Q ss_pred CCCcceeeeecc--CccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 229 GDNTHVSTRVMG--TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 229 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
+.... .+..-| ..+|.|||.+...+++.+|||||+|++|||.++ |..||-.....+...-+.
T Consensus 784 d~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-------------- 848 (996)
T KOG0196|consen 784 DPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-------------- 848 (996)
T ss_pred CCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH--------------
Confidence 43222 222223 478999999999999999999999999999987 999987665543322221
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
..++..-|.+.+..|.+|+..||++|-.+||.+.+|+..|+++..++
T Consensus 849 ---~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 849 ---QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ---hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 11122333445559999999999999999999999999999988653
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=308.89 Aligned_cols=267 Identities=21% Similarity=0.278 Sum_probs=199.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||.|++|.||+|.++.+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 468899999999999999999999999999999865432 223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-CCceEEecccCCccCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~ 228 (399)
|++ ++|.+++.... ...+++..++.++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 58888876422 334688889999999999999999999 999999999999985 56799999999975322
Q ss_pred CCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH-Hhhhhhhcccc-cccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPLFQDRT-RHSL 305 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~-~~~~ 305 (399)
.. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||............ ........... ....
T Consensus 156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Cc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 21 11223457889999998865 45789999999999999999999999765433221111 10000000000 0000
Q ss_pred ccC-----c----cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 IAD-----P----ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 ~~~-----~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+ + .......+.....+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0 0000011223447889999999999999999999996
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=303.18 Aligned_cols=243 Identities=28% Similarity=0.375 Sum_probs=198.2
Q ss_pred eeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
||.|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999754332 335688999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceee
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (399)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999986 456899999999999999999999999 9999999999999999999999999987643321 123
Q ss_pred eeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCC
Q 015816 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 316 (399)
Q Consensus 237 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
...|+..|+|||.+.+..++.++|+||||+++|+|++|..||............. ... . .....++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~-~---------~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND----ILK-G---------NGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH----Hhc-c---------CCCCCCC
Confidence 3468899999999988889999999999999999999999997654211111110 000 0 0001122
Q ss_pred hHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 015816 317 PRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 346 (399)
Q Consensus 317 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 346 (399)
......+.+++.+||+.+|++||+ +.|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 222448899999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=311.60 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=196.9
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|+..+.||+|+||.||++.+..+++.||+|.+...... ....+..|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455677899999999999999999999999998754332 3456888999999996 99999999999999999999999
Q ss_pred cCCCCHHHHhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 151 MPLGSVEDHLHDL-SPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 151 ~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
+. ++|.++.... ......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 5665543321 11246799999999999999999999975 7 99999999999999999999999999864322
Q ss_pred CCCcceeeeeccCccccCccccccC---CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.. ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||....... .... .....
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~~~------ 226 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-DQLT----QVVKG------ 226 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-HHHh----hhcCC------
Confidence 11 11233588999999998765 68999999999999999999999997653211 1111 00000
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..+.+...........+.+|+.+||+.+|++|||+.+++..
T Consensus 227 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 -DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111111112234478999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=308.84 Aligned_cols=244 Identities=22% Similarity=0.299 Sum_probs=199.7
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCHH
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 157 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~ 157 (399)
..||+|+||.||++..+.+++.||||++..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999999999999999986554445567889999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceeee
Q 015816 158 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237 (399)
Q Consensus 158 ~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 237 (399)
+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~ 175 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS 175 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence 98753 46899999999999999999999999 9999999999999999999999999886532221 12233
Q ss_pred eccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCCh
Q 015816 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPP 317 (399)
Q Consensus 238 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
..|+..|+|||.+.+..++.++|+||||+++|+|++|..||.............. .... .+. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~---~~~~----------~~~--~~~ 240 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPP----------KLK--NLH 240 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---hCCc----------ccC--Ccc
Confidence 5688999999999888899999999999999999999999976543322221110 0000 000 001
Q ss_pred HhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 318 RGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 318 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.....+.+++.+||+.+|.+||++.++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 12236788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=310.99 Aligned_cols=248 Identities=32% Similarity=0.418 Sum_probs=199.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
+.|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999999988999999998644322 2346889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||++ |+|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 6777777542 356899999999999999999999999 99999999999999999999999999875321
Q ss_pred CCCcceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
. ....++..|+|||++. ...++.++||||||+++|+|++|..||............. ...
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~------~~~----- 230 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QND----- 230 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh------cCC-----
Confidence 1 2345888999999874 4668899999999999999999999997654322211110 000
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
.+.+ ........+.+++.+||+.+|++||++.+++...
T Consensus 231 --~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 231 --SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred --CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000 0112334789999999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=309.68 Aligned_cols=269 Identities=23% Similarity=0.305 Sum_probs=199.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCC------
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 142 (399)
.++|++.+.||+|+||.||+|.+..+++.||||.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999999999999999998643222 2335678999999999999999999987654
Q ss_pred --eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 143 --QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 143 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
..++||||+. ++|.+++... ...+++.+++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 4599999997 5888887642 346899999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCc--ceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhh
Q 015816 221 GLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 297 (399)
Q Consensus 221 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 297 (399)
|++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||..................+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 998754322211 112234578899999987654 47889999999999999999999997655433332222211111
Q ss_pred cccc-----ccccccCccccCCC---------ChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 298 QDRT-----RHSLIADPELQGQY---------PPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 298 ~~~~-----~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.... .........+.... +......+.+||.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 00000000000000 0011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=320.30 Aligned_cols=258 Identities=27% Similarity=0.410 Sum_probs=214.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.+....++||.|.||.||.|.++...-.||||.++.+ ....++|+.|+.+|+.++|||+|+++++|..+..+|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 3455668999999999999999998999999998654 456788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
..|+|.+||.+.. ...++.-..+.++.||+.|++||..++ +|||||...|+|+.++..||++|||+++++....
T Consensus 346 ~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT- 419 (1157)
T KOG4278|consen 346 CYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT- 419 (1157)
T ss_pred cCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc-
Confidence 9999999999754 556777888999999999999999999 9999999999999999999999999999764332
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........-...|.|||-+....++.++|||+|||+|||+.| |-.||.+......-.+.. ..-.
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-------kgyR-------- 484 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-------KGYR-------- 484 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------cccc--------
Confidence 222222334678999999999999999999999999999998 888988765433322221 1111
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
-+-|..++..+.+|++.||+++|.+||++.|+-+.++.+..
T Consensus 485 --M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 485 --MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred --ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 11222233388999999999999999999999999987653
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=299.77 Aligned_cols=248 Identities=28% Similarity=0.441 Sum_probs=206.1
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|++.+.||+|++|.||+|.+..+++.|++|.+..... .....+.+|+++++.++|||++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47888999999999999999998899999999976654 3446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999986 467999999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||......... ..... . . .+
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~--~~~~~---~---~-----~~- 217 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--FRIVQ---D---D-----HP- 217 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHhc---c---C-----CC-
Confidence 21 23346889999999998888999999999999999999999999755422111 10000 0 0 01
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+......+.+++.+||..+|++|||+.+++.
T Consensus 218 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 ---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112222347889999999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.08 Aligned_cols=268 Identities=24% Similarity=0.335 Sum_probs=199.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecC-----Cee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 144 (399)
.++|++.+.||+|+||.||+|.+..+|+.||||.+.... ......+..|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999999999999999986432 22345678899999999999999999987654 357
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
|+|+||+. ++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 99999997 58888775 357999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCC-cceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH-Hhhhh------
Q 015816 225 LGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARP------ 295 (399)
Q Consensus 225 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~------ 295 (399)
....... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||............ .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 5322211 111223468999999998654 57899999999999999999999999754332211110 00000
Q ss_pred --hhccccc--cccc-cCcccc-CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 296 --LFQDRTR--HSLI-ADPELQ-GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 296 --~~~~~~~--~~~~-~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
....... .... ..+... ....+.....+.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000 000000 00111224478899999999999999999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=300.30 Aligned_cols=251 Identities=26% Similarity=0.330 Sum_probs=200.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC-----CcchHHHHHHHHHHhhcCCCCccceEEEEecC--Cee
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 144 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 144 (399)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999999999999999875321 12235688899999999999999999998764 468
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999975 456899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCC-cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 225 LGPVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 225 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||......... .... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~----~~---- 224 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI--FKIA----TQ---- 224 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH--HHHH----cC----
Confidence 5322111 11122346889999999998888999999999999999999999999764332211 1000 00
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
......+......+.+++.+||. +|..||++.+++.
T Consensus 225 ------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 ------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00012233344578999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=301.69 Aligned_cols=244 Identities=24% Similarity=0.270 Sum_probs=191.8
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHH-hhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLML-SLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||.|+||.||+|.+..+++.||+|.+....... ...+..|..++ ...+||||+++++++...+..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999999999999999986543221 12344454443 455899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999976 467899999999999999999999999 99999999999999999999999999874222
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||............. ..... ...
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~~~--------~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL------SRRIN--------WPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hcccC--------CCC
Confidence 223458899999999988889999999999999999999999997654432211110 00000 000
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 314 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 314 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
.........+.+++.+||+.+|++||++.++.+.|
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 11112234789999999999999999776554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=311.33 Aligned_cols=265 Identities=19% Similarity=0.253 Sum_probs=195.4
Q ss_pred Ceeeec--CceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEG--GFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
..||.| +||+||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356766 9999999999999999999998754322 235688899999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC-Cc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD-NT 232 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 232 (399)
++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+....... ..
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999998643 345899999999999999999999999 9999999999999999999999998643211110 00
Q ss_pred c----eeeeeccCccccCcccccc--CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc-------
Q 015816 233 H----VSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD------- 299 (399)
Q Consensus 233 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 299 (399)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||................+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0 0011235667999999876 35789999999999999999999999765432221100000000000
Q ss_pred -------c---------------cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 300 -------R---------------TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 300 -------~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. ..........+...........+.+|+.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 00000000111111222345678999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.43 Aligned_cols=267 Identities=23% Similarity=0.310 Sum_probs=207.5
Q ss_pred CHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEecC
Q 015816 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADG 141 (399)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 141 (399)
.|.++-..+. +.||+|+|+.|--+....+|..||||++.+...-.+..+.+|++++.+++ |+||++++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3566655544 57999999999999999999999999998876666778999999999985 99999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC---ceEEe
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLS 218 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~ 218 (399)
..+|||||.|.||+|..+|+. ...+++.++..+..+|+.||.|||.+| |.||||||+|||....+ -||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 999999999999999999998 678999999999999999999999999 99999999999997654 47999
Q ss_pred cccCCccCCCCCC-----cceeeeeccCccccCcccc-----ccCCCCcccceeehhHHHHHHHhCCCCcccchHHH---
Q 015816 219 DFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYA-----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA--- 285 (399)
Q Consensus 219 Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--- 285 (399)
||.+..-...... .....+.+|+..|||||+. ....|+.++|.||||||||-||.|.+||.+.-..+
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 9988754222211 1222346899999999975 23578999999999999999999999996532211
Q ss_pred --HHHHHHhhhhhhccc-cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 286 --EQSLVAWARPLFQDR-TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 286 --~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...-......+|... .....+.+. -....+.+..+|+..+|-.||.+|.++..+++
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYeFPdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYEFPDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCcCChh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 110011111111110 011111111 11244567888999999999999999999886
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=321.35 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=211.1
Q ss_pred CCCCeeeecCceEEEEEEECCC---CeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 75 RSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.+.++||+|.||.|++|.+... ...||||.+...... ....|++|+.+|.+|+|||+++|||+..+ ....+|||+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 3456799999999999999743 346999999766544 56789999999999999999999999988 678899999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++|+|.+.|+. .....|.....-.++.|||.|+.||.+++ +|||||...|+||-....|||+|||+.+.....+
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999987 33677888999999999999999999999 9999999999999999999999999999766555
Q ss_pred Ccceee-eeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 231 NTHVST-RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 231 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
..+... ...-...|+|||.++...++.++|||+|||++|||++ |..||-+.........+.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD----------------- 329 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID----------------- 329 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-----------------
Confidence 444322 2234568999999999999999999999999999999 889998877665544432
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
..-...-+..+++.+.+++..||..+|++|||+..|.+.+-
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 11112334556679999999999999999999999986543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=306.47 Aligned_cols=256 Identities=16% Similarity=0.185 Sum_probs=187.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCC---CeEEEEEEeccCCCcch-H----------HHHHHHHHHhhcCCCCccceEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQGN-R----------EFLVEVLMLSLLHHPNLVNLIGY 137 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-~----------~~~~E~~~l~~l~hpniv~~~~~ 137 (399)
++|++.+.||+|+||.||+|.+..+ +..+|+|+......... + ....+...+..+.|+||+++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999999877 66777776433221111 1 11233345566789999999987
Q ss_pred EecCC----eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC
Q 015816 138 CADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213 (399)
Q Consensus 138 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~ 213 (399)
+.... ..++++|++. .++.+.+.. ....++..+..|+.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 65543 3467888775 567666654 334678889999999999999999999 99999999999999999
Q ss_pred ceEEecccCCccCCCCCCc-----ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHH-H
Q 015816 214 HPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-Q 287 (399)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~ 287 (399)
.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||........ .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999754322111 111234699999999999999999999999999999999999999976532111 1
Q ss_pred HH--HHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 288 SL--VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 288 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
.. ..+....... ... .+..+..+.+++..||..+|++||++.++++.|
T Consensus 244 ~~~~~~~~~~~~~~----------~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEG----------KIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhh----------hhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 10 1111111100 000 011234788999999999999999999999876
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=315.24 Aligned_cols=266 Identities=22% Similarity=0.298 Sum_probs=202.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecC-----Ce
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 143 (399)
.++|.+.+.||.|+||.||+|.+..++..||||.+.... ......+..|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357999999999999999999999999999999987532 22335677899999999999999999987654 35
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
.|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 789888875 567999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh-hhhcccc
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PLFQDRT 301 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~ 301 (399)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||................ .......
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 7543221 12233457889999998764 568999999999999999999999997654322211111000 0000000
Q ss_pred -------c------cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 302 -------R------HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 302 -------~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. ......+... ...+.....+.+++.+||+.+|++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 0000000000 0112234578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=301.19 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=196.8
Q ss_pred HHHHHHHhcCCCCCCee--eecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEec
Q 015816 64 FRELAAATKNFRSESLL--GEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD 140 (399)
Q Consensus 64 ~~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 140 (399)
+.+.....++|++.+.+ |.|+||.||++.++.++..+|+|.+........ |+.....+ +||||+++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34455566778887777 999999999999999999999999865432221 22222222 79999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-ceEEec
Q 015816 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSD 219 (399)
Q Consensus 141 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~D 219 (399)
.+..++||||+++++|.+++.. ...+++.+++.++.||+.||.|||+.+ ++||||||+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999976 458999999999999999999999999 99999999999999988 999999
Q ss_pred ccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
||++...... ....|+..|+|||++.+..++.++|||||||++|+|++|..||........ ....+.... ..
T Consensus 154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~ 225 (267)
T PHA03390 154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ-QK 225 (267)
T ss_pred CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh-cc
Confidence 9998753211 223588999999999988999999999999999999999999975432211 111111100 00
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-IADVVT 346 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~ 346 (399)
. ...++.....+.+++.+||+.+|.+||+ ++++++
T Consensus 226 --------~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 --------K----LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------c----CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 0111123347899999999999999996 588874
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=308.13 Aligned_cols=251 Identities=31% Similarity=0.420 Sum_probs=201.1
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.|+..+.||+|+||.||+|.+..++..||+|.+...... ....+..|+.+++.++|||++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 377788999999999999999988999999998644222 23468889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|++ |+|.+.+... ..++++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 106 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred CCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 997 5787777542 456899999999999999999999999 99999999999999999999999999864321
Q ss_pred CCcceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||............ ... . .
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~~----~-~---- 241 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQN----E-S---- 241 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--Hhc----c-C----
Confidence 12345889999999873 467899999999999999999999998764332221111 000 0 0
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
+.. ........+.+++.+||+.+|.+||++.++++.+..+.
T Consensus 242 --~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 --PTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred --CCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000 01122346889999999999999999999998766544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=302.58 Aligned_cols=242 Identities=26% Similarity=0.322 Sum_probs=190.0
Q ss_pred eeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHH---HHHhhcCCCCccceEEEEecCCeeEEEEEecC
Q 015816 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEV---LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~---~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 152 (399)
.||+|+||.||+|.+..+++.||+|.+....... ...+..|. .+++...||||+.+++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999987543321 12233343 34445679999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCc
Q 015816 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (399)
Q Consensus 153 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 232 (399)
|++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 9999998875 567999999999999999999999999 999999999999999999999999998643221
Q ss_pred ceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 233 HVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
......|+..|+|||++.++ .++.++|||||||++|+|++|+.||................ ...+.
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~~~~~- 217 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----------TMAVE- 217 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-----------ccCCC-
Confidence 11234689999999998754 68999999999999999999999997653221111110000 00111
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
.+......+.+++.+||..+|.+|| ++.++++
T Consensus 218 ---~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 ---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1112234788999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=303.44 Aligned_cols=264 Identities=22% Similarity=0.272 Sum_probs=201.2
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecC--CeeEEEEE
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYE 149 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 149 (399)
|++.+.||.|+||.||+|.+..+++.+|+|.+.... ......+..|+.+++.++|||++++++++.+. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999999999999999997653 22345688899999999999999999999888 88999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|++ ++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 998 5888888752 257999999999999999999999999 999999999999999999999999998754332
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.................... ........+
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT-DENWPGVSK 231 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc-hhhcccccc
Confidence 21 11223456888999997754 4688999999999999999999999976654332221111000000 000000000
Q ss_pred --------------ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 309 --------------PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 309 --------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+...........+.+++.+||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000011457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=301.98 Aligned_cols=246 Identities=27% Similarity=0.354 Sum_probs=198.0
Q ss_pred eeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
||.|+||.||+|.+..+++.|++|++..... .....+.+|+.+++.++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999999875543 2345688899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC-----
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN----- 231 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----- 231 (399)
.+++.. ...+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999986 457899999999999999999999999 99999999999999999999999999875332211
Q ss_pred -cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 -THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........++..|+|||.+.+..++.++||||||+++|+|++|..||.............. .. . ..+
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~--~---~~~- 221 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------GK--I---EWP- 221 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------CC--c---CCC-
Confidence 1122335678899999999888899999999999999999999999976553322111100 00 0 000
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
... .....+.+++.+||+.+|++|||+.++.+.|
T Consensus 222 --~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 222 --EDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred --ccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 000 0134788999999999999999995554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=304.73 Aligned_cols=264 Identities=24% Similarity=0.286 Sum_probs=203.2
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
|++.+.||.|++|.||+|.+..+++.+++|.+...... ....+..|+.+++.++||||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999999988999999998754332 3456888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
+ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 D-TDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred C-CCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 7 5888888752 357899999999999999999999999 9999999999999999999999999987543322
Q ss_pred cceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH-Hhhhhhhc----ccc---c
Q 015816 232 THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPLFQ----DRT---R 302 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~----~~~---~ 302 (399)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............ ........ ... .
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 112234578899999998776 7899999999999999999999999765543322111 10000000 000 0
Q ss_pred cccccCcc----ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 303 HSLIADPE----LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 303 ~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
......+. ......+.....+.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000 001112234568899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=322.63 Aligned_cols=204 Identities=28% Similarity=0.414 Sum_probs=175.7
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccC-CCcchHHHHHHHHHHhhcCCCCccceEEEEecC------CeeEE
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLL 146 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~l 146 (399)
|...+.||+||||.||+++++.+|+.||||.+... .....+...+|+++|++|+|||||+++++=++. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999999999999999999764 344567788999999999999999999875543 35689
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec--CCC--ceEEecccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGY--HPKLSDFGL 222 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~~kl~Dfg~ 222 (399)
|||||.||+|...+.+-. +...|++.+.+.++.+++.||.|||.+| |+||||||.||++- ++| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999998644 3567999999999999999999999999 99999999999984 334 369999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccc-cCCCCcccceeehhHHHHHHHhCCCCcccchHH
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 284 (399)
|+.... .......+||..|.+||+.. ...|+..+|.|||||++|+..||..||......
T Consensus 171 Arel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 996433 33567789999999999998 489999999999999999999999999765443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=312.59 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=205.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCC-----eeE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 145 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~ 145 (399)
+|++.+.||.|+||.||+|.+..+++.||||++.... ....+.+..|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999999889999999987643 334467889999999999999999999988775 789
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999998 588888875 458999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCc-ceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHh-hhhhhccccc
Q 015816 226 GPVGDNT-HVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-ARPLFQDRTR 302 (399)
Q Consensus 226 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~ 302 (399)
....... .......++..|+|||++.+. .++.++||||||+++|+|++|.+||.............. ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 4333210 112334578899999999887 899999999999999999999999976654332211110 0000000000
Q ss_pred -------cc-----cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 303 -------HS-----LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 303 -------~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.. ....+.-.....+.....+.+++.+||+.+|.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 0000000001112234578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.47 Aligned_cols=270 Identities=25% Similarity=0.300 Sum_probs=201.1
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCC----
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 142 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---- 142 (399)
...++|++.+.||.|+||.||+|.++.+++.||+|.+..... .....+..|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345789999999999999999999999999999999865432 22345778999999999999999999987654
Q ss_pred ------eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceE
Q 015816 143 ------QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (399)
Q Consensus 143 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 216 (399)
.+++|+||+++ +|..++... ...+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999985 777777642 346899999999999999999999999 99999999999999999999
Q ss_pred EecccCCccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh
Q 015816 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 295 (399)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 295 (399)
|+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||.................
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999875433221 11122346788999998754 4578999999999999999999999976544332222211100
Q ss_pred hhccccccccc-------cCc--ccc---CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 296 LFQDRTRHSLI-------ADP--ELQ---GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 296 ~~~~~~~~~~~-------~~~--~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
........... .+. ... .......+..+.+++..||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000000 000 000 0000112347899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=328.01 Aligned_cols=275 Identities=20% Similarity=0.234 Sum_probs=189.8
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCe-EEEEEEe--------------c---cCCCcchHHHHHHHHHHhhcCCC
Q 015816 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQ-DVAIKQL--------------D---RNGVQGNREFLVEVLMLSLLHHP 129 (399)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~hp 129 (399)
.....+|++.+.||+|+||.||+|..+.... .+++|.+ . .........+.+|+.+|+.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3456789999999999999999987654222 2222211 0 01111234578899999999999
Q ss_pred CccceEEEEecCCeeEEEEEecCCCCHHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcee
Q 015816 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (399)
Q Consensus 130 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nil 208 (399)
|||++++++.+.+..|+|++++. ++|..++..... .........+..|+.||+.||.|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999996 677777653211 1223446678889999999999999999 999999999999
Q ss_pred ecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCC-cccchHHHHH
Q 015816 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA-VDTSKAAAEQ 287 (399)
Q Consensus 209 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p-f~~~~~~~~~ 287 (399)
++.++.+||+|||++........ .......||..|+|||++.+..++.++|||||||++|||++|..+ +.........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999975432211 122335799999999999999999999999999999999998754 4332211111
Q ss_pred HHHHhhhh------hhccccc--cccccCccc---cCCCCh-----HhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 288 SLVAWARP------LFQDRTR--HSLIADPEL---QGQYPP-----RGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 288 ~~~~~~~~------~~~~~~~--~~~~~~~~~---~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.+...... .+..... ...+....+ ....++ .....+.+++.+||+.||++|||+.|+++.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111110 0000000 000000000 000000 112356778999999999999999999863
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=347.33 Aligned_cols=263 Identities=29% Similarity=0.525 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
...|...+.||+|+||.||+|.+..++..||||.+...... ...|+.++++++|||||++++++.+....|+||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34677889999999999999999888999999998643321 12468899999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++|+|.++++. ++|..+..|+.||+.||+|||....++|+||||||+||+++.++..++. ||......
T Consensus 765 ~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--- 833 (968)
T PLN00113 765 IEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--- 833 (968)
T ss_pred CCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc---
Confidence 999999999963 8899999999999999999995433349999999999999998888775 66543211
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
......||..|+|||++.+..++.++|||||||++|||++|+.||+..... ......|........ ......++.
T Consensus 834 ---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 908 (968)
T PLN00113 834 ---TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDC-HLDMWIDPS 908 (968)
T ss_pred ---cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCcc-chhheeCcc
Confidence 112235889999999999999999999999999999999999999643221 122333333222111 112223333
Q ss_pred ccC--CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 311 LQG--QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 311 ~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
+.. ........++.+++.+||+.||++||||.++++.|+.+..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 322 2344566778899999999999999999999999997755
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=311.80 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=199.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecC---------
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--------- 141 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------- 141 (399)
..+|++.+.||.|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36799999999999999999999999999999999766655667788999999999999999999776543
Q ss_pred -----CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-CCce
Q 015816 142 -----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHP 215 (399)
Q Consensus 142 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~ 215 (399)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999997 688888863 46899999999999999999999999 999999999999974 5678
Q ss_pred EEecccCCccCCCCCCc-ceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh
Q 015816 216 KLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 293 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 293 (399)
+|+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...............
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998753221111 11122357889999997654 56889999999999999999999999765443322211110
Q ss_pred hhhhcc------------ccc--cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 294 RPLFQD------------RTR--HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 294 ~~~~~~------------~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+.... ... ......+ .....+.....+.+++.+||+.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRP--LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCC--HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 000 0000000 00011123357889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=303.84 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=205.0
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 147 (399)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+..|+.++..++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 368899999999999999999999999999999875322 22356788999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999986 457999999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCCc------------------ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH
Q 015816 228 VGDNT------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (399)
Q Consensus 228 ~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 289 (399)
..... .......|+..|+|||++.+..++.++||||||+++|++++|..||...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 22210 122234578999999999888899999999999999999999999986643221111
Q ss_pred HHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 015816 290 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI----ADVVT 346 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~ 346 (399)
. .. .....+......+.+++.+||+.+|.+||++ .++++
T Consensus 234 ~------~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 I------LK------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H------Hh------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 00 0011222224478899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=308.27 Aligned_cols=267 Identities=21% Similarity=0.247 Sum_probs=199.3
Q ss_pred cCCC-CCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc--------------hHHHHHHHHHHhhcCCCCccceEE
Q 015816 72 KNFR-SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------------NREFLVEVLMLSLLHHPNLVNLIG 136 (399)
Q Consensus 72 ~~~~-~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~~~~ 136 (399)
++|. +.+.||.|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 4577999999999999999999999999986543221 124678999999999999999999
Q ss_pred EEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceE
Q 015816 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (399)
Q Consensus 137 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 216 (399)
++...+..++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9999999999999997 689999875 567899999999999999999999999 99999999999999999999
Q ss_pred EecccCCccCCCCC------------CcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchH
Q 015816 217 LSDFGLAKLGPVGD------------NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (399)
Q Consensus 217 l~Dfg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~ 283 (399)
|+|||++....... .........++..|+|||.+.+. .++.++|||||||++|+|++|..||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999987533110 00111223467889999988664 478999999999999999999999986654
Q ss_pred HHHHHHHHhhhhhhccccccccccC----------ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 284 AAEQSLVAWARPLFQDRTRHSLIAD----------PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
......................... +.......+.....+.+++.+||+.+|++|||+.+++.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 3322111100000000000000000 00000011122457889999999999999999999996
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.44 Aligned_cols=269 Identities=23% Similarity=0.284 Sum_probs=198.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCccceEEEEecCC------
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 142 (399)
.++|++.+.||.|+||.||+|.++.+++.||||.+....... ...+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999999999999999986543322 245678999999999999999999875433
Q ss_pred --eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 143 --QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 143 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
.+++||||+. ++|...+... ...+++..+..++.||++||.|||+.+ |+|+||||+|||++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 4699999997 5777777642 457999999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCc---------ceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH
Q 015816 221 GLAKLGPVGDNT---------HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (399)
Q Consensus 221 g~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~ 290 (399)
|++......... ...+...+++.|+|||.+.+ ..++.++|||||||++|+|++|++||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 998753222111 11123457888999998765 45899999999999999999999999765544322221
Q ss_pred Hhhhhhhcc-----ccccccccCccccCCCC-------hHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 291 AWARPLFQD-----RTRHSLIADPELQGQYP-------PRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 291 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
......... ........+.......+ ......+.+++.+||+.||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111000000 00000000000000111 112247889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=298.35 Aligned_cols=264 Identities=24% Similarity=0.317 Sum_probs=198.4
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhc---CCCCccceEEEEecCCe-----
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCADGDQ----- 143 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~----- 143 (399)
|++.+.||.|+||.||+|.++.++..||+|.+...... ....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67788999999999999999988999999999744322 224566788777666 59999999999988776
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
.+++|||+. ++|.+++.... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 58998887532 235899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHh-hhhhhccc-c
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-ARPLFQDR-T 301 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~~~-~ 301 (399)
........ .....++..|+|||++.+..++.++|||||||++|+|++|.+||.............. ........ .
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 75432211 1223478899999999998999999999999999999999999976554332211110 00000000 0
Q ss_pred ccc-----ccc--CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 302 RHS-----LIA--DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 302 ~~~-----~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... ... .........+.....+.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 000 000001112233467789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=302.76 Aligned_cols=245 Identities=32% Similarity=0.445 Sum_probs=196.5
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
|...+.||+|+||.||+|.+..++..|++|++...... ....+..|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999999999999999998654322 234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+. ++|.+++... ..++++.+++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 96 6787777642 456899999999999999999999999 9999999999999999999999999986421
Q ss_pred CcceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
......|+..|+|||++. ...++.++|||||||++|+|++|..||............. ...
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~------~~~------- 236 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QND------- 236 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH------hcC-------
Confidence 122346889999999984 4678899999999999999999999987654322211110 000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.+.. ..+.....+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 SPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011122368889999999999999999999953
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.44 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=203.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccC--CCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
-++.-...||.|.||.||.|.+.++|+..|+|-+.-. .......+.+|..++..++|||+|++||+=.+.+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 4577778999999999999999999999999987532 22333567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
||++|+|.+.+.. +.-.++.....+..|++.|+.|||++| ||||||||+||||+.+|.+|++|||.|......
T Consensus 1315 yC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999986 666788888899999999999999999 999999999999999999999999999764332
Q ss_pred CCc--ceeeeeccCccccCccccccC---CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 230 DNT--HVSTRVMGTYGYCAPEYAKTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 230 ~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
... ..-....||+.|||||++.+. .-..++|||||||++.||+||+.||......- ...........
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-------aIMy~V~~gh~- 1459 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-------AIMYHVAAGHK- 1459 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-------HHHhHHhccCC-
Confidence 111 112246799999999999653 45678999999999999999999997654321 11100111110
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.++|.....+-.++|.+||..||++|.++.++++
T Consensus 1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1334445557889999999999999988887774
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=286.92 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=199.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 148 (399)
.++.+++..||.|+-|.|++++.+.+|...|||.+..+... +.+.+++.+.++...+ +|+||+.+|+|......++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 34556677899999999999999999999999999876443 4467788888877665 899999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|.|. ..+..++... .+++++..+-++...++.||.||..+.. |+|||+||+|||+|+.|+|||||||++-...
T Consensus 171 elMs-~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlv- 243 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLV- 243 (391)
T ss_pred HHHH-HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceee-
Confidence 9985 5556666542 5779999999999999999999997643 9999999999999999999999999986432
Q ss_pred CCCcceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.+...+...|-+.|||||.+. ...|+..+||||||++++||.||+.||.........- .. + ..+.
T Consensus 244 --dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l-tk-v---ln~e----- 311 (391)
T KOG0983|consen 244 --DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL-TK-V---LNEE----- 311 (391)
T ss_pred --cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH-HH-H---HhcC-----
Confidence 334455667999999999884 4579999999999999999999999998755433211 10 0 0000
Q ss_pred ccCccccC--CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 306 IADPELQG--QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 306 ~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
-|.+.. .+.+ .+.+++..||..|+.+||...++++.
T Consensus 312 --PP~L~~~~gFSp----~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 --PPLLPGHMGFSP----DFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --CCCCCcccCcCH----HHHHHHHHHhhcCcccCcchHHHhcC
Confidence 011111 1333 77889999999999999999999863
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=300.37 Aligned_cols=266 Identities=21% Similarity=0.270 Sum_probs=209.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC--C----CccceEEEEecCCe
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH--P----NLVNLIGYCADGDQ 143 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p----niv~~~~~~~~~~~ 143 (399)
.+.+|.+...+|+|.||.|-.+.+..++..||||+++.- ....+..+.|+.+|.++.+ | -+|++.++|.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 378899999999999999999999999999999998643 2234566789999999942 3 37888899999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC------------
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR------------ 211 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~------------ 211 (399)
.|||+|.+ |-++.+++.... -.+++...+..+++||+++++|||+.+ ++|.||||+|||+..
T Consensus 166 iCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 99999988 469999998743 567899999999999999999999999 999999999999831
Q ss_pred --------CCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchH
Q 015816 212 --------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (399)
Q Consensus 212 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 283 (399)
+..|+|+|||.|+... ......+.|..|.|||++.+-.++..+||||+||||+|+.+|...|.+...
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 3458999999998522 223557789999999999999999999999999999999999999987776
Q ss_pred HHHHHHHHhhhhhhcccccccc---------ccC-c---------c---------ccCCCChHhHHHHHHHHHHccccCC
Q 015816 284 AAEQSLVAWARPLFQDRTRHSL---------IAD-P---------E---------LQGQYPPRGFYQALAVAAMCVHEQP 335 (399)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~---------~~~-~---------~---------~~~~~~~~~~~~l~~li~~cl~~dP 335 (399)
.+...+.+-....++....... -.| + . ..-.....+..+|++|+.+||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 5544444333222221111000 000 0 0 0011223456789999999999999
Q ss_pred CCCCCHHHHHHH
Q 015816 336 DMRPVIADVVTA 347 (399)
Q Consensus 336 ~~RPs~~eil~~ 347 (399)
.+|+|+.|+++.
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999853
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=297.75 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=200.1
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-----cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
+|.+.+.||+|+||.||+|.+..++..+++|++..... .....+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58888999999999999999988777777777653221 1233566799999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998765444567999999999999999999999999 999999999999975 569999999987532
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||............ ... .
T Consensus 157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~~~-------~ 221 (260)
T cd08222 157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI------VEG-------P 221 (260)
T ss_pred CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------HcC-------C
Confidence 22 11223345888999999998888999999999999999999999999754322111100 000 0
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+. .+......+.+++.+||..+|++||++.++++
T Consensus 222 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 TPS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111 12233447889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=303.00 Aligned_cols=248 Identities=30% Similarity=0.385 Sum_probs=197.7
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.|+..+.||.|+||.||+|++..++..||+|.+..... .....+..|+.+++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 46677889999999999999999999999999864322 223467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+. |+|.+++... ..++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 997 6888777542 456899999999999999999999999 99999999999999999999999999865321
Q ss_pred CCcceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.....|+..|+|||.+. ...++.++|||||||++|+|++|..||............ ....
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~---------- 230 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNE---------- 230 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH--hhcC----------
Confidence 12345889999999874 456889999999999999999999998664332211111 0000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
.+.. ........+.+|+.+||+.+|.+||++.+++....
T Consensus 231 -~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 231 -SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -CCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0000 01122347888999999999999999999996543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=302.69 Aligned_cols=257 Identities=20% Similarity=0.231 Sum_probs=191.4
Q ss_pred CceEEEEEEECCCCeEEEEEEeccC--CCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCHHHHhh
Q 015816 84 GFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH 161 (399)
Q Consensus 84 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 161 (399)
++|.||.++...+++.||||++... .....+.+..|+.+++.++||||+++++++.+.+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4455666666778999999998754 22344678999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC-----cceee
Q 015816 162 DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-----THVST 236 (399)
Q Consensus 162 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~ 236 (399)
... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||.+........ .....
T Consensus 92 ~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 THF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 643 346889999999999999999999999 99999999999999999999999998864322111 11112
Q ss_pred eeccCccccCcccccc--CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccc----------ccc
Q 015816 237 RVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT----------RHS 304 (399)
Q Consensus 237 ~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~ 304 (399)
...++..|+|||++.. ..++.++|||||||++|+|++|..||......... ............ ...
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCchhhhcCCcC
Confidence 3457788999999865 46889999999999999999999999764432211 110000000000 000
Q ss_pred c----ccCc----cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 305 L----IADP----ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 305 ~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. ..++ .............+.+++.+||+.||++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 0000 00111222334578889999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=305.13 Aligned_cols=267 Identities=22% Similarity=0.286 Sum_probs=201.7
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEec-CCe
Q 015816 67 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQ 143 (399)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 143 (399)
+...+++|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+..|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 34567889999999999999999999999999999998864322 234667889999999999999999998865 567
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
.++||||+. ++|..++.. .++++..+..++.||++||.|||+.+ |+||||+|+|||++.++.++|+|||.+
T Consensus 85 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehhc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 899999984 789888863 46888999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHH-hhhhh---h-
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA-WARPL---F- 297 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~~~~---~- 297 (399)
...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||............. ..... .
T Consensus 156 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 156 RIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 743211 122457889999998765 578999999999999999999999997654322211111 00000 0
Q ss_pred ---ccccccccccCccccCC-----CChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 298 ---QDRTRHSLIADPELQGQ-----YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 298 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
................. ..+.....+.+++.+||+.+|++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000000 011223578999999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=306.04 Aligned_cols=269 Identities=20% Similarity=0.269 Sum_probs=202.2
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecC
Q 015816 64 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (399)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 141 (399)
..++....++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34556677899999999999999999999998999999999875322 2245678899999999999999999988643
Q ss_pred ------CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCce
Q 015816 142 ------DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (399)
Q Consensus 142 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 215 (399)
...|++++++ +++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3467888877 6899888863 46899999999999999999999999 9999999999999999999
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 294 (399)
+|+|||++..... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||................
T Consensus 160 kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 160 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999875321 1223468899999998865 578899999999999999999999997544322211110000
Q ss_pred h----hh----ccccc------cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 295 P----LF----QDRTR------HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 295 ~----~~----~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. .. ..... ........+ ..........+.+++.+||+.||.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 00 00000 000000000 00001123468899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=305.94 Aligned_cols=261 Identities=21% Similarity=0.315 Sum_probs=196.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecC------C
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG------D 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~ 142 (399)
..+|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999999989999999998654222 235678899999999999999999998654 3
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
.+++|+||+. .+|..++ ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4699999996 4676655 245899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh----hh
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP----LF 297 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----~~ 297 (399)
+...... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||................+ .+
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8753221 123457889999999866 5689999999999999999999999986543222111111000 00
Q ss_pred ccccc----------cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 298 QDRTR----------HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 298 ~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..... ........+. ...+.....+.+++.+||+.||.+||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFS-TLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHH-HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0000000000 0011223468899999999999999999999953
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=298.67 Aligned_cols=264 Identities=24% Similarity=0.306 Sum_probs=199.2
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEEEEec
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
|++.+.||.|+||.||+|....+++.|+||.+...... ......+|+..++.++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 67788999999999999999988999999998654322 2234567899999999 999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
+++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 789999887632 347899999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeeeeccCccccCccccc-cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH-Hhhhhhhc----ccccccc
Q 015816 232 THVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPLFQ----DRTRHSL 305 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~----~~~~~~~ 305 (399)
......++..|+|||++. +..++.++|+||||+++|+|++|++||............ ........ .......
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 122345788999999874 456889999999999999999999999765443221111 00000000 0000000
Q ss_pred ccCccc-------cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 IADPEL-------QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 ~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.....+ .....+.....+.+++.+||+.+|.+|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000 00111122457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=300.57 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=199.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC---CCCeEEEEEEeccCCC----cchHHHHHHHHHHhhc-CCCCccceEEEEecCCee
Q 015816 73 NFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 144 (399)
+|++.+.||+|+||.||+|.+. .++..||||++..... ...+.+..|+.++..+ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999864 3578899999864322 2235678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999875 456899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCC--CCcccceeehhHHHHHHHhCCCCcccchHHH-HHHHHHhhhhhhcccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAA-EQSLVAWARPLFQDRT 301 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 301 (399)
....... .......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||....... ...... .....
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~-- 227 (288)
T cd05583 154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR---RILKS-- 227 (288)
T ss_pred ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH---HHHcc--
Confidence 5332211 1122345889999999987654 7889999999999999999999996432111 111110 00000
Q ss_pred ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 302 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
.+.. +......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 228 ------~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ------KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ------CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111 11222378889999999999999998888776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=301.37 Aligned_cols=258 Identities=28% Similarity=0.380 Sum_probs=203.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cc------hHHHHHHHHHHhhcCCCCccceEEEEe-cCC
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QG------NREFLVEVLMLSLLHHPNLVNLIGYCA-DGD 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~------~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~ 142 (399)
.++|-++++||+|||+.||+|.+....+.||+|+-..+.. .+ .+...+|..|-+.|.||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3468889999999999999999998899999998654322 11 134678999999999999999999985 556
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---CCceEEec
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSD 219 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~D 219 (399)
.+|-|+|||+|.+|.-||+. ...+++.++..|+.||+.||.||... ++||||-||||.|||+.. .|.|||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 78999999999999999998 67799999999999999999999988 577999999999999954 57899999
Q ss_pred ccCCccCCCCCCc-----ceeeeeccCccccCcccccc----CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH
Q 015816 220 FGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (399)
Q Consensus 220 fg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~ 290 (399)
||+++.+...... ..+....||.+|++||.+-- ..++.++||||+|||+|+.+.|+.||........ +.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--IL 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--IL 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HH
Confidence 9999986554433 23455789999999998743 4678999999999999999999999976543221 11
Q ss_pred HhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHH
Q 015816 291 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 345 (399)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 345 (399)
.... .+. -.++.-...|....+...+|++||+..-++|....++.
T Consensus 695 qeNT-Ilk---------AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 QENT-ILK---------ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhhc-hhc---------ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1110 000 01111111223344778899999999999998777665
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=307.07 Aligned_cols=265 Identities=22% Similarity=0.240 Sum_probs=196.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCC--CeEEEEEEeccCCC--cchHHHHHHHHHHhhc-CCCCccceEEEEec----CCe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESI--NQDVAIKQLDRNGV--QGNREFLVEVLMLSLL-HHPNLVNLIGYCAD----GDQ 143 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~~~ 143 (399)
+|++.+.||+|+||.||+|.+..+ +..||+|.+..... .....+..|+.+++.+ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478889999999999999999988 88999999864322 2245678899999999 59999999987543 245
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
.++++||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999986 789998875 567999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc--ceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH-HHhhhhh---
Q 015816 224 KLGPVGDNT--HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPL--- 296 (399)
Q Consensus 224 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~--- 296 (399)
......... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||........... .......
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 753322111 11223568999999998755 5789999999999999999999999976543221111 0000000
Q ss_pred ----hcccc------ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 297 ----FQDRT------RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 297 ----~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+.... .........+ ....+.....+.+++.+||+.||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0000000000 0111122457889999999999999999999984
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=300.39 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=196.1
Q ss_pred CCCCCCeeeecCceEEEEEEEC---CCCeEEEEEEeccCCC----cchHHHHHHHHHHhhc-CCCCccceEEEEecCCee
Q 015816 73 NFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 144 (399)
+|++.+.||.|+||.||+|.+. .+|..||+|++..... ...+.+.+|+.+++.+ +|+||+.+++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788899999999999999875 4689999999865322 2335678899999999 589999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+|||++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999976 567899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeeccCccccCcccccc--CCCCcccceeehhHHHHHHHhCCCCcccchHHH-HHHHHHhhhhhhcccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA-EQSLVAWARPLFQDRT 301 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 301 (399)
...... ........|+..|+|||.+.+ ..++.++||||||+++|+|++|..||....... ...... .....
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~-- 227 (290)
T cd05613 154 EFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---RILKS-- 227 (290)
T ss_pred eccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH---Hhhcc--
Confidence 532221 111223568899999999865 357889999999999999999999996432111 111111 00000
Q ss_pred ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 302 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
.+. ++......+.+++.+||+.||++|| ++.+++.
T Consensus 228 ------~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 ------EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 011 1122234788899999999999997 5566653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=333.54 Aligned_cols=255 Identities=29% Similarity=0.408 Sum_probs=192.7
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEec-------
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------- 140 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------- 140 (399)
....+|+....||+||||.||+|+++-+|+.||||+|.... ......+.+|+..|.+|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567889999999999999999999999999999997654 2234568899999999999999999843100
Q ss_pred -----------------------------------------------------------------------C--------
Q 015816 141 -----------------------------------------------------------------------G-------- 141 (399)
Q Consensus 141 -----------------------------------------------------------------------~-------- 141 (399)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CeeEEEEEecCCCCHHHHhhccCCCCCCC-CHHHHHHHHHHHHHHHH
Q 015816 142 ---------------------------------DQRLLVYEYMPLGSVEDHLHDLSPGKKPL-DWNTRMKIAAGAARGLE 187 (399)
Q Consensus 142 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l-~~~~~~~i~~qi~~al~ 187 (399)
..+||-||||+..+|.+++.. +... .....|.++++|++||.
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHH
Confidence 124889999997777777765 2222 46789999999999999
Q ss_pred HHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC----------------CCCCcceeeeeccCccccCccccc
Q 015816 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP----------------VGDNTHVSTRVMGTYGYCAPEYAK 251 (399)
Q Consensus 188 ~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~ 251 (399)
|+|++| ||||||||.||++++++.|||+|||++.... .+......+..+||.-|+|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999999 9999999999999999999999999997511 011122345678999999999997
Q ss_pred cC---CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 015816 252 TG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 328 (399)
Q Consensus 252 ~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 328 (399)
+. .|+.|+|+||||||+|||+. ||.+.-... ..+...+ ...+..+ .++.......-..+|+
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa--~iL~~LR--------~g~iP~~---~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA--SILTNLR--------KGSIPEP---ADFFDPEHPEEASLIR 852 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchHHHH--HHHHhcc--------cCCCCCC---cccccccchHHHHHHH
Confidence 65 49999999999999999985 465532211 1111111 1111111 1222223335567999
Q ss_pred HccccCCCCCCCHHHHHH
Q 015816 329 MCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 329 ~cl~~dP~~RPs~~eil~ 346 (399)
++++.||.+||||.|+|.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999985
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=298.91 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=195.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||.||+|.++.+++.||||.+...... ....+..|+.++.... ||||+++++++.+....|+|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 5688899999999999999999998999999999754332 2345666777666664 9999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|+. ++|.+++... ...+++..+..++.||+.||+|||+ .+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 95 ~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 986 5777776542 3478999999999999999999997 57 99999999999999999999999999865322
Q ss_pred CCCcceeeeeccCccccCccccccCC----CCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQ----LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
.. ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||........ .+.... ... ..
T Consensus 168 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~----~~~--~~ 237 (296)
T cd06618 168 SK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLTKIL----QEE--PP 237 (296)
T ss_pred CC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHHHHh----cCC--CC
Confidence 11 112235788999999986543 88999999999999999999999975432211 111111 100 00
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.... .......+.+|+.+||+.||.+||++.++++.
T Consensus 238 ~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SLPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 00123478999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=304.95 Aligned_cols=263 Identities=21% Similarity=0.287 Sum_probs=199.1
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCC----
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 142 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---- 142 (399)
...++|++.+.||+|+||.||+|.+..++..||||++...... ....+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3467899999999999999999999999999999998643222 2346788999999999999999999987653
Q ss_pred --eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 143 --QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 143 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 458999998 6899888863 56899999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHH-HHHhhhh---
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARP--- 295 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~--- 295 (399)
|++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.......... .......
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 998753221 123457889999998865 468899999999999999999999997654322111 1000000
Q ss_pred hhcccc-----c-----cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 296 LFQDRT-----R-----HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 296 ~~~~~~-----~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+.... . ........+ ....+.....+.+++.+||+.||++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0 000000000 0111223346889999999999999999999994
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=265.49 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=208.6
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+|.-.+.||+|.||+||+|+++++++.||+|.+...... .-....+|+.+|+.++|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 355567899999999999999999999999998754322 235678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
|. .+|..|.... ++.++...+..++.|+++||.|+|+++ ++||||||.|.||+.+|.+||+|||+++.+...
T Consensus 83 cd-qdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip- 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP- 154 (292)
T ss_pred hh-HHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence 97 7888888764 577999999999999999999999999 999999999999999999999999999864433
Q ss_pred CcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccc--cccc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTR--HSLI 306 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 306 (399)
.......+-|..|.+|.++.+ .-|+...|+||.||++.|+.. |++.|.+....+....+-+.......... ...+
T Consensus 155 -vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred -eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 223344567999999998866 568999999999999999987 77778877666655554444332222221 1222
Q ss_pred cCccccCCCC---------hHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 307 ADPELQGQYP---------PRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 307 ~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.|-....-++ |.....-.+|+.++|.-+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2211112222 222234477999999999999999998875
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=297.14 Aligned_cols=263 Identities=25% Similarity=0.325 Sum_probs=201.6
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
|++.+.||+|+||.||+|....+++.||+|++.... ......+..|+.+++.++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999999999999999997653 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
+ ++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 6999999862 147999999999999999999999999 99999999999999999999999999875432221
Q ss_pred cceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH-Hhhh-------hhhccccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWAR-------PLFQDRTR 302 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~-------~~~~~~~~ 302 (399)
......++..|+|||.+.+. .++.++|||||||++|||++|.+||............ .... .......
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12223467889999998766 8899999999999999999999999765433221111 0000 0000000
Q ss_pred cccccCcccc----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 303 HSLIADPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 303 ~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
......+... ....+.....+.+++.+||..||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 0001112457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=290.59 Aligned_cols=237 Identities=30% Similarity=0.365 Sum_probs=195.7
Q ss_pred eeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
||.|+||.||++.+..+++.||+|.+...... ....+..|+.+++.++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999988999999998765432 235688899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceee
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (399)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999986 457899999999999999999999999 9999999999999999999999999987532221 1223
Q ss_pred eeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCC
Q 015816 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 316 (399)
Q Consensus 237 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
...++..|+|||.+.+...+.++|+||||+++|+|++|..||............ ... . ...+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~--------~----~~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI------LKD--------P----LRFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------hcC--------C----CCCC
Confidence 456888999999998888999999999999999999999999765432211111 000 0 0111
Q ss_pred hHhHHHHHHHHHHccccCCCCCCCHHH
Q 015816 317 PRGFYQALAVAAMCVHEQPDMRPVIAD 343 (399)
Q Consensus 317 ~~~~~~l~~li~~cl~~dP~~RPs~~e 343 (399)
...+..+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 222347889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=308.65 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=199.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCCe----
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ---- 143 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---- 143 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4568999999999999999999999999999999986432 2233567789999999999999999988766554
Q ss_pred --eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 144 --RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 144 --~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
.++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5799998874 56999999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh----
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL---- 296 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---- 296 (399)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..................
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 98753221 223457889999998865 46889999999999999999999999765443221111000000
Q ss_pred hcccccc----------ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 297 FQDRTRH----------SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 297 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+...... .....+.+. .........+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFK-EVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHH-HHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000 000000000 000112457899999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=325.47 Aligned_cols=147 Identities=31% Similarity=0.418 Sum_probs=133.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ...+..|+.++..++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999997543322 25678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
|||+.+++|.+++.. ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999976 456899999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=290.19 Aligned_cols=282 Identities=23% Similarity=0.352 Sum_probs=220.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccC---CCcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 146 (399)
..+|+++++||+|+|++|-+++++.+.+.||+|++++. ...+.+.+..|-.+..+. +||++|-++..|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 45799999999999999999999999999999999764 233445677777777765 69999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
|.||++||+|--.++. ...|+++.+..+...|+.||.|||+.| ||.||||.+|||+|..|++||+|+|+++..
T Consensus 329 vieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999888876 678999999999999999999999999 999999999999999999999999999863
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHH-HHHHHhhhhh-hccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPL-FQDRTRHS 304 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~-~~~~~~~~ 304 (399)
. .....+.+++||+.|+|||++.+..|...+|+|+|||+++||+.|+.||+....... .....+.-.. +...
T Consensus 402 l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq---- 475 (593)
T KOG0695|consen 402 L--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ---- 475 (593)
T ss_pred C--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc----
Confidence 2 233445678999999999999999999999999999999999999999975332111 1111111111 1110
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCC------HHHHHHHHHHHHhccCCCcccccCCCCCCCCCCc
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV------IADVVTALAYLASQKYESDAEKVQSPCLDPGTPT 374 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~~L~~l~~~~~~~~~~~~~~~~~~~~~p~ 374 (399)
..+|.........++...|++||.+|.. +.++ +....+....|+-..++...|+..|....
T Consensus 476 --------iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~di-k~h~ffr~idwd~leqk~v~ppf~p~i~~ 542 (593)
T KOG0695|consen 476 --------IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDI-KSHAFFRSIDWDLLEQKQVLPPFQPQITD 542 (593)
T ss_pred --------ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhh-hcchhhhhCCHHHHhhcccCCCCCCcccc
Confidence 1222223335566889999999999942 3333 23445556667777777777777765544
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=303.03 Aligned_cols=245 Identities=26% Similarity=0.354 Sum_probs=201.9
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCC
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 154 (399)
.+.||+|.||+||-|+++.+|+.||||+|++.... ...++.+|+.||++++||.||.+--.|+..+.+++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 47899999999999999999999999999875443 34678899999999999999999999999999999999996 6
Q ss_pred CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC---CceEEecccCCccCCCCCC
Q 015816 155 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 155 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~ 231 (399)
++.+.|-... .+.|++.....++.||+.||.|||.++ |+|+||||+|||+... ..+||||||+|+..+ .
T Consensus 648 DMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg---E 719 (888)
T KOG4236|consen 648 DMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG---E 719 (888)
T ss_pred hHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecc---h
Confidence 7766665433 678999999999999999999999999 9999999999999754 479999999999643 2
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
......++||+.|+|||++++..|+..-|+||.|||+|--|+|..||.......++ ++. -.++.|.
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQN-----------AaFMyPp- 785 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQN-----------AAFMYPP- 785 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhc-----------cccccCC-
Confidence 33455688999999999999999999999999999999999999999765432221 110 1111111
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.-..+.....++||..+|+..-.+|-|....+.
T Consensus 786 --~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 --NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred --CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 111234457889999999999999999887664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=308.99 Aligned_cols=242 Identities=25% Similarity=0.333 Sum_probs=197.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++..|++...+|.|+|+.|-.+.+..+++..++|++.... ....+|+.++... +||||+++++.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567889999999999999999999999999999997652 2233466555554 6999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee-cCCCceEEecccCCccCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfg~~~~~~ 227 (399)
|++.|+-|.+.+.. ...+. .++..|+.+|+.|+.|||++| ||||||||+|||+ +..++++|+|||.+....
T Consensus 396 e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999999888875 33333 788899999999999999999 9999999999999 689999999999998533
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. ....+-|..|.|||++....|++++||||||++||+||+|+.||...... .++.....
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~------------- 527 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQ------------- 527 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhc-------------
Confidence 32 22345688999999999999999999999999999999999999765544 11111110
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.+ .+....+....+|+.+||+.||.+||++.++...
T Consensus 528 ~~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 528 MP----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CC----ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 01 1112334488899999999999999999999854
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=304.57 Aligned_cols=273 Identities=25% Similarity=0.316 Sum_probs=223.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.+++....||-||||.|=++..++....+|+|++++....+ .+.+..|-.||..++.|+||++|..|.+..+.|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45677788999999999999998766669999987764433 355788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|-|-||.|+..+.. .+.|+...+..++..+++|++|||+++ ||+|||||+|.+++.+|-+||.|||+|+....
T Consensus 500 EaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999998 788999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
+ ..+-+++||+.|.|||++.+...+.++|.||||+++||||+|.+||........-.++.....
T Consensus 573 g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------------- 636 (732)
T KOG0614|consen 573 G---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------------- 636 (732)
T ss_pred C---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-------------
Confidence 3 334568999999999999999999999999999999999999999998766443332211110
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHHHHhccCCCcccccCCCCCCCC
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVTALAYLASQKYESDAEKVQSPCLDPG 371 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~~l~~~~~~~~~~~~~~~~~~~~ 371 (399)
...+|........+|+.+++..+|.+|.- +.+|-+ ...+..-.|+........|+..|.
T Consensus 637 ---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk-H~Wf~gfdweglr~~~L~pPi~~~ 700 (732)
T KOG0614|consen 637 ---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK-HRWFEGFDWEGLRSRTLPPPIIPS 700 (732)
T ss_pred ---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh-hhhhhcCChhhhhhccCCCCcccc
Confidence 02344555567888999999999999975 555543 333555566666665555555543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=286.11 Aligned_cols=221 Identities=24% Similarity=0.264 Sum_probs=179.4
Q ss_pred cCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCHHHHhhc
Q 015816 83 GGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 162 (399)
Q Consensus 83 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 162 (399)
|.||.||+|.++.+++.||+|.+.... .+..|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999986542 223355555556799999999999999999999999999999999976
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCc
Q 015816 163 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242 (399)
Q Consensus 163 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 242 (399)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||.+...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 456999999999999999999999999 999999999999999999999999987643221 12234677
Q ss_pred cccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHH
Q 015816 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 322 (399)
Q Consensus 243 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (399)
.|+|||.+.+..++.++||||+||++|||++|..|+....... .. . .....++.....
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~---~-------~~~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT---H-------TTLNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc---c-------cccCCcccCCHH
Confidence 8999999988889999999999999999999998875432110 00 0 000122223347
Q ss_pred HHHHHHHccccCCCCCCCHH
Q 015816 323 ALAVAAMCVHEQPDMRPVIA 342 (399)
Q Consensus 323 l~~li~~cl~~dP~~RPs~~ 342 (399)
+.+++.+||+.||++||++.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHccCCHHHhcCCC
Confidence 88999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=284.16 Aligned_cols=284 Identities=21% Similarity=0.254 Sum_probs=205.9
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCe----EEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEec-C
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-G 141 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 141 (399)
+....|+....||+|.||.||+|..++++. .+|||++.... ........+|+.+++.++||||+.+..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 445679999999999999999997665544 68999987542 2233567889999999999999999998877 7
Q ss_pred CeeEEEEEecCCCCHHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC----CceE
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSP-GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG----YHPK 216 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~k 216 (399)
..+++++||.+ -+|.+.|+-... ....++...+..|+.||+.|+.|||++= |+||||||+||||..+ |.||
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 78999999998 688888874322 2457999999999999999999999997 9999999999999877 9999
Q ss_pred EecccCCccCCCCCCc-ceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHH---HHH
Q 015816 217 LSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS---LVA 291 (399)
Q Consensus 217 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~---~~~ 291 (399)
|+|||+++.+...-.. .....++-|..|.|||.+.+ ..|+.+.||||+|||+.||+|-.+.|.......... ...
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 9999999874332221 12344678999999998865 679999999999999999999988886543321111 000
Q ss_pred hhhhhhc------cccccccccCccc-------c----CCC-ChH-------hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 292 WARPLFQ------DRTRHSLIADPEL-------Q----GQY-PPR-------GFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 292 ~~~~~~~------~~~~~~~~~~~~~-------~----~~~-~~~-------~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.....+. .........-|+. . .++ ... -.....+|+.++|..||.+|.|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 0011110 0000000000110 0 000 000 0123678999999999999999999998
Q ss_pred HHHHHHhccC
Q 015816 347 ALAYLASQKY 356 (399)
Q Consensus 347 ~L~~l~~~~~ 356 (399)
..-+.....+
T Consensus 337 h~yF~~d~lp 346 (438)
T KOG0666|consen 337 HPYFTEDPLP 346 (438)
T ss_pred ccccccCCCC
Confidence 6655544444
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=285.63 Aligned_cols=257 Identities=26% Similarity=0.325 Sum_probs=197.8
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhh-cCCCCccceEEEEecCCeeEEEEEec
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.+-+..||.|+||+|++-.++.+|+..|||.+..+.. .+..++..|.+...+ -++||||++||++..+...++.||+|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 3345679999999999999999999999999986655 445678888876554 46899999999999999999999999
Q ss_pred CCCCHHHHhhc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 152 PLGSVEDHLHD-LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 152 ~~g~L~~~l~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+ .+|..+... +...+..+++...-.|....+.||.||...-+ ||||||||+|||++..|.|||||||++-.. .
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqL---v 219 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQL---V 219 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhH---H
Confidence 7 676554432 11225678998888899999999999987655 999999999999999999999999998632 2
Q ss_pred CcceeeeeccCccccCcccccc--CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.+...+.-.|-..|||||.+.. ..|+.+|||||||++|||+.||..|+........+ +...+....+ ....+
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq-l~~Vv~gdpp-----~l~~~ 293 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ-LCQVVIGDPP-----ILLFD 293 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH-HHHHHcCCCC-----eecCc
Confidence 2333445678899999998853 45999999999999999999999999887664332 1111111100 00000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.. .-+....+..+|..||.+|-..||+..++.+.
T Consensus 294 ~~-----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KE-----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cc-----ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 00 01234478999999999999999999998864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=309.17 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=215.5
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEec--
Q 015816 64 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD-- 140 (399)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-- 140 (399)
++.+..-+..|++...||.|.+|.||+++.+.+++..|+|+...... ..+++..|..||+.+ .|||++.+|+++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34444456678999999999999999999999999999999876533 456677788999887 59999999998853
Q ss_pred ---CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEE
Q 015816 141 ---GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (399)
Q Consensus 141 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 217 (399)
+++++||||||.||+..|+++... +..+.|..+..|++.++.|+.+||.+. ++|||||-.|||++.++.|||
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 578999999999999999999876 788999999999999999999999998 999999999999999999999
Q ss_pred ecccCCccCCCCCCcceeeeeccCccccCcccccc-----CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHh
Q 015816 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 292 (399)
+|||++..... ......+..||+.|||||++.. ..|+..+|+||||++..||--|.+|+.......
T Consensus 165 vDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------- 235 (953)
T KOG0587|consen 165 VDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------- 235 (953)
T ss_pred eeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------
Confidence 99999875321 1222345679999999999853 457889999999999999999999987654422
Q ss_pred hhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+|. ...+|.....-+...+..+.++|..||..|-++||++.++++
T Consensus 236 --aLF~------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 --ALFL------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --hhcc------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1121 122444444556677889999999999999999999999885
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=292.23 Aligned_cols=265 Identities=30% Similarity=0.443 Sum_probs=201.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhh--cCCCCccceEEEEecCC----eeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCADGD----QRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~~----~~~ 145 (399)
....+..+||+|.||.||+|... ++.||||++... ....|..|-.|.+. +.|+||++++++-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34556678999999999999987 599999998643 45667777777664 68999999999876655 899
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeeecCCCCCceeecCCCceEEec
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK------AKPPVIYRDLKCSNILLDRGYHPKLSD 219 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~~~ivH~Dlkp~Nill~~~~~~kl~D 219 (399)
||++|.+.|+|.+||.. ..++|....+++..+++||+|||+- .+++|+|||||..||||..+++..|+|
T Consensus 285 LVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999985 6699999999999999999999964 367899999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeeeccCccccCccccccCC-CC-----cccceeehhHHHHHHHhCCCCccc--------chHHH
Q 015816 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ-LT-----LKSDVYSFGVVLLEILSGRKAVDT--------SKAAA 285 (399)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~il~ell~g~~pf~~--------~~~~~ 285 (399)
||+|.....+.........+||.+|||||++.+.. +. .+.||||+|.+||||++...-+.. ....+
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99998876665555555588999999999986531 21 358999999999999986543321 11100
Q ss_pred ------HHHHHHhhhhhhccccccccccCccccCCCC-hHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 286 ------EQSLVAWARPLFQDRTRHSLIADPELQGQYP-PRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 286 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
..++...+ ...... |.+...+- -.....+.+.+..||..||+.|.|+.=+.+++..+....
T Consensus 440 vG~hPt~e~mq~~V----V~kK~R-----P~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 440 VGNHPTLEEMQELV----VRKKQR-----PKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred hcCCCCHHHHHHHH----HhhccC-----CCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 00111111 000011 11110000 023457888999999999999999999999998887544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=309.26 Aligned_cols=255 Identities=29% Similarity=0.447 Sum_probs=215.6
Q ss_pred CCCCeeeecCceEEEEEEECCCC----eEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 75 RSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
+..++||+|+||+||+|.+--.| .+||||++.... .....+++.|+.+|..++|||+++++++|.... +-||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34578999999999999985444 468999886543 345678999999999999999999999998765 889999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++|+|.+|++.. +.++-....+.|..||++||.|||.++ +|||||...||||..-..+||+|||+++.....
T Consensus 778 ~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999973 567888999999999999999999999 999999999999999999999999999986655
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
..........-.+.|||=|.+....|+.++|||||||++||++| |..|++.....+..++.....
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-------------- 917 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-------------- 917 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc--------------
Confidence 54444443445678999999999999999999999999999999 999999887766555442221
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
+...|+....++..++.+||..|+..||++.++...+..+..
T Consensus 918 ---RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 918 ---RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ---cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 124455666688899999999999999999999998877654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=306.64 Aligned_cols=206 Identities=27% Similarity=0.306 Sum_probs=179.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcch---HHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
..-|..++.||-|+||.|.++...+|...||+|.+.+.+.... ..+..|-.||..-..+-||+||..|++.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3458888999999999999999999999999999987654433 3467799999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|+|++||++-.+|.. .+-|++..++.++.++..|+++.|..| +|||||||+|||||.+|+|||+|||+|.-+.
T Consensus 708 MdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999987 677999999999999999999999999 9999999999999999999999999986321
Q ss_pred CCCCcc----------------------------------------eeeeeccCccccCccccccCCCCcccceeehhHH
Q 015816 228 VGDNTH----------------------------------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 267 (399)
Q Consensus 228 ~~~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 267 (399)
...+.. .....+||+.|+|||++....|+..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 110000 0112579999999999999999999999999999
Q ss_pred HHHHHhCCCCcccchH
Q 015816 268 LLEILSGRKAVDTSKA 283 (399)
Q Consensus 268 l~ell~g~~pf~~~~~ 283 (399)
||||+.|+.||.....
T Consensus 861 l~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTP 876 (1034)
T ss_pred HHHHhhCCCCccCCCC
Confidence 9999999999975543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=284.23 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=200.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhh--cCCCCccceEEEEecC----Ce
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCADG----DQ 143 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~----~~ 143 (399)
..++..+.+.||+|.||.||+|.++ |+.||||++.. .+.+.+.+|.+|.+. |+|+||+.+++.-..+ .+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3456778899999999999999998 78999999863 345667778888764 6999999999875443 36
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeecCCCCCceeecCCCceEEe
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-----KAKPPVIYRDLKCSNILLDRGYHPKLS 218 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-----~~~~~ivH~Dlkp~Nill~~~~~~kl~ 218 (399)
++||++|-+.|||+|||.. ..++....++++..+|.||++||. +|+|.|.|||||..|||+..++..-|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 8999999999999999985 679999999999999999999994 588999999999999999999999999
Q ss_pred cccCCccCCCCCC--cceeeeeccCccccCccccccCC----CC--cccceeehhHHHHHHHhC----------CCCccc
Q 015816 219 DFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAKTGQ----LT--LKSDVYSFGVVLLEILSG----------RKAVDT 280 (399)
Q Consensus 219 Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~DvwslG~il~ell~g----------~~pf~~ 280 (399)
|+|+|........ .......+||.+|||||++.... +. ..+||||||.++||+.-. ++||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 9999975433221 11223467999999999986532 11 358999999999999753 356643
Q ss_pred chHHHH--HHHHHhhhhhhccccccccccCccccC-CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 281 SKAAAE--QSLVAWARPLFQDRTRHSLIADPELQG-QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 281 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
....+. .++...+ ..+. ..|.+.. -...+....+.+|++.||..||..|.|+--|-+.|.++..
T Consensus 439 ~Vp~DPs~eeMrkVV---Cv~~------~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVV---CVQK------LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCCHHHHhcce---eecc------cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 221111 0110000 0000 0011111 1122456788999999999999999999999999998874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=305.02 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=205.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECC-------CCeEEEEEEeccCCC-cchHHHHHHHHHHhhcC-CCCccceEEEEecCC
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 142 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 142 (399)
++..+.+.||.|.||.|++|.... ....||||.+..... .+.+.+..|+.+|+.+. ||||+.++++|....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 445666799999999999998541 145799999875543 34567899999999984 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLS---PG-------K--KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~---~~-------~--~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~ 210 (399)
.+++|+||+..|+|.+++.... .- . ..++..+.+.++.|||.|++||++.. +|||||...|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999998754 00 1 23899999999999999999999999 99999999999999
Q ss_pred CCCceEEecccCCccCCCCCCcceeeeecc--CccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHH
Q 015816 211 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMG--TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (399)
Q Consensus 211 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~ 287 (399)
.+..+||+|||+++.......... ....| ...|||||.+....|+.++|||||||+|||+++ |..|+.........
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 999999999999985433332221 11222 345999999999999999999999999999999 88999763322111
Q ss_pred HHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 288 SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
..+... .. ....|.....++.+++..||+.+|++||++.++.+.++...
T Consensus 532 --~~~l~~----G~----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 532 --LEFLKE----GN----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred --HHHHhc----CC----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111111 10 11222333447889999999999999999999999998743
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=268.58 Aligned_cols=238 Identities=30% Similarity=0.378 Sum_probs=194.7
Q ss_pred CceEEEEEEECCCCeEEEEEEeccCCCcc-hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCHHHHhhc
Q 015816 84 GFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 162 (399)
Q Consensus 84 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 162 (399)
+||.||+|.+..+++.+|+|++....... .+.+..|+..++.++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999997665444 67889999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCc
Q 015816 163 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242 (399)
Q Consensus 163 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 242 (399)
...+++..++.++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 334899999999999999999999999 9999999999999999999999999997643322 223456888
Q ss_pred cccCccccccCCCCcccceeehhHHHHHHHhCCCCcccc-hHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHH
Q 015816 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS-KAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 321 (399)
Q Consensus 243 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (399)
.|+|||.+.+..++.++||||||+++|+|++|..||... ......... .. ..... .........
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~---~~----~~~~~--------~~~~~~~~~ 215 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI---GK----PKPPF--------PPPEWKISP 215 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---hc----cCCCC--------ccccccCCH
Confidence 999999998888999999999999999999999999763 222111111 10 00000 000000234
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 015816 322 QALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 322 ~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+.+++.+||..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 7888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=269.79 Aligned_cols=274 Identities=22% Similarity=0.305 Sum_probs=204.9
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccC-CCc-chHHHHHHHHHHhhcCCCCccceEEEEec--------CC
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-GVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCAD--------GD 142 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------~~ 142 (399)
.|+-..+||+|.||.||+|+.+++|+.||+|++-.. ... .-....+|+.+|..|.|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 455567899999999999999999999999876432 111 12345789999999999999999887743 23
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
.+|+||.+|+ -+|.-.|.+. ...++..++..++.++..||.|+|+.. |+|||+||+|+||+.+|.+||+|||+
T Consensus 98 t~ylVf~~ce-hDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 5899999998 6788877652 467999999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCc--ceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 223 AKLGPVGDNT--HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 223 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
++.+...... ...+..+-|..|.+||.+.+ ..|+++.|||+.||++.||+||.+.+..........++...-..+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9764433322 12344566999999997755 67999999999999999999999999887665555544433222222
Q ss_pred cccccc--------ccCccccCC---CChHhH------HHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 300 RTRHSL--------IADPELQGQ---YPPRGF------YQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 300 ~~~~~~--------~~~~~~~~~---~~~~~~------~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
...... +..+.+... .-++.. ....+|+.++|..||.+|+++.+++..--++..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 111111 100101100 001111 266789999999999999999999976554443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=300.76 Aligned_cols=263 Identities=21% Similarity=0.244 Sum_probs=172.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCC----CeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEE------Ee
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESI----NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY------CA 139 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~------~~ 139 (399)
..++|++.+.||+|+||.||+|.+..+ +..||||++..... .+....+ .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999999998 89999998764321 1111111 1112222223222211 24
Q ss_pred cCCeeEEEEEecCCCCHHHHhhccCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 015816 140 DGDQRLLVYEYMPLGSVEDHLHDLSP----------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 203 (399)
Q Consensus 140 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlk 203 (399)
.....++||||+.+++|.+++..... .........+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56688999999999999999875210 0011123456789999999999999999 9999999
Q ss_pred CCceeecC-CCceEEecccCCccCCCCCCcceeeeeccCccccCccccccC----------------------CCCcccc
Q 015816 204 CSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG----------------------QLTLKSD 260 (399)
Q Consensus 204 p~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 260 (399)
|+|||++. ++.+||+|||++....... ........+|+.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5799999999997533222 1223446789999999965322 2445679
Q ss_pred eeehhHHHHHHHhCCCCcccchHHHHHHH-------HHhhhhhhccccccccccCccccC--CCChHhHHHHHHHHHHcc
Q 015816 261 VYSFGVVLLEILSGRKAVDTSKAAAEQSL-------VAWARPLFQDRTRHSLIADPELQG--QYPPRGFYQALAVAAMCV 331 (399)
Q Consensus 261 vwslG~il~ell~g~~pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl 331 (399)
||||||+||||+++..+++.........+ ..|.... ... ..+.+.. ...........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-EPR------ASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-ccc------cchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999998777654321111111 1111100 000 0000000 000111124558999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 015816 332 HEQPDMRPVIADVVTA 347 (399)
Q Consensus 332 ~~dP~~RPs~~eil~~ 347 (399)
+.||++|||+.++++.
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999963
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=255.49 Aligned_cols=207 Identities=25% Similarity=0.314 Sum_probs=175.1
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.......||+|+||.|-+.++..+|...|+|.+...- .+...++.+|+.+..+. .+|++|.+||........++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3445567999999999999999999999999997542 23445678888877664 689999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
|+ .+|..+..+....++.+++..+-+|+..+..||.|||++-. |+|||+||+||||+.+|++|+||||++-...
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~--- 200 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLV--- 200 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeeh---
Confidence 97 79988888777778999999999999999999999999754 9999999999999999999999999986422
Q ss_pred CcceeeeeccCccccCccccc----cCCCCcccceeehhHHHHHHHhCCCCcccchHHH
Q 015816 231 NTHVSTRVMGTYGYCAPEYAK----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 285 (399)
++-..+...|-..|||||.+. ...|+.++||||||+++.||.+++.||+......
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 222223345888999999874 3579999999999999999999999998766543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=264.13 Aligned_cols=267 Identities=21% Similarity=0.302 Sum_probs=203.5
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccC--CCcchHHHHHHHHHHhhcCCCCccceEEEEecC-----CeeE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRL 145 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~ 145 (399)
+.+-.+.||.|+||.||.+++..+|+.||+|++..- .....+.+.+|+.+|.-++|.|++..+++.+-. +++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 455678999999999999999999999999998532 233457789999999999999999998876543 3568
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+++|.|. .+|...|.. .++++.+.+.-+++||++||.|||+.+ |+||||||.|.|++.+..+||||||+++.
T Consensus 134 V~TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 8999987 678777776 889999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh--hhhhccc--
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA--RPLFQDR-- 300 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~~~~-- 300 (399)
-.... ....+..+-|..|.|||++.+ ..|+.+.||||.|||+.||+..+..|..-......+++.-. .+.....
T Consensus 206 ee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 43332 233344567899999999876 57999999999999999999988888766555444443211 1111100
Q ss_pred --------cccccccCcccc----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 301 --------TRHSLIADPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 301 --------~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
........|.+. ...+.....+...++..++..||+.|.+..+.+..+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 000011111111 112223344667788999999999999999888654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=280.73 Aligned_cols=261 Identities=20% Similarity=0.269 Sum_probs=180.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC----------------CCCeEEEEEEeccCCCcchHH--------------HHHHH
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLE----------------SINQDVAIKQLDRNGVQGNRE--------------FLVEV 120 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~ 120 (399)
.++|++.++||+|+||.||+|.+. ..++.||||.+........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 468999999999999999999752 235679999986543222222 34477
Q ss_pred HHHhhcCCCCc-----cceEEEEec--------CCeeEEEEEecCCCCHHHHhhccCC--------------------CC
Q 015816 121 LMLSLLHHPNL-----VNLIGYCAD--------GDQRLLVYEYMPLGSVEDHLHDLSP--------------------GK 167 (399)
Q Consensus 121 ~~l~~l~hpni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~ 167 (399)
.++.+++|.++ +.++++|.. ....+|||||+++++|.++++.... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776554 667777643 3568999999999999999874210 01
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCc
Q 015816 168 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247 (399)
Q Consensus 168 ~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 247 (399)
..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 23567789999999999999999999 999999999999999999999999998653322111 11122357899999
Q ss_pred cccccCC--------------------C--CcccceeehhHHHHHHHhCCC-CcccchHHHH------HHHHHhhhhhhc
Q 015816 248 EYAKTGQ--------------------L--TLKSDVYSFGVVLLEILSGRK-AVDTSKAAAE------QSLVAWARPLFQ 298 (399)
Q Consensus 248 E~~~~~~--------------------~--~~~~DvwslG~il~ell~g~~-pf~~~~~~~~------~~~~~~~~~~~~ 298 (399)
|.+.... | ..+.||||+||++|+|++|.. ||........ ..+..|.. ..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hc
Confidence 9875322 1 134799999999999999885 6653221110 01111110 00
Q ss_pred cccccccccCccccCCCChHhHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 015816 299 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP---DMRPVIADVVT 346 (399)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~eil~ 346 (399)
.. ...-...........+|+.+||..+| .+|+|+.|+++
T Consensus 458 ~~---------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQ---------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cc---------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00 00001112234478889999999866 68999999985
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=277.82 Aligned_cols=197 Identities=25% Similarity=0.370 Sum_probs=173.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchH--------HHHHHHHHHhhcC---CCCccceEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR--------EFLVEVLMLSLLH---HPNLVNLIGYCAD 140 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--------~~~~E~~~l~~l~---hpniv~~~~~~~~ 140 (399)
.+|...+.||.|+||.|++|.++.+...|+||.|.+...-... .+-.||.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4689999999999999999999999999999999765432211 1446999999997 9999999999999
Q ss_pred CCeeEEEEEec-CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEec
Q 015816 141 GDQRLLVYEYM-PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219 (399)
Q Consensus 141 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 219 (399)
++++||+||-- +|.+|.++|.. +..+++.++..|+.||+.|+++||++| |||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 99999999974 56799999987 788999999999999999999999999 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeeeccCccccCccccccCCC-CcccceeehhHHHHHHHhCCCCcc
Q 015816 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVD 279 (399)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~ 279 (399)
||.+.....+ ....++||..|.|||++.+..| +..-|||+||++||.++....||.
T Consensus 714 fgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998653222 2345789999999999999887 466899999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=264.90 Aligned_cols=132 Identities=23% Similarity=0.328 Sum_probs=114.0
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-----C---CCccceEEEEec---
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----H---PNLVNLIGYCAD--- 140 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~~~~~~~~--- 140 (399)
.+|.+.++||.|.|++||+|.+..+.+.||+|+.+.. ....+..+.||.+|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6899999999999999999999999999999998533 223455778999999884 3 369999999854
Q ss_pred -CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 015816 141 -GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 141 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill 209 (399)
+.++|+|+|++ |.+|..+|.... .+.++...+..|++||+.||.|||.... |||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 57899999998 689999998654 5678999999999999999999998764 9999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=273.80 Aligned_cols=268 Identities=22% Similarity=0.265 Sum_probs=207.9
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC------CCccceEEEEecCC
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH------PNLVNLIGYCADGD 142 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~~~~~ 142 (399)
....+|.+....|+|-|++|.+|.+..-|+.||||+|..+... .+.=+.|++||++|+. -|+++++..|...+
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 4567899999999999999999999999999999999876543 2334569999999963 48999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC-CceEEeccc
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFG 221 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg 221 (399)
++|||+|-+. .+|.+.|+.+.. .-.|....+..+++|++.||..|-..| |+|.||||+|||+++. ..+||||||
T Consensus 508 HLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 508 HLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred eeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999886 899999987654 456888899999999999999999999 9999999999999975 568999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 301 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (399)
.|.......- +...-+..|.|||++.+..|+...|+||.||+||||.||+..|.+......+.+..-+...+....
T Consensus 583 SA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 583 SASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 9975332221 122345679999999999999999999999999999999999988766555443322211111100
Q ss_pred -cccccc------------------------------Cc------cccC--CCC---hHhHHHHHHHHHHccccCCCCCC
Q 015816 302 -RHSLIA------------------------------DP------ELQG--QYP---PRGFYQALAVAAMCVHEQPDMRP 339 (399)
Q Consensus 302 -~~~~~~------------------------------~~------~~~~--~~~---~~~~~~l~~li~~cl~~dP~~RP 339 (399)
....+. .| .+.. .++ +.....+.+|+.+||..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 000000 00 0000 112 23467889999999999999999
Q ss_pred CHHHHHH
Q 015816 340 VIADVVT 346 (399)
Q Consensus 340 s~~eil~ 346 (399)
|..+.|.
T Consensus 739 t~nqAL~ 745 (752)
T KOG0670|consen 739 TVNQALK 745 (752)
T ss_pred CHHHHhc
Confidence 9998874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=247.34 Aligned_cols=257 Identities=19% Similarity=0.297 Sum_probs=196.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEecC--CeeEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLL 146 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~l 146 (399)
..++|++.+.+|+|-|+.||.|....+++.++||++++- ..+.+.+|+.||..|. ||||++++++..++ ....|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 356899999999999999999999999999999998743 3567889999999997 99999999998775 45689
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC-CceEEecccCCcc
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKL 225 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~ 225 (399)
|+||+.+.+...+.. .|+...+..++.+++.||.|+|+.| |+|||+||.|++||.. -.++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 999999877666554 4788899999999999999999999 9999999999999964 5799999999986
Q ss_pred CCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHH-HHH----------Hhh
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLV----------AWA 293 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~----------~~~ 293 (399)
.-.+.... -.+.+..|--||.+-. ..|+.+-|+|||||+|..|+..+.||-......++ ..+ .+.
T Consensus 183 YHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 183 YHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred cCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 54443332 2346778999998854 67899999999999999999999998544332221 111 111
Q ss_pred h-------hhhcc------ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 294 R-------PLFQD------RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 294 ~-------~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. +.+.+ +.....+..+.-..-. ..+..+|+.++|..|-.+|||+.|.+.
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~----~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLV----SPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccC----ChHHHHHHHHHHhhccccccchHHHhc
Confidence 1 00000 0001111111111111 247889999999999999999999885
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=259.95 Aligned_cols=272 Identities=24% Similarity=0.335 Sum_probs=216.1
Q ss_pred CHHHHHHHhcCCCCCCeeeecCceEEEEEEECCC-----CeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEE
Q 015816 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIG 136 (399)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~ 136 (399)
...++.....+++...++-+|.||.||.|.++.. .+.|-+|.+...... ....+..|..++..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3456666677899999999999999999987643 234666766543322 3355778999999999999999999
Q ss_pred EEec-CCeeEEEEEecCCCCHHHHhhccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC
Q 015816 137 YCAD-GDQRLLVYEYMPLGSVEDHLHDLS----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 211 (399)
Q Consensus 137 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~ 211 (399)
++.+ ....+.++.++.-|+|..++...+ ...+.++..+...++.|++.|++|||+++ |||.||...|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 8754 567788999999999999998322 22456788889999999999999999999 999999999999999
Q ss_pred CCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHH
Q 015816 212 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (399)
Q Consensus 212 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~ 290 (399)
..++||+|=.+++.....+.............||+||.+.+..|+.++|||||||+||||+| |+.|+...+..+.....
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 99999999999986555554444444445678999999999999999999999999999999 99999876665543332
Q ss_pred HhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 291 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.-.. +...|-+.+.+|+.++.-||+.+|++||++++++.-|..+..+
T Consensus 512 kdGy-----------------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 512 KDGY-----------------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred hccc-----------------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 1111 1112223344899999999999999999999999999888654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=280.16 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=207.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
..+|+....+|.|.||.||+++++.+++..|+|+++.....+..-+..|+-+++..+|||||.+++.+...+.+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35788999999999999999999999999999999877666677778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
|.||+|.+..+- .+++++.++..+++..++||.|||+.+ -+|||||-.|||+++.|.+|++|||.+-... .
T Consensus 94 cgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit--a 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT--A 164 (829)
T ss_pred cCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh--h
Confidence 999999998876 789999999999999999999999999 8999999999999999999999999986422 1
Q ss_pred CcceeeeeccCccccCcccc---ccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 231 NTHVSTRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.-.....+.||+.|||||+. ..+.|...+|||++|++..|+---++|..........-+... ....
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk-----------S~~q 233 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK-----------SGFQ 233 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc-----------cCCC
Confidence 12223457899999999976 567899999999999999999877777543322222111110 0111
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
-|.+ .-.......+.++++.||-.+|++||+++.+|+
T Consensus 234 pp~l--kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTL--KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcc--cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 112233457888999999999999999998875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=283.36 Aligned_cols=245 Identities=26% Similarity=0.348 Sum_probs=187.4
Q ss_pred CCCCeeeecCce-EEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEEecC
Q 015816 75 RSESLLGEGGFG-RVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMP 152 (399)
Q Consensus 75 ~~~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 152 (399)
.-.+.+|.|+-| .||+|... |+.||||.+-... ..-..+|+..|+.- .|||||++|+.-.++...||..|.|.
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 334678999876 57999987 7899999875432 23456799999887 49999999999999999999999997
Q ss_pred CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---C--CceEEecccCCccCC
Q 015816 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---G--YHPKLSDFGLAKLGP 227 (399)
Q Consensus 153 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~kl~Dfg~~~~~~ 227 (399)
.+|.+++...............+.++.|++.||++||+.+ ||||||||.||||+. + .+++|+|||+++...
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 8999999862111111122456889999999999999999 999999999999976 2 478999999999865
Q ss_pred CCCCcce-eeeeccCccccCccccccCCCCcccceeehhHHHHHHHhC-CCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 228 VGDNTHV-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 228 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.+..... .....||.+|+|||++....-+.++|||||||++|+.++| ..||......+...+. ..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~----- 729 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GN----- 729 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Cc-----
Confidence 5543322 3446799999999999998888999999999999999995 8999765433211110 00
Q ss_pred ccCccccC-CCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 IADPELQG-QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 ~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+.. ...++. ...+||.+|++.+|..||+|.+|+.
T Consensus 730 ---~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 730 ---YTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---cceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00000 011111 7788999999999999999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=241.87 Aligned_cols=211 Identities=36% Similarity=0.547 Sum_probs=184.8
Q ss_pred eeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCHHH
Q 015816 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 158 (399)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~ 158 (399)
||+|++|.||++....+++.+++|++...... ....+.+|+.+++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999998765432 34678899999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-CCceEEecccCCccCCCCCCcceeee
Q 015816 159 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTR 237 (399)
Q Consensus 159 ~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 237 (399)
++... ...+++..++.++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99862 146899999999999999999999999 999999999999999 89999999999875332221 1233
Q ss_pred eccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCC
Q 015816 238 VMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 316 (399)
Q Consensus 238 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
..+...|++||.+... .++.++|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4578899999999877 888999999999999999
Q ss_pred hHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 317 PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 317 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..+.+++..|++.||.+||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 267789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=241.47 Aligned_cols=254 Identities=21% Similarity=0.336 Sum_probs=190.2
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEE-EecCCeeEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGY-CADGDQRLLV 147 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~-~~~~~~~~lv 147 (399)
..+.|.+.+.||+|.||.+-+|.++.+++.+++|.+.... ...++|.+|...--.| .|.||+.-|++ |+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3467999999999999999999999999999999987543 3457788898765555 48899988874 6777888999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec--CCCceEEecccCCcc
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKL 225 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~~~~ 225 (399)
+||++.|+|...+.. ..+-+.....++.|+++||.|+|+++ +||||||.+||||- +..+|||||||.++.
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999999998874 56888899999999999999999999 99999999999993 345899999999874
Q ss_pred CCCCCCcceeeeeccCccccCcccccc---C--CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKT---G--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
.+.. -....-+..|.|||.... + ...+.+|||.||+++|..+||.+||.... ........|..-.....
T Consensus 173 ~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 173 VGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKN 246 (378)
T ss_pred cCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccC
Confidence 2211 111224567999997632 2 34688999999999999999999998332 22223333322111111
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..-|.....+.+ .+..+..+-|..+|++|-.+.++.++
T Consensus 247 -----~~~P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 247 -----PALPKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred -----ccCchhhcccCH----HHHHHHHHhcCCcccccchhHHHHHH
Confidence 122333333333 67778999999999999555555443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=246.80 Aligned_cols=262 Identities=22% Similarity=0.273 Sum_probs=200.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccC--CCcchHHHHHHHHHHhhcCCCCccceEEEEecC------C
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------D 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~ 142 (399)
..+|.-+..+|.|.- .|-.|.+.-+++.||+|++... .....+...+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777888999988 7778888888999999998643 233456778899999999999999999998543 3
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
..|+|||+|. .+|...+.. .++-..+..|+.|++.|+.|||+.| |+||||||+||++..++.+||.|||+
T Consensus 95 e~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 5699999997 789888873 3677788999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHH----------------
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE---------------- 286 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---------------- 286 (399)
++... .....+..+.|..|.|||++.+..|.+.+||||+||++.||++|.-.|.+....+.
T Consensus 165 ar~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 165 ARTED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hcccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 98522 22344556789999999999998899999999999999999999988864432111
Q ss_pred HHHHHhhhhhhc------cccccccccCccccC--CCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 287 QSLVAWARPLFQ------DRTRHSLIADPELQG--QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 287 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.++...+..... .......+.|..+.. +.++.....+.+++.+||-.||++|.|+.++|+
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 111111111111 111122222322221 122334567788999999999999999999995
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=240.72 Aligned_cols=199 Identities=35% Similarity=0.453 Sum_probs=175.0
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecC
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 152 (399)
|++.+.||.|++|.||+|.+..+++.+|+|.+...... ..+.+.+|+..+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56778999999999999999988999999999866554 56778899999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 153 LGSVEDHLHDLSPGKKP-LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 153 ~g~L~~~l~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
+++|.+++.. ... +++..+..++.+++.++.|||+.+ ++|+||+|.||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999986 233 899999999999999999999998 99999999999999999999999999876433220
Q ss_pred cceeeeeccCccccCcccc-ccCCCCcccceeehhHHHHHHHhCCCCccc
Q 015816 232 THVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~ 280 (399)
.......++..|++||.+ ....++.++||||||+++|+|++|+.||..
T Consensus 154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 112334678899999998 677888899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=243.26 Aligned_cols=203 Identities=28% Similarity=0.358 Sum_probs=169.7
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECC---CCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEecCC
Q 015816 67 LAAATKNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 142 (399)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 142 (399)
+....+.|.+.++||.|.|++||++.+.. .++.||+|.+..... -..+.+|+++|..+. +.||+++.+.+...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 33445679999999999999999999887 788999999875543 345888999999985 899999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-CCceEEeccc
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFG 221 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg 221 (399)
+.++|+||++..+..+++.. ++..++..+++.++.||.++|.+| ||||||||+|+|.+. .++-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 99999999999998888875 678899999999999999999999 999999999999985 4678999999
Q ss_pred CCccCC--------------CCCC----------------------------cceeeeeccCccccCcccccc-CCCCcc
Q 015816 222 LAKLGP--------------VGDN----------------------------THVSTRVMGTYGYCAPEYAKT-GQLTLK 258 (399)
Q Consensus 222 ~~~~~~--------------~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 258 (399)
++.... .... ........||++|.|||++.. ...+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 987100 0000 001122469999999998854 567899
Q ss_pred cceeehhHHHHHHHhCCCCcccc
Q 015816 259 SDVYSFGVVLLEILSGRKAVDTS 281 (399)
Q Consensus 259 ~DvwslG~il~ell~g~~pf~~~ 281 (399)
+||||.|||+..+++++.||-..
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred cceeeccceeehhhccccccccC
Confidence 99999999999999999999543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=270.68 Aligned_cols=196 Identities=17% Similarity=0.255 Sum_probs=139.2
Q ss_pred hcCC-CCccceEEEE-------ecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 015816 125 LLHH-PNLVNLIGYC-------ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196 (399)
Q Consensus 125 ~l~h-pniv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ 196 (399)
.++| +||+.++++| .....+++++||+ +++|.++|... ...+++.+++.|+.||+.||.|||++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3455 5788888877 2334677889987 47999999742 356999999999999999999999999
Q ss_pred eeecCCCCCceeecCC-------------------CceEEecccCCccCCCCCC--------------cceeeeeccCcc
Q 015816 197 VIYRDLKCSNILLDRG-------------------YHPKLSDFGLAKLGPVGDN--------------THVSTRVMGTYG 243 (399)
Q Consensus 197 ivH~Dlkp~Nill~~~-------------------~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~ 243 (399)
|+||||||+||||+.. +.+|++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4455666666543110000 000112458899
Q ss_pred ccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHH
Q 015816 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 323 (399)
Q Consensus 244 y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 323 (399)
|||||++.+..|+.++|||||||+||||++|.+|+........ .+. .... .+... ......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~-~~~---~~~~----------~~~~~-----~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMS-SLR---HRVL----------PPQIL-----LNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHH-HHH---Hhhc----------Chhhh-----hcCHHH
Confidence 9999999999999999999999999999999988754221110 010 0000 00000 011245
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 015816 324 LAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 324 ~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..++.+||+.+|.+||++.++++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 67889999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=209.10 Aligned_cols=170 Identities=22% Similarity=0.209 Sum_probs=127.4
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
|+|.+++... ..++++.+++.|+.||+.||.|||+++ ||+|||++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 6899999752 456999999999999999999999876 999999999999999 9998753221
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 313 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
...||+.|||||++.+..++.++|||||||++|||++|+.||........ ......... ... .+.. .
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~-~~~-------~~~~-~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGM-PAD-------DPRD-R 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHh-ccC-------Cccc-c
Confidence 12589999999999999999999999999999999999999965432111 011111100 000 0000 0
Q ss_pred CCChHhHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 314 QYPPRGFY--QALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 314 ~~~~~~~~--~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
..+..... .+.+++.+||+.+|.+||++.++++.+..+...
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 01112222 589999999999999999999999988766543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=221.84 Aligned_cols=263 Identities=21% Similarity=0.231 Sum_probs=199.2
Q ss_pred CCCCCCeeeecCceEEEEEEECCCC-eEEEEEEeccCCCcchHHHHHHHHHHhhcCC----CCccceEEEE-ecCCeeEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGVQGNREFLVEVLMLSLLHH----PNLVNLIGYC-ADGDQRLL 146 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~~~~~~-~~~~~~~l 146 (399)
+|++.+.||+|+||.||.|.+..++ ..+|+|............+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999998764 6789998765433333367788998888862 6899999999 57788999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC-----CceEEeccc
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-----YHPKLSDFG 221 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~Dfg 221 (399)
||+.+ |.+|.++..... ...++..+++.|+.|++.+|++||+.| ++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 689999886644 578999999999999999999999999 9999999999999865 469999999
Q ss_pred CCccCC--CCCCc---c--e-eeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHH-HHHHHh
Q 015816 222 LAKLGP--VGDNT---H--V-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAW 292 (399)
Q Consensus 222 ~~~~~~--~~~~~---~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~ 292 (399)
+++... ..... . . .....||..|+++.+..+...+.+.|+||++.++.+++.|..||........ ......
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998321 11111 1 1 2335699999999999999999999999999999999999999966543222 111111
Q ss_pred hhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
....... . ....++. .+.++...+-..+...+|....+...|.......
T Consensus 253 ~~~~~~~---------~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLTD---------R--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhccc---------c--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1110000 0 1122233 4445555555588999999999999987766543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=224.36 Aligned_cols=178 Identities=17% Similarity=0.134 Sum_probs=134.6
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECC-CCeEEEEEEeccCC-----CcchHHHHHHHHHHhhcCCCCccceEEEEecC
Q 015816 68 AAATKNFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNG-----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (399)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 141 (399)
.....+|++.+.||+|+||+||+|.++. +++.||||++.... ......+.+|+.+|+.++|+||+..+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 3455789999999999999999999875 67888999875331 1124568899999999999999853322 2
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCceeecCCCceEEecc
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL-KCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Df 220 (399)
...|+||||++|++|.. +.. . . ...++.|+++||.|||++| |+|||| ||+|||++.++.++|+||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~----~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARP----H---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCc----c---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 45799999999999963 211 1 1 1467899999999999999 999999 999999999999999999
Q ss_pred cCCccCCCCCCcce------eeeeccCccccCccccccC------CCCccccee
Q 015816 221 GLAKLGPVGDNTHV------STRVMGTYGYCAPEYAKTG------QLTLKSDVY 262 (399)
Q Consensus 221 g~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~~Dvw 262 (399)
|+++.......... -+...++..|+|||++... ..+..+|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99986433221111 1345688899999988543 233446666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=201.02 Aligned_cols=210 Identities=24% Similarity=0.295 Sum_probs=176.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC-CCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 149 (399)
...|++.+.||.|+||.+|.|....+|+.||||+-... ....++..|..+.+.|++ ..|..+..+..+..+..+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 35799999999999999999999999999999986433 234567789999999975 678888888899999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---CCceEEecccCCccC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLG 226 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~ 226 (399)
.+ |.+|.+++.-. ...++..+++.++-|++.-++|+|.++ +|||||||+|+|..- ...+.|+|||+|+..
T Consensus 92 LL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 88 68999988753 467999999999999999999999999 999999999999964 457999999999864
Q ss_pred CCCCC-----cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH
Q 015816 227 PVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (399)
Q Consensus 227 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 289 (399)
..... ........||..|.+-....+...+...|+-|+|.+|.++.-|..||.........+.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK 232 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK 232 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence 33221 1223456799999999888888888999999999999999999999998776555443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-25 Score=208.53 Aligned_cols=258 Identities=33% Similarity=0.437 Sum_probs=198.7
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCC-CccceEEEEecCCeeEEEEE
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHP-NLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lv~e 149 (399)
|.+...||.|+||.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +|+.+++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 677889999999999999987 78999998765443 256788999999999988 79999999988777899999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-ceEEecccCCccCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPV 228 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~ 228 (399)
++.++++.+++...... ..++......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||.+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999777652111 37899999999999999999999999 99999999999999988 799999999875333
Q ss_pred CCCcc----eeeeeccCccccCcccccc---CCCCcccceeehhHHHHHHHhCCCCcccchH----HHHHHHHHhhhhhh
Q 015816 229 GDNTH----VSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA----AAEQSLVAWARPLF 297 (399)
Q Consensus 229 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~ 297 (399)
..... ......||..|+|||.+.+ ..++...|+||+|++++++++|..||..... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--- 231 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP--- 231 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC---
Confidence 32221 2355679999999999987 6889999999999999999999999876543 11111111000
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.. .................+.+++..|+..+|..|.+..+....
T Consensus 232 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000000000002223467889999999999999998887765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=239.31 Aligned_cols=255 Identities=21% Similarity=0.263 Sum_probs=192.4
Q ss_pred CCCCeeeecCceEEEEEEECCCCeEEEEEEeccC--CCcch----HHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGN----REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.....+|.|++|.|+.+.........+.|.+... ..... ..+..|+.+-..|+|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4668899999998888887766666666654311 11111 12556777778899999988888777776666679
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|||++ +|..++.. ...++..++-.++.|++.|+.|+|+.| |.||||||+|+++..+|.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99998 99999986 457888999999999999999999999 99999999999999999999999999987555
Q ss_pred CCCc--ceeeeeccCccccCccccccCCCCc-ccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 229 GDNT--HVSTRVMGTYGYCAPEYAKTGQLTL-KSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 229 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.... ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+.+... .........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~~~~~~~ 546 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNYSDQRNI 546 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hcccccccc
Confidence 4444 5556688999999999999999986 589999999999999999999765443322100 000000000
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+ .......+.....++.++|+.||.+|.|+.+|++
T Consensus 547 ~~~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccCh---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000 0111123346677999999999999999999996
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=198.63 Aligned_cols=205 Identities=25% Similarity=0.326 Sum_probs=175.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
-+|+++++||+|+||.++.|.+--+++.||||.-... ...-++..|....+.|. .++|...|.+..++.+..||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3699999999999999999999999999999975432 34556777888888875 68999999999999999999998
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-----CCceEEecccCCcc
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHPKLSDFGLAKL 225 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfg~~~~ 225 (399)
+ |.+|.|++.-+ +..|+..++..++.|++.-++|+|++. +|.|||||+|+||.. ...|.|+|||+|+.
T Consensus 106 L-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8 68898887642 678999999999999999999999999 999999999999974 34689999999987
Q ss_pred CCCCCC-----cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHH
Q 015816 226 GPVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (399)
Q Consensus 226 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 285 (399)
...... ........||.+||+-....+...+...|+-|||-++++.|-|..||.+.....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 443322 223345779999999999999999999999999999999999999998876543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-26 Score=230.50 Aligned_cols=247 Identities=22% Similarity=0.204 Sum_probs=183.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC-CcchHHH---HHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~---~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
+|...+.||.+.|=+|.+|++.. |. |+||++-+.. ....+.+ ..|+. ...++|||++++.-+.......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 67778999999999999999886 55 8999986543 2233333 44455 55678999999988887788889999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC-
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP- 227 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~- 227 (399)
+|.. -+|+|.+.. ..-+...+..+|+.||+.||..+|..| |+|||||.+||||+..+-+.|+||..-+...
T Consensus 101 qyvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 9986 689999976 566888899999999999999999999 9999999999999999999999998765421
Q ss_pred -CCCCc---ceeeeeccCccccCccccccC-----------CCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHH
Q 015816 228 -VGDNT---HVSTRVMGTYGYCAPEYAKTG-----------QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVA 291 (399)
Q Consensus 228 -~~~~~---~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~ 291 (399)
.++.. ....+...-.+|+|||.+-.. ..+++.||||+||++.||++ |++||....--......
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~- 251 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN- 251 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC-
Confidence 11111 111222334689999987431 26789999999999999999 78888765322111100
Q ss_pred hhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 292 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..........+.| ..+++++..|++.||.+|.+++++|+.
T Consensus 252 ----~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ----ADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ----ccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000000111111 157789999999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=194.75 Aligned_cols=171 Identities=12% Similarity=0.113 Sum_probs=133.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHH---------HHHHHHHHhhcCCCCccceEEEEec
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---------FLVEVLMLSLLHHPNLVNLIGYCAD 140 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hpniv~~~~~~~~ 140 (399)
...+|++.++||.|+||.||++.. ++..+|||++.......... +.+|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 357899999999999999999755 36689999997654433322 5789999999999999999988654
Q ss_pred C--------CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC
Q 015816 141 G--------DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 212 (399)
Q Consensus 141 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~ 212 (399)
. ...+|||||++|.+|.++.. +++ ....+|+.+|..+|+.| ++||||+|+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 3 35789999999999988742 232 34669999999999999 9999999999999998
Q ss_pred CceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHH
Q 015816 213 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 272 (399)
Q Consensus 213 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 272 (399)
| ++|+|||........... ..+.....|+.++|+||||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999987642111000 01334556778999999999988765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=188.48 Aligned_cols=138 Identities=15% Similarity=0.084 Sum_probs=109.0
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--c-------h-----------------HHHHHHHHHHhhcCCCC
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--G-------N-----------------REFLVEVLMLSLLHHPN 130 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~hpn 130 (399)
...||+|+||.||+|.+. +|+.||||++...... . . .....|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 7999999999654221 1 0 12235999999998887
Q ss_pred ccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecCCCCCceee
Q 015816 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL-HDKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 131 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~ivH~Dlkp~Nill 209 (399)
+.....+... ..+|||||++|+++...... ..++++..+..++.|++.+|.|+ |+.| |+||||||+|||+
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 7444333222 24899999998776654332 45789999999999999999999 6889 9999999999999
Q ss_pred cCCCceEEecccCCcc
Q 015816 210 DRGYHPKLSDFGLAKL 225 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~~ 225 (399)
+ ++.++|+|||+|..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 47899999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-25 Score=216.74 Aligned_cols=226 Identities=26% Similarity=0.335 Sum_probs=181.4
Q ss_pred eeeecCceEEEEEEE---CCCCeEEEEEEeccCCCcch--HHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEEEEecC
Q 015816 79 LLGEGGFGRVYKGYL---ESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMP 152 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~ 152 (399)
.+|+|+||.|++++- ...|..||+|++.+...... .....|..++...+ ||.+|+++..++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999997653 34577899999876533221 23455777888777 9999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCc
Q 015816 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (399)
Q Consensus 153 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 232 (399)
||.|...+.. ...+++.....+...++-|++++|..+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 9999888876 567888888899999999999999999 99999999999999999999999999985322221
Q ss_pred ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcccc
Q 015816 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 312 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.+||..|||||++. ....++|+||||+++|||+||..||..... ..+ .. ..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~----~~I------l~------------~~ 203 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTM----KRI------LK------------AE 203 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHH----HHH------hh------------hc
Confidence 18999999999998 678899999999999999999999987111 111 00 01
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCH
Q 015816 313 GQYPPRGFYQALAVAAMCVHEQPDMRPVI 341 (399)
Q Consensus 313 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 341 (399)
...|......+..++..++..+|.+|.-.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 23344455577889999999999999644
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-25 Score=194.07 Aligned_cols=246 Identities=22% Similarity=0.363 Sum_probs=190.3
Q ss_pred CCCeeeecCceEEEEEEECCCCeEEEEEEeccC--CCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+..+|.....|..|+|++.+ ..+++|++.-. .....+.|..|.-.|+.+.||||+.+++.|..+..+.++..||+.
T Consensus 194 l~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34558888999999999985 45667776533 333446788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEe--cccCCccCCCCCC
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS--DFGLAKLGPVGDN 231 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~--Dfg~~~~~~~~~~ 231 (399)
|+|+..+++.. .-.++-.++.+++.+|++|++|||+... -|.--.|....++||++.+.+|+ |--++..
T Consensus 272 gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 272 GSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred hHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee------
Confidence 99999998743 3456778999999999999999999863 24444789999999999877664 3222211
Q ss_pred cceeeeeccCccccCccccccCCCC---cccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLT---LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.....-.+.||+||.++..+-+ .++|+|||++++|||.|...||......+-.-. +..
T Consensus 343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk----------------ial 403 (448)
T KOG0195|consen 343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK----------------IAL 403 (448)
T ss_pred ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh----------------hhh
Confidence 1112246889999999776544 579999999999999999999987654332111 112
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
..++-.+||.....+.+|+.-|+..||.+||.+..|+-.|+..
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 2334456777777899999999999999999999999888864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=196.29 Aligned_cols=235 Identities=19% Similarity=0.276 Sum_probs=152.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcC----------CCCccceEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLH----------HPNLVNLIGYCA 139 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~----------hpniv~~~~~~~ 139 (399)
.+.....||.|+++.||.+++..||+.+|||++..... ...+++.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34566889999999999999999999999999753322 23355666665554432 222332233221
Q ss_pred ---------cC---C-----eeEEEEEecCCCCHHHHhhcc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 015816 140 ---------DG---D-----QRLLVYEYMPLGSVEDHLHDL---SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199 (399)
Q Consensus 140 ---------~~---~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH 199 (399)
.. . ..+++|+-+. ++|.+++... ......+.....+.+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 2367888886 7888776532 211223444555777899999999999999 999
Q ss_pred cCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCcccccc--------CCCCcccceeehhHHHHHH
Q 015816 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--------GQLTLKSDVYSFGVVLLEI 271 (399)
Q Consensus 200 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el 271 (399)
+||+|+|+|++.+|.++|+||+..... +.. ......+..|.|||.... -.++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~--g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRA--GTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEET--TEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeec--Cce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999877541 111 111345678999997643 3578899999999999999
Q ss_pred HhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCC
Q 015816 272 LSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR 338 (399)
Q Consensus 272 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 338 (399)
++|..||+........ ......|. +.++.+..||..+|+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~---------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADP---------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTS---------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccc---------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999865332110 00223555 777799999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-23 Score=181.41 Aligned_cols=138 Identities=16% Similarity=0.104 Sum_probs=110.9
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc--------------------------hHHHHHHHHHHhhcCCCC
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------------------------NREFLVEVLMLSLLHHPN 130 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~hpn 130 (399)
...||+|+||.||+|.+. +|+.||||++....... ...+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 79999999987642210 112357899999999998
Q ss_pred ccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceee
Q 015816 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 131 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill 209 (399)
|.....+... ..+|||||++|+++...... ...++...+..++.|++.++.++|+ .| |+||||||+|||+
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 7555444333 24899999998755443222 3467888999999999999999999 99 9999999999999
Q ss_pred cCCCceEEecccCCcc
Q 015816 210 DRGYHPKLSDFGLAKL 225 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~~ 225 (399)
+ ++.++|+|||++..
T Consensus 152 ~-~~~~~liDFG~a~~ 166 (190)
T cd05145 152 H-DGKPYIIDVSQAVE 166 (190)
T ss_pred E-CCCEEEEEccccee
Confidence 9 78999999999975
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-23 Score=187.26 Aligned_cols=197 Identities=22% Similarity=0.225 Sum_probs=143.1
Q ss_pred CCCCccceEEEEec---------------------------CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHH
Q 015816 127 HHPNLVNLIGYCAD---------------------------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179 (399)
Q Consensus 127 ~hpniv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 179 (399)
+|||||.+.++|.+ +..+|+||..++ .+|..|+-. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999887644 235699999887 799999974 557777888999
Q ss_pred HHHHHHHHHHHhCCCCCeeecCCCCCceeec--CC--CceEEecccCCccCCCC----CCcceeeeeccCccccCccccc
Q 015816 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RG--YHPKLSDFGLAKLGPVG----DNTHVSTRVMGTYGYCAPEYAK 251 (399)
Q Consensus 180 ~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~--~~--~~~kl~Dfg~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~ 251 (399)
.|+++|+.|||.+| |.|||+|.+||||. ++ -.+.|+|||++.-.... ..........|.-.-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 99999999999994 33 35799999998632211 0111122345788899999885
Q ss_pred cCCC------CcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHH
Q 015816 252 TGQL------TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 325 (399)
Q Consensus 252 ~~~~------~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 325 (399)
..+- -.++|.|+.|.+.||+++...||....... .+... ......|.+...+++ .+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~-----------Yqe~qLPalp~~vpp----~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRT-----------YQESQLPALPSRVPP----VARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhh-----------hhhhhCCCCcccCCh----HHHH
Confidence 4321 257999999999999999999997632211 11111 111223444445555 7889
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 015816 326 VAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 326 li~~cl~~dP~~RPs~~eil~~L 348 (399)
|+...|+.||.+|++..-....|
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 99999999999999876555544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=174.10 Aligned_cols=186 Identities=19% Similarity=0.131 Sum_probs=138.7
Q ss_pred CCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc----hHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEEEE
Q 015816 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG----NREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 149 (399)
.+...|++|+||+||.+.. .+..++.+.+....... ...+.+|+.+|++|. |++|++++++ ...+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3567899999999998766 47888888776543311 124788999999995 5889999886 45799999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCceeecCCCceEEecccCCccCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL-KCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|+.|.+|...+.. . ...++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999888654321 1 1357889999999999999 999999 79999999999999999999985332
Q ss_pred CCCc---ce--------eeeeccCccccCccccccC-CCC-cccceeehhHHHHHHHhCCCCccc
Q 015816 229 GDNT---HV--------STRVMGTYGYCAPEYAKTG-QLT-LKSDVYSFGVVLLEILSGRKAVDT 280 (399)
Q Consensus 229 ~~~~---~~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~ell~g~~pf~~ 280 (399)
.... .. ......++.|++|+...-. ..+ ...++++.|+-+|.++|+..++-.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 2110 00 0112367788888744221 223 567999999999999999988643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-22 Score=173.71 Aligned_cols=136 Identities=20% Similarity=0.242 Sum_probs=108.9
Q ss_pred CCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-----CCCCccceEEEEecCC---eeE-
Q 015816 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-----HHPNLVNLIGYCADGD---QRL- 145 (399)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~---~~~- 145 (399)
.-...||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ .||||++++++++++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999995 6666655 69998765455567799999999999 5799999999998874 333
Q ss_pred EEEEe--cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeecCCCCCceeecC----CCceEEe
Q 015816 146 LVYEY--MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL-EYLHDKAKPPVIYRDLKCSNILLDR----GYHPKLS 218 (399)
Q Consensus 146 lv~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~ 218 (399)
+|+|| +.+++|.+++.+ ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 557999999975 236655 35678888777 9999999 999999999999974 3489999
Q ss_pred cccCC
Q 015816 219 DFGLA 223 (399)
Q Consensus 219 Dfg~~ 223 (399)
||+-+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-23 Score=206.78 Aligned_cols=211 Identities=27% Similarity=0.375 Sum_probs=152.2
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
...+|...+.|..|+||.||.++++.+.+.+|+| +++.....+. ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn-------ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN-------ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc-------cccccCCccee-----------------
Confidence 3467999999999999999999999999999994 4433221110 33333444444
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+-...++. .++++... +.+++|||+.+ |+|||+||+|.+|..-|++|++|||+++.....
T Consensus 136 ----gDc~tllk~----~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKN----IGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhccc----CCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 444555554 45565443 78999999999 999999999999999999999999998753211
Q ss_pred CC-------------cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh
Q 015816 230 DN-------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 230 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
.. ......++||+.|+|||++....|+..+|+|++|+|+||.+.|+.||.....++.....
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v------ 270 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV------ 270 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh------
Confidence 11 11223468999999999999999999999999999999999999999887554332111
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCC
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 339 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 339 (399)
+.+. +.-++-.... +.++.+++.++|+.+|..|.
T Consensus 271 isd~-----i~wpE~dea~----p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 271 ISDD-----IEWPEEDEAL----PPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhh-----ccccccCcCC----CHHHHHHHHHHHHhChHhhc
Confidence 0000 0011111122 23888999999999999995
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-22 Score=202.84 Aligned_cols=197 Identities=23% Similarity=0.265 Sum_probs=160.8
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC---CCCccceEEEEecCCeeE
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~ 145 (399)
.....|.|.+.||+|+||+||.|...+ |+.||+|+=.+....+ |..=.+++.+|+ -+-|+.+..++.-.+..+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 344568899999999999999999988 9999999876543321 111223344444 245666666667778889
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-------CCceEEe
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-------GYHPKLS 218 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-------~~~~kl~ 218 (399)
||+||.+.|+|.+++.. .+.+++..+..++.|++..++.||..+ |||+||||+|+||.. ..-++|+
T Consensus 771 lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999985 677999999999999999999999999 999999999999942 3468999
Q ss_pred cccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCC
Q 015816 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276 (399)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 276 (399)
|||.+.-+............++|-.+--+|+..|..++..+|.|.|+.+++-||.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999875444444444556788999999999999999999999999999999999974
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=187.27 Aligned_cols=217 Identities=28% Similarity=0.421 Sum_probs=163.6
Q ss_pred HhhcCCCCccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-eecC
Q 015816 123 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV-IYRD 201 (399)
Q Consensus 123 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i-vH~D 201 (399)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.....++++|+.||.|||+.. | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 4578999999999999999999999999999999999986 3567899999999999999999999876 5 9999
Q ss_pred CCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccC-------CCCcccceeehhHHHHHHHhC
Q 015816 202 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-------QLTLKSDVYSFGVVLLEILSG 274 (399)
Q Consensus 202 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ell~g 274 (399)
|++.|+++|....+||+|||+.................-..-|.|||.+.+. ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998764321111111222234579999998763 246779999999999999999
Q ss_pred CCCcccchHHHH-HHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 275 RKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 275 ~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
..||+....... ..++..+.. .. .....|.+.... .....+..++..||..+|.+||++..+-..+..+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-~~-----~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-GG-----SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh-cC-----CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999986433222 233332221 00 011111111100 222278889999999999999999999988876654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.8e-21 Score=170.47 Aligned_cols=142 Identities=13% Similarity=0.112 Sum_probs=112.3
Q ss_pred CCCCCCeeeecCceEEEEEE-ECCCCeEEEEEEeccCCCc------------------------chHHHHHHHHHHhhcC
Q 015816 73 NFRSESLLGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQ------------------------GNREFLVEVLMLSLLH 127 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 127 (399)
-|++.+.||+|+||.||+|. +..+|+.||||++...... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 6677999999998754211 0123567999999997
Q ss_pred CCC--ccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 015816 128 HPN--LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 205 (399)
Q Consensus 128 hpn--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~ 205 (399)
+.+ +..++++ ...++||||++|.+|..+... ...+....+..++.||+.+|.+||+.+. |+||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChh
Confidence 633 3344442 235899999999888766532 3456666778999999999999998874 999999999
Q ss_pred ceeecCCCceEEecccCCcc
Q 015816 206 NILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 206 Nill~~~~~~kl~Dfg~~~~ 225 (399)
||+++ ++.++|+|||.+..
T Consensus 179 NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hEEEE-CCCEEEEEChhhhc
Confidence 99999 88999999998863
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.8e-20 Score=163.50 Aligned_cols=134 Identities=22% Similarity=0.315 Sum_probs=113.6
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc--------hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
+.||+|++|.||+|.+ .|..|++|+........ ...+.+|+.++..+.|++|.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 47789999865432211 1357789999999999998887777777788999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
|++|++|.+++.. .. . .+..++.+++.+|.++|+.+ ++|+|++|+|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~----~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINS----NG---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHh----cc---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865 11 2 78899999999999999999 99999999999999 78999999998863
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-21 Score=185.80 Aligned_cols=176 Identities=25% Similarity=0.369 Sum_probs=132.1
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
.++||.|++|.-.+|.+||..... ....++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 357899999999999999975332 4567888999999999999999 77 9999999999999999999999999
Q ss_pred CCccCCCCC----CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhh
Q 015816 222 LAKLGPVGD----NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 222 ~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
+........ .....+...||..||+||.+.+..|+.++||||||++|+||+. =..+|+.......
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d---------- 471 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTD---------- 471 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhh----------
Confidence 987543333 1223456789999999999999999999999999999999997 3333332211111
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHH
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 344 (399)
+ ...+..|.+..++| .-..|+.+++...|.+||++.+.
T Consensus 472 ~-----r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 472 I-----RDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred h-----hcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 0 11111222222222 23469999999999999954443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=157.54 Aligned_cols=130 Identities=23% Similarity=0.318 Sum_probs=106.7
Q ss_pred eeeecCceEEEEEEECCCCeEEEEEEeccCCCc--------chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.||+|+||.||+|... +..|++|+....... ....+.+|+.++..+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999854 678999986543211 124567899999999988766655556666778999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
++|++|.+++.. ... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEE----GND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998764 111 78999999999999999 99999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-19 Score=156.93 Aligned_cols=142 Identities=16% Similarity=0.070 Sum_probs=110.9
Q ss_pred HHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc----------------------chHHHHHHHHHH
Q 015816 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----------------------GNREFLVEVLML 123 (399)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l 123 (399)
++......|.+.+.||+|+||.||+|... +|+.||||++...... ....+..|+.++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 34444445888999999999999999886 6999999987643210 011256788899
Q ss_pred hhcCCCC--ccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 015816 124 SLLHHPN--LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 201 (399)
Q Consensus 124 ~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~D 201 (399)
..+.|++ +...++. ...++||||++|++|...... .....++.+++.++.++|+.+ |+|||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 9888874 4444432 356899999999998765431 235678899999999999999 99999
Q ss_pred CCCCceeecCCCceEEecccCCcc
Q 015816 202 LKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 202 lkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
|+|+||++++++.++|+|||++..
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred CCcccEEEcCCCcEEEEECCcccc
Confidence 999999999999999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=5e-19 Score=178.23 Aligned_cols=138 Identities=23% Similarity=0.317 Sum_probs=112.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--C------cchHHHHHHHHHHhhcCCCCccceEEEEecC
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--V------QGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 141 (399)
....|...+.||+|+||.||+|.+.. ..+++|+..... . ...+.+.+|+.++..++|++++....++.+.
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 34456778999999999999998764 344444432211 1 1124578899999999999999888887777
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
...++||||++|++|.+++. ....++.+++.+|.|||+.+ ++||||||+|||+ .++.++|+|||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence 78899999999999999885 24679999999999999999 9999999999999 57799999999
Q ss_pred CCcc
Q 015816 222 LAKL 225 (399)
Q Consensus 222 ~~~~ 225 (399)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 9874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.9e-20 Score=184.76 Aligned_cols=257 Identities=23% Similarity=0.267 Sum_probs=191.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLE-SINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 147 (399)
..|.+.+.||+|+|+.|-.+... .....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35777788999999999988764 344557777665443 112233445777777777 99999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeecCCCCCceeecCCC-ceEEecccCCcc
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-DKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKL 225 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~ 225 (399)
++|..|+++.+-+.. ......+...+-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988831 11225666778899999999999999 888 99999999999999999 999999999987
Q ss_pred CCC-CCCcceeeeecc-CccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 226 GPV-GDNTHVSTRVMG-TYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 226 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
... ..........+| ++.|+|||...+. ......|+||+|+++.-+++|..|++....... ....|.. ....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~----~~~~ 249 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKS----NKGR 249 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecc----cccc
Confidence 555 333344445678 9999999998874 556889999999999999999999876544321 0010100 0000
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..............+++.+++..+|..|.+..++-.
T Consensus 250 --------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 --------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 001111122336777999999999999998887763
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.5e-18 Score=147.33 Aligned_cols=134 Identities=19% Similarity=0.158 Sum_probs=97.7
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc--hHH----------------------HHHHHHHHhhcCCCC--
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NRE----------------------FLVEVLMLSLLHHPN-- 130 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~hpn-- 130 (399)
.+.||+|+||.||+|.+. +++.||||++....... ... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999987 68999999986532211 111 134566666655433
Q ss_pred ccceEEEEecCCeeEEEEEecCCCCHHH-HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcee
Q 015816 131 LVNLIGYCADGDQRLLVYEYMPLGSVED-HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNIL 208 (399)
Q Consensus 131 iv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nil 208 (399)
+.+.++. ...++||||++++.+.. .+... ... ..+..++.+++.++.++|. .+ |+|+||||+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 4444443 24689999999855432 12211 011 5678899999999999999 88 999999999999
Q ss_pred ecCCCceEEecccCCcc
Q 015816 209 LDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 209 l~~~~~~kl~Dfg~~~~ 225 (399)
++ ++.++|+|||.+..
T Consensus 148 i~-~~~~~liDfg~a~~ 163 (187)
T cd05119 148 VD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EE-CCcEEEEECccccc
Confidence 99 89999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=139.64 Aligned_cols=135 Identities=23% Similarity=0.199 Sum_probs=113.1
Q ss_pred CCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC--CCccceEEEEecCCeeEEEEEecCC
Q 015816 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.+.||.|.++.||++.... ..+++|....... ...+..|+.+++.++| .++++++.+....+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 45679999999999999864 7899999865433 4568889999999976 5899999988888889999999998
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+.+..+ +......++.+++.+|+++|.....+++|+||+|+||+++..+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766443 4566778899999999999986333499999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.7e-17 Score=148.10 Aligned_cols=135 Identities=21% Similarity=0.223 Sum_probs=105.6
Q ss_pred CCeee-ecCceEEEEEEECCCCeEEEEEEeccCCC-------------cchHHHHHHHHHHhhcCCCCc--cceEEEEec
Q 015816 77 ESLLG-EGGFGRVYKGYLESINQDVAIKQLDRNGV-------------QGNREFLVEVLMLSLLHHPNL--VNLIGYCAD 140 (399)
Q Consensus 77 ~~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpni--v~~~~~~~~ 140 (399)
...|| .||.|+||.+... +..++||.+..... .....+.+|+.++..|.|++| +..+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35688 8999999999775 67899998753211 122457889999999998875 667766443
Q ss_pred CCe----eEEEEEecCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCce
Q 015816 141 GDQ----RLLVYEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (399)
Q Consensus 141 ~~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 215 (399)
... .++|||+++| .+|.+++.. .+++.. .+.+|+.+|.+||+.| |+||||||+|||++.++.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKF 181 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCE
Confidence 222 2599999997 689888864 345544 3678999999999999 9999999999999998999
Q ss_pred EEecccCCcc
Q 015816 216 KLSDFGLAKL 225 (399)
Q Consensus 216 kl~Dfg~~~~ 225 (399)
+|+|||.+..
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999999874
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-16 Score=141.09 Aligned_cols=204 Identities=23% Similarity=0.304 Sum_probs=144.1
Q ss_pred HHHhhcCCCCccceEEEEecC-----CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 015816 121 LMLSLLHHPNLVNLIGYCADG-----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195 (399)
Q Consensus 121 ~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ 195 (399)
.-|-++-|.|||+++.|+.+. ....++.||+..|+|..+|++..+....+......+|+.||+.||.|||+.. |
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 344556799999999998654 3578999999999999999988877888999999999999999999999984 7
Q ss_pred CeeecCCCCCceeecCCCceEEecccCCccCCCC--CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh
Q 015816 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG--DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273 (399)
Q Consensus 196 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 273 (399)
+|+|+++..+.|++..+|-||+.----....... ..........+.++|.|||.=.....+.++|||+||....+|..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 7999999999999999998887522111100000 00011122346789999998776778889999999999999988
Q ss_pred CCCC-cccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 274 GRKA-VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 274 g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
|..- -..............+.. ...++. -..++.+|++..|..||+|.+++.
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~---------~len~l------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVII---------GLENGL------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhhhhee---------eccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence 7643 221111111111111100 011111 123788899999999999998874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.3e-16 Score=149.33 Aligned_cols=250 Identities=24% Similarity=0.272 Sum_probs=185.4
Q ss_pred cCCCCCCeeee--cCceEEEEEEE--CCCCeEEEEEEecc--CCCcchHHHHHHHHHHhhcC-CCCccceEEEEecCCee
Q 015816 72 KNFRSESLLGE--GGFGRVYKGYL--ESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQR 144 (399)
Q Consensus 72 ~~~~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 144 (399)
..|-+...+|. |.+|.||.+.. ..++..+|+|.-.. ........=.+|+...+.++ |+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35667788999 99999999988 78899999998332 22222223345666666664 89999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeecCCCCCceeecCC-CceEEec
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSD 219 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~D 219 (399)
++-+|+|. .+|..+.+.. ...++...++.++.+... ||.++|+.+ ++|-|+||+||++..+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 99999985 7888888763 234788889999999999 999999999 9999999999999998 8899999
Q ss_pred ccCCccCCCCCCc---ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh
Q 015816 220 FGLAKLGPVGDNT---HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 220 fg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
||+...+...... .......|...|++||.++ +.++...|+||+|.++.+..+|..++....... |.
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~--- 336 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WS--- 336 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------cc---
Confidence 9998765444322 2223346888999999885 588899999999999999999876654431100 00
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. +....+..++.......+...+..+++.+|..|++++.+..
T Consensus 337 -~-------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 -Q-------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -c-------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 00111112222223346666899999999999998776653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.2e-15 Score=143.04 Aligned_cols=170 Identities=16% Similarity=0.193 Sum_probs=131.8
Q ss_pred EEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCC
Q 015816 90 KGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 169 (399)
Q Consensus 90 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 169 (399)
.|..+.++.+|.|++.+...........+-++-|+.++||||+++++.++.....|||+|.+ ..|..++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------
Confidence 46777889999999987654433455677889999999999999999999999999999998 478888876
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccc
Q 015816 170 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249 (399)
Q Consensus 170 l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 249 (399)
+....+...+.||+.||.|||+.+. ++|++|..+.|+|++.|..||++|.++........ ......--..|..|+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 3466777889999999999986554 99999999999999999999999988753221111 0111112234666665
Q ss_pred cccCCCCcccceeehhHHHHHHHhC
Q 015816 250 AKTGQLTLKSDVYSFGVVLLEILSG 274 (399)
Q Consensus 250 ~~~~~~~~~~DvwslG~il~ell~g 274 (399)
+.... -..|.|-|||+++|++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 43322 356999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-14 Score=140.60 Aligned_cols=140 Identities=21% Similarity=0.151 Sum_probs=97.4
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcch----------------------------------------HHH
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN----------------------------------------REF 116 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 116 (399)
.+.||.|++|.||+|+.++ |+.||||+..+...... -.+
T Consensus 122 ~~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 3689999999999999874 89999999865321100 013
Q ss_pred HHHHHHHhhcC----CCCccceEEEE-ecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 015816 117 LVEVLMLSLLH----HPNLVNLIGYC-ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR-GLEYLH 190 (399)
Q Consensus 117 ~~E~~~l~~l~----hpniv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~-al~~LH 190 (399)
.+|+..+.+++ |.+-+.+-.++ ......+|||||++|++|.++.... ...++ ...++.+++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHH
Confidence 44555555442 32222222222 2234578999999999998876531 11122 3456666665 478899
Q ss_pred hCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 191 ~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
..| ++|+|++|.||+++.++.++++|||++...
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999 999999999999999999999999998753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.8e-15 Score=145.12 Aligned_cols=144 Identities=17% Similarity=0.131 Sum_probs=96.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc----------------------------------hH---
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG----------------------------------NR--- 114 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~--- 114 (399)
..|+. +.||+|++|.||+|+.+.+|+.||||+..+.-... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45766 78999999999999999889999999997541100 01
Q ss_pred ---HHHHHHHHHhhcC----CCCccceEEEEec-CCeeEEEEEecCCCCHHHHh--hccCCCCCCCCHHHHHHHHHHHHH
Q 015816 115 ---EFLVEVLMLSLLH----HPNLVNLIGYCAD-GDQRLLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAAR 184 (399)
Q Consensus 115 ---~~~~E~~~l~~l~----hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~qi~~ 184 (399)
.+.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.- .........+....+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 1334444444442 3333444344432 45678999999999998742 22100011244444444555543
Q ss_pred HHHHHHhCCCCCeeecCCCCCceeecCCC----ceEEecccCCccC
Q 015816 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDFGLAKLG 226 (399)
Q Consensus 185 al~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~~~~~ 226 (399)
..| ++|+|++|.||+++.++ .++++|||++...
T Consensus 278 ------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 ------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 577 99999999999999888 9999999998753
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.9e-14 Score=118.72 Aligned_cols=129 Identities=19% Similarity=0.098 Sum_probs=96.3
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCcc-ceEEEEecCCeeEEEEEecCCCCH
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
+.|+.|.++.||++... +..|++|+...... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 56899999999999875 78899998764432 123456799999988765544 445443 2345899999998876
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA--KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
... . .....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~--~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE--D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc--c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 543 0 011346789999999999987 12249999999999999 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1e-13 Score=134.08 Aligned_cols=248 Identities=21% Similarity=0.217 Sum_probs=176.7
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCeEEEEEEeccCCCcchHH--HHHHHHHHhhc-CCCCccceEEEEecCCeeE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLE-SINQDVAIKQLDRNGVQGNRE--FLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 145 (399)
.+.+|..+..||.|.|+.|+.+..+ .++..|++|-+.........+ -..|+.+...+ .|.+++.++..+..-.+.|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888999999999999998766 567889999876543332222 24466665555 4888998888777777888
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC-CceEEecccCCc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAK 224 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~ 224 (399)
+--|||.++++...+.. ...+.+...+.+..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||++.
T Consensus 343 ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 99999999998877743 566888899999999999999999999 9999999999999886 788999999986
Q ss_pred cCCCCCCcceeeeeccCcccc--CccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYC--APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
..... ........+++ +|+......+..++|++|||..+.+..+|...-..... |.. +...
T Consensus 416 ~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~~--i~~~-- 478 (524)
T KOG0601|consen 416 RLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SLT--IRSG-- 478 (524)
T ss_pred cccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------cee--eecc--
Confidence 41111 11122333444 55566677888999999999999999998743221110 000 0000
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
..+.. +.....+..+...++..++..||.+.++......
T Consensus 479 ----~~p~~-----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 479 ----DTPNL-----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----cccCC-----CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 00000 1111355668888899999999999888765443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.7e-12 Score=112.22 Aligned_cols=136 Identities=15% Similarity=0.092 Sum_probs=99.0
Q ss_pred CCeeeecCceEEEEEEECC------CCeEEEEEEeccCCC---------------------cc-hHH----HHHHHHHHh
Q 015816 77 ESLLGEGGFGRVYKGYLES------INQDVAIKQLDRNGV---------------------QG-NRE----FLVEVLMLS 124 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~---------------------~~-~~~----~~~E~~~l~ 124 (399)
...||.|--+.||.|.... .+..+|||+...... .. ... ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3569999999999998653 357899999742110 00 111 237999998
Q ss_pred hcCC--CCccceEEEEecCCeeEEEEEecCCCCHH-HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeec
Q 015816 125 LLHH--PNLVNLIGYCADGDQRLLVYEYMPLGSVE-DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL-HDKAKPPVIYR 200 (399)
Q Consensus 125 ~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~ivH~ 200 (399)
++.. -++..++++ ...+|||||+.+..+. ..+.+ ..++......+..+++.+|..| |..+ |||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 8863 455666654 4678999999765432 22322 3355566778899999999999 8888 9999
Q ss_pred CCCCCceeecCCCceEEecccCCcc
Q 015816 201 DLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 201 Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
||++.|||++ ++.+.|+|||.+..
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCcee
Confidence 9999999997 46899999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.5e-14 Score=145.40 Aligned_cols=278 Identities=20% Similarity=0.193 Sum_probs=190.4
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
..+.+.+.+-+-+|+++.++.+.-..+|...++|+....... ..+....+-.++-.-++|.++.....+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 445677888899999999999988888877777665432211 12222233333333345666665555555677899
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
|++|+.+++|...++. .++.+..-+......+..+++|||+.. +.|+|++|.|+|+..++..+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999987 456777777888888999999999998 999999999999999999999999843221
Q ss_pred CCC----C-------------------------CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCC
Q 015816 227 PVG----D-------------------------NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 277 (399)
Q Consensus 227 ~~~----~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p 277 (399)
... . .........||+.|.+||.+.+......+|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 0 00112235799999999999999999999999999999999999999
Q ss_pred cccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHH--HHHHHHHHHhcc
Q 015816 278 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD--VVTALAYLASQK 355 (399)
Q Consensus 278 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e--il~~L~~l~~~~ 355 (399)
|........ +.+..... + -...-+........+++...+..+|.+|..+.- .+..-..+....
T Consensus 1035 ~na~tpq~~----------f~ni~~~~-~----~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1035 FNAETPQQI----------FENILNRD-I----PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred CCCcchhhh----------hhccccCC-C----CCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 987654322 11111000 0 001122233446777999999999999976652 223344445555
Q ss_pred CCCcccccCCCCCC
Q 015816 356 YESDAEKVQSPCLD 369 (399)
Q Consensus 356 ~~~~~~~~~~~~~~ 369 (399)
|+........+...
T Consensus 1100 ~~~l~~q~~~~~p~ 1113 (1205)
T KOG0606|consen 1100 WENLALQKAEFVPQ 1113 (1205)
T ss_pred ccccccccCccCCC
Confidence 55555443333333
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.2e-11 Score=103.52 Aligned_cols=131 Identities=24% Similarity=0.304 Sum_probs=101.6
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--c------hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--G------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
..+++|+-+.+|.+.+. |..+++|.=.+..-. . .....+|+.++.+++--.|.-.+=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35889999999999775 455667653222111 1 1345679999998876666665666677778889999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
|++|..|.+.+... ...++..|-.-+.-||..| |+|+||.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999898762 2567888888899999999 99999999999998775 99999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-11 Score=110.31 Aligned_cols=142 Identities=19% Similarity=0.243 Sum_probs=110.2
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCC--CccceEEEEecCC---eeEEEEEec
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHP--NLVNLIGYCADGD---QRLLVYEYM 151 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~~~---~~~lv~e~~ 151 (399)
+.|+.|..+.||++...+ |..+++|....... .....+..|+.+++.+.+. ++.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998764 68899999765432 1345678899999999763 4577777766542 568999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-------------------------------------- 193 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------------- 193 (399)
+|.++.+.+.. ..++......++.+++++|..||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888776531 34777788888889999999998531
Q ss_pred ---------------CCCeeecCCCCCceeecC--CCceEEecccCCcc
Q 015816 194 ---------------KPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKL 225 (399)
Q Consensus 194 ---------------~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~~~~ 225 (399)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.7e-11 Score=100.90 Aligned_cols=143 Identities=22% Similarity=0.232 Sum_probs=107.1
Q ss_pred CCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--------chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
....|-+|+-+.|+++.+. |+.+.||.=....-. ......+|+.+|.++.--.|.-..-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4678999999999999876 788888863222111 124567899999988765665555566677777899
Q ss_pred EEecCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC---ceEEecccCC
Q 015816 148 YEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLA 223 (399)
Q Consensus 148 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~~ 223 (399)
|||++| .++.+++..... ..........++.+|-+.+.-||..+ |||+||..+||+|..++ .+.++|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 999986 378888876432 22222333789999999999999999 99999999999997654 3589999998
Q ss_pred cc
Q 015816 224 KL 225 (399)
Q Consensus 224 ~~ 225 (399)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.9e-11 Score=109.25 Aligned_cols=263 Identities=16% Similarity=0.162 Sum_probs=163.0
Q ss_pred CCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhh-cCCCCccceEEE------Eec-CCeeEEE
Q 015816 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL-LHHPNLVNLIGY------CAD-GDQRLLV 147 (399)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~------~~~-~~~~~lv 147 (399)
..+.||+|+-+.+|-.-.. ...+.|++.........+. +..|.. -.||-+-.-+.+ .-+ +..+-++
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4578999999999964322 2245688876544333332 222222 245543321111 111 2236788
Q ss_pred EEecCCCCHHHHhh---ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 148 YEYMPLGSVEDHLH---DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 148 ~e~~~~g~L~~~l~---~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
|..++|..--..+. ..........|...+.+++.|+.+.+.||..| .+-+|+.++|+|+++++.|.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 88887653222221 11222445789999999999999999999999 8999999999999999999999866544
Q ss_pred cCCCCCCcceeeeeccCccccCccccc-----cCCCCcccceeehhHHHHHHHhC-CCCcccchHHHH------HHHHHh
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAE------QSLVAW 292 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~------~~~~~~ 292 (399)
. ..+.......+|...|.+||.-. +..-+...|.|.||+++|+++.| +.||.+...... ..+..
T Consensus 166 i---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~- 241 (637)
T COG4248 166 I---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH- 241 (637)
T ss_pred e---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc-
Confidence 2 23344455678999999999653 44567889999999999999986 999975432110 01110
Q ss_pred hhhhhccccccccccCccccCCCCh-HhHHHHHHHHHHcccc--CCCCCCCHHHHHHHHHHHHhc
Q 015816 293 ARPLFQDRTRHSLIADPELQGQYPP-RGFYQALAVAAMCVHE--QPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~--dP~~RPs~~eil~~L~~l~~~ 354 (399)
..|........-..+ .....|- -.+..+..|..+|+.. ++.-|||++.++..|..+..+
T Consensus 242 --g~f~ya~~~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 242 --GRFAYASDQRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred --ceeeechhccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 000000000000000 0011110 1123566688888874 367899999999999877654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.5e-11 Score=112.36 Aligned_cols=171 Identities=18% Similarity=0.199 Sum_probs=131.4
Q ss_pred ceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEe----cCCeeEEEEEecCC-CCHHHH
Q 015816 85 FGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA----DGDQRLLVYEYMPL-GSVEDH 159 (399)
Q Consensus 85 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~~~~lv~e~~~~-g~L~~~ 159 (399)
-.+.|++..+.+|..|++|.++............-+++++++.|+|||++.+++. .+..++||++|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4688999999999999999996554444434445688999999999999998876 34578999999875 467665
Q ss_pred hhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 160 LHDLSP-----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 160 l~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
...... .+..+++..+|.++.||..||.++|+.| +.-+-|.|.+||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 543221 2345788999999999999999999999 99999999999999999999998888764322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 277 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p 277 (399)
.. . |.+.+ -.+-|.=.||.+++.|.||..-
T Consensus 446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 21 0 11111 2356888899999999999643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.1e-09 Score=99.83 Aligned_cols=139 Identities=17% Similarity=0.105 Sum_probs=99.2
Q ss_pred eeeecCceEEEEEEECCCCeEEEEEEeccCCCc-----------chHHHHHHHHHHhhcCCCC--ccceEEEEec-----
Q 015816 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----------GNREFLVEVLMLSLLHHPN--LVNLIGYCAD----- 140 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~----- 140 (399)
.+-......|+++... |+.|.||........ ....+.+|...+..|..-+ ...++++...
T Consensus 29 ~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444456676554 788999977433211 1114678888888775333 3344555543
Q ss_pred CCeeEEEEEecCCC-CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-------C
Q 015816 141 GDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-------G 212 (399)
Q Consensus 141 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-------~ 212 (399)
....+||||++++. +|.+++.... ..+.+......++.+++..+.-||..| |+|+|+++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 23568999999976 7998886432 234566778899999999999999999 999999999999975 4
Q ss_pred CceEEecccCCc
Q 015816 213 YHPKLSDFGLAK 224 (399)
Q Consensus 213 ~~~kl~Dfg~~~ 224 (399)
+.+.|+||+.+.
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 689999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.1e-10 Score=95.16 Aligned_cols=124 Identities=21% Similarity=0.206 Sum_probs=80.8
Q ss_pred EEEEEEECCCCeEEEEEEeccCCC---------------------cc-----hHHHHHHHHHHhhcCCC--CccceEEEE
Q 015816 87 RVYKGYLESINQDVAIKQLDRNGV---------------------QG-----NREFLVEVLMLSLLHHP--NLVNLIGYC 138 (399)
Q Consensus 87 ~Vy~~~~~~~~~~vavK~~~~~~~---------------------~~-----~~~~~~E~~~l~~l~hp--niv~~~~~~ 138 (399)
.||.|.... |..+|||+...... .. .....+|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 489998755 88999999743110 00 02356799999999765 456666543
Q ss_pred ecCCeeEEEEEecC--CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeecCCCCCceeecCCCce
Q 015816 139 ADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY-LHDKAKPPVIYRDLKCSNILLDRGYHP 215 (399)
Q Consensus 139 ~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~~~ivH~Dlkp~Nill~~~~~~ 215 (399)
..+|||||++ |..+..+... .++......++.+++..+.. +|..| |+|+||.+.|||++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 4579999998 5555443322 12234456778888885555 57988 9999999999999988 99
Q ss_pred EEecccCCcc
Q 015816 216 KLSDFGLAKL 225 (399)
Q Consensus 216 kl~Dfg~~~~ 225 (399)
.|+|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999998763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2e-10 Score=113.18 Aligned_cols=150 Identities=19% Similarity=0.249 Sum_probs=102.9
Q ss_pred HHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc-------eeeeeccCccccCccccccC
Q 015816 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-------VSTRVMGTYGYCAPEYAKTG 253 (399)
Q Consensus 181 qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 253 (399)
+++.|+.|+|..-+ +||++|.|++|.++.++.+||+.|+.+.......... ......-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44599999998655 9999999999999999999999999876432211111 11112345789999999998
Q ss_pred CCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 015816 254 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 332 (399)
Q Consensus 254 ~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 332 (399)
..+.++|+|||||++|.+.. |+..+................ +.. ...+....+.++.+=+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~-------------~~~-~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL-------------NAG-AFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc-------------ccc-cccccccCcHHHHHHHHHHhc
Confidence 89999999999999999994 555554433222111110000 000 011112334488888999999
Q ss_pred cCCCCCCCHHHHHH
Q 015816 333 EQPDMRPVIADVVT 346 (399)
Q Consensus 333 ~dP~~RPs~~eil~ 346 (399)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999997777664
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.7e-09 Score=93.88 Aligned_cols=134 Identities=18% Similarity=0.115 Sum_probs=98.2
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc----------------------chHHHHHHHHHHhhcCCC--
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----------------------GNREFLVEVLMLSLLHHP-- 129 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~hp-- 129 (399)
+.++..||-|--|.||.|.+.. |..+|||.-..-..+ ......+|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 5677899999999999999875 899999975321100 112356799999988654
Q ss_pred CccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 015816 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 130 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill 209 (399)
.+.+.+++ +..++||||++|-.|...- ++....-.++..|++-+.-+-..| |||+|+.+-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 56666654 5678999999975554322 223344556666666666666788 9999999999999
Q ss_pred cCCCceEEecccCCc
Q 015816 210 DRGYHPKLSDFGLAK 224 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~ 224 (399)
+++|.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999996554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.8e-08 Score=88.85 Aligned_cols=105 Identities=25% Similarity=0.253 Sum_probs=83.1
Q ss_pred HHHHHHHHHHhhcCCC--CccceEEEEecC----CeeEEEEEecCCC-CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHH
Q 015816 114 REFLVEVLMLSLLHHP--NLVNLIGYCADG----DQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186 (399)
Q Consensus 114 ~~~~~E~~~l~~l~hp--niv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al 186 (399)
....+|...+..|..- .+...+++.... ...+||+|++++. +|.+++... ..++......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence 4567788877777533 345556665543 2458999999874 799998862 2366677889999999999
Q ss_pred HHHHhCCCCCeeecCCCCCceeecCCC---ceEEecccCCcc
Q 015816 187 EYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKL 225 (399)
Q Consensus 187 ~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~~~~ 225 (399)
.-||..| |+|+|+++.|||++.++ .+.|+||+-+..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.9e-08 Score=83.45 Aligned_cols=138 Identities=14% Similarity=0.122 Sum_probs=101.9
Q ss_pred eeecCceEEEEEEECCCCeEEEEEEeccCC------CcchHHHHHHHHHHhhcCCCC--ccceEEEEe---c--CCeeEE
Q 015816 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNG------VQGNREFLVEVLMLSLLHHPN--LVNLIGYCA---D--GDQRLL 146 (399)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~---~--~~~~~l 146 (399)
-|+||.+.|++....+ ..+-+|.-...- +.....|.+|+..|..|..-+ +.++. ++. . ...-+|
T Consensus 26 ~~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 4679999999987764 468888764110 224567999999999886422 44444 332 1 124579
Q ss_pred EEEecCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc--eEEecccCC
Q 015816 147 VYEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--PKLSDFGLA 223 (399)
Q Consensus 147 v~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~ 223 (399)
|+|-++| .+|.+++.+.. -.+.+......++.+|+.++.-||+.| +.|+|+.+.|||++.++. +.++||.-+
T Consensus 103 VTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9997753 58888886522 234577778899999999999999999 999999999999986666 999999877
Q ss_pred cc
Q 015816 224 KL 225 (399)
Q Consensus 224 ~~ 225 (399)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 64
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.7e-07 Score=83.80 Aligned_cols=139 Identities=14% Similarity=0.138 Sum_probs=85.6
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--ccceEEEEecCCeeEEEEEecCCCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYEYMPLGS 155 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~g~ 155 (399)
..||+|..+.||+. . +..+++|...... ......+|..+++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~-~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---K-TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---c-CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999984 2 4567889876432 3345788999998886433 4677888888888899999999863
Q ss_pred -HHHHh---------------------hccCCCCCCCCHHHHHHHHHH----------HHH-HHHHHHh-CCCCCeeecC
Q 015816 156 -VEDHL---------------------HDLSPGKKPLDWNTRMKIAAG----------AAR-GLEYLHD-KAKPPVIYRD 201 (399)
Q Consensus 156 -L~~~l---------------------~~~~~~~~~l~~~~~~~i~~q----------i~~-al~~LH~-~~~~~ivH~D 201 (399)
+...+ +........++... ..+..+ +.. ...+|.. ...+.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 11100111111000 000000 001 1122221 1133479999
Q ss_pred CCCCceeecCCCceEEecccCCc
Q 015816 202 LKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 202 lkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999876
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.6e-07 Score=81.80 Aligned_cols=136 Identities=13% Similarity=0.110 Sum_probs=90.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHH---------HHHHHHHhhcC---CCCccceEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---------LVEVLMLSLLH---HPNLVNLIGYC 138 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---hpniv~~~~~~ 138 (399)
..+|.+.+.+-......|.+.... |..+++|..........+.| .+.+..+..+. --.+..++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 467888888888777777766544 78899999865443333222 22333333332 22333333322
Q ss_pred e-----cCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC
Q 015816 139 A-----DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213 (399)
Q Consensus 139 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~ 213 (399)
. -....++||||++|..|.+... +++ .++..|.+++.-||..| ++|+|..|.|++++.+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 2 2245568999999988766543 222 35567788899999999 9999999999999965
Q ss_pred ceEEecccCCc
Q 015816 214 HPKLSDFGLAK 224 (399)
Q Consensus 214 ~~kl~Dfg~~~ 224 (399)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 49999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.5e-09 Score=106.09 Aligned_cols=189 Identities=18% Similarity=0.098 Sum_probs=138.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC-ccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~e 149 (399)
++-+...+.+++|+++++++.+...+...+ .+.+... .....++++|.+++||| .+..++-+..++...++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 344556677899999999998776654444 6665433 34456899999999999 7777777777888899999
Q ss_pred ecCCC-CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 150 YMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 150 ~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
++.++ +....... ....+...+...+.+.-+++++++|+.- =+|+| ||+..+ +..+.+||+.......
T Consensus 315 i~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 315 ICSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred hhcCCccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCc
Confidence 99876 21111110 1223344455566777788999999875 58998 777766 6899999998864322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 279 (399)
.. ......+|+.++|||+.....+....|+|++|+-..+|--|-+|-.
T Consensus 384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 21 3345679999999999999999999999999998888877777654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=7e-08 Score=95.38 Aligned_cols=140 Identities=18% Similarity=0.160 Sum_probs=91.3
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcch------------------------------H----------HHH
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN------------------------------R----------EFL 117 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~ 117 (399)
..|+.++-|.||+|+.++ |+.||||+..+.-.... + .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 689999999999999987 99999999754311000 0 123
Q ss_pred HHHHHHhhcC-----CCCccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 015816 118 VEVLMLSLLH-----HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192 (399)
Q Consensus 118 ~E~~~l~~l~-----hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 192 (399)
+|..-+.+++ .|+|.-..=+.+-.....|+|||++|..+.+...-. ...++...+.....++. +..+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHH--HHHHHhc
Confidence 4555554442 233322222223345678999999999988875321 23344333322222222 3333346
Q ss_pred CCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 193 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
| ++|.|..|.||+++.+|++.+.|||+....
T Consensus 285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred C---ccccCCCccceEEecCCcEEEEcCcceecC
Confidence 7 999999999999999999999999998653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=7.4e-07 Score=78.64 Aligned_cols=149 Identities=20% Similarity=0.156 Sum_probs=98.6
Q ss_pred CHHHHHHHhcCCCCCCeee---ecCceEEEEEEECCCCeEEEEEEeccCCCcch-------------------H-----H
Q 015816 63 TFRELAAATKNFRSESLLG---EGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-------------------R-----E 115 (399)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg---~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------~-----~ 115 (399)
+...+.....+..+....| .|--+.||+|... ++..+|||++........ + .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 4445555555655555554 5666789998764 388999999854322111 1 1
Q ss_pred HHHHHHHHhhcC--CCCccceEEEEecCCeeEEEEEecCCC-CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 015816 116 FLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD- 191 (399)
Q Consensus 116 ~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~- 191 (399)
...|+.-|+++. +-.+.+.+.+. ...|||||+... .-.-.|.+ -++...++..+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHh
Confidence 345676676664 33444555543 346999998543 11122222 233444688888899999888887
Q ss_pred CCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 192 ~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
.+ +||+||..-|||+. ++.+.|+|||-+..
T Consensus 186 a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 186 AG---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred cC---cccccchhhheEEE-CCeEEEEECccccc
Confidence 77 99999999999999 88999999998763
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.56 E-value=6e-07 Score=80.33 Aligned_cols=143 Identities=21% Similarity=0.222 Sum_probs=83.0
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCC--CccceEEEEec---CCeeEEEEEecC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP--NLVNLIGYCAD---GDQRLLVYEYMP 152 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~---~~~~~lv~e~~~ 152 (399)
+.|+.|..+.||++...+ ..+++|..... .....+..|..+++.+... .+.+++.+... ....+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 568999999999998875 48999997543 3446677888888887533 34566664432 234689999999
Q ss_pred CCCHHH----------------Hhh---ccCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 015816 153 LGSVED----------------HLH---DLSPGKKPLDWNT---------RMKI------------AAGAAR-GLEYLHD 191 (399)
Q Consensus 153 ~g~L~~----------------~l~---~~~~~~~~l~~~~---------~~~i------------~~qi~~-al~~LH~ 191 (399)
|..+.. .+. .......++.... .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 888777 111 1100011111110 0000 011122 2333332
Q ss_pred ----CCCCCeeecCCCCCceeec-CCCceEEecccCCc
Q 015816 192 ----KAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAK 224 (399)
Q Consensus 192 ----~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~ 224 (399)
.....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234499999999999999 66677899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.8e-06 Score=78.19 Aligned_cols=140 Identities=22% Similarity=0.213 Sum_probs=84.2
Q ss_pred eeecCc-eEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEEEEecCCCCHH
Q 015816 80 LGEGGF-GRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVE 157 (399)
Q Consensus 80 lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~L~ 157 (399)
|-.|.. ..||++... +..+.||...... ...+..|+.+++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444554 789998654 4678888875432 334667898888874 334557777777666789999999988776
Q ss_pred HHh-------------------hccCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----C
Q 015816 158 DHL-------------------HDLSPGKKPLDWN--TRMKIAA--------------------GAARGLEYLHD----K 192 (399)
Q Consensus 158 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------qi~~al~~LH~----~ 192 (399)
... +.......++... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 1111001111100 0000000 01111222211 1
Q ss_pred CCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 193 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13449999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.5e-06 Score=89.50 Aligned_cols=79 Identities=15% Similarity=0.217 Sum_probs=57.7
Q ss_pred CCeeeecCceEEEEEEECCCC--eEEEEEEeccCCC-cchHHHHHHHHHHhhcC-CCCc--cceEEEEecC---CeeEEE
Q 015816 77 ESLLGEGGFGRVYKGYLESIN--QDVAIKQLDRNGV-QGNREFLVEVLMLSLLH-HPNL--VNLIGYCADG---DQRLLV 147 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpni--v~~~~~~~~~---~~~~lv 147 (399)
...|+.|.+..+|+......+ ..+++|+...... .....+.+|+.+|+.+. |+++ .+++.++.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 466889999999998775432 4678887654322 23456889999999995 6654 7778887764 467899
Q ss_pred EEecCCCC
Q 015816 148 YEYMPLGS 155 (399)
Q Consensus 148 ~e~~~~g~ 155 (399)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99999764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.2e-05 Score=70.01 Aligned_cols=128 Identities=22% Similarity=0.268 Sum_probs=92.6
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCC----------------CcchHHHHHHHHHHhhcC------CCCccce
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG----------------VQGNREFLVEVLMLSLLH------HPNLVNL 134 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpniv~~ 134 (399)
...||+|+.-.||.- .. +....||+..... ....++..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457999999999973 32 5567899987655 122455667776666555 7899999
Q ss_pred EEEEecCCeeEEEEEecCC------CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcee
Q 015816 135 IGYCADGDQRLLVYEYMPL------GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (399)
Q Consensus 135 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nil 208 (399)
+|+.++....-+|+|.+.. .+|.+++.+ ..++. .... .+-+-..||-... |+.+||+|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHH---HHHHHHHHHHHcC---CeecCCCcccEE
Confidence 9999999999999998632 367788853 45665 3333 3444566777777 999999999999
Q ss_pred ecCC---C-ceEEec
Q 015816 209 LDRG---Y-HPKLSD 219 (399)
Q Consensus 209 l~~~---~-~~kl~D 219 (399)
+... . .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 9642 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.1e-06 Score=70.03 Aligned_cols=129 Identities=21% Similarity=0.185 Sum_probs=91.9
Q ss_pred CCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCcc-ceEEEEecCCeeEEEEEecCC
Q 015816 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~ 153 (399)
++.+.|++|.+|.||+|.+. |..+|+|+-..+. ....+..|+++|..+.--++- ++|.+..+ ++.|||+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 45678999999999999988 5689999865443 456788999999999876654 34444333 366999998
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC-CCceeecCCCceEEecccCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK-CSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlk-p~Nill~~~~~~kl~Dfg~~~~ 225 (399)
-.|.++-.. .+. +-+..++++---|-..| |-|+.|. |..++|..++.+.|+||..|+.
T Consensus 97 ~~L~~~~~~-------~~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIG-------GDR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhc-------ccH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 788776653 122 23344555555566777 9999986 4444454555999999998873
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.32 E-value=3e-06 Score=73.27 Aligned_cols=100 Identities=28% Similarity=0.299 Sum_probs=80.4
Q ss_pred HHHHHHhhcCC-CCccceEEEEecCCeeEEEEEecCCCCHHHH---hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015816 118 VEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEYMPLGSVEDH---LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193 (399)
Q Consensus 118 ~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ 193 (399)
.|.-+++.+.+ +++.+++|+| ..++|.||...+++... +.+ -..-+|..+.+|+.++++.+.+|++.-
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~----~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQ----FLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccccc----ccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 48888888876 6999999999 34678999987655421 111 123689999999999999999999865
Q ss_pred CCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 194 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
...+.-.|++|+|+-+++++++|++|.+.+..
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 44488899999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.4e-06 Score=82.59 Aligned_cols=137 Identities=17% Similarity=0.122 Sum_probs=88.5
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc-----------------------h----H----------HHHHHH
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-----------------------N----R----------EFLVEV 120 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------------~----~----------~~~~E~ 120 (399)
+.||.-+.|.||+|+.++ |+.||||+-++.-... . + .|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999998 9999999864321000 0 0 123344
Q ss_pred HHHh----hcCCCC------ccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 015816 121 LMLS----LLHHPN------LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190 (399)
Q Consensus 121 ~~l~----~l~hpn------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 190 (399)
+-.. .+.|-+ |.++|-.+ .....|+||||+|..+.+.-.- . ...++...+..-+.+...-+ +-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i-~--~~gi~~~~i~~~l~~~~~~q--If 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI-D--KRGISPHDILNKLVEAYLEQ--IF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH-H--HcCCCHHHHHHHHHHHHHHH--HH
Confidence 3333 334544 33333222 3457899999999877665321 1 34466655544444433222 33
Q ss_pred hCCCCCeeecCCCCCceeecC----CCceEEecccCCcc
Q 015816 191 DKAKPPVIYRDLKCSNILLDR----GYHPKLSDFGLAKL 225 (399)
Q Consensus 191 ~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Dfg~~~~ 225 (399)
..| ++|+|-.|.||+++. ++.+.+.|||+...
T Consensus 319 ~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 319 KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred hcC---CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 446 999999999999983 67899999999875
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.3e-06 Score=74.24 Aligned_cols=73 Identities=14% Similarity=0.157 Sum_probs=46.2
Q ss_pred CeeeecCce-EEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCC---CccceEEEEecC---CeeEEEEEe
Q 015816 78 SLLGEGGFG-RVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP---NLVNLIGYCADG---DQRLLVYEY 150 (399)
Q Consensus 78 ~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~~~---~~~~lv~e~ 150 (399)
+.|+.|+.. .||+. +..+++|..... .....+.+|..++..+... .+..+++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457777766 58976 235778875432 2345788899999887532 244444444332 234889999
Q ss_pred cCCCCHH
Q 015816 151 MPLGSVE 157 (399)
Q Consensus 151 ~~~g~L~ 157 (399)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.1e-06 Score=86.48 Aligned_cols=196 Identities=20% Similarity=0.193 Sum_probs=140.9
Q ss_pred HHHHHHHHhhcCCCCccceEEEEecCCee----EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015816 116 FLVEVLMLSLLHHPNLVNLIGYCADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191 (399)
Q Consensus 116 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 191 (399)
...|+..+.+..|+|++.++.|....... .+..+++..-++...++. ...++....+.+..++.+||.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 34577788888999999999987665433 345678888888888887 6778999999999999999999999
Q ss_pred CCCCCeeecCCCCC---ceeecCCCceEEe--cccCCccCCCCCCcceeeeeccCccccCccccccCCCCcc--cceeeh
Q 015816 192 KAKPPVIYRDLKCS---NILLDRGYHPKLS--DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK--SDVYSF 264 (399)
Q Consensus 192 ~~~~~ivH~Dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~Dvwsl 264 (399)
.. ..|.-|..+ +...+..+.+.++ ||+.+......... .....+..|.|||......++.+ .|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHH
Confidence 87 777777666 5556677777777 99988754333222 12234566888888876666554 799999
Q ss_pred hHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHH
Q 015816 265 GVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344 (399)
Q Consensus 265 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 344 (399)
|..+..+..|..+-....... .+.+ ..+.. .+.+...+|+..++++|+++.++
T Consensus 379 gll~~~~~~~~~i~~~~~~~~-------------------~~l~----~~~~~----~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVPV-------------------SLLD----VLSTS----ELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHhhhhhcCcccccccchh-------------------hhhc----cccch----hhhhhhhhhcchhhhhccchhhh
Confidence 999999998876533221100 0000 00000 45668899999999999999999
Q ss_pred HHHH
Q 015816 345 VTAL 348 (399)
Q Consensus 345 l~~L 348 (399)
+...
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 9654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.1e-05 Score=73.62 Aligned_cols=139 Identities=15% Similarity=0.040 Sum_probs=79.0
Q ss_pred eeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCc-cceEEEEecCCeeEEEEEecCCCCHHH
Q 015816 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSVED 158 (399)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g~L~~ 158 (399)
+..|-...+|+.. .++..+++|..........-....|..+++.+..-.+ .+++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 5567778999886 3467888997654322211124678888888864333 33444332 368999999866532
Q ss_pred H-----------------hhccCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHhC-----CCCCeeecCCCCCc
Q 015816 159 H-----------------LHDLSPGKKPLDWNT-RMKIAAGA---------ARGLEYLHDK-----AKPPVIYRDLKCSN 206 (399)
Q Consensus 159 ~-----------------l~~~~~~~~~l~~~~-~~~i~~qi---------~~al~~LH~~-----~~~~ivH~Dlkp~N 206 (399)
. ++.......+++... +..+..++ ...+..+-.. ..+.++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 122111112222221 11221111 1112222111 12348999999999
Q ss_pred eeecCCCceEEecccCCcc
Q 015816 207 ILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 207 ill~~~~~~kl~Dfg~~~~ 225 (399)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.15 E-value=3e-05 Score=66.96 Aligned_cols=125 Identities=26% Similarity=0.333 Sum_probs=89.0
Q ss_pred cCCCCCCeeeecCc-eEEEEEEECCCCeEEEEEEecc---CCC------------------cchHHHHHHHHHHhhcC--
Q 015816 72 KNFRSESLLGEGGF-GRVYKGYLESINQDVAIKQLDR---NGV------------------QGNREFLVEVLMLSLLH-- 127 (399)
Q Consensus 72 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~-- 127 (399)
.+++..+.||.|.- |.||++... |+.||+|++.. ... ....-|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67889999999999 999999887 78999999321 100 01124677887777764
Q ss_pred -CCCc--cceEEEEecC------------------CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHH
Q 015816 128 -HPNL--VNLIGYCADG------------------DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186 (399)
Q Consensus 128 -hpni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al 186 (399)
+.++ |+++||..-. ....||.||++... .++. .-+.+|.+-|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl 177 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDL 177 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHH
Confidence 4566 8999987221 12357888776432 2333 3345667778
Q ss_pred HHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 187 ~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
..+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 8999999 999999999985 3489999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.1e-05 Score=70.80 Aligned_cols=76 Identities=14% Similarity=0.103 Sum_probs=55.2
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC---CCccceEEEEecC---CeeEEEEEe
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH---PNLVNLIGYCADG---DQRLLVYEY 150 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~~~~~~~~~---~~~~lv~e~ 150 (399)
.+.||.|..+.||.....+ + .+.+|.... ......+..|...|+.|.- -.+.++++++... +..+||||+
T Consensus 19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 4569999999999986543 3 467777432 1123578889999988853 3577888887543 568999999
Q ss_pred cCCCCH
Q 015816 151 MPLGSV 156 (399)
Q Consensus 151 ~~~g~L 156 (399)
++|.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.5e-05 Score=69.26 Aligned_cols=74 Identities=16% Similarity=0.156 Sum_probs=47.1
Q ss_pred CeeeecCceEEEEEEECC-CCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCc-cceEEEEecCCeeEEEEEecCCCC
Q 015816 78 SLLGEGGFGRVYKGYLES-INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGS 155 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g~ 155 (399)
+.|..|-...+|++.... .+..|++|+....... .-...+|+.+++.+...++ .++++.+.. .+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCCc
Confidence 457778888999987543 3567889977543221 1123468888888854333 444443322 38999999876
Q ss_pred H
Q 015816 156 V 156 (399)
Q Consensus 156 L 156 (399)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.07 E-value=0.00015 Score=69.95 Aligned_cols=76 Identities=16% Similarity=0.121 Sum_probs=53.5
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccC------C-CcchHHHHHHHHHHhhcC---CCCccceEEEEecCCeeEEE
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRN------G-VQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv 147 (399)
+.||.|.+..||++.....++.|+||.-.+. . ....+.+..|.+.|..+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5699999999999998753368999985321 1 123456677888888763 2356667766 44567899
Q ss_pred EEecCCCC
Q 015816 148 YEYMPLGS 155 (399)
Q Consensus 148 ~e~~~~g~ 155 (399)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.1e-05 Score=70.80 Aligned_cols=143 Identities=17% Similarity=0.131 Sum_probs=83.7
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--ccceEE------EEecCCeeEEEE
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIG------YCADGDQRLLVY 148 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~------~~~~~~~~~lv~ 148 (399)
.+.|..|....+|++... +..+++|+... .....+..|+.++..+.+-+ +.+++. +....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 355777877899998654 45788998754 23445667888887775322 444433 123345678999
Q ss_pred EecCCCCHHH--------------HhhccCCC-C------CCCCHHHHH----------HHHHHHHHHHHHHHhC----C
Q 015816 149 EYMPLGSVED--------------HLHDLSPG-K------KPLDWNTRM----------KIAAGAARGLEYLHDK----A 193 (399)
Q Consensus 149 e~~~~g~L~~--------------~l~~~~~~-~------~~l~~~~~~----------~i~~qi~~al~~LH~~----~ 193 (399)
+|++|..+.. .++..... . ....|.... .....+..++.++... -
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876421 11111000 0 011111110 0111233444555431 1
Q ss_pred CCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 194 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2349999999999999998777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00022 Score=66.96 Aligned_cols=158 Identities=16% Similarity=0.167 Sum_probs=88.0
Q ss_pred CHHHHHHHhcCCCC-----CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--ccceE
Q 015816 63 TFRELAAATKNFRS-----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLI 135 (399)
Q Consensus 63 ~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~ 135 (399)
+-+++......|.+ .+.++.|....+|++... +..+++|+..... ....+..|+.++..|.... +.+++
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 44555555555544 345667777899998643 3468889875421 2344556777777764222 34443
Q ss_pred EE------EecCCeeEEEEEecCCCCHH-----------H---HhhccCCC---CC----CC-CHHHHH-----------
Q 015816 136 GY------CADGDQRLLVYEYMPLGSVE-----------D---HLHDLSPG---KK----PL-DWNTRM----------- 176 (399)
Q Consensus 136 ~~------~~~~~~~~lv~e~~~~g~L~-----------~---~l~~~~~~---~~----~l-~~~~~~----------- 176 (399)
.. ....+..++|++|++|..+. . .++..... .. .+ .|....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 32 12245678999999975432 1 11111100 00 00 111100
Q ss_pred -HHHHHHHHHHHHHHh----CCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 177 -KIAAGAARGLEYLHD----KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 177 -~i~~qi~~al~~LH~----~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
.....+...++++.. .-...++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 011123345555542 112349999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00043 Score=65.30 Aligned_cols=159 Identities=14% Similarity=0.113 Sum_probs=83.8
Q ss_pred cCHHHHHHHhcCCCC-----CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--ccce
Q 015816 62 LTFRELAAATKNFRS-----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNL 134 (399)
Q Consensus 62 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~ 134 (399)
++..++......|.+ .+.|+.|....+|++... +..+++|++. . .....+..|+.++..|...+ +.++
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT--QGEYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeC--CCcEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 344445444455544 245667777899998754 3368899875 2 12334444666665553211 3333
Q ss_pred EE------EEecCCeeEEEEEecCCCCHH-----------HHh---hccCCC-------CCCCCH-HHHHH---------
Q 015816 135 IG------YCADGDQRLLVYEYMPLGSVE-----------DHL---HDLSPG-------KKPLDW-NTRMK--------- 177 (399)
Q Consensus 135 ~~------~~~~~~~~~lv~e~~~~g~L~-----------~~l---~~~~~~-------~~~l~~-~~~~~--------- 177 (399)
+. +....+..+++++|++|..+. ..+ +..... ...+.+ .....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32 122345678999999986431 111 111100 001111 11111
Q ss_pred ---HHHH-HHHHHHHHHhC----CCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 178 ---IAAG-AARGLEYLHDK----AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 178 ---i~~q-i~~al~~LH~~----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
.+.+ +...+..+... -..++||+|+.|.|||++.+...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 11122333211 123499999999999999765568999998763
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00028 Score=65.18 Aligned_cols=73 Identities=18% Similarity=0.234 Sum_probs=47.7
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC---CCCccceEEEEecCCeeEEEEEecCC
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
.+.|+.|....+|+.. .+++.+.||+-.. .....|..|..-|+.|. --.+.+++++....+..+|||||++.
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 3568889999999987 5588999998652 23355778888888884 34577888988877788999999986
Q ss_pred C
Q 015816 154 G 154 (399)
Q Consensus 154 g 154 (399)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=2.8e-05 Score=71.23 Aligned_cols=133 Identities=14% Similarity=0.071 Sum_probs=93.3
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-----c-----------------hHHHHHHHHHHhhcC-CC-
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----G-----------------NREFLVEVLMLSLLH-HP- 129 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~-----------------~~~~~~E~~~l~~l~-hp- 129 (399)
+.+++.||-|--+.||.+-+.. |.+.++|.-..-... . +-...+|...|+.|. |-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 6788999999999999998876 888898864221100 0 012346888888775 32
Q ss_pred CccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 015816 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 130 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill 209 (399)
-+.+.++ .+..++|||++.|-.|...-+- .+ ...+...+..-+.-|-.+| +||+|..--||++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d---~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV-------ED---PPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec-------CC---hHHHHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 2334444 3567899999998776554321 11 2334555555567778889 9999999999999
Q ss_pred cCCCceEEecccCCc
Q 015816 210 DRGYHPKLSDFGLAK 224 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~ 224 (399)
++++.++++||--+.
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999996543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00051 Score=64.25 Aligned_cols=142 Identities=22% Similarity=0.240 Sum_probs=82.2
Q ss_pred CeeeecCceEEEEEEECC------CCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCc-cceEEEEecCCeeEEEEEe
Q 015816 78 SLLGEGGFGRVYKGYLES------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~ 150 (399)
+.|..|-...+|++.... .++.|++|+..... ........|..++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345666667899887643 25789999976542 222345668888888754333 345555542 368999
Q ss_pred cCCCCHHHH-----------------hhccCCCC--C---CCC--HHHHHH--------------------------HHH
Q 015816 151 MPLGSVEDH-----------------LHDLSPGK--K---PLD--WNTRMK--------------------------IAA 180 (399)
Q Consensus 151 ~~~g~L~~~-----------------l~~~~~~~--~---~l~--~~~~~~--------------------------i~~ 180 (399)
++|.++... ++...... . ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 11111110 0 111 111100 112
Q ss_pred HHHHHHHHHHh------CCCCCeeecCCCCCceeecCC----CceEEecccCCc
Q 015816 181 GAARGLEYLHD------KAKPPVIYRDLKCSNILLDRG----YHPKLSDFGLAK 224 (399)
Q Consensus 181 qi~~al~~LH~------~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~~~ 224 (399)
.+...+.+|-. .....++|+|+.|.|||++.+ +.+.|+||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233344432 124459999999999999985 889999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0014 Score=61.01 Aligned_cols=138 Identities=20% Similarity=0.244 Sum_probs=84.1
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEec-cCCCcchHHHHHHHHHHhhcCC--CCccceEEEEecCC--eeEEEEEec
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGD--QRLLVYEYM 151 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~--~~~lv~e~~ 151 (399)
.+.+..|.--.+|..... ++.+++..-. ...........+|..+++.+.- .-+...++.|.++. ..+.||+|+
T Consensus 30 v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 334433333344444433 7888888221 1223344556778888887653 22344566676665 669999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHH-HHHHHHHHHHHhC--------------------------------------
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIA-AGAARGLEYLHDK-------------------------------------- 192 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~-~qi~~al~~LH~~-------------------------------------- 192 (399)
+|..+.+.+.. .... ..++ ..++..|.-||+-
T Consensus 108 eGe~~~~~~~~-----~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 108 EGEVVWSALPP-----ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred cceeccCcCCc-----ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 98543333221 0011 1222 2555555555542
Q ss_pred -----------------CCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 193 -----------------AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 193 -----------------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+.+.++|+|+.+.|++++.++.+=|.||+++..
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 134599999999999999998899999999985
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.002 Score=60.91 Aligned_cols=73 Identities=16% Similarity=0.142 Sum_probs=47.8
Q ss_pred eeeecCceEEEEEEECCCCeEEEEEEecc-------CCCcchHHHHHHHHHHhhcC--CCC-ccceEEEEecCCeeEEEE
Q 015816 79 LLGEGGFGRVYKGYLESINQDVAIKQLDR-------NGVQGNREFLVEVLMLSLLH--HPN-LVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--hpn-iv~~~~~~~~~~~~~lv~ 148 (399)
.||.|....||++.....+..|+||.-.+ ......++...|...|+... .|. +.++|. .+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 58999999999999864346899997431 11223345556888887654 353 444443 3445667999
Q ss_pred EecCC
Q 015816 149 EYMPL 153 (399)
Q Consensus 149 e~~~~ 153 (399)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0019 Score=59.58 Aligned_cols=31 Identities=29% Similarity=0.380 Sum_probs=25.9
Q ss_pred CCeeecCCCCCceeecCCCc-eEEecccCCcc
Q 015816 195 PPVIYRDLKCSNILLDRGYH-PKLSDFGLAKL 225 (399)
Q Consensus 195 ~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~~~~ 225 (399)
+.++|+|+.|.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.39 E-value=1.3e-05 Score=86.00 Aligned_cols=159 Identities=13% Similarity=-0.005 Sum_probs=117.3
Q ss_pred HHHHHhhcCCCCccceEEEEec--CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--C
Q 015816 119 EVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA--K 194 (399)
Q Consensus 119 E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~ 194 (399)
|..-++...|+++...+.=... ....+.+++|+.+|.+.+.|-.-.+....+...-+.....+...+..-+|+.. .
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 4444455678888766554432 34568999999999999998865555566666555555555466666666442 3
Q ss_pred CCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhC
Q 015816 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274 (399)
Q Consensus 195 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g 274 (399)
...+|++||+-|.+|..+..++++++|+.+... ..........+++.|++|+..+.-.++.++|+|..|+.+|+...|
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 457999999999999999999999999998311 111122335678899999999988999999999999999999988
Q ss_pred CCCcc
Q 015816 275 RKAVD 279 (399)
Q Consensus 275 ~~pf~ 279 (399)
..+|-
T Consensus 1437 n~~fi 1441 (2724)
T KOG1826|consen 1437 NAYFI 1441 (2724)
T ss_pred cHHHH
Confidence 87764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0038 Score=60.14 Aligned_cols=73 Identities=15% Similarity=0.089 Sum_probs=49.5
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-------cchHHHHHHHHHHhhcC---CCCccceEEEEecCCeeEE
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-------QGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~l 146 (399)
.+.||.|....||++... +..|+||.-..... -....-..|...|+.+. ..++.+++.++. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 456899999999998874 45699998542111 12233445677776654 246777888876 44678
Q ss_pred EEEecCC
Q 015816 147 VYEYMPL 153 (399)
Q Consensus 147 v~e~~~~ 153 (399)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0029 Score=60.38 Aligned_cols=142 Identities=15% Similarity=0.165 Sum_probs=80.2
Q ss_pred eeeecCceEEEEEEECC----CCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCcc-ceEEEEecCCeeEEEEEecCC
Q 015816 79 LLGEGGFGRVYKGYLES----INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~ 153 (399)
.|-.|-.-.+|++.... .+..|++|+.........+ -..|..+++.+..-++. ++++.+..+ .|.+|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45456677889887532 2467999987654322222 25688888888644443 455665433 58999987
Q ss_pred CCHHHH-----------------hhccCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-C
Q 015816 154 GSVEDH-----------------LHDLSPGKK--PLDWNTRMKIAAGA-----------------ARGLEYL----HD-K 192 (399)
Q Consensus 154 g~L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~qi-----------------~~al~~L----H~-~ 192 (399)
.+|... ++....... ...+..+..+..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665421 111111011 11223333333221 1111112 21 1
Q ss_pred CCCCeeecCCCCCceeecC-CCceEEecccCCcc
Q 015816 193 AKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKL 225 (399)
Q Consensus 193 ~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~ 225 (399)
....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1234899999999999986 46899999988763
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.005 Score=57.76 Aligned_cols=28 Identities=25% Similarity=0.285 Sum_probs=24.9
Q ss_pred CeeecCCCCCceeecCCCceEEecccCCc
Q 015816 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 196 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
.++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 3999999999999988 678999998765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0045 Score=59.35 Aligned_cols=75 Identities=20% Similarity=0.223 Sum_probs=50.0
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEecc------CCCcchHHHHHHHHHHhhcC--CCC-ccceEEEEecCCeeEEE
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDR------NGVQGNREFLVEVLMLSLLH--HPN-LVNLIGYCADGDQRLLV 147 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--hpn-iv~~~~~~~~~~~~~lv 147 (399)
.+.||.|.-..||++.+...+..|+||.-.+ .-....++...|..+|+.+. .|. +.++|.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3578999999999999854356799997431 11223456667888888764 354 4445433 44566789
Q ss_pred EEecCC
Q 015816 148 YEYMPL 153 (399)
Q Consensus 148 ~e~~~~ 153 (399)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999853
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0092 Score=56.02 Aligned_cols=30 Identities=20% Similarity=0.218 Sum_probs=27.4
Q ss_pred CeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 196 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
.+||+|+.++|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0067 Score=56.98 Aligned_cols=139 Identities=17% Similarity=0.138 Sum_probs=91.4
Q ss_pred CCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--ch------------------------HHHHHHHHHHhhcCC
Q 015816 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GN------------------------REFLVEVLMLSLLHH 128 (399)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~------------------------~~~~~E~~~l~~l~h 128 (399)
.+...|..|--+.||.|.... |..+|||++...-.. ++ -....|+.-|++|+.
T Consensus 147 ~inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 344668888899999998765 888999997432110 00 123457777777764
Q ss_pred CCccceEEEEecCCeeEEEEEecCCCCH-HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCce
Q 015816 129 PNLVNLIGYCADGDQRLLVYEYMPLGSV-EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 207 (399)
Q Consensus 129 pniv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Ni 207 (399)
-.|.-.--+.. ....|||+|+..... .-.|. ...++...+..+-.|++.-+.-|-+.++ +||.||.--|+
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~ 296 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNL 296 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhh
Confidence 43221100000 234699999853221 12222 3557777888888888888877776554 99999999999
Q ss_pred eecCCCceEEecccCCc
Q 015816 208 LLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 208 ll~~~~~~kl~Dfg~~~ 224 (399)
|+-+ |.+.|+|-+-+.
T Consensus 297 Lyhd-G~lyiIDVSQSV 312 (520)
T KOG2270|consen 297 LYHD-GKLYIIDVSQSV 312 (520)
T ss_pred eEEC-CEEEEEEccccc
Confidence 9864 589999987665
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0036 Score=55.19 Aligned_cols=29 Identities=34% Similarity=0.391 Sum_probs=20.9
Q ss_pred CeeecCCCCCceee-cCCCceEEecccCCc
Q 015816 196 PVIYRDLKCSNILL-DRGYHPKLSDFGLAK 224 (399)
Q Consensus 196 ~ivH~Dlkp~Nill-~~~~~~kl~Dfg~~~ 224 (399)
.++|+||.|.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 38999999999999 888999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0098 Score=56.39 Aligned_cols=141 Identities=16% Similarity=0.214 Sum_probs=77.6
Q ss_pred eeeecCceEEEEEEECCC---CeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCc-cceEEEEecCCeeEEEEEecCCC
Q 015816 79 LLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLG 154 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g 154 (399)
.|..|=...+|++...+. +..|++|+........ -.-.+|..+++.+..-++ .++++++..+ +|.+|++|.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 354566678888875432 2378999876532211 112458888888865444 3556555332 588998876
Q ss_pred CHHH-----------------HhhccCCC-CC-CCCHHHHHHHHHHH----------------------HHHHH----HH
Q 015816 155 SVED-----------------HLHDLSPG-KK-PLDWNTRMKIAAGA----------------------ARGLE----YL 189 (399)
Q Consensus 155 ~L~~-----------------~l~~~~~~-~~-~l~~~~~~~i~~qi----------------------~~al~----~L 189 (399)
+|.. .++..... .. +-.+..+..+..++ ..-+. ++
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5521 11111100 01 11223222222221 11111 12
Q ss_pred HhCC-CCCeeecCCCCCceeecC-CCceEEecccCCc
Q 015816 190 HDKA-KPPVIYRDLKCSNILLDR-GYHPKLSDFGLAK 224 (399)
Q Consensus 190 H~~~-~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~ 224 (399)
...+ ...++|.|+.+.|||+++ ++.++++||..|-
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1111 223899999999999975 5789999998875
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.018 Score=50.64 Aligned_cols=75 Identities=23% Similarity=0.294 Sum_probs=50.3
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC---CCCccceEEEEecCCeeEEEEEecCCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPLG 154 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~~~g 154 (399)
+.+..|-.-..|...+. ...+.||+-.. .....|..|+.-|+.|. .-.+.+++.+..+..+.|+||||++.+
T Consensus 22 ~~v~gG~inea~~v~dg--~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 22 EEVSGGDINEAWRLRDG--TDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred cccCCccccceeEeecC--CcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34555555555665443 46788887432 22345667776666653 456778888889999999999999876
Q ss_pred CHH
Q 015816 155 SVE 157 (399)
Q Consensus 155 ~L~ 157 (399)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 554
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.054 Score=51.09 Aligned_cols=141 Identities=23% Similarity=0.298 Sum_probs=81.3
Q ss_pred eeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC---CC---ccceEE----EEecCCeeEEEE
Q 015816 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH---PN---LVNLIG----YCADGDQRLLVY 148 (399)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pn---iv~~~~----~~~~~~~~~lv~ 148 (399)
.|.+ .-..+|+....+ ..+++|+.... ....++..|+..|..|.- +- +..+-| ....+...+-|+
T Consensus 33 ~l~s-~eN~~f~~~~~~--g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTED--GRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEecC--CCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 3444 456789887764 34489988765 345566667777777642 21 222212 122223778899
Q ss_pred EecCCCCHHH-H--------------hhcc----C----CCCCCCCHHH-------------HHHHHHHHHHHHHHHHhC
Q 015816 149 EYMPLGSVED-H--------------LHDL----S----PGKKPLDWNT-------------RMKIAAGAARGLEYLHDK 192 (399)
Q Consensus 149 e~~~~g~L~~-~--------------l~~~----~----~~~~~l~~~~-------------~~~i~~qi~~al~~LH~~ 192 (399)
+|++|..+.. . ++.. . .......|.. ......++...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999887762 1 1110 0 0001122320 112333444455555543
Q ss_pred C----C---CCeeecCCCCCceeecCCCc-eEEecccCCc
Q 015816 193 A----K---PPVIYRDLKCSNILLDRGYH-PKLSDFGLAK 224 (399)
Q Consensus 193 ~----~---~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~~~ 224 (399)
- . ..+||+|+.|+|||++.+.. +.++|||-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 1 12899999999999999885 8999999875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.0099 Score=55.78 Aligned_cols=73 Identities=22% Similarity=0.209 Sum_probs=55.4
Q ss_pred CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 141 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
..+.|++|++- |+++ ..+. ...+.++..++.+.+.-+.-+..+- ++-|||+.-+||||+ +|+|-|+||
T Consensus 298 ~~y~yl~~kdh-gt~i-s~ik-------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 298 TLYLYLHFKDH-GTPI-SIIK-------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred ceEEEEEEecC-Ccee-eeee-------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEe
Confidence 34556777763 3333 2222 2467889999999888887777653 499999999999999 899999999
Q ss_pred cCCcc
Q 015816 221 GLAKL 225 (399)
Q Consensus 221 g~~~~ 225 (399)
-+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99985
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.2 Score=47.43 Aligned_cols=94 Identities=19% Similarity=0.093 Sum_probs=51.6
Q ss_pred cccCHHHHHHHhcCCCCC---C-eeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCC--Cccc
Q 015816 60 QTLTFRELAAATKNFRSE---S-LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP--NLVN 133 (399)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~---~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~ 133 (399)
..++...+..+...+-+. + ..-.+.-..||++...+ +..+++|+..... .....+..|+..+..|... .++.
T Consensus 9 ~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~-~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~ 86 (325)
T PRK11768 9 QTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDED-GRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVA 86 (325)
T ss_pred CCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCC-CCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCC
Confidence 344445555544444221 1 12233456789987644 6679999875432 2445666788777766321 1222
Q ss_pred eE---E--EEecCCeeEEEEEecCCCC
Q 015816 134 LI---G--YCADGDQRLLVYEYMPLGS 155 (399)
Q Consensus 134 ~~---~--~~~~~~~~~lv~e~~~~g~ 155 (399)
.. + +...++..+.|+++++|..
T Consensus 87 p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 87 PLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 11 1 2233456788999998764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.091 Score=50.77 Aligned_cols=75 Identities=19% Similarity=0.204 Sum_probs=43.8
Q ss_pred CeeeecCceEEEEEEECCCC-eE-----EEEEEeccCCCcchHHHHHHHHHHhhcCCCCcc-ceEEEEecCCeeEEEEEe
Q 015816 78 SLLGEGGFGRVYKGYLESIN-QD-----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~-~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~ 150 (399)
+.|..|-...+|++...... .. |.++..... ....-.-..|+.+++.+...++- ++++.+.. ++|.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 34556778899998764321 22 444443221 11111124588899888765554 45555543 599999
Q ss_pred cCCCCHH
Q 015816 151 MPLGSVE 157 (399)
Q Consensus 151 ~~~g~L~ 157 (399)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987664
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.027 Score=49.34 Aligned_cols=103 Identities=16% Similarity=0.116 Sum_probs=67.2
Q ss_pred EEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHH
Q 015816 99 DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 177 (399)
Q Consensus 99 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~ 177 (399)
+..+|++...... ...-|..+..++.+++ .|+++..- +...+-++.|+|-.. ... ..-.
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~--------------~i~--~~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI--------------KIN--FSNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc--------------ccc--hhHH
Confidence 4556666544443 3455678888888775 57777632 344566889988421 111 1111
Q ss_pred HHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 178 i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
|... +.+|.-.|+.. ...+|+|..|+||+-|..|.+||.|=+.-
T Consensus 147 i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 147 ITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 2222 46788889542 23999999999999999999999998754
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.017 Score=55.11 Aligned_cols=61 Identities=21% Similarity=0.070 Sum_probs=42.4
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecCCCCCceeecC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL-HDKAKPPVIYRDLKCSNILLDR 211 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~ivH~Dlkp~Nill~~ 211 (399)
...++-+|..|.++..++.. ...++..+..++.--+.|+--+ --.+ ++|.|+.|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEEe
Confidence 34577788899999999875 3455555666666555554333 2334 999999999999953
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.011 Score=57.94 Aligned_cols=49 Identities=24% Similarity=0.346 Sum_probs=39.5
Q ss_pred hHHHHHHHHHHhhcCCCCccceEEEEecC-CeeEEEEEecCCCCHHHHhhc
Q 015816 113 NREFLVEVLMLSLLHHPNLVNLIGYCADG-DQRLLVYEYMPLGSVEDHLHD 162 (399)
Q Consensus 113 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~ 162 (399)
..++.-...+++.+.|+|...++++.... ....+|||++. .+|.+.+..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~ 75 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKT 75 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHh
Confidence 45566678899999999999999887543 45788999995 899999875
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.12 Score=51.00 Aligned_cols=74 Identities=8% Similarity=0.063 Sum_probs=44.4
Q ss_pred CeeeecCceEEEEEEECCC--------CeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCcc-ceEEEEecCCeeEEEE
Q 015816 78 SLLGEGGFGRVYKGYLESI--------NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVY 148 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~ 148 (399)
+.|..|-.-.+|++..... ++.|.+++.......-. .-..|..+++.+..-+|- ++++.+. -..|.
T Consensus 111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~ 185 (442)
T PTZ00296 111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRIE 185 (442)
T ss_pred EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEEE
Confidence 4555666678888875421 46788998754322211 223477777777644443 4555543 23679
Q ss_pred EecCCCCH
Q 015816 149 EYMPLGSV 156 (399)
Q Consensus 149 e~~~~g~L 156 (399)
||++|.+|
T Consensus 186 efi~g~~l 193 (442)
T PTZ00296 186 EWLYGDPL 193 (442)
T ss_pred EeeCCccC
Confidence 99987644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 399 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-58 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-58 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-45 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-43 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-19 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 9e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 518 bits (1336), Expect = 0.0
Identities = 115/314 (36%), Positives = 167/314 (53%), Gaps = 20/314 (6%)
Query: 50 EDGASDQITAQTLTFRELAAATKNFRSE------SLLGEGGFGRVYKGYLESINQDVAIK 103
+ + +F EL T NF + +GEGGFG VYKGY+ N VA+K
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVK 60
Query: 104 QL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 159
+L D + ++F E+ +++ H NLV L+G+ +DGD LVY YMP GS+ D
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 160 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219
L L G PL W+ R KIA GAA G+ +LH+ I+RD+K +NILLD + K+SD
Sbjct: 121 LSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD 176
Query: 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
FGLA+ T +++R++GT Y APE G++T KSD+YSFGVVLLEI++G AVD
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 280 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 339
+ Q L+ + + D ++ +VA+ C+HE+ + RP
Sbjct: 236 EHR--EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 340 VIADVVTALAYLAS 353
I V L + +
Sbjct: 293 DIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 515 bits (1330), Expect = 0.0
Identities = 117/311 (37%), Positives = 166/311 (53%), Gaps = 5/311 (1%)
Query: 40 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 99
++ + +A + + +L AT NF + L+G G FG+VYKG L
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAK 65
Query: 100 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 159
VA+K+ QG EF E+ LS HP+LV+LIG+C + ++ +L+Y+YM G+++ H
Sbjct: 66 VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125
Query: 160 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219
L+ + W R++I GAARGL YLH +I+RD+K NILLD + PK++D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD 182
Query: 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
FG++K G D TH+ST V GT GY PEY G+LT KSDVYSFGVVL E+L R A+
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 280 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 339
S +L WA + I DP L + P + A C+ + RP
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQ-IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301
Query: 340 VIADVVTALAY 350
+ DV+ L Y
Sbjct: 302 SMGDVLWKLEY 312
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 499 bits (1287), Expect = e-179
Identities = 126/305 (41%), Positives = 181/305 (59%), Gaps = 6/305 (1%)
Query: 47 EASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD 106
A ED + + REL A+ NF ++++LG GGFG+VYKG L VA+K+L
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLK 63
Query: 107 RNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 165
QG +F EV M+S+ H NL+ L G+C +RLLVY YM GSV L +
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 166 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225
+ PLDW R +IA G+ARGL YLHD P +I+RD+K +NILLD + + DFGLAKL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285
D THV+T V GT G+ APEY TG+ + K+DV+ +GV+LLE+++G++A D ++ A
Sbjct: 184 MDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 286 EQS--LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 343
+ L+ W + L +++ + + D +LQG Y Q + VA +C P RP +++
Sbjct: 243 DDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 344 VVTAL 348
VV L
Sbjct: 302 VVRML 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 2e-91
Identities = 76/314 (24%), Positives = 112/314 (35%), Gaps = 29/314 (9%)
Query: 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVL 121
L L + + + G FG V+K L N+ VA+K Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS-WQNEYEVY 70
Query: 122 MLSLLHHPNLVNLIGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 177
L + H N++ IG G L+ + GS+ D L + WN
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 178 IAAGAARGLEYLH-------DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230
IA ARGL YLH D KP + +RD+K N+LL ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 231 NTHVSTRVMGTYGYCAPEYAKTG-----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285
+ + +GT Y APE + L+ D+Y+ G+VL E+ S A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 286 EQSLVA--WARPLFQDRTRHSLI--ADPELQGQYPPRGFYQALA-VAAMCVHEQPDMRPV 340
P +D + P L+ + L C + R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 341 IADVVTALAYLASQ 354
V + +
Sbjct: 306 AGCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 4e-72
Identities = 77/340 (22%), Positives = 128/340 (37%), Gaps = 49/340 (14%)
Query: 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL--VE 119
E + N + L+G G +G VYKG L+ + VA+K + F+
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSF---ANRQNFINEKN 57
Query: 120 VLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 174
+ + L+ H N+ I + LLV EY P GS+ +L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 175 RMKIAAGAARGLEYLH------DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK---- 224
++A RGL YLH D KP + +RDL N+L+ +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 225 --LGPVGDNTHVSTRVMGTYGYCAPEYAK-------TGQLTLKSDVYSFGVVLLEILSGR 275
L G+ + + +GT Y APE + + D+Y+ G++ EI
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 276 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPP---RGFYQALAVAAM--- 329
+ + + + +A+ + T + + Q P +LAV ++
Sbjct: 233 TDLFPGE-SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 330 ---CVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQSP 366
C + + R +A L + K SP
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMM---IWERNKSVSP 328
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-69
Identities = 81/288 (28%), Positives = 136/288 (47%), Gaps = 43/288 (14%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-------REFLVEVLMLSLLHHP 129
E +G+GGFG V+KG L VAIK L +G +EF EV ++S L+HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V L G + +V E++P G + L D P+ W+ ++++ A G+EY+
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYM 138
Query: 190 HDKAKPPVIYRDLKCSNILLD-----RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
++ PP+++RDL+ NI L K++DFGL++ + H + ++G + +
Sbjct: 139 QNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQW 192
Query: 245 CAPE--YAKTGQLTLKSDVYSFGVVLLEILSGRKAVD--TSKAAAEQSLVAWARPLFQDR 300
APE A+ T K+D YSF ++L IL+G D + +++ ++
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR------EEG 246
Query: 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
R P + PPR + + +C P RP + +V L
Sbjct: 247 LR------PTIPEDCPPR--LRNV--IELCWSGDPKKRPHFSYIVKEL 284
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-69
Identities = 87/333 (26%), Positives = 134/333 (40%), Gaps = 50/333 (15%)
Query: 31 NSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYK 90
+ + D + + + DG I L +E +G G FG V++
Sbjct: 8 HPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEK------------IGAGSFGTVHR 55
Query: 91 GYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148
DVA+K L EFL EV ++ L HPN+V +G +V
Sbjct: 56 AEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113
Query: 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208
EY+ GS+ LH ++ LD R+ +A A+G+ YLH++ PP+++R+LK N+L
Sbjct: 114 EYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLL 171
Query: 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 268
+D+ Y K+ DFGL++L S GT + APE + KSDVYSFGV+L
Sbjct: 172 VDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVIL 229
Query: 269 LEILSGR------KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 322
E+ + + A + R PR
Sbjct: 230 WELATLQQPWGNLNPAQVVAAVGFKCK----RLEI-------------------PRNLNP 266
Query: 323 ALA-VAAMCVHEQPDMRPVIADVVTALAYLASQ 354
+A + C +P RP A ++ L L
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 4e-66
Identities = 75/311 (24%), Positives = 123/311 (39%), Gaps = 36/311 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+G G FG V K +DVAIKQ++ + + F+VE+ LS ++HPN+V L G C
Sbjct: 16 VGRGAFGVVCKAKWR--AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ LV EY GS+ + LH P M ++G+ YLH +I+
Sbjct: 72 N--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 200 RDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 258
RDLK N+LL G K+ DFG A D T G+ + APE + + K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 259 SDVYSFGVVLLEILSGR---KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY 315
DV+S+G++L E+++ R + ++ RP
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL------------------ 225
Query: 316 PPRGFYQALA-VAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPT 374
+ + + + C + P RP + ++V + +L +D
Sbjct: 226 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGE 284
Query: 375 RTKGDKERKLN 385
+ +
Sbjct: 285 DGRVEPYVDFA 295
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 8e-66
Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+G GGFG+VY+ + +VA+K D + Q E + ++L HPN++ L
Sbjct: 15 IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
G C LV E+ G + L K + + + A ARG+ YLHD+A
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 196 PVIYRDLKCSNILLDRGYHP--------KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
P+I+RDLK SNIL+ + K++DFGLA+ T + G Y + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAP 183
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGR 275
E + + SDV+S+GV+L E+L+G
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-64
Identities = 61/279 (21%), Positives = 110/279 (39%), Gaps = 41/279 (14%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 137
L E G ++KG + D+ +K L R+F E L + HPN++ ++G
Sbjct: 18 LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 138 CADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
C + +MP GS+ + LH+ +D + +K A ARG+ +LH +P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKT 252
+ L ++++D ++S + + S M + APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPE 185
Query: 253 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 312
+D++SF V+L E+++ P F D + + L+
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREV------------------P-FADLSNMEIGMKVALE 226
Query: 313 GQYP--PRGFYQALA-VAAMCVHEQPDMRPVIADVVTAL 348
G P P G ++ + +C++E P RP +V L
Sbjct: 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-63
Identities = 71/310 (22%), Positives = 112/310 (36%), Gaps = 39/310 (12%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+LG+G FG+ K + + +K+L R + R FL EV ++ L HPN++ IG
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
+ + EY+ G++ + W+ R+ A A G+ YLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKL------------GPVGDNTHVSTRVMGTYGY 244
+I+RDL N L+ + ++DFGLA+L + V+G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA---VDTSKAAAEQSLVAWARPLFQDRT 301
APE K DV+SFG+VL EI+ A ++ +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC 248
Query: 302 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAE 361
P F+ + C P+ RP + L L
Sbjct: 249 ---------------PPSFFP---ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290
Query: 362 KVQSPCLDPG 371
Q LD G
Sbjct: 291 GPQLEQLDRG 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 7e-62
Identities = 61/288 (21%), Positives = 106/288 (36%), Gaps = 50/288 (17%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 137
+G+G FG+VY G + +VAI+ +D + + F EV+ H N+V +G
Sbjct: 41 IGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
C ++ ++ + D K LD N +IA +G+ YLH K +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GI 151
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+++DLK N+ D G ++DFGL + G G + APE +
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 255 L---------TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-----RPLFQDR 300
+ SDV++ G + E+ + T A A + W +P
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----IIWQMGTGMKPNL--- 263
Query: 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
++ + L C + + RP ++ L
Sbjct: 264 --------SQIGM---GKEISDIL---LFCWAFEQEERPTFTKLMDML 297
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 8e-62
Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 33/277 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 137
+G G FG VYKG + DVA+K L+ + F EV +L H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
Q +V ++ S+ HLH + + + IA ARG++YLH K +
Sbjct: 89 STA-PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKTGQ 254
I+RDLK +NI L K+ DFGLA +H ++ G+ + APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 255 LTLKSDVYSFGVVLLEILSGR---KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311
+ +SDVY+FG+VL E+++G+ ++ E P ++
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL-----------SKV 250
Query: 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
+ P + + A C+ ++ D RP ++ +
Sbjct: 251 RSNCPK-RMKRLM---AECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 8e-62
Identities = 71/349 (20%), Positives = 130/349 (37%), Gaps = 40/349 (11%)
Query: 30 INSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVY 89
+ IP + + ++S G+ + Q +++ + +G+G +G V+
Sbjct: 2 MTYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQI-------QMVKQIGKGRYGEVW 54
Query: 90 KGYLESINQDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNLIGYCADGD----Q 143
G + VA+K + E+ L+ H N++ I G Q
Sbjct: 55 MGKWR--GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109
Query: 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-----DKAKPPVI 198
L+ +Y GS+ D+L LD + +K+A + GL +LH + KP +
Sbjct: 110 LYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPE------YA 250
+RDLK NIL+ + ++D GLA N +GT Y PE
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA-AAEQSLVAWARPLFQDRTRHSLIAD- 308
Q + +D+YSFG++L E+ + + + + P ++D I
Sbjct: 225 NHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL 284
Query: 309 -PELQGQYPPRGFYQALA-VAAMCVHEQPDMRPVIADVVTALAYLASQK 355
P ++ + + + C P R V LA ++ +
Sbjct: 285 RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 8e-60
Identities = 64/302 (21%), Positives = 118/302 (39%), Gaps = 41/302 (13%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNL 134
+G+G +G V++G + ++VA+K + + + E+ +L H N++
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGF 67
Query: 135 IGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
I Q L+ Y +GS+ D+L LD + ++I A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 191 -----DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV--STRVMGTYG 243
+ KP + +RDLK NIL+ + ++D GLA + N + +GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 244 YCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 297
Y APE + D+++FG+VL E+ S E + +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR----MVSNGIVEDYKPPFYDVVP 238
Query: 298 QDRTRHSLIADPELQGQYP--PRGFYQALAVAAM------CVHEQPDMRPVIADVVTALA 349
D + + + Q P P ++ + ++ C ++ P R + L
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 350 YL 351
+
Sbjct: 299 KI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 2e-58
Identities = 69/306 (22%), Positives = 121/306 (39%), Gaps = 41/306 (13%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNL 134
+ +G+G FG V++G ++VA+K + R + E+ +L H N++
Sbjct: 47 QESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF 101
Query: 135 IGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
I + Q LV +Y GS+ D+L+ + + +K+A A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLH 156
Query: 191 -----DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYG 243
+ KP + +RDLK NIL+ + ++D GLA +T +GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 244 YCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 297
Y APE K + ++D+Y+ G+V EI + E + + +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR----CSIGGIHEDYQLPYYDLVP 272
Query: 298 QDRTRHSLIADPELQGQYP--PRGFYQALAVAAM------CVHEQPDMRPVIADVVTALA 349
D + + Q P P + A+ M C + R + L+
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 350 YLASQK 355
L+ Q+
Sbjct: 333 QLSQQE 338
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-46
Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
+G G FG V+ G L + N VA+K + +FL E +L HPN+V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+V E + G L L T +++ AA G+EYL K I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY--CAPEYAKTGQLT 256
+RDL N L+ K+SDFG+++ D + ++ + APE G+ +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 257 LKSDVYSFGVVLLEILS 273
+SDV+SFG++L E S
Sbjct: 294 SESDVWSFGILLWETFS 310
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-45
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 80 LGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LG G FG VYKG E + VAIK+L + + N+E L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+G C L+ + MP G + D++ + K + + A+G+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+++RDL N+L+ H K++DFGLAKL + + + + A E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 255 LTLKSDVYSFGVVLLEILS-GRK 276
T +SDV+S+GV + E+++ G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 72 KNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH 127
++ + S LG+G FG V ++ VA+KQL +G R+F E+ +L LH
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 128 HPNLVNLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
+V G ++ LV EY+P G + D L + LD + + ++ +G
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKG 139
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-- 243
+EYL + ++RDL NIL++ H K++DFGLAKL P+ + +V G
Sbjct: 140 MEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQS 192
Query: 244 ---YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE + +SDV+SFGVVL E+ +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-43
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 77 ESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
LG+G FG V ++ + VA+K+L + + R+F E+ +L L H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 133 NLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
G C +R L+ EY+P GS+ D+L K+ +D ++ + +G+EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG 131
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YC 245
K I+RDL NIL++ K+ DFGL K+ P G +
Sbjct: 132 TKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWY 184
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
APE + ++ SDV+SFGVVL E+ +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-43
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 77 ESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
LG+G FG V + + + VA+K+L + + R+F E+ +L L H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 133 NLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
G C +R L+ EY+P GS+ D+L K+ +D ++ + +G+EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG 162
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YC 245
K I+RDL NIL++ K+ DFGL K+ P + G +
Sbjct: 163 TKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWY 215
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
APE + ++ SDV+SFGVVL E+ +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-43
Identities = 58/195 (29%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G +G VY+G + + VA+K L + EFL E ++ + HPNLV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
++ E+M G++ D+L ++ + + +A + +EYL K I+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG-TYGYCAPEYAKTGQLTLK 258
R+L N L+ + K++DFGL++L + +T+ + + APE + ++K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 259 SDVYSFGVVLLEILS 273
SDV++FGV+L EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 77 ESLLGEGGFGRVYKGYLESINQD----VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNL 131
LGEG FG+V + + VA+K L +G + E+ +L L+H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 132 VNLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
V G C + L+ E++P GS++++L K ++ ++K A +G++YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYL 142
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----Y 244
+ ++RDL N+L++ + K+ DFGL K + +
Sbjct: 143 GSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFW 195
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
APE + + SDV+SFGV L E+L+
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 80 LGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LG G FG V+KG ESI V IK + D++G Q + +L + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+G C G LV +Y+PLGS+ DH+ + L + A+G+ YL +
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+++R+L N+LL +++DFG+A L P D + + + A E G+
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 255 LTLKSDVYSFGVVLLEILS-GRK 276
T +SDV+S+GV + E+++ G +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 80 LGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LG G FG VYKG E + VAIK+L + + N+E L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+G C L+ + MP G + D++ + K + + A+G+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+++RDL N+L+ H K++DFGLAKL + + + + A E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 255 LTLKSDVYSFGVVLLEILS-GRK 276
T +SDV+S+GV + E+++ G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 68/209 (32%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 77 ESLLGEGGFGRVYKGYLESINQD----VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNL 131
LGEG FG+V + N VA+K L G Q + E+ +L L+H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 132 VNLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
+ G C D LV EY+PLGS+ D+L + + + A G+ YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYL 150
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----Y 244
H + I+RDL N+LLD K+ DFGLAK P G + + G +
Sbjct: 151 HAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFW 203
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
APE K + SDV+SFGV L E+L+
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G +G VY+G + + VA+K L + EFL E ++ + HPNLV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
++ E+M G++ D+L ++ + + +A + +EYL K I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N L+ + K++DFGL++L + +T+ + G + APE + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPESLAYNKFS 190
Query: 257 LKSDVYSFGVVLLEILS 273
+KSDV++FGV+L EI +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-42
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 18/237 (7%)
Query: 46 KEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL 105
+E D +T ++ + + + +G G F VYKG +VA +L
Sbjct: 1 QEERNQQQDDIEELET-KAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL 59
Query: 106 DRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCAD---GDQRLLVY-EYMPLGSVEDH 159
+ + + F E ML L HPN+V G + +++ E M G+++ +
Sbjct: 60 QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 119
Query: 160 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLS 218
L K + +GL++LH + PP+I+RDLKC NI + K+
Sbjct: 120 LKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIG 174
Query: 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
D GLA L + V+GT + APE + DVY+FG+ +LE+ +
Sbjct: 175 DLGLATLK----RASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LG+G FG VY+G + + +D VAIK ++ R EFL E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------GKKPLDWNTRMKIAAGAARGLE 187
L+G + G L++ E M G ++ +L L P P + +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MGT 241
YL+ ++RDL N ++ + K+ DFG+ + D + M
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+PE K G T SDV+SFGVVL EI +
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 72 KNFRSESLLGEGGFGRVYKGYL---ESINQDVAIKQL---DRNGVQGNREFLVEVLMLSL 125
K+ R LG+G FG V +G VA+K L + + +F+ EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
L H NL+ L G +V E PLGS+ D L + T + A A G
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 133
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 242
+ YL K I+RDL N+LL K+ DFGL + P D+ +V +
Sbjct: 134 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPF 188
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+CAPE KT + SD + FGV L E+ + G++
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-41
Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+G G FG V+ GY + VAIK + R G +F+ E ++ L HP L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 65
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L G C + LV E+M G + D+L + T + + G+ YL +
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPE 248
VI+RDL N L+ K+SDFG+ + V D+ + T GT + +PE
Sbjct: 123 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPE 175
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+ + KSDV+SFGV++ E+ S G+
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-41
Identities = 63/294 (21%), Positives = 100/294 (34%), Gaps = 46/294 (15%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
K++ LGEGGF V A+K++ + Q E E M L +HPN+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 132 VNLIGYCADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
+ L+ YC L+ + G++ + + L L + + + G RGLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-------G 240
+H +RDLK +NILL P L D G + +
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 241 TYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 294
T Y APE + + ++DV+S G VL ++ G
Sbjct: 206 TISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGP----------------- 245
Query: 295 PLFQDRTRHSLIADPELQGQY---PPRGFYQAL-AVAAMCVHEQPDMRPVIADV 344
+ + +Q Q AL + + P RP I +
Sbjct: 246 --YDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-41
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 80 LGEGGFGRVYKGYLESINQ-------DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
LG+G F +++KG + +V +K LD+ + F M+S L H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
G C GD+ +LV E++ GS++ +L K ++ ++++A A + +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 193 AKPPVIYRDLKCSNILLDRGYHP--------KLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
+I+ ++ NILL R KLSD G++ V + R+
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERIPWV--- 184
Query: 245 CAPEYAKTGQL-TLKSDVYSFGVVLLEILS-GRK 276
PE + + L +D +SFG L EI S G K
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 77 ESLLGEGGFGRVYKGYL--ESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLV 132
+ LG G FG V KGY + + + VA+K L + N E L E ++ L +P +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
+IG C + + +LV E LG + +L + + +++ + G++YL +
Sbjct: 82 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCA 246
++RDL N+LL ++ K+SDFGL+K +N + + + A
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYA 188
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
PE + + KSDV+SFGV++ E S G+K
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-40
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V G + DVA+K + + G EF E + L HP LV G C+
Sbjct: 16 LGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+V EY+ G + ++L K L+ + +++ G+ +L I+
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIH 127
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N L+DR K+SDFG+ + V D+ + +GT + APE + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 257 LKSDVYSFGVVLLEILS-GRK 276
KSDV++FG+++ E+ S G+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V G DVAIK + + G EF+ E ++ L H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
++ EYM G + ++L + + +++ +EYL K ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 143
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N L++ K+SDFGL++ V D+ + T +G+ + PE + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 257 LKSDVYSFGVVLLEILS 273
KSD+++FGV++ EI S
Sbjct: 200 SKSDIWAFGVLMWEIYS 216
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 77 ESLLGEGGFGRVYKGYLESINQ--DVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLV 132
+ LG G FG V +G + DVAIK L + G + E + E ++ L +P +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
LIG C + +LV E G + L ++ + + ++ + G++YL +K
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCA 246
++RDL N+LL ++ K+SDFGL+K D+ + + + A
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYA 181
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
PE + + +SDV+S+GV + E LS G+K
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG+V+ +++ VA+K L + ++F E +L+ L H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGA 182
G C DGD ++V+EYM G + L P K L + + IA+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV---- 238
A G+ YL + ++RDL N L+ K+ DFG+++ D V
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 239 --MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
M PE + T +SDV+SFGV+L EI +
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG+V+ ++ + VA+K L ++F E +L++L H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-----------GKKPLDWNTRMKIAAGAA 183
G C +G L+V+EYM G + L P PL + +A+ A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV----- 238
G+ YL ++RDL N L+ +G K+ DFG+++ D V R
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 239 -MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
M PE + T +SDV+SFGVVL EI +
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-40
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 23/199 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+G+G FG V G VA+K + + + FL E +++ L H NLV L+G
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 140 DGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+ L +V EYM GS+ D+L S G+ L + +K + +EYL +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAKTGQ 254
+RDL N+L+ K+SDFGL K +T + ++ APE + +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 362
Query: 255 LTLKSDVYSFGVVLLEILS 273
+ KSDV+SFG++L EI S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-40
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 77 ESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLV 132
E ++G G G V G L + VAIK L + R +FL E ++ HPN++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
L G G ++V EYM GS++ L + + G G+ YL D
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEY 249
++RDL N+L+D K+SDFGL+++ + D+ + G + APE
Sbjct: 171 G---YVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 250 AKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+ SDV+SFGVV+ E+L+ G +
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+G+G FG V G VA+K + +N + FL E +++ L H NLV L+G
Sbjct: 29 IGKGEFGDVMLGDYR--GNKVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 140 DGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+ L +V EYM GS+ D+L S G+ L + +K + +EYL +
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAKTGQ 254
+RDL N+L+ K+SDFGL K +T + ++ APE + +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 190
Query: 255 LTLKSDVYSFGVVLLEILS-GRK 276
+ KSDV+SFG++L EI S GR
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LGE FG+VYKG+L VAIK L R EF E ++ + L HPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------------KKPLDWNTRMKIAAG 181
L+G +++ Y G + + L SP K L+ + + A
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST----- 236
A G+EYL V+++DL N+L+ + K+SD GL + D +
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 237 -RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
R M APE G+ ++ SD++S+GVVL E+ S
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-39
Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVN 133
LG G FG VY+G + + D VA+K L + Q +FL+E L++S +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG---KKPLDWNTRMKIAAGAARGLEYLH 190
IG R ++ E M G ++ L + P L + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 191 DKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+ I+RD+ N LL G K+ DFG+A+ M + P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E G T K+D +SFGV+L EI S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-39
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 80 LGEGGFGRVYKGYLESINQ---DVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLI 135
LGEG FG VY+G + +VA+K ++ N+ +F+ E +++ L HP++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
G + + ++ E P G + +L K L T + + + + YL
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEY 249
++RD+ NIL+ KL DFGL++ + D + + +PE
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTRLPIKWMSPES 185
Query: 250 AKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+ T SDV+ F V + EILS G++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-39
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 80 LGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLI 135
+G G FG VY G L + A+K L+R G +FL E +++ HPN+++L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 136 GYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
G C + L+V YM G + + + + + + A+G++YL K
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASKK- 148
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG------TYGYCAPE 248
++RDL N +LD + K++DFGLA+ + V + A E
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALE 202
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILS 273
+T + T KSDV+SFGV+L E+++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 17/214 (7%)
Query: 72 KNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLL 126
+ ++G G FG VYKG L VAIK L + R +FL E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
H N++ L G + +++ EYM G+++ L + + + G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGM 160
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YG 243
+YL + ++RDL NIL++ K+SDFGL+++ + D+ + G
Sbjct: 161 KYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIR 215
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+ APE + T SDV+SFG+V+ E+++ G +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-39
Identities = 68/197 (34%), Positives = 102/197 (51%), Gaps = 15/197 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ GY + VA+K L + G FL E ++ L H LV L
Sbjct: 21 LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ ++ EYM GS+ D L +P L N + +AA A G+ ++ ++ I+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL+ +NIL+ K++DFGLA+L + DN + T G + APE G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEAINYGTFT 188
Query: 257 LKSDVYSFGVVLLEILS 273
+KSDV+SFG++L EI++
Sbjct: 189 IKSDVWSFGILLTEIVT 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 66/197 (33%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
E LG+G FG V+ G VAIK L + G FL E ++ L H LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
+ +V EYM GS+ D L K L + +AA A G+ Y+
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN--- 300
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
++RDL+ +NIL+ K++DFGLA+L + T + APE A G+ T
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFT 359
Query: 257 LKSDVYSFGVVLLEILS 273
+KSDV+SFG++L E+ +
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 78/322 (24%), Positives = 130/322 (40%), Gaps = 47/322 (14%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLH 127
N + ++G G FG V G L+ VAIK L + R +FL E ++
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
HPN++ L G ++V EYM GS++ L + + G A G++
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMK 161
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGY 244
YL D ++RDL NIL++ K+SDFGL ++ + D+ + G +
Sbjct: 162 YLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRW 216
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303
+PE + T SDV+S+G+VL E++S G RP + + +
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE------------------RP-YWEMSNQ 257
Query: 304 SLIADPELQGQ--YPPRG----FYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 357
+I + +G PP YQ + C + + RP +V+ L L +
Sbjct: 258 DVIKAVD-EGYRLPPPMDCPAALYQ---LMLDCWQKDRNNRPKFEQIVSILDKLI--RNP 311
Query: 358 SDAEKVQSPCLDPGTPTRTKGD 379
+ + S P + +
Sbjct: 312 GSLKIITSAAARPSNLLLDQSN 333
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 2e-38
Identities = 65/281 (23%), Positives = 108/281 (38%), Gaps = 18/281 (6%)
Query: 3 WFPCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTL 62
P + + + I K E SD +
Sbjct: 269 TLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDK 328
Query: 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQ--DVAIKQL-DRNGVQGNREFLVE 119
E LG G FG V +G + DVAIK L E + E
Sbjct: 329 KLFLKRDNLLIADIE--LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 386
Query: 120 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
++ L +P +V LIG C + +LV E G + L ++ + + ++
Sbjct: 387 AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELL 442
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
+ G++YL +K ++R+L N+LL ++ K+SDFGL+K D+ + +
Sbjct: 443 HQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-- 497
Query: 240 GT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+ APE + + +SDV+S+GV + E LS G+K
Sbjct: 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 75 RSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPN 130
S+ ++G+G FG VY G Q+ AIK L R FL E L++ L+HPN
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 131 LVNLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
++ LIG + ++ YM G + + ++ + ARG+EYL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYL 140
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG--------T 241
++ ++RDL N +LD + K++DFGLA+ + D + S + T
Sbjct: 141 AEQK---FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWT 195
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
A E +T + T KSDV+SFGV+L E+L+
Sbjct: 196 ----ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-38
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 80 LGEGGFGRVYKGYLESINQD---VAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG V +G L+ + VA+K + D + + EFL E + HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 135 IGYCADGDQR-----LLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGLE 187
+G C + + +++ +M G + +L L G K + T +K A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MGT 241
YL ++ ++RDL N +L ++DFGL+K GD +
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
A E T KSDV++FGV + EI +
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 62/206 (30%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LG G FG VY+G + + D VA+K L + + +FL+E L++S +H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG---KKPLDWNTRMKIAAGAARGLEYLH 190
IG R ++ E M G ++ L + P L + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 191 DKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+ I+RD+ N LL G K+ DFG+A+ M + P
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E G T K+D +SFGV+L EI S
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-38
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 77 ESLLGEGGFGRVYKGYLESINQD---VAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLV 132
++G G FG VY G L + A+K L+R + +FL E +++ HPN++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 133 NLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
+L+G C + L+V YM G + + + + + + A+G+++L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLAS 210
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG------TYGYC 245
K ++RDL N +LD + K++DFGLA+ + V +
Sbjct: 211 KK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM---- 263
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
A E +T + T KSDV+SFGV+L E+++
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-38
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
E LG G FG V+ + VA+K + + G FL E ++ L H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNK-HTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
+ ++ E+M GS+ D L S + +A A G+ ++ +
Sbjct: 251 VVT-KEPIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--- 304
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTG 253
I+RDL+ +NIL+ K++DFGLA++ + DN + T G + APE G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEAINFG 360
Query: 254 QLTLKSDVYSFGVVLLEILS 273
T+KSDV+SFG++L+EI++
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-38
Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 28/213 (13%)
Query: 80 LGEGGFGRVYKGYLESINQD---VAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LG+G FG V + L+ + VA+K L D EFL E + HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 135 IGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKKP--LDWNTRMKIAAGAARGL 186
+G + +++ +M G + L G+ P L T ++ A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MG 240
EYL + I+RDL N +L ++DFGL++ GD +
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
A E T+ SDV++FGV + EI++
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-38
Identities = 65/194 (33%), Positives = 94/194 (48%), Gaps = 9/194 (4%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG+G FG V+ G VAIK L + G FL E ++ L H LV L
Sbjct: 275 LGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 331
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ +V EYM GS+ D L K L + +AA A G+ Y+ ++
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS 259
RDL+ +NIL+ K++DFGLA+L + T + APE A G+ T+KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 260 DVYSFGVVLLEILS 273
DV+SFG++L E+ +
Sbjct: 446 DVWSFGILLTELTT 459
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 9e-38
Identities = 62/209 (29%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 80 LGEGGFGRVYKGYLESINQ---DVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNL 134
+GEG FG V++G S VAIK +N +FL E L + HP++V L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
IG + ++ E LG + L K LD + + A + L YL K
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR- 136
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPE 248
++RD+ N+L+ KL DFGL++ + D+T+ + APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGKLPIKWMAPE 187
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+ T SDV+ FGV + EIL G K
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 69/269 (25%), Positives = 108/269 (40%), Gaps = 27/269 (10%)
Query: 19 KMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSES 78
K ++ L I + + K SE +I + T+ + + E
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRER 391
Query: 79 L-----LGEGGFGRVYKGYLESINQ---DVAIKQL-DRNGVQGNREFLVEVLMLSLLHHP 129
+ +GEG FG V++G S VAIK + +FL E L + HP
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
++V LIG + ++ E LG + L K LD + + A + L YL
Sbjct: 452 HIVKLIGVI-TENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYL 507
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----Y 244
K ++RD+ N+L+ KL DFGL++ + D+T+ G +
Sbjct: 508 ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----GKLPIKW 558
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
APE + T SDV+ FGV + EIL
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 65/282 (23%), Positives = 121/282 (42%), Gaps = 31/282 (10%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLV-EVLMLSLLHHP 129
+++ +G G +GR K +S + + K+LD + + ++ LV EV +L L HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 130 NLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
N+V D L V EY G + + + ++ LD +++ L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 188 YLHDKAKPP--VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
H ++ V++RDLK +N+ LD + KL DFGLA++ + +T + +GT Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYM 183
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305
+PE KSD++S G +L E+ + P F ++ L
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCAL-------------------MPPFTAFSQKEL 224
Query: 306 IADPELQGQYP--PRGFYQAL-AVAAMCVHEQPDMRPVIADV 344
+G++ P + L + ++ + RP + ++
Sbjct: 225 AGKI-REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 50/289 (17%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+F+ L+G GGFG+V+K + IK++ N N + EV L+ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 132 VNLIGYCADGDQRL----------------LVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 175
V+ G D + E+ G++E + + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLA 124
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
+++ +G++Y+H K +I RDLK SNI L K+ DFGL N
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKR 178
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 295
TR GT Y +PE + + D+Y+ G++L E+L
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------------CDT 220
Query: 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
F+ + + D + + + + + ++P+ RP +++
Sbjct: 221 AFETSKFFTDLRDGIISDIFDK----KEKTLLQKLLSKKPEDRPNTSEI 265
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPN 130
LGEG FG+V I++D VA+K L + + + + + E+ +M + H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHL------------HDLSPGKKPLDWNTRMKI 178
++NL+G C ++ EY G++ ++L ++ + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-- 236
ARG+EYL + I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 237 ----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M APE T +SDV+SFGV++ EI +
Sbjct: 220 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 68/219 (31%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 77 ESLLGEGGFGRVYKGYL--ESINQDVAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPNLV 132
+ ++GEG FG+V K + + + D AIK++ + +R+F E+ ++ L HHPN++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAA 180
NL+G C L EY P G++ D L L + AA
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST---- 236
ARG++YL K I+RDL NIL+ Y K++DFGL++ + T
Sbjct: 150 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 237 --RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
R M A E T SDV+S+GV+L EI+S
Sbjct: 204 PVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHP 129
++ LG GG VY +N VAIK + + E L EV S L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V++I + D LV EY+ ++ +++ PL +T + G+++
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHA 127
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPE 248
HD +++RD+K NIL+D K+ DFG+AK + + + T V+GT Y +PE
Sbjct: 128 HDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPE 182
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
AK +D+YS G+VL E+L G
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-37
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPN 130
LGEG FG+V I++D VA+K L D + + + E+ +M + H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKI 178
++NL+G C ++ EY G++ ++L P ++ + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-- 236
ARG+EYL + I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 237 ----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M APE T +SDV+SFGV++ EI +
Sbjct: 266 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-37
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPNLV 132
LG G FG+V + + ++ VA+K L + E+ +M L H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----------GKKPLDWNTRMKIAAGA 182
NL+G C G L++ EY G + + L S + ++
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST------ 236
A+G+ +L K I+RD+ N+LL G+ K+ DFGLA+ N V
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M APE T++SDV+S+G++L EI S
Sbjct: 231 KWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
+GEG FGRV++ + VA+K L + +F E +++ +PN+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------------------GKKPLDWN 173
L+G CA G L++EYM G + + L +SP G PL
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
++ IA A G+ YL ++ ++RDL N L+ K++DFGL++ D
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 234 VSTRV------MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
M PE + T +SDV+++GVVL EI S
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 58/279 (20%), Positives = 93/279 (33%), Gaps = 39/279 (13%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEV-LMLSLLHH 128
++F+ S LG G +G V+K + + A+K+ G + L EV + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P V L +G L E S++ H L L +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAW---GASLPEAQVWGYLRDTLLALAH 172
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH + +++ D+K +NI L KL DFGL +G + G Y APE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYMAPE 226
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL--- 305
+ G +DV+S G+ +LE+ + L
Sbjct: 227 LLQ-GSYGTAADVFSLGLTILEVACNME------------------LPHGGEGWQQLRQG 267
Query: 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
PE + +V M + P +R +
Sbjct: 268 YLPPEFTAGLSS----ELRSVLVMMLEPDPKLRATAEAL 302
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 35/231 (15%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
+F ++LG+G FG+V K ++ AIK++ + L EV++L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 131 LVNLIGYCADGDQRL-------------LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 177
+V + + + EY G++ D +H + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWR 120
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL------------ 225
+ L Y+H + +I+RDLK NI +D + K+ DFGLAK
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 226 -GPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSG 274
G + ++++ + GT Y A E TG K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 36/221 (16%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLV 132
LG G FG+V + + + VA+K L + R + E+ ++ L +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------------GKKPLDWNTRMKI 178
NL+G C G L++ EY G + + L + LD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-- 236
+ A+G+ +L K I+RDL NILL G K+ DFGLA+ N V
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 237 ----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M APE T +SDV+S+G+ L E+ S
Sbjct: 208 RLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-36
Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LGEG FG+V K + VA+K L N + L E +L ++HP+++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHL--------------------HDLSPGKKPLDWN 173
L G C+ LL+ EY GS+ L P ++ L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
+ A ++G++YL + +++RDL NIL+ G K+SDFGL++ D+
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 234 VST------RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ + M A E T +SDV+SFGV+L EI++
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 50/243 (20%), Positives = 89/243 (36%), Gaps = 25/243 (10%)
Query: 48 ASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR 107
+ + + L F+ ++ + + +G GG +V++ E Q AIK ++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL 62
Query: 108 NGVQGN--REFLVEVLMLSLLHHPNL--VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL 163
+ E+ L+ L + + L Y +V E + L
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK- 120
Query: 164 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223
KK +D R + +H +++ DLK +N L+ G KL DFG+A
Sbjct: 121 ---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIA 173
Query: 224 KLGPVGDNTHVSTRVMGTYGYCAPE-----------YAKTGQLTLKSDVYSFGVVLLEIL 272
+ V +GT Y PE +++ KSDV+S G +L +
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 273 SGR 275
G+
Sbjct: 234 YGK 236
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPN 130
LGEG FG+V +++D VA+K L + + + + + E+ +M + H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR------------MKI 178
++NL+G C ++ EY G++ ++L P +N +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-- 236
A ARG+EYL K I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 237 ----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M APE T +SDV+SFGV+L EI +
Sbjct: 254 RLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 61/299 (20%), Positives = 109/299 (36%), Gaps = 52/299 (17%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPN 130
+F LG GGFG V++ + + + AIK++ + RE + EV L+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 131 LVNLIGYCADGD---------QRLLVY---EYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
+V + + ++ +Y + +++D ++ + + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHI 123
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL----------GPV 228
A +E+LH K +++RDLK SNI K+ DFGL
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288
T +GT Y +PE + K D++S G++L E+L
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---------------- 224
Query: 289 LVAWARPLFQDRTRHSLIADPELQGQYP--PRGFYQALA-VAAMCVHEQPDMRPVIADV 344
P R + D ++P Y + + P RP ++
Sbjct: 225 -----YPFSTQMERVRTLTD-VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 61/200 (30%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLI 135
LG+G FG VY + +A+K L + ++ + EV + S L HPN++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
GY D + L+ EY PLG+V L D A L Y H K
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR-- 129
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
VI+RD+K N+LL K++DFG + P + GT Y PE +
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGTLDYLPPEMIEGRMH 184
Query: 256 TLKSDVYSFGVVLLEILSGR 275
K D++S GV+ E L G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 64/280 (22%), Positives = 114/280 (40%), Gaps = 30/280 (10%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHH 128
NFR E +G G F VY+ VA+K++ + + + E+ +L L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
PN++ + ++ +V E G + + K+ + T K LE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
+H + V++RD+K +N+ + KL D GL + T + ++GT Y +PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPE 206
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308
KSD++S G +L E+ + + P + D+ +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDKMNLYSLCK 248
Query: 309 PELQGQYP--PRGFY-QAL-AVAAMCVHEQPDMRPVIADV 344
Q YP P Y + L + MC++ P+ RP + V
Sbjct: 249 KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 45/226 (19%), Positives = 94/226 (41%), Gaps = 31/226 (13%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-------------- 118
++R L +G F ++ E N+ A+K+ +++ ++ R+F
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 119 ---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 175
E+ +++ + + + G + D+ ++YEYM S+ K
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 176 MKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231
+++ + Y+H++ + +RD+K SNIL+D+ KLSDFG ++ +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV---D 204
Query: 232 THVSTRVMGTYGYCAPE--YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ GTY + PE ++ K D++S G+ L +
Sbjct: 205 KKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-35
Identities = 54/278 (19%), Positives = 113/278 (40%), Gaps = 32/278 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLV-EVLMLSLLHHP 129
+ + +GEG FG+ + IK+++ + + RE EV +L+ + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V + +V +Y G + ++ + + L+++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHV 141
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
HD+ +++RD+K NI L + +L DFG+A++ + ++ +GT Y +PE
Sbjct: 142 HDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEI 196
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309
+ KSD+++ G VL E+ + + A F+ + +L+
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA-------------------FEAGSMKNLVLKI 237
Query: 310 ELQGQYP--PRGFYQAL-AVAAMCVHEQPDMRPVIADV 344
+ G +P + L ++ + P RP + +
Sbjct: 238 -ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-35
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLV 132
LG G FG+V + I++ VA+K L + E+ +++ + HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 133 NLIGYCADGDQ-RLLVYEYMPLGSVEDHL------------HDLSPGKKPLDWNTRMKIA 179
NL+G C +++ E+ G++ +L K L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST--- 236
A+G+E+L + I+RDL NILL K+ DFGLA+ +
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 237 ---RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M APE T++SDV+SFGV+L EI S
Sbjct: 212 LPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-35
Identities = 51/268 (19%), Positives = 95/268 (35%), Gaps = 25/268 (9%)
Query: 23 QQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGE 82
+ R + + + + ++ + G D A + ++ + + +G
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGS 66
Query: 83 GGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNL--VNLIGYC 138
GG +V++ E Q AIK ++ + E+ L+ L + + L Y
Sbjct: 67 GGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+V E + L KK +D R + +H ++
Sbjct: 126 ITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IV 177
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---------- 248
+ DLK +N L+ G KL DFG+A + V +G Y PE
Sbjct: 178 HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 249 -YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+++ KSDV+S G +L + G+
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 56/261 (21%), Positives = 95/261 (36%), Gaps = 17/261 (6%)
Query: 19 KMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSES 78
+ L + +G + + + E +
Sbjct: 6 SSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQP 64
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
+G G FG V++ + A+K++ + E++ + L P +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAV 119
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+G + E + GS L L L + + A GLEYLH + ++
Sbjct: 120 REGPWVNIFMELLEGGS----LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---IL 172
Query: 199 YRDLKCSNILLDR-GYHPKLSDFGLAK-LGPVGDNTHVSTR--VMGTYGYCAPEYAKTGQ 254
+ D+K N+LL G L DFG A L P G + T + GT + APE
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
K D++S ++L +L+G
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGC 253
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-34
Identities = 48/219 (21%), Positives = 81/219 (36%), Gaps = 25/219 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHP 129
+ + +G GG +V++ E Q AIK ++ + E+ L+ L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 130 NL--VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
+ + L Y +V E + L KK +D R +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 122
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+H +++ DLK +N L+ G KL DFG+A + V +GT Y P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 248 E-----------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
E +++ KSDV+S G +L + G+
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-34
Identities = 64/226 (28%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLV 132
LG G FG+V I++ VA+K L R + E+ +M L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------------------GKKPLDWN 173
NL+G C L++EY G + ++L L +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
+ A A+G+E+L K+ ++RDL N+L+ G K+ DFGLA+ N
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 234 VST------RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
V + M APE G T+KSDV+S+G++L EI S
Sbjct: 230 VRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 9e-34
Identities = 49/207 (23%), Positives = 77/207 (37%), Gaps = 15/207 (7%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHP 129
+R L+G GG G VY+ + VA+K + + + F E L P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
++V + + Q + + + L + PL + I L+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAA 150
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPE 248
H +RD+K NIL+ L DFG+A D +GT Y APE
Sbjct: 151 HAAG---ATHRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTLYYMAPE 205
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
T ++D+Y+ VL E L+G
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGS 232
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-33
Identities = 42/291 (14%), Positives = 87/291 (29%), Gaps = 55/291 (18%)
Query: 31 NSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFR---ELAAATKNFRSESLLGEGGFGR 87
N IP +S ++ A++ S + FR EL + ++LG+
Sbjct: 29 NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 88
Query: 88 VYKGYLESINQDVAIKQLDRNG----------------------------VQGNREFLVE 119
+ + + + + + F+
Sbjct: 89 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148
Query: 120 VLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYM--PLGSVEDHLHDLSPGKKPLDWNTR 175
++ ++ + D R +Y M L + + L S K L + R
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 208
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
+++ R L LH +++ L+ +I+LD+ L+ F G
Sbjct: 209 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA----R 259
Query: 236 TRVMGTYGYCAPEY-----------AKTGQLTLKSDVYSFGVVLLEILSGR 275
+ G+ PE + +T D ++ G+V+ I
Sbjct: 260 VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 79/333 (23%), Positives = 131/333 (39%), Gaps = 50/333 (15%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPN 130
R +L EGGF VY+ ++ A+K+L N + NR + EV M L HPN
Sbjct: 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 131 LVNLIGYCADGDQR-------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
+V + G + L+ + G + + L + + PL +T +KI
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTC 146
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA---KLGPVGDNTHVSTRVM- 239
R ++++H + KPP+I+RDLK N+LL KL DFG A P + ++
Sbjct: 147 RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 240 ------GTYGYCAPE----YAKTGQLTLKSDVYSFGVVLLEILSGRKA-VDTSKAAAEQS 288
T Y PE Y+ + K D+++ G +L + + D +K
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264
Query: 289 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
+ Q HSLI + P+ R IA+VV L
Sbjct: 265 KYSIPPHDTQYTVFHSLI---------------------RAMLQVNPEERLSIAEVVHQL 303
Query: 349 AYLASQKY---ESDAEKVQSPCLDPGTPTRTKG 378
+A+ + +S ++ G+ T ++G
Sbjct: 304 QEIAAARNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHP 129
+ +LG GG V+ ++DVA+K L R + + F + E + L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHP 72
Query: 130 NLVNL--IGYCADGDQRLLVY---EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 184
+V + G A+ L Y EY+ ++ D +H + P+ +++ A A +
Sbjct: 73 AIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQ 127
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGT 241
L + H +I+RD+K +NI++ K+ DFG+A+ + D+ + T+ V+GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGT 182
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y +PE A+ + +SDVYS G VL E+L+G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-33
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
+LG+G +G VY G S +AIK++ + ++ E+ + L H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
++ + E +P GS+ L G + T GL+YLHD ++
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 199 YRDLKCSNILLDRGY-HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-- 255
+RD+K N+L++ K+SDFG +K + + GT Y APE G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 256 TLKSDVYSFGVVLLEILSGR 275
+D++S G ++E+ +G+
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-33
Identities = 34/288 (11%), Positives = 67/288 (23%), Gaps = 45/288 (15%)
Query: 24 QKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFR---ELAAATKNFRSESLL 80
+ L R + + +L+ A + + + Q L+ + + L
Sbjct: 12 RDLLKREEELIGYCR-EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPL 70
Query: 81 GEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGY 137
G V+ +D A+K E + L +
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 138 C--------------------------ADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKP 169
LL+ L + L + +
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190
Query: 170 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229
+ A R L K +++ N+ + L D VG
Sbjct: 191 EGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--KVG 245
Query: 230 DNTHVSTRVMGTYGYCAPEY--AKTGQLTLKSDVYSFGVVLLEILSGR 275
S+ Y E+ A T T + + G+ + +
Sbjct: 246 TRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 14/206 (6%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHP 129
+F LG+G FG VY + +A+K L ++ ++ + E+ + S L HP
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N++ + Y D + L+ E+ P G + L D A L Y
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYC 130
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H++ VI+RD+K N+L+ K++DFG + P GT Y PE
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPEM 183
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGR 275
+ K D++ GV+ E L G
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHP 129
+ F +G+G FG V+KG + VAIK +D + E + E+ +LS P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
+ G + ++ EY+ GS D L PLD I +GL+YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYL 135
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H + K I+RD+K +N+LL KL+DFG+A G + D +GT + APE
Sbjct: 136 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSG 274
K K+D++S G+ +E+ G
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARG 215
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-32
Identities = 42/293 (14%), Positives = 86/293 (29%), Gaps = 54/293 (18%)
Query: 28 DRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFR---ELAAATKNFRSESLLGEGG 84
+ N IP +S ++ A++ S + FR EL + ++LG+
Sbjct: 31 ELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQED 90
Query: 85 FGRVYKGYLESINQDVAIKQLDR----------------------------NGVQGNREF 116
+ + + + + + F
Sbjct: 91 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150
Query: 117 LVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYM--PLGSVEDHLHDLSPGKKPLDW 172
+ ++ ++ + D R +Y M L + + L S K L
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
+ R+++ R L LH +++ L+ +I+LD+ L+ F G
Sbjct: 211 HARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA-- 263
Query: 233 HVSTRVMGTYGYCAPEY----------AKTGQLTLKSDVYSFGVVLLEILSGR 275
S G+ PE +T D ++ G+ + I
Sbjct: 264 --SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
K + +G+G G VY + Q+VAI+Q++ + E+L++ +PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+VN + GD+ +V EY+ GS+ D + + +D + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGD--NTHVSTRVMGTYGYCAP 247
I+RD+K NILL KL+DFG A++ P +T V GT + AP
Sbjct: 134 SNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAP 185
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
E K D++S G++ +E++ G
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 7e-32
Identities = 63/273 (23%), Positives = 112/273 (41%), Gaps = 21/273 (7%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLV 132
F S LG G G V+K + +A K + R ++ E+ +L + P +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
G + + E+M GS++ L + K++ +GL YL +K
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K +++RD+K SNIL++ KL DFG++ +L ++ ++ V GT Y +PE +
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV-GTRSYMSPERLQ 203
Query: 252 TGQLTLKSDVYSFGVVLLEILSGR-----KAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306
+++SD++S G+ L+E+ GR + + A
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 339
+ PP ++ L V+E P P
Sbjct: 264 LNKFGMDSRPPMAIFELL---DYIVNEPPPKLP 293
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 22/219 (10%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPN 130
+ +LG+G V++G + AIK + + + E +L L+H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 131 LVNLIGYCADGDQRL--LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
+V L + R L+ E+ P GS+ L + S L + + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNH 127
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
L + +++R++K NI+ G KL+DFG A+ + D+ + GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEY 181
Query: 245 CAPEYAKTGQL--------TLKSDVYSFGVVLLEILSGR 275
P+ + L D++S GV +G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 41/231 (17%), Positives = 76/231 (32%), Gaps = 26/231 (11%)
Query: 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGVQGNREFLVE 119
E +K LLGEG F +VY+ +N Q +K EF +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIG 114
Query: 120 VLMLSLL---HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL-SPGKKPLDWNTR 175
++ L + + +LV E G++ + ++ + +K +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-----------KLSDFGLAK 224
+ A +E +HD +I+ D+K N +L G+ L D G +
Sbjct: 175 ISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ + T T G+ E + D + + +L G
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
+ + LG+G FG+VYK + A K ++ + +++VE+ +L+ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V L+G + ++ E+ P G+V+ + +L + L + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLH 134
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAP 247
K I+RDLK N+L+ +L+DFG++ N + +GT + AP
Sbjct: 135 SKRI---IHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAP 186
Query: 248 E-----YAKTGQLTLKSDVYSFGVVLLEILSG 274
E K K+D++S G+ L+E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 20/212 (9%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LSLLHH 128
LG G +G V K Q +A+K++ N + +LM + +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDC 65
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P V G + E M S++ + + + + KIA + LE+
Sbjct: 66 PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAP 247
LH K VI+RD+K SN+L++ K+ DFG+ L + G Y AP
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAP 178
Query: 248 E----YAKTGQLTLKSDVYSFGVVLLEILSGR 275
E ++KSD++S G+ ++E+ R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
+ F LGEG +G VYK + Q VAIKQ+ +E + E+ ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V G +V EY GSV D + K L + I +GLEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLH 142
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGD--NTHVSTRVMGTYGYCAP 247
K I+RD+K NILL+ H KL+DFG+ +L NT + GT + AP
Sbjct: 143 FMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAP 194
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
E + +D++S G+ +E+ G
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 2e-31
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHH 128
+ + LG+GGF + ++ + A K + ++ + + +E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
++V G+ D D +V E S L +L +K L G +Y
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRS----LLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 247
LH VI+RDLK N+ L+ K+ DFGLA +V+ GT Y AP
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAP 184
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGR 275
E + + DV+S G ++ +L G+
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
S +GEG G V + + VA+K +D Q EV+++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V + G++ ++ E++ G++ D + + L+ + + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLH 158
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAP 247
+ I+RD+K +ILL KLSDFG A++ + V R ++GT + AP
Sbjct: 159 AQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQI-----SKDVPKRKSLVGTPYWMAP 210
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
E + D++S G++++E++ G
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-31
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHH 128
++F+ +LLG+G F VY+ +VAIK +D+ + EV + L H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P+++ L Y D + LV E G + +L + K + R G+ Y
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEAR-HFMHQIITGMLY 127
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH +++RDL SN+LL R + K++DFGLA + H T + GT Y +PE
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPE 182
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
A L+SDV+S G + +L GR
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 12/213 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPN 130
++ + ++G G V Y + VAIK+++ Q + + L+ E+ +S HHPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-TRMKIAA---GAARGL 186
+V+ D+ LV + + GSV D + + + IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYG 243
EYLH + I+RD+K NILL +++DFG+ A L GD T R +GT
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 244 YCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGR 275
+ APE + + K+D++SFG+ +E+ +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 24/220 (10%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPN 130
+ +LG+G V++G + AIK + + + E +L L+H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 131 LVNLIGYCADGDQRL--LVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLE 187
+V L + R L+ E+ P GS+ L + P L + + + G+
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAYGLPESEFLIVLRDVVGGMN 126
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
+L + +++R++K NI+ G KL+DFG A+ + D+ + GT
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEE 180
Query: 244 YCAPEYAKTGQL--------TLKSDVYSFGVVLLEILSGR 275
Y P+ + L D++S GV +G
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-31
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHH 128
+ + LG+GGF + ++ + A K + ++ + + +E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
++V G+ D D +V E S L +L +K L G +Y
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRS----LLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 247
LH VI+RDLK N+ L+ K+ DFGLA +V+ GT Y AP
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAP 210
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGR 275
E + + DV+S G ++ +L G+
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNL 131
+ + LG GGFG V + + + VAIKQ + NRE E+ ++ L+HPN+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 132 VNLI------GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAAR 184
V+ A D LL EY G + +L+ L + + +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ--FENCCGLKEGPIRTLLSDISS 132
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP---KLSDFGLAKLGPVGDNTHVSTRVMGT 241
L YLH+ +I+RDLK NI+L G K+ D G AK + + V GT
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV-GT 186
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + + T+ D +SFG + E ++G
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LSLLH 127
+ + +G G +G V K + Q +A+K++ + + ++LM +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSD 79
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
P +V G + E M + + + S + KI + L
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCA 246
+L + K +I+RD+K SNILLDR + KL DFG+ +L ++ TR G Y A
Sbjct: 140 HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMA 193
Query: 247 PEYAKTGQL----TLKSDVYSFGVVLLEILSGR 275
PE ++SDV+S G+ L E+ +GR
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 65/222 (29%), Positives = 90/222 (40%), Gaps = 32/222 (14%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLS-LLHHP 129
F L+G G +G+VYKG Q AIK +D G E E+ ML HH
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 130 NLVNLIG-----YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA--- 180
N+ G D +L LV E+ GSV D + + +W IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICR 136
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR--- 237
RGL +LH I+RD+K N+LL KL DFG++ R
Sbjct: 137 EILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNT 188
Query: 238 VMGTYGYCAPEYAKTGQLT-----LKSDVYSFGVVLLEILSG 274
+GT + APE + KSD++S G+ +E+ G
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 46/209 (22%), Positives = 80/209 (38%), Gaps = 24/209 (11%)
Query: 74 FRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNL 131
+ + + GG G +Y ++N + V +K L +G + + E L+ + HP++
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 132 VNLIGYCADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
V + + D+ +V EY+ S++ L + L
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPAL 195
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
YLH ++Y DLK NI+L KL D G + + GT G+ A
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINS----FGYLYGTPGFQA 245
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE T+ +D+Y+ G L +
Sbjct: 246 PEIV-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHH 128
F +LG GGFG V+ +++ + A K+L++ ++ + + +VE +L+ +H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 129 PNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGL 186
+V+L Y + L LV M G + H++++ R A GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGL 302
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
E+LH + +IYRDLK N+LLD + ++SD GLA G GT G+ A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMA 357
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE + D ++ GV L E+++ R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-29
Identities = 55/295 (18%), Positives = 95/295 (32%), Gaps = 58/295 (19%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEV-LMLSLLH 127
T F +G G FG V+K AIK+ + G + L EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
H ++V A+ D L+ EY GS+ D + + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHP-------------------KLSDFGLAKLGPV 228
Y+H + +++ D+K SNI + R P K+ D G
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---R 183
Query: 229 GDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
+ V G + A E + K+D+++ + ++
Sbjct: 184 ISSPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA------------- 227
Query: 288 SLVAWARPLFQDRTRHSLIAD---PELQGQYPPRGFYQALAVAAMCVHEQPDMRP 339
PL ++ + I P + + + + +H P+ RP
Sbjct: 228 ------EPLPRNGDQWHEIRQGRLPRIPQVLSQ----EFTELLKVMIHPDPERRP 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNL 131
+F + +LG G G + + N+DVA+K++ +RE V++L HPN+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECFSFADRE--VQLLR-ESDEHPNV 80
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
+ D + + E ++++++ L+ T ++ GL +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ---QTTSGLAHLHS 136
Query: 192 KAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 245
+++RDLK NIL+ +SDFGL K L + + V GT G+
Sbjct: 137 LN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 246 APEY---AKTGQLTLKSDVYSFGVVLLEILSG 274
APE T D++S G V ++S
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 42/219 (19%), Positives = 81/219 (36%), Gaps = 22/219 (10%)
Query: 71 TKNFRSESLLGEG--GFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EVLMLSLL 126
+ +++G+G V + + V +++++ FL E+ + L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAA 183
+HPN+V ++ +V +M GS +D + IA G
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG-LAKLGPVGDNTHV----STRV 238
+ L+Y+H ++R +K S+IL+ LS + G V
Sbjct: 139 KALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 239 MGTYGYCAPEYAKTGQL--TLKSDVYSFGVVLLEILSGR 275
+ + +PE + KSD+YS G+ E+ +G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 56/236 (23%), Positives = 97/236 (41%), Gaps = 20/236 (8%)
Query: 49 SEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN 108
S + Q T+ + A + + +G G G+V+K +A+KQ+ R+
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 109 GVQGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 165
G + + ++ +V++ P +V G + E M +
Sbjct: 62 GNKEENKRILMDLDVVL-KSHDCPYIVQCFGTFITNTDVFIAMELMGTCA----EKLKKR 116
Query: 166 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AK 224
+ P+ K+ + L YL +K VI+RD+K SNILLD KL DFG+ +
Sbjct: 117 MQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174
Query: 225 LGPVGDNTHVSTRVMGTYGYCAPE-----YAKTGQLTLKSDVYSFGVVLLEILSGR 275
L + R G Y APE +++DV+S G+ L+E+ +G+
Sbjct: 175 L----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHH 128
FR +LG+GGFG V + + + A K+L++ ++ + L E +L ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 129 PNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGL 186
+V+L Y + L LV M G ++ H++ + P R AA GL
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGL 299
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
E LH + ++YRDLK NILLD H ++SD GLA P G RV GT GY A
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMA 353
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE K + T D ++ G +L E+++G+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 73/214 (34%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLH 127
K F +G G FG VY ++ VAIK++ +G Q N ++ + EV L L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAAR 184
HPN + G LV EY GS D L KKPL ++IAA GA +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASD---LLEVHKKPLQ---EVEIAAVTHGALQ 165
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYG 243
GL YLH I+RD+K NILL KL DFG + + P N+ +GT
Sbjct: 166 GLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANS-----FVGTPY 215
Query: 244 YCAPE---YAKTGQLTLKSDVYSFGVVLLEILSG 274
+ APE GQ K DV+S G+ +E+
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHH 128
++F+ +LGEG F V + +++ AIK L++ + + E ++S L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLE 187
P V L D ++ Y G + ++ + G + A LE
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDET---CTRFYTAEIVSALE 144
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YLH K +I+RDLK NILL+ H +++DFG AK+ + +GT Y +P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 248 E------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
E K+ SD+++ G ++ ++++G
Sbjct: 202 ELLTEKSACKS------SDLWALGCIIYQLVAGL 229
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 57/234 (24%), Positives = 86/234 (36%), Gaps = 44/234 (18%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPN 130
SE +LG G G V + VA+K++ + E +++L S HPN
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALME--IKLLTESD-DHPN 70
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR------ 184
++ + E + L DL K D N +++
Sbjct: 71 VIRYYCSETTDRFLYIALELCN-LN----LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 185 -GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-------------KLSDFGLAKL---GP 227
G+ +LH +I+RDLK NIL+ +SDFGL K G
Sbjct: 126 SGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 228 VGDNTHVSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSG 274
T+++ GT G+ APE +LT D++S G V ILS
Sbjct: 183 SSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 66/242 (27%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 51 DGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV 110
G+ + A F+ E + G+G FG V G +S VAIK++ ++
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 111 QGNREFLVEVLMLSLLHHPNLVNLI------GYCADGDQRL-LVYEYMPLGSVEDHLHDL 163
NRE L + L++LHHPN+V L G D L +V EY+P ++ +
Sbjct: 62 FRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNY 119
Query: 164 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGL 222
+ R + LH + V +RD+K N+L++ KL DFG
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 223 AK-LGPVGDNTH-VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILS 273
AK L P N + +R Y Y APE Y T D++S G + E++
Sbjct: 179 AKKLSPSEPNVAYICSR----Y-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMML 227
Query: 274 GR 275
G
Sbjct: 228 GE 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHPNLVNL 134
LLGEG +G+V + A+K L + ++ E+ +L L H N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 135 --IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR-------- 184
+ Y + + +V EY G E + D P K R + A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQ--AHGYFCQLID 120
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
GLEYLH + ++++D+K N+LL G K+S G+A+ G+ +
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 245 CAPEYAKTGQL--TLKSDVYSFGVVLLEILSGR 275
PE A K D++S GV L I +G
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 68/213 (31%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLH- 127
+F ++G GGFG VY + A+K LD+ ++ + L E +MLSL+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 128 --HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAA 183
P +V + Y +L + + M G + HL G M+ AA
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEA---DMRFYAAEII 302
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
GLE++H++ V+YRDLK +NILLD H ++SD GLA H V GT+G
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHG 355
Query: 244 YCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGR 275
Y APE + G S D +S G +L ++L G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 23/227 (10%)
Query: 60 QTLTFRELAAATKNFRS----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
+ RE + LG G FG V+ S + IK ++++ Q E
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 116 -FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 174
E+ +L L HPN++ + D +V E G + + + K L
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS--- 122
Query: 175 RMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGP 227
A + L Y H + V+++DLK NIL K+ DFGLA+L
Sbjct: 123 -EGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-- 176
Query: 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
+ H + GT Y APE K +T K D++S GVV+ +L+G
Sbjct: 177 FKSDEHSTNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 16/225 (7%)
Query: 56 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
Q T + ++ ++ LG G +G V + + + AIK + + V +
Sbjct: 21 QATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN 80
Query: 116 FLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 173
+ EV +L LL HPN++ L + D LV E G + D + + +
Sbjct: 81 SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEV 136
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGD 230
I G+ YLH +++RDLK N+LL ++ K+ DFGL+ + +
Sbjct: 137 DAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FEN 191
Query: 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ R+ GT Y APE + + K DV+S GV+L +L+G
Sbjct: 192 QKKMKERL-GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY 234
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 17/226 (7%)
Query: 56 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
T A + ++ + +LG+G FG V + Q+ A+K + + V+ +
Sbjct: 10 HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 116 ---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 172
L EV +L L HPN++ L + D LV E G + D + +K
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSE 125
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVG 229
+I G+ Y+H +++RDLK N+LL + + ++ DFGL+
Sbjct: 126 VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST---HF 179
Query: 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ + +GT Y APE G K DV+S GV+L +LSG
Sbjct: 180 EASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC 224
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
F LG G FGRV + A+K LD+ V ++ L E +L ++ P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEY 188
LV L D +V EY+ G + HL + G+ + AA EY
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFS---EPHARFYAAQIVLTFEY 156
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH +IYRDLK N+L+D+ + +++DFG AK V T + GT APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWT---LCGTPEALAPE 208
Query: 249 ------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y K D ++ GV++ E+ +G
Sbjct: 209 IILSKGYNKA------VDWWALGVLIYEMAAGY 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGY 137
LGEG +G V + VA+K +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYL 189
+G+ + L EY G + D + + M A+ G+ YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYL 121
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE- 248
H + +RD+K N+LLD + K+SDFGLA + + + ++ GT Y APE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ DV+S G+VL +L+G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 75/261 (28%), Positives = 111/261 (42%), Gaps = 20/261 (7%)
Query: 24 QKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATK----NFRSESL 79
++ I ++ D LK ++ + S SD A+ + + F L
Sbjct: 97 EEWTTAIQTVADGLKKQAAAEMDFRSGSP-SDNSGAEEMEVSLAKPKHRVTMNEFEYLKL 155
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIG 136
LG+G FG+V ++ + A+K L + + E L E +L HP L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 137 YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAK 194
Y RL V EY G + HL D R + A L+YLH +
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLS--RERVFSED---RARFYGAEIVSALDYLHSEKN 269
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDND 325
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
D + GVV+ E++ GR
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGR 346
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
++ ++G G FG VY+ L + VAIK++ +Q R E+ ++ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCN 108
Query: 131 LVNLIGY-CADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 184
+V L + + G+++ LV +Y+P +V S K+ L R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAK-LGPVGDNTH-VSTRVMGT 241
L Y+H + +RD+K N+LLD KL DFG AK L N + +R
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---- 220
Query: 242 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y Y APE Y T DV+S G VL E+L G+
Sbjct: 221 Y-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGY 137
LGEG +G V + VA+K +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYL 189
+G+ + L EY G + D + + M A+ G+ YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYL 121
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE- 248
H + +RD+K N+LLD + K+SDFGLA + + + ++ GT Y APE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ DV+S G+VL +L+G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 60/242 (24%), Positives = 95/242 (39%), Gaps = 47/242 (19%)
Query: 60 QTLTFRELAAATKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
LT + + K R E LG G G V + + VAI+ + +
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178
Query: 116 FLV--------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 167
E+ +L L+HP ++ + + D + +V E M G +L
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG-------EL---- 226
Query: 168 KPLDW---NTRM--KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHP 215
D N R+ ++YLH+ +I+RDLK N+LL +
Sbjct: 227 --FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281
Query: 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKTGQLTLKSDVYSFGVVLLEIL 272
K++DFG +K+ +G+ + + T GT Y APE T D +S GV+L L
Sbjct: 282 KITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 273 SG 274
SG
Sbjct: 339 SG 340
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 28/229 (12%)
Query: 60 QTLTFRELAAATKNFRS----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
+ RE F +LG+G FG V K Q+ A+K +++ +
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 116 FLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 173
+ EV +L L HPN++ L D +V E G + D + +K
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFS-- 119
Query: 174 TRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 226
AA + G+ Y+H +++RDLK NILL ++ K+ DFGL+
Sbjct: 120 --EHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC- 173
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
NT + R+ GT Y APE + G K DV+S GV+L +LSG
Sbjct: 174 -FQQNTKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 57/260 (21%), Positives = 100/260 (38%), Gaps = 33/260 (12%)
Query: 31 NSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRS------ESLLGEGG 84
L ++ K S R + A S +LG G
Sbjct: 42 VWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGR 101
Query: 85 FGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144
FG+V+K + +A K + G++ E E+ +++ L H NL+ L +
Sbjct: 102 FGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161
Query: 145 LLVYEYMPLGSVEDHL----HDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPP 196
+LV EY+ G + D + ++L+ + G+ ++H
Sbjct: 162 VLVMEYVDGGELFDRIIDESYNLTE-----------LDTILFMKQICEGIRHMHQMY--- 207
Query: 197 VIYRDLKCSNILL-DRGYHP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+++ DLK NIL +R K+ DFGLA+ + GT + APE
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNF-GTPEFLAPEVVNYDF 264
Query: 255 LTLKSDVYSFGVVLLEILSG 274
++ +D++S GV+ +LSG
Sbjct: 265 VSFPTDMWSVGVIAYMLLSG 284
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 61/278 (21%), Positives = 106/278 (38%), Gaps = 26/278 (9%)
Query: 5 PCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTF 64
PC + ++ + + +D I SS + +
Sbjct: 93 PCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152
Query: 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLS 124
+ ++ LG G FG V++ + + A K + E+ +S
Sbjct: 153 DHV---LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 209
Query: 125 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGA 182
+L HP LVNL D ++ +++YE+M G + + + D + +M A
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV---------ADEHNKMSEDEAVEY 260
Query: 183 AR----GLEYLHDKAKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVST 236
R GL ++H+ ++ DLK NI+ R KL DFGL + V
Sbjct: 261 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKV 315
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
GT + APE A+ + +D++S GV+ +LSG
Sbjct: 316 TT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 53/202 (26%), Positives = 80/202 (39%), Gaps = 22/202 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+G G +G V + A K++ + V+ F E+ ++ L HPN++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKP 195
D LV E G E L + K+ AA + + Y H
Sbjct: 77 DNTDIYLVMELCTGG--E--LFERVVHKRVFR----ESDAARIMKDVLSAVAYCHKLN-- 126
Query: 196 PVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
V +RDLK N L KL DFGLA + T+V GT Y +P+ +
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQVLE- 181
Query: 253 GQLTLKSDVYSFGVVLLEILSG 274
G + D +S GV++ +L G
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCG 203
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 63/210 (30%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G V+K Q VAIK+ D + + L E+ ML L HPNLVNL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI--KKIALREIRMLKQLKHPNLVNLL 68
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
+ LV+EY LH+L ++ + + I + + + H
Sbjct: 69 EVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN-- 122
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAKT 252
I+RD+K NIL+ + KL DFG A+L GP V+TR Y +PE
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE---- 172
Query: 253 GQLTLKSDVYSFGV-------VLLEILSGR 275
L + Y V V E+LSG
Sbjct: 173 --LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 61/260 (23%), Positives = 103/260 (39%), Gaps = 23/260 (8%)
Query: 27 LDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFG 86
LD + + D+ + R K E + T +++ ++F ++G G FG
Sbjct: 31 LDILICLYDECNNSPLRREKNILEY--LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFG 88
Query: 87 RVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCA--DG 141
V L++ ++ A+K L++ + E F E +L + L + A D
Sbjct: 89 EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDD 146
Query: 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYR 200
+ LV +Y G D L LS + L + A ++ +H ++R
Sbjct: 147 NNLYLVMDYYVGG---DLLTLLSKFEDRLP-EEMARFYLAEMVIAIDSVHQLH---YVHR 199
Query: 201 DLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS- 259
D+K NIL+D H +L+DFG S V GT Y +PE + +
Sbjct: 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRY 258
Query: 260 ----DVYSFGVVLLEILSGR 275
D +S GV + E+L G
Sbjct: 259 GPECDWWSLGVCMYEMLYGE 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 3e-23
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 32/216 (14%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
K F +LG G F V+ + A+K + ++ + E+ +L + H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIAAGAAR- 184
+V L LV + + G +L D K A+ +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGG-------EL------FDRILERGVYTEKDASLVIQQ 114
Query: 185 ---GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
++YLH+ +++RDLK N+L + ++DFGL+K + N +ST
Sbjct: 115 VLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTAC 168
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
GT GY APE + D +S GV+ +L G
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 73/213 (34%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
+F+ LG G FGRV+ + A+K L + V ++ E LMLS++ HP
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEY 188
++ + G D Q ++ +Y+ G + L + P N K AA LEY
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFP---NPVAKFYAAEVCLALEY 121
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH K +IYRDLK NILLD+ H K++DFG AK V D T+ T + GT Y APE
Sbjct: 122 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY--T-LCGTPDYIAPE 173
Query: 249 ------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y K+ D +SFG+++ E+L+G
Sbjct: 174 VVSTKPYNKS------IDWWSFGILIYEMLAGY 200
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 27/236 (11%)
Query: 56 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
I ++ +++ LG G +G V ++ + + AIK + ++ R
Sbjct: 20 AINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRY 79
Query: 116 FLV-------------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 162
E+ +L L HPN++ L D LV E+ G + + + +
Sbjct: 80 SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN 139
Query: 163 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSD 219
+ D I G+ YLH +++RD+K NILL + + K+ D
Sbjct: 140 ----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVD 192
Query: 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
FGL+ + +GT Y APE K + K DV+S GV++ +L G
Sbjct: 193 FGLSS---FFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY 244
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-23
Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 18/213 (8%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--------EVLML 123
+ + + S LG G FG V+ + N++V +K + + V + E+ +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 124 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
S + H N++ ++ + LV E G L LD I
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
+ YL K +I+RD+K NI++ + KL DFG A G + GT
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIE 194
Query: 244 YCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
YCAPE + +++S GV L ++
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-23
Identities = 58/257 (22%), Positives = 105/257 (40%), Gaps = 22/257 (8%)
Query: 30 INSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVY 89
+ S +S L + + +D + +E ++ LLG GGFG VY
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVY 60
Query: 90 KGYLESINQDVAIKQLDRNGVQGNREFLV------EVLMLSLLHH--PNLVNLIGYCADG 141
G S N VAIK ++++ + E EV++L + ++ L+ +
Sbjct: 61 SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120
Query: 142 DQRLLVYEY-MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYR 200
D +L+ E P+ + D + + + L + + H+ V++R
Sbjct: 121 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHR 173
Query: 201 DLKCSNILLDRGYHP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LK 258
D+K NIL+D KL DFG L +T + GT Y PE+ + +
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD-GTRVYSPPEWIRYHRYHGRS 229
Query: 259 SDVYSFGVVLLEILSGR 275
+ V+S G++L +++ G
Sbjct: 230 AAVWSLGILLYDMVCGD 246
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 5e-23
Identities = 56/244 (22%), Positives = 88/244 (36%), Gaps = 52/244 (21%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-----FLVEVLMLSLLHHPNLVNL 134
+G+G +G V AIK +++N ++ EV ++ LHHPN+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG------------- 181
D LV E G + D L+ +K
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 182 ----------------AAR-------GLEYLHDKAKPPVIYRDLKCSNILL--DRGYHPK 216
+ L YLH++ + +RD+K N L ++ + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 217 LSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYAKTGQL--TLKSDVYSFGVVLLEI 271
L DFGL+K G+ ++T+ GT + APE T K D +S GV+L +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 272 LSGR 275
L G
Sbjct: 270 LMGA 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-23
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 41/228 (17%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-------------------- 118
+G+G +G V Y E+ N A+K L + + F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 119 ------EVLMLSLLHHPNLVNL--IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
E+ +L L HPN+V L + + D +V+E + G V + P KPL
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-----VPTLKPL 134
Query: 171 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230
+ +G+EYLH + +I+RD+K SN+L+ H K++DFG++ G
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGS 190
Query: 231 NTHVSTRVMGTYGYCAPE---YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ +S V GT + APE + DV++ GV L + G+
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 7e-23
Identities = 69/258 (26%), Positives = 109/258 (42%), Gaps = 22/258 (8%)
Query: 27 LDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFG 86
LD ++++ L +LR K + D + R+L +++ ++G G FG
Sbjct: 26 LDGLDALVYDLD-FPALR-KNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFG 83
Query: 87 RVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCA--DG 141
V +S + A+K L + + + F E +++ + P +V L + A D
Sbjct: 84 EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDD 141
Query: 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 201
+V EYMP G D ++ +S P W R A L+ +H I+RD
Sbjct: 142 RYLYMVMEYMPGG---DLVNLMSNYDVPEKW-ARF-YTAEVVLALDAIHSMG---FIHRD 193
Query: 202 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE----YAKTGQLTL 257
+K N+LLD+ H KL+DFG T V GT Y +PE G
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR 252
Query: 258 KSDVYSFGVVLLEILSGR 275
+ D +S GV L E+L G
Sbjct: 253 ECDWWSVGVFLYEMLVGD 270
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-23
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 37/222 (16%)
Query: 71 TKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLS 124
+ F LG+G F V + ++ + A K ++ + + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 125 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIA 179
L HPN+V L + LV++ + G +L + A
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGG-------EL------FEDIVAREFYSEADA 107
Query: 180 AGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNT 232
+ + + Y H +++R+LK N+LL +G KL+DFGLA V D+
Sbjct: 108 SHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSE 162
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
GT GY +PE K + D+++ GV+L +L G
Sbjct: 163 AWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 7e-23
Identities = 63/266 (23%), Positives = 96/266 (36%), Gaps = 77/266 (28%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPNLV 132
LG G FG+V + I++ VA+K L + +R + E+ +++ + HH N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 133 NLIG--------------YCADGDQRLLVY------------------------------ 148
NL+G +C G+ L Y
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 149 ---------------------EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
E L VE+ K L + + A+G+E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+L + I+RDL NILL K+ DFGLA+ + + AP
Sbjct: 208 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E T++SDV+SFGV+L EI S
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-23
Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 52 GASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ 111
G++D + + +L E +LGEG RV +Q+ A+K +++
Sbjct: 1 GSTDSFSGRFEDVYQL--------QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH 52
Query: 112 GNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
EV ++ H N++ LI + + D+ LV+E M GS+ H+H ++
Sbjct: 53 IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHF 108
Query: 171 DWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP------KLSDF 220
+ A+ + L++LH+K + +RDLK NIL HP K+ DF
Sbjct: 109 N----ELEASVVVQDVASALDFLHNKG---IAHRDLKPENILC---EHPNQVSPVKICDF 158
Query: 221 GLAK-LGPVGDNTHVSTRVM----GTYGYCAPEYAKTGQLTLKS-----DVYSFGVVLLE 270
L + GD + +ST + G+ Y APE + D++S GV+L
Sbjct: 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI 218
Query: 271 ILSG 274
+LSG
Sbjct: 219 LLSG 222
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-23
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 64 FRELAAATKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVE 119
++L + F +G G + + ++ N + A+K +D++ E +E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IE 67
Query: 120 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
+ +L HPN++ L DG +V E M G + D + +K + A
Sbjct: 68 I-LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR----QKFFS----EREA 118
Query: 180 AGAAR----GLEYLHDKAKPPVIYRDLKCSNILL-DRGYHP---KLSDFGLAKLGPVGDN 231
+ +EYLH + V++RDLK SNIL D +P ++ DFG AK +N
Sbjct: 119 SAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AEN 174
Query: 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
+ T T + APE + D++S GV+L +L+G
Sbjct: 175 GLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 8e-23
Identities = 65/215 (30%), Positives = 93/215 (43%), Gaps = 30/215 (13%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
+F LLG+G FG+V ++ + A+K L + + E + E +L HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 130 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLE 187
L L Y RL V EY G + HL + R + A LE
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEE---RARFYGAEIVSALE 119
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCA 246
YLH + V+YRD+K N++LD+ H K++DFGL K G T + GT Y A
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 173
Query: 247 PE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE Y + D + GVV+ E++ GR
Sbjct: 174 PEVLEDNDYGRA------VDWWGLGVVMYEMMCGR 202
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 9e-23
Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 65 RELAAATKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-- 118
RE F +LG+G FG V K Q+ A+K +++ + +
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 119 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-- 176
EV +L L HPN++ L D +V E G +L D +
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG-------EL------FDEIIKRKR 117
Query: 177 ---KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 226
AA + G+ Y+H +++RDLK NILL ++ K+ DFGL+
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC- 173
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
NT + R+ GT Y APE + G K DV+S GV+L +LSG
Sbjct: 174 -FQQNTKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 9e-23
Identities = 46/205 (22%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V++ ++ + K ++ E+ +++ LHHP L+NL
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 140 DGDQRLLVYEYMPLGSVEDHL----HDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHD 191
D + +L+ E++ G + D + + +S R GL+++H+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSE-----------AEVINYMRQACEGLKHMHE 167
Query: 192 KAKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
+ +++ D+K NI+ + K+ DFGLA + + V T + APE
Sbjct: 168 HS---IVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPEI 221
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSG 274
+ +D+++ GV+ +LSG
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-23
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPN 130
N+R +G+G F +V ++VAIK +D+ + + EV ++ +L+HPN
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR------ 184
+V L L+ EY G V D+L + RMK AR
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----------HGRMK--EKEARSKFRQI 123
Query: 185 --GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
++Y H K +++RDLK N+LLD + K++DFG + + G
Sbjct: 124 VSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAP 177
Query: 243 GYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y G + DV+S GV+L ++SG
Sbjct: 178 PYAAPELFQGKKYD--GP---EVDVWSLGVILYTLVSGS 211
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 36/236 (15%)
Query: 56 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
I + + + ++G G FG V++ L ++ VAIK++ +Q R
Sbjct: 24 VIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV----LQDKRF 78
Query: 116 FLVEVLMLSLLHHPNLVNLIGY-----CADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKP 169
E+ ++ ++ HPN+V+L + + L LV EY+P +V + K+
Sbjct: 79 KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQT 137
Query: 170 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAK-LGP 227
+ R L Y+H + +RD+K N+LLD KL DFG AK L
Sbjct: 138 MPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 228 VGDNTH-VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
N + +R Y Y APE Y T D++S G V+ E++ G+
Sbjct: 195 GEPNVSYICSR----Y-YRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
+F +G+G FG+V + A+K +++ E E+ ++ L HP
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 130 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLE 187
LVNL Y ++ + +V + + G + HL + +K+ L+
Sbjct: 76 FLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFKEETVKLFICELVMALD 129
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YL ++ +I+RD+K NILLD H ++DF +A + P T + GT Y AP
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAP 183
Query: 248 E--YAKTGQLTLKS-DVYSFGVVLLEILSGR 275
E ++ G + D +S GV E+L GR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-------QGNREFLVEVLMLS 124
+R LLG+GGFG V+ G+ + VAIK + RN V L EV +L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLW 89
Query: 125 LLH----HPNLVNLIGYCADGDQRLLVYEY-MPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
+ HP ++ L+ + + +LV E +P + D++ + K PL
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFF 145
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAKLGPVGDNTHVSTRV 238
+++ H + V++RD+K NIL+D KL DFG L + +
Sbjct: 146 GQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFD 199
Query: 239 MGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGR 275
GT Y PE+ Q L + V+S G++L +++ G
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 59/210 (28%), Positives = 87/210 (41%), Gaps = 34/210 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G V K + + VAIK+ D V + + E+ +L L H NLVNL+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV--KKIAMREIKLLKQLRHENLVNLL 90
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
C + LV+E++ L DL LD+ K G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN-- 144
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAKT 252
+I+RD+K NIL+ + KL DFG A+ P V+TR Y APE
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPE---- 194
Query: 253 GQLTLKSDVYSFGV-------VLLEILSGR 275
L + Y V ++ E+ G
Sbjct: 195 --LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 56/287 (19%), Positives = 105/287 (36%), Gaps = 43/287 (14%)
Query: 12 RKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAAT 71
R+ + ++ N + + K+N + + S + +
Sbjct: 34 REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY 93
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVL---------M 122
+ + + ++G G V + + + A+K ++ + + E L EV +
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 123 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-----K 177
+ HP+++ LI LV++ M G +L D+ T K
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKG-------EL------FDYLTEKVALSEK 200
Query: 178 IAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
R + +LH +++RDLK NILLD +LSDFG + +
Sbjct: 201 ETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEK 255
Query: 234 VSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSG 274
+ GT GY APE + D+++ GV+L +L+G
Sbjct: 256 LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 73 NFRSESLLGEGGFGRVY---KGYLESINQDVAIKQLDRNGVQGNREFLVEVLM----LSL 125
F +LG+G FG+V+ K Q A+K L + ++ V M L
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR--VRTKMERDILVE 82
Query: 126 LHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAA 183
++HP +V L Y + +L L+ +++ G + L + +K A A
Sbjct: 83 VNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEE---DVKFYLAELA 136
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTY 242
L++LH +IYRDLK NILLD H KL+DFGL+K + GT
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTV 190
Query: 243 GYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + ++ +D +SFGV++ E+L+G
Sbjct: 191 EYMAPEVVNRRGHTQS------ADWWSFGVLMFEMLTGT 223
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-22
Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--------EVLMLSLLHHPNL 131
LG G G V + + VAIK + + E+ +L L+HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW---NTRM--KIAAGAAR-- 184
+ + + D + +V E M G +L D N R+
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGG-------EL------FDKVVGNKRLKEATCKLYFYQM 123
Query: 185 --GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
++YLH+ +I+RDLK N+LL + K++DFG +K+ +G+ + + T
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC- 177
Query: 240 GTYGYCAPE---YAKTGQLTLKSDVYSFGVVLLEILSG 274
GT Y APE T D +S GV+L LSG
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 5e-22
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 48/219 (21%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G V+K ++ VA+K++ D GV L E+ +L L H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELKHKNIVRLH 67
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLE 187
+ LV+E+ DL KK D + + +GL
Sbjct: 68 DVLHSDKKLTLVFEFCD--------QDL---KKYFD-SCNGDLDPEIVKSFLFQLLKGLG 115
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYC 245
+ H + V++RDLK N+L++R KL++FGLA+ PV + V+ T Y
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYR 168
Query: 246 APEYAKTGQLTLKSDVYSFGV-------VLLEILSGRKA 277
P+ + + +YS + + E+ + +
Sbjct: 169 PPD------VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-22
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-----EVLMLSLLHHPNLVN 133
LG G FG+V G + VA+K L+R ++ +V E+ L L HP+++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPHIIK 75
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------G 185
L + +V EY+ G + D++ + R++ AR
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICK----------HGRVEEME--ARRLFQQILSA 123
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
++Y H V++RDLK N+LLD + K++DFGL+ + G+ S G+ Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYA 177
Query: 246 APE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE + + D++S GV+L +L G
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 56/261 (21%), Positives = 95/261 (36%), Gaps = 23/261 (8%)
Query: 27 LDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFG 86
LD + + +L S L ++ + +E+ +F ++G G F
Sbjct: 18 LDLLLGVHQELG-ASELA-QDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFS 75
Query: 87 RVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCA--DG 141
V ++ Q A+K +++ + E F E +L + L + A D
Sbjct: 76 EVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDE 133
Query: 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 201
+ LV EY G + L + P + R A ++ +H ++RD
Sbjct: 134 NYLYLVMEYYVGGDLLTLLSKFGE-RIPAEM-ARF-YLAEIVMAIDSVHRLG---YVHRD 187
Query: 202 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 261
+K NILLDR H +L+DFG V GT Y +PE + +
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGS 246
Query: 262 Y-------SFGVVLLEILSGR 275
Y + GV E+ G+
Sbjct: 247 YGPECDWWALGVFAYEMFYGQ 267
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-22
Identities = 72/211 (34%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 127
+F +LG+G FG+V+ + NQ AIK L ++ V + + +VE VL L+
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-E 76
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 185
HP L ++ + L V EY+ G + H+ K L R AA G
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLS---RATFYAAEIILG 130
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 244
L++LH K ++YRDLK NILLD+ H K++DFG+ K +GD T GT Y
Sbjct: 131 LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDY 184
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE + D +SFGV+L E+L G+
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-22
Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 55/228 (24%)
Query: 80 LGEGGFGRVYKGYLESI--NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG- 136
+G G +G VYK + ++D A+KQ++ G+ + E+ +L L HPN+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 137 YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA------------ 183
+ + D+++ L+++Y HDL + ++ K
Sbjct: 87 FLSHADRKVWLLFDYAE--------HDL---WHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 184 ---RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKL--GPVGDNTHV 234
G+ YLH V++RDLK +NIL+ K++D G A+L P+ +
Sbjct: 136 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 235 STRVMGTYGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 275
V+ T+ Y APE L L + D+++ G + E+L+
Sbjct: 193 DPVVV-TFWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 56/235 (23%), Positives = 89/235 (37%), Gaps = 50/235 (21%)
Query: 70 ATKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDR--------NGVQGNREFL 117
+T F +LG G V + + ++ A+K +D VQ RE
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 118 ---VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 174
V++L + HPN++ L LV++ M G +L D+ T
Sbjct: 71 LKEVDILR-KVSGHPNIIQLKDTYETNTFFFLVFDLMKKG-------EL------FDYLT 116
Query: 175 RM-----KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225
K R + LH +++RDLK NILLD + KL+DFG +
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 226 GPVGDNTHVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSG 274
+ + GT Y APE + D++S GV++ +L+G
Sbjct: 174 --LDPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 32/210 (15%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EV-LMLSLLHHPNLVNLIG 136
LG G F V + +S Q+ A K L R Q R ++ E+ ++ P ++NL
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 137 YCADGDQRLLVYEYMPLGS-----VEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLE 187
+ + +L+ EY G + + +S + G+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSE-----------NDVIRLIKQILEGVY 145
Query: 188 YLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
YLH +++ DLK NILL K+ DFG+++ +G + + GT Y
Sbjct: 146 YLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEY 199
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
APE +T +D+++ G++ +L+
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-21
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVN 133
LG G F V K + ++ A K + + + +R E EV +L + HPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYL 189
L + +L+ E + G E L D K+ L T + A + G+ YL
Sbjct: 73 LHDIFENKTDVVLILELVSGG--E--LFDFLAEKESL---TEDE-ATQFLKQILDGVHYL 124
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
H K + + DLK NI+L P KL DFG+A + GT +
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF-GTPEFV 178
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSG 274
APE L L++D++S GV+ +LSG
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
LGEG +G VYK N+ VAIK++ + GV + EV +L L H N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV--PGTAIREVSLLKELQHRNIIELK 99
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA------RGLEYL 189
+ L++EY +DL KK +D N + + + G+ +
Sbjct: 100 SVIHHNHRLHLIFEYAE--------NDL---KKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHP-----KLSDFGLAKL--GPVGDNTHVSTRVMGTY 242
H + ++RDLK N+LL K+ DFGLA+ P+ TH ++ T
Sbjct: 149 HSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TL 201
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 275
Y PE + L S YS V + E+L
Sbjct: 202 WYRPPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 127
+F ++G+G FG+V ++ A+K L + + +E + E VL+ ++
Sbjct: 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-K 97
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 185
HP LV L + +L V +Y+ G + HL R + AA A
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEP---RARFYAAEIASA 151
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 244
L YLH ++YRDLK NILLD H L+DFGL K ++T T GT Y
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEY 205
Query: 245 CAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE Y +T D + G VL E+L G
Sbjct: 206 LAPEVLHKQPYDRT------VDWWCLGAVLYEMLYGL 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 73 NFRSESLLGEGGFGRVY---KGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LS 124
F +LG+GG+G+V+ K + + A+K L + + N + L
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK-DTAHTKAERNILE 76
Query: 125 LLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGA 182
+ HP +V+LI Y +L L+ EY+ G + L G D A
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLERE--GIFMED---TACFYLAEI 130
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GT 241
+ L +LH K +IYRDLK NI+L+ H KL+DFGL K T GT
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGT 184
Query: 242 YGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + + D +S G ++ ++L+G
Sbjct: 185 IEYMAPEILMRSGHNRA------VDWWSLGALMYDMLTGA 218
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 39/220 (17%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHH 128
+ + LGEG + VYKG + + VA+K++ G + EV +L L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKH 59
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS----PGKKPLDWNTRMKIAAGAAR 184
N+V L LV+EY+ DL ++ + R
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLD--------KDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTY 242
GL Y H + V++RDLK N+L++ KL+DFGLA+ P + V+ T
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TL 164
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 275
Y P+ + L S YS + + E+ +GR
Sbjct: 165 WYRPPD------ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 49/217 (22%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G VYK +S + VA+K++ + G+ + E+ +L LHHPN+V+LI
Sbjct: 29 VGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGI--PSTAIREISLLKELHHPNIVSLI 85
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLE 187
LV+E+M DL KK LD + + RG+
Sbjct: 86 DVIHSERCLTLVFEFME--------KDL---KKVLD-ENKTGLQDSQIKIYLYQLLRGVA 133
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYC 245
+ H +++RDLK N+L++ KL+DFGLA+ PV TH V+ T Y
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYR 186
Query: 246 APEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 275
AP+ + + S D++S G + E+++G+
Sbjct: 187 APD------VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
LG G + VYKG ++ VA+K++ G + E+ ++ L H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--PSTAIREISLMKELKHENIVRLYD 70
Query: 137 YCADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
++ LV+E+M L D + + L+ N +GL + H+
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDS-RTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK- 128
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAKT 252
+++RDLK N+L+++ KL DFGLA+ PV + V+ T Y AP+
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPD---- 178
Query: 253 GQLTLKSDVYSFGV-------VLLEILSGR 275
+ + S YS + +L E+++G+
Sbjct: 179 --VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 57/203 (28%), Positives = 85/203 (41%), Gaps = 24/203 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYC 138
LGEG F K + NQ A+K + + ++ E+ + HPN+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAK 194
D LV E + G + + + KK A+ R + ++HD
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKK----KKHFS----ETEASYIMRKLVSAVSHMHDVG- 126
Query: 195 PPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
V++RDLK N+L + K+ DFG A+L P DN + T T Y APE
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPC-FTLHYAAPELLN 182
Query: 252 TGQLTLKSDVYSFGVVLLEILSG 274
D++S GV+L +LSG
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSG 205
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-21
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 49/217 (22%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G VYK + + A+K++ + G+ + E+ +L L H N+V L
Sbjct: 10 IGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKHSNIVKLY 66
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLE 187
+ +LV+E++ DL KK LD + + A G+
Sbjct: 67 DVIHTKKRLVLVFEHLD--------QDL---KKLLD-VCEGGLESVTAKSFLLQLLNGIA 114
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYC 245
Y HD+ V++RDLK N+L++R K++DFGLA+ PV TH ++ T Y
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYR 167
Query: 246 APEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 275
AP+ + + S YS + + E+++G
Sbjct: 168 APD------VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 54/241 (22%), Positives = 92/241 (38%), Gaps = 33/241 (13%)
Query: 48 ASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR 107
AS G + N+ + LG+G F V + ++ + A K ++
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 108 NGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 165
+ + E + L HPN+V L + LV++ + G +L
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG-------EL-- 115
Query: 166 GKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGY 213
+ A+ + + Y H +++R+LK N+LL +G
Sbjct: 116 ----FEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGA 168
Query: 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
KL+DFGLA V D+ GT GY +PE K + D+++ GV+L +L
Sbjct: 169 AVKLADFGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225
Query: 274 G 274
G
Sbjct: 226 G 226
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 33/243 (13%)
Query: 41 SSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDV 100
++ V + +G D++ +F +LG+G FG+V + ++
Sbjct: 1 TTNTVSKFDNNGNRDRMKLT------------DFNFLMVLGKGSFGKVMLSERKGTDELY 48
Query: 101 AIKQLDRNGVQGNREF---LVE--VLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLG 154
A+K L ++ V + + +VE VL L P L L C RL V EY+ G
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQLH-SCFQTMDRLYFVMEYVNGG 106
Query: 155 SVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213
+ H+ + G+ AA A GL +L K +IYRDLK N++LD
Sbjct: 107 DLMYHIQQV--GRFKEP---HAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEG 158
Query: 214 HPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 272
H K++DFG+ K T T+ GT Y APE D ++FGV+L E+L
Sbjct: 159 HIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
Query: 273 SGR 275
+G+
Sbjct: 216 AGQ 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 73 NFRSESLLGEGGFGRVY---KGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LS 124
NF +LG G +G+V+ K + A+K L + + +
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 125 LLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGA 182
+ P LV L Y + +L L+ +Y+ G + HL + ++I
Sbjct: 115 IRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQR--ERFTEH---EVQIYVGEI 168
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
LE+LH +IYRD+K NILLD H L+DFGL+K + GT
Sbjct: 169 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTI 224
Query: 243 GYCAPE---YAKTGQLTLKS-DVYSFGVVLLEILSGR 275
Y AP+ +G K+ D +S GV++ E+L+G
Sbjct: 225 EYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA 259
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVN 133
LG G F V K +S + A K + + + +R E EV +L + HPN++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYL 189
L + +L+ E + G E L D K+ L + A + G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGG--E--LFDFLAQKESL----SEEEATSFIKQILDGVNYL 131
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
H K + + DLK NI+L P KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSG 274
APE L L++D++S GV+ +LSG
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM------LSLL 126
+F +LG+G FG+V + ++ A+K L ++ V + + VE M
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPG 399
Query: 127 HHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAAR 184
P L L C RL V EY+ G + H+ + G+ AA A
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEP---HAVFYAAEIAI 453
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYG 243
GL +L K +IYRDLK N++LD H K++DFG+ K T T+ GT
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPD 507
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE D ++FGV+L E+L+G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-----EVLMLSLLHHPNLVNL 134
+G+G F V + Q A+K +D + E + +L HP++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLH 190
+ + +V+E+M + + + ++ + A+ R L Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAV--ASHYMRQILEALRYCH 147
Query: 191 DKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
D +I+RD+K +LL + KL FG+A +G++ V+ +GT + AP
Sbjct: 148 DNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAP 202
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
E K DV+ GV+L +LSG
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 7e-21
Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVN 133
LG G F V K +S + A K + + + +R E EV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYL 189
L + +L+ E + G E L D K+ L + A + G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGG--E--LFDFLAQKESL----SEEEATSFIKQILDGVNYL 131
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
H K + + DLK NI+L P KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSG 274
APE L L++D++S GV+ +LSG
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 67/217 (30%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 127
NF +LG+G FG+V ++ A+K L ++ + + + + E +L L+ +
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-N 82
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 185
HP L L C RL V E++ G + H+ + R + AA
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEA---RARFYAAEIISA 136
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 244
L +LHDK +IYRDLK N+LLD H KL+DFG+ K G T T GT Y
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDY 190
Query: 245 CAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE Y D ++ GV+L E+L G
Sbjct: 191 IAPEILQEMLYGPA------VDWWAMGVLLYEMLCGH 221
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-21
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 28/210 (13%)
Query: 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
S+ +LG G G+V + + Q A+K L + +E V+ P++V ++
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-QE--VD-HHWQASGGPHIVCIL 88
Query: 136 GYCADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLE 187
+ L++ E M G + + + + + R AA R ++
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQE----RGDQAFTERE--AAEIMRDIGTAIQ 142
Query: 188 YLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
+LH + +RD+K N+L ++ KL+DFG AK + T T Y
Sbjct: 143 FLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPC-YTPYY 195
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
APE + D++S GV++ +L G
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 69/223 (30%), Positives = 99/223 (44%), Gaps = 57/223 (25%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL-------DRNGVQGNREFLVEVLMLSLLHHPNLV 132
LGEG F VYK ++ NQ VAIK++ ++G+ NR L E+ +L L HPN++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI--NRTALREIKLLQELSHPNII 75
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------- 183
L+ LV+++M DL + + + +
Sbjct: 76 GLLDAFGHKSNISLVFDFME--------TDL---EVIIK---DNSLVLTPSHIKAYMLMT 121
Query: 184 -RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTH-VSTRVM 239
+GLEYLH +++RDLK +N+LLD KL+DFGLAK P TH V TR
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-- 176
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 275
Y APE L + +Y GV +L E+L
Sbjct: 177 ---WYRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 9e-21
Identities = 34/164 (20%), Positives = 63/164 (38%), Gaps = 14/164 (8%)
Query: 119 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
++ + N V + + + + +++D + + + + I
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLEDREHGVCLHI 169
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK----------LGPV 228
A +E+LH K +++RDLK SNI K+ DFGL +
Sbjct: 170 FIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 272
T +GT Y +PE + K D++S G++L E+L
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 22/109 (20%), Positives = 42/109 (38%), Gaps = 2/109 (1%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPN 130
+F +G GGFG V++ + + + AIK++ + RE + EV L+ L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 131 LVNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
+V + ++ E LS + +++
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 53/210 (25%), Positives = 79/210 (37%), Gaps = 34/210 (16%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIG 136
+G G FG + + VA+K ++R V E++ L HPN+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKE 83
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEY 188
++ EY G + + + + R AR G+ Y
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICN----------AGRFSED--EARFFFQQLLSGVSY 131
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
H + +RDLK N LLD P K+ DFG +K + + V GT Y A
Sbjct: 132 CHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIA 185
Query: 247 PE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE + +DV+S GV L +L G
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 36/204 (17%), Positives = 85/204 (41%), Gaps = 26/204 (12%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
LG G FG V++ S + K + G ++ + E+ +L++ H N+++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESF 70
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGAAR----GLEYLHDK 192
++ ++++E++ + + + + + + L++LH
Sbjct: 71 ESMEELVMIFEFISGL--D--IFE-----RINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 193 AKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ + D++ NI+ R K+ +FG A+ + + Y APE
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAPEVH 175
Query: 251 KTGQLTLKSDVYSFGVVLLEILSG 274
+ ++ +D++S G ++ +LSG
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 127
+F ++G G + +V L+ ++ A+K + + V + + E V + +
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-N 68
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 185
HP LV L C + RL V EY+ G + H+ K P + + +A +
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEE---HARFYSAEISLA 122
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 244
L YLH++ +IYRDLK N+LLD H KL+D+G+ K G +T T GT Y
Sbjct: 123 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 176
Query: 245 CAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE Y + D ++ GV++ E+++GR
Sbjct: 177 IAPEILRGEDYGFS------VDWWALGVLMFEMMAGR 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 50/222 (22%), Positives = 84/222 (37%), Gaps = 36/222 (16%)
Query: 71 TKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLS 124
F E LG+G F V + Q+ A ++ + + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 125 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIA 179
LL HPN+V L ++ L+++ + G +L + A
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGG-------EL------FEDIVAREYYSEADA 112
Query: 180 AGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNT 232
+ + + + H V++R+LK N+LL +G KL+DFGLA V
Sbjct: 113 SHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQ 167
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
GT GY +PE + D+++ GV+L +L G
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 62/258 (24%), Positives = 104/258 (40%), Gaps = 33/258 (12%)
Query: 29 RINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRV 88
++ + L S V ++ G + + + A + F ES LG G V
Sbjct: 10 GVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIV 69
Query: 89 YKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148
Y+ + + A+K L + + E+ +L L HPN++ L + LV
Sbjct: 70 YRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127
Query: 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIY 199
E + G +L D + AA A + + YLH+ +++
Sbjct: 128 ELVTGG-------EL------FDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVH 171
Query: 200 RDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
RDLK N+L K++DFGL+K+ V + T GT GYCAPE +
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC-GTPGYCAPEILRGCAYG 228
Query: 257 LKSDVYSFGVVLLEILSG 274
+ D++S G++ +L G
Sbjct: 229 PEVDMWSVGIITYILLCG 246
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 55/217 (25%), Positives = 85/217 (39%), Gaps = 44/217 (20%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVN 133
LG G F V K +S A K + + + +R + EV +L + HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--------KIAAGAAR- 184
L + +L+ E + G E L D + + A +
Sbjct: 79 LHEVYENKTDVILILELVAGG--E--LFD------------FLAEKESLTEEEATEFLKQ 122
Query: 185 ---GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTR 237
G+ YLH + + DLK NI+L P K+ DFGLA +
Sbjct: 123 ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNI 177
Query: 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
GT + APE L L++D++S GV+ +LSG
Sbjct: 178 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHP 129
++ LG G FG+V G E VA+K L+R ++ E+ L L HP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----- 184
+++ L + +V EY+ G + D++ N R+ +R
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICK----------NGRLDEKE--SRRLFQQ 124
Query: 185 ---GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
G++Y H V++RDLK N+LLD + K++DFGL+ + G+ S G+
Sbjct: 125 ILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GS 178
Query: 242 YGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + + D++S GV+L +L G
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 127
+F ++G G + +V L+ ++ A++ + + V + + E V + +
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-N 111
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 185
HP LV L C + RL V EY+ G + H+ K P + + +A +
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEE---HARFYSAEISLA 165
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 244
L YLH++ +IYRDLK N+LLD H KL+D+G+ K G +T T GT Y
Sbjct: 166 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 219
Query: 245 CAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE Y + D ++ GV++ E+++GR
Sbjct: 220 IAPEILRGEDYGFS------VDWWALGVLMFEMMAGR 250
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHP 129
+ LGEG FG+V Q VA+K + R ++ + + E+ L LL HP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----- 184
+++ L ++V EY G + D++ + RM R
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYAG-GELFDYIVE----------KKRMTEDE--GRRFFQQ 116
Query: 185 ---GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
+EY H +++RDLK N+LLD + K++DFGL+ + G+ S G+
Sbjct: 117 IICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GS 170
Query: 242 YGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + DV+S G+VL +L GR
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 7e-20
Identities = 30/205 (14%), Positives = 60/205 (29%), Gaps = 41/205 (20%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPN 130
+R G + ++ ++++ VA+ +D GV + +E L L LS + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+ ++ L+V E++ GS+++ ++ A + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAH 146
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
V S + + S G L
Sbjct: 147 RA---GVALSIDHPSRVRV--------SIDGDVVLA--------------YPATMPDA-- 179
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ D+ G L +L R
Sbjct: 180 -----NPQDDIRGIGASLYALLVNR 199
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 9e-20
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 52/223 (23%)
Query: 80 LGEGGFGRVYKGY-LESINQDVAIKQL----DRNGV--QGNREFLVEVL-MLSLLHHPNL 131
+GEG +G+V+K L++ + VA+K++ G+ RE V VL L HPN+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE--VAVLRHLETFEHPNV 76
Query: 132 VNLI----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--- 183
V L D + +L LV+E++ DL LD +
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVD--------QDL---TTYLDKVPEPGVPTETIKDM 125
Query: 184 -----RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
RGL++LH V++RDLK NIL+ KL+DFGLA+ +++ V
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVV 180
Query: 239 MGTYGYCAPEYAKTGQLTLKS------DVYSFGVVLLEILSGR 275
+ T Y APE + L+S D++S G + E+ +
Sbjct: 181 V-TLWYRAPE------VLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 9e-20
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 54/225 (24%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGN-----REFLVEVL-MLSLLHHP 129
+G G +G VYK VA+K + G G RE V +L L HP
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE--VALLRRLEAFEHP 74
Query: 130 NLVNLI----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA- 183
N+V L+ D + ++ LV+E++ DL + LD + A
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVD--------QDL---RTYLDKAPPPGLPAETIK 123
Query: 184 -------RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
RGL++LH +++RDLK NIL+ G KL+DFGLA+ ++
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTP 178
Query: 237 RVMGTYGYCAPEYAKTGQLTLKS------DVYSFGVVLLEILSGR 275
V+ T Y APE + L+S D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPE------VLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 52/253 (20%), Positives = 97/253 (38%), Gaps = 67/253 (26%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
+K + LG G FG V + + + A+K++ ++ NRE + ++ +L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 131 LVNLIGY-------------------------------------CADGDQRL-LVYEYMP 152
++ L+ Y ++ L ++ EY+P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 212
++ L + + N R + ++H + +RD+K N+L++
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSK 177
Query: 213 YHP-KLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVY 262
+ KL DFG AK L P + + +R + Y APE Y T D++
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEY------TPSIDLW 226
Query: 263 SFGVVLLEILSGR 275
S G V E++ G+
Sbjct: 227 SIGCVFGELILGK 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
K +++ +G G G V Y ++++VAIK+L R N R E++++ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVN 119
Query: 128 HPNLVNLIG-YCADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
H N+++L+ + LV E M + +L + + LD +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVI--QMELDHERMSYLLYQ 172
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVM 239
G+++LH +I+RDLK SNI++ K+ DFGLA+ +V TR
Sbjct: 173 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY- 228
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE D++S G ++ E++ +
Sbjct: 229 ----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 56/227 (24%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGV--QGNREFLVEVLMLSLLHHPNLVN 133
+G+G FG V+K Q VA+K++ ++ G RE + +L LL H N+VN
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE----IKILQLLKHENVVN 80
Query: 134 LIGYCADGDQRL--------LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA-- 183
LI C LV+++ HDL L N +K
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCE--------HDL---AGLLS-NVLVKFTLSEIKR 128
Query: 184 ------RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVS 235
GL Y+H +++RD+K +N+L+ R KL+DFGLA+ +
Sbjct: 129 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 275
T + T Y PE L L D++ G ++ E+ +
Sbjct: 186 TNRVVTLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
K +++ +G G G V Y + ++VAIK+L R N R + E++++ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 128 HPNLVNLIG-YCADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAA 180
H N++ L+ + +V E M + +L + + LD + RM +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVI--QMELD-HERMSYLLY 134
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
G+++LH +I+RDLK SNI++ K+ DFGLA + + T +
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVV 188
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
T Y APE D++S G ++ E++ G
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 29/207 (14%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
LG G G+V + + + + A+K L D + RE VE L P++V ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--RE--VE-LHWRASQCPHIVRIVDVY 124
Query: 139 ADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLH 190
+ L+V E + G + + D + + R A+ + ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTERE--ASEIMKSIGEAIQYLH 178
Query: 191 DKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+ +RD+K N+L KL+DFG AK + ++T T Y AP
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPC-YTPYYVAP 232
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
E + D++S GV++ +L G
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 9e-17
Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 38/221 (17%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
K + S + +G G +G V + + VAIK+L R + + R E+L+L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHMQ 81
Query: 128 HPNLVNLI-----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
H N++ L+ LV +M + L + +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIM--GLKFSEEKIQYLVYQ 134
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
+GL+Y+H V++RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW--- 188
Query: 242 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y +T D++S G ++ E+L+G+
Sbjct: 189 --YRAPEVILSWMHYNQT------VDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 37/221 (16%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
+R +G G +G V VAIK+L R + + R E+ +L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHMR 82
Query: 128 HPNLVNLIG-YCADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
H N++ L+ + D LV +M L L + L + +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLM-KHEKLGEDRIQFLVYQ 136
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
+GL Y+H +I+RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 137 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--- 190
Query: 242 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y +T D++S G ++ E+++G+
Sbjct: 191 --YRAPEVILNWMRYTQT------VDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHH 128
+ + S +GEG +G V Y VAIK++ + R L E+ +L H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRH 84
Query: 129 PNLVNLIG----YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGA 182
N++ + + + + +V + M E L+ L + L N +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLL-KTQHLS-NDHICYFLYQI 137
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGT 241
RGL+Y+H A V++RDLK SN+LL+ K+ DFGLA+ P D+T T + T
Sbjct: 138 LRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 242 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y K+ D++S G +L E+LS R
Sbjct: 195 RWYRAPEIMLNSKGYTKS------IDIWSVGCILAEMLSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 52/232 (22%), Positives = 88/232 (37%), Gaps = 48/232 (20%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREF---------LVE 119
+ + + G +G V G +S VAIK++ + + L E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 120 VLMLSLLHHPNLVNL----IGYCADGDQRL-LVYEYMPLGSVEDHLHD-LSPGKKPLDWN 173
+ +L+ HHPN++ L + + +L LV E M L + + +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVIS-P 133
Query: 174 TRMK-IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
++ GL LH+ V++RDL NILL + DF LA+ N
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 233 --HVSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+V+ R Y APE + K D++S G V+ E+ + +
Sbjct: 191 THYVTHRW-----YRAPELVMQFKGFTKL------VDMWSAGCVMAEMFNRK 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
+ +++ S +G G +G V + VA+K+L R + + R E+ +L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-YRELRLLKHMK 86
Query: 128 HPNLVNLI-----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
H N++ L+ + + LV M L+++ + L + +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQ-KLTDDHVQFLIYQ 140
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
RGL+Y+H +I+RDLK SN+ ++ K+ DFGLA+ +V+TR
Sbjct: 141 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW--- 194
Query: 242 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y +T D++S G ++ E+L+GR
Sbjct: 195 --YRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHH 128
+ +F+ +SLLGEG +G V + + VAIK+++ + R L E+ +L H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 129 PNLVNLIG-YCADGDQRL----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGA 182
N++ + D + ++ E M + LH + + L + ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQ-MLS-DDHIQYFIYQT 121
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA----KLGPVGDNTHVSTRV 238
R ++ LH + VI+RDLK SN+L++ K+ DFGLA +
Sbjct: 122 LRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 239 MGTY----GYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
M + Y APE Y++ DV+S G +L E+ R
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRA------MDVWSCGCILAELFLRR 220
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 22/214 (10%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNL 131
+R +G G FG +Y G + ++VAIK + + +E + ++ +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGI 67
Query: 132 VNLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+ A+GD ++V E LG S+ED L + K L T + +A +EY+H
Sbjct: 68 PTIRWCGAEGDYNVMVMEL--LGPSLED-LFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPK---LSDFGLAKL-GPVGDNTHVSTR----VMGTY 242
K I+RD+K N L+ G + DFGLAK + H+ R + GT
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 243 GYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 275
Y A G + + + D+ S G VL+ G
Sbjct: 180 RY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 46/158 (29%), Positives = 62/158 (39%), Gaps = 15/158 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
NFR +G G FG + G N+ VAIK L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIP 68
Query: 133 NLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
+ + G +V E LG S+ED L DL L T + IA +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLEL--LGPSLED-LFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPK-----LSDFGLAK 224
K +IYRD+K N L+ R + + DF LAK
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 56/262 (21%), Positives = 100/262 (38%), Gaps = 56/262 (21%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
N+ + L+G G +G VY Y ++ ++VAIK+++R + + R L E+ +L+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRLK 83
Query: 128 HPNLVNL----IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK----- 177
++ L I L +V E + L L L +K
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT-EEHIKTILYN 137
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237
+ G ++H+ + +I+RDLK +N LL++ K+ DFGLA+ +T++
Sbjct: 138 LL----LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 238 VMGTYGYCAPEYAKTGQLT--------------LKS-------DVYSFGVVLLEILSGRK 276
+ QLT L D++S G + E+L+ +
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 277 AVDTSKAAAEQSLVAWARPLFQ 298
+ PLF
Sbjct: 251 SHINDPTN--------RFPLFP 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 40/229 (17%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLVEVLMLSLLHHP 129
+ LG GG G V+ ++ VAIK++ + L E+ ++ L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-LREIKIIRRLDHD 68
Query: 130 NLVNLIG-YCADGDQRL-------------LVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 175
N+V + G Q +V EYM E L ++ + PL
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVL-EQGPLLEEHA 122
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAK-LGPVGDNTH 233
RGL+Y+H V++RDLK +N+ ++ K+ DFGLA+ + P +
Sbjct: 123 RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 234 VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ + T Y +P Y K D+++ G + E+L+G+
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKA------IDMWAAGCIFAEMLTGK 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNL 131
FR +G G FG +Y G N++VAIK + + + L E + +L +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGI 65
Query: 132 VNLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
N+ + +GD +LV + LG S+ED L + K L T + +A +E++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDL--LGPSLED-LFNFCSRKLSL--KTVLMLADQMINRVEFVH 120
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPK---LSDFGLAKL-GPVGDNTHVSTR----VMGTY 242
K+ ++RD+K N L+ G + DFGLAK + H+ R + GT
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 243 GYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 275
Y A G + + + D+ S G VL+ L G
Sbjct: 178 RY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 3e-13
Identities = 44/264 (16%), Positives = 77/264 (29%), Gaps = 69/264 (26%)
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--------DRNGVQ 111
+ F T+ + +GEG FG V++ + + VAIK + + + +
Sbjct: 9 GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQK 65
Query: 112 GNREFLVEVLMLSLLH---------HPNLVNLIG-YCADG-------------------- 141
E L E+++ L + L +C G
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 142 ---------DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
DQ +V E+ G + + K T I L
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEAS 180
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD-------NTHVSTRVM--GTYG 243
+ +RDL N+LL + KL K + + +R+ G
Sbjct: 181 LR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 244 YCAPEYAK---TGQLTLKSDVYSF 264
+C + TG + D+Y
Sbjct: 239 FCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 46/210 (21%), Positives = 89/210 (42%), Gaps = 37/210 (17%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLML-SLLHHPNLVNLIGYC 138
LG G + V++ + N+ V +K L + + E+ +L +L PN++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 100
Query: 139 ADGDQR--LLVYEYMPLGSVEDHLHDLSPG------KKPLDWNTRMKIAAGAARGLEYLH 190
D R LV+E++ + L+ + L + L+Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KALDYCH 147
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAP 247
+++RD+K N+++D + +L D+GLA+ G N V++R + P
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199
Query: 248 EYAKTGQLTLKS-DVYSFGVVLLEILSGRK 276
E Q+ S D++S G +L ++ ++
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 20/214 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
+++ +GEG FG +++G NQ VAIK R L L +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL-LAGCTGIP 69
Query: 133 NLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
N+ + +G +LV + LG S+ED L DL K + T A ++ +H+
Sbjct: 70 NVYYFGQEGLHNVLVIDL--LGPSLED-LLDLCGRKFSV--KTVAMAAKQMLARVQSIHE 124
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPK-----LSDFGLAKL-GPVGDNTHVSTR----VMGT 241
K+ ++YRD+K N L+ R + DFG+ K H+ R + GT
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y + + + + D+ + G V + L G
Sbjct: 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 52/262 (19%), Positives = 89/262 (33%), Gaps = 53/262 (20%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLL 126
+ L+G G +G V + Y + + VAIK++ R V + L E+ +L+ L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRL 109
Query: 127 HHPNLVNL----IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
+H ++V + I + L +V E + L L +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKTLLYN 164
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-----KLGPVGDNTHVST 236
G++Y+H A +++RDLK +N L+++ K+ DFGLA
Sbjct: 165 LLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 237 RVMGTYGYCAPEYAKTGQLT--------------LKSDVYSFGV-------VLLEILSGR 275
QLT L + Y+ + + E+L+
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281
Query: 276 KAVDTSKAAAEQSLVAWARPLF 297
K A PLF
Sbjct: 282 KENVAYHAD--------RGPLF 295
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 29/175 (16%), Positives = 61/175 (34%), Gaps = 29/175 (16%)
Query: 72 KNFRSESLLGEGGFGRVYKGY--------LESINQDVAIKQLDRNG----------VQGN 113
+ ++ +S G +Y+ Q ++K ++G
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 114 REFLVEVLMLSLLHHPNLVNLIGY-CADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLD 171
+ + L + +G+ R LV LG S++ D+S K L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQS-ALDVS-PKHVLS 157
Query: 172 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK--LSDFGLAK 224
+ +++A LE+LH+ ++ ++ NI +D + L+ +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 42/207 (20%), Positives = 74/207 (35%), Gaps = 50/207 (24%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYC 138
LG G G+V + + + + A+K L EV L P++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVY 80
Query: 139 ADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLH 190
+ L+V E + G + + D + + R A+ + ++YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTERE--ASEIMKSIGEAIQYLH 134
Query: 191 DKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+ +RD+K N+L KL+DFG AK + Y
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--------ETTGE---KYD---- 176
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
D++S GV++ +L G
Sbjct: 177 ---------KSCDMWSLGVIMYILLCG 194
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 62/239 (25%), Positives = 102/239 (42%), Gaps = 52/239 (21%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
+ + LG+G +G V+K + VA+K++ N R E+++L+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-FREIMILTELS 66
Query: 128 -HPNLVNLIG-YCADGDQRL-LVYEYMPLGSVEDHLH------DLSPG-KKPLDWNTRMK 177
H N+VNL+ AD D+ + LV++YM E LH L P K+ + +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQL--- 118
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237
+ ++YLH +++RD+K SNILL+ H K++DFGL++ V +
Sbjct: 119 -----IKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSR-SFVNIRRVTNNI 169
Query: 238 VMGTYGYCAPEYAKTGQLT--------------LKS-------DVYSFGVVLLEILSGR 275
+ LT L S D++S G +L EIL G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 29/176 (16%), Positives = 66/176 (37%), Gaps = 31/176 (17%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-----------GNRE 115
++ +G+GGFG +Y + S + +K + E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 116 FLVEVLMLSLLHHPNLVNLIGYCADGDQ----RLLVYEYMPLG-SVEDHLHDLSPGKKPL 170
+ + + L + + G R ++ + G ++ +++ + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQK-IYEANAKRFSR 151
Query: 171 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK--LSDFGLAK 224
T ++++ LEY+H+ ++ D+K SN+LL+ + L D+GLA
Sbjct: 152 --KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 44/226 (19%), Positives = 88/226 (38%), Gaps = 46/226 (20%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---------- 127
LG G F V+ N VA+K + R E+ +L ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 128 -HPNLVNLIGY----CADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAG 181
+++ L+ + +G ++V+E LG ++ + PL + +I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKKYEHRGIPLI-YVK-QISKQ 139
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP------KLSDFGLAKLGPVGDNTHVS 235
GL+Y+H + +I+ D+K N+L++ P K++D G A +
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 236 TRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
TR Y +PE + +D++S ++ E+++G
Sbjct: 198 TRE-----YRSPEVLLGAPW------GCGADIWSTACLIFELITGD 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 31/175 (17%), Positives = 61/175 (34%), Gaps = 32/175 (18%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+ +G GGFG +Y + + + A + + Q N E+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDC 95
Query: 132 VN---------------LIGY----CADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLD 171
+ G R +V E LG ++ G
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQKISGQN--GTFKK- 150
Query: 172 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK--LSDFGLAK 224
+T +++ LEY+H+ ++ D+K +N+LL + L+D+GL+
Sbjct: 151 -STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 50/221 (22%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL------HHPNL 131
++G+G FG+V K Y ++Q VA+K + RN + +R+ E+ +L L + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 132 VNLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGA 182
++++ C + +E + +L++L + K A
Sbjct: 162 IHMLENFTFRNHIC-------MTFELL-----SMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP--KLSDFGLAKLGPVGDNTHVSTRVMG 240
+ L+ LH K +I+ DLK NILL + K+ DFG + T++ +R
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-- 264
Query: 241 TYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y + D++S G +L E+L+G
Sbjct: 265 ---YRAPEVILGARY------GMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 52/227 (22%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL------- 126
+ +SL+G+G FG+V K Y + VAIK + +N + +EV +L L+
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 127 -HHPNLVNLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRM 176
++ +V+L + C LV+E + +L+DL + + + N
Sbjct: 115 KYY--IVHLKRHFMFRNHLC-------LVFEML-----SYNLYDLLRNTNFRGVSLNLTR 160
Query: 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP--KLSDFGLAKLGPVGDNTHV 234
K A L +L + +I+ DLK NILL K+ DFG + ++
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 235 STRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+R Y +PE Y L D++S G +L+E+ +G
Sbjct: 220 QSRF-----YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 47/264 (17%), Positives = 83/264 (31%), Gaps = 74/264 (28%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-----HH 128
+ LG G F V+ + + VA+K + ++ L E+ +L + +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 129 PNLVNLIGYC-------ADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAA 180
PN ++ +G +V+E LG + + + PL KI
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLP--CVKKIIQ 153
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILL------------------------------- 209
+GL+YLH K + +I+ D+K NILL
Sbjct: 154 QVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 210 ------------------DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K++D G A + TR Y + E
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLI 266
Query: 252 TGQLTLKSDVYSFGVVLLEILSGR 275
+D++S + E+ +G
Sbjct: 267 GSGYNTPADIWSTACMAFELATGD 290
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 2e-06
Identities = 39/239 (16%), Positives = 74/239 (30%), Gaps = 52/239 (21%)
Query: 4 FPCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLK-MNSSLRVKEASEDGASDQITAQTL 62
+ D+++ K + + +L+ + P + + M L V S I L
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESSLNVLE--PAEYRKMFDRLSVFPPSAH-----IPTILL 392
Query: 63 -------TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
++ SL+ + + SI ++ +K + +R
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--SIPSIYLELKVKLENE--YALHRS 448
Query: 116 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP------ 169
+V+ + + +LI D Y Y +G HL ++ ++
Sbjct: 449 -IVDHYNIPKTFDSD--DLIPPYLDQ------YFYSHIG---HHLKNIEHPERMTLFRMV 496
Query: 170 -LDWN-TRMKI----AAGAARG--LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220
LD+ KI A A G L L Y+ C N D Y ++
Sbjct: 497 FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF----YKPYICDN---DPKYERLVNAI 548
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 55/244 (22%), Positives = 88/244 (36%), Gaps = 80/244 (32%)
Query: 78 SLLGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLLHHP--- 129
LGEG FG+V + ++ + VA+K + +N + E+ +L L+
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN----VDRYCEAARSEIQVLEHLNTTDPN 74
Query: 130 ---NLVNLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMK 177
V ++ + C +V+E LG +D G P + K
Sbjct: 75 STFRCVQMLEWFEHHGHIC-------IVFE--LLGL---STYDFIKENGFLPFRLDHIRK 122
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-DRGYHP------------------KLS 218
+A + + +LH + + DLK NIL Y K+
Sbjct: 123 MAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 219 DFGLAKLGPVGDN--THVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLE 270
DFG A ++ T VSTR Y APE + + DV+S G +L+E
Sbjct: 180 DFGSATY--DDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIE 226
Query: 271 ILSG 274
G
Sbjct: 227 YYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 48/247 (19%), Positives = 77/247 (31%), Gaps = 86/247 (34%)
Query: 78 SLLGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLL------ 126
LGEG FG+V + VA+K + RN ++ +E+ +L +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKII-RN----VGKYREAARLEINVLKKIKEKDKE 79
Query: 127 --HHPNLVNLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTR 175
V + + C + +E LG + + +P
Sbjct: 80 NKFL--CVLMSDWFNFHGHMC-------IAFE--LLGK---NTFEFLKENNFQPYPLPHV 125
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-------------------K 216
+A L +LH+ + + DLK NIL +
Sbjct: 126 RHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 217 LSDFGLAKLGPVGDNTH---VSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVV 267
++DFG A H V+TR Y PE + DV+S G +
Sbjct: 183 VADFGSATF---DHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCI 228
Query: 268 LLEILSG 274
L E G
Sbjct: 229 LFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 57/244 (23%), Positives = 87/244 (35%), Gaps = 76/244 (31%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-----HHPNLV 132
+G+G FGRV + A+K + RN + R +E +L + ++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 133 NLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGAA 183
G C L++E PLG L+++
Sbjct: 100 KYHGKFMYYDHMC-------LIFE--PLGP---SLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-------------------------KLS 218
+ L YL + + + DLK NILLD Y KL
Sbjct: 148 KALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 219 DFGLAKLGPVGDN--THVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLE 270
DFG A D + ++TR Y APE + + SD++SFG VL E
Sbjct: 205 DFGCA--TFKSDYHGSIINTRQ-----YRAPEVILNLGW------DVSSDMWSFGCVLAE 251
Query: 271 ILSG 274
+ +G
Sbjct: 252 LYTG 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 399 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.2 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.95 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.82 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.75 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.62 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.54 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.54 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.4 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.23 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.19 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.1 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.88 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.81 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.8 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.77 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.62 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.6 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.56 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.38 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.23 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.18 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.27 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.02 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.57 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.1 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.56 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-62 Score=453.34 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=219.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999997532 223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|||+||+|.+++.. .+.+++.++..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999987 567999999999999999999999999 99999999999999999999999999987544
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
..........+||+.|||||++.+..|+.++|||||||++|||++|++||...........+. .. .
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------~~--------~ 250 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII------KL--------E 250 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HT--------C
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------cC--------C
Confidence 433344456789999999999999999999999999999999999999998765433222111 00 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH-----HHHHHHhccCCCc
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT-----ALAYLASQKYESD 359 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~-----~L~~l~~~~~~~~ 359 (399)
. .++...+.++.+||.+||+.||++|||+.|++. ....+..-.|+..
T Consensus 251 ~----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 251 Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp C----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred C----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 1 112223347899999999999999999998743 2234444455443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-62 Score=451.63 Aligned_cols=263 Identities=27% Similarity=0.392 Sum_probs=216.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-----CCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
++|.+.+.||+|+||.||+|++. .++..||||++........+.|.+|+.+|++++|||||+++++|.+++.+||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46888899999999999999875 3578999999986655556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEE
Q 015816 147 VYEYMPLGSVEDHLHDLS---------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 217 (399)
|||||++|+|.++|.... .....+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 12457999999999999999999999999 999999999999999999999
Q ss_pred ecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhh
Q 015816 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...........+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~--- 246 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG--- 246 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT---
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---
Confidence 99999975433333333334569999999999999999999999999999999998 99999876544322221110
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
. .+ ..|+..+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 247 ----~------~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 247 ----R------VL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ----C------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----C------CC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 0 00 11223334889999999999999999999999999988653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-61 Score=452.81 Aligned_cols=263 Identities=29% Similarity=0.447 Sum_probs=211.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-----CCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
++|.+.+.||+|+||.||+|+++ .+++.||||++........+.|.+|+.+|++++|||||+++++|.+...+||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45778889999999999999875 3588999999986655556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCce
Q 015816 147 VYEYMPLGSVEDHLHDLSP-----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 215 (399)
|||||++|+|.+++..... ...++++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 1357999999999999999999999999 9999999999999999999
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhh
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~ 294 (399)
||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...........+...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g- 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG- 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 9999999986544443444455679999999999999999999999999999999999 89999876544332222110
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
. .+ ..|+..+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 277 ------~------~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 277 ------R------EL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ------C------CC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------C------CC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 0 01 11222334889999999999999999999999999988764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-61 Score=454.22 Aligned_cols=250 Identities=21% Similarity=0.294 Sum_probs=213.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
..|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999999999999999997665556677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
+||+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.... .
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 223 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--E 223 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS--S
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCC--C
Confidence 99999999975 46999999999999999999999999 99999999999999999999999999986432 2
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||...........+... .. +.
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~~----------~~- 289 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LP----------PR- 289 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---SC----------CC-
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---CC----------CC-
Confidence 22345578999999999999999999999999999999999999999876544332222100 00 00
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+...+.++.+||.+||+.||++|||+.|+++
T Consensus 290 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111233448899999999999999999999885
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-61 Score=453.43 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=206.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999999765433 34578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
||+||+|.++|.... ...+++.+++.|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+...
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~-- 176 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-- 176 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC--
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec--
Confidence 999999999997532 456899999999999999999999999 9999999999999999999999999998532
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
.........+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+. ... .+
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~-----------~~ 243 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII--SGS-----------FP 243 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HTC-----------CC
T ss_pred CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH--cCC-----------CC
Confidence 11222345689999999999999999999999999999999999999998765433222111 100 01
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+ +...+.++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1223348899999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=448.41 Aligned_cols=256 Identities=20% Similarity=0.242 Sum_probs=210.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
..|++.+.||+|+||.||+|+++.+|+.||||++...... .+|+.+|+.++|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4688889999999999999999999999999999754332 36999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-ceEEecccCCccCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 230 (399)
+||+|.+++.. .+.+++..+..|+.||+.||+|||+++ ||||||||+||||+.+| .+||+|||+|+......
T Consensus 133 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999987 567999999999999999999999999 99999999999999987 69999999998643322
Q ss_pred Cc---ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 231 NT---HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 231 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|++||...........+. ...
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~------- 272 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEP------- 272 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSC-------
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCC-------
Confidence 11 11233679999999999999999999999999999999999999997643322111110 000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
+. ....++..+..+.+||.+||+.||.+|||+.|+++.|......
T Consensus 273 -~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 273 -PP-IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp -CG-GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC-chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 00 0112233344889999999999999999999999998876653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-60 Score=440.10 Aligned_cols=260 Identities=28% Similarity=0.456 Sum_probs=204.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||+||+|+++. .||||+++.... ...+.|.+|+.+|++++|||||++++++.+ +.+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 467788999999999999998753 599999875432 234679999999999999999999998865 56899999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
||+||+|.++|... ..++++.+++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999752 457999999999999999999999999 999999999999999999999999999864433
Q ss_pred CCcceeeeeccCccccCcccccc---CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.........+||+.|||||++.+ ..|+.++|||||||+||||+||+.||............ .... .
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~--~~~~---------~ 254 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM--VGRG---------Y 254 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHTT---------C
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH--HhcC---------C
Confidence 33334455789999999999863 46999999999999999999999999765432211111 1100 0
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
..|.+ ...++..+..+.+|+.+||+.||++||||.+|++.|+.+..
T Consensus 255 ~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 255 ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 01111 11222334488999999999999999999999999998764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-60 Score=456.55 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=213.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
+.|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46999999999999999999999999999999998766666677999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
+||+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-- 300 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 300 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--
Confidence 99999999974 46999999999999999999999999 999999999999999999999999999864322
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||...........+... .. +.
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~~----------~~- 366 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LP----------PR- 366 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CC----------CC-
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---CC----------CC-
Confidence 22345578999999999999999999999999999999999999999876544332222110 00 00
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+...+..+.+||.+||+.||++|||+.|+++
T Consensus 367 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111223348899999999999999999999985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-60 Score=443.46 Aligned_cols=259 Identities=29% Similarity=0.415 Sum_probs=212.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC-----CCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
++++.+.||+|+||+||+|.+. .+++.||||++..... ...+.|.+|+.++++++|||||+++++|.+++.++|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4567789999999999999864 3578999999975433 345779999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc
Q 015816 147 VYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 214 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 214 (399)
|||||++|+|.++|..... ....+++.+++.|+.||+.||+|||+++ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999975321 1246999999999999999999999999 999999999999999999
Q ss_pred eEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhh
Q 015816 215 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWA 293 (399)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~ 293 (399)
+||+|||+++...............||+.|||||++.++.|+.++|||||||+||||+| |..||...........+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i--- 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI--- 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH---
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence 99999999986443333333445679999999999999999999999999999999998 89999876554332221
Q ss_pred hhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 294 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
. .... ...++..+..+.+|+.+||+.||++||||.+|++.|+.+
T Consensus 261 ~----~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 R----NRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H----TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H----cCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 1000 112223344889999999999999999999999999743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-60 Score=431.38 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=196.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|+++.+|+.||||++.+... .....+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 589999999999999999999999999999999976433 23456899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||| +|+|.+++.. ..++++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 5899999987 678999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCcceeeeeccCccccCccccccCCC-CcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.......+||+.|||||++.+..| +.++|||||||++|+|++|+.||...........+...
T Consensus 165 ---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~-------------- 227 (275)
T 3hyh_A 165 ---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG-------------- 227 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------
T ss_pred ---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------------
Confidence 222345689999999999988876 57999999999999999999999876543322211100
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.. .++...+.++.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 228 VY----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 111223347889999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=432.79 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=201.1
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEec----CCeeEEE
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLV 147 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv 147 (399)
|++.+.||+|+||.||+|.++.++..||||++..... ...+.|.+|+.+|++++|||||+++++|.+ ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3667789999999999999999999999999975433 234568999999999999999999999865 3568999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-CCceEEecccCCccC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLG 226 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~ 226 (399)
||||+||+|.+++.. ...+++..+..|+.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999987 567999999999999999999999875 34999999999999984 789999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.. ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||........ +..... .. .
T Consensus 183 ~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~i~----~~-----~ 246 (290)
T 3fpq_A 183 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVT----SG-----V 246 (290)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHT----TT-----C
T ss_pred CC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHHHH----cC-----C
Confidence 21 22345789999999999865 699999999999999999999999975433221 111110 00 0
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+.+...++ .++.+||.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 247 KPASFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGGGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011112222 37889999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-60 Score=440.65 Aligned_cols=243 Identities=26% Similarity=0.327 Sum_probs=198.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC---CCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
++|++.+.||+|+||+||+|++. .+++.||||++.+... .....+.+|+.+|++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999884 4688999999975432 223468889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
|||||+||+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999987 567999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
... .......+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+. ..
T Consensus 177 ~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------~~------- 241 (304)
T 3ubd_A 177 IDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL------KA------- 241 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC-------
T ss_pred cCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH------cC-------
Confidence 222 222345689999999999999999999999999999999999999998765543322211 10
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 341 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 341 (399)
.+ .++...+.++.+||.+||+.||++|||+
T Consensus 242 -~~----~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 242 -KL----GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -CC----CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 01 1122233478999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=437.47 Aligned_cols=266 Identities=27% Similarity=0.387 Sum_probs=215.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCC-----CeEEEEEEeccCCCc-chHHHHHHHHHHhhcCC-CCccceEEEEecC-
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHH-PNLVNLIGYCADG- 141 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~- 141 (399)
..++|++.+.||+|+||.||+|.+..+ ++.||||++...... ..+.|.+|+.+|.+++| ||||+++++|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 456899999999999999999998654 368999999765433 34679999999999965 8999999999764
Q ss_pred CeeEEEEEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill 209 (399)
..+|||||||++|+|.++|+.... ....+++.+++.|+.|||.||+|||+++ ||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceee
Confidence 568999999999999999975321 1346899999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHH
Q 015816 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~ 288 (399)
++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||........
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-- 296 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 296 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999986544444444455789999999999999999999999999999999998 9999976542211
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 289 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
+..... ... .+ ..|+..+.++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 297 ~~~~i~----~g~------~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 297 FCRRLK----EGT------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHH----HTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHH----cCC------CC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 111111 100 01 11222334889999999999999999999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-57 Score=418.09 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=191.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCC-------
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------- 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------- 142 (399)
..+|++.+.||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 34699999999999999999999999999999999754433 3457899999999999999999999987544
Q ss_pred -----eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEE
Q 015816 143 -----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (399)
Q Consensus 143 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 217 (399)
.+|+|||||+||+|.+++..... ....++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 37999999999999999986321 223566778999999999999999999 999999999999999999999
Q ss_pred ecccCCccCCCCCCc----------ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHH
Q 015816 218 SDFGLAKLGPVGDNT----------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 287 (399)
+|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||.......
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~-- 234 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV-- 234 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH--
Confidence 999999864332211 11234579999999999999999999999999999999996 776432211
Q ss_pred HHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 288 SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
....... .. ..|.. .+.....+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~----~~------~~p~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLTDVR----NL------KFPPL----FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHH----TT------CCCHH----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHh----cC------CCCCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111000 00 00000 1122235678999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-57 Score=420.77 Aligned_cols=267 Identities=24% Similarity=0.348 Sum_probs=198.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHH--HHHHHHHhhcCCCCccceEEEEecCC----eeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF--LVEVLMLSLLHHPNLVNLIGYCADGD----QRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~hpniv~~~~~~~~~~----~~~ 145 (399)
++|.+.+.||+|+||+||+|++. |+.||||++... ..+.+ ..|+..+..++|||||++++++.+++ .+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 45778899999999999999984 899999999643 23333 34566667889999999999998654 579
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCceeecCCCceEEecc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-----KPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
||||||++|+|.++++. .++++..++.++.|++.||+|||++. .++||||||||+||||+.++.+||+||
T Consensus 78 lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 99999999999999985 56999999999999999999999871 123999999999999999999999999
Q ss_pred cCCccCCCCCCcc--eeeeeccCccccCccccccC------CCCcccceeehhHHHHHHHhCCCCcccchHHHH------
Q 015816 221 GLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE------ 286 (399)
Q Consensus 221 g~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------ 286 (399)
|+|+......... .....+||+.|||||++.+. .|+.++|||||||+||||+||.+||........
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 9997643332221 22346799999999998754 477899999999999999999887743221000
Q ss_pred ---HHHHHhhhhhhccccccccccCccccCC-CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 287 ---QSLVAWARPLFQDRTRHSLIADPELQGQ-YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 287 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
............. ...|.+... ........+.+|+.+||+.||++||||.+|++.|+.+..+
T Consensus 233 ~~~~~~~~~~~~~~~~------~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTS------CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccchHHHHHHHHhcc------cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0000000000000 001111111 1123456788999999999999999999999999998764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-55 Score=422.74 Aligned_cols=267 Identities=23% Similarity=0.284 Sum_probs=207.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEec------CCe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQ 143 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~ 143 (399)
++|++.+.||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999999999999999999754332 33568899999999999999999998764 367
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
+|||||||+ |+|.+++.. ..++++.++..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 689999986 678999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCC--CcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 224 KLGPVGD--NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 224 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
+...... ........+||+.|||||++.+. .|+.++||||+||++|||++|++||...........+..........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8643221 12233457899999999998764 57999999999999999999999998766554433332211111000
Q ss_pred ccccc---------ccCcccc----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSL---------IADPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~---------~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..... ...+... ....+....++.+||.+||..||++|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 0000000 0001122347889999999999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-54 Score=408.33 Aligned_cols=201 Identities=25% Similarity=0.347 Sum_probs=172.1
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC---CCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 145 (399)
..++|++.+.||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|+.+ +|||||++++++.+.+++|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999875 467899999986543 345688999999988 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC-CceEEecccCCc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAK 224 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~ 224 (399)
+|||||+||+|.+++. .+++.++..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999985 3899999999999999999999999 9999999999999876 799999999997
Q ss_pred cCCCCCC--------------------------cceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCC
Q 015816 225 LGPVGDN--------------------------THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKA 277 (399)
Q Consensus 225 ~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~p 277 (399)
....... ....+..+||+.|||||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 5322110 0112345799999999998765 589999999999999999999999
Q ss_pred cccch
Q 015816 278 VDTSK 282 (399)
Q Consensus 278 f~~~~ 282 (399)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=430.39 Aligned_cols=252 Identities=22% Similarity=0.278 Sum_probs=212.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+|+.++|||||++++++.+...+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999999999999999997765555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC--CceEEecccCCccCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG--YHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~ 229 (399)
+||+|.++|... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 237 ~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~- 309 (573)
T 3uto_A 237 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 309 (573)
T ss_dssp CCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-
T ss_pred CCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC-
Confidence 999999999642 457999999999999999999999999 9999999999999854 8999999999986432
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
.......+||+.|||||++.+..|+.++|||||||++|||++|.+||...........+..... ....
T Consensus 310 --~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~----------~~~~ 377 (573)
T 3uto_A 310 --KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW----------NMDD 377 (573)
T ss_dssp --TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC----------CCCS
T ss_pred --CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC----------CCCc
Confidence 2233456899999999999999999999999999999999999999987655433222211100 0011
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.... .....+.+||.+||+.||.+|||+.|+++
T Consensus 378 ~~~~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SAFS----GISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGGT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 22347889999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=432.46 Aligned_cols=271 Identities=24% Similarity=0.299 Sum_probs=211.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHH---HHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
++|++.+.||+|+||.||+|+++.+|+.||||++.+... .....+.. ++.+++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 579999999999999999999999999999999965321 11222333 456777789999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
||||||+||+|.++|.. .+.+++..+..|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999987 577999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
.... .....+||+.|||||++.+ ..|+.++|||||||+||||++|.+||..........+..... ..
T Consensus 342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~---~~----- 409 (689)
T 3v5w_A 342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TM----- 409 (689)
T ss_dssp CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---HC-----
T ss_pred cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---CC-----
Confidence 4322 1234689999999999964 589999999999999999999999997643322111111110 00
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHHHHhccCCCcccccCCCCCC
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVTALAYLASQKYESDAEKVQSPCLD 369 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~~l~~~~~~~~~~~~~~~~~~ 369 (399)
. ..++...+.++.+||.+||+.||.+|++ +.||++ ...+....|+........|+..
T Consensus 410 ---~----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~-HpfF~~idW~~l~~~~~~pP~~ 471 (689)
T 3v5w_A 410 ---A----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE-SPFFRSLDWQMVFLQKYPPPLI 471 (689)
T ss_dssp ---C----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT-SGGGTTCCHHHHHTTCSCCSCC
T ss_pred ---C----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc-CccccCCCHHHHHcCCCCcCcc
Confidence 0 1122233448899999999999999998 567653 3334444444443333333333
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=389.52 Aligned_cols=286 Identities=41% Similarity=0.681 Sum_probs=236.8
Q ss_pred CHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCC
Q 015816 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 142 (399)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 142 (399)
++.++...+++|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33444556789999999999999999999975 48999999988766666678999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
..++||||+++|+|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999999865444457999999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
+................||+.|+|||++.+..++.++|||||||++|+|++|+.||.............|...... ...
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 264 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQ 264 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-ccc
Confidence 9764333333333445689999999999999999999999999999999999999976544333333333222111 122
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.....++.+....++..+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 233345555566778888999999999999999999999999999998765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=376.39 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=212.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999999999999999999766555667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999985 46999999999999999999999999 9999999999999999999999999987543222
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||................ . ..
T Consensus 171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~------~~----- 235 (297)
T 3fxz_A 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG--T------PE----- 235 (297)
T ss_dssp --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC--S------CC-----
T ss_pred --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C------CC-----
Confidence 22344679999999999999999999999999999999999999997665433222111000 0 00
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+......+.+|+.+||+.||++|||+.++++
T Consensus 236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0112233447889999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=380.96 Aligned_cols=287 Identities=43% Similarity=0.732 Sum_probs=236.7
Q ss_pred ccccCHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEE
Q 015816 59 AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGY 137 (399)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~ 137 (399)
...+++.++....++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 346788899999999999999999999999999865 4899999998754332 23468899999999999999999999
Q ss_pred EecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCeeecCCCCCceeecCCCc
Q 015816 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK---AKPPVIYRDLKCSNILLDRGYH 214 (399)
Q Consensus 138 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~~~~ivH~Dlkp~Nill~~~~~ 214 (399)
+.+....++||||+++|+|.+++........++++..++.++.||+.||.|||++ + |+||||||+|||++.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCC
Confidence 9999999999999999999999987665566799999999999999999999999 8 999999999999999999
Q ss_pred eEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHH--HHHHHHh
Q 015816 215 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA--EQSLVAW 292 (399)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~ 292 (399)
+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||+...... ......+
T Consensus 173 ~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999997643222 223344569999999999998899999999999999999999999997432211 1122333
Q ss_pred hhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
...... ........+......+++.....+.+++.+||+.||.+|||+.++++.|+..
T Consensus 252 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 252 VKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 333222 2223344455566677888889999999999999999999999999999853
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=380.87 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=210.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++.+.||+|+||.||+|+++.+|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357999999999999999999999999999999996532 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999986 567999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|..||...........+. ...
T Consensus 157 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~~~------- 221 (337)
T 1o6l_A 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------MEE------- 221 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-------
T ss_pred cC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH------cCC-------
Confidence 21 222345679999999999999999999999999999999999999997655433222111 000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 347 (399)
. .++......+.+||.+||+.||.+|| ++.++++.
T Consensus 222 -~----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 -I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -C----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0 11222334889999999999999999 89998863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=377.44 Aligned_cols=259 Identities=26% Similarity=0.410 Sum_probs=214.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57889999999999999999999999999999987665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999863 467999999999999999999999999 99999999999999999999999999976432221
Q ss_pred cc------------eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHH---HHHHhhhhh
Q 015816 232 TH------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ---SLVAWARPL 296 (399)
Q Consensus 232 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~ 296 (399)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH--
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc--
Confidence 11 111457999999999999999999999999999999999999998643221100 0000000
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
...++..+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 242 ----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 242 ----------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ----------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 011122223788899999999999999999999999988754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=380.67 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=210.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
..+|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4679999999999999999999999999999999975432 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999987 567999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCcceeeeeccCccccCccccccCCCC-cccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||............... .
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------~------- 230 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------K------- 230 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------C-------
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------C-------
Confidence 22 22345799999999999888775 7999999999999999999999876544332222110 0
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...+......+.+|+.+||+.||.+|||+.++++.
T Consensus 231 -----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 -----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111223478899999999999999999999863
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=379.93 Aligned_cols=252 Identities=25% Similarity=0.290 Sum_probs=210.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|++.+.||+|+||.||+|.++.+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46799999999999999999999999999999999764332 246789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC----ceEEecc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDF 220 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Df 220 (399)
++||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999976 567999999999999999999999999 99999999999998876 7999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
|++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------ 234 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS------ 234 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC------
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------
Confidence 9997643322 2234579999999999999999999999999999999999999998765433222111000
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
....+.....+ ...+.+||.+||..||.+|||+.++++
T Consensus 235 ----~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 ----YDFDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----CCCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CCCCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00011111222 347889999999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=373.27 Aligned_cols=264 Identities=31% Similarity=0.469 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
..+|++.+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 467999999999999999999874 789999999765433 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 114 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp ECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred ecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 99999999999985210 123999999999999999999999886 3499999999999999999999999999975322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||................ ..
T Consensus 192 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~------------~~ 257 (309)
T 3p86_A 192 --TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC------------KR 257 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC------------CC
T ss_pred --cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------------CC
Confidence 1222334579999999999999999999999999999999999999998765443322211000 00
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccC
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 356 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 356 (399)
. ..+......+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus 258 ~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 258 L----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred C----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 1 1222233478999999999999999999999999998876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=382.98 Aligned_cols=250 Identities=28% Similarity=0.399 Sum_probs=204.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 145 (399)
..++|++.+.||+|+||.||+|+++.+++.||||++.... ......+..|..++..+ +||||+++++++.+.+.+|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999999999999999997532 12345678899999988 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+||||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999987 567999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
... ........+||+.|+|||++.+..++.++|||||||++|||++|..||...........+. ...
T Consensus 174 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~~----- 240 (353)
T 3txo_A 174 GIC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL------NDE----- 240 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-----
T ss_pred ccc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH------cCC-----
Confidence 222 2223345679999999999999999999999999999999999999998765543222211 100
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI------ADVVT 346 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~ 346 (399)
..++......+.+|+.+||+.||.+||++ .++++
T Consensus 241 -------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 -------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01122233478899999999999999998 66664
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=374.97 Aligned_cols=262 Identities=27% Similarity=0.382 Sum_probs=213.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCe---EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
..+|++.+.||+|+||.||+|.+..+++ .||||++..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 3579999999999999999999975444 599999975433 234578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999752 457999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCc-ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 227 PVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 227 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||............... .
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-------~--- 271 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-------Y--- 271 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-------C---
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-------C---
Confidence 332221 12223456788999999999999999999999999999999 99999776544332221100 0
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
. ...+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 272 ---~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 272 ---R----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ---C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ---C----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 0 0112223348899999999999999999999999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=369.48 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=217.1
Q ss_pred cccCHHHHHHHhcC----------CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCC
Q 015816 60 QTLTFRELAAATKN----------FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP 129 (399)
Q Consensus 60 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp 129 (399)
..++++++..+++. |+..+.||+|+||.||+|.+..+|+.||||++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45677777766654 77778999999999999999989999999999876666667899999999999999
Q ss_pred CccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 015816 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 130 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill 209 (399)
||+++++++...+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 999999999999999999999999999999874 56999999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH
Q 015816 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 289 (399)
+.++.+||+|||++...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp CTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCCCcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999998754322 1223446799999999999999999999999999999999999999976544332211
Q ss_pred HHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 290 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. .... .+.+ .........+.+++.+||+.||++|||+.++++.
T Consensus 253 ~---~~~~----------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 L---RDSP----------PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp H---HHSS----------CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H---hcCC----------CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1000 0000 0111223478899999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=382.02 Aligned_cols=265 Identities=25% Similarity=0.384 Sum_probs=215.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-------CCCeEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCccceEEEEecC
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLE-------SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 141 (399)
.++|++.+.||+|+||.||+|.+. .++..||||++...... ..+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367999999999999999999874 34568999999755332 335789999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill 209 (399)
+.+|+||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999986431 1245899999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHH
Q 015816 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~ 288 (399)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986443332222333457889999999999999999999999999999999 999997654322211
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 289 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
.. . ... . ...+......+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 317 ~~---~----~~~------~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 317 LL---K----EGH------R----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HH---H----TTC------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH---h----cCC------C----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11 0 000 0 1112233348899999999999999999999999999887543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=384.07 Aligned_cols=265 Identities=25% Similarity=0.373 Sum_probs=213.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.++.+++.||||++.... ....+.+.+|+.+++.++|||||++++++.+...+|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999986432 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+.||+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999986 567999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceeeeeccCccccCcccccc---CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..................
T Consensus 168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--------- 235 (384)
T 4fr4_A 168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--------- 235 (384)
T ss_dssp T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---------
T ss_pred C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---------
Confidence 2 22345679999999999863 46899999999999999999999999754332222222111110
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCC-HHHHHHHHHHHHhccCCCcccc
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-IADVVTALAYLASQKYESDAEK 362 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~L~~l~~~~~~~~~~~ 362 (399)
. ..++......+.+||.+||+.||.+||+ +.+++ ....+....|+.....
T Consensus 236 --~----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~-~hp~f~~~~w~~~~~~ 286 (384)
T 4fr4_A 236 --V----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ-NFPYMNDINWDAVFQK 286 (384)
T ss_dssp --C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH-TSGGGTTCCHHHHHTT
T ss_pred --c----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH-cChhhhcCCHHHHHhC
Confidence 0 1122233448899999999999999998 55544 4444444444433333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=367.91 Aligned_cols=262 Identities=26% Similarity=0.336 Sum_probs=210.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35799999999999999999999999999999998654332 235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||++|++|.+++.. ..++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999987 567999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ....
T Consensus 163 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~------~~~~------- 228 (294)
T 4eqm_A 163 ETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH------IQDS------- 228 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH------HSSC-------
T ss_pred ccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------hhcc-------
Confidence 221 12223456999999999999999999999999999999999999999876543321110 0000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHh
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-VIADVVTALAYLAS 353 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~~ 353 (399)
.+.......+..+..+.+++.+||+.||.+|| +++++++.|..+..
T Consensus 229 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00111111222334889999999999999998 89999999986654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=384.41 Aligned_cols=254 Identities=20% Similarity=0.226 Sum_probs=209.7
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
..++|++.+.||+|+||.||+|.++.+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456899999999999999999999999999999999765432 335688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec---CCCceEEecccCCc
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLAK 224 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~ 224 (399)
|||++||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999987 567999999999999999999999999 99999999999998 46789999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|.+||..................
T Consensus 162 ~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-------- 231 (444)
T 3soa_A 162 EVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-------- 231 (444)
T ss_dssp CCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------
T ss_pred EecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--------
Confidence 54322 22233467999999999999999999999999999999999999999776543332222111000
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. .....+..+..+.+|+.+||+.||.+|||+.++++
T Consensus 232 -~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 -F-----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -C-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -C-----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 00011122347889999999999999999999996
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=380.39 Aligned_cols=250 Identities=30% Similarity=0.439 Sum_probs=208.2
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhc-CCCCccceEEEEecCCee
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 144 (399)
...++|++.+.||+|+||.||+|+++.+|+.||||++.... ......+..|..++..+ +||||+++++++.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999999999999999997532 22345678899999876 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
|+||||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999986 467999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...........+...
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 233 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD----------- 233 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 532221 2234567999999999999999999999999999999999999999876543322211100
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIA-DVV 345 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil 345 (399)
.+ .++......+.+||.+||+.||.+||++. +++
T Consensus 234 ---~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 ---NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 01 11222334789999999999999999997 554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=376.33 Aligned_cols=256 Identities=20% Similarity=0.250 Sum_probs=208.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccC-----CCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-----GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
.++|++.+.||+|+||.||+|.++.+++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45799999999999999999999999999999998632 1223567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc---eEEecccC
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGL 222 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~ 222 (399)
+||||++|++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888754333456999999999999999999999999 999999999999986654 99999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
+...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||............. . .
T Consensus 180 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~---~----~-- 248 (351)
T 3c0i_A 180 AIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK---G----K-- 248 (351)
T ss_dssp CEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHH---T----C--
T ss_pred eeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHc---C----C--
Confidence 9764322 222334579999999999999999999999999999999999999998754321111110 0 0
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
....+.....+ +..+.+|+.+||+.||++|||+.++++
T Consensus 249 --~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 --YKMNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCCCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCCCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00011111122 347899999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=370.86 Aligned_cols=252 Identities=24% Similarity=0.299 Sum_probs=209.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|++.+.||+|+||.||+|.++.+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35699999999999999999999999999999999754322 346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC----ceEEecc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDF 220 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Df 220 (399)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999976 567999999999999999999999999 99999999999999887 8999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----- 234 (326)
T 2y0a_A 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY----- 234 (326)
T ss_dssp TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC-----
T ss_pred CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC-----
Confidence 9997643222 22345699999999999999999999999999999999999999976554332221111100
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.........+ +..+.+|+.+||+.||.+|||+.++++
T Consensus 235 -----~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 -----EFEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -----CCCHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CcCccccccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0001111122 337889999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=370.05 Aligned_cols=253 Identities=17% Similarity=0.220 Sum_probs=210.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999999999999999987442 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC--CCceEEecccCCccCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~~ 228 (399)
++|++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999752 357999999999999999999999999 999999999999987 78999999999986432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||................. ...
T Consensus 157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----------~~~ 223 (321)
T 1tki_A 157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY----------TFD 223 (321)
T ss_dssp T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC----------CCC
T ss_pred C---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCC----------CCC
Confidence 2 223456799999999999998899999999999999999999999987654332221111000 001
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
......+ +..+.+|+.+||..||.+|||+.++++.
T Consensus 224 ~~~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 224 EEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhhccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111122 3478899999999999999999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=381.05 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=203.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 146 (399)
.++|++.+.||+|+||.||+|+++.+++.||||++.+.... ..+.+..|..++.++ +||||+++++++.+...+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 46799999999999999999999999999999999754322 234578899999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||++||+|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999987 567999999999999999999999999 999999999999999999999999999752
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHH--HHHH-hhhhhhcccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--SLVA-WARPLFQDRTRH 303 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~-~~~~~~~~~~~~ 303 (399)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... ........
T Consensus 204 ~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---- 277 (396)
T 4dc2_A 204 LR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---- 277 (396)
T ss_dssp CC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC----
T ss_pred cc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc----
Confidence 22 222344568999999999999999999999999999999999999999643221110 0000 00000110
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 341 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 341 (399)
. ..++......+.+||.+||+.||.+||++
T Consensus 278 ----~----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 ----Q----IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----C----CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----c----cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0 11222334478999999999999999996
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=376.62 Aligned_cols=254 Identities=19% Similarity=0.257 Sum_probs=209.7
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
..++|++.+.||+|+||.||+|.++.+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456899999999999999999999999999999999765432 335688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC---CceEEecccCCc
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLAK 224 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~~~ 224 (399)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999976 567999999999999999999999999 9999999999999865 459999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||................ +.
T Consensus 180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~------ 248 (362)
T 2bdw_A 180 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--YD------ 248 (362)
T ss_dssp CCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CC------
T ss_pred EecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CC------
Confidence 643221 2234579999999999999999999999999999999999999997655433222111100 00
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
... ......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 249 -~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 -YPS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CCT-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0011223478999999999999999999999853
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=383.99 Aligned_cols=260 Identities=27% Similarity=0.384 Sum_probs=213.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.++|++.+.||+|+||.||+|.++.+++.||||++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 45788999999999999999999988999999998754222 23468889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 193 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999752 346899999999999999999999999 999999999999999999999999999753221
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
..........++..|+|||++.+..++.++|||||||++|||++ |..||.............. ...
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~-------~~~------ 333 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-------GGR------ 333 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT-------TCC------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------CCC------
Confidence 11111112235778999999998999999999999999999998 9999987654433222110 000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
...+...+..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 334 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 334 ----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 01122233478899999999999999999999999998865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=372.33 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=207.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999999999999999998654332 23568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999976 567999999999999999999999999 999999999999999999999999999754333
Q ss_pred CCcceeeeeccCccccCccccccCCC-CcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...+... . ..
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~----~----~~-- 227 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK----K----TY-- 227 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTT----C----TT--
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcc----c----cc--
Confidence 32333345679999999999987775 78999999999999999999999764432111 1111100 0 00
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..........+.+|+.+||+.||.+|||+.|+++.
T Consensus 228 ----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00011233478899999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=376.65 Aligned_cols=267 Identities=26% Similarity=0.358 Sum_probs=207.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCC----eeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~l 146 (399)
.++|++.+.||+|+||.||+|.+. ++.||||++.... .....+..|+.+++.++||||+++++++.+.. .+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 367999999999999999999886 7999999996442 22344567899999999999999999998754 3699
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeeecCCCCCceeecCCCceE
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK----------AKPPVIYRDLKCSNILLDRGYHPK 216 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------~~~~ivH~Dlkp~Nill~~~~~~k 216 (399)
||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999975 4599999999999999999999999 8 99999999999999999999
Q ss_pred EecccCCccCCCCCCcceeeeeccCccccCcccccc-----CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH--
Q 015816 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-- 289 (399)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-- 289 (399)
|+|||++................||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999976443333333334579999999999976 3566789999999999999999999975322110000
Q ss_pred --------HHhhhhhhccccccccccCccccCC-CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 290 --------VAWARPLFQDRTRHSLIADPELQGQ-YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 290 --------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.......... ...+.+... ........+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHK------KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHCSSCCHHHHHHHHTTS------CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcc------cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000000 001111110 1123445699999999999999999999999999988753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=374.12 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=207.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 145 (399)
...+|++.+.||+|+||.||+|+++.+++.||||++.... ....+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468999999999999999999999999999999997532 22346678899999887 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+||||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 98 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999986 467999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ...
T Consensus 171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~~----- 237 (353)
T 2i0e_A 171 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHN----- 237 (353)
T ss_dssp CCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-----
T ss_pred cccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH------hCC-----
Confidence 2221 222345679999999999999999999999999999999999999998765433221111 100
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 346 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 346 (399)
. .++......+.+||.+||+.||.+||+ +.++++
T Consensus 238 ---~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 ---V----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---C----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---C----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 112233348899999999999999995 456653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=369.75 Aligned_cols=246 Identities=29% Similarity=0.399 Sum_probs=208.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999999999999999996532 22346678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999987 567999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
. .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+ ....
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~------- 219 (318)
T 1fot_A 158 D-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LNAE------- 219 (318)
T ss_dssp S-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHCC-------
T ss_pred C-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC-------
Confidence 2 123457999999999999999999999999999999999999999765543222111 1100
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
..+++.....+.+|+.+||+.||.+|| ++.++++
T Consensus 220 -----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 -----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 012222334889999999999999999 8888874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=368.56 Aligned_cols=264 Identities=20% Similarity=0.183 Sum_probs=212.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 149 (399)
..+|++.+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3579999999999999999999999999999999875432 34578899999999 99999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc-----eEEecccCCc
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-----PKLSDFGLAK 224 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~Dfg~~~ 224 (399)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 89999999863 467999999999999999999999999 999999999999998887 9999999998
Q ss_pred cCCCCCCcc-----eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 225 LGPVGDNTH-----VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 225 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
......... ......||+.|+|||++.+..++.++|||||||++|||++|..||.....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 643322211 123567999999999999999999999999999999999999999864332221111111100000
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
. ....... ..+ .+.+++..||+.||.+||++.+|++.|+.+...
T Consensus 239 ~-------~~~~~~~---~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 239 T-------PIEVLCE---NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp S-------CHHHHTT---TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred C-------CHHHHhc---cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 0 0000001 112 788999999999999999999999999887654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=363.33 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=200.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--------------------------chHHHHHHHHHHh
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------------------------GNREFLVEVLMLS 124 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~ 124 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36799999999999999999999999999999998654321 1246889999999
Q ss_pred hcCCCCccceEEEEec--CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC
Q 015816 125 LLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL 202 (399)
Q Consensus 125 ~l~hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dl 202 (399)
.++||||+++++++.+ ....++||||+++++|.+++. ..++++..++.++.||+.||.|||+++ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999987 568999999999999987654 457999999999999999999999999 999999
Q ss_pred CCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCC---CCcccceeehhHHHHHHHhCCCCcc
Q 015816 203 KCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAVD 279 (399)
Q Consensus 203 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~g~~pf~ 279 (399)
||+|||++.++.+||+|||++...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999764322 22234457999999999997655 4788999999999999999999998
Q ss_pred cchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 280 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
............ .... ..+ ..+..+..+.+|+.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~------~~~~-----~~~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMCLHSKIK------SQAL-----EFP-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHHHHHHHH------HCCC-----CCC-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHHHHHHHh------cccC-----CCC-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 654432211110 0000 000 01122347899999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=370.79 Aligned_cols=271 Identities=23% Similarity=0.344 Sum_probs=199.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCe---EEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCCee-
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR- 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~- 144 (399)
.++|++.+.||+|+||.||+|.+..++. .||||++.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4679999999999999999999887665 89999987542 23456789999999999999999999999887655
Q ss_pred -----EEEEEecCCCCHHHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEE
Q 015816 145 -----LLVYEYMPLGSVEDHLHDLSP--GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (399)
Q Consensus 145 -----~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 217 (399)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 999999999999999975321 2236999999999999999999999999 999999999999999999999
Q ss_pred ecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhh
Q 015816 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~----- 253 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI----- 253 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-----
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-----
Confidence 99999976433333333334557889999999999999999999999999999999 999998654432221110
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccCCCccc
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAE 361 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~ 361 (399)
... . ...++..+..+.+|+.+||+.||.+|||+.++++.|+.+....|.....
T Consensus 254 -~~~-------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 254 -GGN-------R----LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp -TTC-------C----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred -cCC-------C----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 000 0 1112233348899999999999999999999999999999877655543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=361.18 Aligned_cols=266 Identities=18% Similarity=0.237 Sum_probs=204.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||.||+|.++.+++.||||++...... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999999999999999999755432 23678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++ +|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9985 666665542 467999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcceeeeeccCccccCccccccCC-CCcccceeehhHHHHHHHhCCCCcc-cchHHHHHHHHHhhhhhhcccc--cccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVD-TSKAAAEQSLVAWARPLFQDRT--RHSL 305 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~--~~~~ 305 (399)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||. ...................... ....
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22233457899999999987765 8999999999999999999888754 3332222111111100000000 0000
Q ss_pred ---------ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 ---------IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 ---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...........+.....+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000111222334558899999999999999999999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=372.05 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=202.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 147 (399)
++|++.+.||+|+||.||+|+++.+++.||||++...... ..+.+.+|+.++..+ +||||+++++++.+...+|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5799999999999999999999999999999999765332 234578899999887 899999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999986 467999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHH---HHHHhhhhhhccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ---SLVAWARPLFQDRTRHS 304 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~ 304 (399)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .............
T Consensus 162 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 235 (345)
T 3a8x_A 162 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 235 (345)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred CC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence 21 22234567999999999999999999999999999999999999999653221100 0000000001100
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 341 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 341 (399)
..++......+.+|+.+||+.||.+||++
T Consensus 236 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 --------IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11222334478999999999999999996
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=360.34 Aligned_cols=285 Identities=39% Similarity=0.625 Sum_probs=225.6
Q ss_pred ccccCHHHHHHHhcCCCCC------CeeeecCceEEEEEEECCCCeEEEEEEeccCC----CcchHHHHHHHHHHhhcCC
Q 015816 59 AQTLTFRELAAATKNFRSE------SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG----VQGNREFLVEVLMLSLLHH 128 (399)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h 128 (399)
...+++.++...+.+|... +.||+|+||.||+|.+ +++.||||++.... ....+.+.+|+.+++.++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4567889999999888777 8999999999999987 47899999986532 1234678899999999999
Q ss_pred CCccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcee
Q 015816 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (399)
Q Consensus 129 pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nil 208 (399)
|||+++++++.+.+..++||||+++++|.+++..... ..++++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 9999999999999999999999999999999975322 456999999999999999999999999 999999999999
Q ss_pred ecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHH
Q 015816 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (399)
Q Consensus 209 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 288 (399)
++.++.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 99999999999999976443333333344679999999998865 58999999999999999999999997643321111
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 289 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.. ...............++.+ ...+......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 245 ~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DI--KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HH--HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HH--HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 00 0000000000011111111 23456677889999999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=375.96 Aligned_cols=269 Identities=27% Similarity=0.383 Sum_probs=215.2
Q ss_pred HHHHHhcCCCCCCeeeecCceEEEEEE-----ECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCccceEEEE
Q 015816 66 ELAAATKNFRSESLLGEGGFGRVYKGY-----LESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYC 138 (399)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~~~~~~ 138 (399)
......++|++.+.||+|+||.||+|. +..+++.||||++...... ..+.+.+|+.++..+ +||||+++++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 334456789999999999999999999 5566799999999764332 335689999999999 789999999999
Q ss_pred ecCCe-eEEEEEecCCCCHHHHhhccCCC---------------------------------------------------
Q 015816 139 ADGDQ-RLLVYEYMPLGSVEDHLHDLSPG--------------------------------------------------- 166 (399)
Q Consensus 139 ~~~~~-~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------- 166 (399)
.+.+. .++||||+++|+|.+++......
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 87654 89999999999999999864321
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCccee
Q 015816 167 -----------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235 (399)
Q Consensus 167 -----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 235 (399)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++............
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 122899999999999999999999999 999999999999999999999999999865444433444
Q ss_pred eeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCC
Q 015816 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ 314 (399)
Q Consensus 236 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
....||+.|+|||++.+..++.++|||||||++|||++ |..||........... ... ... . ..
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--~~~----~~~------~----~~ 316 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--RLK----EGT------R----MR 316 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH--HHH----HTC------C----CC
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH--HHH----cCC------C----CC
Confidence 55678999999999999999999999999999999998 9999976543211110 000 000 0 01
Q ss_pred CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 315 YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 315 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.+......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 112223478999999999999999999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=375.02 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=211.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.++.+++.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999999999999999999766544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC--CCceEEecccCCccCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~~ 228 (399)
+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999999752 347999999999999999999999999 999999999999974 57899999999986432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||............... . ....
T Consensus 204 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~------~----~~~~ 270 (387)
T 1kob_A 204 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC------D----WEFD 270 (387)
T ss_dssp T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC------C----CCCC
T ss_pred C---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------C----CCCC
Confidence 2 2233457999999999999999999999999999999999999999876543322111100 0 0001
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
+. .....+..+.+||.+||+.||.+|||+.++++.
T Consensus 271 ~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 ED----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SS----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11 112233488999999999999999999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=379.83 Aligned_cols=264 Identities=28% Similarity=0.392 Sum_probs=212.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-----CCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|++.+.||+|+||.||+|.+ ..++..||||++..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35799999999999999999994 45678999999865432 2345688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC---ceEEe
Q 015816 145 LLVYEYMPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLS 218 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~ 218 (399)
++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986432 2346999999999999999999999999 99999999999999554 59999
Q ss_pred cccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhh
Q 015816 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF 297 (399)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~ 297 (399)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||................
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~--- 303 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG--- 303 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence 9999874322222222334568999999999999999999999999999999998 999998765543322221100
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.. ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 304 ----------~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 304 ----------RM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ----------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----------CC----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 00 11122234788999999999999999999999999988764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=367.68 Aligned_cols=268 Identities=26% Similarity=0.397 Sum_probs=210.9
Q ss_pred hcCCCCCCeeeecCceEEEEEE----ECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecC--Cee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 144 (399)
.++|++.+.||+|+||.||+|+ +..+++.||||++........+.+.+|+.+++.++||||+++++++... ..+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 3679999999999999999998 5668999999999866555557789999999999999999999998653 568
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999862 345999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCc-ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH---------Hhhh
Q 015816 225 LGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV---------AWAR 294 (399)
Q Consensus 225 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~---------~~~~ 294 (399)
........ .......++..|+|||++.+..++.++|||||||++|+|++|..||............ ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 64332211 1223345778899999999999999999999999999999999998765432111000 0000
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
...... .....+...+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 243 ~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 243 ELLKNN----------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHTT----------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhcc----------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 000000 01112223345899999999999999999999999999988754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=371.28 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=205.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeE----EEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.+|++.+.||+|+||.||+|.+..+++. ||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 5699999999999999999999877765 4777775432 234567899999999999999999999998764 789
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
|+||+.+|+|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 94 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999863 457999999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.............||+.|+|||++.+..++.++|||||||++|||++ |..||................
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----------- 236 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----------- 236 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----------
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-----------
Confidence 44433333344567889999999999999999999999999999999 999998655433222221100
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
....++.....+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0111223344789999999999999999999999999988754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=379.71 Aligned_cols=271 Identities=21% Similarity=0.270 Sum_probs=214.5
Q ss_pred HHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCC
Q 015816 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 142 (399)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 142 (399)
++....++|++.+.||+|+||.||+|+++.+++.||+|++.+.. ......+..|+.+++.++||||+++++++.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 33344678999999999999999999999999999999986421 122345788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
.+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999975 46899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccccCC----CCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhc
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ----LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 298 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 298 (399)
+....... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+......+.
T Consensus 215 a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 293 (410)
T 3v8s_A 215 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293 (410)
T ss_dssp CEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc
Confidence 97543221 12233567999999999997655 88999999999999999999999987654433222211110000
Q ss_pred cccccccccCccccCCCChHhHHHHHHHHHHccccCCCC--CCCHHHHHHHHHHHHhccCCCcc
Q 015816 299 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTALAYLASQKYESDA 360 (399)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L~~l~~~~~~~~~ 360 (399)
.+. .......+.+||.+||..+|.+ ||++.||++. ..+....|....
T Consensus 294 ---------~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H-p~f~~~~w~~~~ 342 (410)
T 3v8s_A 294 ---------FPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH-LFFKNDQWAWET 342 (410)
T ss_dssp ---------CCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS-GGGCCSSCCSTT
T ss_pred ---------CCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC-ccccCCCHHHHh
Confidence 000 0112337889999999999988 9999999864 233444444333
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=371.99 Aligned_cols=245 Identities=24% Similarity=0.280 Sum_probs=208.0
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999986 467999999999999999999999999 99999999999999999999999999985322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+. ...
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~~~-------- 254 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV------SGK-------- 254 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC--------
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH------cCC--------
Confidence 1 234579999999999999999999999999999999999999998765433221111 000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 346 (399)
. .++......+.+||.+||+.||.+||+ +.++++
T Consensus 255 ~----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0 112223348899999999999999998 777775
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=373.27 Aligned_cols=268 Identities=26% Similarity=0.374 Sum_probs=218.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC-------CCeEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCccceEEEEecC
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 141 (399)
.++|++.+.||+|+||.||+|.+.. .+..||||++...... ....+.+|+.+++.+ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4679999999999999999999753 3467999999765332 336788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill 209 (399)
+..++||||+++|+|.+++..... ....+++..++.|+.||+.||.|||+++ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999986431 1245999999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHH
Q 015816 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~ 288 (399)
+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999986544333333344567899999999999999999999999999999999 999998765443322
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccCCC
Q 015816 289 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYES 358 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~ 358 (399)
..... . .. ..+......+.+|+.+||+.||.+|||+.++++.|+.+.......
T Consensus 305 ~~~~~-------~------~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 305 LLKEG-------H------RM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHTT-------C------CC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHcC-------C------CC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 21100 0 00 111222347899999999999999999999999999987654333
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=369.73 Aligned_cols=249 Identities=25% Similarity=0.333 Sum_probs=206.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
..+|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 357999999999999999999999999999999986432 12345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+ +|+|.+++.. ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 6899999986 567999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCcceeeeeccCccccCccccccCCC-CcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... .......
T Consensus 160 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------~~~~i~~--- 222 (336)
T 3h4j_B 160 DG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----------LFKKVNS--- 222 (336)
T ss_dssp TS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------CBCCCCS---
T ss_pred CC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----------HHHHHHc---
Confidence 22 22234579999999999988776 689999999999999999999997642210 0000000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
.....+...+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus 223 ----~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 223 ----CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp ----SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred ----CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 00122233345789999999999999999999999743
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=365.69 Aligned_cols=264 Identities=28% Similarity=0.411 Sum_probs=215.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-----CCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|++.+.||+|+||.||+|.+ +.++..||||++..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46799999999999999999998 34568999999975432 2346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 015816 145 LLVYEYMPLGSVEDHLHDLSP--------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 204 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp 204 (399)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999986432 1234899999999999999999999999 99999999
Q ss_pred CceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchH
Q 015816 205 SNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 283 (399)
Q Consensus 205 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~ 283 (399)
+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999976443333223334567889999999999999999999999999999999 9999976544
Q ss_pred HHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 284 AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
........ . .. . ...+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 259 ~~~~~~~~---~----~~------~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ERLFNLLK---T----GH------R----MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGHHHHHH---T----TC------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHhh---c----CC------c----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 32211111 0 00 0 011222334889999999999999999999999999987653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=371.54 Aligned_cols=265 Identities=27% Similarity=0.422 Sum_probs=214.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-----CCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCe
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 143 (399)
..++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999997 34589999999755332 34568999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPG--------------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 203 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlk 203 (399)
.++||||+++++|.+++...... ...+++.+++.++.||+.||.|||+++ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 99999999999999999864321 267999999999999999999999999 9999999
Q ss_pred CCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccch
Q 015816 204 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSK 282 (399)
Q Consensus 204 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~ 282 (399)
|+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999875332222222334568999999999999999999999999999999999 999997655
Q ss_pred HHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 283 AAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
......... ... . + ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 282 ~~~~~~~~~-------~~~-~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 282 HEEVIYYVR-------DGN-I-----L----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHHHHHHHH-------TTC-C-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred hHHHHHHHh-------CCC-c-----C----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 433221110 000 0 0 11222334889999999999999999999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=364.46 Aligned_cols=270 Identities=21% Similarity=0.300 Sum_probs=195.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
..+|++.+.||+|+||.||+|.++.+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4579999999999999999999999999999999975432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 150 YMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|++ ++|.+++.... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999987532 12346999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc-
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL- 305 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 305 (399)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........................
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 221 12234568999999999876 46899999999999999999999999876654433222111100000000000
Q ss_pred ---ccCccc------------cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 ---IADPEL------------QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 ---~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+.+ ...........+.+|+.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000 00011122347899999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=386.24 Aligned_cols=272 Identities=26% Similarity=0.355 Sum_probs=209.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccC---CCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35799999999999999999999999999999999753 222345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||++...
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999986 5679999999999999999999998 88 999999999999999999999999999752
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ..
T Consensus 300 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~------ 365 (446)
T 4ejn_A 300 IK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EE------ 365 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CC------
T ss_pred cC--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh------CC------
Confidence 22 22223456799999999999999999999999999999999999999977654433222210 00
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHHHHhccCCCcccccCCCCCCC
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTALAYLASQKYESDAEKVQSPCLDP 370 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~~l~~~~~~~~~~~~~~~~~~~ 370 (399)
. .++......+.+||.+||+.||.+|| ++.++++. ..+....|.........|+..|
T Consensus 366 --~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h-p~f~~~~~~~~~~~~~~pp~~p 427 (446)
T 4ejn_A 366 --I----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH-RFFAGIVWQHVYEKKLSPPFKP 427 (446)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS-GGGTTCCHHHHHTTCSCCSCCC
T ss_pred --C----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC-ccccCCCHHHHhhCcCCCCccC
Confidence 0 11222334789999999999999999 99999853 2233334444444444444444
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=373.98 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=202.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC---CCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
..+|++.+.||+|+||.||+|+++ .++..||||++..... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999987 4577899999975432 234578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 124 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999752 457999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcc-eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 227 PVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 227 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||............ ....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i---~~~~------- 267 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV---DEGY------- 267 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH---HTTE-------
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCC-------
Confidence 3322111 1122345788999999999999999999999999999998 99999765543322211 1000
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
....+...+..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus 268 -------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 268 -------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0111122334789999999999999999999999999988764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=361.84 Aligned_cols=274 Identities=18% Similarity=0.213 Sum_probs=213.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCC--eeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv 147 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3579999999999999999999999999999999975432 33567889999999999999999999998765 78999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee----cCCCceEEecccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLA 223 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~~ 223 (399)
|||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999986332 234999999999999999999999999 9999999999999 78888999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccc--------cCCCCcccceeehhHHHHHHHhCCCCcccchHHHH-HHHH-Hhh
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAK--------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLV-AWA 293 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~-~~~ 293 (399)
....... ......||+.|+|||++. +..++.++|||||||++|||++|..||........ .... ...
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 7643322 223456999999999886 57899999999999999999999999964332111 1111 111
Q ss_pred hhhhccccc-cccc--------cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 294 RPLFQDRTR-HSLI--------ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 294 ~~~~~~~~~-~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
......... .... ................+.+++.+||+.||++|||+.|+++....-
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 110000000 0000 000111234566777899999999999999999999999887744
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=356.04 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=212.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||+|.+.. ++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 578999999999999999999875 7889999997543 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 160 (269)
T 4hcu_A 88 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 160 (269)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred CCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-
Confidence 999999999752 456999999999999999999999999 9999999999999999999999999997532211
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..||............... . .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~---~----------~-- 225 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---F----------R-- 225 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---C----------C--
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC---c----------c--
Confidence 111223456788999999999999999999999999999999 99999876544322211100 0 0
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
...+......+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 --LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 011112234788999999999999999999999999988753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=376.25 Aligned_cols=247 Identities=26% Similarity=0.318 Sum_probs=198.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHH-HhhcCCCCccceEEEEecCCeeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.++|++.+.||+|+||.||+|+++.+++.||||++.+.... ....+..|..+ ++.++||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999765332 23456667776 577899999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999986 567999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
... .......+||+.|+|||++.+..++.++|||||||++|||++|..||...........+ ....
T Consensus 190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~~~------ 255 (373)
T 2r5t_A 190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI------LNKP------ 255 (373)
T ss_dssp BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH------HHSC------
T ss_pred ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------Hhcc------
Confidence 221 12234567999999999999999999999999999999999999999876543322111 1100
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 344 (399)
..+++.....+.+||.+||+.||.+||++.+.
T Consensus 256 ------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 256 ------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp ------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred ------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 01122233478999999999999999998643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=368.14 Aligned_cols=259 Identities=26% Similarity=0.441 Sum_probs=208.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeE----EEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
++|++.+.||+|+||.||+|.+..+++. ||+|.+.... ......+.+|+.+++.++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 5789999999999999999999887776 7777775432 223355778999999999999999999986 457899
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999752 357899999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.............||..|+|||++.+..++.++|||||||++|+|++ |..||.................
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------- 235 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER---------- 235 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB----------
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----------
Confidence 54444444455678889999999999999999999999999999999 9999987554333222211100
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
. ..+......+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 236 ~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 236 L-------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp C-------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred C-------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 00111122567799999999999999999999999988654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=358.17 Aligned_cols=265 Identities=21% Similarity=0.285 Sum_probs=201.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||.||+|.+ .+++.||||++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4789999999999999999999 56899999999654322 23678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|++ ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLD-QDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCS-EEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 998 5999988752 367999999999999999999999999 999999999999999999999999998753221
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc--cc--cc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR--TR--HS 304 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~--~~ 304 (399)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...................... .. ..
T Consensus 154 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 112234568999999999865 468999999999999999999999998765443322211110000000 00 00
Q ss_pred cccCcccc-------CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 305 LIADPELQ-------GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 305 ~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...++.+. ..........+.+|+.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 0111223457889999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=366.31 Aligned_cols=249 Identities=25% Similarity=0.338 Sum_probs=198.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC---CCCeEEEEEEeccCCC----cchHHHHHHHHHHhhcCCCCccceEEEEecCCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 143 (399)
.++|++.+.||+|+||.||+|++. .+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 357999999999999999999985 6799999999976432 233457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999986 567999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||............. ...
T Consensus 169 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------~~~--- 237 (327)
T 3a62_A 169 KESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL------KCK--- 237 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HTC---
T ss_pred cccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hCC---
Confidence 742211 122334579999999999999999999999999999999999999998765433221111 000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
...++.....+.+|+.+||+.||.+|| ++.++++
T Consensus 238 ---------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 ---------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011222334889999999999999999 7777775
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=370.10 Aligned_cols=267 Identities=26% Similarity=0.378 Sum_probs=211.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-----CCCCeEEEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCccceEEEEecCCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 143 (399)
.++|++.+.||+|+||.||+|.+ ..++..||||++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46799999999999999999997 3457789999997542 23456789999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPG-------------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 204 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp 204 (399)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 99999999999999999863211 134899999999999999999999999 99999999
Q ss_pred CceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchH
Q 015816 205 SNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 283 (399)
Q Consensus 205 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~ 283 (399)
+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999976443333333444568899999999999999999999999999999998 9999976543
Q ss_pred HHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccC
Q 015816 284 AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 356 (399)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 356 (399)
.... ..... ... . ...+...+..+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus 281 ~~~~--~~~~~----~~~------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 281 DANF--YKLIQ----NGF------K----MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp SHHH--HHHHH----TTC------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHHH--HHHHh----cCC------C----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 2111 11111 000 0 11122233488999999999999999999999999998766543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=355.03 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=212.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.++. +..||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4679999999999999999998875 77899999975433 456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999763 345999999999999999999999999 9999999999999999999999999997543322
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..||................ ..
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------~~--- 224 (268)
T 3sxs_A 159 -YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH----------RL--- 224 (268)
T ss_dssp -EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC----------CC---
T ss_pred -hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC----------CC---
Confidence 112233456778999999999899999999999999999999 999998765543322211100 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
..+...+..+.+++.+||+.||.+|||+.++++.|+.+..+
T Consensus 225 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 225 ----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 01111233788999999999999999999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=364.06 Aligned_cols=262 Identities=24% Similarity=0.341 Sum_probs=202.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCe----
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQ---- 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---- 143 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 467999999999999999999999999999999997653332 3468899999999999999999999876543
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
.|+||||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999986 567999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 224 KLGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 224 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ . ...
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~----~~~-- 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--V----RED-- 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--H----HCC--
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--h----cCC--
Confidence 754332211 2223456999999999999999999999999999999999999999876543321111 0 000
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHH-HHHHHHHh
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV-TALAYLAS 353 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil-~~L~~l~~ 353 (399)
..........+ +..+.+|+.+||+.||.+||++.+++ ..|..+..
T Consensus 236 --~~~~~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 236 --PIPPSARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp --CCCHHHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred --CCCcccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 00000111122 33788999999999999999666555 55555543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=368.01 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=194.2
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999999999999999997543 34567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---CCceEEecccCCccC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLG 226 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~ 226 (399)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++...
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999986 567999999999999999999999999 999999999999975 889999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||......... .... .....
T Consensus 202 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~i---~~~~~----- 268 (349)
T 2w4o_A 202 EH---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM--FRRI---LNCEY----- 268 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH--HHHH---HTTCC-----
T ss_pred Cc---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH--HHHH---HhCCC-----
Confidence 22 12233457999999999999999999999999999999999999999765433211 0000 00000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.......+.....+.+|+.+||+.||++|||+.++++
T Consensus 269 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 ---YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001111223448899999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=377.86 Aligned_cols=273 Identities=20% Similarity=0.238 Sum_probs=215.6
Q ss_pred HHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecC
Q 015816 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (399)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 141 (399)
.++....++|++.+.||+|+||.||+|+++.+++.||||++.+... .....+..|+.++..++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3444456789999999999999999999999999999999964321 1223478899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
..+|+||||++||+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999752 367999999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccc-----cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
+++...... .......+||+.|+|||++. ...|+.++|||||||++|||++|+.||...........+......
T Consensus 221 la~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 221 SCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 997533222 22233467999999999986 567999999999999999999999999876544332222111100
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCC--CCCHHHHHHHHHHHHhccCCC
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTALAYLASQKYES 358 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L~~l~~~~~~~ 358 (399)
+ ..|..... ....+.+||.+||..+|++ ||++.|+++. ..+....|+.
T Consensus 300 ~---------~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H-pff~~i~w~~ 349 (437)
T 4aw2_A 300 F---------QFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKH-PFFSGIDWDN 349 (437)
T ss_dssp C---------CCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS-GGGTTCCTTT
T ss_pred c---------cCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCC-CccCCCCHHH
Confidence 0 01111111 2337889999999988888 9999998853 3334444443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=355.84 Aligned_cols=266 Identities=21% Similarity=0.235 Sum_probs=213.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+ +|+||+++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 357999999999999999999999999999999986443 234577899999999 79999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc-----eEEecccCCc
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-----PKLSDFGLAK 224 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~Dfg~~~ 224 (399)
|+ +++|.+++... ..++++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++.
T Consensus 87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 89999999863 346999999999999999999999999 999999999999987766 9999999997
Q ss_pred cCCCCCCc-----ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 225 LGPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 225 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 64433221 1234467999999999999999999999999999999999999999764322111111111000000
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
...+.+...++ ..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 240 ------~~~~~~~~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 240 ------TPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp ------SCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ------ccHHHHHhhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 00011112233 38899999999999999999999999999887653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=365.24 Aligned_cols=267 Identities=25% Similarity=0.374 Sum_probs=214.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-------CCCeEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecC
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLE-------SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 141 (399)
.++|++.+.||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367999999999999999999985 3567899999975533 2345688999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPG------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill 209 (399)
+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 9999999999999999999864321 234899999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHH
Q 015816 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~ 288 (399)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999976443332223334567889999999998899999999999999999999 999998765433222
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccCC
Q 015816 289 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 357 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~ 357 (399)
..... . .+ ..+......+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus 271 ~~~~~-------~------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 271 LLKEG-------H------RM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHT-------C------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHhcC-------C------CC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 11100 0 00 11122334789999999999999999999999999998765443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=353.74 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=210.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
..++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34679999999999999999999999999999999987666667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee---cCCCceEEecccCCccC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~ 226 (399)
|+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999999986 567999999999999999999999999 9999999999999 78899999999999754
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||................ ..
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-------- 225 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT--FT-------- 225 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CC--------
T ss_pred cCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CC--------
Confidence 3222 2234569999999999865 49999999999999999999999998765433222111000 00
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
........+ +..+.+|+.+||+.||.+|||+.++++.
T Consensus 226 ~~~~~~~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 226 FPEKDWLNV----SPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCchhhhcC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000112 3478899999999999999999999963
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=368.56 Aligned_cols=256 Identities=21% Similarity=0.249 Sum_probs=198.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457999999999999999999999999999999997543 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc--eEEecccCCccCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--PKLSDFGLAKLGPV 228 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~~ 228 (399)
+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999976 567999999999999999999999999 999999999999987765 99999999874221
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcc-cceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLK-SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......... ............
T Consensus 171 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~~~~~~~~~~~----- 240 (361)
T 3uc3_A 171 ---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KTIQRILSVKYS----- 240 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HHHHHHHTTCCC-----
T ss_pred ---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HHHHHHhcCCCC-----
Confidence 122234569999999999988887665 899999999999999999997643311110 000110100000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
..........+.+||.+||+.||.+|||+.++++.-.
T Consensus 241 -----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 241 -----IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp -----CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred -----CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 0000112347889999999999999999999997543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=351.90 Aligned_cols=254 Identities=30% Similarity=0.471 Sum_probs=199.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc----chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
..+|++.+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 357899999999999999999986 789999998654322 24678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC--------CCceEEe
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--------GYHPKLS 218 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~--------~~~~kl~ 218 (399)
||||+++++|.+++. ...+++..++.++.||+.||.|||+++..+|+||||||+|||++. ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999986 457999999999999999999999998555889999999999986 6789999
Q ss_pred cccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhc
Q 015816 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 298 (399)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 298 (399)
|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............. .
T Consensus 159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~ 228 (271)
T 3dtc_A 159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA------M 228 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH------T
T ss_pred cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh------c
Confidence 999997532221 223569999999999999999999999999999999999999998755432221110 0
Q ss_pred cccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 299 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
.. .....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 229 ~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 NK----------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp SC----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CC----------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00 00112223334889999999999999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=359.19 Aligned_cols=266 Identities=26% Similarity=0.326 Sum_probs=204.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||.||+|.+..+|+.||||++....... .+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999999999999999986553322 3567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998875 567999999999999999999999999 999999999999999999999999999753322
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh--------hhccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP--------LFQDR 300 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~ 300 (399)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||................. .+...
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 --SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred --ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 222234578999999999875 6789999999999999999999999987665443322211100 00000
Q ss_pred cc--cccccCccccCC---CChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TR--HSLIADPELQGQ---YPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~--~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.. .....++..... ..+.....+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 000001100000 00123447889999999999999999999995
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=368.15 Aligned_cols=254 Identities=24% Similarity=0.309 Sum_probs=204.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 148 (399)
..++|++.+.||+|+||.||+|.++.+|+.||||++...... ..+|+.++.++ +||||+++++++.+....|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 356799999999999999999999999999999999765332 34588888887 7999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC----CceEEecccCCc
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG----YHPKLSDFGLAK 224 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~~~ 224 (399)
||++||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+... +.+||+|||++.
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999986 567999999999999999999999999 9999999999998543 359999999998
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+...... .
T Consensus 169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~---~----- 238 (342)
T 2qr7_A 169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS---G----- 238 (342)
T ss_dssp ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH---C-----
T ss_pred cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc---C-----
Confidence 643222 223345789999999999888899999999999999999999999975432211122111110 0
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...+.....+.....+.+|+.+||+.||++|||+.++++.
T Consensus 239 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 239 ---KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001111222334588999999999999999999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=360.52 Aligned_cols=252 Identities=25% Similarity=0.282 Sum_probs=209.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45699999999999999999999999999999999754322 246789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC----ceEEecc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDF 220 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Df 220 (399)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999986 567999999999999999999999999 99999999999999887 7999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...............
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~------- 233 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV------- 233 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-------
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------
Confidence 9997543322 123456999999999999999999999999999999999999999765543322111100
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.....+.....+ +..+.+|+.+||+.||++|||+.++++
T Consensus 234 ---~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 ---SYDFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ---CCCCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ---ccccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000011111222 237889999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=356.75 Aligned_cols=268 Identities=24% Similarity=0.280 Sum_probs=204.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-----cchHHHHHHHHHHhhcC---CCCccceEEEEecC
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLH---HPNLVNLIGYCADG 141 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~ 141 (399)
..++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 45789999999999999999999999999999999864321 12346677888777765 99999999999876
Q ss_pred C-----eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceE
Q 015816 142 D-----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (399)
Q Consensus 142 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 216 (399)
. ..++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 5 5799999997 69999998632 334999999999999999999999999 99999999999999999999
Q ss_pred EecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh
Q 015816 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..................
T Consensus 161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999754322 2223457999999999999999999999999999999999999999876554433222111111
Q ss_pred hcccccccccc--CccccC-------CCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 297 FQDRTRHSLIA--DPELQG-------QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 297 ~~~~~~~~~~~--~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
........... ...+.. ...+.....+.+|+.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11000000000 000000 011123457899999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=360.10 Aligned_cols=269 Identities=23% Similarity=0.327 Sum_probs=205.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.+|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 579999999999999999999999999999999975332 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999999764444577999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. ........|++.|+|||++.+..++.++||||||+++|+|++|..||........ ....... ... .
T Consensus 189 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----~~~------~ 255 (310)
T 2wqm_A 189 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKIE----QCD------Y 255 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHHHH----TTC------S
T ss_pred C--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHHhh----ccc------C
Confidence 2 1222345689999999999999999999999999999999999999965432111 1111010 000 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccCCCc
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESD 359 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~ 359 (399)
+... ....+..+.+|+.+||+.||.+|||+.++++.|+.+.....++.
T Consensus 256 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 256 PPLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp CCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred CCCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 0000 11223478999999999999999999999999999987665544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=359.70 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=206.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCC-------eEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESIN-------QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 143 (399)
.++|++.+.||+|+||.||+|.+..++ ..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 357899999999999999999998776 5799999976655566789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc--------e
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--------P 215 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~ 215 (399)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999862 334999999999999999999999999 999999999999998887 9
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCC-CCcccchHHHHHHHHHhh
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQSLVAWA 293 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~ 293 (399)
||+|||++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|. +||.............
T Consensus 161 kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-- 232 (289)
T 4fvq_A 161 KLSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-- 232 (289)
T ss_dssp EECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--
T ss_pred eeccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh--
Confidence 999999986421 1223458999999999987 77999999999999999999954 5555443332221111
Q ss_pred hhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 294 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.. ..+.... ...+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 233 -----~~--------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 233 -----DR--------HQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp -----TT--------CCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred -----cc--------CCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 00 0000111 22678899999999999999999999999977653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=360.12 Aligned_cols=265 Identities=27% Similarity=0.395 Sum_probs=215.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-----CCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecCCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 143 (399)
.++|++.+.||+|+||.||+|.+ ..+++.||||++..... ...+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35799999999999999999985 45688999999975543 2346788999999999 99999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSP--------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill 209 (399)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999986431 1235899999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHH
Q 015816 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~ 288 (399)
+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF- 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-
Confidence 9999999999999986544433333344567889999999999999999999999999999999 99999765432111
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 289 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
......... ...+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 258 -~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 258 -YKMIKEGFR--------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -HHHHHHTCC--------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHhccCCC--------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 110110000 011122334889999999999999999999999999987754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=360.92 Aligned_cols=266 Identities=22% Similarity=0.283 Sum_probs=202.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.++|++.+.||+|+||.||+|.+.. ++.||||++...... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4679999999999999999999965 899999999754322 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||++ ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFME-KDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCS-EEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCC-CCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9998 5888888752 456999999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc---
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS--- 304 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 304 (399)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........................
T Consensus 172 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 172 P--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp C--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred C--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 2 222334568999999999876 5689999999999999999999999976544332211111000000000000
Q ss_pred ---------cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 305 ---------LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 305 ---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
............+....++.+|+.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000011122347889999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=363.67 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEE----EEEEeccC-CCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDV----AIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
..+|++.+.||+|+||.||+|.+..+++.| |+|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357999999999999999999998877765 66666533 2334577899999999999999999999998764 88
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+|+||+.+|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999999863 456999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
..............||+.|+|||++.+..++.++|||||||++|+|++ |..||................
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~---------- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---------- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 443333333334557889999999999999999999999999999999 999998755433222221100
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
....++.....+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0111222344789999999999999999999999999988754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=355.19 Aligned_cols=254 Identities=26% Similarity=0.335 Sum_probs=204.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 3579999999999999999999999999999999875432 345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee---cCCCceEEecccCCccC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~ 226 (399)
|+++++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999999754333577999999999999999999999999 9999999999999 45678999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||...................
T Consensus 178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------- 244 (285)
T 3is5_A 178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY--------- 244 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc---------
Confidence 322 2234456999999999986 578999999999999999999999998765443332221111000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
....... ...+.+|+.+||+.||.+|||+.|+++
T Consensus 245 --~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 --AVECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CC--CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000112 237889999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=366.05 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=181.6
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEEEEecCCCC
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGS 155 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~ 155 (399)
.+.||+|+||.||+|.++.+++.||||++... ....+.+|+.+++.+. ||||+++++++.+....|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 37899999999999999999999999998643 3466788999999997 9999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC---ceEEecccCCccCCCCCCc
Q 015816 156 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKLGPVGDNT 232 (399)
Q Consensus 156 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~ 232 (399)
|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++...... .
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~ 163 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--N 163 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC--C
Confidence 9999987 577999999999999999999999999 99999999999998765 8999999999753322 2
Q ss_pred ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHH-HHHHhhhhhhccccccccccCccc
Q 015816 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ............. ..+
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~--------~~~ 235 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD--------FSF 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC--------CCC
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC--------CCC
Confidence 2234456899999999999999999999999999999999999999764332110 0000011000000 000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
........+..+.+|+.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00001122347899999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=367.35 Aligned_cols=268 Identities=28% Similarity=0.408 Sum_probs=213.7
Q ss_pred cCCCCCCeeeecCceEEEEEE----ECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEe--cCCeeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~ 145 (399)
++|++.+.||+|+||.||+|. +..+++.||||++........+.+.+|+.+++.++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 579999999999999999999 46789999999998765555677899999999999999999999886 456789
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 999999999999999763 346999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCc-ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH--------HHhhhhh
Q 015816 226 GPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL--------VAWARPL 296 (399)
Q Consensus 226 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~--------~~~~~~~ 296 (399)
....... .......||..|+|||++.+..++.++|||||||++|+|++|..||........... .......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 4333221 122334588889999999999999999999999999999999999976543221100 0000000
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
... ......++..+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 257 ~~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEE----------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhc----------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 000 0111223334458999999999999999999999999999886544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=352.15 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=209.4
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
..++|++.+.||+|+||.||+|.++.+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 357899999999999999999999999999999999754332 335688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc---eEEecccCCc
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLAK 224 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~~~ 224 (399)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999999986 567999999999999999999999999 999999999999986655 9999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||................ ..
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~------ 225 (284)
T 3kk8_A 157 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--YD------ 225 (284)
T ss_dssp ECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CC------
T ss_pred EcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc--cc------
Confidence 543222 2234569999999999999999999999999999999999999997765443322211100 00
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.+ .......+..+.+|+.+||+.||++|||+.++++.
T Consensus 226 ---~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 ---YP---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---CC---TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---CC---chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 00011223478899999999999999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=364.11 Aligned_cols=268 Identities=21% Similarity=0.274 Sum_probs=199.9
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
...++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3456899999999999999999999999999999999754332 23457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec-----CCCceEEeccc
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-----RGYHPKLSDFG 221 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~-----~~~~~kl~Dfg 221 (399)
||||++ ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 111 v~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 999998 599999987 567999999999999999999999999 99999999999994 55569999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
++...... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||......................
T Consensus 183 ~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 183 LARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 99753221 1223345689999999999764 58999999999999999999999998765543322221111100000
Q ss_pred cccccccCc-------cccCC-----CChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADP-------ELQGQ-----YPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~-------~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
........+ ..... .+......+.+|+.+||+.||.+|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000000 00000 00112357889999999999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=353.05 Aligned_cols=256 Identities=30% Similarity=0.529 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcch-------HHHHHHHHHHhhcCCCCccceEEEEecCCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-------REFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 143 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++........ +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 3679999999999999999999999999999999865433221 57889999999999999999999997665
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc-----eEEe
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-----PKLS 218 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~ 218 (399)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||||||+|||++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 6999999999999988752 457999999999999999999999886 34999999999999988776 9999
Q ss_pred cccCCccCCCCCCcceeeeeccCccccCcccc--ccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh
Q 015816 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA--KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
|||++..... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||.................
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~- 245 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE- 245 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-
Confidence 9999974221 23446799999999998 455678999999999999999999999976443222111111100
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
. ..+ ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 246 ---~------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 ---G------LRP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---C------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---C------CCC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0 011 12223334889999999999999999999999999753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=356.33 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=217.5
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
..++|++.+.||+|+||.||+|.++.++..||+|++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 456799999999999999999999999999999999754 3345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 90 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999998633 456999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||............. ..
T Consensus 165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---~~------------ 228 (288)
T 3kfa_A 165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KD------------ 228 (288)
T ss_dssp S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TT------------
T ss_pred c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---cc------------
Confidence 2 222333557889999999999999999999999999999999 999997654332222111 00
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.....+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 229 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 229 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 00111222334889999999999999999999999999887653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=365.36 Aligned_cols=263 Identities=24% Similarity=0.237 Sum_probs=205.8
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccC-----CCcchHHHHHHHHHHhhcCCCCccceEEEEecC
Q 015816 67 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-----GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (399)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 141 (399)
+....++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345677899999999999999999999999999999998643 233456789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPG------------------------------------KKPLDWNTRMKIAAGAARG 185 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~a 185 (399)
...++||||+++|+|.+++...... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999999632110 1234677889999999999
Q ss_pred HHHHHhCCCCCeeecCCCCCceeecCCC--ceEEecccCCccCCCCC--CcceeeeeccCccccCcccccc--CCCCccc
Q 015816 186 LEYLHDKAKPPVIYRDLKCSNILLDRGY--HPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAPEYAKT--GQLTLKS 259 (399)
Q Consensus 186 l~~LH~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 259 (399)
|.|||+.+ |+||||||+|||++.++ .+||+|||++....... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998776 89999999997532211 1112344679999999999865 6889999
Q ss_pred ceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCC
Q 015816 260 DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 339 (399)
Q Consensus 260 DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 339 (399)
|||||||++|+|++|+.||.............. ... ....+. .......+.+|+.+||+.||.+||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~------~~~---~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN------KKL---CFENPN-----YNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCC---CTTSGG-----GGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHh------ccc---ccCCcc-----cccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999987654433221110 000 000111 011234788999999999999999
Q ss_pred CHHHHHH
Q 015816 340 VIADVVT 346 (399)
Q Consensus 340 s~~eil~ 346 (399)
|+.++++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999996
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=378.61 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=208.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.+|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999964321 23457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999976 567999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCCcceeeeeccCccccCccccccCCC-CcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+. ... .
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~------~~~-----~- 233 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC------DGI-----F- 233 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH------TTC-----C-
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh------cCC-----c-
Confidence 22 2334579999999999988776 689999999999999999999998654432211110 000 0
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..+......+.+|+.+||+.||.+|||+.++++.
T Consensus 234 ------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 ------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1111223478899999999999999999999963
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=353.94 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=209.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 4679999999999999999998874 7889999997543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999753 356999999999999999999999999 9999999999999999999999999997532211
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||................ .
T Consensus 175 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-------------~- 239 (283)
T 3gen_A 175 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-------------R- 239 (283)
T ss_dssp -HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-------------C-
T ss_pred -cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-------------C-
Confidence 111222346788999999999999999999999999999998 999998765443322221100 0
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
...+......+.+|+.+||+.||.+|||+.++++.|..+..
T Consensus 240 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 240 ---LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 01111223478899999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=368.47 Aligned_cols=247 Identities=23% Similarity=0.284 Sum_probs=200.6
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
.+.||+|+||.||+|.+..+|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999999999999999999876555667899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee--cCCCceEEecccCCccCCCCCCcce
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHV 234 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~ 234 (399)
.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....... .
T Consensus 174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~ 244 (373)
T 2x4f_A 174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244 (373)
T ss_dssp HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence 9998752 356999999999999999999999999 9999999999999 567899999999998643322 2
Q ss_pred eeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCC
Q 015816 235 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ 314 (399)
Q Consensus 235 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||............. . .... . .......
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~----~~~~---~-~~~~~~~ 314 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL--A----CRWD---L-EDEEFQD 314 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--H----TCCC---S-CSGGGTT
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h----ccCC---C-Chhhhcc
Confidence 233469999999999999999999999999999999999999998765433221111 0 0000 0 0111112
Q ss_pred CChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 315 YPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 315 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+ ...+.+||.+||+.||.+|||+.++++
T Consensus 315 ~----~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 I----SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp S----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2 348899999999999999999999997
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=384.05 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=214.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
..+|++.+.||+|+||.||+|.++.++..||||++.... ...+.|.+|+.+|++++||||+++++++.+...+++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 456888999999999999999999989999999997543 3467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999998632 456899999999999999999999999 9999999999999999999999999998643221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........++..|+|||++.+..++.++|||||||++|||++ |..||............ .. .
T Consensus 373 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~---~~----~--------- 435 (495)
T 1opk_A 373 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EK----D--------- 435 (495)
T ss_dssp -EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---HT----T---------
T ss_pred -eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc----C---------
Confidence 111223346789999999999999999999999999999999 99999765433221111 10 0
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
.....+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 436 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 001122233348899999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=374.69 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=208.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCC-eeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e 149 (399)
.++|++.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.+|++++||||+++++++.+.. ..++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 467889999999999999999986 7899999997543 4577999999999999999999999987665 7899999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999998632 334799999999999999999999999 999999999999999999999999999742211
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.....++..|+|||++.+..++.++|||||||++|||++ |..||............ . ...
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~----~~~------- 403 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---E----KGY------- 403 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH---H----TTC-------
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----cCC-------
Confidence 122357889999999999999999999999999999998 99999765432221111 0 000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
....+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 404 ---~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 ---KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 0112223334889999999999999999999999999988754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=359.27 Aligned_cols=262 Identities=29% Similarity=0.441 Sum_probs=211.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEE--EEEEeccCC-CcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDV--AIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 147 (399)
++|++.+.||+|+||.||+|.+..++..+ |+|.+.... ....+.+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999999888865 999886432 23346688999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCce
Q 015816 148 YEYMPLGSVEDHLHDLS------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 215 (399)
|||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999998632 12357999999999999999999999999 9999999999999999999
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhh
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~ 294 (399)
||+|||++..... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~---- 254 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 254 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG----
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh----
Confidence 9999999874211 112233457889999999998899999999999999999998 99999776543221111
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccC
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 356 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 356 (399)
.... . ...+......+.+|+.+||+.||.+|||+.++++.|..+.....
T Consensus 255 ---~~~~------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 255 ---PQGY------R----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp ---GGTC------C----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---hcCC------C----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0000 0 11122233488999999999999999999999999998887544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=374.53 Aligned_cols=274 Identities=21% Similarity=0.227 Sum_probs=214.6
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEec
Q 015816 64 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCAD 140 (399)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 140 (399)
+.+.....++|++.+.||+|+||.||+|+++.+|+.||||++.+... .....+..|+.++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 33444456789999999999999999999999999999999965321 122447889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 141 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
.+.+|+||||++||+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999863 347999999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccc-------cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 293 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 293 (399)
|++....... .......+||+.|+|||++. ...|+.++|||||||++|||++|+.||...........+...
T Consensus 207 Gla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 207 GSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp TTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred hhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 9997643222 11223467999999999987 457899999999999999999999999876544322221111
Q ss_pred hhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCC---CCHHHHHHHHHHHHhccCCCc
Q 015816 294 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR---PVIADVVTALAYLASQKYESD 359 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~~L~~l~~~~~~~~ 359 (399)
.... ..+.....+ +..+.+||.+||. +|.+| |+++++++ ...+....|+..
T Consensus 286 ~~~~---------~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~-Hpff~~i~w~~l 339 (412)
T 2vd5_A 286 KEHL---------SLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT-HPFFFGLDWDGL 339 (412)
T ss_dssp HHHC---------CCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT-SGGGTTCCSTTS
T ss_pred ccCc---------CCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc-CCCcCCCCHHHH
Confidence 0000 011111122 3388999999999 99998 58988874 334444455544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=370.94 Aligned_cols=268 Identities=23% Similarity=0.303 Sum_probs=196.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcC-CCCccceEEEEecCC--ee
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD--QR 144 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~--~~ 144 (399)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.++..+. ||||+++++++...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999999999999999986442 223456789999999997 999999999997544 78
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
|+||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999998 689999975 46999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCC-------------------CcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHH
Q 015816 225 LGPVGD-------------------NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (399)
Q Consensus 225 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 284 (399)
...... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|++||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 532210 1112334679999999999876 67999999999999999999999999876554
Q ss_pred HHHHHHHhhhhhhcccccccccc------------------CccccC------------CCChHhHHHHHHHHHHccccC
Q 015816 285 AEQSLVAWARPLFQDRTRHSLIA------------------DPELQG------------QYPPRGFYQALAVAAMCVHEQ 334 (399)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~------------~~~~~~~~~l~~li~~cl~~d 334 (399)
.....+......... .....+. ...... .........+.+|+.+||+.|
T Consensus 238 ~~~~~i~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 238 NQLERIIGVIDFPSN-EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHCCCCH-HHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHhcCCCCH-HHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 433222111000000 0000000 000000 000022347899999999999
Q ss_pred CCCCCCHHHHHHH
Q 015816 335 PDMRPVIADVVTA 347 (399)
Q Consensus 335 P~~RPs~~eil~~ 347 (399)
|++|||+.|+++.
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=361.58 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=200.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCC------
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 142 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 142 (399)
..++|++.+.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 34679999999999999999999999999999999975433 34467899999999999999999999986543
Q ss_pred ---------------------------------------------------eeEEEEEecCCCCHHHHhhccCCCCCCCC
Q 015816 143 ---------------------------------------------------QRLLVYEYMPLGSVEDHLHDLSPGKKPLD 171 (399)
Q Consensus 143 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~ 171 (399)
..++||||+++++|.+++..... ....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchh
Confidence 37999999999999999986432 34467
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCc----------ceeeeeccC
Q 015816 172 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT----------HVSTRVMGT 241 (399)
Q Consensus 172 ~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt 241 (399)
+..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 7789999999999999999999 999999999999999999999999999864433211 122335699
Q ss_pred ccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHH
Q 015816 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 321 (399)
Q Consensus 242 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (399)
+.|+|||++.+..++.++|||||||++|+|++|..|+..... ....... . ..+. .......
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-----~~~~~~~----~------~~~~----~~~~~~~ 300 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-----IITDVRN----L------KFPL----LFTQKYP 300 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-----HHHHHHT----T------CCCH----HHHHHCH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-----HHHHhhc----c------CCCc----ccccCCh
Confidence 999999999999999999999999999999999877533211 1100000 0 0000 0112234
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 015816 322 QALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 322 ~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+.+|+.+||+.||.+|||+.++++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 6788999999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=359.91 Aligned_cols=260 Identities=26% Similarity=0.389 Sum_probs=205.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCC----eEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.+|++.+.||+|+||.||+|.+..++ ..||||++...... ....+.+|+.+++.++||||+++++++.+....++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 56888899999999999999987543 45999999754332 33568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 124 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999762 467999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCc-ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 227 PVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 227 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||............. ....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-------~~~~-- 268 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-------DGFR-- 268 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TTCC--
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-------CCCc--
Confidence 322211 11222346789999999999999999999999999999999 999997654433221110 0000
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
...+...+..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus 269 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 269 --------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011122334789999999999999999999999999988754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=352.69 Aligned_cols=248 Identities=28% Similarity=0.415 Sum_probs=207.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++.+.||+|+||.||+|.+..++..||||++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4679999999999999999999999999999999864321 2245688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999987 467999999999999999999999999 9999999999999999999999999886422
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 223 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-------------
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-------------
Confidence 21 2234579999999999999999999999999999999999999998765443322221110
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...+......+.+|+.+||+.||.+|||+.++++.
T Consensus 224 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 -----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01122233478899999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=357.97 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=209.6
Q ss_pred cCCCCCCeeeecCceEEEEEE----ECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecC--Cee
Q 015816 72 KNFRSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 144 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 144 (399)
+.|++.+.||+|+||.||+|. +..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 458899999999999999999 567899999999975432 3446789999999999999999999999876 678
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999999652 456999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCc-ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH--------HHhhhh
Q 015816 225 LGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL--------VAWARP 295 (399)
Q Consensus 225 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~--------~~~~~~ 295 (399)
........ .......||..|+|||++.+..++.++|||||||++|+|++|..|+........... ......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 64433221 223345688899999999999999999999999999999999998754432211100 000000
Q ss_pred hhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
.... ......++..+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 255 ~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKE----------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHT----------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhc----------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000 0011223334458999999999999999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=363.96 Aligned_cols=244 Identities=23% Similarity=0.326 Sum_probs=205.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--------chHHHHHHHHHHhhcCCCCccceEEEEecC
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 141 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999999999999999999765321 223567899999999999999999999999
Q ss_pred CeeEEEEEecCCC-CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 142 DQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 142 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
...++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999766 99999986 567999999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCC-CcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
|++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ...
T Consensus 175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~~ 239 (335)
T 3dls_A 175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VEA 239 (335)
T ss_dssp TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TTT
T ss_pred ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hhh
Confidence 9997643322 2234679999999999988777 88999999999999999999999753210 000
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. . ..+......+.+|+.+||+.||++|||+.++++.
T Consensus 240 ~-----~-------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 A-----I-------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp C-----C-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred c-----c-------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 0111123478999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=360.09 Aligned_cols=266 Identities=25% Similarity=0.364 Sum_probs=203.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECC---CCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCC--
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD-- 142 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-- 142 (399)
..++|++.+.||+|+||.||+|.+.. ++..||||++...... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45679999999999999999998764 5668999998754332 3356889999999999999999999998755
Q ss_pred ---eeEEEEEecCCCCHHHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEE
Q 015816 143 ---QRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (399)
Q Consensus 143 ---~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 217 (399)
..++||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 3599999999999999985322 23567999999999999999999999999 999999999999999999999
Q ss_pred ecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhh
Q 015816 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~----- 263 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL----- 263 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-----
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH-----
Confidence 99999976433332233334567889999999999999999999999999999999 899997654332211110
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
.. . .+ ..+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 264 -~~-~------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 264 -HG-H------RL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp -TT-C------CC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -cC-C------CC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 0 01 111223347899999999999999999999999999887643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=368.43 Aligned_cols=274 Identities=21% Similarity=0.247 Sum_probs=212.1
Q ss_pred ccCHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-----CCCccceE
Q 015816 61 TLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----HPNLVNLI 135 (399)
Q Consensus 61 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~ 135 (399)
.+++.+.....++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+..|+.+++.+. ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 344444445668999999999999999999999999999999998642 233456778999999986 99999999
Q ss_pred EEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC----
Q 015816 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---- 211 (399)
Q Consensus 136 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---- 211 (399)
+++...+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 9999999999999999 899999998632 345999999999999999999999999 999999999999975
Q ss_pred ---------------------CCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHH
Q 015816 212 ---------------------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 270 (399)
Q Consensus 212 ---------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e 270 (399)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 78999999999975322 1234579999999999999999999999999999999
Q ss_pred HHhCCCCcccchHHHHHHHHHhhhhhhcccc--------ccccccCccccCCCC--------------------hHhHHH
Q 015816 271 ILSGRKAVDTSKAAAEQSLVAWARPLFQDRT--------RHSLIADPELQGQYP--------------------PRGFYQ 322 (399)
Q Consensus 271 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~--------------------~~~~~~ 322 (399)
|++|+.||....................... .............++ ......
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 9999999987655443333222111110000 000000000000000 001146
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 015816 323 ALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 323 l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+.+|+.+||+.||.+|||+.|+++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCCCHHHHhc
Confidence 779999999999999999999984
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=384.30 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=206.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|+++.+|+.||||++..... .....+..|+.+++.++||||+++++++.+...+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 579999999999999999999999999999999965322 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||++||+|.+++.........+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999875444567999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHH-HHHHHHhhhhhhcccccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA-EQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... ...+.. ......
T Consensus 342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---~i~~~~------- 409 (543)
T 3c4z_A 342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RVLEQA------- 409 (543)
T ss_dssp TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---HHHHCC-------
T ss_pred CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---HHhhcc-------
Confidence 22 12334579999999999999999999999999999999999999997643210 011111 111100
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 341 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 341 (399)
..+++..+..+.+||.+||+.||.+||++
T Consensus 410 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 -----VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -----cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11222334488999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=354.61 Aligned_cols=262 Identities=21% Similarity=0.253 Sum_probs=205.2
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999999999999999987543322 3668899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999986 467999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||............. .....
T Consensus 185 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------~~~~~--- 253 (309)
T 2h34_A 185 TDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-------QAIPR--- 253 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-------SCCCC---
T ss_pred cccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-------cCCCC---
Confidence 3221 112234569999999999999999999999999999999999999998765432211111 00000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHhc
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-VIADVVTALAYLASQ 354 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~~~ 354 (399)
.......++ ..+.+++.+||+.||++|| +++++++.|+.+...
T Consensus 254 -~~~~~~~~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 254 -PSTVRPGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -GGGTSTTCC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -ccccCCCCC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 001112223 3788999999999999999 999999999876544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=353.80 Aligned_cols=259 Identities=26% Similarity=0.367 Sum_probs=200.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCC---CeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.++|++.+.||+|+||.||+|.+..+ +..||+|++...... ..+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 45799999999999999999998653 557999998754332 3456889999999999999999999985 467899
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999862 346999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||............. ...
T Consensus 167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-------~~~---- 234 (281)
T 1mp8_A 167 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGE---- 234 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC----
T ss_pred Cccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-------cCC----
Confidence 3221 111233457889999999999999999999999999999997 999997654332211110 000
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.. ..++..+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 235 --~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 --RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00 11223334889999999999999999999999999988653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=362.97 Aligned_cols=265 Identities=25% Similarity=0.305 Sum_probs=209.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEe----cCCeeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA----DGDQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~~~~l 146 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 467999999999999999999999999999999987655555677899999999999999999999986 3457899
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999875544678999999999999999999999999 999999999999999999999999998743
Q ss_pred CCCCCcc-------eeeeeccCccccCccccccCC---CCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh
Q 015816 227 PVGDNTH-------VSTRVMGTYGYCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 227 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......... ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~-- 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQ-- 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHHH--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHhh--
Confidence 2111000 012245799999999987554 789999999999999999999999643221110 000000
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
... ....++..+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 262 --~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 --NQL----------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --CC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred --ccC----------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000 001112233488999999999999999999999999997754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=384.37 Aligned_cols=253 Identities=28% Similarity=0.392 Sum_probs=208.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... ......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 457999999999999999999999999999999996532 22345678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||++||+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999997632 345999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHH-HHHHHhhhhhhccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 306 (399)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||........ ..+...... .
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~---~------- 404 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---V------- 404 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH---C-------
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc---c-------
Confidence 222 23345799999999999999999999999999999999999999976432110 111111100 0
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
...++......+.+||.+||+.||.+|| ++.|+++
T Consensus 405 -----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 -----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0112223334889999999999999999 6788875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=358.82 Aligned_cols=266 Identities=23% Similarity=0.319 Sum_probs=200.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc-hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999999999999999986543221 12355799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
++ ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 98 6999988763 456999999999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC-
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD- 308 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 308 (399)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..............................
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 222334568999999999876 67899999999999999999999999876654433322211110000000000000
Q ss_pred -------cccc----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 309 -------PELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 309 -------~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+... ....+.....+.+|+.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 0001123347889999999999999999999996
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=356.98 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=200.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhh--cCCCCccceEEEEec----CCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCAD----GDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~----~~~~ 144 (399)
.++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46799999999999999999988 4899999998643 34556667777766 799999999998654 3468
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCceeecCCCceE
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--------DKAKPPVIYRDLKCSNILLDRGYHPK 216 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~ivH~Dlkp~Nill~~~~~~k 216 (399)
++||||+++|+|.+++. ...+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 99999999999999996 357999999999999999999999 888 99999999999999999999
Q ss_pred EecccCCccCCCCCCcc--eeeeeccCccccCccccccC------CCCcccceeehhHHHHHHHhC----------CCCc
Q 015816 217 LSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSG----------RKAV 278 (399)
Q Consensus 217 l~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g----------~~pf 278 (399)
|+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999997533222211 12234799999999999876 456799999999999999999 7888
Q ss_pred ccchHHHH--HHHHHhhhhhhccccccccccCcccc-CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 279 DTSKAAAE--QSLVAWARPLFQDRTRHSLIADPELQ-GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 279 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
........ ....... ..... .+.+. .......+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~----~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVV----CVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHHHHHHH----TTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhhhhHHH----hccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54322110 0111000 00000 00110 011224566899999999999999999999999999876
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=365.11 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=198.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCC--CCccceEEEEecCCeeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~l 146 (399)
.++|++.+.||+|+||.||+|.+.. ++.||||++...... ..+.+.+|+.+++.++| |||+++++++.+....++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 3569999999999999999999864 899999998755332 23668899999999986 999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||| +.+++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++...
T Consensus 87 v~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 557899999987 567999999999999999999999999 99999999999997 578999999999865
Q ss_pred CCCCCcceeeeeccCccccCcccccc-----------CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKT-----------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 295 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 295 (399)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ...
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~---- 232 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-LHA---- 232 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHH----
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-HHH----
Confidence 43333333445679999999999865 67899999999999999999999999754322110 110
Q ss_pred hhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
.. ++.....++......+.+|+.+||+.||.+|||+.++++...
T Consensus 233 ~~----------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 233 II----------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HH----------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred Hh----------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 00 011111222222347889999999999999999999997543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=358.62 Aligned_cols=270 Identities=27% Similarity=0.382 Sum_probs=214.9
Q ss_pred HHHHHhcCCCCCCeeeecCceEEEEEEE-----CCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCccceEEEE
Q 015816 66 ELAAATKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYC 138 (399)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~~~~~~ 138 (399)
......++|++.+.||+|+||.||+|.+ ..+++.||||++...... ..+.+.+|+.++..+ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3334457899999999999999999985 456789999999765332 335688999999999 799999999998
Q ss_pred ecCC-eeEEEEEecCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 015816 139 ADGD-QRLLVYEYMPLGSVEDHLHDLSPG------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 205 (399)
Q Consensus 139 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~ 205 (399)
...+ ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~ 177 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 177 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccc
Confidence 7754 589999999999999999863321 123899999999999999999999999 999999999
Q ss_pred ceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHH
Q 015816 206 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAA 284 (399)
Q Consensus 206 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~ 284 (399)
|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999999999999986444333333444668899999999999999999999999999999998 99999764422
Q ss_pred HHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 285 AEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
... ...... .. .. ..+......+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 258 ~~~--~~~~~~----~~------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 258 EEF--CRRLKE----GT------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HHH--HHHHHH----TC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH--HHHhcc----Cc------cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 111 100000 00 00 11112234789999999999999999999999999988754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=362.85 Aligned_cols=265 Identities=26% Similarity=0.393 Sum_probs=213.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCe-----EEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCccceEEEEecCCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQ-----DVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 143 (399)
.++|++.+.||+|+||.||+|.+..++. .||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4689999999999999999999977664 799999975533 2346688999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSP----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~ 213 (399)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 9999999999999999975311 1346899999999999999999999999 99999999999999999
Q ss_pred ceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHh
Q 015816 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAW 292 (399)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~ 292 (399)
.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.......... ..
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--~~ 279 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY--KL 279 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH--HH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH--HH
Confidence 999999999975433333333344567889999999999999999999999999999998 999997643221111 11
Q ss_pred hhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
...... ...+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 280 ~~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 280 VKDGYQ--------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCC--------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 110000 011112234788999999999999999999999999887653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=351.70 Aligned_cols=261 Identities=28% Similarity=0.433 Sum_probs=196.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
..+|++.+.||+|+||.||+|.+.. .||||++...... ..+.+.+|+.+++.++||||+++++++ .....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 4579999999999999999998753 5999998755332 336688999999999999999999965 456789999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999652 467999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCcceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
...........||+.|+|||++. +..++.++|||||||++|+|++|+.||.......... ........ .
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~~~~----~-- 244 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--EMVGRGSL----S-- 244 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH--HHHHHTSC----C--
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH--HHhccccc----C--
Confidence 22233334467999999999986 6778999999999999999999999997654332211 11110000 0
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.........+ +..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 245 ~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 245 PDLSKVRSNC----PKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCTTSSCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchhhccccC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0001111223 3488999999999999999999999999997753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=348.35 Aligned_cols=258 Identities=24% Similarity=0.311 Sum_probs=209.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 5699999999999999999999999999999998754322 3567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC----ceEEeccc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDFG 221 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg 221 (399)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999986 567999999999999999999999999 99999999999998877 89999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 301 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (399)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------- 227 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN------- 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-------
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc-------
Confidence 997533221 2234569999999999999999999999999999999999999998765433222111000
Q ss_pred ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHHHh
Q 015816 302 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT--ALAYLAS 353 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~l~~ 353 (399)
....+.....+ +..+.+|+.+||+.||.+|||+.++++ .+..+..
T Consensus 228 ---~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 228 ---YDFDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ---CCCCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ---cCCcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 00011111222 337889999999999999999999997 3454443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=368.53 Aligned_cols=272 Identities=17% Similarity=0.226 Sum_probs=205.9
Q ss_pred hcCCCCCCeeeec--CceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 71 TKNFRSESLLGEG--GFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
..+|++.+.||+| +||.||+|+++.+++.||||++...... ..+.+.+|+.+++.++|||||++++++.+.+.+|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4579999999999 9999999999999999999999754322 23567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998632 356999999999999999999999999 999999999999999999999999987642
Q ss_pred CCCCC-----cceeeeeccCccccCcccccc--CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH-HHhhhhhhc
Q 015816 227 PVGDN-----THVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQ 298 (399)
Q Consensus 227 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~ 298 (399)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .....+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 21110 111122468999999999987 6799999999999999999999999975433211100 000000000
Q ss_pred cccc-------------------ccccc--------CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 299 DRTR-------------------HSLIA--------DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 299 ~~~~-------------------~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.... ..... ........+......+.+|+.+||+.||.+|||+.++++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000 00000 0000011222334578999999999999999999999953
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=353.87 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=207.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 46799999999999999999999999999999999865544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee---cCCCceEEecccCCccCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 227 (399)
+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.++|+|||++....
T Consensus 88 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999976 467999999999999999999999999 9999999999999 788999999999987532
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||............. ....
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~------~~~~------ 224 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK------EGYY------ 224 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HCCC------
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------cCCC------
Confidence 21 1233468999999999999999999999999999999999999997654432221111 0000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.......+..+..+.+++.+||+.||.+|||+.++++.
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 225 --EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp --CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred --CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00011112233488999999999999999999999963
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=352.05 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=208.7
Q ss_pred hcCCCCCC-eeeecCceEEEEEEE--CCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 71 TKNFRSES-LLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 71 ~~~~~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
.++|++.+ .||+|+||.||+|.+ ..+++.||||++...... ..+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35688887 999999999999954 566889999999754322 246789999999999999999999999 566789
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999987 567999999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCcc-eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 226 GPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 226 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||............... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-------~-- 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------E-- 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------C--
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------C--
Confidence 43332211 1222446789999999998899999999999999999999 99999876554322221110 0
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.+ ..+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 238 ----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 238 ----RM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ----CC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 01 11223334899999999999999999999999999988654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=363.11 Aligned_cols=265 Identities=25% Similarity=0.405 Sum_probs=213.9
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC-----CCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCC
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 142 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 142 (399)
...++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999886 3578899999975433 23356889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceE
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLS------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 216 (399)
..++||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 9999999999999999997531 11256799999999999999999999999 99999999999999999999
Q ss_pred EecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhh
Q 015816 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARP 295 (399)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~ 295 (399)
|+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---- 254 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM---- 254 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH----
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH----
Confidence 999999975332222122233457889999999999999999999999999999999 899997765433222111
Q ss_pred hhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
... .+ ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 255 --~~~-------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 255 --EGG-------LL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --TTC-------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --cCC-------cC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 000 00 1112233478999999999999999999999999987644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=356.21 Aligned_cols=258 Identities=24% Similarity=0.310 Sum_probs=201.1
Q ss_pred hcCCCCC-CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEE
Q 015816 71 TKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 71 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.+.|++. +.||+|+||.||+|.+..+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3568874 7899999999999999999999999999776555667899999999884 7999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc---eEEecccCCcc
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLAKL 225 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~~~~ 225 (399)
||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999987 467999999999999999999999999 999999999999998776 99999999875
Q ss_pred CCCCCC-----cceeeeeccCccccCcccccc-----CCCCcccceeehhHHHHHHHhCCCCcccchHHH----------
Q 015816 226 GPVGDN-----THVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA---------- 285 (399)
Q Consensus 226 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---------- 285 (399)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 332211 111223469999999999875 568899999999999999999999997543210
Q ss_pred --HHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 286 --EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 286 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+..... ... ... ....... ....+.+|+.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~i~---~~~---~~~-~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQ---EGK---YEF-PDKDWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHH---HCC---CCC-CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHh---ccC---ccc-Cchhccc----CCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000110000 000 000 0000011 2347899999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=350.76 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=208.4
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 45679999999999999999999999999999999875432 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999999975 567999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcceeeeeccCccccCccccccCCC-CcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
...........||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+... .. .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~----~~---~-- 227 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK----KT---Y-- 227 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT----CT---T--
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc----cc---c--
Confidence 222222344579999999999987665 7899999999999999999999976543211 11111110 00 0
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..........+.+|+.+||+.||.+|||+.++++
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 -----LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0001123347889999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=374.21 Aligned_cols=263 Identities=22% Similarity=0.273 Sum_probs=199.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecC------C
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------D 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~ 142 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999999999999999997542 22346688999999999999999999999655 3
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999985 5777664 24899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh-hh------
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RP------ 295 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~------ 295 (399)
++.... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+... ..
T Consensus 211 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 985332 22234467999999999999999999999999999999999999999876544332221110 00
Q ss_pred ---------hhccccccccccCcccc-----CC---CChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 296 ---------LFQDRTRHSLIADPELQ-----GQ---YPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 296 ---------~~~~~~~~~~~~~~~~~-----~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.............+... .. ........+.+|+.+||+.||++|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000000 00 00112457899999999999999999999996
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=347.27 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=212.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.+.. ++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEecC-CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3578899999999999999999974 78999999976533 456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~- 157 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD- 157 (267)
T ss_dssp CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-
Confidence 9999999999862 356899999999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
.........++..|+|||++.+..++.++||||||+++|+|++ |..||............. ... .
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~---~~~----------~- 223 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---TGF----------R- 223 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TTC----------C-
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh---cCC----------c-
Confidence 1111223457788999999998999999999999999999999 899998654433221110 000 0
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 224 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 011112234788999999999999999999999999988753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=376.64 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=211.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
..++|++.+.||+|+||.||+|.++. +..||||++.... ...+.+.+|+.+|+.++||||+++++++. .+..++|||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 34678899999999999999999875 7889999997543 45678999999999999999999999986 567899999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 263 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999997521 236899999999999999999999999 999999999999999999999999999853221
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. ........+|..|+|||++....++.++|||||||++|||++ |+.||............. ... .
T Consensus 338 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~~~----~------ 403 (454)
T 1qcf_A 338 E-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE---RGY----R------ 403 (454)
T ss_dssp H-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH---HTC----C------
T ss_pred c-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCC----C------
Confidence 1 111222346788999999999999999999999999999999 999998765433222111 100 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
...+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 404 ----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 01122233488999999999999999999999999997754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=349.51 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=186.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 3579999999999999999999998999999999864321 2236788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++... ..++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999852 367999999999999999999999999 9999999999999999999999999997533
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... .. ....
T Consensus 164 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------~~----~~~~ 227 (278)
T 3cok_A 164 MPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------NK----VVLA 227 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSS
T ss_pred CCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------HH----Hhhc
Confidence 221 1223356899999999999999999999999999999999999999764321110 00 0000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+. ..+......+.+|+.+||+.||++|||+.++++
T Consensus 228 ~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 DY----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11 122223448899999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=373.12 Aligned_cols=195 Identities=26% Similarity=0.346 Sum_probs=157.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEec-----CCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-----GDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 143 (399)
.++|++.+.||+|+||.||+|.++.+++.||||++..... ...+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3689999999999999999999999999999999965422 234678899999999999999999999843 357
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 799999986 567999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc-------------------------ceeeeeccCccccCcccc-ccCCCCcccceeehhHHHHHHHh
Q 015816 224 KLGPVGDNT-------------------------HVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILS 273 (399)
Q Consensus 224 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~ 273 (399)
+........ ...+..+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 864322111 122346789999999976 56779999999999999999999
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=358.17 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=210.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999999875432 2345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999986 467999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............. . ..
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~----~~------- 257 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--K----NE------- 257 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--H----TC-------
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--c----CC-------
Confidence 222 22334569999999999999999999999999999999999999998755433221111 0 00
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. ..+......+.+|+.+||+.||++|||+.++++.
T Consensus 258 -~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 -Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 1111223378899999999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=358.54 Aligned_cols=263 Identities=21% Similarity=0.266 Sum_probs=210.8
Q ss_pred cCHHHHHHHhcCCCCC-CeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcC-CCCccceEEE
Q 015816 62 LTFRELAAATKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLH-HPNLVNLIGY 137 (399)
Q Consensus 62 ~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~~~~~ 137 (399)
+.+.......+.|.+. +.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++..+. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3445556677788887 899999999999999999999999999875432 23567889999999985 6999999999
Q ss_pred EecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---CCc
Q 015816 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYH 214 (399)
Q Consensus 138 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~~~ 214 (399)
+.+....++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 999999999999999999999986522 467999999999999999999999999 999999999999998 789
Q ss_pred eEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh
Q 015816 215 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 294 (399)
+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 173 ~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 249 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred EEEeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Confidence 999999999754322 12234579999999999999999999999999999999999999997765433222111110
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. .............+.+|+.+||+.||.+|||+.++++
T Consensus 250 ~--------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 250 V--------------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp C--------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c--------------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 0011111223347889999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=352.14 Aligned_cols=246 Identities=22% Similarity=0.241 Sum_probs=196.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++.+.||+|+||+||+|.+..+++.||||++...... ....+..|+..+..+ +||||+++++++.+....++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 36799999999999999999999999999999998654332 223455566655555 899999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 57999988763 456999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+........ + .. ...
T Consensus 209 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~--------~~-----~~~ 269 (311)
T 3p1a_A 209 TA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ--L--------RQ-----GYL 269 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH--H--------TT-----TCC
T ss_pred cC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--H--------hc-----cCC
Confidence 22 22334569999999999876 799999999999999999999776654322110 0 00 000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+.+...+ ...+.+|+.+||+.||++|||+.++++
T Consensus 270 ~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 PPEFTAGL----SSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccccCC----CHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11112222 347899999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=366.68 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=198.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcC--CCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv 147 (399)
.+|++.+.||+|+||.||+|.+.. ++.||||++...... ..+.+.+|+.+++.++ ||||+++++++...+.+|+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 469999999999999999999876 899999999754332 3467899999999996 59999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|| +.+++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++....
T Consensus 135 ~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 567899999987 567999999999999999999999999 99999999999996 5799999999998644
Q ss_pred CCCCcceeeeeccCccccCcccccc-----------CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKT-----------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
...........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+.. .
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~~~----~ 280 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHA----I 280 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHH----H
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-HHHH----H
Confidence 3332223345679999999999865 4689999999999999999999999975432111 0110 0
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
.. +.....++......+.+|+.+||+.||.+|||+.++++..
T Consensus 281 ~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 281 ID----------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HC----------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hC----------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 10 0011111222234788999999999999999999999753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=346.48 Aligned_cols=254 Identities=23% Similarity=0.367 Sum_probs=206.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecC--CeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv 147 (399)
++|++.+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 57899999999999999999986 789999999765332 345789999999999999999999999887 788999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ ++|+||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999998622 336999999999999999999999875 349999999999999999999999998875321
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCc---ccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTL---KSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||............ ....
T Consensus 165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------~~~~---- 227 (271)
T 3kmu_A 165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV------ALEG---- 227 (271)
T ss_dssp -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH------HHSC----
T ss_pred -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH------HhcC----
Confidence 12246899999999998765554 799999999999999999999866543322111 0000
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
..+ ..+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 228 --~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 --LRP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011 1122233478999999999999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=375.53 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=207.4
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
..++|++.+.||+|+||.||+|.++.+++.||||++.... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999999999999999986432 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec---CCCceEEecccCCc
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLAK 224 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~ 224 (399)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999999986 467999999999999999999999999 99999999999995 45679999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||..................
T Consensus 173 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------- 240 (486)
T 3mwu_A 173 CFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA-------- 240 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------
T ss_pred ECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 54322 22334579999999999976 5999999999999999999999999876554332222111000
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...+ .....+..+.+||.+||+.||.+|||+.++++.
T Consensus 241 -~~~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 -FDLP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -SCSG-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CCCc-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 011223478899999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=359.21 Aligned_cols=269 Identities=26% Similarity=0.271 Sum_probs=202.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-----chHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
..++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 456899999999999999999999999999999998653222 124678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+++ +|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999985 888888752 456899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc--cc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD--RT 301 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~ 301 (399)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..................... ..
T Consensus 161 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 161 SFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred eccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 64322 222334578999999999865 45899999999999999999999999876544332221111000000 00
Q ss_pred ccccccCccccCC---CC-----hHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 302 RHSLIADPELQGQ---YP-----PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 302 ~~~~~~~~~~~~~---~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
......+...... .+ ......+.+||.+||+.||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000000000 01 2233589999999999999999999999964
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=366.78 Aligned_cols=255 Identities=20% Similarity=0.247 Sum_probs=194.9
Q ss_pred hcCCCCC-CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHh-hcCCCCccceEEEEec----CCee
Q 015816 71 TKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLS-LLHHPNLVNLIGYCAD----GDQR 144 (399)
Q Consensus 71 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~----~~~~ 144 (399)
.++|.+. +.||+|+||.||+|.++.+++.||||++.. ...+.+|+.++. ..+||||+++++++.. ...+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567776 689999999999999999999999999863 345678888874 4589999999999875 5678
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---CCceEEeccc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFG 221 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg 221 (399)
||||||++||+|.+++.... ...+++..++.|+.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 99999999999999998632 346999999999999999999999999 999999999999997 7899999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHH-HHHHhhhhhhccc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQDR 300 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~ 300 (399)
++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ....... ...
T Consensus 210 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~ 283 (400)
T 1nxk_A 210 FAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQ 283 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTC
T ss_pred cccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCc
Confidence 99753221 2234567999999999999999999999999999999999999999754321100 0000000 000
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
..... .........+.+||.+||+.||.+|||+.++++.-.
T Consensus 284 ---~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 284 ---YEFPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp ---CCCCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ---ccCCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 00000 001123347899999999999999999999997543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=348.41 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=208.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999986432 123467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999986 457999999999999999999999999 99999999999999999999999999865322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. ......|++.|+|||++.+..++.++||||||+++|+|++|..||............. .. +
T Consensus 167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------~~--------~ 228 (284)
T 2vgo_A 167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV------NV--------D 228 (284)
T ss_dssp S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------TT--------C
T ss_pred c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh------cc--------c
Confidence 1 1234569999999999999999999999999999999999999998765433221111 00 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. .+++.....+.+++.+||+.||.+|||+.++++.
T Consensus 229 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 L----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp C----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred c----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0 1222233478899999999999999999999963
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=363.47 Aligned_cols=267 Identities=15% Similarity=0.163 Sum_probs=204.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCC-----CeEEEEEEeccCCCcch-----------HHHHHHHHHHhhcCCCCccce
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQGN-----------REFLVEVLMLSLLHHPNLVNL 134 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~~ 134 (399)
.++|++.+.||+|+||.||+|.+..+ ++.||||++........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45799999999999999999999764 57899999875432111 123456667778899999999
Q ss_pred EEEEecC----CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec
Q 015816 135 IGYCADG----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (399)
Q Consensus 135 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~ 210 (399)
++++... ...|+||||+ +++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 9998764 4589999999 89999999862 467999999999999999999999999 99999999999999
Q ss_pred --CCCceEEecccCCccCCCCCCc-----ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchH
Q 015816 211 --RGYHPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (399)
Q Consensus 211 --~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 283 (399)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999753322111 111335599999999999999999999999999999999999999985322
Q ss_pred HHHH-H-HHHhhhhhhccccccccccCcccc-CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 284 AAEQ-S-LVAWARPLFQDRTRHSLIADPELQ-GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 284 ~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.... . ........... +.++.+. ..++ ..+.+++..||+.||.+||++.+|++.|..+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIAS------LMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp CHHHHHHHHHHHHHCHHH------HHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHH------HHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 1111 0 11000000000 0011110 1223 3788999999999999999999999999888754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=391.86 Aligned_cols=272 Identities=26% Similarity=0.342 Sum_probs=217.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 145 (399)
...+|++.+.||+|+||.||+|.++.+++.||||++.... ....+.+..|..++..+ +||||+.+++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467999999999999999999999999999999987431 22346678899999887 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
|||||++||+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999987 467999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.... .......+||+.|+|||++.+..|+.++|||||||+||||++|..||...........+ ....
T Consensus 492 ~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~~----- 558 (674)
T 3pfq_A 492 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------MEHN----- 558 (674)
T ss_dssp CCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HSSC-----
T ss_pred cccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH------HhCC-----
Confidence 3222 22244568999999999999999999999999999999999999999876543322211 1110
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCH-----HHHHHHHHHHHhccCCCcccccCCCCCC
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI-----ADVVTALAYLASQKYESDAEKVQSPCLD 369 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~L~~l~~~~~~~~~~~~~~~~~~ 369 (399)
..++......+.+||.+||+.||.+||++ .+|++ ...+....|+........|+..
T Consensus 559 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~-h~ff~~i~w~~l~~~~~~pp~~ 619 (674)
T 3pfq_A 559 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE-HAFFRYIDWEKLERKEIQPPYK 619 (674)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS-SGGGSSCCHHHHTTTCSCCSCC
T ss_pred -------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc-CccccCCCHHHHHhCCCCCCCC
Confidence 11223334588999999999999999997 55553 2333333443333333333333
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=360.45 Aligned_cols=266 Identities=25% Similarity=0.371 Sum_probs=205.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 5799999999999999999999999999999998654332 23557889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999988888765 567999999999999999999999999 999999999999999999999999999753221
Q ss_pred CCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh--------hhhccc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR--------PLFQDR 300 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~ 300 (399)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||................ ..+...
T Consensus 178 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 --GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred --ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 1223345689999999998765 78999999999999999999999998765543322111100 000000
Q ss_pred cccccccCccccCC-----CChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADPELQGQ-----YPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
........+..... ..+.....+.+|+.+||+.||.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00011111111111 11123458899999999999999999999996
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=351.27 Aligned_cols=254 Identities=32% Similarity=0.487 Sum_probs=199.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||+|.+. ++.||||++... ...+.+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 56889999999999999999886 789999998643 345678999999999999999999998874 489999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeeecCCCCCceeecCCCc-eEEecccCCccCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD---KAKPPVIYRDLKCSNILLDRGYH-PKLSDFGLAKLGP 227 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~~~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~~~~~~ 227 (399)
++++|.+++..... ...+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++. +||+|||++....
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 82 EGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp TTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99999999986321 2347899999999999999999999 67 999999999999998886 7999999987432
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............. .. .. .
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~----~~------~ 221 (307)
T 2eva_A 158 T-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-VH----NG------T 221 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH-HH----TT------C
T ss_pred c-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH-Hh----cC------C
Confidence 1 1223469999999999999999999999999999999999999997543221111110 00 00 0
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
.+.....++ ..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 222 ~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 222 RPPLIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CCCCBTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred CCCcccccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 111112233 37889999999999999999999999999887643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=375.74 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=204.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.++|++.+.||+|+||.||+|.++.++..||||++.... ......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999999999999999999999999997543 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC---CceEEecccCCcc
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLAKL 225 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~~~~ 225 (399)
|||++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999986 567999999999999999999999999 9999999999999764 4599999999976
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.... .......||+.|+|||++. ..++.++|||||||++|+|++|..||..................
T Consensus 189 ~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 255 (494)
T 3lij_A 189 FENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT--------- 255 (494)
T ss_dssp CBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred CCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 4322 2233457999999999986 57999999999999999999999999876554332222111100
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. .......+ +..+.+|+.+||+.||.+|||+.++++.
T Consensus 256 ~-~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 F-DSPEWKNV----SEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp C-CSGGGTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred C-CchhcccC----CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0 01111122 3378899999999999999999999963
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=362.04 Aligned_cols=265 Identities=17% Similarity=0.178 Sum_probs=201.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECC---CCeEEEEEEeccCCCc-----------chHHHHHHHHHHhhcCCCCccceEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNGVQ-----------GNREFLVEVLMLSLLHHPNLVNLIGY 137 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~~~~~ 137 (399)
++|++.+.||+|+||.||+|.+.. ++..||||++...... ....+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999987 7889999998755322 11346678889999999999999999
Q ss_pred Eec----CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC
Q 015816 138 CAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213 (399)
Q Consensus 138 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~ 213 (399)
+.. ....|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 987 77899999999 8999999986 447999999999999999999999999 99999999999999877
Q ss_pred --ceEEecccCCccCCCCCC-----cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchH--H
Q 015816 214 --HPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA--A 284 (399)
Q Consensus 214 --~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~ 284 (399)
.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999975432111 1111345799999999999999999999999999999999999999964221 1
Q ss_pred HHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 285 AEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
............+...... ......+ +..+.+++..||+.||++|||+.+|++.|+.+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLK-----WAPSGSS----CCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHH-----HSCTTSC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHhhcccccHHHHh-----hcccccc----HHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111111111100000 0000122 2388999999999999999999999999986554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=367.28 Aligned_cols=278 Identities=17% Similarity=0.210 Sum_probs=215.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCC--eeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv 147 (399)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3579999999999999999999999999999999975432 33467889999999999999999999998765 78999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee----cCCCceEEecccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLA 223 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~~ 223 (399)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999986332 234999999999999999999999999 9999999999999 77888999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCcccccc--------CCCCcccceeehhHHHHHHHhCCCCcccchHHH-HHH-HHHhh
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKT--------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA-EQS-LVAWA 293 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~-~~~~~ 293 (399)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ... +....
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 753322 22234569999999999865 567889999999999999999999996433211 111 11111
Q ss_pred hhhhccc---ccc------ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 294 RPLFQDR---TRH------SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 294 ~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
....... ... .-.................+.+++.+||+.||++||++.++++.+..+....
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 1100000 000 0000011112344667778899999999999999999999999998887653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=373.50 Aligned_cols=257 Identities=29% Similarity=0.414 Sum_probs=206.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.++. +..||||++.... ...+.+.+|+.+|++++||||+++++++.+ +..++||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 4578889999999999999999986 5779999997543 345779999999999999999999999876 678999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 260 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999997521 346899999999999999999999999 9999999999999999999999999998643221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........++..|+|||++.+..++.++|||||||++|||++ |..||............. . ..
T Consensus 335 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~----~~-------- 398 (452)
T 1fmk_A 335 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---R----GY-------- 398 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T----TC--------
T ss_pred -eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c----CC--------
Confidence 112223457889999999999999999999999999999999 999998765433222111 0 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
....++..+..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 399 --~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 399 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 011222334488999999999999999999999999997654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=358.89 Aligned_cols=256 Identities=21% Similarity=0.316 Sum_probs=208.3
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--------chHHHHHHHHHHhhc-CCCCccceEEE
Q 015816 67 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLL-HHPNLVNLIGY 137 (399)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~hpniv~~~~~ 137 (399)
......+|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 345567899999999999999999999988999999998754321 124578899999999 79999999999
Q ss_pred EecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEE
Q 015816 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (399)
Q Consensus 138 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 217 (399)
+......++||||++|++|.+++.. ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999986 567999999999999999999999999 999999999999999999999
Q ss_pred ecccCCccCCCCCCcceeeeeccCccccCcccccc------CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHH
Q 015816 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 291 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~ 291 (399)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............
T Consensus 242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9999987543222 2234679999999999863 368899999999999999999999997654432222111
Q ss_pred hhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 292 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... .. . ........ +..+.+|+.+||+.||++|||+.++++
T Consensus 319 ~~~--~~-------~-~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQ--YQ-------F-SSPEWDDR----SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTC--CC-------C-CHHHHSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCC--CC-------C-CCcccccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 00 0 00000112 237889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=348.01 Aligned_cols=254 Identities=22% Similarity=0.275 Sum_probs=203.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC----CcchHHHHHHHHHHhhcCCCCccceEEEEe--cCCe
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG----VQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQ 143 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~ 143 (399)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999999999999999996532 233467899999999999999999999984 4568
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
.++||||++++ |.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999866 777776543 457999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCC--CCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccc
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 301 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (399)
................||+.|+|||++.+.. ++.++|||||||++|+|++|..||.............. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~------~-- 228 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------G-- 228 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------C--
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc------C--
Confidence 7644333333334566999999999987644 47899999999999999999999987554332211110 0
Q ss_pred ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 302 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
... .+......+.+|+.+||+.||.+|||+.++++.
T Consensus 229 ------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 ------SYA----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCC----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCC----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001 111223378899999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=348.96 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=210.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 3579999999999999999999999999999999865432 2345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999986 567999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
... .......||+.|+|||++.+..++.++||||||+++|+|++|..||............. ..
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~-------- 230 (294)
T 2rku_A 167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK------KN-------- 230 (294)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------TT--------
T ss_pred cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------hc--------
Confidence 221 22334569999999999999999999999999999999999999998765433211110 00
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
.. ..+......+.+++.+||+.||++|||+.++++.-
T Consensus 231 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 231 EY----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred cC----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 00 11122234788999999999999999999999753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=358.67 Aligned_cols=264 Identities=28% Similarity=0.399 Sum_probs=207.4
Q ss_pred hcCCCCCCeeeecCceEEEEEE-----ECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGY-----LESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|++.+.||+|+||.||+|. +..++..||||++..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 3679999999999999999999 456788999999964432 2345688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---CCceEEe
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPG---KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLS 218 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~ 218 (399)
|+||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999864321 245899999999999999999999999 999999999999984 4569999
Q ss_pred cccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhh
Q 015816 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF 297 (399)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~ 297 (399)
|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...............
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---- 261 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG---- 261 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT----
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC----
Confidence 9999874332222222334568899999999999999999999999999999998 99999866543322211100
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
. .+ ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 262 ---~------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 ---G------RM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp ---C------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---C------CC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 0 00 11122234788999999999999999999999999988754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=359.09 Aligned_cols=249 Identities=31% Similarity=0.406 Sum_probs=204.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
+.|++.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45899999999999999999999999999999997543322 256889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+. |+|.+++... ..++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9998 6888888642 467999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCcceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||............ .. ..
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~--~~----~~----- 269 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQ----NE----- 269 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HH----SC-----
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--Hh----cC-----
Confidence 22356999999999984 578999999999999999999999999765543321111 10 00
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
.+... +...+..+.+|+.+||+.||++|||+.++++...
T Consensus 270 --~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 270 --SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp --CCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred --CCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 00000 1122337889999999999999999999997543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=377.08 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=209.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++.+.||+|+||.||+|.++.+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4579999999999999999999999999999999965432 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee---cCCCceEEecccCCc
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAK 224 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~ 224 (399)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++.
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999986 567999999999999999999999999 9999999999999 567899999999987
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...........+......
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------- 245 (484)
T 3nyv_A 178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT-------- 245 (484)
T ss_dssp HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 543222 2234569999999999876 7999999999999999999999999876554332222111000
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...+ .....+..+.+||.+||+.||.+|||+.++++.
T Consensus 246 -~~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 -FELP-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -CCSG-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0000 011233478999999999999999999999964
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=347.86 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=211.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
+.|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 568999999999999999999999999999999975543 3457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.. .++++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 172 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT- 172 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT-
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc-
Confidence 999999999963 57999999999999999999999999 999999999999999999999999999753322
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.............. . ..+.
T Consensus 173 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~------~~~~ 238 (303)
T 3a7i_A 173 -QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-------N------NPPT 238 (303)
T ss_dssp -BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------S------CCCC
T ss_pred -ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-------C------CCCC
Confidence 1122345699999999999999999999999999999999999999986554332221110 0 0111
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
+...++ ..+.+|+.+||+.||.+|||+.++++.....
T Consensus 239 ~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 239 LEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp CCSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred CccccC----HHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 112233 3789999999999999999999999865433
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=374.86 Aligned_cols=253 Identities=23% Similarity=0.299 Sum_probs=206.2
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-------------cchHHHHHHHHHHhhcCCCCccceEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-------------QGNREFLVEVLMLSLLHHPNLVNLIG 136 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~~~~ 136 (399)
..++|++.+.||+|+||.||+|.++.+++.||||++..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35689999999999999999999999999999999975432 22467889999999999999999999
Q ss_pred EEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC---
Q 015816 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY--- 213 (399)
Q Consensus 137 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~--- 213 (399)
++.+...+|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999986 567999999999999999999999999 99999999999998776
Q ss_pred ceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh
Q 015816 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 293 (399)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 293 (399)
.+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+...
T Consensus 187 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp SEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 6999999999764322 1233456999999999987 46999999999999999999999999876554332222111
Q ss_pred hhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 294 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.. .........+ +..+.+|+.+||+.||.+|||+.++++.
T Consensus 263 ~~----------~~~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KY----------YFDFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CC----------CCCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC----------CCCccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 0000111122 2378999999999999999999999964
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=349.46 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=207.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEec---------
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--------- 140 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------- 140 (399)
...+|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999999899999999997542 456789999999999999999998854
Q ss_pred -------CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC
Q 015816 141 -------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213 (399)
Q Consensus 141 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~ 213 (399)
...+++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 445899999999999999997532 357999999999999999999999999 99999999999999999
Q ss_pred ceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh
Q 015816 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 293 (399)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 293 (399)
.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+...... ..
T Consensus 160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-----~~-- 229 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF-----FT-- 229 (284)
T ss_dssp EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH-----HH--
T ss_pred CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH-----HH--
Confidence 99999999987643322 123356999999999999999999999999999999999999987532111 00
Q ss_pred hhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 294 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
. ... ..+...+ ...+.+++.+||+.||.+|||+.++++.|..+...
T Consensus 230 -~-~~~---------~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 -D-LRD---------GIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -H-HHT---------TCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -H-hhc---------ccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0 000 0011122 23788999999999999999999999999987643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=347.19 Aligned_cols=266 Identities=23% Similarity=0.291 Sum_probs=206.7
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEE-ecCCeeEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVY 148 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~ 148 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45789999999999999999999999999999998754432 23577899999999988877666655 6678889999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee---cCCCceEEecccCCcc
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKL 225 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~ 225 (399)
||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 89999999852 456999999999999999999999999 9999999999999 7889999999999986
Q ss_pred CCCCCCc-----ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh-hhhhcc
Q 015816 226 GPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLFQD 299 (399)
Q Consensus 226 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~ 299 (399)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 4333221 1223457999999999999999999999999999999999999999764332111111100 000000
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
. .+.....++ ..+.+|+..||+.||++|||+.++++.|+.+....
T Consensus 238 ~-------~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 238 P-------IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp C-------HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred h-------hhhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 0 001112222 37899999999999999999999999999887643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=367.66 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=195.5
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--------cchHHHHHHHHHHhhcCCCCccceEEEEec
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--------QGNREFLVEVLMLSLLHHPNLVNLIGYCAD 140 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 140 (399)
...++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456789999999999999999999999999999999865321 112347889999999999999999999865
Q ss_pred CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC---CceEE
Q 015816 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKL 217 (399)
Q Consensus 141 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl 217 (399)
+..|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 568999999999999999876 577999999999999999999999999 9999999999999754 45999
Q ss_pred ecccCCccCCCCCCcceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh
Q 015816 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 294 (399)
+|||++..... .......+||+.|+|||++. ...++.++|||||||++|+|++|..||........ +.....
T Consensus 284 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~ 358 (419)
T 3i6u_A 284 TDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 358 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHH
T ss_pred eecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHh
Confidence 99999986332 22234467999999999985 36788999999999999999999999975432111 000000
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.. .....+.....+ ...+.+|+.+||+.||.+|||+.++++
T Consensus 359 ----~~---~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 ----SG---KYNFIPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ----TT---CCCCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----cC---CCCCCchhhccc----CHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 000011111122 347899999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=345.64 Aligned_cols=265 Identities=23% Similarity=0.293 Sum_probs=209.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEE-ecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~e 149 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+.++ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 468999999999999999999999999999999986543 235688999999999998876666555 66778899999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee---cCCCceEEecccCCccC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~ 226 (399)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 89999999742 457999999999999999999999999 9999999999999 47889999999999764
Q ss_pred CCCCCc-----ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh-hhhhccc
Q 015816 227 PVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLFQDR 300 (399)
Q Consensus 227 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 300 (399)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 433221 1123457999999999999999999999999999999999999999764321111111000 0000000
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
.+.+...++ ..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 239 -------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 -------IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp -------HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -------hHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 001112223 37899999999999999999999999999887543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=347.68 Aligned_cols=261 Identities=28% Similarity=0.375 Sum_probs=206.8
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCe---EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCee-EEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR-LLV 147 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-~lv 147 (399)
.|++.+.||+|+||.||+|.+..++. .||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46677899999999999999755444 799999875433 2346788999999999999999999999876665 999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+.+++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999975 2467899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCC--CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCC-cccchHHHHHHHHHhhhhhhccccccc
Q 015816 228 VGD--NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA-VDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 228 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
... .........+|+.|+|||.+.+..++.++|||||||++|+|++|..| |................
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---------- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR---------- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC----------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC----------
Confidence 221 11122335678999999999999999999999999999999995554 54433222111111000
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccC
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 356 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 356 (399)
. ...+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 246 ---~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 246 ---R----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ---C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ---C----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 0 01112223478999999999999999999999999998876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=347.85 Aligned_cols=259 Identities=26% Similarity=0.374 Sum_probs=209.4
Q ss_pred cCCCCCC-eeeecCceEEEEEEEC--CCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSES-LLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
++|.+.. .||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+++.++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566665 8999999999999864 4688899999976533 2346788999999999999999999999 45678999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999974 2456999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCc-ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 228 VGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 228 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
..... .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.............. ..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-------~~---- 230 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------GK---- 230 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-------TC----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-------CC----
Confidence 32221 11223456899999999998899999999999999999998 9999977554332221110 00
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.+ ..++..+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 231 --~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 231 --RM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp --CC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --cC----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 01 12223344899999999999999999999999999988654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=363.96 Aligned_cols=267 Identities=19% Similarity=0.271 Sum_probs=202.6
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEec--------
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 140 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------- 140 (399)
...++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999999999999999998654222 2369999999999999999999843
Q ss_pred ------------------------------CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 015816 141 ------------------------------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190 (399)
Q Consensus 141 ------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 190 (399)
...+++||||++ ++|.+.+.........+++..++.++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334889999998 6888877654434678999999999999999999999
Q ss_pred hCCCCCeeecCCCCCceeec-CCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccC-CCCcccceeehhHHH
Q 015816 191 DKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVL 268 (399)
Q Consensus 191 ~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il 268 (399)
+++ |+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 99999999999998 68899999999998543222 22345689999999988764 599999999999999
Q ss_pred HHHHhCCCCcccchHHHHHHHHHhh-hhh-h------cc---ccccccccCccccCCCChHhHHHHHHHHHHccccCCCC
Q 015816 269 LEILSGRKAVDTSKAAAEQSLVAWA-RPL-F------QD---RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 337 (399)
Q Consensus 269 ~ell~g~~pf~~~~~~~~~~~~~~~-~~~-~------~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 337 (399)
|+|++|+.||............... ... . .. ...............++...+..+.+|+.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999876554332221111 000 0 00 00000000011111122334457899999999999999
Q ss_pred CCCHHHHHH
Q 015816 338 RPVIADVVT 346 (399)
Q Consensus 338 RPs~~eil~ 346 (399)
|||+.|+++
T Consensus 313 R~t~~e~l~ 321 (383)
T 3eb0_A 313 RINPYEAMA 321 (383)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999995
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=344.72 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=200.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367999999999999999999999899999999986432 22345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999986 457999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCcceeeeeccCccccCccccccCCC-CcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.. .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||............. . ..
T Consensus 163 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~---~~------ 227 (276)
T 2h6d_A 163 DG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR---G---GV------ 227 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H---CC------
T ss_pred CC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh---c---Cc------
Confidence 22 12234568999999999987765 689999999999999999999998754433221111 0 00
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. ..+......+.+++.+||+.||.+|||+.++++.
T Consensus 228 --~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 --F----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --c----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 0111223478899999999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=350.05 Aligned_cols=260 Identities=22% Similarity=0.287 Sum_probs=207.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEe--cCCeeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~l 146 (399)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 45799999999999999999999999999999999755332 3456889999999999999999999874 4678999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA--KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
||||+++++|.+++.........+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999864433556999999999999999999999876 2349999999999999999999999999987
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||............. . ..
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~---~----~~--- 232 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR---E----GK--- 232 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H----TC---
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh---h----cc---
Confidence 53222 111233568999999999999999999999999999999999999998765432221110 0 00
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
.+ ..+...+..+.+++.+||+.||.+|||+.++++.+.
T Consensus 233 ---~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 ---FR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ---CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ---cc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 00 111223348899999999999999999999997654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=370.83 Aligned_cols=200 Identities=26% Similarity=0.359 Sum_probs=170.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecC-----Ce
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 143 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999999999999999999975422 2346788999999999999999999999776 57
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
.|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999997 699999986 567999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc--------------------ceeeeeccCccccCcccc-ccCCCCcccceeehhHHHHHHHhCCCCc
Q 015816 224 KLGPVGDNT--------------------HVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILSGRKAV 278 (399)
Q Consensus 224 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf 278 (399)
+........ ...+..+||+.|+|||++ .+..++.++|||||||++|||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 864332211 123456799999999986 5677999999999999999999854443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=343.87 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=201.7
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
|.....||+|+||.||+|.+..+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 44556899999999999999999999999999876655667899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-CCceEEecccCCccCCCCCCc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNT 232 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~ 232 (399)
++|.+++.... ....+++..++.++.||+.||.|||+++ |+|+||||+|||++. ++.+||+|||++...... .
T Consensus 104 ~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~ 177 (295)
T 2clq_A 104 GSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--N 177 (295)
T ss_dssp EEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC--C
Confidence 99999998632 1345779999999999999999999999 999999999999987 899999999999753322 1
Q ss_pred ceeeeeccCccccCccccccCC--CCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 233 HVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||............. .... ..+.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~--------~~~~ 246 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV---GMFK--------VHPE 246 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH---HHHC--------CCCC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh---cccc--------cccc
Confidence 1223456999999999987643 8899999999999999999999997543322111100 0000 0111
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+......+.+|+.+||+.||++|||+.++++
T Consensus 247 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 ----IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12223348889999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=362.79 Aligned_cols=265 Identities=21% Similarity=0.270 Sum_probs=207.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 579999999999999999999999999999999976532 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
+++++|.+++.. ...+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 113 ~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~-- 183 (360)
T 3eqc_A 113 MDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-- 183 (360)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH--
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc--
Confidence 999999999987 45799999999999999999999996 8 9999999999999999999999999986421
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh-hc-cc---ccc-
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL-FQ-DR---TRH- 303 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~-~~---~~~- 303 (399)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.................. .. .. ...
T Consensus 184 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 184 --DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp --HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred --cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 11223457999999999999999999999999999999999999999876544332211000000 00 00 000
Q ss_pred --------------------ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 304 --------------------SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 304 --------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
..+................+.+|+.+||+.||.+|||+.++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000000011123478999999999999999999999964
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=346.95 Aligned_cols=248 Identities=21% Similarity=0.258 Sum_probs=202.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 146 (399)
...+|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 45679999999999999999999999999999999875432 3345688899999998 89999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC--------------
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-------------- 212 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~-------------- 212 (399)
||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999864322367999999999999999999999999 9999999999999844
Q ss_pred -----CceEEecccCCccCCCCCCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHH
Q 015816 213 -----YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (399)
Q Consensus 213 -----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 286 (399)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++........
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~ 239 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH
T ss_pred ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH
Confidence 47999999998753321 223599999999999765 667899999999999999999987754432110
Q ss_pred HHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 287 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+ .. . ..+.+... ....+.+|+.+||+.||.+|||+.++++
T Consensus 240 --~---~~----~-------~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 240 --I---RQ----G-------RLPRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --H---HT----T-------CCCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --H---Hc----C-------CCCCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0 00 0 00111122 2348899999999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=356.75 Aligned_cols=268 Identities=27% Similarity=0.410 Sum_probs=212.9
Q ss_pred hcCCCCCCeeeecCceEEEEEE----ECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCC--ee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~ 144 (399)
.++|++.+.||+|+||.||+|. +..+++.||||++........+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 3568999999999999999998 45679999999998765555678999999999999999999999987654 78
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999863 356999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcc-eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH---------HHhhh
Q 015816 225 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL---------VAWAR 294 (399)
Q Consensus 225 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~---------~~~~~ 294 (399)
......... ......++..|+|||++.+..++.++|||||||++|+|++|..||........... .....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 643332211 12234577889999999988999999999999999999999999875432211100 00000
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
....... ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+..+
T Consensus 274 ~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 274 ELLKNNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHTTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhhcCC----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000 0111223344899999999999999999999999999988753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=356.60 Aligned_cols=261 Identities=20% Similarity=0.261 Sum_probs=199.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCC------
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 142 (399)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999999999999999998654322 2356889999999999999999999997763
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 7899999975 56999999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc--
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD-- 299 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 299 (399)
++.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.........
T Consensus 175 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 986322 1234578999999999877 78999999999999999999999999876554332221111000000
Q ss_pred --cc----------ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 300 --RT----------RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 300 --~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.. .........+ ....+.....+.+|+.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00 0000000000 1112233458899999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=344.13 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=209.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 3578999999999999999999875 7889999997543 345778999999999999999999999864 568999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 99999999997521 236999999999999999999999999 9999999999999999999999999997643221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........++..|+|||++.+..++.++||||||+++|+|++ |..||............ .. .. ..
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---~~----~~------~~ 229 (279)
T 1qpc_A 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---ER----GY------RM 229 (279)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HT----TC------CC
T ss_pred -cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH---hc----cc------CC
Confidence 111223456789999999998899999999999999999999 99999765543322111 10 00 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
..+...+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 230 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 230 ----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 11122334889999999999999999999999999988653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=347.56 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=206.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC---CCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4679999999999999999998653 345699999876532 3446789999999999999999999998754 5789
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999762 356999999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.... ........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||............... .
T Consensus 164 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-------~---- 231 (281)
T 3cc6_A 164 EDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-------D---- 231 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-------C----
T ss_pred cccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-------C----
Confidence 3221 112233457889999999999999999999999999999998 99999754433222111100 0
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.. ..+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 232 --~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 232 --RL----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp --CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CC----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 00 11112234788999999999999999999999999987653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=358.49 Aligned_cols=267 Identities=16% Similarity=0.180 Sum_probs=207.0
Q ss_pred cCCCCCCeeeecCceEEEEEEECC--------CCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccc----------
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES--------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN---------- 133 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~---------- 133 (399)
++|++.+.||+|+||.||+|.+.. .++.||||++... ..+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 579999999999999999999987 3889999998644 45788999999999999988
Q ss_pred -----eEEEEec-CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCce
Q 015816 134 -----LIGYCAD-GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 207 (399)
Q Consensus 134 -----~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Ni 207 (399)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777765 67899999999 899999998631 367999999999999999999999999 99999999999
Q ss_pred eecCCC--ceEEecccCCccCCCCCCc-----ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCccc
Q 015816 208 LLDRGY--HPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (399)
Q Consensus 208 ll~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 280 (399)
|++.++ .+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999754322111 111334799999999999999999999999999999999999999986
Q ss_pred chHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccC
Q 015816 281 SKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 356 (399)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 356 (399)
....... ............. ...........+ +..+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus 271 ~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 271 CLPNTED-IMKQKQKFVDKPG--PFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GTTCHHH-HHHHHHHHHHSCC--CEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCcCHHH-HHHHHHhccCChh--hhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 5321111 1111111111000 000000000112 2488999999999999999999999999998876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=355.46 Aligned_cols=270 Identities=22% Similarity=0.297 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEec--------
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 140 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------- 140 (399)
..+|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999999999999999998654332 24578899999999999999999999977
Q ss_pred CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 141 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
...+++||||++ ++|.+.+... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccC-CCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 346899999998 5777777652 356999999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCC--cceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhh
Q 015816 221 GLAKLGPVGDN--THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 297 (399)
Q Consensus 221 g~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 297 (399)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...................
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99976432221 122234568999999998876 568999999999999999999999998766554433332221111
Q ss_pred ccccccc-----cccCccccCC--CC-hH------hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 298 QDRTRHS-----LIADPELQGQ--YP-PR------GFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 298 ~~~~~~~-----~~~~~~~~~~--~~-~~------~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
....... .......... .. .. ....+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1100000 0000000000 00 00 12357899999999999999999999964
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=354.82 Aligned_cols=259 Identities=27% Similarity=0.373 Sum_probs=203.2
Q ss_pred HHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEec---
Q 015816 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD--- 140 (399)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--- 140 (399)
.++....++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 334445678999999999999999999999999999999986543 3456788999999998 79999999999977
Q ss_pred ---CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEE
Q 015816 141 ---GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (399)
Q Consensus 141 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 217 (399)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEE
Confidence 468899999999999999998632 357999999999999999999999999 999999999999999999999
Q ss_pred ecccCCccCCCCCCcceeeeeccCccccCccccc-----cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHh
Q 015816 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 292 (399)
+|||++...... ........||+.|+|||++. +..++.++|||||||++|+|++|..||.............
T Consensus 171 ~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~- 247 (326)
T 2x7f_A 171 VDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP- 247 (326)
T ss_dssp CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-
T ss_pred eeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh-
Confidence 999998753221 11223456999999999986 5678999999999999999999999997655432221110
Q ss_pred hhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. ... .. .....+ +..+.+|+.+||..||.+|||+.++++.
T Consensus 248 -~----~~~--~~----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 -R----NPA--PR----LKSKKW----SKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -H----SCC--CC----CSCSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -c----Ccc--cc----CCcccc----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000 00 001122 2378899999999999999999999963
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=356.24 Aligned_cols=263 Identities=28% Similarity=0.412 Sum_probs=208.2
Q ss_pred CCCCCeeeecCceEEEEEEE----CCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEec--CCeeEE
Q 015816 74 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLL 146 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 146 (399)
|++.+.||+|+||.||+|.. ..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+ ...+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999988764 45789999999976533 234668999999999999999999999987 467899
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999975 45999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCc-ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH--------HHhhhhhh
Q 015816 227 PVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL--------VAWARPLF 297 (399)
Q Consensus 227 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~--------~~~~~~~~ 297 (399)
...... .......||..|+|||++.+..++.++|||||||++|+|++|..||........... ........
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 433221 123345688899999999999999999999999999999999999976543211100 00000000
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
... .....+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 265 ~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 265 ERG----------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcc----------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 000 01112223344899999999999999999999999999988754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=347.80 Aligned_cols=262 Identities=27% Similarity=0.407 Sum_probs=205.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCC---CeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEe-cCCeeE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRL 145 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~ 145 (399)
..+|++.+.||+|+||.||+|.+..+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++. .....+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35688999999999999999997543 34689999875433 23467889999999999999999999864 456789
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999975 2456899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCC--cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 226 GPVGDN--THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 226 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
...... ........||+.|+|||.+.+..++.++|||||||++|+|++ |.+||............... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~------~-- 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------R-- 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT------C--
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC------C--
Confidence 432221 112233567889999999999999999999999999999999 56666554332221111000 0
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
.. ..+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 250 -----~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 250 -----RL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -----CC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 011122347899999999999999999999999999887653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=360.53 Aligned_cols=265 Identities=26% Similarity=0.387 Sum_probs=201.0
Q ss_pred CCCCCCeeeecCceEEEEEEECCC---CeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEec-CCeeEEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLV 147 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv 147 (399)
.|++.+.||+|+||.||+|.+..+ +..||||.+..... ...+.+.+|+.+++.++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 477789999999999999997543 34689999865332 344678999999999999999999998754 4578999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999752 456899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCc--ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 228 VGDNT--HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 228 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||............. ...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-------~~~--- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------QGR--- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-------TTC---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-------cCC---
Confidence 22211 11233457889999999999999999999999999999999 678886543322111110 000
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccCCCcc
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDA 360 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~ 360 (399)
.. ..+...+..+.+++.+||+.||++|||+.++++.|+.+.........
T Consensus 314 ---~~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~ 362 (373)
T 3c1x_A 314 ---RL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362 (373)
T ss_dssp ---CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred ---CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence 00 11122234789999999999999999999999999998876554443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=358.40 Aligned_cols=260 Identities=16% Similarity=0.162 Sum_probs=210.5
Q ss_pred HhcCCCCCCeeeecCceEEEEEE-----ECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC---CCCccceEEEEecC
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGY-----LESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADG 141 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~ 141 (399)
..++|++.+.||+|+||.||+|. +..+++.||||++... ....+..|+.+++.++ |+||+.+++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35679999999999999999994 6677999999999754 3456777888888876 89999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---------
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSP-GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--------- 211 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~--------- 211 (399)
+..|+||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+++ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999975322 2467999999999999999999999999 999999999999998
Q ss_pred --CCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHH
Q 015816 212 --GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (399)
Q Consensus 212 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 289 (399)
++.+||+|||++...............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999975433333444556779999999999999999999999999999999999999986532210
Q ss_pred HHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHHHhccCC
Q 015816 290 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR-PVIADVVTALAYLASQKYE 357 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~eil~~L~~l~~~~~~ 357 (399)
.. ....+ ... .....+.+++..||+.+|.+| |++.++.+.|+.+....+.
T Consensus 293 -------~~--------~~~~~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 293 -------CK--------PEGLF-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp -------EE--------ECSCC-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred -------ee--------echhc-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 00 00000 011 123467789999999999999 6888888999887765443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=346.16 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=201.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecC-CeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-DQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e 149 (399)
.++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 467999999999999999999885 7899999987543 456789999999999999999999997654 47899999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999997521 223899999999999999999999999 999999999999999999999999998743221
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.....+++.|+|||++.+..++.++||||||+++|+|++ |..||............ .... .
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-------~~~~------~ 232 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGY------K 232 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------TTTC------C
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcCC------C
Confidence 223357889999999999999999999999999999998 99999765432211111 0000 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
+ ..+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 233 ~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 M----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1 11222334889999999999999999999999999988754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=348.01 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=204.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3567999999999999999999999999999999997542 35678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999742 467999999999999999999999999 999999999999999999999999999753322
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........||+.|+|||++.+..++.++||||||+++|+|++|..||............. ... ...
T Consensus 179 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~--~~~---- 244 (314)
T 3com_A 179 --MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP------TNP--PPT---- 244 (314)
T ss_dssp --BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HSC--CCC----
T ss_pred --ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh------cCC--Ccc----
Confidence 122234568999999999999999999999999999999999999998655432221110 000 000
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 245 ---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 245 ---FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ---CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01112223478899999999999999999999963
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=350.94 Aligned_cols=253 Identities=25% Similarity=0.317 Sum_probs=199.5
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--------cchHHHHHHHHHHhhcCCCCccceEEEEecC
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--------QGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 141 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34679999999999999999999999999999999865422 1123478899999999999999999998766
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc---eEEe
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLS 218 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~ 218 (399)
. .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 8999999999999999976 567999999999999999999999999 999999999999987654 9999
Q ss_pred cccCCccCCCCCCcceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh
Q 015816 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 295 (399)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 295 (399)
|||++..... ........||+.|+|||++. ...++.++|||||||++|+|++|..||........ +......
T Consensus 160 Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~ 234 (322)
T 2ycf_A 160 DFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS 234 (322)
T ss_dssp CCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH
T ss_pred cCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh
Confidence 9999975322 11223456999999999873 56789999999999999999999999975432111 0000000
Q ss_pred hhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. .....+.....+ ...+.+|+.+||+.||++|||+.++++
T Consensus 235 ----~---~~~~~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 ----G---KYNFIPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ----T---CCCCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----C---ccccCchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 000011111222 347889999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=350.54 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=203.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46799999999999999999999999999999999876666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.... .
T Consensus 98 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--~ 169 (302)
T 2j7t_A 98 CPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--K 169 (302)
T ss_dssp CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHH--H
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccc--c
Confidence 9999999998753 456999999999999999999999999 9999999999999999999999999875311 0
Q ss_pred CcceeeeeccCccccCcccc-----ccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 231 NTHVSTRVMGTYGYCAPEYA-----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.........||+.|+|||++ .+..++.++|||||||++|+|++|..||............ .. .. .. .
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~----~~-~~-~ 241 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--AK----SD-PP-T 241 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HH----SC-CC-C
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH--hc----cC-Cc-c
Confidence 11112335689999999988 4678899999999999999999999999876543321111 10 00 00 0
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+...+..+.+++.+||+.||.+|||+.++++
T Consensus 242 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 -------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0111223347889999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=354.66 Aligned_cols=262 Identities=25% Similarity=0.350 Sum_probs=193.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEe--------cC
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCA--------DG 141 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--------~~ 141 (399)
..+|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++..+. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357999999999999999999999999999999987665555677899999999996 999999999984 34
Q ss_pred CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
..+++||||+. |+|.+++..... ..++++..++.++.||+.||.|||+++ ++|+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 45799999997 799998875332 456999999999999999999999875 349999999999999999999999999
Q ss_pred CCccCCCCCCcc----------eeeeeccCccccCcccc---ccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHH
Q 015816 222 LAKLGPVGDNTH----------VSTRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (399)
Q Consensus 222 ~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 288 (399)
++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-- 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-- 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence 998643322111 11134689999999998 567889999999999999999999999975432110
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcc
Q 015816 289 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 355 (399)
...... ....... ...+.+|+.+||+.||.+|||+.++++.|..+....
T Consensus 262 ----~~~~~~----------~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 262 ----VNGKYS----------IPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------CC----------CCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ----hcCccc----------CCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 000000 0001111 125778999999999999999999999999887643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=351.19 Aligned_cols=264 Identities=23% Similarity=0.331 Sum_probs=201.6
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc--CCCCccceEEEEecC----C
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL--HHPNLVNLIGYCADG----D 142 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~~~~----~ 142 (399)
...++|++.+.||+|+||.||+|.+. ++.||||++... ....+..|.+++..+ +||||+++++++... .
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 34568999999999999999999986 899999998543 234455566666554 899999999999887 7
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeeecCCCCCceeecCCCc
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK--------AKPPVIYRDLKCSNILLDRGYH 214 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~~~~ivH~Dlkp~Nill~~~~~ 214 (399)
..++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSC
T ss_pred ceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCC
Confidence 89999999999999999975 4699999999999999999999998 7 999999999999999999
Q ss_pred eEEecccCCccCCCCCCcc--eeeeeccCccccCccccccCCCCcc------cceeehhHHHHHHHhC----------CC
Q 015816 215 PKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTGQLTLK------SDVYSFGVVLLEILSG----------RK 276 (399)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~ell~g----------~~ 276 (399)
+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|||++| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999997533222111 1123579999999999988776665 9999999999999999 56
Q ss_pred CcccchHHHH--HHHHHhhhhhhccccccccccCccccCC-CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 277 AVDTSKAAAE--QSLVAWARPLFQDRTRHSLIADPELQGQ-YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 277 pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
||........ ...... ..... ..+.+... .....+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 261 p~~~~~~~~~~~~~~~~~----~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREI----VCIKK-----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTTTTSCSSCCHHHHHHH----HTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHhhhcCCCCchhhhHHH----Hhhhc-----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 6643211100 000000 00000 00111000 112456689999999999999999999999999999876
Q ss_pred c
Q 015816 354 Q 354 (399)
Q Consensus 354 ~ 354 (399)
.
T Consensus 332 ~ 332 (337)
T 3mdy_A 332 S 332 (337)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=345.15 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=207.8
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---------cchHHHHHHHHHHhhcC-CCCccceEEEE
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---------QGNREFLVEVLMLSLLH-HPNLVNLIGYC 138 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 138 (399)
...++|++.+.||+|+||.||+|.++.+++.||||++..... ...+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 345789999999999999999999999999999999975431 11345788999999995 99999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEe
Q 015816 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 218 (399)
Q Consensus 139 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 218 (399)
.+....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999986 567999999999999999999999999 9999999999999999999999
Q ss_pred cccCCccCCCCCCcceeeeeccCccccCccccc------cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHh
Q 015816 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292 (399)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 292 (399)
|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||..............
T Consensus 167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 999997543222 223456899999999885 45789999999999999999999999976554332221110
Q ss_pred hhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.. .. ......+..+..+.+|+.+||+.||.+|||+.++++
T Consensus 244 ~~------~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GN------YQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TC------CC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CC------cc--------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00 00 000111223347899999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=346.68 Aligned_cols=254 Identities=22% Similarity=0.278 Sum_probs=191.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc-h-HHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-N-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.++|++.+.||+|+||.||+|.+..+|+.||||++....... . +.+..+...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467999999999999999999999999999999997543222 2 23444555678889999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
||++ |+|.+++.........+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9998 588888765443467899999999999999999999998 9 9999999999999999999999999997532
Q ss_pred CCCCcceeeeeccCccccCcccc----ccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYA----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
.. .......||+.|+|||++ .+..++.++|||||||++|+|++|..||.......... ..... ..
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~----~~--- 230 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL-KQVVE----EP--- 230 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH-HHHHH----SC---
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH-HHHhc----cC---
Confidence 22 222334699999999996 56678999999999999999999999997533222111 11111 00
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+.. .....+..+.+|+.+||+.||++|||+.++++
T Consensus 231 ----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 ----SPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0000 01122347899999999999999999999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=355.58 Aligned_cols=264 Identities=21% Similarity=0.268 Sum_probs=196.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCC------
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 142 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3679999999999999999999999999999999975432 23356889999999999999999999997765
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
..|+||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999998 57888885 34899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh---------
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA--------- 293 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------- 293 (399)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus 174 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred cccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 975322 11233457999999999999999999999999999999999999999876543322111000
Q ss_pred -------hhhhcccccccccc----CccccCC----CChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 294 -------RPLFQDRTRHSLIA----DPELQGQ----YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 294 -------~~~~~~~~~~~~~~----~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.............. .+..... ........+.+|+.+||+.||.+|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000000000 0000000 011225678999999999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=378.05 Aligned_cols=258 Identities=26% Similarity=0.369 Sum_probs=204.7
Q ss_pred CCCCCC-eeeecCceEEEEEEEC--CCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 73 NFRSES-LLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 73 ~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++.+.. .||+|+||.||+|.++ .++..||||++..... ...+.+.+|+.+|+.++|||||++++++.. +.+++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999875 3467899999976533 345789999999999999999999999976 5699999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 415 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp ECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999752 456999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCc-ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 229 GDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 229 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.. ..
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-------~~----- 556 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------GK----- 556 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-------TC-----
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------CC-----
Confidence 2211 11222346789999999999999999999999999999998 9999987654432222110 00
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
....++..+..+.+|+.+||+.||++||++.+|++.|+.+...
T Consensus 557 -----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 557 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0112223344899999999999999999999999999977543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=363.80 Aligned_cols=263 Identities=23% Similarity=0.295 Sum_probs=209.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC-CCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 149 (399)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.++| ++|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 3679999999999999999999999999999998865432 3457889999999987 566666777788889999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee---cCCCceEEecccCCccC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~ 226 (399)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||++...
T Consensus 84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 89999999853 457999999999999999999999999 9999999999999 68899999999999864
Q ss_pred CCCCCc-----ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh-hhhhccc
Q 015816 227 PVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLFQDR 300 (399)
Q Consensus 227 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 300 (399)
...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||............... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 433221 1123567999999999999999999999999999999999999999764432221111111 1100000
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
...+...++ ..+.+|+..||+.||++||++.+|++.|+.+..
T Consensus 237 -------~~~l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 237 -------IEALCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp -------HHHHHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -------HHHHhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 001112233 378999999999999999999999999988854
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=380.22 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=202.7
Q ss_pred CeeeecCceEEEEEEE--CCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.+ +.+++.||||++..... ...+.+.+|+.+++.++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999955 45678999999975432 234679999999999999999999999975 468899999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC-c
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-T 232 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 232 (399)
|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999986 567999999999999999999999999 99999999999999999999999999976433322 1
Q ss_pred ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||............... . .
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-------~------~--- 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------E------R--- 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------C------C---
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------C------C---
Confidence 22233457889999999999999999999999999999998 99999876654432222111 0 0
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
..++...+..+.+|+..||+.||++||++.+|++.|+.+..
T Consensus 591 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 591 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11122333488999999999999999999999999987754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=376.31 Aligned_cols=257 Identities=29% Similarity=0.412 Sum_probs=210.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.+|+.++||||+++++++.+ ...||||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 4568889999999999999999986 5779999997643 345789999999999999999999999876 678999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++|+|.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 343 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 416 (535)
T 2h8h_A 343 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN- 416 (535)
T ss_dssp CTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-
T ss_pred hcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC-
Confidence 99999999997521 346899999999999999999999999 999999999999999999999999999753221
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
.........++..|+|||++.+..++.++|||||||+||||++ |+.||...........+. . ..
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~---~----~~-------- 481 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---R----GY-------- 481 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH---T----TC--------
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c----CC--------
Confidence 1111222346789999999999999999999999999999999 999998765433222111 0 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
....+...+..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 482 --~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 482 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 011122333488999999999999999999999999997653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=353.61 Aligned_cols=263 Identities=24% Similarity=0.292 Sum_probs=204.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecC-----Cee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 144 (399)
..+|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 45899999999999999999999999999999999754332 236788999999999999999999999765 468
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999998 699999975 56999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCc-ceeeeeccCccccCccccc-cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh-hhhc---
Q 015816 225 LGPVGDNT-HVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PLFQ--- 298 (399)
Q Consensus 225 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~--- 298 (399)
........ .......||+.|+|||++. +..++.++|||||||++|+|++|+.||................ ....
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 54322111 1123457999999999865 4568999999999999999999999997655433222211100 0000
Q ss_pred -------------cccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 299 -------------DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 299 -------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
............+ .+.....+.+|+.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRL----FPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHH----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHh----CCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000001 1122347899999999999999999999996
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=348.38 Aligned_cols=259 Identities=17% Similarity=0.233 Sum_probs=201.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEec--CCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999999999999999998643 3567889999999997 9999999999988 66789999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-ceEEecccCCccCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGP 227 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 227 (399)
||+++++|.+++.. +++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++....
T Consensus 113 e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999864 889999999999999999999999 99999999999999776 89999999997543
Q ss_pred CCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHH--HHHHhhh-hhhccc-cc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--SLVAWAR-PLFQDR-TR 302 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~-~~~~~~-~~ 302 (399)
.... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......... ....... +..... ..
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 3221 233568999999999876 67999999999999999999999999543322111 1100000 000000 00
Q ss_pred cccccC----------------ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 303 HSLIAD----------------PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 303 ~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.....+ ..............+.+||.+||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 00011111223458899999999999999999999996
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=367.12 Aligned_cols=244 Identities=15% Similarity=0.179 Sum_probs=191.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccC---CCcchHHHHHHHH---HHhhcCCCCccceE-------EE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVL---MLSLLHHPNLVNLI-------GY 137 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~hpniv~~~-------~~ 137 (399)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+. +++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999999989999999999743 2234467889994 55556899999998 77
Q ss_pred EecCCe-----------------eEEEEEecCCCCHHHHhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 015816 138 CADGDQ-----------------RLLVYEYMPLGSVEDHLHDLS---PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197 (399)
Q Consensus 138 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~---~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 197 (399)
+.+.+. .|+||||+ +|+|.+++.... .....+++..++.|+.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 766543 78999999 589999998521 11123445888899999999999999999 9
Q ss_pred eecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccC-----------CCCcccceeehhH
Q 015816 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-----------QLTLKSDVYSFGV 266 (399)
Q Consensus 198 vH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~ 266 (399)
+||||||+|||++.++.+||+|||++.... .......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998521 12344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 267 VLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 267 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
++|||++|+.||......... ..... ....++ ..+.+|+.+||+.||.+|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~------~~~~~------------~~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS------EWIFR------------SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS------GGGGS------------SCCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch------hhhhh------------hccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999654321100 00000 001223 37899999999999999999999996
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=356.92 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=188.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecC------C
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG------D 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~ 142 (399)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4689999999999999999999999999999999865432 2346688999999999999999999998754 5
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
..|+|||++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 6899888864 56999999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc--
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD-- 299 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 299 (399)
++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.........
T Consensus 179 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 975321 1234579999999999876 78999999999999999999999999876554332222111000000
Q ss_pred --ccc----------cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 300 --RTR----------HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 300 --~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
... ........+. ...+.....+.+|+.+||+.||.+|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0000000000 0001123478899999999999999999999853
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=362.49 Aligned_cols=264 Identities=25% Similarity=0.300 Sum_probs=199.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecC------CeeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~ 145 (399)
.+|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++|||||++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 468999999999999999999999999999999865422 233699999999999999999988532 2467
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC-CceEEecccCCc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAK 224 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~ 224 (399)
+||||++ ++|.+.+.........+++..++.++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 9999998 4777766543333678999999999999999999999999 9999999999999965 678999999998
Q ss_pred cCCCCCCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHH-Hhhh-h---hhc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWAR-P---LFQ 298 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~-~---~~~ 298 (399)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+ .... + .+.
T Consensus 206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 643222 22345789999999998664 7999999999999999999999999876543322211 1100 0 000
Q ss_pred c-ccccccccCccccC-----CCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 299 D-RTRHSLIADPELQG-----QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 299 ~-~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. .........+.+.. .+++.....+.+||.+||+.||.+|||+.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 00000011111110 112233458999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=359.71 Aligned_cols=256 Identities=25% Similarity=0.362 Sum_probs=203.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC---CCCeEEEEEEeccCCC----cchHHHHHHHHHHhhc-CCCCccceEEEEecCC
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 142 (399)
..+|++.+.||+|+||.||+|++. .+++.||||++..... ...+.+.+|+.+++.+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 367999999999999999999984 4799999999865321 2335567799999999 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999986 467999999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCcccccc--CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
+....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ .......
T Consensus 206 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~- 281 (355)
T 1vzo_A 206 SKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKS- 281 (355)
T ss_dssp EEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHC-
T ss_pred CeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhcc-
Confidence 87532211 122334579999999999975 45789999999999999999999999743221111000 0010100
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTAL 348 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L 348 (399)
.+ .++......+.+||.+||+.||.+|| ++.++++..
T Consensus 282 -------~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 -------EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -------CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11 12223334788999999999999999 999998654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=339.57 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=201.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEec----CCeeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~ 145 (399)
..|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 347888899999999999999999999999999875432 234568899999999999999999998865 45689
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec-CCCceEEecccCCc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAK 224 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~ 224 (399)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||||||+|||++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999986 467999999999999999999999875 3499999999999998 78999999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........... ... ..
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--~~~----~~---- 245 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR--RVT----SG---- 245 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH--HHT----TT----
T ss_pred ccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH--HHh----cc----
Confidence 53221 2334569999999998864 699999999999999999999999976433222111 000 00
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..........+ ..+.+|+.+||+.||.+|||+.++++
T Consensus 246 -~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 -VKPASFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CCCGGGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCccccCCCCC----HHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00111111222 37889999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=362.17 Aligned_cols=203 Identities=22% Similarity=0.317 Sum_probs=176.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc------CCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL------HHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~~~~ 144 (399)
..+|++.+.||+|+||.||+|.+..+++.||||++... ....+.+..|+.+++.+ +|+||+++++++.....+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 35799999999999999999999999999999999643 22345677888888877 577999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc--eEEecccC
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--PKLSDFGL 222 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~ 222 (399)
++||||+. ++|.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 79999998633 345999999999999999999999999 999999999999999887 99999999
Q ss_pred CccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHH
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 285 (399)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|.+||.......
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9753221 233579999999999999999999999999999999999999998765543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=349.21 Aligned_cols=266 Identities=26% Similarity=0.412 Sum_probs=189.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 45789999999999999999999988899999999865432 23466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 149 EYMPLGSVEDHLHDLS----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 9999999999997421 12456999999999999999999999999 9999999999999999999999999986
Q ss_pred cCCCCCC---cceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 225 LGPVGDN---THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 225 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ .... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~--~~ 245 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--LQND--PP 245 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HTSS--CC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--hccC--CC
Confidence 5332211 112234569999999999865 57899999999999999999999999765433221111 0000 00
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.......++.....++ ..+.+|+.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0001111122222333 47899999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=351.22 Aligned_cols=273 Identities=24% Similarity=0.284 Sum_probs=201.9
Q ss_pred CHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc-----------hHHHHHHHHHHhhcCCCCc
Q 015816 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-----------NREFLVEVLMLSLLHHPNL 131 (399)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpni 131 (399)
.+.++....++|++.+.||+|+||.||+|.+.. |..||||++....... .+.+.+|+.+++.++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 356777888999999999999999999999876 9999999986432211 2678899999999999999
Q ss_pred cceEEEEec-----CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 015816 132 VNLIGYCAD-----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 206 (399)
Q Consensus 132 v~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~N 206 (399)
+++++++.. ...+|+||||++ |+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 999999843 346899999998 688888875 2457999999999999999999999999 9999999999
Q ss_pred eeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHH
Q 015816 207 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (399)
Q Consensus 207 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 285 (399)
||++.++.+||+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999974222 222334578999999999876 779999999999999999999999998765433
Q ss_pred HHHHH-Hhhhh-h-----------hccccccccccCc-cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 286 EQSLV-AWARP-L-----------FQDRTRHSLIADP-ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 286 ~~~~~-~~~~~-~-----------~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..... ..... . ............+ .......+.....+.+|+.+||+.||.+|||+.++++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 32211 11000 0 0000000000000 0000111222347889999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=344.35 Aligned_cols=268 Identities=23% Similarity=0.295 Sum_probs=204.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCeEEEEEEeccCCC--cchHHHHHHHHHHhhc---CCCCccceEEEEe----
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLE-SINQDVAIKQLDRNGV--QGNREFLVEVLMLSLL---HHPNLVNLIGYCA---- 139 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~~~~---- 139 (399)
..++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 6789999999864322 2234566788777766 8999999999987
Q ss_pred -cCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEe
Q 015816 140 -DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 218 (399)
Q Consensus 140 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 218 (399)
.....++||||++ |+|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 69999998643 345999999999999999999999999 9999999999999999999999
Q ss_pred cccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhc
Q 015816 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 298 (399)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 298 (399)
|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....................
T Consensus 163 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 163 DFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp SCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999975321 1223345689999999999999999999999999999999999999987655433222111100000
Q ss_pred ccccccccc---------CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 299 DRTRHSLIA---------DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 299 ~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
......... .......+.+.....+.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 000001122233458889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=351.53 Aligned_cols=273 Identities=22% Similarity=0.239 Sum_probs=196.7
Q ss_pred HHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCe--
Q 015816 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ-- 143 (399)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-- 143 (399)
......++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+..++..+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 44566789999999999999999999999999999999986542 233456778888899999999999999865433
Q ss_pred -----eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeecCCCCCceeecC-CCce
Q 015816 144 -----RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--DKAKPPVIYRDLKCSNILLDR-GYHP 215 (399)
Q Consensus 144 -----~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~~~ivH~Dlkp~Nill~~-~~~~ 215 (399)
.++||||+++ +|...+.........+++..++.++.||+.||.||| +++ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999985 666555543333678999999999999999999999 998 999999999999997 8999
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 294 (399)
||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||................
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 999999998543222 22345689999999998654 48999999999999999999999998765543322221100
Q ss_pred hh--------hc-cccccc-----cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 295 PL--------FQ-DRTRHS-----LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 295 ~~--------~~-~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.. .. ...... ..................+.+|+.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00 000000 000001111222234568999999999999999999999995
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=356.31 Aligned_cols=264 Identities=19% Similarity=0.211 Sum_probs=203.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC--------CCCccceEEEEe---
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH--------HPNLVNLIGYCA--- 139 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~~~~~~~--- 139 (399)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999999999999999999643 223466889999999985 788999999987
Q ss_pred -cCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCceeecCCC----
Q 015816 140 -DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGY---- 213 (399)
Q Consensus 140 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dlkp~Nill~~~~---- 213 (399)
+...+|+||||+ +++|.+++.... ...+++..++.|+.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 566899999999 577777776522 35699999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------ceEEecccCCccCCCCCCcceeeeeccCccccCcc
Q 015816 214 ---------------------------------------------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248 (399)
Q Consensus 214 ---------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 248 (399)
.+||+|||++...... .....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 7999999999753221 23356999999999
Q ss_pred ccccCCCCcccceeehhHHHHHHHhCCCCcccchHH------HHHH-HHHhhhh--------------hhcccccccccc
Q 015816 249 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA------AEQS-LVAWARP--------------LFQDRTRHSLIA 307 (399)
Q Consensus 249 ~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~-~~~~~~~--------------~~~~~~~~~~~~ 307 (399)
++.+..++.++|||||||++|+|++|+.||...... .... +...... .+........+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999999754321 1111 1110000 000000000000
Q ss_pred Ccc---------ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 308 DPE---------LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 308 ~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... -....+......+.+|+.+||+.||++|||+.++++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 001335566778999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=348.01 Aligned_cols=270 Identities=23% Similarity=0.340 Sum_probs=209.7
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhh--cCCCCccceEEEEecC
Q 015816 64 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCADG 141 (399)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~ 141 (399)
+.-.....++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|++++.. ++||||+++++++...
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3333455678999999999999999999984 899999998643 34667889988887 7899999999999887
Q ss_pred C----eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCceee
Q 015816 142 D----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--------DKAKPPVIYRDLKCSNILL 209 (399)
Q Consensus 142 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~ivH~Dlkp~Nill 209 (399)
. ..++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+|||+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 6 78999999999999999975 46999999999999999999999 888 9999999999999
Q ss_pred cCCCceEEecccCCccCCCCCCcc--eeeeeccCccccCccccccC------CCCcccceeehhHHHHHHHhC-------
Q 015816 210 DRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSG------- 274 (399)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g------- 274 (399)
+.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 999999999999997543322211 12345699999999998765 334789999999999999999
Q ss_pred ---CCCcccchHHH--HHHHHHhhhhhhccccccccccCccccCC-CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 275 ---RKAVDTSKAAA--EQSLVAWARPLFQDRTRHSLIADPELQGQ-YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 275 ---~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
..||....... ...... ...... ..+.+... ........+.+|+.+||+.||.+|||+.++++.|
T Consensus 261 ~~~~~p~~~~~~~~~~~~~~~~---~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDPSVEEMRK---VVCEQK------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHH---HHTTSC------CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccCccccCcCcccHHHHHH---HHHHHH------hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 67875432110 001110 000000 00111110 1224556899999999999999999999999999
Q ss_pred HHHHhcc
Q 015816 349 AYLASQK 355 (399)
Q Consensus 349 ~~l~~~~ 355 (399)
+.+..+.
T Consensus 332 ~~i~~~~ 338 (342)
T 1b6c_B 332 SQLSQQE 338 (342)
T ss_dssp HHHHHTT
T ss_pred HHHHHHh
Confidence 9987653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=344.67 Aligned_cols=268 Identities=22% Similarity=0.314 Sum_probs=198.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEe-----------
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA----------- 139 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----------- 139 (399)
..+|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367999999999999999999999999999999997665555677899999999999999999999874
Q ss_pred ---cCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec-CCCce
Q 015816 140 ---DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHP 215 (399)
Q Consensus 140 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~ 215 (399)
+....++||||++ |+|.+++.. .++++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 3467899999998 699999863 57999999999999999999999999 99999999999997 56799
Q ss_pred EEecccCCccCCCCCC-cceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh
Q 015816 216 KLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 293 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 293 (399)
||+|||++........ ........+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...............
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999986432111 111233457999999998865 78999999999999999999999999876543322211111
Q ss_pred hhhhcccccc-----------ccccCccc-cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 294 RPLFQDRTRH-----------SLIADPEL-QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 294 ~~~~~~~~~~-----------~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.+........ .....+.. .....+.....+.+|+.+||+.||.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000000000 00000000 000111234488999999999999999999999963
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=349.74 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=200.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCee----
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR---- 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~---- 144 (399)
.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46899999999999999999999999999999999754332 236688999999999999999999999887655
Q ss_pred --EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 145 --LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 145 --~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
++||||+. ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 68888874 34999999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc--
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD-- 299 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 299 (399)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....................
T Consensus 191 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 975321 1234568999999999877 78999999999999999999999999876544332221110000000
Q ss_pred --ccc----------cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 300 --RTR----------HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 300 --~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... ........+ ....+.....+.+|+.+||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhhhhhhhhhhccCCCcchhH-HHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000 000000000 0011223458899999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=345.77 Aligned_cols=264 Identities=19% Similarity=0.234 Sum_probs=206.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCC------CccceEEEEecCCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYL-ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP------NLVNLIGYCADGDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~ 143 (399)
.++|++.+.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|+.+++.++|+ +|+++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45899999999999999999998 567899999998643 23346688899999988765 49999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC------------
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR------------ 211 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~------------ 211 (399)
.++||||+ +++|.+++.... ..++++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 799999998632 346899999999999999999999999 999999999999987
Q ss_pred -------CCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHH
Q 015816 212 -------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (399)
Q Consensus 212 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 284 (399)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999753221 23456999999999999999999999999999999999999999876554
Q ss_pred HHHHHHHhhhhhhcccc-----ccccc---------------------cCccccCCCChHhHHHHHHHHHHccccCCCCC
Q 015816 285 AEQSLVAWARPLFQDRT-----RHSLI---------------------ADPELQGQYPPRGFYQALAVAAMCVHEQPDMR 338 (399)
Q Consensus 285 ~~~~~~~~~~~~~~~~~-----~~~~~---------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 338 (399)
................. ..... ................+.+|+.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 43332221111000000 00000 00000011233456789999999999999999
Q ss_pred CCHHHHHH
Q 015816 339 PVIADVVT 346 (399)
Q Consensus 339 Ps~~eil~ 346 (399)
||+.|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=358.47 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=195.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCC------eeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~ 145 (399)
.+|++.+.||+|+||.||+|.+..++. ||+|++...... ..+|+.+++.++||||+++++++.... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 469999999999999999999988665 888887543222 235999999999999999999985543 378
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec-CCCceEEecccCCc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAK 224 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~ 224 (399)
+||||+++ ++...+.........+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999985 444444332223567999999999999999999999999 99999999999999 79999999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh---------
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR--------- 294 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------- 294 (399)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||................
T Consensus 191 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 191 ILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp ECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 643222 22345689999999998664 59999999999999999999999998765543322211110
Q ss_pred ---hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 295 ---PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 295 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+.+... .........+...+++.....+.+|+.+||+.||.+|||+.++++
T Consensus 268 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 268 TMNPNYMEH-KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCGGGSSS-CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhChhhhhh-ccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000 000000000111122233458999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=344.57 Aligned_cols=261 Identities=28% Similarity=0.401 Sum_probs=199.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC-CC--eEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLES-IN--QDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|++.+.||+|+||.||+|.+.. ++ ..||||++..... ...+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3579999999999999999998643 23 3699999875432 23467889999999999999999999998765 8
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999999863 356899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcc-eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 225 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 225 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
......... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||............. ....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~~~~- 242 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGE- 242 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TSCC-
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH------ccCC-
Confidence 643332211 2233457889999999998899999999999999999999 999998765433221110 0000
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.. ..+...+..+.+++.+||+.||.+|||+.++++.|..+...
T Consensus 243 -----~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 243 -----RL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----CC----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00 11122334889999999999999999999999999877653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=353.40 Aligned_cols=266 Identities=25% Similarity=0.349 Sum_probs=196.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHH--HhhcCCCCccceEEEEec-----CCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM--LSLLHHPNLVNLIGYCAD-----GDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~~~~~~~~-----~~~ 143 (399)
.++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|.++ +..++||||+++++.+.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 36799999999999999999977 4899999998643 23444445544 455899999999986532 235
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeeecCCCCCceeecCCCc
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK---------AKPPVIYRDLKCSNILLDRGYH 214 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------~~~~ivH~Dlkp~Nill~~~~~ 214 (399)
+++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence 7899999999999999975 4468999999999999999999999 8 999999999999999999
Q ss_pred eEEecccCCccCCCCCC------cceeeeeccCccccCcccccc-------CCCCcccceeehhHHHHHHHhCCCCcccc
Q 015816 215 PKLSDFGLAKLGPVGDN------THVSTRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (399)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~~ 281 (399)
+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99999999976432211 112234569999999999976 45678899999999999999998776432
Q ss_pred hHHHHH-HH----------HHhhhhhhccccccccccCccccCC--CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 282 KAAAEQ-SL----------VAWARPLFQDRTRHSLIADPELQGQ--YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 282 ~~~~~~-~~----------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
...... .. .......... ....+.+... ........+.+||.+||+.||++|||+.++++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSR-----EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTT-----SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcc-----cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 211000 00 0000000000 0001111111 1223556799999999999999999999999999
Q ss_pred HHHHhc
Q 015816 349 AYLASQ 354 (399)
Q Consensus 349 ~~l~~~ 354 (399)
+.+...
T Consensus 314 ~~ll~~ 319 (336)
T 3g2f_A 314 AELMMI 319 (336)
T ss_dssp HHHHHC
T ss_pred HHHHHH
Confidence 988754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=339.32 Aligned_cols=254 Identities=25% Similarity=0.327 Sum_probs=206.8
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999999999999999986542 2345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC---CceEEecccCC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLA 223 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~~ 223 (399)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999876 457999999999999999999999999 9999999999999764 47999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||............... ...
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~- 240 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG------KYA- 240 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCC-
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCC-
Confidence 7543222 1223458999999999875 5899999999999999999999999876543322211100 000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. .......+ +..+.+++.+||+.||.+|||+.++++.
T Consensus 241 --~-~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 --F-DLPQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp --C-CSGGGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --C-Cchhhhhc----CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 00011122 3378899999999999999999999973
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=357.20 Aligned_cols=255 Identities=10% Similarity=0.009 Sum_probs=184.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhc--CCCCccceE-------EEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL--HHPNLVNLI-------GYC 138 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l--~hpniv~~~-------~~~ 138 (399)
..+|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+..|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34589999999999999999999999999999999875432 234567785555554 699988755 455
Q ss_pred ecC-----------------CeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 015816 139 ADG-----------------DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR------MKIAAGAARGLEYLHDKAKP 195 (399)
Q Consensus 139 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~qi~~al~~LH~~~~~ 195 (399)
... ..+|+||||++ |+|.+++... ...+++..+ +.++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 433 33799999999 8999999863 223454555 678899999999999999
Q ss_pred CeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCcccccc--CCCCcccceeehhHHHHHHHh
Q 015816 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILS 273 (399)
Q Consensus 196 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~ 273 (399)
|+||||||+||||+.++.+||+|||++.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999998532 11224567799999999987 789999999999999999999
Q ss_pred CCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 274 GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 274 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
|+.||......... .+... ...............+..+..+.+|+.+||+.||++|||+.++++
T Consensus 289 g~~Pf~~~~~~~~~--------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKG--------SWKRP-SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTT--------CCCBC-CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCccccc--------chhhh-hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999765321100 00000 000000111111111233458999999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=347.52 Aligned_cols=267 Identities=22% Similarity=0.271 Sum_probs=203.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecC-----Cee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 144 (399)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4679999999999999999999999999999999965432 2335678999999999999999999988654 678
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 699999875 56999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcc--------eeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh
Q 015816 225 LGPVGDNTH--------VSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 295 (399)
Q Consensus 225 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 295 (399)
......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 643221111 1223568999999998754 7899999999999999999999999987654433222111100
Q ss_pred hhccccccccccCc----------ccc----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 296 LFQDRTRHSLIADP----------ELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 296 ~~~~~~~~~~~~~~----------~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.............+ ... ....+.....+.+|+.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000000 000 0001123447889999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=348.17 Aligned_cols=263 Identities=19% Similarity=0.232 Sum_probs=204.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc-----------------hHHHHHHHHHHhhcCCCCccc
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-----------------NREFLVEVLMLSLLHHPNLVN 133 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~hpniv~ 133 (399)
.++|++.+.||+|+||.||+|.+ +++.||||++....... .+.+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 69999999986432111 177899999999999999999
Q ss_pred eEEEEecCCeeEEEEEecCCCCHHHH------hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCc
Q 015816 134 LIGYCADGDQRLLVYEYMPLGSVEDH------LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSN 206 (399)
Q Consensus 134 ~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~N 206 (399)
+++++.+.+..++||||+++++|.++ +... ....+++..++.++.||+.||.|||+ ++ |+||||||+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 99999999999999999999999998 4431 14679999999999999999999999 99 9999999999
Q ss_pred eeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccC-CCCc-ccceeehhHHHHHHHhCCCCcccchH-
Q 015816 207 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTL-KSDVYSFGVVLLEILSGRKAVDTSKA- 283 (399)
Q Consensus 207 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~ell~g~~pf~~~~~- 283 (399)
||++.++.+||+|||++...... ......||..|+|||++.+. .++. ++|||||||++|+|++|..||.....
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999753222 33446799999999999877 6766 99999999999999999999986543
Q ss_pred HHHHHHHHhhhhhhccccccccccCccc---cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 284 AAEQSLVAWARPLFQDRTRHSLIADPEL---QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
........ ...............+.. ........+..+.+|+.+||+.||.+|||+.++++
T Consensus 259 ~~~~~~i~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VELFNNIR--TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHHT--SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHh--ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 21111110 000000000000000000 00011223458899999999999999999999996
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=345.43 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=198.3
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcC--CCCccceEEEEecCCee
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQR 144 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~ 144 (399)
...++|++.+.||+|+||.||+|.+.. ++.||||++...... ..+.+.+|+.+++.++ ||||+++++++.+....
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 345679999999999999999999865 889999999754332 3467889999999997 59999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
++||| +.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+++ +.+||+|||++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence 99999 567899999987 567999999999999999999999999 999999999999975 899999999998
Q ss_pred cCCCCCCcceeeeeccCccccCcccccc-----------CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh
Q 015816 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKT-----------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 293 (399)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 293 (399)
...............||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ....
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~- 252 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-LHAI- 252 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHHH-
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-HHHH-
Confidence 6433332222334579999999999865 47889999999999999999999999754322111 1100
Q ss_pred hhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015816 294 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 348 (399)
.. +.....++......+.+|+.+||+.||.+|||+.++++.-
T Consensus 253 ---~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 253 ---ID----------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp ---HC----------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---Hh----------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 10 0011111222234788999999999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=338.66 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=195.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEec---------
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--------- 140 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------- 140 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356799999999999999999999999999999998643 2234678899999999999999999998865
Q ss_pred ----CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceE
Q 015816 141 ----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (399)
Q Consensus 141 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 216 (399)
....++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 35679999999999999999852 456888999999999999999999999 99999999999999999999
Q ss_pred EecccCCccCCCCCC------------cceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchH
Q 015816 217 LSDFGLAKLGPVGDN------------THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (399)
Q Consensus 217 l~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~ 283 (399)
|+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 999999975432110 1122345689999999999764 78999999999999999998 5543221
Q ss_pred HHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 284 AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.. ........ . ...+...++...+..+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~~--~~~~~~~~---~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RV--NILKKLRS---V--------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH--HHHHHHHS---T--------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH--HHHHhccc---c--------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11 11111110 0 011112233334457889999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=342.45 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=200.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCe-----
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ----- 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----- 143 (399)
.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35799999999999999999999999999999999754332 23568899999999999999999999987654
Q ss_pred -eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 144 -RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 144 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 68887774 34999999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhc---
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ--- 298 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--- 298 (399)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....................
T Consensus 173 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 975321 1234568999999999876 7889999999999999999999999987654332221111000000
Q ss_pred -ccc----------ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 299 -DRT----------RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 299 -~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... .......+.+ ....+.....+.+|+.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0000000000 1122334558999999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.44 Aligned_cols=204 Identities=25% Similarity=0.309 Sum_probs=175.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CC-----CccceEEEEecCCe
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HP-----NLVNLIGYCADGDQ 143 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~~~~~~~~~~~ 143 (399)
..++|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.++ |+ +|+.+++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 457899999999999999999999999999999999643 223456778888888885 44 49999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeeecCCCCCceeec--CCCceEEec
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD--KAKPPVIYRDLKCSNILLD--RGYHPKLSD 219 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~~~~ivH~Dlkp~Nill~--~~~~~kl~D 219 (399)
.|+||||++ ++|.+++.... ...+++..++.++.||+.||.|||+ .+ |+||||||+|||++ .++.+||+|
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred eEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999997 69999998632 3569999999999999999999994 57 99999999999994 578899999
Q ss_pred ccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHH
Q 015816 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (399)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 285 (399)
||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp CTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999764221 234579999999999999999999999999999999999999998765543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=343.90 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=182.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHH-HHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||.||+|.++.+|+.||||++...... ....+..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 6789999999999999999999999999999999755322 2345566665 7778899999999999999999999999
Q ss_pred ecCCCCHHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 150 YMPLGSVEDHLHDLS-PGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|++ ++|.+++.... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 998 58888776321 1246799999999999999999999998 9 9999999999999999999999999997532
Q ss_pred CCCCcceeeeeccCccccCcccc----ccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYA----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
.. .......||+.|+|||++ .+..++.++|||||||++|+|++|..||........ .......
T Consensus 178 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~----- 244 (327)
T 3aln_A 178 DS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVVK----- 244 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCC-----
T ss_pred cc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHhc-----
Confidence 22 122334699999999998 466789999999999999999999999976432110 0000000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
...+.+...........+.+|+.+||+.||.+|||+.++++.
T Consensus 245 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 245 --GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp --SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 001111111112233488999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=342.65 Aligned_cols=264 Identities=18% Similarity=0.218 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCC-eEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC------ccceEEEEecCCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN------LVNLIGYCADGDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~~~~~~~~~~~ 143 (399)
.++|++.+.||+|+||.||+|.+..++ +.||||++... ....+.+.+|+.+++.++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999998776 79999999643 233466788999999997665 8999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee--------------
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-------------- 209 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill-------------- 209 (399)
.++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 99999999 577878776532 357999999999999999999999999 9999999999999
Q ss_pred -----cCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHH
Q 015816 210 -----DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (399)
Q Consensus 210 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 284 (399)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999753221 23456999999999999999999999999999999999999999876554
Q ss_pred HHHHHHHhhhhhhccc-----ccccccc---------------------CccccCCCChHhHHHHHHHHHHccccCCCCC
Q 015816 285 AEQSLVAWARPLFQDR-----TRHSLIA---------------------DPELQGQYPPRGFYQALAVAAMCVHEQPDMR 338 (399)
Q Consensus 285 ~~~~~~~~~~~~~~~~-----~~~~~~~---------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 338 (399)
................ ....... ...............+.+|+.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 3332221111100000 0000000 0000011122345688999999999999999
Q ss_pred CCHHHHHH
Q 015816 339 PVIADVVT 346 (399)
Q Consensus 339 Ps~~eil~ 346 (399)
||+.++++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=346.33 Aligned_cols=264 Identities=16% Similarity=0.213 Sum_probs=202.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-----------CCCccceEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----------HPNLVNLIGYCA 139 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~~~ 139 (399)
..+|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999999999999999999643 223456788999998886 899999999987
Q ss_pred cCC----eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCceeec----
Q 015816 140 DGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLD---- 210 (399)
Q Consensus 140 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dlkp~Nill~---- 210 (399)
... .+++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 654 789999999 899999998643 35699999999999999999999998 9 99999999999994
Q ss_pred --CCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHH--
Q 015816 211 --RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-- 286 (399)
Q Consensus 211 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-- 286 (399)
..+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 445899999999975322 12334689999999999999999999999999999999999999975542111
Q ss_pred -----HHHHHhhhh--------------hhccccccccccCc---------cccCCCChHhHHHHHHHHHHccccCCCCC
Q 015816 287 -----QSLVAWARP--------------LFQDRTRHSLIADP---------ELQGQYPPRGFYQALAVAAMCVHEQPDMR 338 (399)
Q Consensus 287 -----~~~~~~~~~--------------~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~R 338 (399)
..+...... .+........+... .....++......+.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 111110000 00000000000000 01123456677889999999999999999
Q ss_pred CCHHHHHH
Q 015816 339 PVIADVVT 346 (399)
Q Consensus 339 Ps~~eil~ 346 (399)
||+.++++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=369.39 Aligned_cols=259 Identities=26% Similarity=0.358 Sum_probs=207.5
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECC---CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
..++|++.+.||+|+||.||+|.+.. .+..||||.+...... ..+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34679999999999999999999864 3567999998654332 3367899999999999999999999985 45789
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 467 lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 999999999999999852 346999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
..... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||............... .
T Consensus 541 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-------~--- 609 (656)
T 2j0j_A 541 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-------E--- 609 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-------C---
T ss_pred cCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------C---
Confidence 43222 112233457889999999999999999999999999999997 99999876544322211100 0
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.+ ..++..+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 610 ---~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 610 ---RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 00 1122233488999999999999999999999999998764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=344.93 Aligned_cols=259 Identities=23% Similarity=0.331 Sum_probs=201.5
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
..++|++.+.||+|+||.||+|.+.. .||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 35689999999999999999999864 499999865422 2335577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++ ++.++|+|||++....
T Consensus 108 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999999762 346999999999999999999999999 99999999999998 6799999999987532
Q ss_pred CCC---CcceeeeeccCccccCcccccc---------CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhh
Q 015816 228 VGD---NTHVSTRVMGTYGYCAPEYAKT---------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 295 (399)
Q Consensus 228 ~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 295 (399)
... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---- 256 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG---- 256 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH----
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc----
Confidence 211 1112233458999999999864 457899999999999999999999998765433221110
Q ss_pred hhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 296 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
... .... ....++ ..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 257 ---~~~-~~~~----~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 257 ---TGM-KPNL----SQIGMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ---TTC-CCCC----CCSSCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ---cCC-CCCC----CcCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 000 0000 001122 2688899999999999999999999999977654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=342.82 Aligned_cols=254 Identities=19% Similarity=0.247 Sum_probs=176.2
Q ss_pred HhcCCCCCC-eeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHH-HHHhhcCCCCccceEEEEec----CCe
Q 015816 70 ATKNFRSES-LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYCAD----GDQ 143 (399)
Q Consensus 70 ~~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~----~~~ 143 (399)
..++|.+.+ .||+|+||.||+|.++.+++.||||++... .....|+ ..++.++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 356898854 699999999999999999999999998643 2222333 34566799999999999876 455
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---CCceEEecc
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDF 220 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Df 220 (399)
.++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 899999999999999998632 357999999999999999999999999 999999999999986 455999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
|++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............ .....
T Consensus 176 g~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~-- 246 (336)
T 3fhr_A 176 GFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIR-- 246 (336)
T ss_dssp TTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhh--
Confidence 999753221 223456899999999999889999999999999999999999999754432211000 00000
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.. ...............+.+|+.+||+.||.+|||+.++++.
T Consensus 247 --~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 247 --LG---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --cc---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0000011112233478999999999999999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=341.63 Aligned_cols=245 Identities=27% Similarity=0.431 Sum_probs=195.3
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc------chHHHHHHHHHHhhc----CCCCccceEEE
Q 015816 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLL----HHPNLVNLIGY 137 (399)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpniv~~~~~ 137 (399)
....++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999999999999999999755332 123356799999988 89999999999
Q ss_pred EecCCeeEEEEEe-cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec-CCCce
Q 015816 138 CADGDQRLLVYEY-MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHP 215 (399)
Q Consensus 138 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~ 215 (399)
+.+.+..++|||+ +.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 9999999999999 789999999987 457999999999999999999999999 99999999999999 88999
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCccccccCCCC-cccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 294 (399)
||+|||++....... .....||..|+|||++.+..+. .++|||||||++|+|++|+.||.......
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------- 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL--------- 246 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH---------
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh---------
Confidence 999999997643221 2345699999999999877664 58999999999999999999997642210
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
... ...+......+.+|+.+||+.||++|||+.++++.
T Consensus 247 ---~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 ---EAE------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---HTC------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---hhc------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 01112233478899999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=341.95 Aligned_cols=245 Identities=23% Similarity=0.372 Sum_probs=203.2
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc------chHHHHHHHHHHhhcC--CCCccceEEEEe
Q 015816 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLH--HPNLVNLIGYCA 139 (399)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpniv~~~~~~~ 139 (399)
.....+|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999999999999999999754322 2244667999999996 599999999999
Q ss_pred cCCeeEEEEEecCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec-CCCceEE
Q 015816 140 DGDQRLLVYEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKL 217 (399)
Q Consensus 140 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl 217 (399)
+.+..++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999976 899999987 567999999999999999999999999 99999999999999 7899999
Q ss_pred ecccCCccCCCCCCcceeeeeccCccccCccccccCCC-CcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhh
Q 015816 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 296 (399)
+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......
T Consensus 192 ~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----------- 256 (320)
T 3a99_A 192 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----------- 256 (320)
T ss_dssp CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH-----------
T ss_pred eeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh-----------
Confidence 999999764322 1233569999999999987666 688999999999999999999997643210
Q ss_pred hccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 297 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
... ..+...++ ..+.+|+.+||+.||.+|||+.++++.
T Consensus 257 -~~~--------~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 -RGQ--------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -HCC--------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -ccc--------ccccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00111222 378899999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=352.26 Aligned_cols=205 Identities=24% Similarity=0.337 Sum_probs=158.0
Q ss_pred cCCCC-CCeeeecCceEEEEEEEC--CCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEe--cCCeeEE
Q 015816 72 KNFRS-ESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLL 146 (399)
Q Consensus 72 ~~~~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~l 146 (399)
+.|++ .++||+|+||.||+|.++ .+++.||||++.... ....+.+|+.+|+.++||||+++++++. ....+|+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34666 568999999999999976 468899999997543 2456889999999999999999999995 4678999
Q ss_pred EEEecCCCCHHHHhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee----cCCCceEE
Q 015816 147 VYEYMPLGSVEDHLHDLS-----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKL 217 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl 217 (399)
||||+. ++|.+++.... .....+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999997 68888876321 11235999999999999999999999999 9999999999999 67889999
Q ss_pred ecccCCccCCCCCC-cceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccch
Q 015816 218 SDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (399)
Q Consensus 218 ~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~ 282 (399)
+|||++........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999986432211 122334679999999999877 459999999999999999999999997543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=332.60 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=182.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc-hHH-HHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~-~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.++|++.+.||+|+||.||+|.++.+|+.||||++....... ... +..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999999999999999997653322 223 344455778889999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
||+ ++.+..+.... ...+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 45555555432 46799999999999999999999995 8 9999999999999999999999999987532
Q ss_pred CCCCcceeeeeccCccccCccccc-----cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
.. .......||+.|+|||++. ...++.++|||||||++|+|++|+.||......... ... . ....
T Consensus 177 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~-~---~~~~-- 246 (318)
T 2dyl_A 177 DD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTK-V---LQEE-- 246 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHH-H---HHSC--
T ss_pred CC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-HHH-H---hccC--
Confidence 22 1223456999999999984 567899999999999999999999999764322111 000 0 0000
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.... + ....++ ..+.+|+.+||+.||.+|||+.++++
T Consensus 247 ~~~~--~-~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 PPLL--P-GHMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCC--C-SSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCC--C-ccCCCC----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000 0 001222 37889999999999999999999996
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=327.44 Aligned_cols=235 Identities=16% Similarity=0.146 Sum_probs=186.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999999999999999997654332 267889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||++|++|.+++.. . ....++..|+.||+.||+|||++| |+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 99999999999953 2 355678999999999999999999 9999999999999999999998553
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
|++ .++.++|||||||++|+|++|+.||.......... .............
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~ 225 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-------PAERDTAGQPIEP 225 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-------ECCBCTTSCBCCH
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-------HHHHHhccCCCCh
Confidence 333 37889999999999999999999997643211000 0000000000000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccC
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 356 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 356 (399)
...... .+..+.+|+.+||+.||.+| |+.++++.|..+.....
T Consensus 226 ~~~~~~----~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 226 ADIDRD----IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHCTT----SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred hhcccC----CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 011122 33478999999999999999 99999999998876543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=344.85 Aligned_cols=253 Identities=24% Similarity=0.295 Sum_probs=187.2
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEEec
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
.|.+.+.||+|+||+||.+.. .+|+.||||++... ..+.+.+|+.++..+ +||||+++++++.+....|+||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 455678899999999987644 45999999998643 245678899999876 8999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCC-------------Cce
Q 015816 152 PLGSVEDHLHDLSPGKKP---LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-------------YHP 215 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~---l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~-------------~~~ 215 (399)
. |+|.+++......... .++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999999863221111 133356789999999999999999 9999999999999754 489
Q ss_pred EEecccCCccCCCCCCcc--eeeeeccCccccCcccccc-------CCCCcccceeehhHHHHHHHh-CCCCcccchHHH
Q 015816 216 KLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~ 285 (399)
||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999998644322111 1234579999999999865 678999999999999999999 999997654322
Q ss_pred HHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 286 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. ... ..... .+.............+.+|+.+||+.||.+|||+.++++
T Consensus 248 ~-~i~---~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 S-NII---RGIFS---------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H-HHH---HTCCC---------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-HHh---cCCCC---------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 111 10000 011111123445678999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=358.53 Aligned_cols=272 Identities=24% Similarity=0.313 Sum_probs=207.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEec------CCe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~ 143 (399)
..+|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 3689999999999999999999999999999999875422 234668899999999999999999998765 677
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCc---eEEecc
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDF 220 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Df 220 (399)
.++||||++||+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999986432 346899999999999999999999999 999999999999997665 999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhc--
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ-- 298 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-- 298 (399)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ |......
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-----~~~~i~~~~ 240 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-----WHGKVREKS 240 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-----SSTTCC---
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-----hhhhhhccc
Confidence 9998643322 22345799999999999999999999999999999999999999976432211 1100000
Q ss_pred -------cc--cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHHHhc
Q 015816 299 -------DR--TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD-----VVTALAYLASQ 354 (399)
Q Consensus 299 -------~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----il~~L~~l~~~ 354 (399)
.. ................+.....+.+|+..||..||++|||+.+ +.+.+..+...
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00 0000000111122345567789999999999999999999988 44566655544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=341.03 Aligned_cols=250 Identities=23% Similarity=0.268 Sum_probs=187.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 149 (399)
..+|.+.+.||+|+||+||.. ...+++.||||++...... .+.+|+.+++.+ +|||||++++++.+....|+|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 346888999999999997643 3345899999999654332 345799999999 79999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-----CCceEEecccCCc
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHPKLSDFGLAK 224 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfg~~~ 224 (399)
|+. |+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ...+||+|||++.
T Consensus 99 ~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 997 6999999863 234555567899999999999999999 999999999999953 3357899999997
Q ss_pred cCCCCCCc-ceeeeeccCccccCccccc---cCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 225 LGPVGDNT-HVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 225 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
........ .......||+.|+|||++. ...++.++|||||||++|||++ |..||............ ..
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~-------~~ 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-------GA 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT-------TC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh-------cc
Confidence 64332211 2234467999999999997 4677889999999999999999 99999654332211110 00
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. ... . ..........+.+|+.+||+.||.+|||+.++++
T Consensus 245 ~-~~~-----~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 C-SLD-----C--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-CCT-----T--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-Ccc-----c--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 000 0 0111233456788999999999999999999994
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=358.22 Aligned_cols=241 Identities=21% Similarity=0.316 Sum_probs=194.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC-CCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCe-----
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ----- 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----- 143 (399)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999999976 789999999865433 233568899999999999999999999987665
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
.||||||++|++|.+++. ..+++.+++.|+.||+.||.|||+++ |+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 799999999999988764 26999999999999999999999999 9999999999999985 8999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||...... .
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------~--- 283 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------------G--- 283 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------------S---
T ss_pred hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc---------------c---
Confidence 753322 345699999999998765 489999999999999999999888642110 0
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-VIADVVTALAYLA 352 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~ 352 (399)
+.. ..........+.+||.+||+.||.+|| +++++.+.|..+.
T Consensus 284 --~~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 --LPE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --CCT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --ccc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 000011234788899999999999999 5666777776554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=318.76 Aligned_cols=232 Identities=20% Similarity=0.294 Sum_probs=182.1
Q ss_pred hcCCCCC-CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHH-hhcCCCCccceEEEEec----CCee
Q 015816 71 TKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLML-SLLHHPNLVNLIGYCAD----GDQR 144 (399)
Q Consensus 71 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~----~~~~ 144 (399)
..+|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 789999999999999999999999999853 35577888888 56689999999999876 6778
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---CCceEEeccc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFG 221 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg 221 (399)
++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999998732 347999999999999999999999999 999999999999998 7899999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 301 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (399)
++... .+..++.++|||||||++|+|++|..||......... .......
T Consensus 166 ~a~~~------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~~~~~~~ 214 (299)
T 3m2w_A 166 FAKET------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKTRI 214 (299)
T ss_dssp TCEEC------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSCCSS
T ss_pred ccccc------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------HHHHHHH
Confidence 98631 1245788999999999999999999999764332110 0000000
Q ss_pred ccccccCc-cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 302 RHSLIADP-ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 302 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.......+ ... ......+.+|+.+||+.||.+|||+.++++.
T Consensus 215 ~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 215 RMGQYEFPNPEW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CTTCCSSCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccCCchhc----ccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000000 000 1224488999999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=337.18 Aligned_cols=244 Identities=17% Similarity=0.177 Sum_probs=184.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc---chHHHHHHHHHHhhcCC-CCc---------cceE--
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHH-PNL---------VNLI-- 135 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h-pni---------v~~~-- 135 (399)
..+|+..+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++| +|+ +...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34578889999999999999999999999999998743222 35678999999999987 221 1111
Q ss_pred ----------EEEec-----CCeeEEEEEecCCCCHHHHhhcc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 015816 136 ----------GYCAD-----GDQRLLVYEYMPLGSVEDHLHDL---SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197 (399)
Q Consensus 136 ----------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 197 (399)
.++.. ...++++|+++ +++|.+++... ......+++..++.++.||+.||+|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111 22457777766 58999988532 222456888999999999999999999999 9
Q ss_pred eecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCcccc----------ccCCCCcccceeehhHH
Q 015816 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----------KTGQLTLKSDVYSFGVV 267 (399)
Q Consensus 198 vH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~i 267 (399)
+||||||+||||+.++.+||+|||++..... .....+| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999999875221 1344568 999999999 55668899999999999
Q ss_pred HHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 268 LLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 268 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+|||++|+.||........ ....+. ....++ ..+.+|+.+||+.||++||++.++++
T Consensus 307 l~elltg~~Pf~~~~~~~~------~~~~~~------------~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG------SEWIFR------------SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC------SGGGGS------------SCCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhh------HHHHHh------------hcccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999976432110 000000 001222 47899999999999999999888864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=326.87 Aligned_cols=242 Identities=17% Similarity=0.143 Sum_probs=185.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--------cchHHHHHHHHHHhhcC---------CCCccc
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--------QGNREFLVEVLMLSLLH---------HPNLVN 133 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------hpniv~ 133 (399)
.++|++.+.||+|+||.||+|++ +|+.||||++..... ...+.+.+|+.+++.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35789999999999999999998 589999999975532 22367889999998886 777777
Q ss_pred eEEEEe------------------------------cCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHH
Q 015816 134 LIGYCA------------------------------DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183 (399)
Q Consensus 134 ~~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 183 (399)
+.+++. +....|+||||+++|++.+.+. ...+++..++.|+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence 777642 2678999999999998777774 35689999999999999
Q ss_pred HHHHHHH-hCCCCCeeecCCCCCceeecCCC--------------------ceEEecccCCccCCCCCCcceeeeeccCc
Q 015816 184 RGLEYLH-DKAKPPVIYRDLKCSNILLDRGY--------------------HPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242 (399)
Q Consensus 184 ~al~~LH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 242 (399)
.||+||| +++ |+||||||+||||+.++ .+||+|||+++.... ...+||+
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD 241 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence 9999999 899 99999999999999887 899999999985321 2347999
Q ss_pred cccCccccccCCCCcccceeehhHH-HHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccccCCCChHhHH
Q 015816 243 GYCAPEYAKTGQLTLKSDVYSFGVV-LLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 321 (399)
Q Consensus 243 ~y~aPE~~~~~~~~~~~DvwslG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (399)
.|+|||++.+.. +.++||||||++ .+++++|..||........ ... ...... .. .........+....
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~--~~~---~~~~~~-~~----~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY--LTD---KMLKQM-TF----KTKCNTPAMKQIKR 310 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH--HHH---HHHHTC-CC----SSCCCSHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH--HHH---hhhhhh-cc----CcccchhhhhhcCH
Confidence 999999998766 899999998777 7888999999854221110 000 000000 00 00000112234567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHH
Q 015816 322 QALAVAAMCVHEQPDMRPVIADVV 345 (399)
Q Consensus 322 ~l~~li~~cl~~dP~~RPs~~eil 345 (399)
.+.+||.+||+.| |+.|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 8999999999976 899888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.33 Aligned_cols=186 Identities=17% Similarity=0.110 Sum_probs=133.8
Q ss_pred eeecCceEEEEEEECCCCeEEEEEEeccCCC----------cchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEEE
Q 015816 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV----------QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++.|++|.+..++..-.|+.||+|++..... ...++|.+|+++|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5566777777666666789999999965421 1224689999999999 6999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||++|++|.++|.. .+++++. .|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999987 5677764 58999999999999999 99999999999999999999999999986332
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 278 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf 278 (399)
. .......+||+.|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 392 ~--~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 D--CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred C--CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2 223345689999999999975 5678899999999998887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=260.98 Aligned_cols=185 Identities=21% Similarity=0.258 Sum_probs=144.7
Q ss_pred CCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc--------hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
...+.||+|+||.||+|... +..+++|+........ .+.+.+|+.++++++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44578999999999999544 7889999875432221 2347899999999999999966666667778899
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||++|++|.+++.. +..++.||+.||.|||+++ |+||||||+|||++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999974 5689999999999999999 999999999999999 9999999999864
Q ss_pred CCCCCcc-----eeeeeccCccccCcccccc--CCCCcccceeehhHHHHHHHhCCCCc
Q 015816 227 PVGDNTH-----VSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAV 278 (399)
Q Consensus 227 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf 278 (399)
....... ......||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3221111 1235679999999999977 67888999999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=220.79 Aligned_cols=151 Identities=15% Similarity=0.077 Sum_probs=121.8
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc------------------chHHHHHHHHHHhhcCC
Q 015816 67 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------------------GNREFLVEVLMLSLLHH 128 (399)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h 128 (399)
+......|.+.+.||+|+||.||+|.+ .+|+.||||++...... ....+.+|+.+++.++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 334445677889999999999999999 77999999999643221 2345889999999998
Q ss_pred CCccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcee
Q 015816 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (399)
Q Consensus 129 pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nil 208 (399)
| +++++++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||+.+ |+||||||+|||
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 556565443 56799999999999988 421 124579999999999999999 999999999999
Q ss_pred ecCCCceEEecccCCccCCCCCCcceeeeeccCccccCcccccc
Q 015816 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252 (399)
Q Consensus 209 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 252 (399)
++ ++.+||+|||++. .+..|+|||++..
T Consensus 226 l~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSV---------------EVGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCE---------------ETTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCe---------------ECCCCCHHHHHHH
Confidence 99 9999999999986 3556899998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.2e-23 Score=186.60 Aligned_cols=137 Identities=14% Similarity=0.042 Sum_probs=108.2
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeE--EEEEEeccCCCcc------------------------hHHHHHHHHHHhhc
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQD--VAIKQLDRNGVQG------------------------NREFLVEVLMLSLL 126 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l 126 (399)
-|++.+.||+|+||.||+|.+..+|+. ||||++....... ...+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999999667899 9999975432110 12578899999999
Q ss_pred CCCCc--cceEEEEecCCeeEEEEEecCC-C----CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCee
Q 015816 127 HHPNL--VNLIGYCADGDQRLLVYEYMPL-G----SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-DKAKPPVI 198 (399)
Q Consensus 127 ~hpni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~iv 198 (399)
.|++| ..++++ ...+|||||+.+ | +|.++... .++..+..++.||+.||.||| +.+ |+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 88764 444442 357899999942 3 67666543 234567889999999999999 999 99
Q ss_pred ecCCCCCceeecCCCceEEecccCCcc
Q 015816 199 YRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 199 H~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
||||||+|||++. .++|+|||+|..
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999998 999999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=8.6e-19 Score=166.08 Aligned_cols=134 Identities=13% Similarity=0.093 Sum_probs=99.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--------------chH--------HHHHHHHHHhhcCCCC
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------------GNR--------EFLVEVLMLSLLHHPN 130 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------~~~--------~~~~E~~~l~~l~hpn 130 (399)
-|++...||.|+||.||+|.+.. |+.||||++...... ... ...+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 49999999999999999999864 999999997532110 001 1234666777775544
Q ss_pred cc--ceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcee
Q 015816 131 LV--NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (399)
Q Consensus 131 iv--~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nil 208 (399)
+. ..+++ ...+|||||++|++|..+... .....++.||+.+|.|||+.| ||||||||.|||
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL 237 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNIL 237 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence 32 22222 234799999999887654421 134578899999999999999 999999999999
Q ss_pred ecCCC----------ceEEecccCCc
Q 015816 209 LDRGY----------HPKLSDFGLAK 224 (399)
Q Consensus 209 l~~~~----------~~kl~Dfg~~~ 224 (399)
+++++ .+.|+||+-+.
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred EeCCCCcccccccccceEEEEeCCcc
Confidence 98776 38999999765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=3.1e-14 Score=129.16 Aligned_cols=145 Identities=17% Similarity=0.102 Sum_probs=114.1
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEE
Q 015816 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 147 (399)
.....|++...++.|+.+.||++... +..+++|+...........+.+|+.+++.+. +..+.++++++.+....|+|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34567888888999999999999754 6789999986532223345888999999885 66788999999988899999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA---------------------------------- 193 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------- 193 (399)
|||++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999998876421 1123478899999999999810
Q ss_pred ----------------------CCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 194 ----------------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 194 ----------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
.+.++|+|++|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1338999999999999876566799998775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.36 E-value=9.7e-13 Score=118.75 Aligned_cols=136 Identities=15% Similarity=0.078 Sum_probs=99.3
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--ccceEEEEecCCeeEEEEEe
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~ 150 (399)
.|.+....+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344433334566699999965 34778999997643 2245678999999886544 55688888888889999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------------------------------------- 193 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------- 193 (399)
++|.+|. ... .+ ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998874 211 11 2357788888888888743
Q ss_pred ------------------CCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 194 ------------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 194 ------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
...++|+|++|.|||++.++.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1229999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.29 E-value=1.2e-11 Score=117.51 Aligned_cols=142 Identities=13% Similarity=0.185 Sum_probs=106.5
Q ss_pred CCCeeeecCceEEEEEEECCCCeEEEEEEec--cCCC-cchHHHHHHHHHHhhcC--CCCccceEEEEecC---CeeEEE
Q 015816 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNGV-QGNREFLVEVLMLSLLH--HPNLVNLIGYCADG---DQRLLV 147 (399)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~---~~~~lv 147 (399)
..+.|+.|.++.||++... +..+++|+.. .... .....+.+|+.+++.+. +..+.+++.++.+. ...|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3467899999999998765 4678888875 3221 22346778999999987 45578889988776 458999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA---------------------------------- 193 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------- 193 (399)
|||++|..+.+.. -..++..+...++.+++.+|..||+..
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999987764422 234778888999999999999999731
Q ss_pred ---------------------CCCeeecCCCCCceeecCCCc--eEEecccCCcc
Q 015816 194 ---------------------KPPVIYRDLKCSNILLDRGYH--PKLSDFGLAKL 225 (399)
Q Consensus 194 ---------------------~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~ 225 (399)
.+.++|+|++|.|||++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.20 E-value=5.5e-12 Score=116.92 Aligned_cols=189 Identities=19% Similarity=0.202 Sum_probs=123.5
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCC--ccceEEEEecCC---eeEEEEEe
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPN--LVNLIGYCADGD---QRLLVYEY 150 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~~~~~~~~~~---~~~lv~e~ 150 (399)
.+.++.|....||++. ..+++|+.... .....+.+|+.+|+.+. +.. +..++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3568999999999863 46889986432 23456888999998874 332 344555443333 34899999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------------------------------------- 193 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------- 193 (399)
++|.+|..... ..++..+...++.+++..|..||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988865432 23677888889999999999999621
Q ss_pred ------------------CCCeeecCCCCCceeecC--CCceEEecccCCccCCCCCCcceeee------------eccC
Q 015816 194 ------------------KPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPVGDNTHVSTR------------VMGT 241 (399)
Q Consensus 194 ------------------~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~------------~~gt 241 (399)
.+.++|+|++|.||+++. +..+.|+||+.+.............. ....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 134899999999999998 55678999998864321100000000 0000
Q ss_pred ccccC-ccccccCCCCcccceeehhHHHHHHHhCCCCccc
Q 015816 242 YGYCA-PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (399)
Q Consensus 242 ~~y~a-PE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 280 (399)
..... |+.... .....+.|++|.++|.+.+|..+|..
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 01111 222111 12236889999999999999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=3.7e-08 Score=89.16 Aligned_cols=135 Identities=19% Similarity=0.172 Sum_probs=100.7
Q ss_pred eeeecCce-EEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 79 LLGEGGFG-RVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 79 ~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
.+..|..| .||+......+..+++|+-... ....+..|..+|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455544 6999888777788999986432 3456788999998875 32367788999999999999999999888
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------------------------------------------- 193 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------------- 193 (399)
.+.... .......++.+++..|.-||+..
T Consensus 108 ~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 776543 11233457777888888888531
Q ss_pred ------------CCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 194 ------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 194 ------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
.+.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999987777899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=8.1e-08 Score=88.82 Aligned_cols=135 Identities=21% Similarity=0.164 Sum_probs=95.7
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCC---CccceEEEEe-cCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP---NLVNLIGYCA-DGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~-~~~~~~lv~e~~~~ 153 (399)
+.++.|....||+. +..+++|+... ......+..|..+|+.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 46888888899988 46788998532 22345688999999998752 3556666664 44567899999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA---------------------------------------- 193 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------------- 193 (399)
.+|..... ..++..+...++.+++..|..||+..
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88876321 12455556666666666666666432
Q ss_pred -----------------CCCeeecCCCCCceeecC---CCce-EEecccCCcc
Q 015816 194 -----------------KPPVIYRDLKCSNILLDR---GYHP-KLSDFGLAKL 225 (399)
Q Consensus 194 -----------------~~~ivH~Dlkp~Nill~~---~~~~-kl~Dfg~~~~ 225 (399)
.+.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 223699999999999987 4554 8999998763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=4e-07 Score=87.28 Aligned_cols=76 Identities=18% Similarity=0.149 Sum_probs=50.0
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-------cchHHHHHHHHHHhhcCC--CCc-cceEEEEecCCeeEE
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-------QGNREFLVEVLMLSLLHH--PNL-VNLIGYCADGDQRLL 146 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pni-v~~~~~~~~~~~~~l 146 (399)
.+.||.|.++.||++....++..|+||....... .....+..|..+++.+.. |.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 3579999999999998765678899998653211 123456779988887742 433 455544 3455789
Q ss_pred EEEecCCC
Q 015816 147 VYEYMPLG 154 (399)
Q Consensus 147 v~e~~~~g 154 (399)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=1.5e-07 Score=88.91 Aligned_cols=80 Identities=10% Similarity=0.002 Sum_probs=54.9
Q ss_pred Cee-eecCceEEEEEEEC--C----CCeEEEEEEeccCC---CcchHHHHHHHHHHhhcC-C--CCccceEEEEecC---
Q 015816 78 SLL-GEGGFGRVYKGYLE--S----INQDVAIKQLDRNG---VQGNREFLVEVLMLSLLH-H--PNLVNLIGYCADG--- 141 (399)
Q Consensus 78 ~~l-g~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~~--- 141 (399)
+.| +.|....+|++... . ++..+++|+..... ......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999988754 0 15678999865432 111245677888888774 2 3467788887665
Q ss_pred CeeEEEEEecCCCCHH
Q 015816 142 DQRLLVYEYMPLGSVE 157 (399)
Q Consensus 142 ~~~~lv~e~~~~g~L~ 157 (399)
...++||||++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.40 E-value=3e-06 Score=79.10 Aligned_cols=141 Identities=18% Similarity=0.270 Sum_probs=79.3
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-----CCCccceE-E--EEecCCeeEEEEE
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----HPNLVNLI-G--YCADGDQRLLVYE 149 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~-~--~~~~~~~~~lv~e 149 (399)
+.|+.|..+.||++... +..+++|+.... ...+..|+.+++.|. .|.++... + +....+..++||+
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34666778999998765 345999998652 234445566555553 24444310 0 1234567899999
Q ss_pred ecCCCCHH--------------HHhhccCC-C--C--C-----CCCHHHH------------------------------
Q 015816 150 YMPLGSVE--------------DHLHDLSP-G--K--K-----PLDWNTR------------------------------ 175 (399)
Q Consensus 150 ~~~~g~L~--------------~~l~~~~~-~--~--~-----~l~~~~~------------------------------ 175 (399)
|++|.++. ..++.... . . . .-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 11221110 0 0 0 0122110
Q ss_pred -HHHHHHHHHHHHHHHh----------CCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 176 -MKIAAGAARGLEYLHD----------KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 176 -~~i~~qi~~al~~LH~----------~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
..+..++..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112224446666653 013349999999999999888899999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.23 E-value=7.2e-06 Score=75.69 Aligned_cols=139 Identities=18% Similarity=0.192 Sum_probs=91.3
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC---CCCccceEEEEecCCeeEEEEEecCC
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+.+++.+....+..++||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 35689999999999875 3678899987532 3456788999888874 35688889988888889999999998
Q ss_pred CCHH--------H---HhhccCC-CC---------C--------CCCHHHHH---HHH----------------HHHHHH
Q 015816 154 GSVE--------D---HLHDLSP-GK---------K--------PLDWNTRM---KIA----------------AGAARG 185 (399)
Q Consensus 154 g~L~--------~---~l~~~~~-~~---------~--------~l~~~~~~---~i~----------------~qi~~a 185 (399)
..+. . .|+.... .. + .-+|.... ++. ..++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 1 2222211 00 0 01343221 111 112222
Q ss_pred H-HHHHh-CCCCCeeecCCCCCceeecCCCceEEeccc
Q 015816 186 L-EYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (399)
Q Consensus 186 l-~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 221 (399)
+ ..|.. ...+.+||+|+.+.|++++.++ +.|+||+
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23421 2245699999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.19 E-value=9e-06 Score=74.18 Aligned_cols=78 Identities=18% Similarity=0.183 Sum_probs=56.2
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC--C-CccceEEEEecCCeeEEEEEe
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH--P-NLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p-niv~~~~~~~~~~~~~lv~e~ 150 (399)
..-...+|.|..+.||++...+ |+.|++|+...........|..|+..|+.|.- + .+.+++++. ..++||||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred eEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 4445679999999999998764 88999998765544444567889999988852 2 345555542 34789999
Q ss_pred cCCCCH
Q 015816 151 MPLGSV 156 (399)
Q Consensus 151 ~~~g~L 156 (399)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.10 E-value=1.6e-05 Score=76.71 Aligned_cols=76 Identities=14% Similarity=0.176 Sum_probs=46.0
Q ss_pred CeeecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeec--cCccccCccccccC---CCCcccceeehhHHHHH
Q 015816 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM--GTYGYCAPEYAKTG---QLTLKSDVYSFGVVLLE 270 (399)
Q Consensus 196 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~DvwslG~il~e 270 (399)
.++|+|++|.|||++.++ +.|+||+.+........ -.... -...|++|+..... .-....++.++...+|+
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 399999999999999876 99999998874221100 00001 11346666654311 11223445577888888
Q ss_pred HHhCC
Q 015816 271 ILSGR 275 (399)
Q Consensus 271 ll~g~ 275 (399)
.+.+.
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.88 E-value=4.2e-05 Score=65.71 Aligned_cols=101 Identities=15% Similarity=0.096 Sum_probs=67.4
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCcc
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (399)
-+|.+.|..+ +.+|++.++|.++.|.+.+|.-+-.... -..+=+.|..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 4788888864 6899999999999999999877622111 12333457899999999998764 2111
Q ss_pred eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCC
Q 015816 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275 (399)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~ 275 (399)
.....+.|||... ...+.+.=|||||+++|..+--.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1233567888763 34567889999999999998633
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.81 E-value=8.4e-05 Score=68.10 Aligned_cols=71 Identities=10% Similarity=0.085 Sum_probs=44.1
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCc-cceEEEEecCCeeEEEEEec-CCC
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYM-PLG 154 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~-~~g 154 (399)
.+.|+.|....+|++ ..+++|+....... .-....|+.+++.+..-++ .+++++ +.+.-++|+||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 567999999999998 45889987643211 1112457777777653233 455554 333457899999 654
Q ss_pred CH
Q 015816 155 SV 156 (399)
Q Consensus 155 ~L 156 (399)
+|
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00029 Score=64.95 Aligned_cols=159 Identities=14% Similarity=0.116 Sum_probs=86.2
Q ss_pred cCHHHHHHHhcCCCCC-----CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--ccce
Q 015816 62 LTFRELAAATKNFRSE-----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNL 134 (399)
Q Consensus 62 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~ 134 (399)
++..++......|.+. +.|+.|....+|++...+ | .+++|+..... ....+..|+.++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 4455566665666552 346678888999987653 3 68899886521 2234556777777664211 2223
Q ss_pred EEE------EecCCeeEEEEEecCCCCHHH--------------HhhccCCC-CCC----CC---HHHHHH---------
Q 015816 135 IGY------CADGDQRLLVYEYMPLGSVED--------------HLHDLSPG-KKP----LD---WNTRMK--------- 177 (399)
Q Consensus 135 ~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~-~~~----l~---~~~~~~--------- 177 (399)
+.. ....+..++||+|++|..+.. .++..... ..+ .. |...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 211 122356789999999765321 11211100 000 11 211000
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 178 ---IAAGAARGLEYLHDK----AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 178 ---i~~qi~~al~~LH~~----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
+...+...+++++.. ....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001134445555531 12349999999999999987666899998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.77 E-value=6.1e-05 Score=72.79 Aligned_cols=74 Identities=18% Similarity=0.222 Sum_probs=50.5
Q ss_pred CCeeeecCceEEEEEEECC-------CCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCc-cceEEEEecCCeeEEEE
Q 015816 77 ESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVY 148 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~ 148 (399)
.+.|+.|....||++.... .+..|++|+..... ....+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3567888889999998753 25789999884321 12556689998888853333 566766543 2899
Q ss_pred EecCCCCH
Q 015816 149 EYMPLGSV 156 (399)
Q Consensus 149 e~~~~g~L 156 (399)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00018 Score=69.96 Aligned_cols=74 Identities=12% Similarity=0.007 Sum_probs=47.8
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCc-cceEEEEecCCeeEEEEEecCCCCH
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
+.|+.|-...+|++.....+..|++|+......... ....|..++..|...++ .++++.+. + .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467788889999998765458899998754321111 11468888888875444 46777663 2 259999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00024 Score=67.28 Aligned_cols=142 Identities=18% Similarity=0.230 Sum_probs=83.3
Q ss_pred CeeeecCceEEEEEEECC-------CCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEecCCeeEEEEE
Q 015816 78 SLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 149 (399)
+.|..|-...+|++.... ++..|++|+.... ......+.+|..+++.|. +.-..++++++.++ +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 457778788899988642 3578999986332 234456678999988875 32335667666542 9999
Q ss_pred ecCCCCHHH--------------H---hhccCC-CCCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 015816 150 YMPLGSVED--------------H---LHDLSP-GKKPLD--WNTRMKIAAGAAR-------------------GLEYL- 189 (399)
Q Consensus 150 ~~~~g~L~~--------------~---l~~~~~-~~~~l~--~~~~~~i~~qi~~-------------------al~~L- 189 (399)
|++|.+|.. . |+.... ...... +.++..+..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999765431 1 111110 111222 3455555544422 12333
Q ss_pred ---HhC-CCCCeeecCCCCCceeecCC----CceEEecccCCc
Q 015816 190 ---HDK-AKPPVIYRDLKCSNILLDRG----YHPKLSDFGLAK 224 (399)
Q Consensus 190 ---H~~-~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~~~ 224 (399)
... ....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 221 12349999999999999876 789999998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00058 Score=63.37 Aligned_cols=142 Identities=13% Similarity=0.031 Sum_probs=71.4
Q ss_pred CeeeecCceE-EEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC--CCccceEEEEecCCeeEEEEEecCCC
Q 015816 78 SLLGEGGFGR-VYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPLG 154 (399)
Q Consensus 78 ~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g 154 (399)
+.|+.|+... +|+.... ++..+++|....... ..+..|+.+++.+.. -.+.+++.+..+.. ++|||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 3465554443 6676542 256677776543211 223446666666642 23556666643332 7899999876
Q ss_pred CHHHHhhcc---------------------CCC-CCCCCHHHHH-------H-HH------------HHHHHHHHHHH--
Q 015816 155 SVEDHLHDL---------------------SPG-KKPLDWNTRM-------K-IA------------AGAARGLEYLH-- 190 (399)
Q Consensus 155 ~L~~~l~~~---------------------~~~-~~~l~~~~~~-------~-i~------------~qi~~al~~LH-- 190 (399)
.+.+++... ... -..++..... . +. ..+...+..+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 665443210 000 0112221110 0 00 01112222221
Q ss_pred -hCCCCCeeecCCCCCceeecCC----CceEEecccCCcc
Q 015816 191 -DKAKPPVIYRDLKCSNILLDRG----YHPKLSDFGLAKL 225 (399)
Q Consensus 191 -~~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~~~~ 225 (399)
......++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123349999999999999874 6799999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00098 Score=61.53 Aligned_cols=160 Identities=15% Similarity=0.081 Sum_probs=86.1
Q ss_pred ccCHHHHHHHhcCCCC-----CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCC--Cccc
Q 015816 61 TLTFRELAAATKNFRS-----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP--NLVN 133 (399)
Q Consensus 61 ~~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~ 133 (399)
.++...+......|.+ ...|+ |....||++... +|+.+++|...... .....+..|..+++.+... .+.+
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence 3444444444444432 23466 778899987654 36679999986432 2345666788888777421 2333
Q ss_pred eEEE-----EecCCeeEEEEEecCCCCHH-----H------H---hhccCC-----CCCCCCHHHH--------------
Q 015816 134 LIGY-----CADGDQRLLVYEYMPLGSVE-----D------H---LHDLSP-----GKKPLDWNTR-------------- 175 (399)
Q Consensus 134 ~~~~-----~~~~~~~~lv~e~~~~g~L~-----~------~---l~~~~~-----~~~~l~~~~~-------------- 175 (399)
++.. ....+..++||+|++|..+. . . ++.... ....+++...
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 166 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 166 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence 3332 12245668899999875431 0 1 111100 0111222111
Q ss_pred --------HHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 176 --------MKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 176 --------~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
...+.+++..+.-+-. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1111222222222211 1223489999999999999 4 899999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00047 Score=65.00 Aligned_cols=74 Identities=9% Similarity=0.059 Sum_probs=43.5
Q ss_pred CeeeecCceEEEEEEECC--------CCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC-ccceEEEEecCCeeEEEE
Q 015816 78 SLLGEGGFGRVYKGYLES--------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~ 148 (399)
..|+.|....+|++.... .+..+++|+..... ........|..+++.+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778888999998653 12678899865421 11112346888887775333 34666554 2 36899
Q ss_pred EecCCCCH
Q 015816 149 EYMPLGSV 156 (399)
Q Consensus 149 e~~~~g~L 156 (399)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0019 Score=60.19 Aligned_cols=31 Identities=16% Similarity=0.180 Sum_probs=27.2
Q ss_pred CCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 195 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999987753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.27 E-value=0.017 Score=55.37 Aligned_cols=141 Identities=13% Similarity=0.143 Sum_probs=82.2
Q ss_pred CeeeecCceEEEEEEECCC-------CeEEEEEEeccCCCcchHHHHHHHHHHhhcCC-CCccceEEEEecCCeeEEEEE
Q 015816 78 SLLGEGGFGRVYKGYLESI-------NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 149 (399)
+.|..|-...+|++..... +..|++++..... ...-...+|..+++.+.. .-..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 4577788889999987531 5779999865432 111123468888877753 22445565432 268999
Q ss_pred ecCCCCHHH--------------H---hhcc-------CC--CCCCCCHHHHHHHHHHHH-------------------H
Q 015816 150 YMPLGSVED--------------H---LHDL-------SP--GKKPLDWNTRMKIAAGAA-------------------R 184 (399)
Q Consensus 150 ~~~~g~L~~--------------~---l~~~-------~~--~~~~l~~~~~~~i~~qi~-------------------~ 184 (399)
|++|.+|.. . ++.. .. ...+.-+.++..+..++- .
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865321 0 1110 00 112222444444443321 2
Q ss_pred HHHHHHh---------------------CCCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 185 GLEYLHD---------------------KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 185 al~~LH~---------------------~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
.+.+|.. .....++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 2233221 11234899999999999 888899999998875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.02 E-value=0.097 Score=49.67 Aligned_cols=29 Identities=28% Similarity=0.281 Sum_probs=24.8
Q ss_pred eeecCCCCCceee------cCCCceEEecccCCcc
Q 015816 197 VIYRDLKCSNILL------DRGYHPKLSDFGLAKL 225 (399)
Q Consensus 197 ivH~Dlkp~Nill------~~~~~~kl~Dfg~~~~ 225 (399)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998763
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.57 E-value=0.36 Score=41.39 Aligned_cols=115 Identities=11% Similarity=0.105 Sum_probs=79.7
Q ss_pred CCCCccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeecCCCCC
Q 015816 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE-YLHDKAKPPVIYRDLKCS 205 (399)
Q Consensus 127 ~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~~~~~ivH~Dlkp~ 205 (399)
.||++ -..+-.+++.+.+.++.-+++.=...+.. ++..+.+.++.+|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 68888 44555777787777776544433334433 788899999999888776 5543 588889999
Q ss_pred ceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccce-eehhHHHHHHHhCCCCccc
Q 015816 206 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV-YSFGVVLLEILSGRKAVDT 280 (399)
Q Consensus 206 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv-wslG~il~ell~g~~pf~~ 280 (399)
||+++.++.+++.-.|+-.. ++|.-+. ..|. -.+=|++..++.++..|+.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~~------ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES-------------------LPPDEWD------DERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp GEEECTTCCEEESCCEETTT-------------------BSSCSCC------HHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred eEEEeCCCcEEEEEcCCccc-------------------CCCCCCC------HHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999998876432 2332211 1122 2566788899999888764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.10 E-value=0.3 Score=41.74 Aligned_cols=124 Identities=12% Similarity=0.142 Sum_probs=83.0
Q ss_pred HHHHHhhcCCCCccceEEEEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 015816 119 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198 (399)
Q Consensus 119 E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iv 198 (399)
|+.+|.. .||+++.. .+-.+.+.+.+.++.-+.+.=...+. .++....+.++.+|+....+++. -+
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~~-----r~ 101 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNRT-----RY 101 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGGS-----SE
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhcC-----ce
Confidence 4444432 68988877 56677777777666544222222233 37888999999999988855543 48
Q ss_pred ecCCCCCceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCc
Q 015816 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 278 (399)
Q Consensus 199 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf 278 (399)
|--|.|+||+++.++.+++.-.|+... ++|.- ++...=+-.+=|++..+++++..|
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik~~-------------------l~P~~-----~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQNV-------------------VDPLP-----VSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEETTT-------------------BSCCC-----CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEEEecceEEEcCCCCEEEEEccCccC-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 889999999999999999998876432 12221 111111224667889999998888
Q ss_pred cc
Q 015816 279 DT 280 (399)
Q Consensus 279 ~~ 280 (399)
+.
T Consensus 158 e~ 159 (215)
T 4ann_A 158 DA 159 (215)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.56 E-value=0.044 Score=53.16 Aligned_cols=62 Identities=8% Similarity=0.073 Sum_probs=18.6
Q ss_pred CCCCeeeecCceEEEEEEECCCCeEEEE------EEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEe
Q 015816 75 RSESLLGEGGFGRVYKGYLESINQDVAI------KQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCA 139 (399)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vav------K~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~ 139 (399)
.+.+.|| ||.||+|.......+||+ |........ ....+.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 999999999865568888 665432222 2245788999999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 399 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-76 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (598), Expect = 9e-76
Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 27/285 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPN 130
+G G FG VYKG + DVA+K L+ Q + F EV +L H N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
++ +GY Q +V ++ S+ HLH + + + + IA A+G++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
K +I+RDLK +NI L K+ DFGLA + +H ++ G+ + APE
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 251 KT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307
+ + +SDVY+FG+VL E+++G+ + + L D ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352
++ + A C+ ++ D RP+ ++ ++ LA
Sbjct: 239 PKAMK------------RLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 2e-67
Identities = 76/280 (27%), Positives = 121/280 (43%), Gaps = 31/280 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+ + LG G FG V+ GY + VA+K L + G FL E ++ L H L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L + ++ EYM GS+ D L P L N + +AA A G+ ++ +
Sbjct: 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
+ I+RDL+ +NIL+ K++DFGLA+L + + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAIN 183
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311
G T+KSDV+SFG++L EI++ R + T +I + E
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHG------------------RIPYPGMTNPEVIQNLE- 224
Query: 312 QGQYPPRGFY---QALAVAAMCVHEQPDMRPVIADVVTAL 348
+G R + + +C E+P+ RP + + L
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 3e-66
Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 27/290 (9%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+ + LG G +G VY+G + + VA+K L + ++ EFL E ++ + HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L+G C ++ E+M G++ D+L + ++ + + +A + +EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE- 132
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K I+RDL N L+ + K++DFGL++L GD + APE
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 189
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL--IADP 309
+ ++KSDV++FGV+L EI + + + + +
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGM------------------SPYPGIDLSQVYELLEK 231
Query: 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESD 359
+ + + P + + C P RP A++ A + + SD
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 1e-65
Identities = 66/279 (23%), Positives = 108/279 (38%), Gaps = 29/279 (10%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
K+ LG G FG V G DVAIK + + G EF+ E ++ L H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L G C ++ EYM G + ++L + +++ +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K ++RDL N L++ K+SDFGL++ D S + PE
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLM 174
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DP 309
+ + KSD+++FGV++ EI S + ++ T
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYS------------------LGKMPYERFTNSETAEHIAQ 216
Query: 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
L+ P + + C HE+ D RP +++ +
Sbjct: 217 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-65
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNL 131
+F S LG G G V+K + +A K + R + E+ +L + P +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V G + + E+M GS++ L + K++ +GL YL +
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K K +++RD+K SNIL++ KL DFG++ ++ +GT Y +PE +
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 252 TGQLTLKSDVYSFGVVLLEILSGR 275
+++SD++S G+ L+E+ GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (528), Expect = 5e-65
Identities = 71/309 (22%), Positives = 123/309 (39%), Gaps = 42/309 (13%)
Query: 61 TLTFRELAAATKNFRSE---------SLLGEGGFGRVYKGYLESINQD---VAIKQLDRN 108
TF + A + F E ++G G FG V G+L+ + VAIK L
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 109 GVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 167
+ R+FL E ++ HPN+++L G +++ E+M GS++ L
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---ND 122
Query: 168 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227
+ + G A G++YL D ++RDL NIL++ K+SDFGL++
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 228 VGDNTHVSTRV---MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284
+ T + APE + + T SDV+S+G+V+ E++S
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS----------- 228
Query: 285 AEQSLVAWARPLFQDRTRHSLIA--DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIA 342
+ + D T +I + + + P + C + + RP
Sbjct: 229 -------YGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 343 DVVTALAYL 351
+V L +
Sbjct: 282 QIVNTLDKM 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 3e-64
Identities = 74/281 (26%), Positives = 120/281 (42%), Gaps = 25/281 (8%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+G G FG V+ GY + VAIK + R G +F+ E ++ L HP L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L G C + LV+E+M G + D+L + T + + G+ YL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
VI+RDL N L+ K+SDFG+ + D ST + +PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFS 175
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311
+ + KSDV+SFGV++ E+ S K +++ +E + +D + + P L
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL 226
Query: 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352
+ C E+P+ RP + ++ LA +A
Sbjct: 227 AST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-64
Identities = 73/291 (25%), Positives = 115/291 (39%), Gaps = 43/291 (14%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
K + +G+G FG V G VA+K + + + FL E +++ L H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62
Query: 132 VNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
V L+G + L +V EYM GS+ D+L S G+ L + +K + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
++RDL N+L+ K+SDFGL K +T + APE
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEAL 172
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--- 307
+ + + KSDV+SFG++L EI S R + ++
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFG------------------RVPYPRIPLKDVVPRVE 214
Query: 308 ---DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 355
+ PP V C H MRP + L ++ + +
Sbjct: 215 KGYKMDAPDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-64
Identities = 61/285 (21%), Positives = 114/285 (40%), Gaps = 37/285 (12%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPN 130
++ +G G +GR K +S + + K+LD + + + EV +L L HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 131 LVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
+V D L V EY G + + + ++ LD +++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 189 LHDK--AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
H + V++RDLK +N+ LD + KL DFGLA++ + +T + +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306
PE KSD++S G +L E+ + P F ++ L
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCAL-------------------MPPFTAFSQKELA 223
Query: 307 A------DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 345
+ +Y + + ++ + RP + +++
Sbjct: 224 GKIREGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 6e-64
Identities = 64/300 (21%), Positives = 120/300 (40%), Gaps = 29/300 (9%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+ +G+G FG V++G ++VA+K + + E+ +L H N++ I
Sbjct: 8 QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIA 64
Query: 137 YCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
+ Q LV +Y GS+ D+L+ + + +K+A A GL +LH +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHME 119
Query: 193 A-----KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYC 245
KP + +RDLK NIL+ + ++D GLA +T +GT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 246 APEY------AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQ 298
APE K + ++D+Y+ G+V EI + + + P +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 299 DRTRHSL--IADPELQGQYPPRGFYQALA-VAAMCVHEQPDMRPVIADVVTALAYLASQK 355
+ + P + ++ + +A + C + R + L+ L+ Q+
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 1e-63
Identities = 70/306 (22%), Positives = 112/306 (36%), Gaps = 50/306 (16%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNRE-FLVEV-LMLSL 125
N +LG G FG+V I++ VA+K L RE + E+ +M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-------------------DLSPG 166
H N+VNL+G C L++EY G + ++L +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 167 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226
L + + A A+G+E+L K ++RDL N+L+ G K+ DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286
N V + APE G T+KSDV+S+G++L EI S
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG----------- 263
Query: 287 QSLVAWARPLFQDRTRHSL---IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 343
+ + + + P + + C RP +
Sbjct: 264 -------VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 344 VVTALA 349
+ + L
Sbjct: 317 LTSFLG 322
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (518), Expect = 1e-63
Identities = 70/305 (22%), Positives = 113/305 (37%), Gaps = 51/305 (16%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQGNR-EFLVEVLMLSLL 126
N +GEG FGRV++ + VA+K L + +F E +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD--------------------LSPG 166
+PN+V L+G CA G L++EYM G + + L SPG
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 167 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226
PL ++ IA A G+ YL + ++RDL N L+ K++DFGL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286
D + PE + T +SDV+++GVVL EI S
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG----------- 239
Query: 287 QSLVAWARPLFQDRTRHSL---IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 343
+ + + D + P + + +C + P RP
Sbjct: 240 -------LQPYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 344 VVTAL 348
+ L
Sbjct: 292 IHRIL 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-63
Identities = 73/308 (23%), Positives = 128/308 (41%), Gaps = 36/308 (11%)
Query: 65 RELAAATKNFRSESL-LGEGGFGRVYKGYLESIN--QDVAIKQLDRNGVQGNRE-FLVEV 120
++L N + LG G FG V +G DVAIK L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
++ L +P +V LIG C + +LV E G + L ++ + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVM 239
+ G++YL +K ++RDL N+LL ++ K+SDFGL+K LG +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299
+ APE + + +SDV+S+GV + E LS + ++
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG------------------QKPYKK 215
Query: 300 RTRHSLIA--DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 357
++A + + + PP + A+ + C + + RP V + Y
Sbjct: 216 MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM----RACYY 271
Query: 358 SDAEKVQS 365
S A KV+
Sbjct: 272 SLASKVEG 279
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-63
Identities = 65/275 (23%), Positives = 113/275 (41%), Gaps = 24/275 (8%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLVEVLMLSLLHHPN 130
+++ LGEG +G V + VA+K +D + V E+ + +L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V G+ +G+ + L EY G + D + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ +RD+K N+LLD + K+SDFGLA + + + ++ GT Y APE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 251 KTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309
K + DV+S G+VL +L+G D + ++ + + + + D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK---IDS 234
Query: 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
LA+ + E P R I D+
Sbjct: 235 A------------PLALLHKILVENPSARITIPDI 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-62
Identities = 77/298 (25%), Positives = 132/298 (44%), Gaps = 29/298 (9%)
Query: 79 LLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNL 134
++G G FG VY G L + A+K L+R G +FL E +++ HPN+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 135 IGYCADGDQR-LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
+G C + L+V YM G + + + + A+G+++L K
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK- 149
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAK 251
++RDL N +LD + K++DFGLA+ D+ H T + A E +
Sbjct: 150 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311
T + T KSDV+SFGV+L E+++ + + L Q R L
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGR--------RLL 254
Query: 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQSPCLD 369
Q +Y P Y+ V C H + +MRP +++V+ ++ + S V + ++
Sbjct: 255 QPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVN 309
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 1e-61
Identities = 66/281 (23%), Positives = 112/281 (39%), Gaps = 32/281 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHP 129
+ + + +G G F VYKG +VA +L + + + F E ML L HP
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 130 NLVNLIGYCADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
N+V + +LV E M G+++ +L K + +G
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKG 124
Query: 186 LEYLHDKAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
L++LH + PP+I+RDLKC NI + K+ D GLA L + V+GT +
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 179
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304
APE + + DVY+FG+ +LE+ + + AA+ +
Sbjct: 180 MAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YR 223
Query: 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 345
+ + + + C+ + D R I D++
Sbjct: 224 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-61
Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 34/278 (12%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHH 128
++F LG+G FG VY + +A+K L + ++ + EV + S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
PN++ L GY D + L+ EY PLG+V L D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSY 121
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
H K VI+RD+K N+LL K++DFG + P + T + GT Y PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 174
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308
+ K D++S GV+ E L G +P F+ T
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVG-------------------KPPFEANTYQETYKR 215
Query: 309 -PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 345
++ +P A + + + P RP++ +V+
Sbjct: 216 ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-61
Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 38/282 (13%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
+ LG+G FG+VYK + + A K +D + +++VE+ +L+ HPN+V
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
L+ + ++ E+ G+V+ + +L ++PL + + L YLHD
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-- 250
+I+RDLK NIL KL+DFG++ +GT + APE
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMC 184
Query: 251 ---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307
K K+DV+S G+ L+E+ P + ++
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEI-------------------EPPHHELNPMRVLL 225
Query: 308 DPELQGQYPPRGFY-----QALAVAAMCVHEQPDMRPVIADV 344
+ + P C+ + D R + +
Sbjct: 226 K-IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 4e-61
Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 39/297 (13%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQGNRE-FLVEVLMLS-L 125
LG G FG+V + + VA+K L + RE + E+ +LS L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD--------------LSPGKKPLD 171
+H N+VNL+G C G L++ EY G + + L + + LD
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 172 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231
+ + A+G+ +L K I+RDL NILL G K+ DFGLA+ N
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 291
V + APE T +SDV+S+G+ L E+ S + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY-- 258
Query: 292 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
+ + P + + C P RP +V +
Sbjct: 259 -------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-61
Identities = 76/302 (25%), Positives = 125/302 (41%), Gaps = 42/302 (13%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLES--INQDVAIKQLDRNGV-QGNREFLVEV-LMLSLLH 127
+ + + ++GEG FG+V K ++ + D AIK++ +R+F E+ ++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD------------LSPGKKPLDWNTR 175
HPN++NL+G C L EY P G++ D L + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
+ AA ARG++YL + I+RDL NIL+ Y K++DFGL++ V
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 295
T + A E T SDV+S+GV+L EI+S
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG------------------GT 225
Query: 296 LFQDRTRHSLIA--DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353
+ T L + + P + + C E+P RP A ++ +L +
Sbjct: 226 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
Query: 354 QK 355
++
Sbjct: 286 ER 287
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 5e-61
Identities = 67/279 (24%), Positives = 115/279 (41%), Gaps = 33/279 (11%)
Query: 77 ESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLV 132
+ LG G FG V KGY + + + VA+K L E L E ++ L +P +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
+IG C + + +LV E LG + +L + + +++ + G++YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAK 251
++RDL N+LL ++ K+SDFGL+K L + T + APE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DP 309
+ + KSDV+SFGV++ E S + ++ + A +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYG------------------QKPYRGMKGSEVTAMLEK 225
Query: 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
+ P + + +C + RP A V L
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 6e-61
Identities = 68/287 (23%), Positives = 123/287 (42%), Gaps = 32/287 (11%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNGVQGNR-EFLVEVLMLSLLH 127
+ ++G G FG VYKG L++ + VAIK L + R +FL E ++
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
H N++ L G + +++ EYM G+++ L + + + G A G++
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMK 124
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCA 246
YL ++RDL NIL++ K+SDFGL++ L + T+ ++ + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306
PE + T SDV+SFG+V+ E+++ + + + H ++
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYG------------------ERPYWELSNHEVM 223
Query: 307 A--DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351
+ + P + C ++ RP AD+V+ L L
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 8e-61
Identities = 74/279 (26%), Positives = 115/279 (41%), Gaps = 29/279 (10%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
++ R E LG+G FG V+ G VAIK L + G FL E ++ L H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L + +V EYM GS+ D L K L + +AA A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
++RDL+ +NIL+ K++DFGLA+L + + APE A
Sbjct: 132 M---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL 187
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DP 309
G+ T+KSDV+SFG++L E+ + R + ++ +
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKG------------------RVPYPGMVNREVLDQVER 229
Query: 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
+ PP + C ++P+ RP + L
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (494), Expect = 8e-60
Identities = 75/287 (26%), Positives = 108/287 (37%), Gaps = 47/287 (16%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLH 127
K F +G G FG VY ++ VAIK++ +G Q N ++ + EV L L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
HPN + G LV EY + + KKPL + GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLA 129
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YLH +I+RD+K NILL KL DFG A + + +GT + AP
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAP 180
Query: 248 EYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304
E GQ K DV+S G+ +E+ +P + S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAER-------------------KPPLFNMNAMS 221
Query: 305 LI------ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 345
+ P LQ + F C+ + P RP ++
Sbjct: 222 ALYHIAQNESPALQSGHWSEYFRN---FVDSCLQKIPQDRPTSEVLL 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-58
Identities = 74/287 (25%), Positives = 116/287 (40%), Gaps = 35/287 (12%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGV---QGNREFLVEVLMLSL 125
K+ R LG+G FG V +G ++ + VA+K L + + + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
L H NL+ L G ++ V E PLGS+ D L + T + A A G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 123
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGY 244
+ YL K I+RDL N+LL K+ DFGL + P D+ +V + +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304
CAPE KT + SD + FGV L E+ + + +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYG------------------QEPWIGLNGSQ 222
Query: 305 LIADPELQGQYPPRGFY---QALAVAAMCVHEQPDMRPVIADVVTAL 348
++ + +G+ PR V C +P+ RP + L
Sbjct: 223 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-58
Identities = 63/296 (21%), Positives = 118/296 (39%), Gaps = 34/296 (11%)
Query: 54 SD-QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG 112
SD +I + + + K + +G+G G VY + Q+VAI+Q++
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60
Query: 113 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 172
+ E+L++ +PN+VN + GD+ +V EY+ GS+ D + + +D
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDE 115
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
+ + LE+LH VI+RD+K NILL KL+DFG +
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQ 170
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292
+ ++GT + APE K D++S G++ +E++ G
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG------------------ 212
Query: 293 ARPLFQDRTR----HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
P + + + + + + Q P + C+ + R ++
Sbjct: 213 -EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-58
Identities = 66/288 (22%), Positives = 121/288 (42%), Gaps = 32/288 (11%)
Query: 74 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDR-NGVQGNREFLVEVLMLSLLHH 128
F+ +LG G FG VYKG E + VAIK+L + N+E L E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P++ L+G C +L + + MP G + D++ + K + + A+G+ Y
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
L D+ +++RDL N+L+ H K++DFGLAKL + + + + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA- 307
T +SDV+S+GV + E+++ + + +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFG------------------SKPYDGIPASEISSI 225
Query: 308 -DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354
+ + PP + C D RP +++ + +A
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-57
Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 37/292 (12%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSL 125
+ LG+G FG VY+G + + +D VAIK ++ R EFL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL------SPGKKPLDWNTRMKIA 179
+ ++V L+G + G L++ E M G ++ +L L +P P + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
A G+ YL+ ++RDL N ++ + K+ DFG+ + D + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299
+ +PE K G T SDV+SFGVVL EI + +Q
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA------------------EQPYQG 238
Query: 300 RTRHSL---IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 348
+ + + + L P + MC P MRP ++++++
Sbjct: 239 LSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-56
Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 30/284 (10%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHP 129
+F+ +LGEG F V + +++ AIK L++ + E ++S L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
V L D ++ Y G + ++ D A LEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL 124
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H +I+RDLK NILL+ H +++DFG AK+ + +GT Y +PE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD- 308
SD+++ G ++ ++++G P F+ + +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAG-------------------LPPFRAGNEYLIFQKI 222
Query: 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352
+L+ +P + F +A + + R ++ A
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 8e-55
Identities = 70/296 (23%), Positives = 107/296 (36%), Gaps = 34/296 (11%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNRE-FLVEVLMLSLLHH 128
+GEG FG V++G S VAIK RE FL E L + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P++V LIG + + ++ E LG + L K LD + + A + L Y
Sbjct: 68 PHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAY 123
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
L K ++RD+ N+L+ KL DFGL++ + +++ + APE
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308
+ T SDV+ FGV + EIL R
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPF------------QGVKNNDVIGRIENGER 227
Query: 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQ 364
+ PP ++ C P RP ++ L+ + + EK Q
Sbjct: 228 LPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE------EKAQ 273
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 8e-54
Identities = 71/299 (23%), Positives = 117/299 (39%), Gaps = 38/299 (12%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQG-NREFLVEV-LMLSL 125
+ LG G FG+V + I++ VA+K L +R + E+ +++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 126 LHHPNLVNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHD------------LSPGKKPLDW 172
HH N+VNL+G C G +++ E+ G++ +L K L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
+ + A+G+E+L + I+RDL NILL K+ DFGLA+ +
Sbjct: 134 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292
+ APE T++SDV+SFGV+L EI S + +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEE 245
Query: 293 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351
++ TR P + C H +P RP +++V L L
Sbjct: 246 FCRRLKEGTR------MRAPDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 8e-54
Identities = 71/304 (23%), Positives = 117/304 (38%), Gaps = 44/304 (14%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGN-REFLVEV-LML 123
LGEG FG+V +++D VA+K L + + + + + E+ +M
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 124 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------------KKPLD 171
+ H N++NL+G C ++ EY G++ ++L P ++ L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 172 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231
+ A ARG+EYL K I+RDL N+L+ K++DFGLA+ D
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 291
+T + APE T +SDV+SFGV+L EI +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG---------------- 234
Query: 292 WARPLFQDRTRHSL--IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349
+ L + + P + + C H P RP +V L
Sbjct: 235 --GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 350 YLAS 353
+ +
Sbjct: 293 RIVA 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 5e-53
Identities = 57/279 (20%), Positives = 99/279 (35%), Gaps = 35/279 (12%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
++ LG G FG V++ + + A K + E+ +S+L HP LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
NL D ++ +++YE+M G + + + D + + ++ +GL ++H+
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 193 AKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
++ DLK NI+ R KL DFGL D GT + APE A
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVA 197
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI---- 306
+ + +D++S GV+ +LSG F +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSG-------------------LSPFGGENDDETLRNVK 238
Query: 307 -ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
D + + P+ R I
Sbjct: 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (446), Expect = 3e-52
Identities = 51/279 (18%), Positives = 101/279 (36%), Gaps = 35/279 (12%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
+ LG G FG V++ ++ + K ++ E+ +++ LHHP L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
NL D + +L+ E++ G + D + + + A GL+++H+
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 193 AKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+++ D+K NI+ + + K+ DFGLA + + T + APE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIV 200
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI---- 306
+ +D+++ GV+ +LSG F +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSG-------------------LSPFAGEDDLETLQNVK 241
Query: 307 -ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
D E +A + ++P R + D
Sbjct: 242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-52
Identities = 79/303 (26%), Positives = 126/303 (41%), Gaps = 37/303 (12%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSL-LHH 128
+F +LG+G FG+V+ + NQ AIK L ++ V + + +VE +LSL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P L ++ + V EY+ G + H+ D + AA GL++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQF 118
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH K ++YRDLK NILLD+ H K++DFG+ K +GD GT Y APE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308
+ D +SFGV+L E+L G + F + L
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIG-------------------QSPFHGQDEEELFHS 214
Query: 309 PELQGQYPPRGF-YQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQSPC 367
+ + PR +A + +P+ R + + E + E+++
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR----EINWEELERKE 270
Query: 368 LDP 370
+DP
Sbjct: 271 IDP 273
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 170 bits (432), Expect = 4e-51
Identities = 68/288 (23%), Positives = 123/288 (42%), Gaps = 39/288 (13%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLH 127
+ + +LG GG V+ +++DVA+K L + + F E + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 128 HPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
HP +V + G +V EY+ ++ D +H + P+ +++ A A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 121
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTY 242
+ L + H +I+RD+K +NI++ K+ DFG+A+ + G++ + V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302
Y +PE A+ + +SDVYS G VL E+L+G P F +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTG-------------------EPPFTGDSP 219
Query: 303 HSLIADPELQGQYPPRGFYQAL-----AVAAMCVHEQPDMRPVIADVV 345
S+ + PP ++ L AV + + P+ R A +
Sbjct: 220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (430), Expect = 2e-50
Identities = 59/280 (21%), Positives = 94/280 (33%), Gaps = 32/280 (11%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHP 129
+ +LG G F V + + VAIK + + ++G E+ +L + HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V L G L+ + + G + D + + K ++ ++YL
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYL 123
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
HD + LD +SDFGL+K+ D V + GT GY APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEV 180
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI--- 306
+ D +S GV+ +L G P F D L
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCG-------------------YPPFYDENDAKLFEQI 221
Query: 307 --ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
A+ E Y A + + P+ R
Sbjct: 222 LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 170 bits (432), Expect = 5e-50
Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 33/274 (12%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLH-- 127
+F ++G GGFG VY + A+K LD+ + QG L E +MLSL+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 128 -HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
P +V + D+ + + M G + HL AA GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGL 120
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
E++H++ V+YRDLK +NILLD H ++SD GLA +GT+GY A
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 247 PEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305
PE + G +D +S G +L ++L G K + + R +L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----------RMTL 222
Query: 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 339
EL + P + ++ + + R
Sbjct: 223 TMAVELPDSFSP----ELRSLLEGLLQRDVNRRL 252
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-49
Identities = 46/279 (16%), Positives = 103/279 (36%), Gaps = 36/279 (12%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
+ LG G FG V++ S + K + G E+ +L++ H N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNIL 64
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
+L ++ ++++E++ + + ++ L+ + L++LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 193 AKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ + D++ NI+ R K+ +FG A+ GDN + + Y APE
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI---- 306
+ ++ +D++S G ++ +LSG F T +I
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG-------------------INPFLAETNQQIIENIM 216
Query: 307 -ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
A+ + +A+ + ++ R ++
Sbjct: 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (420), Expect = 7e-49
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHH 128
++F+ LG G FGRV+ + A+K L + V ++ E LMLS++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P ++ + G D Q ++ +Y+ L L + AA LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH K +IYRDLK NILLD+ H K++DFG AK P V+ + GT Y APE
Sbjct: 120 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPE 171
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRK 276
T D +SFG+++ E+L+G
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (417), Expect = 8e-49
Identities = 62/293 (21%), Positives = 106/293 (36%), Gaps = 50/293 (17%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---------QGNREFLVEV-LM 122
N+ + +LG G V + + ++ A+K +D G + L EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 123 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 182
+ HPN++ L LV++ M G + D+L + K L KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRAL 119
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
+ LH +++RDLK NILLD + KL+DFG + D V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTP 173
Query: 243 GYCAPEYAKTGQL------TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 296
Y APE + + D++S GV++ +L+G P
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-------------------SPP 214
Query: 297 FQDRTRHSLI-----ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
F R + ++ + + + + + QP R +
Sbjct: 215 FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (403), Expect = 1e-46
Identities = 57/300 (19%), Positives = 96/300 (32%), Gaps = 31/300 (10%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPN 130
+++ +GEG FG +++G NQ VAIK R + E LL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+ N+ + +G +LV + + L + T A ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHP-----KLSDFGLAKLGPVGDNT-----HVSTRVMG 240
+K ++YRD+K N L+ R + DFG+ K + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300
T Y + + + + D+ + G V + L G KAA + Q
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA-YLASQKYESD 359
L A P FY+ + D P + + L D
Sbjct: 236 PLRELCAG-------FPEEFYK---YMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-46
Identities = 70/282 (24%), Positives = 108/282 (38%), Gaps = 25/282 (8%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-----NREFLVEVLMLSLLHHPNLVN 133
LGEG F VYK ++ NQ VAIK++ NR L E+ +L L HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
L+ LV+++M D + L + +GLEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+++RDLK +N+LLD KL+DFGLAK G T + T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 254 QL-TLKSDVYSFGVVLLEILSGRKAV--DTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310
++ + D+++ G +L E+L + D+ + P + + D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 311 LQGQYPPRGFY--------QALAVAAMCVHEQPDMRPVIADV 344
+P + L + P R
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 7e-46
Identities = 64/286 (22%), Positives = 103/286 (36%), Gaps = 44/286 (15%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLH 127
+ + LG G F V K +S A K + + + +R + EV +L +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
HPN++ L + +L+ E + L D K+ L + G+
Sbjct: 72 HPNVITLHEVYENKTDVILILELVA----GGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 188 YLHDKAKPPVIYRDLKCSNILLDR----GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
YLH + + DLK NI+L K+ DFGLA D + + GT
Sbjct: 128 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 181
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303
+ APE L L++D++S GV+ +LSG F T+
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------ASPFLGDTKQ 222
Query: 304 SLIA-----DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
+A + E + +Y A + + P R I D
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 9e-46
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 7/208 (3%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHP 129
+ + S +GEG +G V Y VAIK++ Q + L E+ +L H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N++ + + Y+ + L+ L + L + RGL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYI 125
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPE 248
H V++RDLK SN+LL+ K+ DFGLA+ P D+T T + T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 249 YAKTGQLTLKS-DVYSFGVVLLEILSGR 275
+ KS D++S G +L E+LS R
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-45
Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
++ ++G G FG VY+ L + VAIK++ ++ NR E+ ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 133 NLIGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
L + ++ LV +Y+P H S K+ L R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
Y+H + +RD+K N+LLD KL DFG AK + + + Y
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRA 190
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
T DV+S G VL E+L G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 5e-45
Identities = 58/296 (19%), Positives = 104/296 (35%), Gaps = 29/296 (9%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 133
+R +G G FG +Y G + ++VAIK + + +E + ++ +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 66
Query: 134 LIGYC-ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
I +C A+GD ++V E + + + T + +A +EY+H K
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 193 AKPPVIYRDLKCSNIL---LDRGYHPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGY 244
I+RD+K N L +G + DFGLAK + + GT Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304
+ + + + D+ S G VL+ G KAA ++ + +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY------ERISEKKM 233
Query: 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA-YLASQKYESD 359
L YP + C + D +P + + Q + D
Sbjct: 234 STPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-44
Identities = 61/292 (20%), Positives = 106/292 (36%), Gaps = 23/292 (7%)
Query: 70 ATKNFRSESLLGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLL 126
A + + + +GEG +G+V+K L++ + VA+K++ + + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 127 ---HHPNLVNLIGYCADGDQRLLVYEYMPLGSV--EDHLHDLSPGKKPLDWNTRMKIAAG 181
HPN+V L C + V + + + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
RGL++LH V++RDLK NIL+ KL+DFGLA++ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 301
Y APE D++S G + E+ + S + + L +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 302 RHSLIADPELQ---------GQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
+A P ++ + C+ P R
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-44
Identities = 59/281 (20%), Positives = 104/281 (37%), Gaps = 44/281 (15%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE------FLVEVLMLSLLH 127
++ LLG GGFG VY G S N VAIK ++++ + E +EV++L +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 128 --HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
++ L+ + D +L+ E L D + L
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQ---DLFDFITERGALQEELARSFFWQVLEA 122
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
+ + H+ V++RD+K NIL+D KL DFG L V T GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVY 175
Query: 245 CAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303
PE+ + + + V+S G++L +++ G F+
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-------------------DIPFEHDE-E 215
Query: 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
+ + + + + C+ +P RP ++
Sbjct: 216 IIRGQVFFRQRVSS----ECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-43
Identities = 54/285 (18%), Positives = 107/285 (37%), Gaps = 20/285 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPN 130
NF+ +GEG +G VYK + + VA+K++ D + E+ +L L+HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V L+ ++ LV+E++ + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
V++RDLK N+L++ KL+DFGLA+ V + V+ +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILL 175
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310
+ D++S G + E+++ R + + + + + P+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 311 LQGQYP-----------PRGFYQALAVAAMCVHEQPDMRPVIADV 344
+ +P P ++ + +H P+ R
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 9e-43
Identities = 52/273 (19%), Positives = 96/273 (35%), Gaps = 29/273 (10%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
+LG G G+V + + + + A+K L ++ + RE L P++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREV---ELHWRASQCPHIVRIVDVY 74
Query: 139 ----ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
A L+V E + G + + D G + +I ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN- 131
Query: 195 PPVIYRDLKCSNILLDRGY---HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
+ +RD+K N+L KL+DFG AK ++ T Y APE
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLG 186
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311
+ D++S GV++ +L G ++ A + + E
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------ISPGMKTRIRMGQYEF 236
Query: 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
+ + + +P R I +
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-42
Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 12/207 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHH 128
+F LLG+G FG+V ++ + A+K L + + E + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P L L D+ V EY G + HL ++ A LEY
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEY 120
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH + V+YRD+K N++LD+ H K++DFGL K G T GT Y APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPE 175
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ D + GVV+ E++ GR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (362), Expect = 8e-41
Identities = 50/285 (17%), Positives = 107/285 (37%), Gaps = 22/285 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPN 130
+ +GEG +G VYK + A+K++ ++ + E+ +L L H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V L + +LV+E++ +D L + L+ T G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
D+ V++RDLK N+L++R K++DFGLA+ + + ++ +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLM 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310
+ + + D++S G + E+++G A + + + ++ P+
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 311 LQGQYPPRGFY-----------QALAVAAMCVHEQPDMRPVIADV 344
+ + + + + P+ R
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-40
Identities = 52/287 (18%), Positives = 100/287 (34%), Gaps = 22/287 (7%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHP 129
+ + +GEG +G V+K ++ VA+K++ D + L E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V L + LV+E+ +D LD +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H + V++RDLK N+L++R KL++FGLA+ + S V+ +
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVL 173
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ------------SLVAWARPLF 297
+ D++S G + E+ + + + +Q +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 344
D + + P+ + + P R +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 9e-40
Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 20/216 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPN 130
+ + +G+G FG V+K Q VA+K++ + L E+ +L LL H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 131 LVNLIGYCADGDQR--------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 182
+VNLI C LV+++ + L + ++
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQML 126
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS--TRVMG 240
GL Y+H + +++RD+K +N+L+ R KL+DFGLA+ + N+ + T +
Sbjct: 127 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 241 TYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGR 275
T Y PE + D++ G ++ E+ +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 5e-39
Identities = 64/271 (23%), Positives = 94/271 (34%), Gaps = 35/271 (12%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHP 129
F LG G FGRV + A+K LD+ V ++ L E +L ++ P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
LV L D +V EY+ G + HL AA EYL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYL 157
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H +IYRDLK N+L+D+ + +++DFG AK T + GT APE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309
+ D ++ GV++ E+ +G P F +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-------------------YPPFFADQPIQIYEKI 250
Query: 310 ELQGQYPPRGFYQAL-AVAAMCVHEQPDMRP 339
P F L + + R
Sbjct: 251 VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 8e-39
Identities = 40/206 (19%), Positives = 82/206 (39%), Gaps = 9/206 (4%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHP 129
+R +G G +G V VAIK+L R + E+ +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N++ L+ + ++ + + L + + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H +I+RDLK N+ ++ K+ DFGLA+ ++ ++ V+ +
Sbjct: 138 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVI 190
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGR 275
+ T D++S G ++ E+++G+
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (328), Expect = 2e-35
Identities = 39/207 (18%), Positives = 80/207 (38%), Gaps = 19/207 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNL 131
+++ LG G + V++ + N+ V +K L + + E+ ++ +L PN+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 132 VNLIGYCADGDQRL--LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
+ L D R LV+E++ + + L + L+Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC 145
Query: 190 HDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
H +++RD+K N+++D +L D+GLA+ + RV Y
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHPGQEYNVRVASRYFKGPEL 200
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
D++S G +L ++ +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-34
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 18/214 (8%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV----QGNREFLVEVLMLS 124
+NF +LG G +G+V+ S + A+K L + + + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 125 LL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
+ P LV L + L+ +Y+ G + HL ++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIV 139
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
LE+LH +IYRD+K NILLD H L+DFGL+K V D T + GT
Sbjct: 140 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIE 195
Query: 244 YCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGR 275
Y AP+ + G D +S GV++ E+L+G
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-33
Identities = 42/207 (20%), Positives = 85/207 (41%), Gaps = 9/207 (4%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHH 128
+ +++ S +G G +G V + VA+K+L R + + E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
N++ L+ + + + + + L + + RGL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
+H +I+RDLK SN+ ++ K+ DFGLA+ + ++ V +
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEI 189
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
D++S G ++ E+L+GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 6e-32
Identities = 49/212 (23%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHP 129
K +++ +G G G V Y ++++VAIK+L R + E++++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 130 NLVNLIGYCA------DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
N+++L+ + LV E M + + LD +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQML 129
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
G+++LH +I+RDLK SNI++ K+ DFGLA+ + + T + T
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRY 183
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE D++S G ++ E++ +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 8e-31
Identities = 38/215 (17%), Positives = 76/215 (35%), Gaps = 16/215 (7%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 133
+ LG G F V+ N VA+K + + V E+ +L ++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTK 73
Query: 134 LIGYCADGDQRLLVYEY------------MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
A+ +LL + + + + +I+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
GL+Y+H + +I+ D+K N+L++ L +A LG T +
Sbjct: 134 LLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
T Y +PE +D++S ++ E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.2 bits (197), Expect = 3e-18
Identities = 21/161 (13%), Positives = 45/161 (27%), Gaps = 30/161 (18%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV----------QGNREFLVEVLMLSLLH 127
L+GEG V+ Y E + +K G+ F V + +
Sbjct: 6 KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 128 HPNLVNLIGYCA----DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
L L G + ++ E + + ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-----------RVENPDEVLDMIL 113
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224
+ + + +++ DL N+L+ + DF +
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 399 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.91 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.37 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.35 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.04 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-60 Score=431.41 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=208.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.++|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46799999999999999999999999999999999765332 33568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
||+||+|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999975 568999999999999999999999999 999999999999999999999999999865443
Q ss_pred CCcceeeeeccCccccCccccccCCC-CcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.........+||+.|||||++.+..+ +.++|||||||++|||++|++||............ .... ..
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~~~----~~------- 224 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEK----KT------- 224 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HHTT----CT-------
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-HhcC----CC-------
Confidence 33334455789999999999988776 57899999999999999999999765432111111 0000 00
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
........+..+.+|+.+||+.||++|||+.|+++
T Consensus 225 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 ---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00011122347889999999999999999999874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-59 Score=430.90 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=212.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+++.++|||||++++++.+.+.+|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999999999999998665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
+||+|.+++.. ..+++.+++.|+.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+.....
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-- 169 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--
Confidence 99999998874 46999999999999999999999999 999999999999999999999999999864322
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||............. .. . .. .
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~--~~----~--~~---~--- 235 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--TN----G--TP---E--- 235 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HH----C--SC---C---
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH--hC----C--CC---C---
Confidence 223345679999999999999999999999999999999999999997655433222111 00 0 00 0
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...++..+..+.+||.+||+.||.+|||+.|+++
T Consensus 236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112233458899999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-59 Score=423.95 Aligned_cols=246 Identities=28% Similarity=0.424 Sum_probs=210.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|+++.+++.||||++.+.. ....+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999999999999999986432 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|||++|+|.+++.. ...+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999986 567999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. ......||+.|||||++.+..|+.++|||||||++|||++|+.||............... .
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------------~ 220 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------------E 220 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------------C
T ss_pred C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------C
Confidence 2 234467999999999999999999999999999999999999999876544332221110 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. ..++..+.++.+|+.+||+.||++|||+.|+++
T Consensus 221 ~----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 F----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0 112223348899999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-59 Score=430.18 Aligned_cols=251 Identities=23% Similarity=0.305 Sum_probs=209.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999986432 223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|||+||+|.+++.. .+.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999987 578999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
..........+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+. .. .
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~~--------~ 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KL--------E 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------TT--------C
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH------cC--------C
Confidence 433334455679999999999999999999999999999999999999998765433222111 00 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
. .++...+..+.+||.+||+.||.+|||++|+++.
T Consensus 227 ~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp C----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred C----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1 1122233478999999999999999999998653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-58 Score=418.71 Aligned_cols=262 Identities=28% Similarity=0.472 Sum_probs=205.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
.++|++.+.||+|+||+||+|+.+ ..||||++.... ....+.|.+|+.+|++++|||||++++++.+ ..+++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 357999999999999999999865 359999987543 2344678999999999999999999998755 5689999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|||++|+|.+++... ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999752 457999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCcceeeeeccCccccCcccccc---CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
...........||+.|||||++.+ ..|+.++|||||||++|||+||+.||............ ........
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~~~~~~p----- 229 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VGRGYLSP----- 229 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHHTSCCC-----
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--HhcCCCCC-----
Confidence 333334455689999999999864 45899999999999999999999999865433221111 11100000
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
..+.....++ ..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 230 -~~~~~~~~~~----~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 230 -DLSKVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -CGGGSCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -cchhccccch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0011222333 4889999999999999999999999999988753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-58 Score=426.37 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=209.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
+.|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999999999999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++|+|.+++... ..++++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|..... .
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~ 163 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 163 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--H
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--C
Confidence 999999998752 457999999999999999999999999 99999999999999999999999999864211 1
Q ss_pred cceeeeeccCccccCccccc-----cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 232 THVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
........||+.|||||++. +..|+.++|||||||++|||++|+.||............ ... . ...
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i--~~~----~--~~~- 234 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--AKS----E--PPT- 234 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HHS----C--CCC-
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH--HcC----C--CCC-
Confidence 11223467999999999983 456899999999999999999999999765443221111 100 0 000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...++..+.++.+||.+||+.||++|||+.|+++
T Consensus 235 ------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 ------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112233458899999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-59 Score=423.34 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=199.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEec--CCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 147 (399)
++|++.+.||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.++++++|||||++++++.+ ...+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999999999999999999765433 23568899999999999999999999865 4568999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA--KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
||||++|+|.+++.........+++..++.++.||+.||.|||+++ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999754434678999999999999999999999864 12399999999999999999999999999986
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.... ........||+.|||||++.+..|+.++|||||||++|||++|+.||...........+.. ..
T Consensus 164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~--~~--------- 230 (269)
T d2java1 164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GK--------- 230 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--TC---------
T ss_pred cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc--CC---------
Confidence 4322 2233456799999999999999999999999999999999999999987654432221110 00
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+. .+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 231 --~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 --FRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 011 12223348899999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-58 Score=424.43 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=214.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||+||+|.++.+++.||||++.... ...+.|.+|+.+|++++|||||++++++.+.+.+++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 457889999999999999999999999999999987543 3567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
|++|+|.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 95 ~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999997632 467999999999999999999999999 9999999999999999999999999998643322
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcc-cchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD-TSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........||+.|+|||++.+..|+.++|||||||++|||++|..||. ........... .. .
T Consensus 170 -~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i---~~----~--------- 232 (287)
T d1opja_ 170 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EK----D--------- 232 (287)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HT----T---------
T ss_pred -ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH---hc----C---------
Confidence 222334568999999999999999999999999999999999766654 33322221111 11 0
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.....++..+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 233 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 233 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0111222333489999999999999999999999999987654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-58 Score=424.73 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=196.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.+.|++.+.||+|+||+||+|+++.+|+.||||++...... ....+.+|+.+|+.++|||||++++++.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35699999999999999999999999999999999765433 23457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec---CCCceEEecccCCccC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLAKLG 226 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~ 226 (399)
||+||+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999986 678999999999999999999999999 99999999999994 5789999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.. .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.............. ..
T Consensus 161 ~~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~------~~------ 225 (307)
T d1a06a_ 161 DP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK------AE------ 225 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT------TC------
T ss_pred cC---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc------cC------
Confidence 22 2223446799999999999999999999999999999999999999987654432221111 00
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
........+..+..+.+|+.+||+.||++|||+.|+++
T Consensus 226 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 226 --YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01111112233448899999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-57 Score=421.12 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=202.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCe---EEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
++|++.+.||+|+||+||+|.++.+++ .||||.+...... ..+.|.+|+.+|++++|||||++++++.+.+.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 457888999999999999999986654 5899988654333 346799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
||||++|+|.+++... ...+++.+++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999988752 457999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcc---eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 228 VGDNTH---VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 228 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
...... ......||+.|||||++.+..++.++|||||||++|||+| |+.||...........+ .. ..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i---~~----~~-- 250 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQ----DY-- 250 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HT----TC--
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc----CC--
Confidence 322211 1122457999999999999999999999999999999998 89999876544322211 11 00
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
....+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 251 --------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 --------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 011122334488999999999999999999999999998765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=413.61 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=203.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||+|.+++ ++.||||++.... ...+.|.+|+.++++++|||||++++++.+++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 578899999999999999999875 7889999997543 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++|+|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999998752 467899999999999999999999999 99999999999999999999999999976433222
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhC-CCCcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||............... . .
T Consensus 157 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~---~----~-------- 220 (263)
T d1sm2a_ 157 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---F----R-------- 220 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT---C----C--------
T ss_pred -eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc---C----C--------
Confidence 222345689999999999999999999999999999999994 6666554433222211110 0 0
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
...+...+..+.+|+.+||+.||++|||+++|++.|+.+.+
T Consensus 221 --~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 221 --LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 01112223478999999999999999999999999998865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-58 Score=429.44 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=207.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
.++|++.+.||+|+||+||+|+++.+|+.||+|++..... .....+.+|+.+|+.++|||||+++++|.+.+.+|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4679999999999999999999999999999999975533 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|++||+|.+++.. ...+++..+..++.||+.||.|||+ ++ |+||||||+||||+.++.+||+|||+|.....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999986 5679999999999999999999997 48 99999999999999999999999999975321
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh-hhhhc-------cc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLFQ-------DR 300 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~-------~~ 300 (399)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||............... ..... ..
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 1233468999999999999999999999999999999999999999765432211110000 00000 00
Q ss_pred ccc----ccccCc---------cccC----CCC-hHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRH----SLIADP---------ELQG----QYP-PRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~----~~~~~~---------~~~~----~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... .....+ .... ..+ .....++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000 000000 0000 000 012347889999999999999999999997
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.7e-57 Score=425.23 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=212.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999999999999999999876555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec--CCCceEEecccCCccCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~~~~~~~ 228 (399)
|+||+|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 105 ~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999999642 457999999999999999999999999 99999999999996 467899999999986432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. .......||+.|||||++.+..|+.++|||||||++|+|++|+.||...........+.... .
T Consensus 179 ~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~------~------- 242 (350)
T d1koaa2 179 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD------W------- 242 (350)
T ss_dssp T---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------C-------
T ss_pred c---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------C-------
Confidence 2 23345679999999999999999999999999999999999999998665433222111100 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.......+..+..+.+||.+||+.||++|||+.|+++
T Consensus 243 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 243 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp -CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000111223347899999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.6e-57 Score=425.60 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=212.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||+|+++.+|+.||||++..........+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999999999999999998765555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec--CCCceEEecccCCccCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~ 229 (399)
+||+|.+++.. ...++++.+++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||+|......
T Consensus 109 ~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999998765 2457999999999999999999999999 99999999999998 5789999999999864332
Q ss_pred CCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
.......||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........+... ..
T Consensus 183 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--------------~~ 245 (352)
T d1koba_ 183 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--------------DW 245 (352)
T ss_dssp ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--------------CC
T ss_pred ---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------CC
Confidence 2344567999999999999999999999999999999999999999876554332221110 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+.....+..+.++.+||.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111122233448899999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-57 Score=417.12 Aligned_cols=252 Identities=24% Similarity=0.300 Sum_probs=210.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999999999999999999654321 346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC----ceEEecc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDF 220 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Df 220 (399)
|||||||+||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 999999999999999987 567999999999999999999999999 99999999999998776 5999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
|++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 162 G~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~----- 233 (293)
T d1jksa_ 162 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY----- 233 (293)
T ss_dssp TTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-----
T ss_pred hhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----
Confidence 9998643222 23345799999999999999999999999999999999999999987654432221111100
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+..... .+..+.+||.+||+.||++|||++|+++
T Consensus 234 -----~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 -----EFEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----CCCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCCchhcCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111112 2347889999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=421.89 Aligned_cols=248 Identities=27% Similarity=0.348 Sum_probs=211.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999999999999999997542 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|||+||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999987 678999999999999999999999999 99999999999999999999999999985332
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. .......+||+.|+|||++.+..|+.++|||||||++|||++|++||............... .
T Consensus 158 ~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--------------~ 221 (337)
T d1o6la_ 158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--------------E 221 (337)
T ss_dssp T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------C
T ss_pred C--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--------------C
Confidence 2 22334568999999999999999999999999999999999999999876654332221110 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 346 (399)
. .+|...+.++.+||.+||+.||.+||+ ++++++
T Consensus 222 ~----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 122233347899999999999999995 788875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-57 Score=418.68 Aligned_cols=246 Identities=30% Similarity=0.388 Sum_probs=205.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
+.|+..+.||+|+||+||+|++..+|+.||||++....... .+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35899999999999999999999999999999997654432 246889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|||++|+|..++.. ..++++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999877765 578999999999999999999999999 99999999999999999999999999985322
Q ss_pred CCCcceeeeeccCccccCcccccc---CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.....||+.|||||++.+ ..|+.++|||||||++|||++|..||............ .. ..
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i--~~----~~----- 230 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQ----NE----- 230 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HH----SC-----
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--Hh----CC-----
Confidence 234579999999999853 56899999999999999999999999765543322111 10 00
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.+.+. +...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 231 --~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 --SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --CCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 00110 1122347899999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=407.55 Aligned_cols=248 Identities=27% Similarity=0.435 Sum_probs=200.5
Q ss_pred CCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEec----CCeeEEE
Q 015816 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLV 147 (399)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv 147 (399)
|++.+.||+|+||+||+|+++.+++.||+|++..... ...+.+.+|+.+|++++|||||++++++.+ ...+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3677789999999999999999999999999875432 234568899999999999999999999865 3568999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec-CCCceEEecccCCccC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLG 226 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~ 226 (399)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ ++|+||||||+||||+ .++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999987 567999999999999999999999875 3499999999999996 5789999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
.. ......+||+.|||||++.+ .|+.++|||||||++|||++|+.||......... ..... .. .
T Consensus 166 ~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~--~~~i~----~~-----~ 229 (270)
T d1t4ha_ 166 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVT----SG-----V 229 (270)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHT----TT-----C
T ss_pred cC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH--HHHHH----cC-----C
Confidence 22 22345679999999999865 6999999999999999999999999754332211 11110 00 0
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..+.+...+++ ++.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~----~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 230 KPASFDKVAIP----EVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCGGGGGCCCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcccCccCCH----HHHHHHHHHccCCHhHCcCHHHHhC
Confidence 01112222233 6889999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-57 Score=421.98 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=209.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCe-----EEEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCccceEEEEecCCee
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQ-----DVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 144 (399)
++|++.+.||+|+||+||+|++..+++ .||+|++.... ......+.+|+.++.++ +|||||++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578999999999999999999876543 69999986543 33456789999999998 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 015816 145 LLVYEYMPLGSVEDHLHDLSP-------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 205 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~ 205 (399)
|+|||||++|+|.+++..... ....+++..++.|+.||+.||+|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999975321 1245899999999999999999999999 999999999
Q ss_pred ceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHH
Q 015816 206 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAA 284 (399)
Q Consensus 206 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~ 284 (399)
|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986544444444445678999999999999999999999999999999998 89999764432
Q ss_pred HHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015816 285 AEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 349 (399)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 349 (399)
... ..... ... ....+...+..+.+||.+||+.||++|||++||++.|.
T Consensus 274 ~~~--~~~~~----~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANF--YKLIQ----NGF----------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHH--HHHHH----TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--HHHHh----cCC----------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 211 11111 100 01122233448999999999999999999999999885
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=409.15 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=206.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||+|.++. +..||||++.... ...+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 578889999999999999999874 7899999997543 345779999999999999999999998765 5679999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++|+|.+++.... ..++++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 90 ~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~- 163 (272)
T d1qpca_ 90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (272)
T ss_dssp TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred CCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc-
Confidence 9999999886532 346999999999999999999999999 9999999999999999999999999998643322
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCC-CcccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK-AVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........||+.|||||++.+..++.++|||||||++|||+||.. ||...........+ .. .. .+
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i---~~----~~------~~- 229 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---ER----GY------RM- 229 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HT----TC------CC-
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hh----cC------CC-
Confidence 222334568999999999999999999999999999999999654 55544332221111 10 00 01
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
..+...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 230 ---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 230 ---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 112223347899999999999999999999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-56 Score=402.33 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=213.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||+||+|+++ +++.||||++..... ..++|.+|+.++++++|||||++++++.+++.+++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 368999999999999999999986 588999999976543 467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999997652 457899999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+.. ...
T Consensus 155 -~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-------~~~------- 219 (258)
T d1k2pa_ 155 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-------GLR------- 219 (258)
T ss_dssp -CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-------TCC-------
T ss_pred -ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-------CCC-------
Confidence 222334669999999999999999999999999999999998 8999987665443322211 000
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 350 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 350 (399)
...+...+..+.+|+.+||+.||++|||+.++++.|..
T Consensus 220 ---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 ---LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 01112223478999999999999999999999998853
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=410.18 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=208.3
Q ss_pred cCCCCCCe-eeecCceEEEEEEECC--CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESL-LGEGGFGRVYKGYLES--INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
++|.+.+. ||+|+||.||+|.++. ++..||||++...... ..+.|.+|+.+|++++|||||++++++.+ +.+|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 9999999999998764 4558999999755332 34679999999999999999999999875 468999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
||||++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998642 467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCc-ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 228 VGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 228 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
..... .......||+.|||||++.+..++.++|||||||++|||+| |+.||...........+. ...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-------~~~---- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGK---- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTC----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC----
Confidence 33222 22234568999999999999999999999999999999998 999998765433222211 100
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
.+ ..++..+.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 230 --~~----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 230 --RM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp --CC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CC----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01 122233348899999999999999999999999988654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-56 Score=407.98 Aligned_cols=249 Identities=28% Similarity=0.429 Sum_probs=201.6
Q ss_pred CeeeecCceEEEEEEEC--CCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEecCC
Q 015816 78 SLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 153 (399)
+.||+|+||.||+|.++ .+++.||||++..... ...+.|.+|+.+|++++|||||++++++.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 4567899999965432 234679999999999999999999999965 467899999999
Q ss_pred CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCCc-
Q 015816 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT- 232 (399)
Q Consensus 154 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 232 (399)
|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999987 677999999999999999999999999 999999999999999999999999999864433222
Q ss_pred ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCccc
Q 015816 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 311 (399)
Q Consensus 233 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......||+.|||||++.+..++.++|||||||++|||++ |+.||...........+. ... .+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-------~~~------~~-- 229 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGE------RM-- 229 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTC------CC--
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-------cCC------CC--
Confidence 22234578999999999999999999999999999999998 899998765443222221 100 01
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 312 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 312 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
..+...+..+.+|+.+||+.||++|||+++|++.|+..
T Consensus 230 --~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11222334889999999999999999999999988754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=405.58 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=202.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCC----eEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
..|++.++||+|+||.||+|.++.++ ..||||++...... ....|.+|+.++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 46888899999999999999987654 47999999755433 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
||||+.+++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999988752 467999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCC-cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCc-ccchHHHHHHHHHhhhhhhccccccc
Q 015816 227 PVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV-DTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 227 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
..... ........||+.|||||++.+..++.++|||||||++|||++|..|+ ........... .. ...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~---i~----~~~--- 230 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---IN----DGF--- 230 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HH----TTC---
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH---Hh----ccC---
Confidence 33222 22223356899999999999999999999999999999999965554 43333222111 11 100
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
. ...+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 231 ---~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 231 ---R----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---C----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---C----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 0 11122233478999999999999999999999999998765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.9e-56 Score=413.40 Aligned_cols=245 Identities=29% Similarity=0.402 Sum_probs=210.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+++.++|||||++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999999999999999996432 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
|||+||+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999987 677999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.....+||+.|||||++.+..|+.++|||||||++|+|++|+.||...........+. .. .
T Consensus 157 -----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~--------~ 217 (316)
T d1fota_ 157 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL------NA--------E 217 (316)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HC--------C
T ss_pred -----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH------cC--------C
Confidence 2234679999999999999999999999999999999999999998765443322211 00 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
..+++..+.++.+++.+||+.||.+|+ |++++++
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 012223334789999999999999996 8899885
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-55 Score=403.39 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=206.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCccceEEEEecCC----e
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGD----Q 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~ 143 (399)
.++|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+|+.+++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 357999999999999999999999999999999997654432 346889999999999999999999987654 3
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
+||||||++|++|.+++.. ..++++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.++|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7999999999999999987 567999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCC-CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 224 KLGPVGD-NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 224 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
....... ........+||+.|||||++.+..++.++|||||||++|||+||++||............ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~------~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH------VREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH------HhcCCC
Confidence 6533222 122334567999999999999999999999999999999999999999876543322111 111000
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 015816 303 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-VIADVVTALAYLA 352 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~ 352 (399)
........+ +..+.+||.+||+.||.+|| |++++++.|.++.
T Consensus 233 ----~~~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 ----PPSARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----CGGGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CCchhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000111222 34889999999999999999 8999999988764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-55 Score=414.44 Aligned_cols=245 Identities=24% Similarity=0.272 Sum_probs=208.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 148 (399)
++|++.+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+...+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999999999999999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 228 (399)
||+.+|+|..++.. ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999987 567999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
. .....||+.|||||++.+..|+.++|||||||++|||++|+.||...........+.. . .
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------~--------~ 254 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS------G--------K 254 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------C--------C
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc------C--------C
Confidence 1 2346799999999999999999999999999999999999999987654332221110 0 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 346 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 346 (399)
+ ..+...+..+.+||.+||+.||.+|+ |++++++
T Consensus 255 ~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0 11222334789999999999999994 8999885
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=409.73 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=207.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCe----EEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 146 (399)
.+|++.+.||+|+||+||+|.+..+|+ .||+|.+.... ....+.|.+|+.++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999987776 58888886432 33457799999999999999999999999875 5678
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccC
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 226 (399)
++||+.+|+|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999999988762 567999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccccc
Q 015816 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 305 (399)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (399)
.............||+.|||||++.++.|+.++|||||||++|||+| |.+||............... .
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-------~---- 230 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-------E---- 230 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-------C----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-------C----
Confidence 54444434445679999999999999999999999999999999998 88999765443322222110 0
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 306 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
....++..+..+.+|+.+||+.||.+|||+.+|++.|..+...
T Consensus 231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 0112223344889999999999999999999999999887643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=412.84 Aligned_cols=248 Identities=29% Similarity=0.431 Sum_probs=207.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCC---CcchHHHHHHHHHHh-hcCCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLS-LLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv 147 (399)
++|++.+.||+|+||+||+|.++.+|+.||||++.+.. ....+.+..|+.++. .++|||||++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999996432 223456677777765 68999999999999999999999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
||||++|+|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999987 567999999999999999999999999 9999999999999999999999999998533
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 307 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
.. ........||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+...
T Consensus 155 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-------------- 218 (320)
T d1xjda_ 155 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------------- 218 (320)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred cc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 22 22334467999999999999999999999999999999999999999876554332222111
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 015816 308 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIA-DVVT 346 (399)
Q Consensus 308 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~ 346 (399)
.+. ++...+..+.+||.+||+.||.+|||+. ++++
T Consensus 219 ~~~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCC----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111 1122234789999999999999999996 6653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.3e-55 Score=398.24 Aligned_cols=252 Identities=24% Similarity=0.293 Sum_probs=209.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc---------hHHHHHHHHHHhhcC-CCCccceEEEEec
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---------NREFLVEVLMLSLLH-HPNLVNLIGYCAD 140 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 140 (399)
.++|++.+.||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999997653321 135788999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 141 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
.+..|||||||++|+|.+++.. ..++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999986 568999999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCcccccc------CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhh
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 294 (399)
|++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...............
T Consensus 155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~- 230 (277)
T d1phka_ 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG- 230 (277)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-
T ss_pred hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC-
Confidence 9998643322 2344679999999998853 45788999999999999999999999876654332222110
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... ......+..+.++.+|+.+||+.||++|||+.|+++
T Consensus 231 -----~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 -----NYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -----CCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -----CCC--------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000 001111233348999999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=405.93 Aligned_cols=253 Identities=16% Similarity=0.214 Sum_probs=209.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEe
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 150 (399)
.++|++.+.||+|+||+||+|.++.+|+.||||++.... .....+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999999999999999997653 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC--CCceEEecccCCccCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPV 228 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~~ 228 (399)
|+||+|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||++. .+.+||+|||++.....
T Consensus 83 ~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999752 347999999999999999999999999 999999999999985 45899999999985332
Q ss_pred CCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
........||+.|+|||.+.+..|+.++|||||||++|+|++|..||...........+.... ....
T Consensus 157 ---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~----------~~~~ 223 (321)
T d1tkia_ 157 ---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE----------YTFD 223 (321)
T ss_dssp ---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC----------CCCC
T ss_pred ---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------CCCC
Confidence 223445679999999999999999999999999999999999999998765443222111000 0001
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 309 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 309 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
......+ +.++.+|+.+||..||.+|||+.|+++.
T Consensus 224 ~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 224 EEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111122 2378899999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-55 Score=404.44 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=212.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC-----CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|++.+.||+|+||+||+|++++ +++.||||++...... ..+.|.+|+.+|+.++||||+++++++.+....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 4679999999999999999999753 5678999999754433 345799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 015816 145 LLVYEYMPLGSVEDHLHDLSP--------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 204 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp 204 (399)
++||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+++ ||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 999999999999999975321 1335899999999999999999999999 99999999
Q ss_pred CceeecCCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCC-CCcccchH
Q 015816 205 SNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR-KAVDTSKA 283 (399)
Q Consensus 205 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~-~pf~~~~~ 283 (399)
+||||+.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. +||.....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999999997543333333444567899999999999999999999999999999999985 67776554
Q ss_pred HHHHHHHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 284 AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
.+....+ . ... .+. .+...+.++.+|+.+||+.||++||||.||++.|+++.
T Consensus 249 ~e~~~~v---~----~~~------~~~----~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 EEVIYYV---R----DGN------ILA----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHH---H----TTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHH---H----cCC------CCC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 4332221 1 000 011 12223347899999999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=400.81 Aligned_cols=261 Identities=25% Similarity=0.240 Sum_probs=199.5
Q ss_pred CCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcc-----hHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-----NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
+++||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+|+.++|||||++++++.+++.+|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 568999999999999999999999999986543221 246889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
.++++..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 98877766654 567999999999999999999999999 9999999999999999999999999997533222
Q ss_pred cceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc--cccccccC
Q 015816 232 THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR--TRHSLIAD 308 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 308 (399)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||......+....+.......... ........
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 22334579999999998864 568999999999999999999999998765544322221110000000 00000000
Q ss_pred ccccC---CC-----ChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 309 PELQG---QY-----PPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 309 ~~~~~---~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..... .. .+.....+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000 00 1122457899999999999999999999984
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-54 Score=412.96 Aligned_cols=249 Identities=25% Similarity=0.329 Sum_probs=202.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC---cchHHHHH---HHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
++|++.+.||+|+||.||+|+++.+|+.||||++..... .....+.+ |+.+++.++|||||++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 579999999999999999999999999999999864322 11223333 467777788999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+|||||+||+|.+++.. ...+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999987 567899999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccc
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 304 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (399)
.... .....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||..........+.... ..
T Consensus 157 ~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~------ 223 (364)
T d1omwa3 157 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT------ 223 (364)
T ss_dssp CSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS---SS------
T ss_pred cCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cc------
Confidence 4322 1234579999999999864 57999999999999999999999999765432221111100 00
Q ss_pred cccCccccCCCChHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 015816 305 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 346 (399)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 346 (399)
..+ ..+...+..+.+||.+||+.||++||| ++++++
T Consensus 224 --~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 --MAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CCC----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCC----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 011 112223347899999999999999999 678775
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=398.34 Aligned_cols=255 Identities=29% Similarity=0.405 Sum_probs=202.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 151 (399)
++|++.+.||+|+||.||+|+++++ ..||||++... ....+.|.+|+.++++++|||||++++++.+ +.+++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 5799999999999999999999874 67999999654 3456789999999999999999999999855 5689999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++|+|..++.... ...+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 94 ~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~- 167 (285)
T d1fmka3 94 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 167 (285)
T ss_dssp TTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC-
Confidence 9999999887532 356999999999999999999999999 9999999999999999999999999997643222
Q ss_pred cceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCc-ccchHHHHHHHHHhhhhhhccccccccccCcc
Q 015816 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV-DTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 310 (399)
Q Consensus 232 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........||+.|+|||++.++.++.++|||||||++|||++|..|+ ...........+. ... .
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~---~~~----------~-- 232 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGY----------R-- 232 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTC----------C--
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcC----------C--
Confidence 22233467999999999999999999999999999999999965554 4443322222211 000 0
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 311 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 311 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
...++..+.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 233 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 233 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred --CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 1122233448899999999999999999999999888644
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=397.32 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=201.0
Q ss_pred cCCCCCCeeeecCceEEEEEEECCC---CeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 147 (399)
++|++.+.||+|+||.||+|.+..+ +..||||.+...... ..+.+.+|+.++++++|||||++++++.+ +.+|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 5799999999999999999998654 457999998654333 23568999999999999999999999964 678999
Q ss_pred EEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCC
Q 015816 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 227 (399)
|||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999987652 467999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccc
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 306 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (399)
... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+ . ...
T Consensus 160 ~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i---~----~~~----- 226 (273)
T d1mp8a_ 160 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---E----NGE----- 226 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---H----TTC-----
T ss_pred CCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH---H----cCC-----
Confidence 222 222344668999999999999999999999999999999998 89999866543322111 1 000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 307 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
.+ ..++..+..+.+||.+||+.||++|||+.+|++.|+.+.++
T Consensus 227 -~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 -RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01 12223344899999999999999999999999999887543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=394.43 Aligned_cols=252 Identities=28% Similarity=0.410 Sum_probs=201.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEec-CCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~ 150 (399)
++|++.+.||+|+||.||+|.++ |..||||+++.. ...+.+.+|+.++++++|||||++++++.+ .+.+++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 56888999999999999999986 789999999654 345779999999999999999999999865 4568999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 230 (399)
+++|+|.+++.... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 83 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC--
Confidence 99999999997521 235899999999999999999999999 99999999999999999999999999975321
Q ss_pred CcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
......+|..|+|||++.+..++.++|||||||++|||+| |++||...........+ . .. ..+
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i---~----~~------~~~ 219 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---E----KG------YKM 219 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH---T----TT------CCC
T ss_pred ---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---H----cC------CCC
Confidence 2233468999999999999999999999999999999998 78888765433221111 1 00 011
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
..++..+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 220 ----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 220 ----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 22223334889999999999999999999999999988653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=406.33 Aligned_cols=254 Identities=21% Similarity=0.267 Sum_probs=200.9
Q ss_pred hcCCCCCC-eeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhh-cCCCCccceEEEEec----CCee
Q 015816 71 TKNFRSES-LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL-LHHPNLVNLIGYCAD----GDQR 144 (399)
Q Consensus 71 ~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~----~~~~ 144 (399)
.++|++.. .||+|+||.||+|+++.+++.||||++.. ...+.+|+.++.+ ++|||||++++++.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788875 69999999999999999999999999853 3567789998765 489999999999875 4678
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---CCceEEeccc
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFG 221 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg 221 (399)
|+|||||+||+|.+++.... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||++. .+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 99999999999999998632 357999999999999999999999999 999999999999985 5679999999
Q ss_pred CCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccc
Q 015816 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 301 (399)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (399)
+++...... .....+||+.|||||++.+..|+.++|||||||++|+|+||+.||............ ....
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-------~~~i 229 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KTRI 229 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CC
T ss_pred eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-------HHHH
Confidence 998643322 234467999999999999999999999999999999999999999764322111100 0000
Q ss_pred ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 302 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
.. ....+.....+..+.++.+||.+||+.||++|||+.|+++.
T Consensus 230 ~~---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 230 RM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CS---CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hc---CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 00001111112334578999999999999999999999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-54 Score=398.39 Aligned_cols=262 Identities=29% Similarity=0.425 Sum_probs=209.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeE--EEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCccceEEEEecCCeeEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQD--VAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 147 (399)
++|++.+.||+|+||.||+|+++.+|.. ||||.+.... ....+.+.+|+.+|+++ +|||||++++++.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 5788999999999999999999888774 7778775432 23456799999999998 799999999999999999999
Q ss_pred EEecCCCCHHHHhhcc------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCce
Q 015816 148 YEYMPLGSVEDHLHDL------------SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (399)
Q Consensus 148 ~e~~~~g~L~~~l~~~------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 215 (399)
|||+++|+|.++++.. ......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999753 122467999999999999999999999999 9999999999999999999
Q ss_pred EEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCC-CCcccchHHHHHHHHHhhh
Q 015816 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQSLVAWAR 294 (399)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~ 294 (399)
||+|||+++.... ........||..|+|||.+.+..|+.++|||||||++|||++|. +||........... ..
T Consensus 167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~---i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---LP 240 (309)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---GG
T ss_pred EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH---HH
Confidence 9999999975322 11223456899999999999999999999999999999999975 56765543332111 11
Q ss_pred hhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhccC
Q 015816 295 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 356 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 356 (399)
... .+ ..+...+..+.+||.+||+.||++||||.+|++.|+.+.....
T Consensus 241 ----~~~------~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 241 ----QGY------RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp ----GTC------CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ----hcC------CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 000 11 1222334489999999999999999999999999999876443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-54 Score=398.30 Aligned_cols=262 Identities=27% Similarity=0.408 Sum_probs=210.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCC-------eEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCccceEEEEecCC
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESIN-------QDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 142 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 142 (399)
++|++.+.||+|+||.||+|++..++ ..||||++...... ....+.+|...+.++ +|||||+++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 57889999999999999999986554 47999999765443 346788899988888 7999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~ 210 (399)
..++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 99999999999999999975431 1356899999999999999999999999 99999999999999
Q ss_pred CCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHH
Q 015816 211 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (399)
Q Consensus 211 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~ 289 (399)
.++.+||+|||++................||+.|+|||.+.++.|+.++|||||||++|||++ |.+||...........
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 999999999999986544444444455679999999999999999999999999999999998 7888876654432221
Q ss_pred HHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 290 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
+ . ... .+ ..+...+..+.+|+.+||+.||.+|||+.||++.|+.+.+
T Consensus 250 i---~----~~~------~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 250 L---K----EGH------RM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H---H----TTC------CC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---H----cCC------CC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1 1 110 11 1122233478999999999999999999999999998865
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=396.11 Aligned_cols=267 Identities=21% Similarity=0.298 Sum_probs=203.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+...+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 579999999999999999999999999999999965432 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+.+ ++.+++.... ...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9975 5555554322 467999999999999999999999999 999999999999999999999999999763322
Q ss_pred CCcceeeeeccCccccCccccccCC-CCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccC
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 308 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
........||+.|+|||++.... ++.++|||||||++|+|++|+.||..............................
T Consensus 156 --~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp --SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 22233457999999999876655 578999999999999999999999876544322221111100000000000000
Q ss_pred ccccCCC-----------ChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 309 PELQGQY-----------PPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 309 ~~~~~~~-----------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
+...... .+.....+.+|+.+||..||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000000 1122357889999999999999999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=399.57 Aligned_cols=263 Identities=27% Similarity=0.381 Sum_probs=199.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECC-----CCeEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCccceEEEEecC-Ce
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG-DQ 143 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~ 143 (399)
++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+..|..++.++ +|+||+.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 579999999999999999999754 4578999998754332 345678888888776 689999999998764 46
Q ss_pred eEEEEEecCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 211 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~ 211 (399)
+++|||||++|+|.+++..... ....+++.+++.++.||+.||.|||+++ |+||||||+||||+.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence 8999999999999999975321 1345899999999999999999999999 999999999999999
Q ss_pred CCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhC-CCCcccchHHHHHHHH
Q 015816 212 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSLV 290 (399)
Q Consensus 212 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~~ 290 (399)
++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++| .+||........ ..
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--~~ 247 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC 247 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--HH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--HH
Confidence 999999999999864443333334456799999999999999999999999999999999986 567765432211 11
Q ss_pred HhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 291 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
.... ... .+ ..+...+..+.+|+.+||+.||++|||+.++++.|+.+.+
T Consensus 248 ~~~~----~~~------~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 248 RRLK----EGT------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHH----HTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHh----cCC------CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111 000 01 1122233478999999999999999999999999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-54 Score=392.99 Aligned_cols=257 Identities=28% Similarity=0.402 Sum_probs=198.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCC---CeEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 145 (399)
++|++.+.||+|+||.||+|++..+ ...||||++..... ...+.|.+|+.+|++++|||||++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5799999999999999999987532 34799999875432 233578999999999999999999999976 4678
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999988752 456999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcc-eeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHHHHHHHhhhhhhcccccc
Q 015816 226 GPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 303 (399)
Q Consensus 226 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (399)
........ ......|+..|+|||++.+..++.++|||||||++|||+| |..||............ .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i------~~~~~-- 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------DKEGE-- 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTSCC--
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH------HhCCC--
Confidence 54333222 2234568889999999999999999999999999999998 89999866554332211 11100
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015816 304 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 351 (399)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 351 (399)
.+ ..++..+..+.+|+.+||+.||++|||+.+|++.|...
T Consensus 233 ----~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 ----RL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01 11222334889999999999999999999999988754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=391.09 Aligned_cols=241 Identities=23% Similarity=0.377 Sum_probs=200.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc------chHHHHHHHHHHhhcC--CCCccceEEEEecCC
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLH--HPNLVNLIGYCADGD 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~ 142 (399)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ....+.+|+.+|++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999999999999999998754222 1234668999999987 899999999999999
Q ss_pred eeEEEEEecCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-CCceEEecc
Q 015816 143 QRLLVYEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDF 220 (399)
Q Consensus 143 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Df 220 (399)
..++||||+.+ +++.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999976 678888876 567999999999999999999999999 999999999999985 479999999
Q ss_pred cCCccCCCCCCcceeeeeccCccccCccccccCCC-CcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
|+|...... ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... . ..
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i-----~-------~~ 219 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----I-------RG 219 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----H-------HC
T ss_pred ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH-----h-------hc
Confidence 999753222 2344679999999999987765 57799999999999999999999764211 0 00
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 300 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...+...+ +.++.+||.+||+.||++|||++|+++
T Consensus 220 --------~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 --------QVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------CCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------ccCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00111222 348899999999999999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=395.12 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=213.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-----CCCeEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCccceEEEEecCCee
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 144 (399)
++|++.+.||+|+||.||+|++. .+++.||||++...... ....+.+|+.+++.+ +|||||++++++.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57889999999999999999863 46778999999765433 345688999999999 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeec
Q 015816 145 LLVYEYMPLGSVEDHLHDLSP--------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~ 210 (399)
++|||||++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 999999999999999975321 2346899999999999999999999999 99999999999999
Q ss_pred CCCceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHh-CCCCcccchHHHH-HH
Q 015816 211 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE-QS 288 (399)
Q Consensus 211 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~-~~ 288 (399)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||........ ..
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999987555444444555789999999999999999999999999999999999 5666655433221 11
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 289 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
..... . ....+...+..+.+||.+||+.||++||||.+|++.|+...+
T Consensus 260 ~i~~~---~--------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 260 MIKEG---F--------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHT---C--------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcC---C--------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 11110 0 011122233488999999999999999999999999986543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=389.37 Aligned_cols=267 Identities=22% Similarity=0.259 Sum_probs=202.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCC-CeEEEEEEeccCCC--cchHHHHHHHHHHhhc---CCCCccceEEEEec----
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESI-NQDVAIKQLDRNGV--QGNREFLVEVLMLSLL---HHPNLVNLIGYCAD---- 140 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~---- 140 (399)
.++|++.+.||+|+||+||+|++..+ ++.||||++..... .....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999654 67899999864322 2234566788877766 79999999999853
Q ss_pred -CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEec
Q 015816 141 -GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219 (399)
Q Consensus 141 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 219 (399)
...++++|||+.++.+...... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 3468999999997766544433 2567999999999999999999999999 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcc
Q 015816 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 299 (399)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 299 (399)
||++.... .........||+.|+|||++.+..|+.++|||||||++|||++|++||.....................
T Consensus 160 fg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99987432 223344567999999999999999999999999999999999999999876554433222111110000
Q ss_pred ccc--cccc-------cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 300 RTR--HSLI-------ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 300 ~~~--~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
... .... ..........+.....+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000 0000001122233457889999999999999999999885
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.9e-52 Score=384.45 Aligned_cols=265 Identities=20% Similarity=0.246 Sum_probs=202.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||+||+|+++ +|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+.+..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57999999999999999999997 5899999999754332 24678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
|+.++.+..+... ...+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9987766666654 678999999999999999999999999 999999999999999999999999999763322
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc--c---
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR--H--- 303 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~--- 303 (399)
........|++.|+|||.+.+ ..++.++|||||||++|||++|+.||........................ .
T Consensus 154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 222334468999999999865 45799999999999999999999999876544332221111100000000 0
Q ss_pred ------ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 304 ------SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 304 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
.....+.......+.....+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000001112223457889999999999999999999984
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-52 Score=384.94 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=203.2
Q ss_pred CCeeeecCceEEEEEEECCCC---eEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCccceEEEEec-CCeeEEEEEec
Q 015816 77 ESLLGEGGFGRVYKGYLESIN---QDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEYM 151 (399)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~ 151 (399)
.++||+|+||+||+|++..++ ..||||+++... ....+.|.+|+.+|++++|||||++++++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 468999999999999986543 369999997533 3344679999999999999999999999875 46889999999
Q ss_pred CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCCCC
Q 015816 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (399)
Q Consensus 152 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 231 (399)
++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999998752 456889999999999999999999999 99999999999999999999999999986433221
Q ss_pred c--ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccccccccCc
Q 015816 232 T--HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 309 (399)
Q Consensus 232 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
. .......||+.|+|||.+.+..++.++||||||+++|||++|..||....... +...... ... .+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~----~g~------~~ 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL----QGR------RL 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTC------CC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHH----cCC------CC
Confidence 1 22233568999999999999999999999999999999999888876533221 1111111 000 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 310 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 310 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
..++..+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 254 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11222334789999999999999999999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=389.91 Aligned_cols=262 Identities=25% Similarity=0.395 Sum_probs=212.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC-----CCeEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCccceEEEEecCCee
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 144 (399)
.++|++.+.||+|+||.||+|.++. ++..||||++...... ....|.+|+.++++++|||||++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 3678899999999999999998853 3578999999754332 234688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEe
Q 015816 145 LLVYEYMPLGSVEDHLHDLS------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 218 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 218 (399)
++||||+++|+|.+++.... .....+++..+..++.||+.||.|||+++ |+||||||+||||+.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999986421 12345799999999999999999999999 9999999999999999999999
Q ss_pred cccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCC-CCcccchHHHHHHHHHhhhhhh
Q 015816 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQSLVAWARPLF 297 (399)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~ 297 (399)
|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. +||...........+.
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~------ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------ 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH------
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------
Confidence 999998644333333334457899999999999999999999999999999999984 7776654433322211
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015816 298 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 352 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 352 (399)
+.. .+ ..++..+..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 250 -~~~------~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 250 -EGG------LL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp -TTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -hCC------CC----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 100 01 112223348999999999999999999999999987553
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=387.69 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=198.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHH--HHHHHhhcCCCCccceEEEEecCC----eeE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGD----QRL 145 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~hpniv~~~~~~~~~~----~~~ 145 (399)
++|.+.+.||+|+||.||+|++. |+.||||++... ....+.. |+..+..++|||||++++++.+.+ .+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 45778899999999999999874 899999998643 2334444 455556789999999999997654 579
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCceeecCCCceEEecc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-----KPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
+|||||++|+|.++++. .++++..++.++.|++.||+|||+.. .++|+||||||+||||+.++.+||+||
T Consensus 78 lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 99999999999999985 46999999999999999999999741 112999999999999999999999999
Q ss_pred cCCccCCCCCCcc--eeeeeccCccccCccccccCC------CCcccceeehhHHHHHHHhCCCCcccchHHHHH--H--
Q 015816 221 GLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTGQ------LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--S-- 288 (399)
Q Consensus 221 g~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~-- 288 (399)
|+++......... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||......... .
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 9998643332221 223467999999999987542 678899999999999999999887432211000 0
Q ss_pred ----HHHhhhhhhccccccccccCccccCCC-ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015816 289 ----LVAWARPLFQDRTRHSLIADPELQGQY-PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 354 (399)
Q Consensus 289 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 354 (399)
............ ...|.+.... .......+.+|+.+||+.||++|||+.||++.|+.+..+
T Consensus 233 ~~~~~~~~~~~~~~~~-----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTS-----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhcc-----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 000000000000 0011111111 123456789999999999999999999999999988764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=378.72 Aligned_cols=269 Identities=22% Similarity=0.263 Sum_probs=201.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEec--------
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 140 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------- 140 (399)
.++|++.+.||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3689999999999999999999999999999999864422 334678899999999999999999998855
Q ss_pred CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecc
Q 015816 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (399)
Q Consensus 141 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 220 (399)
....|+||||+.++.+..+... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 3468999999987766655543 567999999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCc--ceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhh
Q 015816 221 GLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 297 (399)
Q Consensus 221 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 297 (399)
|++......... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||..................+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999754332211 122335799999999998754 68999999999999999999999998765544433332221111
Q ss_pred ccccccccccC---c--ccc--CCCCh-------HhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 298 QDRTRHSLIAD---P--ELQ--GQYPP-------RGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 298 ~~~~~~~~~~~---~--~~~--~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
........... . ... ..... .....+.+||.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11100000000 0 000 00000 01235678999999999999999999994
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=384.93 Aligned_cols=263 Identities=25% Similarity=0.284 Sum_probs=197.2
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCccceEEEEec------CCeeEE
Q 015816 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQRLL 146 (399)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~~l 146 (399)
+|+..++||+|+||+||+|+++.+|+.||||++...... +.+|+.+|++++||||++++++|.. ..++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588889999999999999999999999999999754322 2369999999999999999999854 335789
Q ss_pred EEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-ceEEecccCCcc
Q 015816 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKL 225 (399)
Q Consensus 147 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~ 225 (399)
|||||+++ +...+.........+++.+++.|+.||+.||+|||++| |+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999855 44444332223668999999999999999999999999 99999999999999775 899999999976
Q ss_pred CCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh---------hh
Q 015816 226 GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA---------RP 295 (399)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---------~~ 295 (399)
..... ......||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||............... ..
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 43322 2334579999999998764 57899999999999999999999999876544332221110 00
Q ss_pred hhcccc--ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 296 LFQDRT--RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 296 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...... ...............+.....+.+|+.+||..||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000000000111112233457899999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=382.77 Aligned_cols=261 Identities=20% Similarity=0.257 Sum_probs=198.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecCC------
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 142 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 142 (399)
.++|++.+.||+|+||+||+|.++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999999999999999999754332 2356889999999999999999999997654
Q ss_pred eeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccC
Q 015816 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (399)
Q Consensus 143 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 222 (399)
.+|+||||+ +.+|..++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 579999999 5778877764 57999999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeeccCccccCcccccc-CCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc-
Q 015816 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR- 300 (399)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 300 (399)
|..... ..+...||+.|+|||++.+ ..++.++|||||||++|+|++|++||......................
T Consensus 168 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 986322 1244679999999999876 467899999999999999999999998765543322221111000000
Q ss_pred -------------cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 301 -------------TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 301 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
..........+ ....+.....+.+||.+||..||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000000 0111223347889999999999999999999996
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=380.51 Aligned_cols=268 Identities=23% Similarity=0.280 Sum_probs=199.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCccceEEEEecCC----eeE
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRL 145 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~ 145 (399)
..+|++.+.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 3579999999999999999999999999999999975433 23457889999999999999999999997643 234
Q ss_pred EEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCcc
Q 015816 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (399)
Q Consensus 146 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 225 (399)
++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55566778999999975 46999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCC-cceeeeeccCccccCccccc-cCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc-
Q 015816 226 GPVGDN-THVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR- 302 (399)
Q Consensus 226 ~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 302 (399)
...... .......+||+.|+|||++. +..++.++||||+||++|+|++|+.||........................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 322211 11223467999999999984 456789999999999999999999999876544332222111100000000
Q ss_pred --------cccccCcccc----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 303 --------HSLIADPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 303 --------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
......+... ....+.....+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 0001112247889999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=370.11 Aligned_cols=266 Identities=18% Similarity=0.215 Sum_probs=207.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCccceEEEEecCCeeEEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 149 (399)
++|++.+.||+|+||+||+|++..+++.||||++..... .....+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 579999999999999999999999999999999965433 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCCccCCCC
Q 015816 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (399)
Q Consensus 150 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 229 (399)
++.+++|..++.. .+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999998888876 678999999999999999999999999 999999999999999999999999999864332
Q ss_pred CCcceeeeeccCccccCccccccCC-CCcccceeehhHHHHHHHhCCCCcccchHHH-HHHHHHhhhhhhcccc------
Q 015816 230 DNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAA-EQSLVAWARPLFQDRT------ 301 (399)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~------ 301 (399)
. .......+++.|+|||++.+.. ++.++|||||||++|||++|+.||....... ................
T Consensus 155 ~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred C--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 2 2233346788999999887654 6899999999999999999999874433222 1111111110000000
Q ss_pred -----ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 302 -----RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 302 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
...............+.....+.+|+.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000001111222334457889999999999999999999884
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-49 Score=369.56 Aligned_cols=262 Identities=22% Similarity=0.260 Sum_probs=202.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCc-cceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||+|+||.||+|++..+|+.||||++..... ...+..|+.+++.++|+|+ +.+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 469999999999999999999999999999999875432 3457889999999987765 5555666788889999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC---CCceEEecccCCccCC
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGP 227 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~~ 227 (399)
+. ++|.+.+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++. +..++|+|||+|+...
T Consensus 85 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 LG-PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred cC-Cchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 95 6676666542 567999999999999999999999999 999999999999763 5579999999998654
Q ss_pred CCCCc-----ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhh-hhhhcccc
Q 015816 228 VGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLFQDRT 301 (399)
Q Consensus 228 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~ 301 (399)
..... .......||+.|||||++.+..++.++|||||||++|||++|+.||............... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 235 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-- 235 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--
Confidence 33221 1234467999999999999999999999999999999999999999765543332221111 110000
Q ss_pred ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 302 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
..+.+...+++ ++.+++..||+.||++||++.++.+.|+.+..
T Consensus 236 -----~~~~~~~~~p~----~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 236 -----PIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -----CHHHHTTTSCH----HHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----ChhHhccCCCH----HHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 01112223333 78899999999999999999999988887643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-49 Score=373.07 Aligned_cols=259 Identities=17% Similarity=0.222 Sum_probs=198.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEec--CCeeEEEE
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLVY 148 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~ 148 (399)
++|++.+.||+|+||+||+|+++.+|+.||||++... ..+.+.+|+.+|+.++ ||||+++++++.. ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999999999999999999643 3567889999999995 9999999999974 45689999
Q ss_pred EecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCC-ceEEecccCCccCC
Q 015816 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGP 227 (399)
Q Consensus 149 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 227 (399)
|||.+++|..+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+|....
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987654 35999999999999999999999999 99999999999998654 69999999997543
Q ss_pred CCCCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHH--HHHhh---------hh
Q 015816 228 VGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS--LVAWA---------RP 295 (399)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~---------~~ 295 (399)
... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.......... +.... ..
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 222 23445799999999998664 57999999999999999999999997544322111 10000 00
Q ss_pred -hhcccccccccc--------CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 296 -LFQDRTRHSLIA--------DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 296 -~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
............ ..............++.+||.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 000001111223457899999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-49 Score=365.41 Aligned_cols=263 Identities=21% Similarity=0.244 Sum_probs=209.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC-CCccceEEEEecCCeeEEEEEe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEY 150 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~ 150 (399)
++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+|+.+++.+.| +||+.+++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57999999999999999999999999999999986542 23456778999999875 8999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecC-----CCceEEecccCCcc
Q 015816 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHPKLSDFGLAKL 225 (399)
Q Consensus 151 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfg~~~~ 225 (399)
+ +++|.+++... ...+++..+..++.|++.||+|||++| |+||||||+|||++. ++.+||+|||+|+.
T Consensus 83 ~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9 68999988762 457999999999999999999999999 999999999999974 57899999999986
Q ss_pred CCCCCCc-----ceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccc
Q 015816 226 GPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 300 (399)
Q Consensus 226 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 300 (399)
....... ......+||+.|||||++.+..++.++|||||||++|||++|..||.....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~- 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS- 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC-
Confidence 4332211 1233467999999999999999999999999999999999999999754332211111111000000
Q ss_pred cccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015816 301 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 353 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 353 (399)
...+.+...+|+ ++.+++..|+..+|++||+++.+.+.|+.+..
T Consensus 235 -----~~~~~l~~~~p~----~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 235 -----TPLRELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp -----SCHHHHTTTSCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred -----CChHHhcCCCCH----HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 001112223343 78899999999999999999999988887654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=374.79 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=202.5
Q ss_pred cCCCCCCeeeecCceEEEEEEE---CCCCeEEEEEEeccCCC----cchHHHHHHHHHHhhcCC-CCccceEEEEecCCe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYL---ESINQDVAIKQLDRNGV----QGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQ 143 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 143 (399)
++|++.+.||+|+||+||+|.+ +.+|+.||||++..... ...+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999987 44789999999865422 234567889999999977 899999999999999
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
+++||||+.+|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999987 567889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccC--CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhcccc
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 301 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (399)
....... ........|++.|+|||.+.+. .++.++|||||||+||+|++|+.||................ ...
T Consensus 177 ~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~~-- 251 (322)
T d1vzoa_ 177 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKS-- 251 (322)
T ss_dssp EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHC--
T ss_pred hhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--ccC--
Confidence 7543222 2223346799999999998654 57889999999999999999999997654322111111000 000
Q ss_pred ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 015816 302 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 346 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 346 (399)
.+ ..+...+..+.+|+.+||+.||++||| ++|+++
T Consensus 252 ------~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ------EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 01 122233448999999999999999994 778774
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=375.58 Aligned_cols=263 Identities=22% Similarity=0.272 Sum_probs=193.6
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEec------CCe
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQ 143 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~ 143 (399)
++|++.+.||+|+||+||+|.++.+|+.||||++...... ....+.+|+.+++.++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999999999999999999755332 23568899999999999999999999964 468
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
+|+|||||.++ +...+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 89999999755 444443 35899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHH-hhh--------
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA-WAR-------- 294 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~~-------- 294 (399)
+.... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||............. ...
T Consensus 167 ~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 75322 223345679999999999999999999999999999999999999997654433221110 000
Q ss_pred -------hhhcccccccccc------CccccC--CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015816 295 -------PLFQDRTRHSLIA------DPELQG--QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 347 (399)
Q Consensus 295 -------~~~~~~~~~~~~~------~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 347 (399)
............. +..... .........+.+|+.+||..||++||||+|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000000 000000 0112345678999999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=372.32 Aligned_cols=262 Identities=20% Similarity=0.255 Sum_probs=198.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCccceEEEEecC-----Ce
Q 015816 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 143 (399)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 143 (399)
.++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999999999999999999755332 335688999999999999999999998643 34
Q ss_pred eEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceEEecccCC
Q 015816 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (399)
Q Consensus 144 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 223 (399)
.+++|+|+.+|+|.+++.. ..+++.+++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4667788889999999963 56999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccC-CCCcccceeehhHHHHHHHhCCCCcccchHHHHHHHHHhhhhhhccccc
Q 015816 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 302 (399)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (399)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........................
T Consensus 169 ~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 7421 223345699999999987654 5689999999999999999999999876554333222111110000000
Q ss_pred c--------------ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015816 303 H--------------SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 346 (399)
Q Consensus 303 ~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 346 (399)
. .......+. .........+.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 000000000 000112347889999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-43 Score=337.07 Aligned_cols=265 Identities=17% Similarity=0.178 Sum_probs=191.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-----------CCCccceEEEEec
Q 015816 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----------HPNLVNLIGYCAD 140 (399)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~~~~ 140 (399)
.+|++.+.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999999999999999997542 23456778998888775 5789999988754
Q ss_pred --CCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeecCCC----
Q 015816 141 --GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGY---- 213 (399)
Q Consensus 141 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dlkp~Nill~~~~---- 213 (399)
....+++|+++..+.......... ....+++..+..++.||+.||+|||+ .| |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 456677777765554333332221 25678999999999999999999998 88 99999999999998654
Q ss_pred --ceEEecccCCccCCCCCCcceeeeeccCccccCccccccCCCCcccceeehhHHHHHHHhCCCCcccchHHHHH----
Q 015816 214 --HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ---- 287 (399)
Q Consensus 214 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---- 287 (399)
.++++|||.+..... .....+||+.|+|||++.+..++.++||||+||++++|++|+.||.........
T Consensus 168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 499999999875321 223457999999999999999999999999999999999999999754322111
Q ss_pred HHHHhhh--h---------------hhccccccccccC---------ccccCCCChHhHHHHHHHHHHccccCCCCCCCH
Q 015816 288 SLVAWAR--P---------------LFQDRTRHSLIAD---------PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 341 (399)
Q Consensus 288 ~~~~~~~--~---------------~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 341 (399)
.+..... . .+........+.. ..............+.+|+.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 0000000 0 0000000000000 001123345567789999999999999999999
Q ss_pred HHHHH
Q 015816 342 ADVVT 346 (399)
Q Consensus 342 ~eil~ 346 (399)
.|+|+
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99974
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.1e-26 Score=199.59 Aligned_cols=163 Identities=13% Similarity=0.079 Sum_probs=118.8
Q ss_pred CCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCc-----c-------------hHHHHHHHHHHhhcCCCCccceEE
Q 015816 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----G-------------NREFLVEVLMLSLLHHPNLVNLIG 136 (399)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~-------------~~~~~~E~~~l~~l~hpniv~~~~ 136 (399)
.+.+.||+|+||.||+|.+. +|+.||||++...... . ......|...+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46789999999999999986 4899999987532110 0 122456888999999999999887
Q ss_pred EEecCCeeEEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeecCCCceE
Q 015816 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (399)
Q Consensus 137 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 216 (399)
+. ..+++|||+++..+.+ ++...+..++.||+.||.|||++| |+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred ec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence 64 2379999998755432 333446789999999999999999 9999999999999965 589
Q ss_pred EecccCCccCCCCCCcceeeeeccCccccC------ccccccCCCCcccceeehhHHH
Q 015816 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCA------PEYAKTGQLTLKSDVYSFGVVL 268 (399)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DvwslG~il 268 (399)
|+|||+|......... .|.. .+.+ ...|+.++|+||+.--+
T Consensus 143 liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999998753211110 1111 1111 35788999999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.91 E-value=3.9e-09 Score=93.07 Aligned_cols=148 Identities=18% Similarity=0.114 Sum_probs=105.1
Q ss_pred HHHHHhcCCCCCCeeeecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCccceEEEEecCCee
Q 015816 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQR 144 (399)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 144 (399)
++......|++.+..+.++.+.||+... .++.++||+...........+.+|...+..+. +--+.+++.+..+++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 4555667777776655566679998753 36678899886554434445677888887774 33356788888888899
Q ss_pred EEEEEecCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 015816 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------------------------------- 193 (399)
Q Consensus 145 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------- 193 (399)
++||++++|.++.+.... . .....++.+++..+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~----~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED----E-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTT----C-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEecccccccccccc----c-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999999888665432 1 112345666777777777531
Q ss_pred -------------------------CCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 194 -------------------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 194 -------------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1127999999999999987667799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.37 E-value=1.1e-06 Score=76.50 Aligned_cols=129 Identities=16% Similarity=0.098 Sum_probs=85.3
Q ss_pred eeecC-ceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC--CCccceEEEEecCCeeEEEEEecCCCCH
Q 015816 80 LGEGG-FGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (399)
Q Consensus 80 lg~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g~L 156 (399)
+..|. -+.||+..... +..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTT-SCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCC-CCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 44444 46899987654 6678889765432 2345668887776643 2356778888888889999999997654
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 015816 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------------------------------------------- 193 (399)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------------- 193 (399)
.+.. ... ..++.++...|.-||+..
T Consensus 94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 3211 111 122334444555555321
Q ss_pred ------------CCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 194 ------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 194 ------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
.+.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1237999999999999987667899998775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.32 E-value=1.5e-06 Score=80.93 Aligned_cols=76 Identities=18% Similarity=0.139 Sum_probs=48.9
Q ss_pred CeeeecCceEEEEEEECCCCeEEEEEEeccC-------CCcchHHHHHHHHHHhhcC-C-C-CccceEEEEecCCeeEEE
Q 015816 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRN-------GVQGNREFLVEVLMLSLLH-H-P-NLVNLIGYCADGDQRLLV 147 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-p-niv~~~~~~~~~~~~~lv 147 (399)
+.||.|....||++....+++.|+||.-... .....+....|...|+.+. + | .+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 4689999999999998877888999975421 1122344566888887663 2 3 35555544 44567899
Q ss_pred EEecCCCC
Q 015816 148 YEYMPLGS 155 (399)
Q Consensus 148 ~e~~~~g~ 155 (399)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.35 E-value=0.0003 Score=62.97 Aligned_cols=67 Identities=13% Similarity=0.061 Sum_probs=43.7
Q ss_pred eEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCc--cceE-----EEEecCCeeEEEEEecCCC
Q 015816 86 GRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL--VNLI-----GYCADGDQRLLVYEYMPLG 154 (399)
Q Consensus 86 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~~~-----~~~~~~~~~~lv~e~~~~g 154 (399)
-.||++...+ |..|++|+...... ..+++..|...+..|....| +..+ ..+......+.++++++|.
T Consensus 36 N~vy~v~~~d-g~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDED-RRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTT-CCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCC-CCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 4899998754 88899999865432 35667778888877642211 1111 1234456778899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.29 E-value=0.00049 Score=63.30 Aligned_cols=73 Identities=18% Similarity=0.249 Sum_probs=49.3
Q ss_pred CeeeecCceEEEEEEECC-------CCeEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCc-cceEEEEecCCeeEEEEE
Q 015816 78 SLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYE 149 (399)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e 149 (399)
+.|+.|-.=.+|++.... ....|.+++.... ...-...+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 468888888999998753 2456778876532 223345578888888753344 477777653 58999
Q ss_pred ecCCCCH
Q 015816 150 YMPLGSV 156 (399)
Q Consensus 150 ~~~~g~L 156 (399)
|++|.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.04 E-value=0.0079 Score=52.87 Aligned_cols=159 Identities=15% Similarity=0.038 Sum_probs=82.9
Q ss_pred cCHHHHHHHhcCCCCCCeee-----ecCceEEEEEEECCCCeEEEEEEeccCCCcchHHHHHHHHHHhhcCC-----CCc
Q 015816 62 LTFRELAAATKNFRSESLLG-----EGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-----PNL 131 (399)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----pni 131 (399)
++.+++.....+|.+++... .|---+.|++.... ..+++|+..... ..+.+..|+.++..|.. |..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS--CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC--CcEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 56678888888898865543 45456789987654 458999986432 23445556666666642 222
Q ss_pred cceE---EEEecCCeeEEEEEecCCCCHHH--------------HhhccCC---CC--CCCCHH----------------
Q 015816 132 VNLI---GYCADGDQRLLVYEYMPLGSVED--------------HLHDLSP---GK--KPLDWN---------------- 173 (399)
Q Consensus 132 v~~~---~~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~---~~--~~l~~~---------------- 173 (399)
+... .+.........++.++.+..... .++.... .. ......
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2211 01222345566777766533210 0110000 00 000000
Q ss_pred --HHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCceeecCCCceEEecccCCc
Q 015816 174 --TRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (399)
Q Consensus 174 --~~~~i~~qi~~al~~LH~~-~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 224 (399)
.....+..+...+.-.+.. -..++||+|+.++||+++.+...-|+||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1112222222222222221 12239999999999999988777899999875
|